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Preface 
Res ipsa loquitur 
(The thing speaks for itself)
(Cicero, Pro Milone, 53)
It has indeed been a great privilege to be the Editor of the new book Front Lines of
Thoracic Surgery, with the efficient assistance of the InTech technical team. 
In this original and promising editorial format, the book collects the up-to-date
contributions on some of the most debated topics in today’s clinical practice of cardiac,
aortic and general thoracic surgery and anesthesia, as viewed by authors personally 
involved in their evolution.
The strong and genuine enthusiasm of the authors was clearly perceptible in all their
contributions, and I’m sure that will further stimulate the reader to understand their 
messages. Moreover, the strict adhesion of the authors’ original observations and 
findings to the evidence base proved that facts are the best guarantee of their scientific 
value. 
Unfortunately however, no matter how strong their rational theoretical basis and 
evidence may be, new ideas and hypothesis are not usually accepted as easily and as 
quickly as any author would expect.  That is the case in science in general and in 
surgery in particular. 
This is probably most related to “tradition”, which is obviously widely recognized as
the most important founding value of any culture. However, tradition is apparently 
resistant to innovations in different science fields in inverse proportion to the
complexity of their own theoretical content.
This places surgery in an unfavorable position since, even though extensive theoretical
and technological research precedes and justifies any surgical treatment, performance 
of any surgical act relies on very few, elementary, “mechanical” principles. 
In considering the evolution of the vascular anastomosis technique, it is interesting to
note that the famous Carrel “triangulation” original sketch still reported straight, not
an atraumatic needle, similar to that in use then for gastrointestinal suture. That was in
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fact the necessary scenario for “triangulation” to stand for a very significant technical 
advancement at that point in time. Nonetheless, in spite of its persisting fame, 
“triangulation” was made obsolete by the advent of curved and proportionally 
dimensioned needles as well as of many other technical refinements.  
After a century-long path, apparently pulverizing the retaining force of “tradition”, 
the extreme evolution of surgical technique has today reached man-driven robotic 
surgery, suggesting that the theoretically insurmountable limits other science fields 
have (like absolute zero for lowest temperature, or light speed for highest velocity) do 
not seem to have been yet identified in surgery!  
However the new “thing” brought to the final surgical act by the complex, highly 
technologic and expensive robot apparatus is, essentially, at this point in time, the 
significantly increased precision of the surgical act resulting from the amplification of 
the surgeon's hand movement in relation to that transferred to the activated 
instrument in the operative field. Mini-access and magnified operative field view in 
fact were options already brought to clinical practice by video assisted, mini-invasive 
surgery.  
All together these new technical modifications of the final surgical act are 
advantageous enough to justify the sacrifice, at least for selected surgical conditions, of 
the still unparalleled versatility of the direct hand movements in the operative field.  
Sometimes in my work on vascular anastomosis devices, I thought that proposing 
innovations in this basic surgical ambit could be quite similar to trying to popularize 
the use of the fork and knife in China. The thorough analysis and explanation of the 
many details that provide that a fork and knife are a better and easier method of 
controlling food than chopsticks for anyone, independently from his own local 
tradition, is as ingenuous and almost stupid as it is ineffective.  
In surgery however, it is just the full and clear understanding of the little technical 
“things”, that can reveal the expected and very relevant final effects to the patient and 
thus can eventually urge someone to accept the difficult, monopolizing and often 
bitter, but always exciting, challenge of bringing it into clinical practice.  
I'm grateful to Dr Giuseppe Rescigno, Division of Cardiac Surgery, Lancisi Hospital, 
Ancona for the review of Dr H. Hiroshi's Chapter on Off Pump CABG. 
 
Dr. Stefano Nazari 
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Mitral Valve Subvalvular Apparatus Repair with 
Artificial Neochords Application  
Sergey Y. Boldyrev, Kirill O. Barbukhatty, 
 Olga A. Rossokha and Vladimir A. Porhanov 
Department of Adult Cardiac Surgery, Regional Clinic Hospital #1, Krasnodar,  
Kuban State Medical University, Krasnodar, 
 Russian Federation 
1. Introduction  
Degenerative mitral valve (МV) disease is a common disorder affecting around 2% of the 
population (Enriquez-Sarano M et al., 2009). The most common ending in patients with 
degenerative valve disease is leaflet rolapsed due to elongation or rupture of the chordal 
apparatus, resulting in varying degrees of МV regurgitation due to leaflet malcoaptation 
during ventricular contraction.  The emphasis of clinical decision-making in patients with 
degenerative disease centres around the severity of regurgitation and its impact on symptom 
status, ventricular function and dimension, the sequelae of systolic flow reversal such as atrial 
dilatation/fibrillation and secondary pulmonary hypertension (PH), and the risk of sudden 
death (1-4). Current standard of care for MV rolapsed with severe mitral regurgitation (MR) is 
surgical MV repair (Adams et al., 2010). Implantation of neo-chordae with the use of expanded 
polytetrafluoroethylene (ePTFE) sutures (Gore Associates, Flagstaff, AZ, USA) has since its 
introduction into clinical practice by Frater et al. proven to be a valuable technique for 
contemporary MV repair. Chordal replacement enables preservation of native valve anatomy, 
physiological leaflet motion and creation of large mitral orifice area. Furthermore, it has 
contributed to the reparability independent of valve complexity (Seeburger et al., 2007). 
2. Functional anatomy of the mitral valve 
Historically, the mitral valve is described as composed of the leaflets, chordae, and papillary 
muscles. However, the mitral valve structurally and functionally is part of the left ventricle 
and intimately associated with the atrium and fibrous skeleton of the heart. Thus, alterations 
to the fibrous skeleton and ventricular and atrial muscle contribute to and affect valvular 
function.  
2.1 Leaflets 
The leaflets are the valve component that creates the division between the atrium and 
ventricle. There are two distinct leaflets: the anterior or aortic and posterior or mural. The 
anterior leaflet is usually comprised of a single trapezoidal-shaped unit. The posterior leaflet 
is punctuated with multiple slits and clefts that define usually three, but up to six, distinct 
scallops (Fig. 1). The anterior and posterior leaflets are separated at the commissures but 
there is usually some continuity of the valve tissue close to the annulus. Further, if one looks 
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at the chordal distribution, at the commissures, chordae are distributed to both leaflets from 
a common structural source—so the leaflets form a single functional unit. Nevertheless, it is 
useful for the purposes of valve repair to differentiate anterior from posterior. However, one 
must remember that multiple separately suspended distinct units come together to make the 
valve competent. To describe components of mitral valve repair it is useful to label the 
scallops by position (Fig. 1); posteriorly from left to right P1, P2, P3, with corresponding 
regions of the anterior leaflet A1, A2, and A3. 
 
 
Fig. 1. Photograph of the mitral valve. Note multiple clefts in the posterior leaflet (arrows). 
The posterior leaflet is divided into 3 scallops or segments (lateral, middle, and medial 
scallops) identified as P1, P2, and P3. The corresponding segments of the anterior leaflet are 
labeled A1, A2, and A3. 
When in the closed position, the orifice is obscured by the anterior and posterior leaflets. 
The anterior comprises about one half to two thirds of this area, the posterior comprises 
about one third to one half of this area. The point of attachment of the anterior leaflet 
comprises one third of the circumference of the annulus (the fibrous area) and the posterior 
leaflets comprises two thirds of the circumference of the annulus (the muscular area). The 
fibrous support of the anterior leaflet is fixed, the muscular support of the posterior leaflet 
can enlarge and does so when annular dilatation is associated with mitral regurgitation. The 
leaflets themselves are comprised of clear and rough zones. The clear zone is between the 
line of closure and the annulus and can be quite thin, almost transparent. The rough zone 
extends from the line of closure to the free edge, characterized by thicker, nodular ridges 
which promote sealing of the orifice on valve closure.  
2.2 Annulus 
Of the four heart valves, the mitral valve is the only valve that has a distinguishable 
annulus. However, the presence of a fibrous annular structure is variable and 
discontinuous. The firmest site of support for the mitral valve is the region of fibrous 
continuity between the aortic and mitral valves, the extent of which is delineated by the 
right and left fibrous trigones (Fig. 2). Nevertheless, for surgical purposes, the annulus is 
considered the area of attachment of the valve leaflets to the atrial muscle. The annulus is a 
functional component of the mitral valve. The annulus is quite flexible and changes shape 
throughout the cardiac cycle. With normal systolic function, the annulus will reduce in size 
by 20% to 40%. Functionally the mitral annulus is not two-dimensional but in fact three-
dimensional assuming a saddle shape. The curvature imposed by the saddle shape reduces 
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mechanical stress on the leaflets. The curvature of the saddle shape or height of the “saddle 
horn” is reduced in a model of ischemic mitral regurgitation. This may have implications in 
choosing techniques for annular reduction and stabilization. 
 
 
Fig. 2. Relational anatomy of the mitral valve: left and right fibrous trigones (LFT and RFT); 
anterior and posterior mitral leaflets (AL and PL); pulmonic, aortic, and tricuspid valves 
(PV, AV, and TV). 
2.3 Tendinous chords 
The tendinous chords, as functional extensions of the papillary muscles, perform the dual 
function of maintaining valvular competence by preventing leaflet prolapse and 
maintaining ventricular geometry by providing cross-ventricular support. The chords 
originate from the apical portions of the papillary muscles or directly from the posterior 
ventricular wall. They insert either into the free edge of the leaflets or on their ventricular 
surface. Chords have been characterized a number of ways. The most useful for repair 
purposes is to describe the first-degree chords as those inserting into the valve edge and the 
second-degree chords as those inserting into the underside of the leaflet. Both first-degree 
and second-degree chords originate from the papillary muscles and third-degree chords 
originate from the ventricular wall and insert into the base of the posterior leaflet.  
2.4 Papillary muscles 
There are two papillary muscles associated with the mitral valve (Fig. 3) When looking from 
the atrial side, the anterolateral is to the left and the posteromedial is to the right. The 
muscles are located under their respective commissures. They originate from the lower third 
of the left ventricular free wall. The papillary muscles are extensions of the ventricular 
muscle from which they originate. The chords originate from the fibrous tips of these 
muscles, extending to insert on the mitral leaflets. The blood supply of the anterolateral 
papillary muscle derives from the left circumflex and/or diagonal systems. The blood 
supply of the posteromedial papillary muscle derives from the posterolateral coronary 
branches whether it originates from the left or right coronary system. The papillary muscles 
adjust tension and stabilize the valve during the cardiac cycle, rather than pulling the chords 
and leaflets into position. The function of the papillary muscles and their position is greatly 
dependent on the status of the ventricular myocardium underlying it. Displacement of the 
papillary muscle by distorted ventricular geometry is one mechanism for the creation of 
mitral regurgitation. 
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Fig. 1. Photograph of the mitral valve. Note multiple clefts in the posterior leaflet (arrows). 
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mechanical stress on the leaflets. The curvature of the saddle shape or height of the “saddle 
horn” is reduced in a model of ischemic mitral regurgitation. This may have implications in 
choosing techniques for annular reduction and stabilization. 
 
 
Fig. 2. Relational anatomy of the mitral valve: left and right fibrous trigones (LFT and RFT); 
anterior and posterior mitral leaflets (AL and PL); pulmonic, aortic, and tricuspid valves 
(PV, AV, and TV). 
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Fig. 3. Mitral apparatus. ALPM,  Anterolateral papillary muscle; PMPM,  posteromedial 
papillary muscle; AoL, aortic leaflet; Ant.Com.L.,  anterior commissural leaflet; Post.Com.L.,  
posterior commissural leaflet; Ant.Scal. , anterior scallop; Mid.Scal ., middle scallop; h,  height 
of a leaflet; l,  length of the attachment of a leaflet; Post.Scal. , posterior scallop; Rt. Trigone,  
right fibrous trigone; Lt. Trigone,  left fibrous trigone; 1,  anterior main chorda; 2,  posterior 
main chorda; 3,  anterior paramedial chorda; 4,  posterior paramedial chorda; 5,  anterior 
paracommissural chorda; 6,  posterior paracommissural chorda; 7,  anterior commissural 
chorda; 8,  posterior commissural chorda; 9,  anterior cleft chorda; 10,  posterior cleft chorda. 
3. Pathophysiology 
Today, multiple terminologies used to describe mitral pathology. Terms such as prolapse, 
flail, partial flail, redundant, overshooting, stretching, elongation, floppy, billowing, 
ballooning, Barlow, dysplasia, myxoid, and myxomatous, for example, have different 
meanings for different specialists. The confusion comes first from the fact that several of 
these terms are synonyms. For example, flail leaflet, overshooting leaflet and leaflet prolapse 
are synonyms. Other synonyms are Barlow, billowing, ballooning, myxomatous valve, and 
mitral valve prolapse. Another source of confusion comes from the fact that for some 
specialists a given term such as « prolapse» means a disfunction (leaflet prolapsed) while for 
others it refers to a disease (mitral valve prolapse). The same chaotic situation applies to the 
term « floppy valve», which is used to define either  a valve morphology, or dysfunction, or 
a disease. Similar confusion exists in tricuspid and aortic valve diseases, in which many of 
previously listed terms are used without clear distinction. Clarification can be obtained by 
using a pathophysiological triad with a sound distinction between the terms describing 
valve etiology (i.e., the cause of the disease), valve lesions resulting from the disease, and 
valve dysfunction resulting from the lesions. 
 
Etiology - The cause of the disease 
↓ 
Lesions - Result from the disease 
↓ 
Dysfunction - Result from the lesions 
 
The pathophysiological triad facilitates communication between cardiologists, 
echocardiographers and surgeons and greatly clarifies clinical investigation.  
 




Cardiac valves can be affected by numerous disease (Tab # 1). Primary valve disease involve 
the valvular tissue. Secondary valve disease affect the supporting of the valves – that is, the 
ventricles for the mitral and tricuspid valves and the aorta  and pulmonary artery for the 
aortic and pulmonary valves, respectively. The determination of the etiology of valvular 
disease is important because it helps to establish the medical treatment, which should 
precede or follow valve reconstruction.  
 
Primary valve Disease
• Congenital malformation 




• Degenerative disease 
Barlow, s disease 
Marfan,s  disease 
Fibroelastic deficiency 
• Infective  endocarditis 
• Valvular or  annular calcification 
• Trauma 
•  Valvular tumors
Secondary to Myocardial Disease 
• Ischemic cardiomyopathy 
• Dilated cardiomyopathy 
• Hypertrophic obstructive 
cardiomyopathy 
• Myocardial sarcoidosis 
• Endomyocardial fibrosis 
• Myocardial tumors 
 
Table 1. Etiology of valvular disease. 
5. Lesions  
Any of the previously listed disease can cause lesions affecting one or several components of 













Chordae fusion   
Papillary muscle rupture 
Papillary muscle elongation 
Ventricular aneurysm 
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6. Valve dysfunction: The «Functional classification» 
The pioneering cardiac surgeon Alain Carpentier, MD, PhD, developed  a functional 
classification to reflect the underlying pathological changes that contributed to MR 
(Carpentier A. 1983) (Figure 4). As described in this classification, type I MR is characterized 
as normal leaflet motion but with annular dilatation or leaflet perforation; type II lesions are 
related to leaflet prolapse and may be caused by myxomatous disease, such as chord 
rupture or elongation, or by papillary muscle rupture or elongation; and type III lesions are 
caused by restricted leaflet motion. Type IIIA is typically caused by rheumatic valve disease 
with normal ventricular motion and subvalvular fibrosis and calcification; type IIIB is 
typically caused by ischemic or idiopathic cardiomyopathy  with impaired ventricular 
function and dilation but a “normal” morphology to the leaflets, chords, and papillary 
muscles, frequently with restriction at the P3 segment. Type I MR may occur with billowing 
myxomatous leaflets but without elongated chordae and prolapse (type II), if extensive 
annular dilatation leads to inadequate leaflet coaptation (Fornes P et al., 1999). 
 
 
Fig. 4. Functional classification. 
7. Degenerative valvular disease 
The tree main types of degenerative valvular disease are Barlow,s disease, fibroelastoc  
deficiency, and Marfan,s disease. 
7.1 Myxomatous mitral valve disease (Barlow’s disease) 
Barlow’s disease is the most frequent degenerative valvular disease with a prevalence of 
4% to 5 % in the general population, generally appears early in life. Patients present with 
a prolonged history of a murmur, thickened leaflets, substantial excess tissue, and a 
dilated annulus, which may be calcified (1). Chordae may be elongated and thinned. 
Often isolated ruptures are present, contributing to the focal prolapse. Classically, the 
most common abnormality is focal enlargement of the posterior central scallop (P2) with 
an associated ruptured chorda. Mills et al. comparing unileaflet versus bileaflet prolapse, 
found that patients with unileaflet prolapse were younger and had a higher incidence of 
flail leaflets (3). Patients with bileaflet prolapse were less likely to be hypertensive and 
had mechanically stronger chordae though leaflet strength was similar to patients with 
unileaflet prolapse.  
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7.2 Marfan’s disease 
Marfan's syndrome of the mitral valve is characterized by excess tissue, thickened leaflets, 
and a dilated annulus. Patients with Marfan syndrome have a shortened life expectancy 
because of cardiovascular complication, 80% of them developing mitral valve regurgitation. 
7.3 Fibroelastic deficiency 
Fibroelastic deficiency occurs mostly in the elderly with a short history of valvular 
dysfunction. The leaflets are transparent, and except for the prolapsing segment there is no 
excess tissue. The chordae are thin, fragile, and elongated. The annulus is dilated and often 
infiltrated with calcium (Table #3). 
 
 
Table 3. Кеу differences between Barlow,s disease and fibroelastic deficiency 
7.4 Pathologic anatomy of degenerative mitral valve disease   
According to A. Marc Gillinov and coworkers, pathologic anatomy of degenerative mitral 
valve disease is presented in group of 1072 patients as follows (Table #4).  
 
 
Table 4. Pathologic anatomy of degenerative mitral valve disease (n = 1072). 
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8. Surgical treatment 
8.1 Principles of valve reconstruction 
Guided by functional valve analysis, the surgeon should indentify all the lesions. The 
ultimate aim of valve reconstruction is to restore durable normal valve function. Three basic 
conditions are required to achieve this goal: preserving or restoring normal leaflet motion of 
all valve segments, creating a large surface of leaflet coaptation, remodeling the mitral valve 
orifice. Ideally correct application of repair techniques will produce appropriate coaptation. 
The rough zones of the leaflet should be in contact. The ratio of leaflet surface area to valve 
orifice area should be corrected to its natural 2:1 ratio. Because annular dilatation is a 
component of chronic mitral regurgitation, some type of annular support is necessary. 
Annuloplasty often completes the repair but cannot compensate for an inadequate repair. 
Echocardiography with color flow and spectral Doppler evaluation is an important 
noninvasive method for assessing the significance of cardiac murmurs. Information 
regarding valve morphology and function, chamber size, wall thickness, ventricular 
function, pulmonary and hepatic vein flow, and estimates of pulmonary artery pressures 
can be readily integrated. Zoghbi et al., 2003 presented qualitative and quantitative 
parameters useful in grading mitral regurgitation severity (Table#5). 
 
 
Table 5. Qualitative and quantitative parameters useful in grading mitral regurgitation 
severity. 
Three different MV operations are currently used for correction of MR: 1) MV repair; 2) MV 
replacement with preservation of part or all of the mitral apparatus; and 3) MV replacement 
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with removal of the mitral apparatus. Each procedure has its advantages and disadvantages, 
and therefore, the indications for each procedure are somewhat different (Bonow et al., 
2008).  
In most cases, MV repair is the operation of choice when the valve is suitable for repair 
and appropriate surgical skill and expertise are available. This procedure preserves the 
patient’s native valve without a prosthesis and therefore avoids the risk of chronic 
anticoagulation (except in patients in atrial fibrillation) or prosthetic valve failure late 
after surgery. Additionally, preservation of the mitral apparatus leads to better 
postoperative LV function and survival than in cases in which the apparatus is disrupted. 
Improved postoperative function occurs with repair because the mitral apparatus is an 
integral part of the left ventricle that is essential for maintenance of normal shape, 
volume, and function of the left ventricle. However, MV repair is technically more 
demanding than MV replacement, may require longer extracorporeal circulation time, 
and may occasionally fail. In USA (Savage et al., 2003) and Europe (Lung et al., 2003) the 
valve with MV regurgitation is repaired in only 50% of cases. Valve morphology and 
surgical expertise are of critical importance for the success of valve repair. The 
reoperation rate after MV repair is similar to the reoperation rate after MV replacement. 
There is a 7% to 10% reoperation rate at 10 years in patients undergoing MV repair, 
usually for severe recurrent MR. Approximately 70% of the recurrent MR is thought to be 
due to the initial procedure and 30% to progressive valve disease. The reoperation rate is 
lower in those patients who had the initial operation for posterior leaflet abnormalities 
than in those who had bileaflet or anterior leaflet abnormalities. In many cases, the type of 
operation, MV repair versus replacement, is important in timing surgery. In fact, although 
the type of surgery to be performed is never actually established until the operation, 
many situations lend themselves to preoperative prediction of the operation that can be 
performed. This prediction is based on the skill and experience of the surgeon in 
performing repair and on the location and type of MV disease that caused the MR. 
Nonrheumatic posterior leaflet prolapse due to degenerative MV disease or a ruptured 
chordae tendineae can usually be repaired using a resection of the portion of the valve 
and an annuloplasty. Involvement of the anterior leaflet or both anterior and posterior 
leaflets diminishes the likelihood of repair because the operation requires other 
interventions, such as chordal shortening, chordal transfer, and innovative anatomic 
repairs. Consequently, the skill and experience of the surgeon are probably the most 
important determinants of the eventual operation that will be performed. 
8.2 Surgical approach  
According to M. Scorsin  (Scorsin et al., 2010), in 90% cases of posterior mitral valve prolapse 
is repaired with standart techniques: 1  - quadrangular \ triangular resection + placation of 
annulus, sliding, folding; 2- artificial chordate sutures. Current techniques for anterior 
leaflet prolapsed include valvular and subvalvular  approach. In turn, valvular approach 
include papillary muscle placation, chordal shortening, leaflet resection, transposition of 
chordate. Subvalvular approach include artificial chordate. Among several repair techniques 
chordal replacement using ePTFE sutures has been introduced into clinical practise by 
Frater. There are several advantages to use of ePTFE suture for chordal replacement - 
preservation of native valve anatomy, physiological leaflet motion and creation of large 
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mitral orifice area. Properly inserted, ePTFE sutures restore stress on the valve leaflet to a 
normal range. Long-term studies in experimental animals and in humans show that ePTFE 
chordae do not shrink or stiffen; indeed, these artificial chordae become covered by a 
fibrosis and intima simulating true chordae.  
8.3 Evolution of modern valve repair techniques with artificial chordae 
Medical literature describes numerous techniques to create and to determine ideal length 
for artificial chordae. Bizzarri et al has analysed evolution of modern valve repair 
techniques with   artificial chordae (Bizzarri et al., 2010). Morita et al., 1996 were the first 
to use 4-0 PTFE figure of 8 to repair both leaflets prolapse passing from the papillary body 
to the leaflet and back adding a Kay annuloplasty at the end of the procedure.  Zussa, 
1997, one of the pioneers of this technique, repaired an anterior leaflet with PTFE strings 
passing through the head of the papillary muscle and tying over a reinforcing autologous 
pericardial pledget. The strings were then anchored to the free margin of the anterior 
mitral leaflet at the unsupported areas and reinforced with a small autologous pericardial 
pledget. The two strands were tied after filling the ventricular cavity with saline solution 
for adjusting the chordal length. Murakami et al., 1998 approached the anterior leaflet 
prolapse using mattress e-PTFE suture with Teflon or autologous pledget passed through 
the free margin of the leaflet from the ventricular side to the atrial side. The two arms of 
the suture, reinforced with pledgets, were brought down to the papillary muscle and 
passed through it. The length of the e-PTFE chordae was then adjusted by approximating 
the coapting area of the opposite leaflet and the ends of the sutures were then tied 
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Chordae tendinae reconstruction, in patients with prolapsed of anterior leaflet was done 
by Matsumoto et al., 1999 in children using the following technique: double-armed 
mattress e-PTFE sutures were passed through the free prolapsed edge from the 
ventricular side to the atrial side and then the two ends were passed through the papillary 
muscle at 3 to 4 mm from its top, drawing the free edge down to the entry point on the 
papillary muscle of the two ends of the suture. The sutures were passed through a 
pledget, which would be on the side where the sutures emerged from the papillary 
muscle. The knot was tied at the level of the opposing normal leaflet. The new chorda was 
pulled back through the papillary muscle until the pledget came up against the muscle. 
Another e-PTFE suture was placed in the same fashion. A Kay-Reed annuloplasty was 




Kawahira et al., 1999 used 4-0 e-PTFE sutures through the prolapsed leaflet from its 
ventricular to atrial aspect, placing pledgets for reinforcement on the ventricular surface of 
the leaflet. The sutures were anchored to the papillary muscles in a mattress fashion. This 
maneuver could be carried out in reverse order: attaching e- PTFE suture initially to the 
papillary muscle, subsequently passing it through the leaflet from it's ventricular to atrial 
aspect. In this circumstance, the knot would be placed on the atrial aspect of the mitral 
valve. Adams et al., 2001 placed one or more 4-0 Gore- Tex sutures into the head of the 
papillary muscle. Papillary muscle exposure was enhanced after quadrangular posterior 
leaflet resection. Before annuloplasty poor leaflet apposition is present in all leaflet segments 
with saline testing and segmental anterior leaflet prolapse is best identified by height 
comparison with a normal reference point. After ring annuloplasty symmetric leaflet 
apposition limits leaflet incompetence to the prolapsing anterior leaflet segment. Both arms 
of the previously placed Gore-Tex suture are passed through the margin of the prolapsing 
leaflet segment. Passing the suture through the free edge of the cusp twice as well as starting 
with a surgeon's knot are techniques to prevent overaggressive sliding of the knots when 
tying the Gore-Tex suture (Figure 7). 
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Tomita, 2002 applied the method of David to use the reconstruction of the valve with CV-4 
e-PTFE sutures. The double armed suture is passed twice through the fibrous portion of the 
papillary muscle head that anchors the elongated or ruptured chordae and is tied down 
(seven or eight knots are needed for this type of suture material). The two arms of the suture 
are then brought up to the free margin of the leaflet and passed through the point where the 
original chorda was attached (thickened portion of the leaflet). The needle is brought from 
the ventricular side of the leaflet to its atrial side and then passed once through the leaflet. 
The length of the PTFE chordae is adjusted by approving the coating area of the opposite 
leaflet. Then both ends of the suture are passed through the leaflet again and tied together 
on the ventricular side. Another PTFE suture is placed when the prolapsed portion is wide. 
Kay's annuloplasty is added at the end. 
With time, it appeared mandatory to find the correct technique to determine the length of 
the artificial chordae. Sarsam et al., 2002 passed one or more 5-0 e-PTFE sutures, supported 
by a felt pledget through the fibrous portion of the papillary muscle. The suture was left 
untied. The two arms of the suture were then passed once through the rough free edge of 
the prolapsing leaflet from the ventricular to the atrial side. If the native chorda to the 
corresponding part of the opposing leaflet are normal, the edges of the anterior and 
posterior leaflet are temporarily approximated by a simple or figure 8 suture and then the 
suture is tied against the temporary suture. Three knots are used. The suture in passed again 
through the edge of the leaflet from the ventricular to the atrial side and tied permanently. 
The temporary suture is then removed (Figure 8). 
 





Soga, 2003 made a resection of both the anterior and posterior mitral leaflets and 
subvalvular apparatus and placed two 3-0 e-PTFE mattress sutures: one placed and tied at 
the tip of the anterior papillary muscle, and one at the tip of the posterior papillary muscle. 
The suture of the anterior PM is placed at the 9-10 o'clock position on the mitral annulus (as 
defined by mid-anterior annulus to be 0 o'clock), and the suture for the posterior PM at the 
5-6 o'clock. According to the authors, the length of the artificial CT can be determined 
during intraoperative cardiac arrest, and may be suitable if the sutures are tied just less than 
taut before insertion of the prosthetic. After the valve replacement, the motion of the 
prosthetic leaflets is examined to ensure that the leaf let are not entrapped by the 3-0 e-PTFE 
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Tomita, 2005 repaired chordae tendinae with CV-4 e-PTFE sutures. Double armed sutures 
are passed twice through the fibrous portion of the PM head that anchors the elongated or 
ruptured chordae and are tied down (7 or 8 knots are needed for this suture material). The 
two arms of the suture are brought up to the free margin of the leaflet and passed through 
the point where the original chorda was attached (thickened portion of the leaflet). The 
needle is brought from the ventricular side of the leaflet to its atrial side and passed once 
more through the leaflet. The length of PTFE chordae is adjusted by referring the contact 
area of the opposite leaflet and then both ends of the suture are passed through the leaflet 
again and tied together on the ventricular side. When the prolapsed portion became wide, 
another PTFE suture was placed in the same fashion. At the end Kay's suture annuloplasty 
(n = 24) or ring annuloplasty was performed. Minami, 2005 used double armed mattress 
sutures of 4-0, 5- 0 or 6-0 e-PTFE placed to reinforce with felt pledgets between the PM and 
free margin of the anterior leaflet. The length of the PTFE sutures was adjusted with the 
adjacent normal anterior leaflet or facing posterior leaflet. When the prolapsed portion 
became wide, another suture was placed in the same fashion. The number of sutures ranged 
from 1 to 3. In addition, Kay annuloplasty was perfomed. 
Matsui, 2005 employed a new device (Matsuda Ika-Kogyo, Tokyo, Japan) consisting of two 
metallic tubes with a circular, hook shaped distal tip made entirely of stainless steel. The 
distal tip, which is perpendicularly attached to the inner tube, was designed to hold the 
Gore-Tex thread at the reference point on the PM immovable. The outer tube could slide on 
the surface of the inner tube to measure the length from the tip of inner tube to the hook of 
outer tube. A 4-0 or 5-0 Gore-Tex mattress suture, reinforced with a felt pledget, was placed 
into the head of the PM. Both arms of the suture where left untied. Length was determined 
by measuring the distance between the leaflet edge and the site of implantation of the 
artificial chordae on the PM, using a normal valve segment adjacent to the prolapsing 
segment as a reference. The distal tip of the inner tube of the device was placed at the 
sutured site of the artificial chordae on the PM. The proximal hook of the outer tube was slid 
to the edge of the adjacent non prolapsing leaflet and then fixed at that point after reading 
the distance between the distal tip and proximal hook to the device. Devices were then 
moved to the prolapsed segments so as to hold an edge of the prolapsed leaflet with a 
proximal hook. As the determined distance and edge of the leaflet were fixed with the 
device, the Gore-Tex suture could be tied in the usual manner without knot slipping. The 
action of knot-tying itself works to immobilize the device by its strength. After removing the 
device, followed by saline testing, a Carpenter- Edwards annuloplasty ring was attached 
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Prêtre et al., 2006 applied the artificial chordae to the mitral valve using an approach 
through the aortic valve for an anterior and posterior leaflet prolaps. In the anterior repair 
an atriotomy was performed first, the artificial chordae was placed in the usual manner, and 
then a flexible annular ring was tied on the mitral annulus. An aortotomy was performed to 
expose the native chordae and to calibrate the length of the artificial chordae that were 
locked but not tied down. The mitral valve was inspected through the atriotomy while 
saline water was injected through the aortotomy in the left ventricle. The chordae were tied 
from the aortotomy and the incisions closed in the usual fashion. In the posterior leaflet 
prolapse, repair was done and a ring was inserted using a classical atrial incision. The 
ascending aorta was opened and the artificial chordae were set on the papillary muscles and 
the anterior leaflet was calibrated. The valve was re-inspected through the atriotomy with 
instillation of saline in the left ventricle for adjusting the chordae until they were definitively 




Lawrie et al., 2006 published their experience on 152 consecutive patients. 5-0 PTFE sutures 
were placed into the bases of the papillary muscles in a figure-8 fashion, and were brought 
through the free edge of the prolapsing segment. Dots were made to mark the desired final 
line of leaflet apposition. The left ventricle was inflated with saline solution and the chordal 
length was adjusted to align the edges of the leaflets. Leaflet alignment was checked and the 
PTFE was tied down. The knot was locked with a 6-0 polypropylene stitch which was tied 
over the end of the PTFE to prevent sliding of the PTFE knots. An annuloplasty ring was 
then implanted.  
Calafiore, 2006 in the anterior leaflet prolapse passed 4-0 PTFE sutures through the fibrous 
tip of the papillary muscle and fixed the sutures. The new chorda was passed in the border 
of the anterior leaflet in the proper place and its final length was measured with a ruler. A 
mark was applied to indicate this distance and the suture was tied with the aid of a nerve 
hook (Figure 12). 
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Rankin, 2006 in the anterior and/or posterior leaflet prolapsed placed 4-0 prolene 
pledgetted horizontal mattress sutures longitudinally into each papillary muscle, passing 
one arm through the fibrous tip, and tying firmly; through this anchor suture, a double-
armed Gortex suture was passed but not tied. A Carpentier annuloplasty ring was sutured. 
With the ring in position, the chordae were retrieved from the ventricle, and both needles 
were woven into the prolapsing segment, straddling the point of maximal prolapse. Two or 
three bites were taken through the coaptation surface to the line of coaptation. The two arms 
of the suture were tied on the atrial surface with a slip-knot to bring the leaflet to the 
annular plane, and a clip was placed across the knot. Pericardial pledgets could be used if 
the leaflet tissue seems fragile. Cold saline solution was infused to check the length of the 
suture; once the valve was competent, eight more knot were tied tightly against the clip, the 




Tam, 2006 used the following technique for any prolapsing segment. A calliper was used to 
measure the length of the reference chordae. A 4-0 ePTFE suture was used to create loops 
around the calliper. Non-sliding knots were placed at the end of each loop while still on the 
calliper. After making a desired number of loops, the needles were passed through the loops 
and tied. Two needles at the end of the sutures were passed through an ePTFE pledget, 
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which was now ready to be secured to the papillary muscle. The ePTFE chordae were 
secured at the tip of the papillary muscle with two pledgets and attached to the edge of the 




Mandegar, 2007 for any leaflet prolapse used following technique. During preoperative 
transesophageal echocardiography, a line was drawn between the base of the anterior and 
posterior mitral leaflet to measure the distance between the head of the posterior papillary 
muscle and the plane at the co-optation of the leaflets; this measured the artificial chordal 
length. During surgery, 4-0 Gore- Tex was passed through the fibrous tip of the papillary 
muscle with a pledget and was fixed with a loose knot. Two tight reverse knots were made 
for every millimeter of 4-0 Gore-Tex that was required. The needles were passed through 
the edge of the anterior leaflet at the prolapsing portion, and the Gore-Tex was knotted onto 
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Gillinov, 2007 describe a technique for reparing anterior leaflet prolapse. Chordal length 
was determined with a calliper, and ePTFE chordae were constructed making loops around 
it. A pledget was used to prepare the number of 5-0 ePTFE loops that were needed. When all 
chordal loops were constructed, each needle was passed through the head of the papillary 
muscle, and was affixed to the free edge of the anterior leaflet with a figure 8 suture of CV-5 





Scorsin et al., 2007: any leaflet prolapse. Artificial chordae system device was composed of 2 
sets of 4 artificial chordae, attached to a 3-mm strip of knitted polyester 18 mm wide, leaving 
4 mm between each chorda. The device was applied by suturing the strip to the free edge of 
the prolapsed leaflet by continuous suture. Each array was anchored to the tip of the 
correspondent papillary muscle by only one stitch. After this procedure, a prosthetic 




Maselli and De Paulis, 2007 used a novel system to repair the valve consisting of two 
components: leaflet component and the papillary component. The first one was achieved 
with a CV-5 PTFE suture. A circular loop was obtained at the middle of the suture by tying 
it around a Hegar dilator with a diameter of 13 mm. Flattened loop's length should equals 
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half the circumference. Given a circumference of approximately 4 cm for a circle with a 
diameter of 13 mm the length of the loop would be approximately 2 cm. Papillary 
component was obtained by cutting a CV-4 PTFE suture in 2 halves; 5 double knots were 
placed at a distance of 2 mm at the needleless tip of each CV-4 semisuture. The needleless 
tip of the suture was anchored on a drape; knots were placed with the help of forceps and a 
needle holder and slid into definitive position by inserting the tip of the needle or a nerve 
hook in the knot itself. To realize papillary component for each neochorda 2 CV-4 half 
sutures with knots were needed. After the assessment of the mitral valve lesions, the 
papillary component was set in place by first fixing 2 semisutures to a papillary head and 
tying the sutures so that the papillary head was "sandwiched" between 2 e-PTFE pledgets to 
reduce trauma. Two CV-5 loops were fixed on the desired leaflet 2 to 3 mm apart from the 
leaflet's edge, passing the needle from the atrial to the ventricular side and leaving knots on 
the ventricular aspect of the leaflet. A single PTFE pledget was interposed on the atrial side. 
To obtain reversible coupling of the leaflet component with the papillary, a loop which 
could be tightened and loosened as many times as required, was placed in the leaflet 
component with the help of forceps and a curved instrument. The papillary component 
passed inside the loop and the loop was tightened. The loop had to fall in the gap between 
two knots. Chordal length was fixed by closing the loop under the selected reference knot of 
the papillary component. Same steps were repeated for the other chordae. To shorten or 
elongate the neochorda without touching its papillary or leaflet anchoring, the loop was 
released and slid under a reference knot respectively closer or farther from the papillary 
muscle tip, and tightened again (Figure 18). 
 
    
Fig. 18. 
Boon et al., 2007 used CV-5 e-PTFE sutures for older children, while CV-7 was typically 
used in neonates and small infants. The suture was first tied to the fibrous tip of the PM 
and the two ends were fixed to the free edge of the valve leaflet in a V-shape. For the 
anterior leaflet, a new chord length was measured by bringing the free edge of the valve 
to the level of the anterior annulus. The length could also be compared to healthy non-
elongated native chords in the adjacent area. Then both ends of the sutures would be 
passed again through the free edge and tied on the ventricular side of the leaflet, to 
prevent the knot from interfering with the co-optation zone. Because the sutures are 
placed in a V-shape, one suture accounts for 2 new artificial chords. In addition, ring 
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half the circumference. Given a circumference of approximately 4 cm for a circle with a 
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Fig. 18. 
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annuloplasty or Wooler-Kay bilateral commissural plication annuloplasty was performed. 
Chan, 2008: for anterior leaflet prolapse a 4-0 Gore-Tex suture with pledgets was used. 
The suture was first passed through the papillary muscle and secured with 6 to 8 knots. 
Both braids were then passed through the prolapsed leaflet edge no more than 4 mm 
apart. The suture was then tensed up. The non-prolapsing posterior leaflet was used to 
check the reference length. A single-arm rubber- protected artery forceps was clipped on 
the mark, and knots were tied on it.  
Salvador, 2008: for anterior leaflet prolapse repair a e-PTFE double-armed suture (GORE-
TEX CV-5) were passed through the PM with a mattress technique and reinforced with 
autologous pericardial pledgets (rarely, GORE-TEX pledgets), on both sides of the muscle. 
Each end of the suture were fixed to the free margin of the prolapsed leaflet and 
reinforced with a small autologous pericardial pledget or a small GORE-TEX pledget. The 
length of the artificial chordae was adjusted to maintain the corresponding free margin of 
the leaflet at the desired level in the ventricular cavity. To determine the correct length of 
the artificial chordae, the neochordae were tied at the end of all the other repair 
procedures after the ventricular cavity is filled with saline solution. Smith and Stein, 2008 
made the first endoscopic placement of multiple pre-measured artificial chordae with 
Robotic assistance and nitinol clip fixation. Robotic bileaflet mitral valve repair used a 
more lateral approach and 5 right thoracoscopic ports, ranging in size from 8 to 20 mm. 
Left atriotomy was perform to expose mitral valve using a robotically controlled 
EndoWrist atrial retractor (Intuitive Surgical Inc.). The prolapsing segment was identified 
with valve hooks. The "ski-tip" style ends of the robotic retractor blades are longed into 
the anterior leaflet, then the atrial septum is lifted to visualize PM. The length of the 
artificial chordae loops were determined with the measure of the distance between the 
correct plane of apposition on an adjacent normal non-prolapsing segment of the mitral 
leaflet and the respective PM (done with a More Suture Ruler device). Artificial chordae, 
with 4 loops each, were constructed of 4-0 PTFE GORE-TEX per the technique by von 
Oppel and Mohr. A single felt pledget constructed the platform with multiple neochords 
of definite length extending from its base. Both free suture needles from the pledget 
platform were passed through the respective PM with 2 robotic large needle drivers. After 
the correct placement in the muscle head, the needles were retrieved and the neochordae 
platform was secured with extracorporeal knots tied by the assistant using a closed knot 
pusher. Each neochordae loop was attached to the edge of the prolapsing leaflet by 
applying a single-armed V60 U-clip per loop. The singlearmed U-clip was placed in the 
leaflet edge with a robotic large needle holder and the neochordae loop was captured in 
the open clip circle. The U-clip was deployed by pulling the needle off the clip portion, 
securing the neochordae loop to the leaflet. Additional reduction of the leaflet height 
could be achieved by folding the leaflet edge toward the ventricle before deploying the U-
clip. The remaining loops were distributed at equal distance along the edge of the 
prolapsed segment by applying the same technique. After the pledget platform was 
secured, the 2 free suture needles were placed through the anterior prolapse. The correct 
apposition was confirmed with saline test. The assistan, at the patient side, tied the knots. 
Annuloplasty was performed at the surgeon's discretion. For concomitant left atrial 
ablation a SurgiFlex XL probe was applied endocardially. Lastly the heart was de-aired 
and the left atrium was closed with a running suture line ( Figure 19). 
 





Doi, 2009 measured the length of the chordae of the posterior leaflet, opposing the 
prolapsing portion of the anterior leaflet by TEE. The length of chordae was a measurement 
of the distance between the head of the PM and the free edge of the posterior leaflet. Length 
of the opposing chordae of the posterior leaflet was measured directly by using a calliper. 
Double-armed mattress sutures with CV-5 GORE-TEX were placed at the fibrous tip of the 
PM using PTFE on both sides and tied down firmly. In all cases Doi performed Duran ring 
annuloplasty. Thereafter, the ePTFE suture is placed through the anterior leaflet. The 
needles were passed through the rough zone of the prolapsing portion from the atrial to the 
ventricular side, and again through the free margin of the leaflet from the ventricular to the 
atrial side. The caliper that was fixed at the length of the opposing chordae was inserted 
inside the loop created by the ePTFE suture. The suture was easily tied at the exact length of 





The main difference between the techniques is in the measurement of the length of the 
artificial chordae. The oldest and most common method to calibrate the length of the neo-
chordae consists in filling the left ventricular cavity with saline solution. Other authors 
elongated the prosthetic chordae trying to approximate the coaptation area between the two 
mitral leaflets. Recently, a variety of different calipers that allow in some manner to check 
the length and to tighten the number of necessary chordae have been introduced to better 
define the adequacy of the PTFE chordae implantation.  
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8.4 New device 
In our Cardiothoracic Surgery Center we worked out our own device to measure proper 
length of chords and multiple loops formation (Figure 21). 
 
 
Fig. 21. Boldyrev – Barbukhatty- Porhanov device. 
The gist of the given model is that on the end of the working body we placed props located 
perpendicularly to the plane of the graduated scale and fitted with circular cuttings for loop 
fixation, and on a scale there is a core clamp.By means of our appliance one is able to 
perform at the same time intraoperative measurement of the chordal apparatus and to 
generate necessary quantity of loops for chord prosthetic repair. This device is in process of 
patenting in the Russian Federation (request № 2011101697\14(002183), January 18, 2011)  
8.5 South Russian experience 
Material and Methods: From 2008 to 2011 we have treated 30 patients with moderately 
severe (3+) or severe (4+) mitral regurgitation. Echocardiographic findings are showed in 
the Table 6.  
  
MV regurgitation grade by color Doppler                                          3 ± 0,44 
Regurgitation volume, ml     109 ± 19,4 
MV EF,%                                                   57 ± 5,4 
Left atrium size, mm       51,4 ± 6,8 
Left ventricular end diastolic dimension, mm                60,9 ± 5,2 
Left ventricular end diastolic volume, ml                199,5 ± 38,4 
LV EF, % 49,2 ± 8,5 
Pulmonary hypertension, mm Hg 49,2 ± 8,5 
Table 6. Preoperative echocardiographic data. 
They all underwent MV chord system repair. There were 17 male and 13 female patients. 
Age range was from 16 to 70 years (mean age 55,3 ± 13). Mean  ejection fraction was 49%, 
and minimal - 35% (3 cases). Etiology 20 (66%) patient had fibroelastoc  deficiency, 2 (7%) -  
ischemic heart disease,  3 ( 10%) had Barlow,s disease, 2 (7%) had Marfan,s disease, and 3 
(10%) had mitral valve malformation. 7 (23%) patients were found to have posterior leaflet 
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prolapse, 5 (17%) patients – bileaflet  prolapse, and 18 (60%) – anterior leaflet prolapse. We 
performed 7 posterior mitral valve leaflet chord reconstructions, in 4 cases with multiple 
loops.  Anterior mitral leaflet chord repair was carried out in 18 (60%) patients (including 
multiple loops in 10 cases). 5 (17%) patient had total AML chord repair ( Figure 22, 23). 
 
 
Fig. 22. Patient Ch. Preoperative echocardiography (left, two-chambered position at the 
mitral valve level) and postoperative view (right, four-chambered position).  
 
 
Fig. 23. Patient Ch. Intraoperative photo total anterior mitral leaflet chord repair.  
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1(3%) patient underwent total chordae replacement (anterior and posterior leaflets). We 
applied quadrangular resection with leaflet height adjustment of posterior leaflet for 
bileaflet prolapses with AMV chord repair. When we carried out repair with multiple loops 
we used a device (proper modification) to measure length and formation of neochords. To 





Fig. 24. Scheme of multiple loops performance (from A to E). 
All patients underwent suturing annuloplasty or were implanted supporting rings MedIng. 
Results: All patients survived. Operative results were assessed by echocardiography (Table 7). 
 
MV regurgitation grade by color Doppler                                          1,14 ± 0,8 
Regurgitation volume, ml          20 ± 11,8 
MV EF,%                                                   20 ± 11,8 
Left atrium size, mm       42,6 ± 4,2 
Left ventricular end diastolic dimension, mm                51,8 ± 7,4 
Left ventricular end diastolic volume, ml                51,8 ± 7,4 
LV EF, % 54,6 ± 9,6 
Pulmonary hypertension, mm Hg 34,8 ± 7,1 
Table 7. Postoperative echocardiographic data. 
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We believe the quantitative assessment of regurgitation described by Zoghbi and co-authors 
(Zoghbi W et al, 2003) is the most unbiased. In immediate postoperative period in 1 patient 
we noticed systolic anterior motion syndrome with further release. In the follow-up period 
ranging from 1 to 30 months, 1 patient required reoperation in 4 months for 3 + mitral 
regurgitation; the mechanism of recurrent mitral regurgitation showed AL chords tearing 
off with high arterial hypertension ( Table № 8). 
 
 
Table 8. Freedom from reoperation. 
9. Conclusions 
On the basis of our results we state that artificial chords are rather attractive method for MV 
repair in patients with abnormal chord apparatus. Despite some difficulty while selecting 
proper neochords, this technique is applicable and reliable in most cases. Mitral valve repair 
is a challenging technique deserving continuous attention over time. In the future we are 
waiting for more novel procedures to ensure better results in mid and long term morbidity. 
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Post Myocardial Infarction  
Ventricular Septal Defect 
Michael S. Firstenberg and Jason Rousseau  
Division of Cardiac Surgery, The Ohio State University Medical Center, Columbus, 
USA 
1. Introduction 
With advances in the management of acute myocardial infarction (AMI) the incidence of 
mechanical complications continues to decline. Nevertheless, when they occur, 
unfortunately, despite similar advances and growing experiences in the surgical 
management of these problems, morbidity and mortality remain high. Post-myocardial 
infarction ventricular septal defects (PI-VSD) have fascinated and challenged clinicians for 
years. The timing of presentation can be quite variable, as they tend to occur in patients 
several days after their initial cardiovascular insult (acute PI-VSD) – and unfortunately, they 
can occur in patients who appear to have been making significance progress on the road to 
recovery.  In addition, although more rare, some patients might not present until weeks, if 
not longer, after their infarction with symptoms that prompt the discovery of a chronic PI-
VSD.  Early PI-VSDs tend to be catastrophic and typically result in early death.  The 
pathophysiology is also variable and complex, but common themes include: 1) worsening 
cardiac output, often with manifestations of shock and end-organ damage, from acute left 
ventricular (LV) dysfunction and from increased left-right shunting, 2) acute right 
ventricular (RV) dysfunction from a sudden increase in pressure, volume, and flow from left 
to right shunts, and 3) pulmonary hypertension also from the increase in RV flow. Definitive 
management remains surgical, however controversies continue to exist regarding the timing 
of surgery and the role of concomitant coronary revascularization.  Unfortunately, despite 
early repair and standardization of techniques, both short and long-term outcomes remain 
less than ideal. 
2. History 
As with many cardiovascular conditions, post-myocardial infarction ventricular septal 
defects (PI-VSD) were described first at autopsy (Latham, 1845) and then pre-mortum in 
1923, many years before the pathophysiology was understood (Brunn, 1923). It was not until 
1934 that the association with coronary artery disease was described (Sager, 1934).  The first 
report of a surgical repair came in 1956 when Denton Cooley described the surgical 
management in a patient 9 weeks after the initial diagnosis (Cooley, 1956). With advances in 
cardiovascular surgery and peri-operative management of the cardiac surgery patient there 
were increasing reports of survival in what was previously felt to be a lethal problem.  Most 
of the successful cases occurred in patients who presented in congestive heart failure many 
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ventricular (RV) dysfunction from a sudden increase in pressure, volume, and flow from left 
to right shunts, and 3) pulmonary hypertension also from the increase in RV flow. Definitive 
management remains surgical, however controversies continue to exist regarding the timing 
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less than ideal. 
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defects (PI-VSD) were described first at autopsy (Latham, 1845) and then pre-mortum in 
1923, many years before the pathophysiology was understood (Brunn, 1923). It was not until 
1934 that the association with coronary artery disease was described (Sager, 1934).  The first 
report of a surgical repair came in 1956 when Denton Cooley described the surgical 
management in a patient 9 weeks after the initial diagnosis (Cooley, 1956). With advances in 
cardiovascular surgery and peri-operative management of the cardiac surgery patient there 
were increasing reports of survival in what was previously felt to be a lethal problem.  Most 
of the successful cases occurred in patients who presented in congestive heart failure many 
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weeks after their initial acute event.  It was these experiences that set the foundation for the 
belief that operative management should be delayed as long as possible to allow for scarring 
of the necrotic myocardium to provide for a more stable repair. As experiences grew – in 
terms of the initial diagnosis and surgical management – early repair was advocated, 
particularly in patients who were stable before hemodynamic deterioration and subsequent 
end-organ failure.  
3. Clinical presentation 
The incidence of PI-VSD has decreased considerably over the years with advances in 
myocardial reperfusion strategies.  Historically, up to 5% of all myocardial infractions were 
associated with mechanical complications such free-wall rupture, papillary muscle rupture, 
and PI-VSD (Agnihotri, 2008). With current treatment algorithms that advocate early and 
aggressive attempts at revascularization of the acute ischemic myocardial – such as 
thrombolytic therapy, early percutanous interventions with coronary stenting (PCI), and, 
less frequently, emergent coronary artery bypass surgery (CABG) – the overall incidence has 
dropped significantly.  Large multi-centers studies evaluating the pathophysiologies of 
acute myocardial infarctions have shown a current incidence of approximately 0.2% of all 
AMI.  With delays in therapies, or late clinical presentation, and the resulting increase in 
myocardial damage, this incidence increases up to 2%. Despite the relatively low risk of 
developing a PI-VSD, it account for a disproportionally high risk of mortality. Over 5% of all 
early deaths after AMI are attributed directly to the pathophysiologic complications of PI-
VSD (Poulsen, 2008). 
The timing of the development of a PI-VSD can be quite variable with the average time to 
clinical presentation is between 2 and 4 days, however presentation can be as few as a few 
hours after AMI or as long as several weeks.  
Patient risk factors include gender, with men at a greater risk than women (3:2 ratio), 
increasing age, and current smoking history. The mean age of presentation in GUSTO was 
62.5 years and ranged from 44 to 81 years (Crenshaw, 2000). 
4. Diagnosis 
The diagnosis of a PI-VSD must be considered in the differential in any patient presenting 
with hemodynamic impairment, particularly in the context of a sudden deterioration in a 
patient who otherwise had been doing well, either during or after an AMI. As a PI-VSD 
presents in a similar manner as other mechanical complications of AMI, such a papillary 
muscle rupture (with acute mitral regurgitation), free wall rupture (with contained 
tamponade), or severe LV failure and pulmonary edema the initial diagnosis is often 
suspected during initial investigations and confirmed with additional imaging.   
The typical presentation occurs in a patient who is otherwise recovering after initial 
management of an uncomplicated AMI. Patients often complain of recurrent chest pain from 
what is most likely new onset or recurrence of myocardial necrosis and will develop a new 
systolic murmur that can be harsh, pansystolic, and often-best ascultated at the left lower 
sternal border.  Patients can often have a bundle branch block from disruption of the septal 
conduction system and will quickly deteriorate hemodynamically with findings suggestive 
of acute cardiogenic shock.   
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With the acute clinical deterioration, a rapid assessment of the etiology is critical. Unlike 
other mechanical complications, such as papillary muscle rupture, PI-VSDs will have 
imagining confirming a left to right shunt – such as contrast injected into the left ventricle 
during catheterization crossing the defect into the RV and entering into the pulmonary 
arteries (Figure 1). Likewise, oxymetric assessment with right heart catheterization will 
demonstrate a “step-off” from the mixing of de-oxygenated RV blood with the 




Fig. 1. Representative cardiac catheterization in which contrast is injected into the left 
ventricular cavity and then crosses the defect into the right ventricle. Contrast flowing into 
the pulmonary artery is then diagnostic for a ventricular septal defect.  
4.1 Echocardiography 
Transthoracic echocardiography (TTE) remains the cornerstone of the non-invasive 
assessment of PI-VSD (Kishon, 1993). TTE is indicated in any patient who presents with 
evidence of acutely impaired ventricular function or in unexplained hemodynamic 
deterioration suggests a mechanical complication following an acute myocardial infarction 
(Buda, 1991).  Echocardiography has the benefit of being able to assess both left and right 
ventricular function, the presence of potentially co-existing and confounding valvular 
diseases – typically mitral regurgitation, and with color flow imaging it can be 100% specific 
and sensitive in diagnosing a PI-VSD.  Despite the utility of TEE in the acute assessment of a 
deterioritating patient, a high index of suspicion is needed when looking for a PI-VSD as 
traditional echo windows might miss a small or apical defect. Large pericardial effusions 
might suggest an associated free wall rupture. 
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Fig. 2. Transesophageal echo, 4-chamber view, demonstration an apical VSD with from from 
the left ventricle (LV) to the right ventricle (RV).  The left atrium (LA) is also shown to 
illustrate the typical relationship of the defect to the mitral valve. 
4.2 Cardiac catheterization 
Since patients who present with ECG and laboratory evidence of myocardial ischemia often 
undergo early cardiac catheterization with coronary angiography, this test often represents 
the initial study to suggest or confirm a diagnosis. Because the pathophysiology typically is 
associated with extensive and acute ischemia of a large territory of myocardium, it is not 
surprising that the findings at catheterization are often different than what would be 
expected for patients with a history of chronic coronary artery disease in which 
compensatory development of septal collaterals has had time to developed. During the 
acute presentation, the findings often suggest a complete occlusion of a large coronary 
artery in the setting of relatively minimal disease.  Single vessel disease is found in 64% of 
patients and since the left anterior descending (LAD) artery is often the culprit vessel this 
explains why antero-apical septal VSDs are found in 60% of cases. Conversely, acute 
occlusions of a dominant right coronary or circumflex artery accounts for the remaining 
cases that occur in the posterior septum. Seven percent have concomitant double vessel 
disease, and 29% have triple vessel disease.   
More importantly is that the cardiac catheterization might be the initial confirming 
diagnostic test. As mentioned above, quantitative assessment of oxygen step-offs, when 
performed, will demonstrate an increase in the partial pressure of oxygen (PaO2) between 
the right atrium and ventricle – diagnostic of the left to right shunt.  Left ventricular contrast 
injections, although less likely to be performed in a deteriorating patient secondary to the 
concern that additional contrast might further injure an already compromised renal 
function, is critical in patients with a suspected PI-VSD. Contrast injected into the LV will 
cross the defect (left-right shunt) and enter into the pulmonary arterial tree. This 
“pulmonary arteriogram” is characteristic for a VSD (Figure 1, see above).    
Despite what may be perceived as the obvious value of early catheterization, the value is 
debatable. Opponents of mandatory catheterization advocate that in a clinically deteriorating 
patient in whom the diagnosis is clear it delays surgical management, the dye load may 
worsen already impaired renal function, and some reports suggest that considering the 
patterns of coronary disease typically encountered that coronary revascularization is actually a 
risk factor for a poor outcome (Muehrcke DD , 1992).  Despite these theoretically arguments, 
 
Post Myocardial Infarction Ventricular Septal Defect  
 
33 
from a practical standpoint it is hard to argue the clear benefits of defining the coronary 
anatomy prior to a surgical intervention aimed at treating a complication of coronary – 
particularly given the long-established importance of optimal or complete revascularization.  
Again, since these patients have already undergone catheterization as part of the initial 
management of their initial ischemic event the question whether to proceed with 
catheterization is rarely encountered. However, as many of the patients develop septal rupture 
several days (or weeks) after their initial acute coronary insult, it is hard to argue the need for 
repeat cardiac catheterization if the diagnosis is clear, particularly if the nuances of the 
coronary anatomy have recently been determined.  Conversely, in less clear clinical situations, 
repeat catheterization might suggest an alternative, and potentially more likely, diagnosis such 
as acute stent thrombosis or disruption of an already unstable plaque.   
4.3 Magnetic Resonance Imaging 
Although the diagnosis is often made at the time of initial cardiac catheterization or 
echocardiography, occasionally a PI-VSD may be encountered during other diagnostic 
imaging. While patients might be too hemodynamically unstable or the presence of an intra-
aortic balloon pump (or other ferrous containing or non-MRI safe device) might preclude 
MRI, with the growing indications and utilization of MRI for operative planning, PI-VSD 
might be encountered. Patients with low ejection fractions, cardiomyopathies, or suspicion 
for unusual cardiac anatomy, might have MRI performed to assess for myocardial viability, 
fibrosis, or valvular pathology.  In these patients a PI-VSD may be an unsuspected finding 
(Figure 3). Although there is little literature describing the utility of MRI in PI-VSDs, using 
concepts derived from the literature on congenital shunts and pathology, MRI might be of 
value in assisting in defining the extent of the defect, the shunt fraction, right ventricular 
function, and other associated pathophysiology (Didier, 1986). MRI might be of additive 
value in cases of questionable catheterization or echocardiographic studies or in assessing 
the post-operative patient in which a residual shunt is suspected. Nevertheless, MRI is, in 
general, not considered a first-line imagining diagnostic tool. 
 
 
Fig. 3. Cardiac MRI demonstrating an apical defect. Gated cine images indicated a left to 
right shunt in which quantitative assessment can be used to determine the shunt fractions 
and size of the defect. 
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The pathogensis reflects two different types of rupture. The first, a simple rupture, is a direct 
through-and-through defect that is typically located anteriorly (when associated with a LAD 
territory infarct). Conversely, complex ruptures are believed to result from tracking of blood 
as it dissects thru the septum with left ventricular entry sites remote from right ventricular 
exit sites – these tracks then enlarge over time due to the pressure gradient between the left 
and right ventricle.  Multiple defects are found in 5-11% of cases and emphasized the need 
for a complex pre-operative and intra-operative assessment of all pathways to insure a 
complete repair (Edwards, 1984). Incomplete closure of residual or secondary defects can 
account for post-operative recurrences. Transmural infarcts can be quite extensive with 
defects developing to several centimeters in diameter and can often involve extensive areas 
of the left ventricular free wall. For complex defects, as blood dissects through the necrotic 
myocardium there can be further expansion and damage with loss of cellular integrity.  
With local cellular destruction there is fragmentation with degeneration of myocytes with 
enzymatic digestion and destruction. In patients who survive the acute presentation, up to 
66% develop chronic ventricular aneurysms and a third will have significant functional 
mitral regurgitation from the secondary effects on the ventricular free wall.   
The pathologic consequences and outcomes of surgery of anterior and posterior defects 
appear to be different in ways beyond what can be explained by the degree of shunting.  
Earlier autopsy studies have shown that anterior PI-VSDs were associated with 33% of the 
LV and only 10% of the RV being infarcted, while posterior defects were associated with 
only 20% of the LV and 33% of the RV being infarcted (Cummings, 1977). Particularly 
considering the acute pressure/volume overload and associated RV failure, it becomes 
understandable why posterior based defects have a worse prognosis. 
6. Natural history 
The natural history of untreated PI-VSD is also poorly understood. As advances in the acute 
and chronic management of coronary artery disease continues to evolve, so does 
complications of CAD. In general, 25% of patients with PI-VSDs die within the first 24 hours 
(Berger, 1992). Death is most likely a function of pre-existing comoribidites and potentially 
irreversible and catastrophic heart failure that comes from not only the acute pump failure 
from the precipitating infarct but also the massive acute left to right heart shunting that 
compromises systemic perfusion further. The sudden increase in pulmonary overcirculation 
also contributes to the development of significant right heart failure. For those patients who 
survive the acute event, 1, 2, and 4-week survival is 50%, 35%, and 20% respectively 
(Lemery, 1992). It is easy to appreciate that those patients who survive the first month may 
have inherently favorable factors that might further self-select for a good post-operative 
outcome. Prolonged untreated survival has been reported with up to 7% of patient 
surviving to 1 year – obviously the physiologic insult and over-circulation is minimal.  
7. Timing/indications for surgery 
The mere presence of a PI-VSD is considered an indication for surgery with the majority of 
patients undergoing urgent or emergent operative intervention. The primary goal of VSD 
closure is to reduce the end-organ damage from the combined insults of acute right 
ventricular overload/failure and systemic cardiogenic shock. 
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As soon as the diagnosis is made an intra-aortic balloon pump should be placed. Coronary 
augmentation will assist the ischemic and compromised myocardium, but more importantly 
it will unload the left ventricle and improve cardiac output, end-organ perfusion, and 
reduce pulmonary shunting and over-circulation.  However, the physiologic improvements 
with IABP and other inotropic or vasoactive medications should only be viewed as transient 
and allow for finishing the pre-operative assessment. 
Although some advocate a strategy of delayed repair, this approach is rarely successful.  The 
theory is to give the friable necrotic myocardium time (3-6 weeks) to fibrosis thereby allowing 
for an easier and more secure repair. The scarred tissue will better hold suture and less likely 
to tear apart and result in an early post-operative failure. This approach appears reasonable, 
but it is rare that patients remain stable or can be support during this time period.  While 
guidelines for delayed surgical management are lacking, this might be an option in those who 
are hemodynamically/physiologically stable with a delayed presentation, have no or minimal 
signs of pulmonary hypertension or over-circulation, and have a stable fluid balance with 
good renal function. Unfortunately, such patients are rare and less than 5-10% of all PI-VSD 
patients will survive to allow for delayed repair.  Such an approach may represent a “survival 
of the fittest” perspective in those with minimal shunting and with strict attention to medical 
comorbidities and nutrition a period of close watchful waiting may work. This approach may 
also be used to justify waiting in patients who have other severe comordities preclude 
intervention and would in theory require optimization prior to surgery. Nevertheless, it is 
hard to argue that any other problem would improve to the point of making surgery safer in 
the setting of worsening right ventricular heart failure – a problem that by itself is very 
difficult to treat both pre and post-operatively. Although, one can argue that in these patients, 
unless early surgical repair is clearly contraindicated, that their physiologic reserve combined 
to a minimal pathophysiologic insult predisposes to a good outcome regardless of whether an 
early or late repair is performed.     
8. Operative management 
The initial attempts at repairing PI-VSD followed a surgical approach similar to that for 
congenital VSDs – through a ventriculotomy in the right ventricular outflow track (RVOT) 
(Cooley, 1957). It was quickly appreciated the significant limitations of this approach.  
Firstly, in an already compromised right ventricle, the outflow tract incision only further 
reduced residual RV function. In addition, while suited for many common types congenital 
VSD’s near the aortic valve, the RVOT incision offered poor exposure of defects that tended 
to be much further down the septum towards the apex. Most importantly, because the patch 
and suture line was on the RV side, the defect was still exposed to LV pressures and 
consequently was at increased risk for patch dehiscence, early recurrence, and extension of 
the defect. Pioneering work by animal studies by Heimbecker in 1968 advocated an 
approach to the VSD thru the left ventricle in the region of the culprit vessel through 
infarcted myocardium – i.e., anterior defects approached through the anterior wall while 
posterior defects through the inferior wall.  These techniques addressed the deficiencies of a 
RVOT approach (Heimbecker, 1968). The benefits of these animal studies were subsequently 
validated clinically within several years (Javid, 1972)(Buckley, 1971) 
8.1 General considerations 
After the patient arrives in the operating room, the patient is routinely anesthetized and 
pharmacologically paralyzed. If not already in place, all patients should have arterial 
monitoring lines and a pulmonary artery (Swan-Ganz) catheter inserted. Pressures and 
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(Cooley, 1957). It was quickly appreciated the significant limitations of this approach.  
Firstly, in an already compromised right ventricle, the outflow tract incision only further 
reduced residual RV function. In addition, while suited for many common types congenital 
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oxygen saturations should be obtained to determine shunt fractions and to assist in 
determining the completeness of repair at the end of the procedure. Given that this subset of 
patients possesses a left-to-right shunt, it is of upmost importance to avoid pharmacologic 
agents that cause pulmonary vasodilation, thus worsening the shunt, increasing pulmonary 
over-circulation, and potentially worsening right heart dysfunction. Preoperative antibiotics 
including a first generation cephalosporin, such as cefazolin, and vancomycin are 
administered.  In cases of antibiotic allergies, appropriate alternatives should be chosen. 
Median sternotomy is performed and the patient is prepared for cardiopulmonary bypass.  
Minimally invasive techniques are typically not advocated for this type of extensive and 
complex procedure in which complete exposure of heart is helpful. However, in situations of 
re-operative surgery, depending on surgeon preferences, consideration should be given to 
peripheral cannulation (i.e. femoral or axillary) prior to sternotomy as a re-entry injury to an 
already compromised and dilated RV can be catastrophic. The patient is heparized prior to 
standard aortic – right atrial cannulation. Some advocate routine bicaval venous drainage, but 
typically, as procedures on the tricuspid or mitral valves are not performed, this is not 
necessary. Cold-blood antegrade and retrograde cardioplegia is delivered via conventional 
root and coronary sinus catheters.  Topical cooling to further reduce the metabolic demands of 
the already compromised heart is also liberally used.  This author also routinely uses ice-slush 
wrapped in gauze to further cool the right ventricle to assist in reducing the temperature and 
thereby assisting in myocardial protection. Active or passive systemic cooling is performed 
with an ideal temperature of 25º-28ºC to further assist end-organ protection.   
In general, once the defect is identified, a piece of either glutaraldehyde-fixed bovine 
pericardium or Dacron is cut to not only cover the defect but a generous rim of surrounding, 
and potentially non-viable, myocardium. Continuous suture or interrupted pledgeted 
sutures are used to suture the patch to the residual septum. Tension on the repair must be 
avoided to minimize the risk of the sutures tearing through once the ventricle is pressurized 
and begins to contract. For posterior defects the patch might require anchoring to the 
annulus of the mitral valve. For cases in which the annulus of the mitral valve and/or peri-
valvular tissues is involved, mitral valve replacement may be required.     
The intra-operative approach and management of the defect is based upon the location of 
the VSD and, the need for concomitant procedures. The pre-operative assessment of the 
location of the defect is critical in determining the optimal approach to closing it. 
8.2 Apical defects 
Apical septal ruptures involve the cardiac apex, which includes the apical portion of the 
right ventricle, septum, and the left ventricle. Daggett and colleagues described the 
technique of apical amputation and repair of the PI-VSD in 1970. The initial incision is 
created through the infracted tissue of the cardiac apex. The necrotic myocardium is then 
  
 
Fig. 4. Repair of apical repair involves excising the apical defect and bringing together the 
residual edges of the left and right ventricular walls using a primary repair reinforced with 
pledgets. 
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excised until healthy muscle is exposed and deemed adequate for repair. The healthy tissues 
of the right and left ventricle are then approximated to the septum using interrupted, felt 
pledgeted, heavy Tycron suture in a mattress fashion (Figure 4).  Felt strips are placed along 
the right and left septal walls during this process to create a ‘felt sandwich’. The apical 
repair can be reinforced with a second layer of suture. Meticulous hemostasis is critical. 
 
  
Fig. 5. Left: Intra-operative view of the extensive apical infarction that has resulted in the the 
echocardiographic findings demonstrated in Figure 2. The left anterior descending artery 
(LAD) is shown. Right: The same patient after opening and debridement of the infracted 
apex. The necrotic septum is visualized with a probe in the left ventricle (LV) and the bypass 
“pump sucker” is in the right ventricle (RV). 
8.3 Anterior defects 
The anterior septal rupture involves the anterior septum as well as the anterior left ventricular 
free wall. This, as discussed earlier, is a typically a result of acute infarct of the LAD territory. 
The initial approach is via an incision in the infarcted left ventricular myocardium. The 
infarcted area is then excised and debrided back to healthy, viable myocardium. The septum is 
then inspected and necrotic tissue is excised in the same fashion. This is can be straightforward 
in a single, obvious defect.  However, great care must be taken if the defect is noted to be 
tracking through the myocardium – a finding that might not be obvious and hence a larger 
patch may be used than what would be employed to cover the defect.   
Small defects can be plicated to the right ventricular free wall using interrupted, pledgeted 
suture as first suggested by Shumacker (Shumaker, 1972). For anything other than very 
small (<1.0 cm) defects, most anterior septal infarcts will require repair with a patch. This is 
created in a fashion that will allow for a tension-free repair. Excess tension in the repair can 
lead to devastating consequences and a return trip to the operating room. 
The more complex approaches use a prosthetic patch that is anchored to the posterior wall 
of the septum using interrupted, pledgeted Tycron or Proline suture. The suture is passed 
from a right to left direction so that the patch-septum interface lies in the left ventricle, as 
opposed to the right. The anterior sutures are placed through the right ventricular free wall 
and tagged with hemostats (Figure 6). All sutures are placed prior to placing them through 
the patch. They can now be placed through the designated anterior region of the prosthetic 
patch and then through a second pledget if desired prior to tying the suture knots. The left 
ventricular free wall is then re-approximated using interrupted, mattress suture. A second 
layer of running suture is placed for reinforcement.  
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Fig. 6. Picture representation of the various steps used to repair an anterior defect with the 
patch excluding the necrotic septum from the higher pressure left ventricular cavity. The 




Fig. 7. Intra-operative picture with the apex of the heart elevated (head and aortic cannula to 
the right). The incision is through the infarcted anterior wall. The septal defect is shown in the 
middle of the cavity with circumferential sutures around a wide margin. The sutures will then 
be placed through a pericardial patch to exclude the infracted septal muscle and defect from 
the left ventricular cavity. Note:  This is from a different patient than from the images above 
8.4 Posterior defects 
The posterior or inferior septal rupture involves a transmural infarction of the myocardium 
in the posterior descending arterial distribution. The inferior wall is often thin and after 
infarction, is quite friable. For this reason, primary repair is not a durable option and is 
rarely successful. Attempt at primary repair, in which the myocardium is placed under 
tension, can have disastrous and immediate, and potentially fatal, consequences.  Hence, 
posterior/inferior septal ruptures are the most technically demanding of the PI-VSDs. 
After the heart is arrested, the inferior wall is lifted out of the pericardial well and exposed.  
The transmural infarct may involve both ventricles, or the septum and left ventricle alone.  
The transinfarct incision is created in a longitudinal fashion in the left ventricle. The 
nonviable myocardium is excised, which will create adequate exposure of the septal defect.  
The papillary muscles are inspected. If the base is involved in the infarct resulting in 
ruptured papillary muscle, then mitral valve replacement is warranted.  If a small posterior 
VSD (<1.0 cm) is identified, primary repair to the ventricular free wall using pledgetted 
suture as described earlier is satisfactory – but this situation is very rare and placement of a 
small patch may result in a more durable outcome than risking a primary repair involving 
ischemic myocardial tissue.   
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Large defects will require a tension free repair by utilizing a patch closure. This technique 
often necessitates the use of two separate patches, one dedicated to the septal repair and the 
other to the wall of the ventricle.  Principles as described previously apply. The pledgetted 
mattress sutures are placed from the right ventricle to the left along the circumference of the 
VSD.  The sutures are passed through the contoured patch and tied down. Great care should 
be taken to avoid lacerating the myocardium.  Some authors suggest placing a second 
pledget on the patch side of the repair to minimize this risk. The posterior ventricular wall is 
repaired with the second patch using mattress sutures.  Occasionally, depending on the size 
and quality of free wall myocardium, the free-edges can be approximated and closed 
primarily (and re-enforced with a pericardial or felt strip) rather than using a second patch. 
 
 
Fig. 8. Similar to anterior repairs, the high pressure left ventricular cavity is isolated from 
the necrotic septum with a patch repair.  The incision is along the distal right coronary along 
and parallel to the posterior descending artery through the infracted basal muscle. 
8.5 General principles 
Closure of the ventriculotomy is performed by folding the free edge of the patch to the edge of 
the ventricle to exclude it from the circulation. The ventriculotomy repair is then closed with a 
primary closure re-enforced with strips of either Teflon felt or pericardium.  Exclusion of the 
necrotic myocardium from the left ventricular is also important in minimizing the risk of small 
debris breaking off at any point and causing a systemic embolism.  
Regardless of the location of the ventriculotomy, it cannot be emphasized enough the 
importance of a tension free closure. Any unnecessary tension through injuried or friable 
myocardium may predispose to catastrophic and potentially fatal post-operative bleeding 
once the ventricle becomes pressurized.  In extreme cases involving extensive myocardial 
(free wall and septal) damage, temporary mechanical support with either extra-corporeal 
membrane oxygenation (ECMO) or a left ventricular assist device may help unload the 
ventricle to assist in recovery. The hypothesis behind this approach is by reducing the LV 
pressure, it will encourage recovery, reduce the pressure on the repair, and allow for further 
decision making in patients in whom there is extensive ventricular destruction and residual 
ventricular function may not be adequate to support physiologic needs (Firstenberg, 2009). 
Although the benefits of concomintant revascularization on long-term outcomes are 
debatable, complete coronary revascularization, if possible, is typically advocated 
(Heitmiller, 1986). As with other risk models for outcomes after surgery (e.g. EuroScore and 
STS models), it is the need for revascularization and the extent of underlying CAD that 
defines the long-term outcome rather than the actual performing of the procedure. Overall, 
the paradigm of complete and/or optimal revascularization should apply in cases of PI-VSD 
management.  It is hard to argue the conceptual benefits of revascularization in the setting of 
an already acutely and chronically compromised myocardium.  
9. Post-operation management 
The post-operative management of patients following successful repair should be similar to 
that of other high-risk surgical patients. However, there are several key points that need to 
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be considered. As these patients often present and are taken to the operating room in acute 
decompensated heart failure, strict attention to optimizing biventricular function is critical. 
Post-operative left ventricular dysfunction is not uncommon and, unless already in place, 
there should be a low threshold for placement of an intra-aortic balloon pump (IABP). 
While, as discussed later, the use of an IABP is often associated with worse outcomes, the 
relationship is the need for it and the potential delaying in initiating it’s use rather than the 
therapy itself that influences the outcomes. Right heart failure is common and often these 
patients require considerable therapies directed specifically at assisting in right heart 
recovery. Conventional intravenous agents such as epinephrine, milrinone, and dobutamine 
are often required – and sometimes at high doses. Inhaled agents that selectively reduce 
pulmonary vascular resistance and assist in reducing RV afterload such as inhaled nitric 
oxide (20-80 ppm) or Epoprostenol (2,500 – 20,000 ng/min) may be required (Rich, 1993). 
Ventricular arrhythmias are also common from the residual ischemic/necrotic myocardium 
(as well as secondary to the ventriculotomy) and anti-arrhythmic medications, such as 
Amiodarone, should be used liberally. In addition, as the repaired septal defect and free 
wall are often quite friable, strict attention to avoid hypertension is critical as even transient 
elevations in blood pressure can result in disruptions in the patch repair that might 
precipitate uncontrolled and fatal LV bleeding.  Any acute increase in chest tube drainage 
should raise the concern for ventricular suture line dehiscensce and there should be a low 
threshold for returning the patient to the operating room for re-exploration – however, 
excess manipulation of the heart in the search for bleeding should be avoiding at the risk of 
catastrophic suture-line tearing in a beating and pressurized ventricle. Although recovery in 
these patients is unpredictable and may be prolonged and a slow wean of inotropes may be 
required, there should be a low threshold for repeat and/or frequent echocardiographic 
assessment in a patient who is not improving as predicted. Repeat echocardiophy might 
show a residual shunt or valvular dysfunction, more importantly would be identification 
easy to correct problems, such as tamponade.   
10. Outcomes: predictors of survival 
The increasing rarity of PI-VSD implies that few centers are able to report an extensive 
series.  While several large single center experiences and outcomes have been reported, most 
summarize years of experience and may not consider the ongoing evolution in the peri-
operative management and improvement in surgical skills and judgment of these critically 
ill patients. 
Deja and colleagues reported their experience with 117 patients from the Glenfield General 
Hospital in England.  The mean age was 65 ± 8 years and there were 43 females.  Of the 117, 
76 were anterior defects while 34 were posterior. One third of patients presented in 
cardiogenic shock. The average time from AMI to the development (or diagnosis) of a PI-
VSD was 6 days and there was an additional 9-day average interval before surgical 
intervention.  There overall mortality was 37% - not including a 6.4% intra-operative 
mortality.  40% have evidence of a residual left-right shunt with 13 patients undergoing 
early re-operation with 30% mortality in the re-op group. Table 1 summarizes their overall 
results. Their overall predictors of post-operative mortality include: shock at time of 
surgery, clinical deterioration while awaiting surgery, need for concomitant CABG, and pre-
operative renal failure (as a marker for shock and organ failure). Criticisms of these results 
include that earlier surgical intervention after initial diagnosis might have resulted in less 
end-organ damage and an already compromised patient (Deja MA, 2002). 
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Overall surgical mortality (%) 37% 
Intra-operative mortality (%) 6.4 % 
ICU Stay (days) 4.8 days 
Major inotropic support 90 % 
Used of Intra-aortic balloon pump 75 % 
Need for extra-corporeal membrane oxygenation (ECMO) 2 % 
Ventilator Time (hours) 40 hours 
Tracheostomy 5% 
Continuous renal replacement 16 % 
Re-exploration/bleeding 5 % 
Stroke 5 % 
Residual shunt 40% 
Table 1. Post-Operative Complications Following Surgical Repair (From Deja MA, 2002) 
National registry data has proven useful to define the real-world experiences with the 
presentation and management of PI-VSD. In the report of 189 patients from Sweden, several 
factors were able to predictable favorable vs unfavorable short (<30 days) and long-term 
(>30) outcomes (Tables 2 and 3) (Jeppsson, 2005). 
 
Favorable Predictors Unfavorable Predictors No effect on outcome 
Short time from MI to Dx IABP Age 
Short time from Dx to OR Stroke/Coma Gender 
Short time from MI to OR Renal failure Pre-OP IABP 
Pre-operative catheterization Re-op for bleeding Pre-OP Lytic therapy 
Anterior rupture  Concomitant CABG 
  Residual shunt 
Table 2. Predictors of short-term (<30-day) survival based on National Swedish Experience 
(Adapted from Jeppsson et al.  Euro J Cardiothor Surg 2005;27:216-221). CABG: Coronary 
artery bypass surgery, Dx: Diagnosis, IABP: Intra-aortic balloon pump, MI: Myocardial 
infarction. 
 
Favorable Predictors Unfavorable 
Predictors 
No effect on outcome 
Younger age Pre-Op IABP Anterior rupture 
 Pre-Op Cath Time from MI to OR 
 Need for CABG Post-Op stroke 
 Renal Failure requiring 
dialysis Pre-OP Lytic therapy 
 Residual shunt Post-Op IABP 
  Re-op for bleeding 
Table 3. Predictors of Long-Term (>30 day).   See above for legend. 
In a similar national registry experience, Cerin and colleagues reported the outcomes in 58 
patients treated with PI-VSD from 1992 to 2000 in Italy (Cerin, 2003). The mean age was 73 
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Overall surgical mortality (%) 37% 
Intra-operative mortality (%) 6.4 % 
ICU Stay (days) 4.8 days 
Major inotropic support 90 % 
Used of Intra-aortic balloon pump 75 % 
Need for extra-corporeal membrane oxygenation (ECMO) 2 % 
Ventilator Time (hours) 40 hours 
Tracheostomy 5% 
Continuous renal replacement 16 % 
Re-exploration/bleeding 5 % 
Stroke 5 % 
Residual shunt 40% 
Table 1. Post-Operative Complications Following Surgical Repair (From Deja MA, 2002) 
National registry data has proven useful to define the real-world experiences with the 
presentation and management of PI-VSD. In the report of 189 patients from Sweden, several 
factors were able to predictable favorable vs unfavorable short (<30 days) and long-term 
(>30) outcomes (Tables 2 and 3) (Jeppsson, 2005). 
 
Favorable Predictors Unfavorable Predictors No effect on outcome 
Short time from MI to Dx IABP Age 
Short time from Dx to OR Stroke/Coma Gender 
Short time from MI to OR Renal failure Pre-OP IABP 
Pre-operative catheterization Re-op for bleeding Pre-OP Lytic therapy 
Anterior rupture  Concomitant CABG 
  Residual shunt 
Table 2. Predictors of short-term (<30-day) survival based on National Swedish Experience 
(Adapted from Jeppsson et al.  Euro J Cardiothor Surg 2005;27:216-221). CABG: Coronary 
artery bypass surgery, Dx: Diagnosis, IABP: Intra-aortic balloon pump, MI: Myocardial 
infarction. 
 
Favorable Predictors Unfavorable 
Predictors 
No effect on outcome 
Younger age Pre-Op IABP Anterior rupture 
 Pre-Op Cath Time from MI to OR 
 Need for CABG Post-Op stroke 
 Renal Failure requiring 
dialysis Pre-OP Lytic therapy 
 Residual shunt Post-Op IABP 
  Re-op for bleeding 
Table 3. Predictors of Long-Term (>30 day).   See above for legend. 
In a similar national registry experience, Cerin and colleagues reported the outcomes in 58 
patients treated with PI-VSD from 1992 to 2000 in Italy (Cerin, 2003). The mean age was 73 
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years/old. Thirty-six percent presented in acute renal failure, 33% were in atrial fibrillation, 
and 22% were insulin dependent diabetics.  57% were in NYHA Class IV heart failure with 
41% in cardiogenic shock.  Intra-aortic balloon pumps were used in only 20% of patients and 
60% presented with significant mitral regurgitation.  The timing of surgery was 14 ± 12 days 
from the acute event with 76% undergoing surgery within the first 3 weeks and 31% within 
the first 24 hours. A key point is again emphasizing the importance of early diagnosis and 
surgery before the onset of shock and organ failure (Table 4). 
 
 Survivors (n=28) Death (n=30) 
Time to OR (d) 21 ± 13 11 ± 8 
OR < 24hrs 18 % 43 % 
Pre-Shock 28 % 57 % 
Pre-sPAP (mmHg) 42 ± 11 56 ± 14 
CPB time (time) 95 ± 28 126 ± 35 
Post-IABP 39 % 90 % 
Post-LVEF (%) 45 ± 2 29 ± 2 
Post-Op Renal Failure 25 % 66 % 
Table 4. Italian Registry Data.  Legend:  CPB: Cardiopulmonary bypass, IABP: Intra-aortic 
balloon pump, LVEF: Left ventricular ejection fraction, sPAP: Systolic pulmonary artery 
pressures.  Table adapted from Cerin et al.  Inter Soc Cardiovasc Surg 2003;11:149-154 
More recently, Mantovani et al reported their 19-year, single center, experience in 50 
patients. Between 1983 and 2002, 50 consecutive patients with a mean age of 66 ± 9 years 
(range: 45-81) who presented with either anterior (n=30, 60%) or posterior (n=20, 40%) PI-
VSDs.  Patients developed their defects on average 4 days post-AMI with most within the 
first week (76%) and only 2 patients presenting after 2 days. Cardiac catheterization was 
performed in 98% of patients (51% single vessel disease, 35% double, and 14% triple).  56% 
of patients required a pre-operative IABP and 74% underwent emergent surgery on average 
2 days after diagnosis of a PI-VSD. Operative mortality (within 30 days) was 36% with 6 
dying in the operating room.  Posterior defects were associated with 50% mortality versus 
25% for anterior.  Other univariate risk factors for early death included: emergent surgery 
(p=0.02); cross-clamp time >100 minutes (p=0.035); and delayed surgical intervention (>3 
days post diagnosis, p=0.0055).  Interestingly, in their experience factors not associated with 
operative mortality included: gender, extent of CAD (single vs triple vessel disease), need 
for CABG, age (>65 years), or the year of operation (before/after 1992).  In a logistic 
regression analysis, only emergent surgery (odds ration: 10.23) and a delayed treatment 
(OR: 4.03) were the only predictors of early mortality. Long-term survival was 76.5 ± 7.8 and 
56.1 ± 11.5% at 5 and 10 years. No obvious predictors of long-term survival were found in 
their analysis although patients with residual myocardium at risk from unrevascularized 
regions tended to have a worse long-term prognosis (Mantovani, 2006).         
In the GUSTO trial in which 41,021 patients were randomized to different strategies of 
reperfusion during AMI, 84 developed a PI-VSD.  34 of these were managed surgically, with 
31 (90%) undergoing early treated and 3 (10%) undergoing delayed surgery. Survival in the 
surgical group was 53% at 30 days and 47% at 1 year. Conversely, for those treated 
medically, as an indicator of the lethality of this problem, survival at 30 days and 1 year was 
6% and 3%, respectively (Crenshaw, 2000).  All patients who presented in Class III or IV 
heart failure died.  
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11. Controversial topics 
11.1 Percutaneous closure devices 
Successful application of closure devices in children with congenital VSDs combined with 
the morbidity and mortality associated with surgical management has prompted 
enthusiasm for the use of percutaneous closure devices. The role of such devices has been 
proposed for both the primary closure of acute defects and to assist in the closure of 
recurrent or residual shunts (Shah, 2005).     
While conceptually promising, initial experiences were discouraging and improvements in 
outcomes were not observed (Pienvichit, 2001). Difficulties in covering not only the actual 
defect, but also the residual necrotic myocardium predisposed to early recurrence. Early 
devices tended not to be large enough and were very difficult to position (or re-position if 
necessary).   
In addition, the lack of a overall survival benefit further illustrates that clinical outcomes are 
not only dictated by closure of the VSD, but sometimes more importantly, a function of the 
extend of the myocardial infarction – which might be inherently so extensive as to preclude 
survival. 
11.2  Mechanical support 
As discussed, despite advances in surgical and post-operative management, operative 
mortality is still 10-60%. Even with early intervention biventricular failure is often a 
significant factor in early post-operative deaths. Short and long-term mechanical support, 
beyond intra-aortic balloon counterpulsation, is a reasonable option in patients with post-
operative ventricular (left, right, or bi) failure and who are felt to be salvagable. Short-term 
support may be required as a bridge to recovery, while long-term device may be indicated 
for those with irreversible ventricular failure.   
In cases in which there is extensive ventricular infarction/failure, associated free-wall 
rupture, or when there is excessive bleeding or tension from the ventriculotomy temporary 
left ventricular support should be considered. With LVAD inflow drainage from the left 
atrium, the LV is unloaded (i.e. ‘atrialized’) and may allow time for recovery/healing prior 
to exposing the injured LV to system pressures and contractile function (Firstenberg 2009). 
Right ventricular support is also difficult following the acute volume/pressure overload of a 
PI-VSD with recovery unpredictable and potentially prolonged. Unfortunately, there is little 
data to support this use in this application other than clinical judgment and center 
experience. 
Residual shunts after repair pose a unique challenge for patient’s requiring mechanical 
support. Careful attention to left and right ventricular flows and pressures are critical to 
compensate for the residual shunt – and prevent worsening of over-circulation (Sai-
Sudhakar, 2006). If residual shunts are significant then biventricular support may allow for a 
period of recovery and stabilization prior to an attempted repair in an otherwise very high-
risk surgical patient.  
The need for mechanical support, while attractive in unstable post-operative patients, is also 
associated with difficult problems. Often there is need for aggressive anti-coagulation, the 
need for multiple surgical procedures (i.e. device change-outs, explants, etc), and overall 
patient recovery is more difficult when tethered to external VAD controllers.   
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A total artificial heart precludes native cardiac recovery and obligates transplantation, 
nevertheless, it may be an option with appropriate resources and experience in highly 
selected patient with few other comorbidities. 
11.3 Residual/recurrent defects 
Residual shunts are found in up to 25% of patients after definitive repair (Skillington, 1990). 
The etiology of residual shunts is either a missed defect at the time of initial repair, 
dehiscence of a patch (sewn to necrotic or friable tissue), or further extension of the initial 
defect. Fortunately, most residual shunts tend to be physiologically tolerated and 
spontaneous closure has been reported.  Operative re-intervention is associated with a >60% 
mortality (Jeppsson, 2005) and surgery is reserved for patients in heart failure failing 
medical management or those with large shunts (Qp:Qs>2.0) (Murashita, 2010).  Because of 
the high operative mortality with repairing residual or recurrent shunts there has been 
interest, but limited success, with percutanous closure devices (Shah, 2005).  Nevertheless, 
the role of percutaneous closure and the ideal devices are undefined (Pienvichit, 2001) and 
probably best reserved for use in those centers with extensive experience in the closure of 
congenital VSDs. 
12. Conclusions 
Post-myocardial infarction ventricular septal defects complicate up to 0.02% of acute 
myocardial infarctions. Despite advances in the surgical care of these moribund patients, 
operative mortality still approaches 50% with major risks including cardiogenic shock, renal 
failure, right and/or left ventricular failure, size of VSD, posterior/inferior locations, and 
residual VSD. While some patient may present late or benefit from a delayed repair, 
typically surgical intervention is indicated prior to irreversible end-organ damage. Repair 
techniques emphasize closure of the defect and protecting the injured septum from left 
ventricular pressures. Post-operative management is typically challenging considering the 
inherent pre-operative biventricular dysfunction and associated end-organ damage. Those 
who survive there initial event and operation tend to have favorable 5 and 10-year survivals. 
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1. Introduction 
Coronary artery bypass grafting (CABG) using cardiopulmonary bypass (CPB) and 
cardioplegic arrest has been performed safely over several decades. Cardiac surgery under 
cardiac arrest provides a bloodless stable operative field, that can facilitate anastomosis. In 
last decade, CABG without CPB, off-pump CABG (OPCAB) has become more common with 
advances in surgical instruments and technique. This chapter summarizes the surgical 
technique, risks and benefits of OPCAB. 
2. Technical aspects 
2.1 Anesthesia 
After standard sternotomy and appropriate graft harvesting, a pericardial well is created. 
A standard dose of heparin is administered by the anaesthesiologist. The anaesthesia team 
should be prepared to perform appropriate hemodynamic monitoring. We use 
transesophageal echocardiography and Swan-Gantz catheters to monitor cardiac function 
in all patients. Activated clotting time above 350 is sufficient to perform OPCAB; 
however, a full dose of heparin may be given in cases undergoing emergent conversion to 
CABG using CPB. The anaesthesiologist should inform the surgical team any abrupt 
decrease in blood pressure, ST changes on EKG and arrhythmia, because these are signs 
for possible emergent conversion to CPB. 
2.2 Retropericardial suture 
The patient is placed in the Trendelenburg position and the sternal retractor is open 
widely. Right side stitches holding the pericardial well are released to minimize 
compression of the right heart. While the apex of the heart is gently elevated using one 
hand, retropericardial sutures are placed to support the heart (Figure 1). To minimize 
hemodynamic instability, we place the first retropericardial stitch into the mid-portion of 
the diaphragm. The stitch is pulled out to the right side of the lower edge of the skin 
incision and tightly secured so that the heart is somewhat elevated. The second deep 
pericardial stitch is applied to the midportion between the inferior vena cava and the left 
lower pulmonary vein, and the stitch is passed though a rubber catheter so that the heart 
will not be injured by the retropericardial sutures.  
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Fig. 1. A model of retropericardial suture. 
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The third stitch is applied inferior to the left upper pulmonary vein and is also passed through 
a rubber catheter. Usually three retropericardial sutures are sufficient to support the heart; 
however, an additional retropericardial suture can be added between the last two 
retropericardial sutures. An abrupt drop in blood pressure may occur during retropericardial 
suture placement. This hemodynamics instability is usually transient and injection of a small 
dose of vasoconstrictor or volume management will be enough to regain blood pressure. ST 
segment changes on EKG during the heart displacement is often observed in patients with 
severe left main disease. Preoperative intra-aortic balloon pump (IABP) placement would be 
helpful to maintain hemodynamic stability. If there is a persistent drop in blood pressure, ST-
segment changes, and/or ventricular arrhythmia occurs during the manipulation of the heart, 
it is an indication to abort the OPCAB and convert to on-pump CABG. If the patient is not 
tolerating the short period of heart displacement during retropericardial suture placement, the 
patient most likely would not tolerate a longer period of heart displacement while performing 
anastomoses. Some surgeons may use suction-cup device to place the heart in an appropriate 
position. The use of a suction cup device and the use of retropericardial sutures have been 
proven to have similar effects (Gunnert et al., 2008). 
2.3 Anterior wall revascularization 
Anastomosis to the left anterior descending artery (LAD) using the internal mammary artery 
(IMA) graft is key to the success of OPCAB so that the LAD can be perfused after anastomosis. 
Without the Trendelenburg position, minimal elevation of the left heart with one or two 
sponges is usually sufficient to approach to the LAD. If the right ventricle is compressed and 
venous return is decreased, a significant decrease in blood pressure can  occur. To avoid stress 
on the right system, the right pleura may be opened. This allows the heart to herniate into the 
right pleural space during heart displacement and minimizes the hemodynamic compromise.. 
After exposure of the target vessel, a suction type coronary stabilizer is placed on the target 
vessel. Before making coronary arteriotomy, a proximal snare is placed to the coronary artery 
slightly proximal to the anastomosis area using a silicone suture (Figure 2 top). EKG and blood 
pressure are carefully monitored by anesthesiologists. An arteriotomy is made on the target. 
Then a intracoronary shunt is quickly inserted into the coronary artery (Figure 2 middle) and 
the proximal snare is released (Figure 3 bottom) (Emmiler et al., 2008).  
The sizing of the shunt is important. If a larger shunt is selected relative to the coronary 
artery size, the surgeon may encounter difficulty in placing the shunt into the coronary 
artery; moreover, vigorous forceful insertion of the shunt may cause injury or local 
dissection of the coronary artery. On the contrary, if a smaller shunt relative to the coronary 
artery is selected, the surgeon may experience excessive amount of bleeding from the 
anastomosis site, and smaller shunt may not able to supply enough blood distally. A CO2 
mister-blower helps to provide a bloodless operative field. Anastomosis is performed in the 
standard manner; however additional care is always taken not to place a suture into the 
shunt. Right before completion of the anastomosis the proximal snare is tightened, the shunt 
is removed, and then the sutures are tied. Removal of the proximal snare allows abrupt 
restoration of distal coronary flow. In some cases of a small target coronary artery, the 
anastomosis can be performed without a shunt using a proximal snare only. If the target 
vessel is totally occluded vessel, the proximal snare is not necessary because of lack of 
forward blood flow. The IMA flow should be checked with ultrasound doppler before  
posterior or inferior wall revascularization. 
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Fig. 2. Suction stabilizer and proximal snare is placed on to the target vessel (top). A shunt 
tube is placed thought the arteriotomy (middle). Proximal snare is open after shunt tube 
placement and the coronary vessel is ready to anastomose (bottom) 
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2.4 Posterior and inferior wall revascularization 
After IMA-LAD anastomosis, anastomoses to the obtuse marginal branch (OM) or posterior 
descending artery can be performed. Prior to the OM anastomosis, the patient is placed in a 
steep Trendelenburg and left side up position on the operating table. The heart is gently 
elevated using a hand and then the heart can be rested on the retropericardial sutures. If the 
blood pressure drops, the heart is placed back into the natural position and wait for 
recovery. The previous IMA-LAD graft should stay open and this IMA-LAD flow will help 
the hemodynamics during the OM anastomosis is completed. Phenylephrine is a first drug 
of choice for hypotension during the anastomosis, because phenylephrine increase blood 
pressure without causing tachycardia. If persistent hypotension occurs, conversion to on-
pump should be considered. However, we found most of patient with normal left 
ventricular function will tolerate displacement of the heart during the anastomoses. After 
adequate exposure of the target vessel, a stabilizer is placed onto the target. Confirmation of 
stable hemodynamics is necessary prior to making an arteriotomy. In a sequential manner, 
proximal snare placement, arteriotomy, shunt placement, release of the proximal snare, and 
then anastomosis are performed. Arterial blood drawn by the anesthetist should be avoided 
during the anastomosis of the posterior wall. After the OM anastomosis, the position of the 
operating table is returned to zero and maintain the Trendelenburg position. Anastomosis to 
the inferior wall is performed in a similar manner. 
2.5 Proximal anastomosis 
Proximal anastomoses are performed after all distal anastomoses. The patient is placed in a 
slight reverse Trendelenburg position, systolic blood pressure is controlled by anesthesia 
with a target of 110 mm Hg, so that the proximal clamp is not dislodged during the 
proximal anastomosis. Displacement of the proximal clamp during the proximal 
anastomosis is dangerous and may cause massive exsanguination, and may also cause aortic 
dissection. After achieving an adequate blood pressure, a side-biting clamp is gently applied 
to the ascending aorta. An aortotomy is made and proximal anastomosis is completed in the 
standard manner. The side-biting clamp is removed and the grafts are de-aired. Proximal 
anastomosis of the graft may be performed before the distal anastomosis, especially if a 
proximal automatic anastomosis device is used. The automatic proximal anastomosis device 
is useful for the patient with severe calcification of the aorta. 
2.6 Doppler assessment to the grafts 
After completion of all anastomoses, the blood flow of the grafts should be accessed using 
an ultrasound flow probe. A poor graft flow mandates additional attention to the 
anastomosis and consider revision of the graft anastomosis (Kim et al., 2005). Protamine is 
administered after confirmation of the graft flow and then the chest is closed in the standard 
manner. 
2.7 Postoperative management  
Without using CPB, the fibrinolytic activity of the patient who undergo OPCAB is lower 
than those who undergo conventional CABG using CPB. After OPCAB surgery, patient may 
develop a hypercoagulable state. To avoid platelet aggregation at the anastomosis site, 
clopidogrel is started as early as postoperative day 0 (Quigley et al, 2003). Other 
postoperative managements are similar to those after on-pump CABG. 
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Fig. 3. Examples of anterior (top), posterolateral (middle), and inferior (bottom) 
revascularization. 
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3. Advantages of OPCAB 
In general, those who are considered to be contraindicated for on-pump CABG, such as 
patients with calcified aorta, advanced age, and significant comorbidities, can be a candidate 
for OPCAB. OPCAB does not require CPB and theoretically eliminates all CBP-related 
complications. OPCAB can reduce blood loss and the need of transfusion. OPCAB has known 
to provide less myocardial enzyme release, fewer incidence of neurocognitive dysfunction and 
postoperative renal injury than conventional CABG. Studies found OPCAB can make patient 
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Table 1. The patients that benefit most from CABG 
3.1 Mortalities 
Studies have shown that postoperative mortality is favorable to OPCAB (Puskas et al., 2003, 
Cleveland et al., 2001, Puskas et al., 2008). Mortality benefit from OPCAB is more obvious in 
high risk patients. (Hirose et al., 2010). The reasons are multifactorial as discussed below; 
however, the benefit most likely related to the avoidance of CPB. 
3.2 Stroke 
Postoperative strokes are the most disabling complication after CABG. Avoidance of aortic 
cannulation and aortic cross clamping decreases the risk of stroke and distal emboli. The 
incidence of postoperative stroke is favorable to OPCAB compared to on-pump CABG; 
however stroke has not been completely eliminated by OPCAB (Puskas et al., 2003, 
Cleveland et al., 2001, Sabik at al., 2002). The use of side-biting clamp for proximal 
anastomosis is potentially the cause of postoperative stroke. Calafiore reported that the 
stoke rate without using side-biting clamp was 0.2%, which was significantly lower than the 
stroke rate with side-biting clamp (1.2%) (Calafiore et al., 2002). All in-situ grafting using 
bilateral mammary arteries, gastroepiploic arteries and Y-composite grafting eliminates 
proximal aortic anastomoses. Using this aorta-non-touch surgery, theoretically no 
intraoperative stroke would occur and the postoperative risk of stroke should be minimal 
(Hirose et al., 2004). An investigation demonstrated that OPCAB significantly reduced the 
incidence of intraoperative stroke; however, the incidence of delayed strokes occurring more 
than 48 hours after OPCAB was similar to that after on-pump CABG (Nishiyama et al., 
2009). These delayed strokes are not to be related to aortic manipulation during surgery, but 
could be related to a hypercoagulable state and/or postoperative atrial fibrillation. 
3.3 Neurocongnitive dysfunction 
Neurocongnitive disorder after CPB is a well known phenomenon, so called “pump head.” 
Prolonged CPB time is a risk factor for postoperative neurocongnitive disorder, most likely 
related to non-pulsatile flow, hypothermia, low perfusion pressure, systemic inflammatory 
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could be related to a hypercoagulable state and/or postoperative atrial fibrillation. 
3.3 Neurocongnitive dysfunction 
Neurocongnitive disorder after CPB is a well known phenomenon, so called “pump head.” 
Prolonged CPB time is a risk factor for postoperative neurocongnitive disorder, most likely 
related to non-pulsatile flow, hypothermia, low perfusion pressure, systemic inflammatory 
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state, and most importantly micro-emboli from CPB. Studies of s100 protein, a marker of 
neurological damage, have shown lowers s100 protein after OPCAB compared to those after 
on-pump CABG; however, the incidence of clinical neurocongnitive manifestation was 
similar between OPCAB and on-pump CABG (Lloyd et al., 2000). The benefit of OPCAB in 
relation to neurocongnitive disorder remains controversial (Van Dijk et al., 2002, Browne et 
al., 1999, Marasco et al., 2008). 
3.4 Inflammatory reaction 
Contact between the blood and the CPB circuit triggers an inflammatory cascade. Cytokines, 
complements and coagulation-fibrinolytic system are activated by CPB, which inducing 
CPB-related inflammatory responses (Ngaage, 2003). This inflammatory response 
contributes to the increase in capillary permeability, fluid shift, and decrease in tissue 
perfusion. Systemic inflammatory response syndrome may cause multi-organ failure, 
including lung, brain, kidney and heart, which may promote patient mortality. Significant 
decrease in inflammatory markers has been observed in OPCAB compared to that in on-
pump CABG (Ascione et al., 2000). Avoidance of CBP reduces the inflammatory state and 
contributes to early patient recovery (Raga, 2004). CPB-related inflammatory response could 
cause pulmonary edema resulting in hypoxia, brain edema resulting in neurocognitive 
disorder, renal hypoperfusion resulting in acute renal failure, and edema of the heart 
resulting in low cardiac output syndrome. 
3.5 Blood transfusion 
Perioperative anaemia among the patient undergoing CABG is common.  Hemodilution 
may occur from the circuit and tubing of the CPB.  The use of CPB activate fibrinolytic 
activity and reduce the actual number of platelet and function of the platelet, which 
aggregates perioperative blood loss anaemia (Khuri et al., 1992). Studies have shown that 
OPCAB has clear benefits in blood preservation. Postoperative blood loss and transfusion 
requirements are smaller in OPCAB than in on-pump CABG in almost all studies 
(Muneretto et al., 2003). Avoiding the need for transfusion is critical in caring for Jehovah’s 
Witness patients. 
3.6 Renal function 
Hypoperfusion of the kidney during CABG may cause postoperative renal dysfunction. 
Risk factors for renal dysfunction are often observed in patients who undergo CABG, such 
as patients with diabetes, hypertension and peripheral vascular disease. Non-pulsatile flow 
and low perfusion pressure due to CPB contribute to hypoperfusion of the kidney, causing 
postoperative kidney injury (Laffey et al., 2002). The duration of CPB has been known to be 
directly related to the incidence of postoperative renal failure. The postoperative rise in 
creatinine after OPCAB is less frequently observed than that after on-pump CABG (Celik et 
al., 2005). A lower incidence of postoperative renal failure is observed after OPCAB 
(Calafiore et al., 2003). This renal protection with OPCAB would be most beneficial for 
patients showing moderate or severe preoperative renal dysfunction (Hirose et al., 2001). 
3.7 Respiratory function 
A randomized trial showed that OPCAB provides lower pulmonary compliance, better gas 
exchange after surgery than on-pump CABG (Staton et al., 2005). Clinically, intubation time 
after surgery as shorter after OPCAB than after on-pump CABG (Puskas et al., 2008). 
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3.8 Atrial fibrillation 
Atrial fibrillation is the most common arrhythmia after cardiac surgery and occurs in 25-40 
% of patients. The incidence of atrial fibrillation after OPCAB is known to be less than that 
for on-pump CABG (Ascione et al., 2000, Raga et al., 2004). Avoiding atrial cannulation and 
preserving the anterior epiaortic fat pad may contribute to lowering the incidence of 
postoperative atrial fibrillation (Cummings et al., 2004). 
3.9 Patient recovery 
Due to the benefits listed above, OPCAB provides overall decreased postoperative 
complications and mortality (Puskas et al., 2008, Reston et al., 2003, Legare et al., 2004). 
Postoperative hospitalization is shorter in OPCAB patients than that in on-pump CABG 
(Puskas et al., 2003, Cleveland et al., 2001, Van Dijk et al., 2001). Earlier patient recovery in 
OPCAB could be related to reduced inflammatory reaction compared to that after on-pump 
CABG. The benefits of early recovery following OPCAB are more strongly apparent in high-
risk patients (Stamou et al., 2005, Puskas et al., 2009). 
3.10 Cost 
The cost effectiveness of OPCAB can be explained by the reduced utilization of the blood 
products, shorter intubation time, shorter ICU stay, shorter hospitalization, and reduced 
postoperative complications, as described above (Scott et al., 2009, Puskas et al., 2004). 
4. Potential problems and disadvantages of OPCAB 
In general, the disadvantage of OPCAB is associated with surgical technique. Despite 
advances in surgical instruments, exposure of the posterior wall could be potentially 
difficult, especially in a patient with poor ventricular function or when the surgeon has not 
had adequate training in OPCAB. Inadequate exposure of the target results in fewer number 




Unable to maintain hemodynamics during anastomosis 
ST changes or ventricular tachycardia during anastomosis 
Redo surgery 
Poor ventricular function, ischemic mitral regurgitation 
Poor coronary target 
Small, intramyocardial, and/or calcified coronary artery 
Young healthy patient 
Table 2. The patients that the benefit least from OPCAB 
4.1 Myocardial protection 
Postoperative cardiac enzyme release is lower after OPCAB than after on-pump CABG. 
(Van Dijk et al., 2001) However, in a patient in cardiogenic shock with a failing heart, 
placement on the CPB is unavoidable to prevent further end organ damage, and the role of 
OPCAB is limited because of hemodynamic instability. If the patient is experiencing global 
ischemia, pump failure and unstable hemodynamics, OPCAB should not be performed. 
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perfusion. Systemic inflammatory response syndrome may cause multi-organ failure, 
including lung, brain, kidney and heart, which may promote patient mortality. Significant 
decrease in inflammatory markers has been observed in OPCAB compared to that in on-
pump CABG (Ascione et al., 2000). Avoidance of CBP reduces the inflammatory state and 
contributes to early patient recovery (Raga, 2004). CPB-related inflammatory response could 
cause pulmonary edema resulting in hypoxia, brain edema resulting in neurocognitive 
disorder, renal hypoperfusion resulting in acute renal failure, and edema of the heart 
resulting in low cardiac output syndrome. 
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Perioperative anaemia among the patient undergoing CABG is common.  Hemodilution 
may occur from the circuit and tubing of the CPB.  The use of CPB activate fibrinolytic 
activity and reduce the actual number of platelet and function of the platelet, which 
aggregates perioperative blood loss anaemia (Khuri et al., 1992). Studies have shown that 
OPCAB has clear benefits in blood preservation. Postoperative blood loss and transfusion 
requirements are smaller in OPCAB than in on-pump CABG in almost all studies 
(Muneretto et al., 2003). Avoiding the need for transfusion is critical in caring for Jehovah’s 
Witness patients. 
3.6 Renal function 
Hypoperfusion of the kidney during CABG may cause postoperative renal dysfunction. 
Risk factors for renal dysfunction are often observed in patients who undergo CABG, such 
as patients with diabetes, hypertension and peripheral vascular disease. Non-pulsatile flow 
and low perfusion pressure due to CPB contribute to hypoperfusion of the kidney, causing 
postoperative kidney injury (Laffey et al., 2002). The duration of CPB has been known to be 
directly related to the incidence of postoperative renal failure. The postoperative rise in 
creatinine after OPCAB is less frequently observed than that after on-pump CABG (Celik et 
al., 2005). A lower incidence of postoperative renal failure is observed after OPCAB 
(Calafiore et al., 2003). This renal protection with OPCAB would be most beneficial for 
patients showing moderate or severe preoperative renal dysfunction (Hirose et al., 2001). 
3.7 Respiratory function 
A randomized trial showed that OPCAB provides lower pulmonary compliance, better gas 
exchange after surgery than on-pump CABG (Staton et al., 2005). Clinically, intubation time 
after surgery as shorter after OPCAB than after on-pump CABG (Puskas et al., 2008). 
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Atrial fibrillation is the most common arrhythmia after cardiac surgery and occurs in 25-40 
% of patients. The incidence of atrial fibrillation after OPCAB is known to be less than that 
for on-pump CABG (Ascione et al., 2000, Raga et al., 2004). Avoiding atrial cannulation and 
preserving the anterior epiaortic fat pad may contribute to lowering the incidence of 
postoperative atrial fibrillation (Cummings et al., 2004). 
3.9 Patient recovery 
Due to the benefits listed above, OPCAB provides overall decreased postoperative 
complications and mortality (Puskas et al., 2008, Reston et al., 2003, Legare et al., 2004). 
Postoperative hospitalization is shorter in OPCAB patients than that in on-pump CABG 
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OPCAB could be related to reduced inflammatory reaction compared to that after on-pump 
CABG. The benefits of early recovery following OPCAB are more strongly apparent in high-
risk patients (Stamou et al., 2005, Puskas et al., 2009). 
3.10 Cost 
The cost effectiveness of OPCAB can be explained by the reduced utilization of the blood 
products, shorter intubation time, shorter ICU stay, shorter hospitalization, and reduced 
postoperative complications, as described above (Scott et al., 2009, Puskas et al., 2004). 
4. Potential problems and disadvantages of OPCAB 
In general, the disadvantage of OPCAB is associated with surgical technique. Despite 
advances in surgical instruments, exposure of the posterior wall could be potentially 
difficult, especially in a patient with poor ventricular function or when the surgeon has not 
had adequate training in OPCAB. Inadequate exposure of the target results in fewer number 
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Redo surgery 
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Table 2. The patients that the benefit least from OPCAB 
4.1 Myocardial protection 
Postoperative cardiac enzyme release is lower after OPCAB than after on-pump CABG. 
(Van Dijk et al., 2001) However, in a patient in cardiogenic shock with a failing heart, 
placement on the CPB is unavoidable to prevent further end organ damage, and the role of 
OPCAB is limited because of hemodynamic instability. If the patient is experiencing global 
ischemia, pump failure and unstable hemodynamics, OPCAB should not be performed. 
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These patients need immediate placement on CPB to reestablish systemic circulation. 
Hemodynamic instability may occur during the positioning of the OPCAB especially doing 
anastomosis to the posterior wall of the heart. If pharmacological support is not adequate, 
IABP is helpful to maintain hemodynamic stability during OPCAB (Vohra & Dimitri, 2006). 
In patients with poor ventricular function, IAPB placement prior to surgery is 
recommended. 
4.2 Redo cardiac surgery 
Redo surgery requires extensive dissection of the scar tissue. Structural  injury during redo-
sternotomy will result in a high mortality and morbidity (Gillinov et al., 1999). 
Decompression of the heart by CPB is recommended for redo surgery (Hirose & Amano 
2005). 
4.3 Multivessel disease 
In the early era of OPCAB, revascularization of the posterolateral wall was challenging. 
However, after improvement of the coronary stabilizer, anastomoses to the posterolateral 
vessels are no longer a contraindication (Hirose et al., 2003, Song et al. 2003). Similarly, with 
left main disease, is no longer a contraindication for OPCAB (Hirose, 2004). In case of left 
main disease, revascularization of the left anterior descending artery prior to the 
posterolateral branches is essential. IABP may be helpful to stabilize hemodynamics, while 
anastomoses, especially in a patient with poor ventricular function and left main disease. 
4.4 Poor ventricular function 
Although mutilvessel disease is no longer contraindication for OPCAB, incomplete 
revascularization has been observed more often in OPCAB than on-pump CABG. A large 
heart with poor ventricular function is difficult to manipulate and to expose the target 
vessel. Heart displacement without decompression of the heart is challenging in these 
patients with poor ventricular function and distended left ventricle. 
4.5 Small and calcified target 
The reasons for incomplete revascularization could be the quality of the target vessel, as an 
example a small, calcified, or intramyocardial coronary artery. Bypass to these small 
coronary arteries and/or calcified arteries is challenging, even under on-pump cardiac 
arrest. Tedious endarterectomy for calcified vessels should be performed under CPB. 
Extensive dissection of intramyocardial coronary artery under a beating heart carries risk of 
ventricular rupture and should be performed with a decompressed heart under CPB. 
Incomplete revascularization will negatively affect the patient long-term outcome (Scott et 
al., 2000, Synnergre et al., 2008). A hybrid procedure involving OPCAB and percutaneous 
intervention could be an option in these difficult OPCAB patients. 
4.6 Emergent conversion to on-pump 
In palatines with hemodynamic instability during anastomosis, emergent conversion to on-
pump CABG is necessary. Conversion to on-pump surgery requires emergent arterial and 
venous cannulation, which may need to be done while CPR is in progress due to sudden 
ventricular arrhythmia or cardiac arrest. Emergent conversion from OPCAB to on-pump 
carries a ten-fold higher risk of operative mortality than elective OPCAB (Tabata et al., 
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2006). One of the risk factors for  emergent conversion is ischemic mitral regurgitation.  Pre-
existing ischemic mitral regurgitation may be accelerated during OPCAB due to 
displacement of the heart during anastomosis and due to distal ischemia. 
4.7 Training 
Cardiac motions during anastomosis are a major disturbance to the surgeon, and the 
OPCAB has a prominent learning curve. There is a direct correlation between the number of 
cases the surgeon has performed and the incidence of postoperative complications and graft 
patency. The surgeon with limited experience in OPCAB may produce a significant number 
of cardiac complications (Brown et al., 2001). Extensive training in performing OPCAB is 
necessary to improve patient outcomes. 
4.8 Graft patency 
Graft patency after OPCAB may be related to the surgeon’s skill level. A previous study by 
Khan showed a decreased 3-months-graft patency rate in the OPCAB group compared to 
that in the on-pump group (Khan et al., 2004). However, the article was criticized because of 
the lack of the surgeon’s adequate OPCAB experiences, lack of postoperative antiplatelet 
therapy with clopidogrel, and failure to use a suction device for stabilization of the heart 
(Dewey et al., 2004). A recent randomized trial by Puskas (Puskas et al., 2009), and the 
European study (Widimsky et al., 2004) independently confirmed similar 1-year graft 
patency rate between OPCAB and on-pump CABG. 
5. Conclusion 
Recent advances in surgical instruments and technique allows surgeons to perform OPCAB 
safely.  
 
OPCAB for left main disease and multivessel revascularization is no longer a 
contraindication.
Except for patient undergoing redo CABG, hemodynamically compromised patients, and 
patient with poor target vessels, OPCAB can be performed by an experienced surgeon 
without increasing risks.
OPCAB requires a significant intensive training period.
OPCAB may expand the indications of CABG to patients with higher risks.
OPCAB contributes to shortening the length of stay and promotes an early recovery. 
Table 3. Summary of the advantages and disadvantages of OPCAB 
Although there is a steep learning curve for OPCAB techniques, OPCAB provides a 
favorable or at least equivalent postoperative outcome compared to on-pump CABG, with 
minimal contraindications. OPCAB will significantly reduce the risk of CPB-related 
complications. These benefits of OPCAB are more significant in high-risk patients, and there 
is a possibility to expand the indication of CABG. 
6. References 
Abu-Omar Y, Taggart DP. (2009) The present status of off-pump coronary artery bypass 
grafting. Eur J Cardiothorac Surg. Vol. 36, No. 2, 312-321. 
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These patients need immediate placement on CPB to reestablish systemic circulation. 
Hemodynamic instability may occur during the positioning of the OPCAB especially doing 
anastomosis to the posterior wall of the heart. If pharmacological support is not adequate, 
IABP is helpful to maintain hemodynamic stability during OPCAB (Vohra & Dimitri, 2006). 
In patients with poor ventricular function, IAPB placement prior to surgery is 
recommended. 
4.2 Redo cardiac surgery 
Redo surgery requires extensive dissection of the scar tissue. Structural  injury during redo-
sternotomy will result in a high mortality and morbidity (Gillinov et al., 1999). 
Decompression of the heart by CPB is recommended for redo surgery (Hirose & Amano 
2005). 
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In the early era of OPCAB, revascularization of the posterolateral wall was challenging. 
However, after improvement of the coronary stabilizer, anastomoses to the posterolateral 
vessels are no longer a contraindication (Hirose et al., 2003, Song et al. 2003). Similarly, with 
left main disease, is no longer a contraindication for OPCAB (Hirose, 2004). In case of left 
main disease, revascularization of the left anterior descending artery prior to the 
posterolateral branches is essential. IABP may be helpful to stabilize hemodynamics, while 
anastomoses, especially in a patient with poor ventricular function and left main disease. 
4.4 Poor ventricular function 
Although mutilvessel disease is no longer contraindication for OPCAB, incomplete 
revascularization has been observed more often in OPCAB than on-pump CABG. A large 
heart with poor ventricular function is difficult to manipulate and to expose the target 
vessel. Heart displacement without decompression of the heart is challenging in these 
patients with poor ventricular function and distended left ventricle. 
4.5 Small and calcified target 
The reasons for incomplete revascularization could be the quality of the target vessel, as an 
example a small, calcified, or intramyocardial coronary artery. Bypass to these small 
coronary arteries and/or calcified arteries is challenging, even under on-pump cardiac 
arrest. Tedious endarterectomy for calcified vessels should be performed under CPB. 
Extensive dissection of intramyocardial coronary artery under a beating heart carries risk of 
ventricular rupture and should be performed with a decompressed heart under CPB. 
Incomplete revascularization will negatively affect the patient long-term outcome (Scott et 
al., 2000, Synnergre et al., 2008). A hybrid procedure involving OPCAB and percutaneous 
intervention could be an option in these difficult OPCAB patients. 
4.6 Emergent conversion to on-pump 
In palatines with hemodynamic instability during anastomosis, emergent conversion to on-
pump CABG is necessary. Conversion to on-pump surgery requires emergent arterial and 
venous cannulation, which may need to be done while CPR is in progress due to sudden 
ventricular arrhythmia or cardiac arrest. Emergent conversion from OPCAB to on-pump 
carries a ten-fold higher risk of operative mortality than elective OPCAB (Tabata et al., 
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2006). One of the risk factors for  emergent conversion is ischemic mitral regurgitation.  Pre-
existing ischemic mitral regurgitation may be accelerated during OPCAB due to 
displacement of the heart during anastomosis and due to distal ischemia. 
4.7 Training 
Cardiac motions during anastomosis are a major disturbance to the surgeon, and the 
OPCAB has a prominent learning curve. There is a direct correlation between the number of 
cases the surgeon has performed and the incidence of postoperative complications and graft 
patency. The surgeon with limited experience in OPCAB may produce a significant number 
of cardiac complications (Brown et al., 2001). Extensive training in performing OPCAB is 
necessary to improve patient outcomes. 
4.8 Graft patency 
Graft patency after OPCAB may be related to the surgeon’s skill level. A previous study by 
Khan showed a decreased 3-months-graft patency rate in the OPCAB group compared to 
that in the on-pump group (Khan et al., 2004). However, the article was criticized because of 
the lack of the surgeon’s adequate OPCAB experiences, lack of postoperative antiplatelet 
therapy with clopidogrel, and failure to use a suction device for stabilization of the heart 
(Dewey et al., 2004). A recent randomized trial by Puskas (Puskas et al., 2009), and the 
European study (Widimsky et al., 2004) independently confirmed similar 1-year graft 
patency rate between OPCAB and on-pump CABG. 
5. Conclusion 
Recent advances in surgical instruments and technique allows surgeons to perform OPCAB 
safely.  
 
OPCAB for left main disease and multivessel revascularization is no longer a 
contraindication.
Except for patient undergoing redo CABG, hemodynamically compromised patients, and 
patient with poor target vessels, OPCAB can be performed by an experienced surgeon 
without increasing risks.
OPCAB requires a significant intensive training period.
OPCAB may expand the indications of CABG to patients with higher risks.
OPCAB contributes to shortening the length of stay and promotes an early recovery. 
Table 3. Summary of the advantages and disadvantages of OPCAB 
Although there is a steep learning curve for OPCAB techniques, OPCAB provides a 
favorable or at least equivalent postoperative outcome compared to on-pump CABG, with 
minimal contraindications. OPCAB will significantly reduce the risk of CPB-related 
complications. These benefits of OPCAB are more significant in high-risk patients, and there 
is a possibility to expand the indication of CABG. 
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1. Introduction 
1.1 Coronary Artery Bypass Grafting defined 
It has been reported that over 13 million individuals in the United States have been diagnosed 
with Coronary Artery Disease (Morrow & Gersh, 2008), and it is the leading cause of death in 
the United States with more than 650,000 deaths in 2005 (Centers for Disease Control and 
Prevention, 2009). One of the most effective and common methods of treating Coronary Artery 
Disease  is Coronary Artery Bypass Grafting surgery (Niles et al., 2001).  Typically, those 
patients with severe narrowing of the left main coronary artery and/or those with disease in at 
least 3 coronary arteries are candidates for Coronary Artery Bypass Grafting Surgery.     
1.2 Comorbidity with Coronary Artery Disease  
There is also a high comorbidity between Peripheral Vascular Disease and Coronary 
Artery Disease (Brandt et al., 2004; Eagle et al., 1994; Hertzer et al., 1984). While several 
studies have reported short-term adverse outcomes in Coronary Artery Bypass Grafting 
patients that also have Peripheral Vascular Disease (Gersh et al., 1989; Grover et al., 1990; 
Higgins et al., 1992; Kunadian et al., 2007; Magovern et al., 1996; O’Connor et al., 1992; 
Rosenthal et al., 2003; Sutton-Tyrrell et al., 1998) the long-term outcomes have not been 
thoroughly investigated. To address this gap in the literature, Chu et al. (2008) conducted 
a study investigating the long-term impact of Coronary Artery Bypass Grafting surgery in 
patients who concurrently had Peripheral Vascular Disease. After comparing 370 
Peripheral Vascular Disease and 794 non-Peripheral Vascular Disease patients, Chu and 
colleagues determined there were no significant group differences in 30 day mortality or 
major cardiac adverse events; however, patients with Peripheral Vascular Disease had a 
significantly worse 9 year survival rate (i.e., almost twice the risk of mortality) when 
compared to those without Peripheral Vascular Disease. While the short-term outcomes of 
this study are contradictory to previous studies, the long-term outcomes suggest that 
those with Peripheral Vascular Disease have poorer outcomes over time when compared 
to those without Peripheral Vascular Disease.      
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1.3 Variations of Coronary Artery Bypass Grafting Surgery 
Typically Coronary Artery Bypass Grafting surgery is performed via Cardiopulmonary 
Bypass; however, there are several drawbacks associated with Cardiopulmonary Bypass 
which may lead to complications following or during surgery (Edmunds et al., 2003). As a 
result of these complications, a technique utilizing an Off-Pump Coronary Artery Bypass 
procedure was developed. The Off-Pump Coronary Artery Bypass technique has recently 
gained popularity and can also be performed without involving Cardiopulmonary Bypass 
(Benetti et al., 1995; Buffolo et al., 1996; Calafiore et al., 1996; Dewey et al., 2001; Guler et al., 
2001; Guru et al., 2007;Magee et al., 2001; Puskas et al., 1998; Trehan et al., 2001). While Off-
Pump Coronary Artery Bypass has gained notoriety, some surgeons have opted out of using 
the technique due to suspicions that Off-Pump Coronary Artery Bypass may compromise 
patient outcomes. To help clarify these suspicions, researchers have turned their focus to 
investigating the effectiveness of Off-Pump Coronary Artery Bypass for treating patients with 
Coronary Artery Disease. The results of such studies have often been counter indicative. Some 
studies suggest that Off-Pump Coronary Artery Bypass has similar outcomes to conventional 
Coronary Artery Bypass Grafting surgery with respect to length of hospital stay, morbidity, 
and neurological deficiencies (Halkos et al., 2008; Puskas et al., 1998; Puskas et al., 2001) as well 
as comparable graft patency and hospitalization costs (Puskas et al., 2004). Conversely, other 
studies have reported less favorable Off-Pump Coronary Artery Bypass patient outcomes (e.g., 
lower graft patency rates and less complete revascularization) when compared to Coronary 
Artery Bypass Grafting patient outcomes (Khan et al., 2004). Still several other studies report 
no difference in early mortality, morbidity and hospitalization costs between the two 
procedures (Bull et al., 2001; Cheng et al., 2005; Cheng et al., 2002; Marasco et al., 2008; Takagi 
et al., 2007). Clearly, the studies to date comparing the Off-Pump Coronary Artery Bypass and 
Coronary Artery Bypass Grafting procedures present an unclear picture of potential 
differential outcomes for patients.  In order to further investigate the difference between these 
two methods, Chu and colleagues (2009a) conducted a study using a nationwide database of 
over 63,000 Coronary Artery Bypass Grafting and Off-Pump Coronary Artery Bypass patients. 
The results revealed that the Off-Pump Coronary Artery Bypass and Coronary Artery Bypass 
Grafting procedures had similar in-hospital mortality, post-operative stroke incidences, and 
routine discharge rates. However, Off-Pump Coronary Artery Bypass patients had 
comparatively longer hospital stays and higher hospital costs than Coronary Artery Bypass 
Grafting patients. 
2. Coronary Artery Bypass Grafting and medical/demographic predictors 
2.1 Coronary Artery Bypass Grafting and obesity 
The accepted medical model for outcomes following Coronary Artery Bypass Grafting 
Surgery can be found in Figure 1. Falling second to Coronary Artery Disease, obesity is the 
second leading cause of death in the United States (Mokdad et al., 2000). It is well-known 
that patients categorized as obese are at unique risk for developing various cardiovascular 
diseases, including Coronary Artery Disease. Due to the general increased morbidity and 
reduced life expectancy of obese patients (Fontaine et al., 2003), many researchers have 
hypothesized that obesity should be linked to poorer outcomes post-Coronary Artery 
Bypass Grafting surgery. Yet, current research investigating the association between obesity 
(e.g., body mass index, BMI) and cardiac surgery outcomes has been contradictory. Some 
studies report no difference in short-term outcomes post-Coronary Artery Bypass Grafting 
between obese and non-obese patients (Engel et al., 2009; Engelman et al., 1999; Potapov et 
al., 2003; Rahmanian et al., 2007; Reeves et al., 2003; Schwann et al., 2003; Syrakas et al., 
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2007). Others have found that morbid obesity independently predicts perioperative 
complications as well as operative mortality (Prabhakar et al., 2002). One study by Syrakas 
and colleagues (2007) even found that normal weight patients had a higher 30-day mortality 
rate than their obese peers post-surgery. In fact, overall, research seems to suggest that 
morbid obesity does not increase short-term mortality risk for Coronary Artery Bypass 
Grafting patients (Baslaim et al., 2008; Shirad et al., 2009; Syrakas et al., 2007). Since research 
regarding the association between obesity and cardiac surgery has included mostly short-
term outcomes, Del Prete and associates (2010) investigated the independent effect of 
obesity on long-term survival in patients (472 obese and 691 non-obese) who had Coronary 
Artery Bypass Grafting surgery. Results revealed obese and non-obese patients had similar 
intraoperative characteristics (e.g., cardiopulmonary bypass time, aortic cross-clamp time, 
and number of vein and IMA grafts) and post-operative outcomes. Of particular interest 
was that the rates of mortality and major adverse cardiac events after 30 days were not 
significantly different between the two groups. Most interestingly, the researchers 
determined that obese Coronary Artery Bypass Grafting patients demonstrated long-term 
survival (9 years follow-up) similar to non-obese Coronary Artery Bypass Grafting patients. 
While these findings are counterintuitive, these results combined with results of studies 
examining short-term outcomes seem to indicate that obesity is not a significant risk for 
patients undergoing Coronary Artery Bypass Grafting surgery. 
2.2 Coronary Artery Bypass Grafting and age 
Due to improvements in medical care, the average life expectancy has increased 
significantly in recent years.  Subsequently, there has been an increase in the number of 
geriatric patients with cardiac disease that need surgical intervention such as Coronary 
Artery Bypass Grafting surgery. In addition, this population also tends to have multiple 
comorbidities which may cause complications; however, Coronary Artery Bypass Grafting 
procedures in octogenarian patients (those over the age of 80), have demonstrated improved 
morbidity and mortality outcomes (Alexander et al., 2000; Kolh et al., 2001; Shigemitsu et al., 
2001). However, while most of these Coronary Artery Bypass Grafting surgeries are 
technically successful, they may cause significant physiological adverse events, potentially 
deconditioning them substantially.  Unfortunately, there has not been a wealth of literature 
investigating these physiological outcomes which may affect the health and well-being of 
these patients. As a result, Gopaldas et al. (2010) conducted a study investigating the 
disposition of octogerians following Coronary Artery Bypass Grafting surgery. 
Gopaldas identified 5,731 patients over age 80 who underwent Coronary Artery Bypass 
Grafting surgery.  It was discovered that the surgical mortality rate was 7%, and 21% of 
patients had a routine hospital discharge. Those that did not have a routine discharge had 
home health care (27%) or were transferred to another care facility (45%). In addition, 
several predictors of surgical mortality and nonroutine discharge were found:  older age, 
females, a higher comorbidity index, and referral from the emergency room were all found 
to be independent predictors of these unfavorable outcomes. Thus, it is clear that while 
mortality rate in octogenarians is low, there are several circumstances that need to be 
considered to ensure more favorable outcomes following discharge. 
2.3 Coronary Artery Bypass Grafting and gender 
Women are particularly affected by heart disease, and coronary heart disease has 
consistently been reported as the leading cause of morbidity and mortality of women in 
most developed countries (Center for Disease Control and Prevention, 2010; Lloyd-Jones et 
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1.3 Variations of Coronary Artery Bypass Grafting Surgery 
Typically Coronary Artery Bypass Grafting surgery is performed via Cardiopulmonary 
Bypass; however, there are several drawbacks associated with Cardiopulmonary Bypass 
which may lead to complications following or during surgery (Edmunds et al., 2003). As a 
result of these complications, a technique utilizing an Off-Pump Coronary Artery Bypass 
procedure was developed. The Off-Pump Coronary Artery Bypass technique has recently 
gained popularity and can also be performed without involving Cardiopulmonary Bypass 
(Benetti et al., 1995; Buffolo et al., 1996; Calafiore et al., 1996; Dewey et al., 2001; Guler et al., 
2001; Guru et al., 2007;Magee et al., 2001; Puskas et al., 1998; Trehan et al., 2001). While Off-
Pump Coronary Artery Bypass has gained notoriety, some surgeons have opted out of using 
the technique due to suspicions that Off-Pump Coronary Artery Bypass may compromise 
patient outcomes. To help clarify these suspicions, researchers have turned their focus to 
investigating the effectiveness of Off-Pump Coronary Artery Bypass for treating patients with 
Coronary Artery Disease. The results of such studies have often been counter indicative. Some 
studies suggest that Off-Pump Coronary Artery Bypass has similar outcomes to conventional 
Coronary Artery Bypass Grafting surgery with respect to length of hospital stay, morbidity, 
and neurological deficiencies (Halkos et al., 2008; Puskas et al., 1998; Puskas et al., 2001) as well 
as comparable graft patency and hospitalization costs (Puskas et al., 2004). Conversely, other 
studies have reported less favorable Off-Pump Coronary Artery Bypass patient outcomes (e.g., 
lower graft patency rates and less complete revascularization) when compared to Coronary 
Artery Bypass Grafting patient outcomes (Khan et al., 2004). Still several other studies report 
no difference in early mortality, morbidity and hospitalization costs between the two 
procedures (Bull et al., 2001; Cheng et al., 2005; Cheng et al., 2002; Marasco et al., 2008; Takagi 
et al., 2007). Clearly, the studies to date comparing the Off-Pump Coronary Artery Bypass and 
Coronary Artery Bypass Grafting procedures present an unclear picture of potential 
differential outcomes for patients.  In order to further investigate the difference between these 
two methods, Chu and colleagues (2009a) conducted a study using a nationwide database of 
over 63,000 Coronary Artery Bypass Grafting and Off-Pump Coronary Artery Bypass patients. 
The results revealed that the Off-Pump Coronary Artery Bypass and Coronary Artery Bypass 
Grafting procedures had similar in-hospital mortality, post-operative stroke incidences, and 
routine discharge rates. However, Off-Pump Coronary Artery Bypass patients had 
comparatively longer hospital stays and higher hospital costs than Coronary Artery Bypass 
Grafting patients. 
2. Coronary Artery Bypass Grafting and medical/demographic predictors 
2.1 Coronary Artery Bypass Grafting and obesity 
The accepted medical model for outcomes following Coronary Artery Bypass Grafting 
Surgery can be found in Figure 1. Falling second to Coronary Artery Disease, obesity is the 
second leading cause of death in the United States (Mokdad et al., 2000). It is well-known 
that patients categorized as obese are at unique risk for developing various cardiovascular 
diseases, including Coronary Artery Disease. Due to the general increased morbidity and 
reduced life expectancy of obese patients (Fontaine et al., 2003), many researchers have 
hypothesized that obesity should be linked to poorer outcomes post-Coronary Artery 
Bypass Grafting surgery. Yet, current research investigating the association between obesity 
(e.g., body mass index, BMI) and cardiac surgery outcomes has been contradictory. Some 
studies report no difference in short-term outcomes post-Coronary Artery Bypass Grafting 
between obese and non-obese patients (Engel et al., 2009; Engelman et al., 1999; Potapov et 
al., 2003; Rahmanian et al., 2007; Reeves et al., 2003; Schwann et al., 2003; Syrakas et al., 
Psychiatric Factors Which Impact Coronary Heart Disease and  
Influence Outcomes Post-Coronary Artery Bypass Grafting Surgery 63 
2007). Others have found that morbid obesity independently predicts perioperative 
complications as well as operative mortality (Prabhakar et al., 2002). One study by Syrakas 
and colleagues (2007) even found that normal weight patients had a higher 30-day mortality 
rate than their obese peers post-surgery. In fact, overall, research seems to suggest that 
morbid obesity does not increase short-term mortality risk for Coronary Artery Bypass 
Grafting patients (Baslaim et al., 2008; Shirad et al., 2009; Syrakas et al., 2007). Since research 
regarding the association between obesity and cardiac surgery has included mostly short-
term outcomes, Del Prete and associates (2010) investigated the independent effect of 
obesity on long-term survival in patients (472 obese and 691 non-obese) who had Coronary 
Artery Bypass Grafting surgery. Results revealed obese and non-obese patients had similar 
intraoperative characteristics (e.g., cardiopulmonary bypass time, aortic cross-clamp time, 
and number of vein and IMA grafts) and post-operative outcomes. Of particular interest 
was that the rates of mortality and major adverse cardiac events after 30 days were not 
significantly different between the two groups. Most interestingly, the researchers 
determined that obese Coronary Artery Bypass Grafting patients demonstrated long-term 
survival (9 years follow-up) similar to non-obese Coronary Artery Bypass Grafting patients. 
While these findings are counterintuitive, these results combined with results of studies 
examining short-term outcomes seem to indicate that obesity is not a significant risk for 
patients undergoing Coronary Artery Bypass Grafting surgery. 
2.2 Coronary Artery Bypass Grafting and age 
Due to improvements in medical care, the average life expectancy has increased 
significantly in recent years.  Subsequently, there has been an increase in the number of 
geriatric patients with cardiac disease that need surgical intervention such as Coronary 
Artery Bypass Grafting surgery. In addition, this population also tends to have multiple 
comorbidities which may cause complications; however, Coronary Artery Bypass Grafting 
procedures in octogenarian patients (those over the age of 80), have demonstrated improved 
morbidity and mortality outcomes (Alexander et al., 2000; Kolh et al., 2001; Shigemitsu et al., 
2001). However, while most of these Coronary Artery Bypass Grafting surgeries are 
technically successful, they may cause significant physiological adverse events, potentially 
deconditioning them substantially.  Unfortunately, there has not been a wealth of literature 
investigating these physiological outcomes which may affect the health and well-being of 
these patients. As a result, Gopaldas et al. (2010) conducted a study investigating the 
disposition of octogerians following Coronary Artery Bypass Grafting surgery. 
Gopaldas identified 5,731 patients over age 80 who underwent Coronary Artery Bypass 
Grafting surgery.  It was discovered that the surgical mortality rate was 7%, and 21% of 
patients had a routine hospital discharge. Those that did not have a routine discharge had 
home health care (27%) or were transferred to another care facility (45%). In addition, 
several predictors of surgical mortality and nonroutine discharge were found:  older age, 
females, a higher comorbidity index, and referral from the emergency room were all found 
to be independent predictors of these unfavorable outcomes. Thus, it is clear that while 
mortality rate in octogenarians is low, there are several circumstances that need to be 
considered to ensure more favorable outcomes following discharge. 
2.3 Coronary Artery Bypass Grafting and gender 
Women are particularly affected by heart disease, and coronary heart disease has 
consistently been reported as the leading cause of morbidity and mortality of women in 
most developed countries (Center for Disease Control and Prevention, 2010; Lloyd-Jones et 
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al., 2010; Stoney et al., 2003).  In 2006, 1 in 6 reported female deaths were due to Coronary 
Artery Disease (Januzzi et al., 2000), and research suggests that being female is related to 
poorer Coronary Artery Bypass Grafting outcomes (Blankstein et al., 2005; Culler et al., 2008; 
Kim et al., 2007; Sawatzky et al., 2009). Women have higher mortality rates, remain in the 
hospital longer (Dao, 2010b), experience a more difficult recovery (Sawatzky et al., 2009), 
and self-report being less satisfied with health status after Coronary Artery Bypass Grafting 
surgery (Sawatzky et al., 2009).  
Dao and colleagues (2011c) conducted a study investigating gender differences and outcomes 
following Coronary Artery Bypass Grafting surgery. It was reported that being female and 
having an anxiety disorder diagnosis independently and collectively contributed to in-hospital 
length of stay and non-routine discharge following a Coronary Artery Bypass Grafting 
surgery. In addition, significant differences were found between groups in age, gender, race, 
median household income, medical comorbidities, and having an anxiety disorder diagnosis. 
Specifically, patients with non-routine discharges were more likely to be older, female, non-
Caucasian, have more medical comorbidities, and have an anxiety disorder diagnosis. 
2.4 Autonomic Nervous System dysregulation 
As mentioned previously, the association between depression and cardiac events, 
particularly Coronary Artery Disease, has been validated consistently in research; yet, the 
mechanism behind this relationship is unclear. One proposed underlying factor in this 
relationship is altered autonomic nervous system (Autonomic Nervous System) activity. 
Altered Autonomic Nervous System activity has been suggested to contribute to elevated 
mortality risk (and poorer general outcomes) in patients with Coronary Artery Disease, and 
individuals with Major Depressive Disorder often have Autonomic Nervous System 
dysregulation (Barnes et al., 1983; Esler et al., 1982; Lake et al., 1982). In addition, research 
suggests that depressed individuals have higher baseline heart rates (Lake et al., 1982; Siever 
et al., 1985; Veith et al., 1994), increased heart rate response to stressors (Carney et al., 1988a; 
Guinjoan et al., 1995), and decreased heart rate variability (HRV) (Appelhans et al., 2006; 
Carney et al., 1988b; Dallack et al., 1990; Rechlin et al., 1994) when compared to similar 
peers. In particular, increased Heart Rate Variability has been associated with greater 
abilities to regulate stress, arousal, and attention, while decreased Heart Rate Variability has 
been associated with inadequate parasympathetic modulation and increased cardiac 
sympathetic modulation (Task Force of the European Society of Cardiology and the North 
American Society for Pacing and Electrophysiology, 1995).  Most relevant to this chapter, 
studies suggest that Heart Rate Variability is lower in Coronary Artery Disease patients 
with comorbid depression than those with Coronary Artery Disease alone (Krittayaphong et 
al., 1997; Stein et al., 2000). Taken together, this literature suggests that depressed 
individuals may not only have an elevated initial heart rate and higher heart rate in reaction 
to stressors, but they may also have lower Heart Rate Variability that makes it more difficult 
to manage these other elevated heart rate situations. 
Another factor not previously understood was whether patients with Autonomic Nervous 
System dysregulation also have increased mortality with these concurrent disorders. Dao 
and colleagues (2010a) proposed a study investigating three variables (heart rate, Heart Rate 
Variability, and plasma norepinephrine levels) in the following groups: 1) Patients with 
Coronary Artery Disease and depression, 2) Patients with Depression alone, 3) Patients with 
Coronary Artery Disease  alone, and 4) Patients without neither Coronary Artery Disease 
nor depression.  The focus of the study was to compare the association of heart rate, Heart 
Psychiatric Factors Which Impact Coronary Heart Disease and  
Influence Outcomes Post-Coronary Artery Bypass Grafting Surgery 65 
Rate Variability, and plasma norepinephrine levels with depression and Autonomic 
Nervous System activity in addition to their relationship to Coronary Artery Bypass 
Grafting outcomes.  In addition, a second analysis was conducted investigating the 3 
aforementioned variables in cardiac patients (Coronary Artery Disease  and Depression 
versus Coronary Artery Disease  alone) and surgery outcomes (length of hospital stay, 
routine versus non-routine discharge status) while controlling for other factors (medical 
factors such as diabetes and demographic factors such as age). It was hypothesized that 
patients with Coronary Artery Disease and Depression would have the greatest amount of 
Autonomic Nervous System dysregulation while the group without Coronary Artery 
Disease or depression would have the least Autonomic Nervous System dysregulation. In 
addition, it was hypothesized that the aforementioned variables would predict outcomes 
following Coronary Artery Bypass Grafting surgery.  Analyses revealed that patients with 
Coronary Artery Disease and Depression had greater Autonomic Nervous System 
dysregulation when compared to those that had either Coronary Artery Disease or 
depression alone. Also, it was determined that depression, as well as elevated heart rate and 
depressed Heart Rate Variability, predicted increased length of hospital stay and non-
routine discharge. 
2.5 Diabetes 
It has been found that systematic disease may increase the risks associated with Coronary 
Artery Bypass Grafting surgery. Several studies have reported that diabetes is a critical 
factor and mortality rates are two to three times higher than in non-diabetics (Johnson et al., 
1982; Lawrie et al., 1986; Salomon et al., 1983). In addition, patients with diabetes tend to 
have more post-CABG surgery complications which reduce long-term survival.   
3. Coronary Artery Bypass Grafting and psychological predictors 
3.1 Depression and Post-Traumatic Stress Disorder 
A proposed psychological model for outcomes following Coronary Artery Bypass Grafting 
Surgery is proposed in Figure 1. Research has demonstrated that medical and demographic 
factors such as age, gender, diabetes, etc. cannot fully explain the outcomes following 
Coronary Artery Bypass Grafting surgery (Blumenthal et al., 2003; Saur et al., 2001). Several 
studies have been published investigating the association between Coronary Artery Disease 
and psychological functioning, primarily depression (Bankier et al., 2004; Oxland et al., 
2006).  It has been reported that up to 60% of patients with Coronary Artery Disease have 
comorbid depression which has a significant impact on the outcomes of Coronary Artery 
Disease (Blumenthal et al., 2003; Connerney et al., 2001; Krannich et al., 2007; Tully et al., 
2008). Those with depression have higher rates of mortality as well as an overall risk of 
major cardiac events (Blumenthal et al., 2003; Carney et al., 1988; Connerney et al., 2001). 
Specifically, depressive symptoms also signicantly predict mortality 2 to 5 years after 
Coronary Artery Bypass Grafting surgery, independent of medical  and operative  factors 
(Blumenthal et al., 2003; Burg et al., 2003a; Burg et al., 2003b. Unlike depression, the impact 
of other psychological conditions, such as Post-traumatic Stress Disorder on outcomes after 
Coronary Artery Bypass Grafting surgery has received less attention in research.   
The gap in the literature investigating the relationship between Post-traumatic Stress 
Disorder on outcomes after Coronary Artery Bypass Grafting surgery needs to be examined 
independently from depression for several reasons. Specifically, studies have demonstrated 
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al., 2010; Stoney et al., 2003).  In 2006, 1 in 6 reported female deaths were due to Coronary 
Artery Disease (Januzzi et al., 2000), and research suggests that being female is related to 
poorer Coronary Artery Bypass Grafting outcomes (Blankstein et al., 2005; Culler et al., 2008; 
Kim et al., 2007; Sawatzky et al., 2009). Women have higher mortality rates, remain in the 
hospital longer (Dao, 2010b), experience a more difficult recovery (Sawatzky et al., 2009), 
and self-report being less satisfied with health status after Coronary Artery Bypass Grafting 
surgery (Sawatzky et al., 2009).  
Dao and colleagues (2011c) conducted a study investigating gender differences and outcomes 
following Coronary Artery Bypass Grafting surgery. It was reported that being female and 
having an anxiety disorder diagnosis independently and collectively contributed to in-hospital 
length of stay and non-routine discharge following a Coronary Artery Bypass Grafting 
surgery. In addition, significant differences were found between groups in age, gender, race, 
median household income, medical comorbidities, and having an anxiety disorder diagnosis. 
Specifically, patients with non-routine discharges were more likely to be older, female, non-
Caucasian, have more medical comorbidities, and have an anxiety disorder diagnosis. 
2.4 Autonomic Nervous System dysregulation 
As mentioned previously, the association between depression and cardiac events, 
particularly Coronary Artery Disease, has been validated consistently in research; yet, the 
mechanism behind this relationship is unclear. One proposed underlying factor in this 
relationship is altered autonomic nervous system (Autonomic Nervous System) activity. 
Altered Autonomic Nervous System activity has been suggested to contribute to elevated 
mortality risk (and poorer general outcomes) in patients with Coronary Artery Disease, and 
individuals with Major Depressive Disorder often have Autonomic Nervous System 
dysregulation (Barnes et al., 1983; Esler et al., 1982; Lake et al., 1982). In addition, research 
suggests that depressed individuals have higher baseline heart rates (Lake et al., 1982; Siever 
et al., 1985; Veith et al., 1994), increased heart rate response to stressors (Carney et al., 1988a; 
Guinjoan et al., 1995), and decreased heart rate variability (HRV) (Appelhans et al., 2006; 
Carney et al., 1988b; Dallack et al., 1990; Rechlin et al., 1994) when compared to similar 
peers. In particular, increased Heart Rate Variability has been associated with greater 
abilities to regulate stress, arousal, and attention, while decreased Heart Rate Variability has 
been associated with inadequate parasympathetic modulation and increased cardiac 
sympathetic modulation (Task Force of the European Society of Cardiology and the North 
American Society for Pacing and Electrophysiology, 1995).  Most relevant to this chapter, 
studies suggest that Heart Rate Variability is lower in Coronary Artery Disease patients 
with comorbid depression than those with Coronary Artery Disease alone (Krittayaphong et 
al., 1997; Stein et al., 2000). Taken together, this literature suggests that depressed 
individuals may not only have an elevated initial heart rate and higher heart rate in reaction 
to stressors, but they may also have lower Heart Rate Variability that makes it more difficult 
to manage these other elevated heart rate situations. 
Another factor not previously understood was whether patients with Autonomic Nervous 
System dysregulation also have increased mortality with these concurrent disorders. Dao 
and colleagues (2010a) proposed a study investigating three variables (heart rate, Heart Rate 
Variability, and plasma norepinephrine levels) in the following groups: 1) Patients with 
Coronary Artery Disease and depression, 2) Patients with Depression alone, 3) Patients with 
Coronary Artery Disease  alone, and 4) Patients without neither Coronary Artery Disease 
nor depression.  The focus of the study was to compare the association of heart rate, Heart 
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Rate Variability, and plasma norepinephrine levels with depression and Autonomic 
Nervous System activity in addition to their relationship to Coronary Artery Bypass 
Grafting outcomes.  In addition, a second analysis was conducted investigating the 3 
aforementioned variables in cardiac patients (Coronary Artery Disease  and Depression 
versus Coronary Artery Disease  alone) and surgery outcomes (length of hospital stay, 
routine versus non-routine discharge status) while controlling for other factors (medical 
factors such as diabetes and demographic factors such as age). It was hypothesized that 
patients with Coronary Artery Disease and Depression would have the greatest amount of 
Autonomic Nervous System dysregulation while the group without Coronary Artery 
Disease or depression would have the least Autonomic Nervous System dysregulation. In 
addition, it was hypothesized that the aforementioned variables would predict outcomes 
following Coronary Artery Bypass Grafting surgery.  Analyses revealed that patients with 
Coronary Artery Disease and Depression had greater Autonomic Nervous System 
dysregulation when compared to those that had either Coronary Artery Disease or 
depression alone. Also, it was determined that depression, as well as elevated heart rate and 
depressed Heart Rate Variability, predicted increased length of hospital stay and non-
routine discharge. 
2.5 Diabetes 
It has been found that systematic disease may increase the risks associated with Coronary 
Artery Bypass Grafting surgery. Several studies have reported that diabetes is a critical 
factor and mortality rates are two to three times higher than in non-diabetics (Johnson et al., 
1982; Lawrie et al., 1986; Salomon et al., 1983). In addition, patients with diabetes tend to 
have more post-CABG surgery complications which reduce long-term survival.   
3. Coronary Artery Bypass Grafting and psychological predictors 
3.1 Depression and Post-Traumatic Stress Disorder 
A proposed psychological model for outcomes following Coronary Artery Bypass Grafting 
Surgery is proposed in Figure 1. Research has demonstrated that medical and demographic 
factors such as age, gender, diabetes, etc. cannot fully explain the outcomes following 
Coronary Artery Bypass Grafting surgery (Blumenthal et al., 2003; Saur et al., 2001). Several 
studies have been published investigating the association between Coronary Artery Disease 
and psychological functioning, primarily depression (Bankier et al., 2004; Oxland et al., 
2006).  It has been reported that up to 60% of patients with Coronary Artery Disease have 
comorbid depression which has a significant impact on the outcomes of Coronary Artery 
Disease (Blumenthal et al., 2003; Connerney et al., 2001; Krannich et al., 2007; Tully et al., 
2008). Those with depression have higher rates of mortality as well as an overall risk of 
major cardiac events (Blumenthal et al., 2003; Carney et al., 1988; Connerney et al., 2001). 
Specifically, depressive symptoms also signicantly predict mortality 2 to 5 years after 
Coronary Artery Bypass Grafting surgery, independent of medical  and operative  factors 
(Blumenthal et al., 2003; Burg et al., 2003a; Burg et al., 2003b. Unlike depression, the impact 
of other psychological conditions, such as Post-traumatic Stress Disorder on outcomes after 
Coronary Artery Bypass Grafting surgery has received less attention in research.   
The gap in the literature investigating the relationship between Post-traumatic Stress 
Disorder on outcomes after Coronary Artery Bypass Grafting surgery needs to be examined 
independently from depression for several reasons. Specifically, studies have demonstrated 
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that both depression and Post-traumatic Stress Disorder involve increased secretion of 
corticotropin-releasing factor. However, patients with Post-traumatic Stress Disorder have 
hypocortisolemia due to the increased secretion, whereas severe depression is associated 
with hypercortisolemia, showing that the pathophysiology of the 2 disorders might be 
different (Lyons et al., 2001).  In addition, the psychiatric comorbidities of Post-traumatic 
Stress Disorder and depression may potentially affect cardiac prognosis adversely. Thus, by 
treating only depression and not the Post-traumatic Stress Disorder, cardiac outcomes may 
be adversely affected. 
Dao et al (2010c) proposed a study examining the effect of clinical depression, PTSD, and 
comorbid depression and PTSD on outcomes following Coronary Artery Bypass Grafting 
surgery. It was hypothesized that depression, PTSD, and comorbid depression and PTSD 
would independently contribute to an increased risk for mortality following Coronary 
Artery Bypass Grafting surgery. In addition, it was hypothesized that comorbid depression 
and PTSD will have the greatest effect on mortality rates and outcomes in general. It was 
determined that, depression, posttraumatic stress disorder, and comorbid depression and 
posttraumatic stress disorder are prevalent in patients undergoing Coronary Artery Bypass 
Grafting surgery. In addition, depression, posttraumatic stress disorder, and comorbid 
depression and posttraumatic stress disorder increased the risk of mortality following 
Coronary Artery Bypass Grafting surgery. 
3.2 Geographic status 
Another topic that has received limited focus in literature to date is the impact geographic 
status may have on Coronary Artery Bypass Grafting outcomes. While death rates due to heart 
disease have decreased in recent decades (Cooper et al., 2000), vulnerable populations (e.g., 
individuals in rural areas) persist (Barnett et al., 2000; Pearson et al., 1998).  In fact, recent 
reports indicate that Coronary Artery Disease is 1.3 times more prevalent in rural areas than in 
urban areas (McCrone et al., 2007). Another recent survey revealed that Coronary Artery 
Disease was the second health priority for those residing in rural areas (Gamm et al., 2002). 
Given that individuals who reside in rural areas are more likely to experience circumstances 
and situations that could compromise their physical and mental health (Healthcare Cost 
Utilization Project, 2001), it makes sense that health concerns such as Coronary Artery Disease 
are such a persistent issue. These circumstances include poverty, physical inactivity, and 
alcohol abuse and dependence (Miller et al., 1987).  Furthermore, the lack of rural health 
services and difficulties of traveling long distances to larger hospitals, increase the possibility 
that these rural residents will not receive the best preventative, medical, and psychological 
care (Wallace et al., 2006). Overall, the clear association between geographic status and 
Coronary Artery Disease leads to questions regarding whether geographic status may actually 
be a predictor of adverse outcomes following Coronary Artery Bypass Grafting surgery. Since 
depression is associated with adverse Coronary Artery Bypass Grafting outcomes (discussed 
previously), depressive symptomatology must also be taken into account in these 
investigations. This is particularly important because those who reside in rural areas 
experience the stressors mentioned above (poverty, alcohol abuse, etc.) and are likely to 
endorse some symptoms of depression as a result of these (or similar) situations.   
In an attempt to address some of the above questions, Dao and colleagues (2010b) proposed 
a study investigating the relationships between depression, geographical status, and 
outcomes following Coronary Artery Bypass Grafting surgery. The primary focus was to 
determine the relationship between Coronary Artery Bypass Grafting outcomes, depression, 
and geographical status while controlling for medical and sociodemographic factors.  
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Secondarily, the study was designed to assess whether geographic status would serve as a 
moderating variable that would subsequently affect the relationship between depression 
and Coronary Artery Bypass Grafting surgery outcomes. The colleagues hypothesized that 
those living in the rural areas would have increased depression and that depression and 
geographical status would contribute to outcomes following Coronary Artery Bypass 
Grafting surgery (mortality and length of hospital stay). The results of the study indicated 
that rural patients were more likely than urban patients to have a concurrent depression 
diagnosis. In addition, both depression and living in rural areas combined were associated 
with less favorable outcomes (i.e., increased length of hospital stay) following Coronary 
Artery Bypass Grafting surgery. Similarly, those living in rural areas and having a 
depression diagnosis had an elevated probability of in-hospital mortality. 
3.3 Anxiety as a moderator/mediator 
Compared to depression and PTSD, there has been limited research on the influence of 
clinical anxiety in the relationship between psychological distress and outcomes following 
Coronary Artery Bypass Grafting surgery. The evidence that does exist suggests that anxiety 
in Coronary Artery Bypass Grafting patients contributes to post-surgery complications and 
elevated risk of sudden cardiac death (Rozanski et al., 1999; Stengrevics et al., 1996).  In 
addition, it has been reported that up to 50% of patients undergoing Coronary Artery 
Bypass Grafting surgery have elevated anxiety scores (Januzzi et al., 2000; Rymaszewska et 
al; 2003; Krannich et al., 2007). Yet, there had been no previous evidence that those with 
anxiety would have better outcomes post-Coronary Artery Bypass Grafting surgery than 
those with depression and/or PTSD. In an effort to address this literature gap, Dao et al. 
(2011c) conducted a study investigating the relationship between anxiety and outcomes 
following Coronary Artery Bypass Grafting surgery.  Results indicated that 27% of patients 
undergoing Coronary Artery Bypass Grafting surgery had a comorbid anxiety diagnosis, 
and patients who had non-routine discharge were more likely to have comorbid anxiety 
diagnoses compared to patients who had a routine discharge. Thus, for this study sample it 
was largely concluded that anxiety disorders are prevalent in patients who are undergoing a 
Coronary Artery Bypass Grafting surgery. Further, for this sample, anxiety was a significant 
independent predictor of both length of hospital stay and non-routine discharge for patients 
receiving Coronary Artery Bypass Grafting surgery. 
It is expected that the number of octogenarians will increase from 6.9 million to 25 million 
by 2050 (Spencer, 1989). While there is a clear relationship between age and adverse 
Coronary Artery Bypass Grafting outcomes, the mechanism(s) underlying this relationship 
are not fully understood. There are two lines of evidence suggesting that psychosocial risk 
factors might mediate this relationship. Recent studies have suggested that Coronary Artery 
Bypass Grafting outcomes (e.g., mortality and patient disposition) cannot be fully explained 
by factors such as age, gender, and medical co-morbidities (Blumenthal et al., 2003). It has 
been reported that depression and anxiety can independently predict mortality and patient 
disposition following Coronary Artery Bypass Grafting surgery (Dao et al., 2010c). The 
second line of evidence has been shown in studies which have demonstrated the 
relationship between increased age with depression and anxiety disorders. The most 
common geriatric psychiatric disorders among the elderly are generalized anxiety disorder 
and depression (Beekmanet al., 1998). By simply looking at the relationship between age and 
Coronary Artery Bypass Grafting outcomes as linear, we may limit the understanding of 
potential critical mechanisms (i.e., mediators) influencing Coronary Artery Bypass Grafting 
outcomes. 
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that both depression and Post-traumatic Stress Disorder involve increased secretion of 
corticotropin-releasing factor. However, patients with Post-traumatic Stress Disorder have 
hypocortisolemia due to the increased secretion, whereas severe depression is associated 
with hypercortisolemia, showing that the pathophysiology of the 2 disorders might be 
different (Lyons et al., 2001).  In addition, the psychiatric comorbidities of Post-traumatic 
Stress Disorder and depression may potentially affect cardiac prognosis adversely. Thus, by 
treating only depression and not the Post-traumatic Stress Disorder, cardiac outcomes may 
be adversely affected. 
Dao et al (2010c) proposed a study examining the effect of clinical depression, PTSD, and 
comorbid depression and PTSD on outcomes following Coronary Artery Bypass Grafting 
surgery. It was hypothesized that depression, PTSD, and comorbid depression and PTSD 
would independently contribute to an increased risk for mortality following Coronary 
Artery Bypass Grafting surgery. In addition, it was hypothesized that comorbid depression 
and PTSD will have the greatest effect on mortality rates and outcomes in general. It was 
determined that, depression, posttraumatic stress disorder, and comorbid depression and 
posttraumatic stress disorder are prevalent in patients undergoing Coronary Artery Bypass 
Grafting surgery. In addition, depression, posttraumatic stress disorder, and comorbid 
depression and posttraumatic stress disorder increased the risk of mortality following 
Coronary Artery Bypass Grafting surgery. 
3.2 Geographic status 
Another topic that has received limited focus in literature to date is the impact geographic 
status may have on Coronary Artery Bypass Grafting outcomes. While death rates due to heart 
disease have decreased in recent decades (Cooper et al., 2000), vulnerable populations (e.g., 
individuals in rural areas) persist (Barnett et al., 2000; Pearson et al., 1998).  In fact, recent 
reports indicate that Coronary Artery Disease is 1.3 times more prevalent in rural areas than in 
urban areas (McCrone et al., 2007). Another recent survey revealed that Coronary Artery 
Disease was the second health priority for those residing in rural areas (Gamm et al., 2002). 
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alcohol abuse and dependence (Miller et al., 1987).  Furthermore, the lack of rural health 
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experience the stressors mentioned above (poverty, alcohol abuse, etc.) and are likely to 
endorse some symptoms of depression as a result of these (or similar) situations.   
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outcomes following Coronary Artery Bypass Grafting surgery. The primary focus was to 
determine the relationship between Coronary Artery Bypass Grafting outcomes, depression, 
and geographical status while controlling for medical and sociodemographic factors.  
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Secondarily, the study was designed to assess whether geographic status would serve as a 
moderating variable that would subsequently affect the relationship between depression 
and Coronary Artery Bypass Grafting surgery outcomes. The colleagues hypothesized that 
those living in the rural areas would have increased depression and that depression and 
geographical status would contribute to outcomes following Coronary Artery Bypass 
Grafting surgery (mortality and length of hospital stay). The results of the study indicated 
that rural patients were more likely than urban patients to have a concurrent depression 
diagnosis. In addition, both depression and living in rural areas combined were associated 
with less favorable outcomes (i.e., increased length of hospital stay) following Coronary 
Artery Bypass Grafting surgery. Similarly, those living in rural areas and having a 
depression diagnosis had an elevated probability of in-hospital mortality. 
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elevated risk of sudden cardiac death (Rozanski et al., 1999; Stengrevics et al., 1996).  In 
addition, it has been reported that up to 50% of patients undergoing Coronary Artery 
Bypass Grafting surgery have elevated anxiety scores (Januzzi et al., 2000; Rymaszewska et 
al; 2003; Krannich et al., 2007). Yet, there had been no previous evidence that those with 
anxiety would have better outcomes post-Coronary Artery Bypass Grafting surgery than 
those with depression and/or PTSD. In an effort to address this literature gap, Dao et al. 
(2011c) conducted a study investigating the relationship between anxiety and outcomes 
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undergoing Coronary Artery Bypass Grafting surgery had a comorbid anxiety diagnosis, 
and patients who had non-routine discharge were more likely to have comorbid anxiety 
diagnoses compared to patients who had a routine discharge. Thus, for this study sample it 
was largely concluded that anxiety disorders are prevalent in patients who are undergoing a 
Coronary Artery Bypass Grafting surgery. Further, for this sample, anxiety was a significant 
independent predictor of both length of hospital stay and non-routine discharge for patients 
receiving Coronary Artery Bypass Grafting surgery. 
It is expected that the number of octogenarians will increase from 6.9 million to 25 million 
by 2050 (Spencer, 1989). While there is a clear relationship between age and adverse 
Coronary Artery Bypass Grafting outcomes, the mechanism(s) underlying this relationship 
are not fully understood. There are two lines of evidence suggesting that psychosocial risk 
factors might mediate this relationship. Recent studies have suggested that Coronary Artery 
Bypass Grafting outcomes (e.g., mortality and patient disposition) cannot be fully explained 
by factors such as age, gender, and medical co-morbidities (Blumenthal et al., 2003). It has 
been reported that depression and anxiety can independently predict mortality and patient 
disposition following Coronary Artery Bypass Grafting surgery (Dao et al., 2010c). The 
second line of evidence has been shown in studies which have demonstrated the 
relationship between increased age with depression and anxiety disorders. The most 
common geriatric psychiatric disorders among the elderly are generalized anxiety disorder 
and depression (Beekmanet al., 1998). By simply looking at the relationship between age and 
Coronary Artery Bypass Grafting outcomes as linear, we may limit the understanding of 
potential critical mechanisms (i.e., mediators) influencing Coronary Artery Bypass Grafting 
outcomes. 
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Dao and colleagues (2011c) constructed a study to examine whether clinical levels of anxiety 
and depression act as a mediator between patient age and mortality and patient discharge 
status among octogenarian patients following Coronary Artery Bypass Grafting surgery. It 
was hypothesized that clinical anxiety and depression levels would mediate the relationship 
between increased age and Coronary Artery Bypass Grafting outcomes. This hypothesis was 
based on the established relationships between increased age and adverse Coronary Artery 
Bypass Grafting outcomes (Blumenthal et al., 2003), as well as the relationship between 
increased age and prevalence of anxiety and depression symptoms. Study results indicated 
that patients with an anxiety/depression diagnosis had a 6% higher postoperative mortality 
rate and had an 18% greater likelihood of having postoperative complications. In addition, it 
was found that an anxiety/depression diagnosis served as a partial mediator of the 
relationship between age and post-Coronary Artery Bypass Grafting outcomes for both 
postoperative mortality and discharge status. 
 
 
Fig. 1. Proposed Model of Psychological Factors Predicting Outcomes following Coronary 
Artery Bypass Grafting Surgery Versus the Traditional Medical Model 
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4. Treatments for comorbid psychological factors prior to Coronary Artery 
Bypass Grafting surgery 
4.1 Treatment using Heart Rate Variability 
Over the past several years, the relationship between emotional states and outcomes in 
cardiac patients has been the subject of increased scrutiny by researchers and clinicians 
(Doering et al., 2005). In particular, post-traumatic stress symptoms have been reported in 
up to 15 percent of Coronary Artery Bypass Grafting patients (Doerfler et al., 1994; Stoll et 
al., 2000). Similar to Coronary Artery Bypass Grafting patients with depression, higher 
levels of post-traumatic stress symptoms are related to increased mortality (Oxlad & Wade, 
2006), lower health-related quality of life (Rothenhausler et al., 2010), and increased length 
of post-operative hospital stay (Oxlad et al., 2006). While several treatments for Post-
Traumatic Stress Disorder have been proven to be effective, one of the primary drawbacks 
of these interventions is that they can be very lengthy and take weeks or months for 
treatment. Specifically, long term treatments are unrealistic and unfeasible given the sudden 
onset of Coronary Artery Bypass Grafting surgeries (Doerfler et al., 1994). Since there is 
evidence that patients suffering from Post-Traumatic Stress Disorder have an increased 
likelihood of mortality following Coronary Artery Bypass Grafting surgery (Dao et al., 
2010a), in combination with length of treatment necessary for effective Post-Traumatic Stress 
Disorder care, there is a necessary need for an effective, short term treatment for improving 
outcomes following Coronary Artery Bypass Grafting surgery. 
As mentioned earlier, Heart Rate Variability is a measure which examines the interplay 
between the parasympathetic and sympathetic influences on heart rate and represents the 
psychophysiological mechanism of emotion regulation (Appelhans & Luecken, 2006). In 
addition, increased Heart Rate Variability has been correlated with the increased capability 
of regulating stress, arousal, and attention (Bornstein et al., 2002).  Recent research has 
demonstrated that the emotion regulation characteristics of patients with Post-Traumatic 
Stress Disorder have been associated with low Heart Rate Variability (Tan et al., 2010). Also, 
the physiological profile of a Coronary Artery Bypass Grafting patients with Post-Traumatic 
Stress Disorder may be complicated given purported research that low Heart Rate 
Variability is related to cardiovascular disease (van der Kolk, 2006). As previously 
discussed, it has been reported that patients with Coronary Artery Disease and a diagnosis 
of Post-Traumatic Stress Disorder have lower Heart Rate Variability than those patients 
with Coronary Artery Disease alone (Dao et al., 2010a; Krittayaphong et al., 1997; Stein et al., 
2000).  Since Post-Traumatic Stress Disorder and cardiovascular disease are associated with 
decreased Heart Rate Variability and Autonomic Nervous System dysregulation, Heart Rate 
Variability biofeedback training may reduce complications post-surgery. This has been 
supported by previous reports demonstrating that biofeedback training can increase Heart 
Rate Variability (Cohen et al., 2002; Tan et al., 2009). Other research has shown that Heart 
Rate Variability biofeedback training may be effective in reducing psychiatric symptoms 
associated with trauma (Karavidas et al., 2007; Zucker et al., 2009). Heart Rate Variability 
biofeedback training entails determining an individual’s heart rate resonance frequency at 
baseline, calculating the optimal resonance frequency, and then providing specific breathing 
techniques to maximize his/her Heart Rate Variability (Lehrer et al., 2000).  
Tan and colleagues (2010) reported that veterans with Post-Traumatic Stress Disorder 
exhibited significantly lower Heart Rate Variability compared to those without Post-Traumatic 
Stress Disorder. It was also discovered that those individuals receiving Heart Rate Variability 
biofeedback along with treatment as usual (TAU) had a significant reduction in Post-
Traumatic Stress Disorder symptoms when compared to those receiving TAU alone (Tan et al., 
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As mentioned earlier, Heart Rate Variability is a measure which examines the interplay 
between the parasympathetic and sympathetic influences on heart rate and represents the 
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the physiological profile of a Coronary Artery Bypass Grafting patients with Post-Traumatic 
Stress Disorder may be complicated given purported research that low Heart Rate 
Variability is related to cardiovascular disease (van der Kolk, 2006). As previously 
discussed, it has been reported that patients with Coronary Artery Disease and a diagnosis 
of Post-Traumatic Stress Disorder have lower Heart Rate Variability than those patients 
with Coronary Artery Disease alone (Dao et al., 2010a; Krittayaphong et al., 1997; Stein et al., 
2000).  Since Post-Traumatic Stress Disorder and cardiovascular disease are associated with 
decreased Heart Rate Variability and Autonomic Nervous System dysregulation, Heart Rate 
Variability biofeedback training may reduce complications post-surgery. This has been 
supported by previous reports demonstrating that biofeedback training can increase Heart 
Rate Variability (Cohen et al., 2002; Tan et al., 2009). Other research has shown that Heart 
Rate Variability biofeedback training may be effective in reducing psychiatric symptoms 
associated with trauma (Karavidas et al., 2007; Zucker et al., 2009). Heart Rate Variability 
biofeedback training entails determining an individual’s heart rate resonance frequency at 
baseline, calculating the optimal resonance frequency, and then providing specific breathing 
techniques to maximize his/her Heart Rate Variability (Lehrer et al., 2000).  
Tan and colleagues (2010) reported that veterans with Post-Traumatic Stress Disorder 
exhibited significantly lower Heart Rate Variability compared to those without Post-Traumatic 
Stress Disorder. It was also discovered that those individuals receiving Heart Rate Variability 
biofeedback along with treatment as usual (TAU) had a significant reduction in Post-
Traumatic Stress Disorder symptoms when compared to those receiving TAU alone (Tan et al., 
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2010). Thus, evidence exists in support of the use of biofeedback as a potential, beneficial 
treatment for Post-Traumatic Stress Disorder. However, it remains unclear as to whether this 
treatment would be beneficial in reducing Post-Traumatic Stress Disorder symptoms in 
patients with Coronary Artery Disease or if it might improve outcomes post-Coronary Artery 
Bypass Grafting surgery. Incorporating Heart Rate Variability biofeedback training may result 
in Autonomic Nervous System regulation and subsequently improve outcomes post-surgery 
by reducing Post-Traumatic Stress Disorder symptoms.  
Dao et al (2011b) proposed a study examining the efficacy of a Heart Rate Variability 
biofeedback treatment in 65 patients with Post-Traumatic Stress Disorder symptoms prior to 
Coronary Artery Bypass Grafting surgery. This study was designed to assess the impact of 
the Heart Rate Variability biofeedback intervention on Post-Traumatic Stress Disorder 
symptoms and in-hospital length of stay. It was hypothesized that symptoms associated 
with Post-Traumatic Stress Disorder would decrease following Heart Rate Variability 
biofeedback training and that their length of inpatient hospital duration would decrease 
following their Coronary Artery Bypass Grafting surgeries. The results from the study 
suggested that Heart Rate Variability biofeedback treatment can cause improvement in Post-
Traumatic Stress Disorder symptoms in patients undergoing Coronary Artery Bypass 
Grafting surgery. It was also suggested that this treatment pre-surgery might improve 
patient quality of life and decrease the length of hospital stay.  
4.2 Treatment using brief Cognitive Behavioral Therapy 
While there have been some studies investigating the benefits of treating depression or anxiety 
in Coronary Artery Bypass Grafting patients postoperatively (Freedlandet al., 2009a; 
Freedlandet al., 2009b; Lie et al., 2007; Rollman et al., 2009), there has been little published 
investigating the impact of cognitive–behavioral approaches in treating depression or anxiety 
on Coronary Artery Bypass Grafting patients prior to surgery. Specifically, the SADHART 
(Sertraline Anti-Depressant Heart Attack Trial) study found a trend toward reduced 
cardiovascular mortality and morbidity when utilizing selective serotonin reuptake inhibitors. 
However, this trial had too small of a sample size and a too brief treatment duration to draw 
useful conclusions (Levin et al., 2005). Another study, the ENRICoronary Artery Disease 
(Enhancing Recovery in Coronary Heart Disease) trial found that cognitive behavioral therapy 
(CBT) after myocardial infarction had an effect on depression (Berkmanet al., 2003), but did 
not affect cardiac events such as nonfatal infarction, death from any cause, and cardiac death. 
To further address questions stemming from the previous trials, Dao et al (2011a) proposed 
a study to examine the feasibility of a brief, tailored Cognitive Behavioral Therapy 
intervention entitled “Managing Anxiety and Depression using Education and Skills” 
(MADES), for treating patients with Coronary Artery Disease and symptoms of depression 
or anxiety prior to Coronary Artery Bypass Grafting surgery. The specific focus of this study 
was to assess the impact of this brief intervention on depression/anxiety symptoms and in-
hospital length of stay.  This study demonstrated that brief, tailored Cognitive Behavioral 
Therapy was not only feasible, but was successful in improving depressive/anxiety 
symptoms and quality of life while simultaneously reducing in-hospital length of stay. 
5. Conclusion 
5.1 What we still don’t know 
The studies reviewed in this chapter are important for several reasons (for a brief synopsis 
of each article, please refer to Table 1). First, these studies highlight the importance of 
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psychological risk factors such as depression and anxiety in predicting adverse Coronary 
Artery Bypass Grafting outcomes. Second, the relations were more pronounced for certain 
groups of patients (e.g., rural versus non-rural and females versus males), which could 
help explain why females often seem to derive less functional benefit from Coronary 
Artery Bypass Grafting surgery than men. Third, while the treatment of presurgical and 
postsurgical depression and anxiety have not been extensively studied to date, the results 
thus far are somewhat promising. The aforementioned studies, however, do not fully 
explain the nature of psychological risk factors and outcomes following Coronary Artery 
Bypass Grafting surgery. In other words, are psychological risk factors such as depression 
and anxiety causal factors, directly related to adverse outcomes following Coronary 
Artery Bypass Grafting surgery? Or, are psychological risk factors risk markers, indirectly 
related to outcomes following Coronary Artery Bypass Grafting surgery through 
behavioral variables?  
As pointed out by Rumsfeld and Ho (2005), the relations between psychological factors and 
adverse Coronary Artery Bypass Grafting outcomes may be mediated by behavioral 
mechanisms that are well documented in the literature to be associated with psychological 
symptoms. For instance, symptoms such as low energy or fatigue, loss of interest in activities, 
diminished ability to concentrate or indecisiveness, and psychomotor retardation are common 
in individuals diagnosed with depression. Thus, it is not surprising that these individuals are 
significantly less likely to adhere to prescribedmedications, follow lifestyle recommendations 
(e.g., exercising), practice self-management (e.g., monitor weight), and even follow up or 
receive recommended cardiac testing compared to those with no depression.  
Overall, no studies to date have concurrently examined the physiological mechanisms 
(elevated plasma norepinephrine levels, cortisol, heart rate variability) and behavioral 
mechanisms (not following through with medication suggestions, lack of exercise, etc.) to 
determine which mechanisms (if any) are more responsible for adverse outcomes following 
Coronary Artery Bypass Grafting surgery.  
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Table 1. Review of Research Reporting Predictors of Outcomes Following Coronary Artery 
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6. References 
Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients 80 
years: results from the National Cardiovascular Network. J Am CollCardiol 
2000;35:731–8. 
Appelhans BM, Luecken LJ: Heart rate variability as an index of regulated emotional 
responding.  Review of General Psychology 2006, 10:229-240. 
Bankier B, Januzzi JL, Littman AB: The high prevalence of psychiatric disorders in stable 
outpatients with coronary  heart disease.  Psychosom Med 2004, 66:645-650. 
Barnes RF, Veith RC, Borson S, Verhey J, Raskind MA, Halter JB: High levels of plasma 
catecholamines in dexamethasone-resistant depressed patients.  Am J Psychiat 
1983, 140:1623-1625. 
Barnett E, Halverson JA, Elmes GA, et al. Metropolitan and non-metropolitan trends in 
coronary heart disease mortality within Appalachia, 1980–1997. Ann Epidemiol. 
2000;10(6):370-379. 
Baslaim G, Bashore J, Alhoroub K. Impact of obesity on early outcomes after cardiac 
surgery: Experience in a Saudi Arabian center. Ann ThoracCardiovascSurg 
2008;14:369. 
Beekman A, Breemer M, Deeg D, et al. Anxiety disorder in later life: a report from the 
longitudinal aging study  Amsterdam. International Journal of Geriatric Psychiatry. 
1998; 13:717-726. 
Benetti FJ, Ballester C, Sani G, Doonstra P, Grandjean J. Video assisted coronary bypass 
surgery. J Card Surg 1995;10:620–5. 
 









Primary Outcome Result 












Rural pts were more likely than 
urban pts to have a depression 
diagnosis 
Depression was a predictor of 
mortality and length of stay 
following CABG surgery 
Rural pts had increased lengths of 
hospital stays and increased mortality 
rates when compared to urban pts 







PTSD on outcomes 
following CABG 
surgery  
Depression and PTSD were 
prevalent in pts undergoing CABG 
surgery 
Depression and PTSD (and in 
combination) increased the risk of 
mortality as well as physical health 
risk factors following CABG surgery 




efficacy of a brief 
CBT for pts prior 
to CABG surgery 
The intervention improved 
depressive and anxiety symptoms 
and quality of life and reduced 
length of hospital stay 








PTSD prior to 
CABG surgery 
HRV biofeedback training results in 
improvement in PTSD symptoms in 
patients undergoing CABG surgery, 
improves the quality of life, and 
decreases the length of hospital stay 
Dao 2011c 17,885 Rural pts who 
underwent 
CABG surgery
Examine the effect 





Anxiety disorders are prevalent in 
rural patients who are undergoing a 
CABG operation 
Anxiety was a significant 
independent predictor of both length 
of hospital stay and non-routine 
discharge for patients receiving 
CABG surgery 
Females with an anxiety disorder 
seemed to have more aversive 
outcomes than males with an anxiety 
disorder 
Table 1. Review of Research Reporting Predictors of Outcomes Following Coronary Artery 




Psychiatric Factors Which Impact Coronary Heart Disease and  
Influence Outcomes Post-Coronary Artery Bypass Grafting Surgery 73 




Primary Outcome Result 
Gopaldas 2009 5,731 Pts who were  







discharge status in 
pts> 80 years of age 
27% were referred to home health 
care, 45% were transferred to 
another facility, 21% had normal 
discharge 
While those older than 80 years of 
age have acceptable mortality 
risk, these pts require further 
specialized care at discharge 







Work-hour reform did not affect 
mortality rates 
Work-hour reform was associated 
with increased morbidity 
Mahoney 2011 51,266 Pts who were  












actsas a mediator through which 
age influences mortality and 
patient discharge status 
Table 1. Review of Research Reporting Predictors of Outcomes Following Coronary Artery 
Bypass Grafting Surgery (continuation) 
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1. Introduction 
Ischemic cardiomyopathy (ICM) is defined as diffuse akinesis of the ventricle after 
myocardial ischemia1). A subset of patients with ICM develop progressive heart failure as a 
consequence of adverse left ventricular (LV) remodeling, leading to a depressed ejection 
fraction, a dilated LV, a large akinetic region of the myocardium, an abnormal globular 
shape to the ventricular chamber, and functional mitral regurgitation (MR)2-5). Although a 
dilated LV with poor cardiac function is a risk by itself, coexisting functional MR worsens 
the prognosis of ICM6,7). Thus, for patients with ICM and functional MR, it is very important 
to repair the geometric changes of LV remodeling and to decrease the extent of functional 
MR. 
For patients with ICM, surgical ventricular restoration (SVR) is an established treatment to 
reduce ventricular size and restore the elliptical shape of the LV8-12). Anatomical restoration 
by SVR may decrease the severity of MR, through various mechanisms, including reduction 
of ventricular dimensions, lowering of end systolic volumes, and restoration of blood flow 
to the ischemic region of the mitral subvalvular apparatus13,14). However, concomitant 
procedures for the mitral valve are required for further reduction of functional MR. In this 
chapter, our therapeutic strategy for patients with ICM is demonstrated, and we describe 
the details of the surgical techniques of SVR and mitral valve surgery. 
2. Patients 
Between May 2000 and May 2010, SVR was performed in 335 patients with ICM (n=199) and 
non-ischemic cardiomyopathy (n=136). Of the 199 patients with ICM, 88 had concomitant 
mitral valve surgery for functional MR. 
These patients with ICM and functional MR included 77 males and 11 females, ranging in 
age from 32 to 83 years (mean, 61±10 years). The preoperative New York Heart Association 
(NYHA) functional class was class III for 55% (48/88) and class IV for 45% (40/88). 
Preoperative heart failure was medically controlled with inotropes in 34 patients (39%), and 
2 of these patients (2%) required intra-aortic balloon pumping (IABP). Due to uncontrollable 
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heart failure and worsening multiorgan failure, an emergent operation was performed in 12 
patients (14%). 
3. Materials and methods 
3.1 Assessment of cardiac geometry and regional function of the LV 
Two-dimensional echocardiography was used to evaluate cardiac geometry, including 
dimensions and LV volume, valvular morphology, and the subvalvular apparatus. As 
indices of LV volume, the LV end-systolic and end-diastolic volume indices (LVESVI and 
LVEDVI) were calculated. 
Regional LV function was examined by cardiac magnetic resonance imaging (MRI)15,16) and 
color kinesis echocardiography17). Regional LV strain was assessed by speckle-tracking 
echocardiography under normal and dobutamine-stress conditions18). 
a. Cardiac MRI 
Cardiac MRI is a medical imaging technology for the non-invasive assessment of cardiac 
structure and function. Although it shows the precise myocardial anatomy in normal hearts, 
it is also useful for post-ischemic myocardial assessment15,16). To investigate LV wall motion, 
MRI images were obtained by cine acquisition. The depth and extension of the scarred LV 
wall were evaluated with 4 MRI projections. The 4-chamber view was used to assess the 
septum and lateral wall. The 2-chamber view (the vertical long-axis view) was useful for the 
anterior and posterior walls of the LV. The 3-chamber view (the LV outflow tract view) 
provided a detailed analysis of the mitral subvalvular apparatus. The short-axis view 
enabled a staged analysis of the septum and papillary muscles. Late gadolinium 
enhancement was also performed to investigate the irreversible myocardium of the LV 
wall19). 
b. Color kinesis echocardiography 
Color kinesis is a non-invasive technology for the echocardiographic assessment of LV wall 
motion based on acoustic quantification17). This technique automatically detects endocardial 
motion in real time using integrated backscatter data to identify pixel transitions from blood 
to tissue during systole on a frame-by-frame basis. We have reported the usefulness of intra-
operative color kinesis echocardiography under cardiopulmonary bypass (CPB) assist for 
patients with idiopathic dilated cardiomyopathy20). LV wall motion was observed by direct 
vision of the cardiac echogram (HP SONO 5500; Agilent Technologies, Palo Alto, CA, USA) 
under different preloads controlled by CPB (volume reduction test). The objective of this test 
was to assess the akinetic region of the LV wall for SVR. 
c. Speckle-tracking echocardiography 
Speckle-tracking echocardiography is a unique imaging technique that analyzes 
multidirectional components of LV deformation within an ultrasonic window by tracking 
interference patterns and natural acoustic reflections21). The tracking system is obtained by 
automatic measurement of the distance between 2 pixels of an LV segment during the 
cardiac cycle, independent of the angle of insonation22,23). 
Echocardiography was carried out using a Vivid 7 ultrasonography machine (GE Medical 
Systems, Milwaukee, WI, USA) with an M3S probe. Short-axis images from the mid-level 
(i.e., papillary muscle level) of the LV were obtained from the parasternal window to assess 
myocardial segmental viability and LV dyssynchrony. Caution was exercised to ensure 
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short-axis images with circular cross-sections and minimal out-of-plane movement. Short-
axis images were analyzed by the EchoPAC platform (2DS software package, version 7; GE 
Medical Systems), which uses a speckle-tracking technique to derive rotation and strain for 
selected regions of the myocardium24). LV torsion is also calculated automatically from the 
LV basal and apical rotation data in the platform. For assessing segmental myocardial 
viability, the myocardial region obtained from the short-axis images of the midlevel LV was 
divided into four segments (septal, anterolateral, posterior, inferoseptal), and the 




Fig. 1. Late gadolinium enhancement of cardiac magnetic resonance imaging (in the left 
panel) and two-dimensional speckle-tracking echocardiographic imaging (in the right panel) 
in a representative case with ischemic cardiomyopathy. Severe ischemic injury and a 
suggestion of fibrotic change (a tissue characteristic) are depicted in the lateral, posterior, 
and inferoseptal segments by late gadolinium enhancement, while end-systolic 
circumferential strain of speckle-tracking echocardiographic imaging detected nearly +20% 
lengthening at the posterior region only (shown as dark blue). Two-dimensional speckle-
tracking echocardiography could identify such transmurally injured “dyskinetic scars” (a 
mechanodynamic myocardial property), which is critically important in ventricular 
restoration tactics. 
d. Prediction of the non-functional akinetic region of the LV 
Using these results, the exclusion area of non-functional myocardium for SVR was predicted 
preoperatively. A representative case with ICM is shown in Fig. 1. On the left side, late 
gadolinium enhancement of cardiac MRI demonstrated regional stains on the endocardium 
in the lateral, posterior, and infero-septal segments. On the right side, two-dimensional 
speckle-tracking echocardiography revealed LV torsion at the corresponding short-axis slice 
level seen on cardiac MRI. Severe ischemic injury and suggestions of fibrotic change (a 
tissue characteristic) were depicted by cardiac MRI, while end-systolic circumferential strain 
of speckle-tracking echocardiographic imaging detected nearly +20% lengthening at the 
posterior region only (shown as dark blue). Thus, two-dimensional speckle-tracking 
echocardiography could identify such transmurally injured “dyskinetic scars” (a 
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mechanodynamic myocardial property), which are critically important in ventricular 
restoration tactics. 
3.2 Technical details of our three SVR procedures for ICM 
Surgical resection is the oldest and simplest technique for LV aneurysm following 
myocardial infarction. At the end of the 1970s, SVR with patchplasty had been reported 
for the posterior and anterior regions of the LV27,28). In 1980s, Dor and associates 
established a new surgical technique with a circular patch (endoventricular circular patch 
plasty; EVCCP) for antero-septo-apical aneurysms29). Around the same time, Cooley 
reported ventricular endoaneurysmorrhaphy with an elliptical patch to allow prompt 
recovery and restoration of ventricular function30). As Hutchins and coworkers suggested 
the importance of cardiac geometry after SVR, cardiac surgeons modified their technique 
to obtain a postoperative elliptical shape of the LV31). Recently, we have developed new 
techniques of septal anterior ventricular exclusion (SAVE) for the anterior wall of the LV 
and a posterior restoration procedure (PRP) for the posterior wall in patients with dilated 
cardiomyopathy8,24). We performed SVR with three different procedures (EVCPP, SAVE, 
and PRP) for patients with ICM, and the details of our modified techniques are described 
below. 
a. Modified endoventricular circular patch plasty (EVCPP) 
The presence of an antero-septo-apical akinetic region is a good indication for EVCPP, as 
reported by Dor and coworkers29). At first, coronary revascularization was completely 
performed under blood cardioplegic cardiac arrest. Valvular surgery, including mitral, 
tricuspid, and aortic valves, was completed prior to EVCPP. To obtain a better surgical field 
of the anterior LV wall, two 1-0 silk sutures were placed at the apex (Fig. 2A). The antero-
apical LV wall was opened in the center of the akinetic region (Fig. 2B). When thrombus 
formation was detected in the LV trabeculation, it was entirely removed. The anatomical 
margin of the contractile myocardium around the scar, the so-called “contractility trail”, was 
observed through the ventriculotomy. To prevent late ventricular tachycardia or fibrillation 
(VT/VF), cryoablation was performed on the viable LV myocardium along the junction. To 
plicate the circular defect of the LV muscle, 2-0 polypropylene purse-string suture 
(Prolene®; Ethicon, Somerville, NJ, USA) was placed around the entire circumference of the 
contractility trail (Fig. 2C). Then, a collagen-impregnated Dacron knitted fabric (MAQUET 
Cardiovascular LLC, Wayne, NJ, USA) (approximately 3×4 cm) was placed over the plicated 
defect of the myocardium and fixed with 2-0 polypropylene running suture after deaeration 
of the LV (Fig. 2D). Finally, two felt strips were placed along the ventriculotomy on each 
side, and the excluded external scar was folded to reinforce the suture line with 2-0 
polypropylene horizontal mattress sutures with a large needle (Matsuda-ika Kogyo, Tokyo, 
Japan). The line was secured by double 2-0 polypropylene over-and-over sutures from both 
ends (Fig. 2E). 
b. Septal anterior ventricular exclusion (SAVE) 
The presence of a large antero-septal akinetic region is a good indication for SAVE or the 
Pacopexy technique developed by Isomura et al8,12). As for EVCPP, complete coronary 
revascularization was first preformed under blood cardioplegic arrest. Valvular surgery, 
including mitral, tricuspid, and aortic valves, was undertaken prior to SAVE. The aortic 
crossclamp was released to allow the heart to start beating, and perfusion pressure was  
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Fig. 2A. The schema shows the heart with ICM including the antero-apical akinetic region. 
2B. The antero-apical LV wall is opened in the center of the region. The margin of the 
contractile myocardium around the scar, the so-called “contractility trail”, is observed 
through the ventriculotomy. 2C. To plicate the circular defect of the LV muscle, 2-0 
polypropylene purse-string suture is placed around the entire circumference of the 
contractility trail. 2D. A collagen-impregnated Dacron knitted fabric (approximate 3×4 cm) 
is placed over the plicated defect of the myocardium and fixed with 2-0 polypropylene 
running suture after deaeration of the LV. 2E. Two felt strips are placed along the 
ventriculotomy on each side, and the excluded external scar is folded to reinforce the suture 
line with 2-0 polypropylene horizontal mattress sutures with a large needle. The line is 
secured by double 2-0 polypropylene over-and-over sutures from both ends. 
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kept >75 mmHg to ensure ongoing coronary perfusion. Thus, the SAVE operation was 
usually performed on the beating heart. During beating, the transitional zone between the 
scar and the viable myocardium was easily detected by direct manipulation of the LV 
muscle. 
Two 1-0 silk sutures were placed at the apex to achieve a better surgical field (Fig. 3A). The 
anterior wall of the LV was opened along the left anterior descending artery from the apex 
toward the base (Fig. 3B). Cryoablation was performed on the viable LV myocardium along 
the incision to prevent late VT/VF. For patients with a dilated posterior wall between two 
papillary muscles, chordal cutting of the basal chordae and papillary muscle approximation 
was performed via this incision (see Technical details of our mitral valve surgery). Multiple 0 
braided polyester horizontal mattress sutures (Ticron®; Tyco, Waltham, MA, USA) with 
pledgets were placed along the exclusion line of the septum, in a direction that proceeded 
from the apex to a septal site 1-2 cm below the aortic valve (Fig. 3C). A collagen-
impregnated Dacron knitted fabric was trimmed to create an elliptical shape, approximately 
3×8 cm, and placed along the site of the exclusion, with sutures placed 1 cm from the patch 
edge to leave a patch rim outside these sutures. The last two sutures were tied after 
deaeration of the LV (Fig. 3D). Finally, two felt strips were placed along the ventriculotomy 
on each side, and the excluded external scar was folded to reinforce the suture line with 2-0 
polypropylene horizontal mattress sutures anchoring the allowance of Dacron fabric (Fig. 
3E). The suture line was secured by double 2-0 polypropylene over-and-over sutures from 
both ends (Fig. 3F). 
Some patients requiring SAVE were treated by overlapping cardiac volume reduction 
operations in this series32). 
c. Posterior restoration procedure (PRP) 
The posterior akinetic region of the LV was repaired with the PRP procedure developed by 
Isomura et al24). One of the most important operative concepts was the postoperative 
elliptical shape of the LV. To achieve the elliptical shape, the LV apex and bilateral papillary 
muscles were preserved in this operation. 
As for EVCPP and SAVE, complete coronary revascularization was first preformed under 
blood cardioplegic arrest. Valvular surgery, including mitral, tricuspid, and aortic valves, 
was undertaken prior to PRP. PRP was also performed in a beating heart as for the SAVE 
procedure. Two 1-0 silk sutures were placed at the apex. The akinetic region was opened 1 
cm proximal from the apex on the posterior wall between bilateral papillary muscles (Fig. 
4A). The incision was extended toward the base of the heart, reaching 1 cm above the 
mitral annulus (Fig. 4B). Cryoablation was performed on the viable LV myocardium 
along the incision to prevent late VT/VF, especially for the LV muscle between the end of 
the incision and the mitral annulus. Multiple 0 braided polyester horizontal mattress 
sutures with pledgets were placed along the exclusion line on the viable LV myocardium 
(Fig. 3C). As for the SAVE procedure, a collagen-impregnated Dacron knitted fabric was 
trimmed to create an elliptical shape and placed over the exclusion with a 1-cm allowance 
for LV closure. The last two sutures on the apex side were tied after deaeration of the LV 
(Fig. 4D). Finally, the LV was closed in a similar manner as in the SAVE procedure, and 
the bilateral papillary muscles were approximated during the PRP procedure (Fig. 4E). 
The line was secured by double 2-0 polypropylene over-and-over sutures from both ends 
(Fig. 4F). 
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Fig. 3A. The schema shows the heart with ICM including a large antero-septal akinetic 
region. 3B. The antero-lateral LV wall is opened along the left descending artery from the 
apex toward the base. 3C. Multiple 0 braided polyester horizontal mattress sutures with 
pledgets are placed along the exclusion line of the septum, in a direction that proceeds from 
the apex to a septal site 1-2 cm below the aortic valve. 3D. A collagen-impregnated Dacron 
knitted fabric (approximate 3×4 cm) is placed over the plicated defect of the myocardium 
and fixed with 2-0 polypropylene running suture. The last two sutures on the apex side are 
tied after deaeration of the LV. 3E. Two felt strips are placed along the ventriculotomy on 
each side, and the excluded external scar is folded to reinforce the suture line with 2-0 
polypropylene horizontal mattress sutures anchoring the allowance of Dacron fabric. 3F. 
The suture line is secured by double 2-0 polypropylene over-and-over sutures from both 
ends. 
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kept >75 mmHg to ensure ongoing coronary perfusion. Thus, the SAVE operation was 
usually performed on the beating heart. During beating, the transitional zone between the 
scar and the viable myocardium was easily detected by direct manipulation of the LV 
muscle. 
Two 1-0 silk sutures were placed at the apex to achieve a better surgical field (Fig. 3A). The 
anterior wall of the LV was opened along the left anterior descending artery from the apex 
toward the base (Fig. 3B). Cryoablation was performed on the viable LV myocardium along 
the incision to prevent late VT/VF. For patients with a dilated posterior wall between two 
papillary muscles, chordal cutting of the basal chordae and papillary muscle approximation 
was performed via this incision (see Technical details of our mitral valve surgery). Multiple 0 
braided polyester horizontal mattress sutures (Ticron®; Tyco, Waltham, MA, USA) with 
pledgets were placed along the exclusion line of the septum, in a direction that proceeded 
from the apex to a septal site 1-2 cm below the aortic valve (Fig. 3C). A collagen-
impregnated Dacron knitted fabric was trimmed to create an elliptical shape, approximately 
3×8 cm, and placed along the site of the exclusion, with sutures placed 1 cm from the patch 
edge to leave a patch rim outside these sutures. The last two sutures were tied after 
deaeration of the LV (Fig. 3D). Finally, two felt strips were placed along the ventriculotomy 
on each side, and the excluded external scar was folded to reinforce the suture line with 2-0 
polypropylene horizontal mattress sutures anchoring the allowance of Dacron fabric (Fig. 
3E). The suture line was secured by double 2-0 polypropylene over-and-over sutures from 
both ends (Fig. 3F). 
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was undertaken prior to PRP. PRP was also performed in a beating heart as for the SAVE 
procedure. Two 1-0 silk sutures were placed at the apex. The akinetic region was opened 1 
cm proximal from the apex on the posterior wall between bilateral papillary muscles (Fig. 
4A). The incision was extended toward the base of the heart, reaching 1 cm above the 
mitral annulus (Fig. 4B). Cryoablation was performed on the viable LV myocardium 
along the incision to prevent late VT/VF, especially for the LV muscle between the end of 
the incision and the mitral annulus. Multiple 0 braided polyester horizontal mattress 
sutures with pledgets were placed along the exclusion line on the viable LV myocardium 
(Fig. 3C). As for the SAVE procedure, a collagen-impregnated Dacron knitted fabric was 
trimmed to create an elliptical shape and placed over the exclusion with a 1-cm allowance 
for LV closure. The last two sutures on the apex side were tied after deaeration of the LV 
(Fig. 4D). Finally, the LV was closed in a similar manner as in the SAVE procedure, and 
the bilateral papillary muscles were approximated during the PRP procedure (Fig. 4E). 
The line was secured by double 2-0 polypropylene over-and-over sutures from both ends 
(Fig. 4F). 
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Fig. 3A. The schema shows the heart with ICM including a large antero-septal akinetic 
region. 3B. The antero-lateral LV wall is opened along the left descending artery from the 
apex toward the base. 3C. Multiple 0 braided polyester horizontal mattress sutures with 
pledgets are placed along the exclusion line of the septum, in a direction that proceeds from 
the apex to a septal site 1-2 cm below the aortic valve. 3D. A collagen-impregnated Dacron 
knitted fabric (approximate 3×4 cm) is placed over the plicated defect of the myocardium 
and fixed with 2-0 polypropylene running suture. The last two sutures on the apex side are 
tied after deaeration of the LV. 3E. Two felt strips are placed along the ventriculotomy on 
each side, and the excluded external scar is folded to reinforce the suture line with 2-0 
polypropylene horizontal mattress sutures anchoring the allowance of Dacron fabric. 3F. 
The suture line is secured by double 2-0 polypropylene over-and-over sutures from both 
ends. 
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Fig. 4A. The schema shows the heart with ICM including a posterior akinetic region. 4B. The 
akinetic region is opened 1 cm proximal from the apex on the posterior wall between 
bilateral papillary muscles. The incision is extended toward the base of the heart, reaching 1 
cm below the mitral annulus. 4C. Multiple 0 braided polyester horizontal mattress sutures 
with pledgets are placed along the exclusion line of the septum, with a direction that 
proceeds from the apex to a septal site 1-2 cm below the aortic valve. 4D. A collagen-
impregnated Dacron knitted fabric is trimmed to create an elliptical shape and is placed 
over the exclusion with a 1-cm allowance for closure of the LV. The last two sutures on the 
apex side are tied after deaeration of the LV. 4E. Two felt strips are placed along the 
ventriculotomy on each side, and the excluded external scar is folded to reinforce the suture 
line with 2-0 polypropylene horizontal mattress sutures anchoring the allowance of Dacron 
fabric. The bilateral papillary muscles are approximated during the PRP procedure. 4F. The 
suture line is secured by double 2-0 polypropylene over-and-over sutures from both ends. 
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3.3 Anatomical relationships between the mitral leaflet and the subvalvular apparatus 
for ICM 
The mitral valve consists of the anterior and posterior leaflets, annulus, and chordae, 
supported by two papillary muscles to regulate forward blood flow from the left atrium to 
the LV. Under normal conditions, both mitral leaflets create a deep coaptation zone at end-
systole to prevent regurgitant blood flow. However, earlier experimental and clinical studies 
demonstrated that restricted diastolic opening of the mitral leaflets increased valve 
tethering, resulting in functional MR in hearts with LV dysfunction33,34). The mechanism of 
functional MR can be understood in terms of an altered force balance on the mitral leaflets 
in systole; i.e., a combination of increased tethering forces that restrain the leaflets from 
closing and result from an altered three-dimensional geometry of leaflet attachments 
associated with LV dilatation and decreased ventricular forces that act to close the mitral 
leaflets. As a consequence of geometric remodeling, laterally displaced papillary muscles 
were detected in dilated LVs with ICM35). Although annular dilation is also one of the 
primary causes of functional MR, understanding of the geometric imbalance between the LV 
dimensions and the subvalvular apparatus is important to repair functional MR in patients 
with ICM36). 
3.4 Mitral valve surgery for functional MR in patients with ICM 
Earlier reports demonstrated that functional MR may result from dilation of the mitral 
annulus, laterally displaced papillary muscles, and enhanced tethering force of the valve 
leaflets in the hearts with dilated LV33,35-37). For these patients, functional MR was relieved 
by mitral valve plasty (MVP) including mitral annuloplasty (MAP) with an undersized 
flexible annuloplasty ring38), chordal cutting of the basal chordae39,40), papillary muscle 
approximation41-44), and chordal translocation45). We usually repair functional MR using 
MAP with a semi-rigid ring, and/or chordal cutting, and/or papillary muscle 
approximation. Chordal cutting and papillary muscle approximation were indicated for 
patients with a severely dilated LV caused by broad myocardial infarction, who would be 
repaired by the SAVE procedure. Details of our techniques are described below. 
3.5 Technical details of our mitral valve surgery 
To perform MAP, the mitral valve was observed via the right-sided left atriotomy. When the 
MAZE procedure was required, radiofrequency ablation was performed prior to mitral 
valve surgery following Cox and associates46). The Cosgrove Valve Retractor System (Kapp 
Surgical Instrument, Inc. Cleveland, OH, USA) was used to obtain a wide surgical field 
around the mitral valve. First, 2-0 polyfilament braided vertical mattress sutures (Matsuda-
ika Kogyo, Tokyo, Japan) were placed on the mitral annulus. The coaptation zone of the 
mitral valve was directly inspected by the water test to identify the valvular morphology. 
Basically, the etiology of functional MR with ICM involved tethering of the subvalvular 
apparatus caused by a dilated LV and annular dilatation. After identification of no organic 
changes of the mitral leaflet, a mitral annuloplasty ring was seated on the mitral annulus 
(Fig. 5A). An undersized semi-rigid ring (Carpenter-Edwards Physio Ring®; Edwards Life 
Science Corporation, Irvine, CA, USA) was used for patients with central MR, while a just-
sized asymmetric rigid ring (Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring®; 
Edwards Life Science Corporation) was used for patients with asymmetric MR from the 
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Fig. 4A. The schema shows the heart with ICM including a posterior akinetic region. 4B. The 
akinetic region is opened 1 cm proximal from the apex on the posterior wall between 
bilateral papillary muscles. The incision is extended toward the base of the heart, reaching 1 
cm below the mitral annulus. 4C. Multiple 0 braided polyester horizontal mattress sutures 
with pledgets are placed along the exclusion line of the septum, with a direction that 
proceeds from the apex to a septal site 1-2 cm below the aortic valve. 4D. A collagen-
impregnated Dacron knitted fabric is trimmed to create an elliptical shape and is placed 
over the exclusion with a 1-cm allowance for closure of the LV. The last two sutures on the 
apex side are tied after deaeration of the LV. 4E. Two felt strips are placed along the 
ventriculotomy on each side, and the excluded external scar is folded to reinforce the suture 
line with 2-0 polypropylene horizontal mattress sutures anchoring the allowance of Dacron 
fabric. The bilateral papillary muscles are approximated during the PRP procedure. 4F. The 
suture line is secured by double 2-0 polypropylene over-and-over sutures from both ends. 
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repaired by the SAVE procedure. Details of our techniques are described below. 
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To perform MAP, the mitral valve was observed via the right-sided left atriotomy. When the 
MAZE procedure was required, radiofrequency ablation was performed prior to mitral 
valve surgery following Cox and associates46). The Cosgrove Valve Retractor System (Kapp 
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Basically, the etiology of functional MR with ICM involved tethering of the subvalvular 
apparatus caused by a dilated LV and annular dilatation. After identification of no organic 
changes of the mitral leaflet, a mitral annuloplasty ring was seated on the mitral annulus 
(Fig. 5A). An undersized semi-rigid ring (Carpenter-Edwards Physio Ring®; Edwards Life 
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postero-median commissure. Chordal cutting was usually performed via the 
ventriculotomy during SVR, and thus the LA was closed with double 4-0 polypropylene 
over-and-over sutures. 
For patients with a severely dilated LV requiring SAVE, chordal cutting was performed via 
the ventriculotomy during SVR. The basal chordae of the anterior and posterior mitral 
leaflets were completely cut with a pair of long scissors (Fig. 5B). Before suturing for SVR, 
two 0 braided polyester horizontal mattress sutures with pledgets (Ticron®; Tyco, Waltham, 
MA, USA) were placed to plicate the posterior LV wall between bilateral papillary muscles 
(Fig. 5C). They were then tied to approximate bilateral papillary muscles (Fig. 5D). SVR 
followed mitral valve surgery. 
  
(A)     
 
(B) 
Fig. 5A. The mitral valve is observed via the right-sided left atriotomy.  After identification 
of no organic changes of the mitral leaflet, a mitral annuloplasty ring is seated on the mitral 
annulus. 5B. For patients with a severely dilated LV requiring the SAVE procedure, the 
basal chordae of the anterior and posterior mitral leaflets are completely cut with a pair of 
long scissors via the ventriculotomy. 
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Fig. 5C. Before suturing for PRP, two 0 braided polyester horizontal mattress sutures with 
pledgets are placed to plicate the posterior LV wall between bilateral papillary muscles. 5D. 
Two sutures are tied to approximate bilateral papillary muscles. 5E. MVR is performed via 
the ventriculotomy during SVR in a beating heart. The mitral leaflets are preserved as much 
as possible to prevent LV rupture, and 2-0 polyfilament braided vertical mattress sutures are 
placed on the mitral annulus from the LA toward the LV. These sutures are then anchored 
to the mitral leaflets. 
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of no organic changes of the mitral leaflet, a mitral annuloplasty ring is seated on the mitral 
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long scissors via the ventriculotomy. 
 
Surgical Ventricular Restoration for Ischemic Cardiomyopathy with Functional Mitral Regurgitation 
 
93 
       





Fig. 5C. Before suturing for PRP, two 0 braided polyester horizontal mattress sutures with 
pledgets are placed to plicate the posterior LV wall between bilateral papillary muscles. 5D. 
Two sutures are tied to approximate bilateral papillary muscles. 5E. MVR is performed via 
the ventriculotomy during SVR in a beating heart. The mitral leaflets are preserved as much 
as possible to prevent LV rupture, and 2-0 polyfilament braided vertical mattress sutures are 
placed on the mitral annulus from the LA toward the LV. These sutures are then anchored 
to the mitral leaflets. 
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For patients requiring PRP, the bilateral papillary muscles were surgically approximated 
during closure of the posterior wall of the LV. Thus, the posterior wall was approximated 
during the usual PRP procedure. 
Although MVP is a standard operation for ICM with functional MR, mitral valve 
replacement (MVR) is indicated for a few limited cases. In the early period of this series, 
MVR via the ventriculotomy was performed to reduce aortic crossclamping time. Patients 
with ICM and MR caused by organic valvular changes were also treated by MVR, although 
they were excluded in this series. 
MVR was performed via the ventriculotomy during SVR in a beating heart. The ascending 
aorta was declamped after closure of the LV, and the LV was opened in the akinetic region. 
The mitral leaflets were preserved as much as possible to prevent LV rupture, and 2-0 
polyfilament braided vertical mattress sutures were placed on the mitral annulus from the 
LA toward the LV. These sutures were then anchored to the mitral leaflets. A prosthetic 
mitral valve was seated in the infravalvular position (Fig. 5E). 
3.6 Overview of the operative procedure 
a. Preparation for SVR and mitral valve surgery 
Under general cardiac anesthesia and monitoring, the chest was entered via median 
sternotomy. CPB was installed via the ascending aorta with bicaval drainage under 
generalized heparinization. For patients requiring coronary artery bypass grafting (CABG), 
all anastomoses were completed prior to opening the LA. An LA vent tube was introduced 
via the right upper pulmonary vein (PV) to obtain a bloodless surgical field. When the 
MAZE procedure was required, left PV isolation was performed with a radiofrequency 
ablation system (AtriCure, Inc, West Chester, OH, USA). Under mild hypothermia, the 
ascending aorta was crossclamped. Antegrade tepid blood cardioplegia was delivered to 
obtain cardioplegic cardiac arrest. For maintenance, retrograde tepid blood cardioplegia was 
infused every 20 to 30 minutes. 
b. MAP via the right-sided left atriotomy 
MAP was performed via the right-sided left atriotomy. Details of the technique were 
described above. The LA was closed in two layers. 
Aortic valve replacement was performed via the aortotomy prior to SVR, when it was 
required. Tricuspid valve surgery was also performed via the right atriotomy when it was 
necessary. 
c. SVR and other mitral procedures via the ventriculotomy 
After completion of MAP, the akinetic scar was opened to perform SVR and other mitral 
procedures via the LV. Selection of SVR depended on the location of the scar: the antero-
septo-apical region for EVCCP, a broad antero-septal region for SAVE, and the posterior 
region for PRP. First, chordal cutting of both mitral leaflets was performed when it was 
indicated for patients requiring SAVE. Details of the technique were described above. 
Secondly, papillary muscle approximation was performed for patients with a severely 
dilated LV requiring SAVE. The technical details were described above. For patients 
requiring PRP, the incision of the posterior wall was placed just between both papillary 
muscles, resulting in papillary muscle approximation by usual LV closure. 
Finally, SVR was performed after completion of other mitral procedures. The details of the 
procedure were described above. 
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d. Supplemental procedures 
For patients with LV dyssynchrony or the inevitable cases with transection of a previously 
implanted LV lead during SVR, an epicardial permanent LV lead was placed on the lateral 
wall for cardiac resynchronization therapy (CRT) or CRT defibrillator (CRT-D)47). For the 
extremely severe cases with out-of-date generators for CRT or CRT-D, a new generator was 
upgraded during the operation. 
3.7 Statistical analysis 
The results are expressed as means±SEM. An analysis was performed using the paired or 
unpaired Student’s t-test to compare between before and after SVR, respectively. The 
criterion for statistical significance was set at a value of P<0.05. 
4. Results 
1. Operative procedures 
In 88 patients with ICM and MR, SVR was performed with three different procedures: 
EVCPP in 25 patients (28%), SAVE in 50 patients (57%) and PRP in 13 patients (15%). Two 
cases with antero-septal scars repaired by an overlapping cardiac volume reduction 
operation had a SAVE procedure. Mitral valve surgery was performed with MAP in 78 
patients (89%) and MVR in 10 patients (11%). Of a total of 78 patients repaired with MAP, an 
under-sized Carpentier-Edwards Physio Ring was used in 72 patients (92%), and a just-sized 
Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring was used in 6 patients (8%). 
Of a total of 46 cases repaired with SAVE plus MAP, chordal cutting was required in 10 
patients (22%), and papillary muscle approximation was required in 16 patients (35%). In 
the early period of this series, 10 patients were treated by MVR with the Carpentier-
Edwards pericardial bioprosthesis (Edwards Life Science Corporation). Detailed 
combinations of SVR and mitral valve surgery are summarized in Table 1. 
 
Table 1. Surgical Ventricular Restoration and Mitral Valve Surgery.  
Of the 88 patients with ICM and functional MR, concomitant procedures included CABG in 
63 (72%), tricuspid valve surgery in 30 (34%), aortic valve surgery in 4 (5%), and the MAZE 
procedure in 7 (8%). The number of grafts for patients requiring CABG was 2.0±1.4/patient. 
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Tricuspid annuloplasty was performed with the Carpentier-Edwards classic annuloplasty 
ring (Edwards Life Science Corporation) in 13 patients, the Edwards MC3 annuloplasty ring 
(Edwards Life Science Corporation) in 9 patients, the Cosgrove-Edwards annuloplasty 
system (Edwards Life Science Corporation) in 3 patients, the St. Jude Medical Tailor flexible 
band (St. Jude Medical, Inc. St. Paul, MN, USA) in 2 patients, and the DeVega technique in 3 
patients. Aortic valve replacement was performed with the Carpentier-Edwards pericardial 
bioprosthesis (Edwards Life Science Corporation) in 4 patients (5%). Intra- and post-
operative CRT or CRT-D was required in 26 patients (30%). 
2. Early surgical results 
Aortic crossclamping and CPB times are shown in Table 2. IABP was preoperatively 
introduced in 2 patients (2%) requiring the SAVE procedure, and 20 patients (23%) required 
postoperative IABP (6 for EVCPP, 10 for SAVE, and 4 for PRP). Two patients repaired by the 
SAVE procedure required a left ventricular assist system and percutaneous 
cardiopulmonary support after the operation. 
 
Table 2. ACC and CPB Time. (Hirota et al.) 
Overall hospital mortality was 13% (11/88), with 9 patients in the SAVE group. Hospital 
mortalities of elective and emergent operations were 9% and 29%, respectively. The most 
frequent morbidity was non-sustained and sustained VT/VF (17/88; 19%). Details of 
hospital mortality and morbidity are shown in Table 3. 
Geometric and hemodynamic parameters are summarized in Table 4. Both diastolic and 
systolic LV volumes (LVEDVI and LVESVI) were significantly decreased with each 
procedure (p<0.05). LVEDVI and LVESVI were the largest with SAVE (LVEDVI: EVCPP 
166±46 ml/m2, SAVE 185±53 ml/m2, PRP 154±48 ml/m2; LVESVI: EVCPP 129±44 ml/m2, 
SAVE 149±49 ml/m2, PRP 117±50 ml/m2). As an index of the extent of volume reduction, 
the volume reduction rate (reduction volume by SVR/preoperative LV volume × 100 [%]) 
was calculated. The volume reduction rates of LVEDV and LVESV were similar (LVEDV: 
EVCPP 27%, SAVE 22%, PRP 26%; LVEDV: EVCPP 19%, SAVE 21%, PRP 26%). EF and peak 
pulmonary artery pressure were not significantly improved with any procedure. The 
severity of functional MR was less after each procedure. The majority of moderate or severe 
MR was improved to none or trivial MR (Fig. 6). NYHA functional class also improved with 
each procedure, and of all surviving patients in classes III and IV, 78% improved to class I or 
II (Fig. 7). 
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Fig. 6. The surgical effects on mitral regurgitation (MR) in patients with ischemic 
cardiomyopathy (ICM). In a total of 88 patients, the severity of MR was decreased after the 
operation. The similar effect was detected in three different procedures including 
endoventricular circular patch plasty (EVCCP), septal anterior ventricular exclusion (SAVE), 
and the posterior restoration procedure (PRP). 
 
 
Fig. 7. The surgical effects on the New York Heart Association (NYHA) functional class in 
patients with ischemic cardiomyopathy (ICM) and mitral regurgitation (MR). In a total of 79 
survived patients, the functional class was improved after the operation. The similar effect 
was detected in three different procedures including endoventricular circular patch plasty 
(EVCCP), septal anterior ventricular exclusion (SAVE), and the posterior restoration 
procedure (PRP). 
3. Mid- to long-term surgical results 
Mid- to long-term survival rates of elective operations were estimated by Kaplan-Meier 
analysis (Fig. 8). In this series, 1-year and 5-year overall survival rates were 84% (EVCPP 
81%; SAVE 79%; PRP 100%) and 66% (EVCPP 50%; SAVE 66%; PRP 67%), respectively. 
 




Fig. 8. Kaplan-Meier survival curves in patients with ischemic cardiomyopathy (ICM) and 
mitral regurgitation (MR). (A) In a total of 88 patients, overall survival repaired by the three 
different procedures including endoventricular circular patch plasty (EVCCP), septal 
anterior ventricular exclusion (SAVE), and the posterior restoration procedure (PRP). (B) 
Survival curve in patients repaired by EVCCP. (C) Survival curve in patients repaired by 
SAVE. (D) Survival curve in patients repaired by PRP. 
 
Fig. 9. The surgical effects of papillary muscle approximation on mitral regurgitation (MR) 
and left ventricular (LV) volume in patients repaired by the SAVE procedure and ring 
annuloplasty. In a total of 50 patients, the severity of MR was decreased irrespective of 
papillary muscle approximation. LV volumetric indices including LV end-diastolic diameter 
(LVDd), LV end-diastolic volume index (LVEDVI) and LV end-systolic volume index 
(LVESVI) were also decreased irrespective of papillary muscle approximation. However, the 
volume reduction rate was much smaller in patients repaired by concomitant papillary 
muscle approximation. 
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4. Effects of papillary muscle approximation in the SAVE procedure 
Of the 50 patients treated with the SAVE procedure, 16 underwent papillary muscle 
approximation. To illustrate the effects of papillary muscle approximation, dimensional 
parameters and severity of MR are summarized in Fig. 9. Preoperative LVESVI was greater 
in patients repaired by SAVE and papillary muscle approximation than in patients repaired 
by SAVE alone (174±56 vs. 141±48 ml/m2), but the difference was not significant. The 
volume reduction rate was also increased by additional papillary muscle approximation 
(26% vs. 19%). Irrespective of papillary muscle approximation, the severity of MR was 
improved after SAVE and mitral ring annuloplasty. 
5. Discussion 
We have reported the results of our surgical treatment of severe patients with ICM and 
functional MR and described the details of our surgical strategy. Three kinds of SVR 
technique effectively reduced LV dimension and changed the spherical shape of the LV into 
an elliptical shape. Concomitant mitral valve surgery decreased the severity of MR during 
SVR. This combined surgery would contribute to better surgical outcomes for these patients. 
The final goal of SVR for ICM with functional MR is re-establishment of the geometric 
balance of the remodeled LV to increase the forward flow by obtaining concentric 
contraction and decreasing the extent of MR. We detected the akinetic region of the LV with 
various techniques and excluded it with three kinds of SVR based on the location of the 
region. Subsequently, the contractile myocardium was connected by the elliptical patch 
placed on the “contractility trail”. Simultaneously, for patients with a dilated posterior LV 
wall between two papillary muscles, it was approximated during SVR to restore 
subvalvular geometry beneath the mitral valve. Although there is no gold standard 
technique for patients with ICM and functional MR, our combined surgery appears to 
achieve the final goal at this moment. 
For patients with ischemic heart disease, SVR has yielded beneficial short-term effects on 
functional status, exercise performance, long-term results, and quality of life48,49). However, 
concomitant SVR is still controversial during CABG for these patients48,49,50). Recently, the 
Surgical Treatment for Ischemic Heart Failure (STICH) trial addressed this question and 
demonstrated that anatomical change by SVR was not associated with a greater 
improvement in symptoms or exercise tolerance or with a reduction in the rate of death or 
hospitalization for cardiac causes50). Patient selection issues and hemodynamic effects of LV 
volume reduction have been proposed to explain these contradictory results50). Thus, it 
would be very difficult to conclude anything about the efficacies associated with SVR, even 
though a large, multicenter, randomized trial such as STICH has been done. Especially for a 
small number of patients with ICM and functional MR, the same would be true. 
More recently, we have suggested the effectiveness of SVR for patients with ICM51). 
According to our results, SVR is most effective when a >33% volume reduction rate achieves 
an LVESVI of <90 ml/m2. No long-term benefits occur when SVR induces an LV volume 
reduction of <15%, leaving a residual LVESVI >90 ml/m2. Although the results also 
contradict the STICH trial findings, long-term prognosis in ICM would be determined by 
the relationships between accurate methods for measuring ventricular volume and the 
extent of SVR volume reduction. 
Due to the diverse patient population, it is very difficult to compare the surgical outcomes 
among clinical studies and trials. Although details of patients’ background were 
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disregarded, the cumulative survival rate was assessed by a systematic review of the 
literature associated with SVR in ischemic heart disease48). According to the review, the 
weighted average early mortality (defined as in-hospital or 30-day mortality) was 6.9%, and 
the cumulative 1-year and 5-year survivals were 88.5% and 71.5%, respectively. Although 
our surgical outcome did not reach the cumulative value, the extent of LV dysfunction with 
coexisting MR secondary to ischemia was much more severe in our series. More than 50% of 
patients had a large antero-septal akinetic region of the LV requiring the SAVE procedure, 
and all of them were classified as NYHA functional class III and IV. In fact, the remodeled 
hearts presented with severe LV dysfunction (EF <20%) with a dilated LV (LVESVI > 140 
ml/m2). Moreover, more than half of the patients had concomitant severe MR (grade III and 
IV) in the present series. Earlier clinical reports demonstrated that the mortality risk is 
related to the degree of functional MR in patients with ICM52,53). Thus, our early and late 
surgical results would be acceptable in patients with such severe backgrounds. 
Although SVR improved cardiac function and functional status for patients with ICM, it was 
reported that potential determinants of hospital mortality included preoperative advanced 
heart failure status, postoperative large LV volume (LVESVI > 60 ml/m2, LVESV > 80 ml), 
coexisting MR, and need for mitral valve surgery53,54). Many potential risks were involved in 
this series, and baseline LVESV would be much larger in a patient population with ICM and 
functional MR. In the present series, preoperative LVESVI (140±50 ml/m2) was larger than 
in other reports, and thus, postoperative LVESVI (104±42 ml/m2) was not included in the 
smaller LV volume category with low mortality. Although more exclusions to reduce 
LVESV would result in better surgical results, we believe that excessive exclusions involving 
contractile myocardium should be avoided for such ICM patients with severely dilated LV 
accompanying MR. Accordingly, prediction of the exclusion area of non-functional scar or 
myocardium is very important to perform effective SVR for these patients. 
As one of the additional surgical adjuncts, we performed papillary muscle approximation to 
reduce LV volume for patients with a severely dilated LV requiring the SAVE procedure. 
The SAVE procedure effectively excludes a broad akinetic region of the antero-septo-apical 
wall, and papillary muscle approximation shortens the posterior wall between both 
papillary muscles. Thus, these combined procedures achieve further reduction of the 
LVESV. Although the volume reduction rate was increased by papillary muscle 
approximation, the early surgical effect on functional MR was almost the same, irrespective 
of papillary muscle approximation. Although the long-term effect on the LV dimension has 
not been elucidated, it may contribute to prevention of MR due to re-dilation of the LV. 
6. Conclusion 
SVR for patients with ICM and functional MR requires various surgical combinations 
depending on the location of the akinetic region, ventricular size, and subvalvular 
morphology beneath the MV. The surgical strategy is very important to achieve better 
surgical outcomes for such high-risk patients. 
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Coronary artery disease takes a leading role in the etiology of chronic heart insufficiency in 
60% of the cases (Belenkov et al., 2002; Kalon et al., 1993; Oganov & Maslennikova, 2000; 
Simonsen, 2003). According to the data of different authors patients with coronary artery 
disease experience development of ischemic cariomyopathy preconditioned by diffuse, 
significantly pronounced atherosclerosis of coronary arteries manifesting as cardiomegaly 
termed as “heart remodeling” and symptoms of congestive heart failure in 10-35% of the 
cases (Belenkov et al., 2002; Mareev, 2002). 
Postinfarction left ventricular remodeling is one of the most urgent challenges of modern 
cardiology and cardiac surgery. The heart remodeling process is a combination of changes 
in cavities’ form and volume and in mass of postinfarction heart myocardium in response to 
significant inadequate hemodynamic conditions of its functioning not connected with 
sarcomeres elongation caused by their prior overstretching (Jackson, 2002; Maisch, 1996; 
Rosenberg & Nepomnyashchih, 2003). Among the patients with different cardiomyopathies 
these are the ones with ischemic cardiomyopathy who have the most unfavorable prognosis, 
which makes the problem of ischemic heart failure much more significant (Bellenger, 2000; 
Buckberg, 2005; Frazier, 2000). 
Quite frequently the surgical intervention becomes the only treatment method for the 
patients with chronic heart insufficiency basing on deep changes of functional myocardium 
morphology. Different approaches to surgical ventricular reconstruction aimed at 
mechanical changes of the heart cavities sizes in combination with coronary artery bypass 
grafting (CABG) take the leading place in the complex treatment of this pathology. 
Nevertheless their outcomes show that in the late postoperative period repeated heart 
remodeling and CHF progressing i.e. return to the initial preoperative values of the heart 
cavities sizes and functional capacity of the heart takes place in a part of the operated 
patients (Batista, 1996; Dickstein, 1997; Dor, 1985; Gradinac, 1998; Menicanti & Di Donato, 
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2002; Menicanti & Di Donato, 2004; Moreira et al., 2001; Popovic et al., 1998; Popovic et al., 
2001; Ratcliffe, 1998; Shah, 2003; Soo, 2005; Stolf, 1998). 
The efforts to find clinical and instrumental prognostic criteria of unfavorable late outcomes 
of surgical treatment in patients with ICMP have not resulted in anything. According to 
publications, the following preoperative values have been associated with higher 
postoperative mortality and morbidity of the patients with ICMP: size of left ventricle (LV) 
(Yamaguchi, 2005), LV end-systolic volume index (LVESVI) (especially > 80 ml/m2 
(Athanasuleas, 2004) and > 100 ml/m2 (Yamaguchi, 2000)), LV ejection fraction (EF) (< 20% 
(Di Donato, 2001; Yamaguchi, 2005) or < 30%(Yamaguchi, 2000; Athanasuleas, 2004)), mitral 
regurgitation (Sartipy et al., 2006; Schroder, 2005), number of segments affected by 
dyssynergia (Di Donato, 1997), pulmonary hypertension >33mmHg (Di Donato, 1997), 
QRS>130ms (Yamaguchi, 2005), preoperative renal failure (Yamaguchi, 2005), time after 
previous myocardial infarction (Yamaguchi, 2005), age older than 75 years old 
(Athanasuleas, 2004). Nevertheless, there have not been any definite preoperative clinical 
predictors of postoperative LV remodeling offered. 
Myocardium is a unique tissue consisting of highly differentiated cells – cardiomyocites 
which possess a number of morphological features in norm responding by a set of 
nonspecific structural changes to pathomorphism of cardiovascular diseases. In our 
opinion, the degree of revensability/irreversibility of advanced pathological processes in 
myocardium plays a key role in the success of reconstructive cardiac surgical 
interventions. 
It has been 10-12 years since researchers started their first search for morphological 
predictors of postoperative heart remodeling in patients with cardiomyopathies, carrying 
out the analysis of the postoperative period course and evaluating morphofunctional 
condition of LV myocardium by the data of intraoperative biopsies (Gradinac, 1998; Moreira 
et al., 2001; Popovic et al., 2001; Stolf, 1998). However, the results of these solitary studies 
have been quite controversial (Moreira et al., 2001; Popovic et al., 2001). We have not found 
data about any attempts to search for morphological predictors of progressive postoperative 
LV remodeling in patients with ICMP. In the available Russian publications there are 
separate articles devoted to studies of morphofunctional condition of LV myocardium and 
myocardium of RA auricle in patients with coronary artery disease of different functional 
classes (Kuznetsov, 2003; Salikova et al., 2002). These works can hardly boast wide analysis 
of morphological parameters (Kuznetsov, 2003) and some authors only provide descriptive 
morphology without deep investigation of the mechanisms of possible pathogenesis of heart 
remodeling (Salikova et al., 2002). 
At the same time, identification of morphological predictors of postoperative LV remodeling 
will not solve all the problems which cardiac surgeons face when choose the tactics for 
surgical intervention and think of the prognosis for each individual patient since pre- and 
postoperative morphological diagnostics of the pathological processes reversibility degree 
in ischemic myocardium in reality is limited very much by a definite degree of a risk 
associated with harvesting biopsies from heart walls which very often becomes a reason to 
refuse from this diagnostics. In the light of this, one of the perspective directions of scientific 
research is the finding of molecular predictors of postoperative heart remodeling in 
peripheral blood of patients together with tissue and cellular aspects of this phenomenon for 
the blood is always available for laboratory testing and monitoring of its content.  
Morphological Predictors and Molecular Markers of Progressing  
Postoperative Remodeling of Left Ventricle in Patients with Ischemic Cardiomyopathy 
 
109 
Until today, there have not been performed any complex fundamental scientific works 
devoted to the identification of tissue, cellular and molecular predictors of postoperative LV 
remodeling basing directly on real patients cases. The contemporary concept of CHF 
surgical treatment must be based on peculiarities of functional morphology of each 
individual patient’s myocardium. Thorough patient selection basing on a complex clinical-
morphological and biochemical analysis of the prognosis for surgical treatment outcome 
may improve the efficacy of a standard SVR procedure making a surgeon refuse from it in 
predeterminedly prospectless patients in favor of alternative methods of surgical treatment 
such as primary heart transplantation, implant of the devices preventing heart chambers 
dilatation, cardioresynchronizing therapy, etc. 
The latter area has better perspective for the problem of organ transplantation is a very 
topical issue in modern medicine since the number of recipients exceeds significantly the 
number of donors. Cardiac support device (CSD) is a special device for suppression of heart 
chambers dilatation. Multi-centers randomized clinical trial for this device is being carried 
out at present and according to preliminary data its application is quite efficient for ischemic 
and dilated cardiomyopathies (Acorn cardiovascular, inc.™ Selected abstracts, 2000; Patel, 
1997; Sabbah, 2001). 
Objective of the study: The development of a diagnostic algorithm and justification of a 
modern concept of CHF surgical treatment basing on identification of morphological and 
blood markers of progressive postoperative LV remodeling in patients with ICMP. 
2. Materials and methods 
2.1 Design of the study. Object 
One hundred and ninety five patients with ICMP and with previous myocardial infarctions 
have become the object of the study. All the patients were admitted to the cardiovascular 
surgery department at Tomsk Institute of Cardiology during the period from 2002 to 2009. 
Preoperative diagnostics included transthoracic EchoCG, Halter ECG monitoring, 
coronaroventriculography with manometry, SPECT imaging with 99mTc-technetril, MRI 
imaging of the heart with dye.  
The clinical inclusion criteria for the patients enrolled into the study were the following 
parameters: LV end-diastolic volume index (LVEDVI) > 90 ml/m2, LVESVI > 70 ml/m2 , 
LV end-diastolic pressure (LVEDP) > 30 mmHg, EF LV < 40%, akinetic and dyskinetic areas 
of LV, angina II-IV CCS FC, heart failure (HF) II-IV NYHA, coronary artery disease from 1 -
10 years, lesions of coronary arteries – stenosis of more than 75% of LAD or of the trunk, or 
not less than 75% stenosis in at least two coronary arteries. The age of the patients included 
into the study was between 37 and 68 years (53.6±8.3), mean number of affected coronary 
arteries was 2.7±0.4. Lack of organic lesions of heart valves  apart from ischemic mitral valve 
regurgitation was also a clinical criterion for patients’ selection. 
The reason for the development of ICMP in all the patients was an extensive transmural 
myocardial infarction. In 135 patients (69.2%) heart insufficiency appeared after their first 
myocardial infarction. All the patients in conditions of bypass and cardioplegia underwent 
surgical reconstruction of LV by V.Dor and L.Menicanti methods in different combinations 
with myocardial revascularization, reduction and reconstruction of LV volume and shape 
due to exclusion of its scarred septal, anterior and basal parts by endoventriculoplasty and 
by restoration of the mitral valve (MV) function. 
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associated with harvesting biopsies from heart walls which very often becomes a reason to 
refuse from this diagnostics. In the light of this, one of the perspective directions of scientific 
research is the finding of molecular predictors of postoperative heart remodeling in 
peripheral blood of patients together with tissue and cellular aspects of this phenomenon for 
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Clinical characteristics Value 
Number of the patients  195 (100 %) 
Men 177 (90.8 %) 
Women 18 (9.2 %) 
Mean age (years) 53.6±8.3 
Number of previous MI 
1 135 (69.2 %) 
2 39 (20.0 %) 
3 15 (7.7 %) 
4 6 (3.1 %) 
Angina functional class (CSS) 
Without 
angina 9 (4.6 %) 
I 15 (7.7 %) 
II 36 (18.5 %) 
III 132 (67.7 %) 
IV 3 (1.5 %) 
NYHA functional class 2.86±0.40 
Number of the coronary arteries with 
atherosclerotic lesions  
1 72 (36.9 %) 
2 54 (27.7 %) 
3 69 (35.4 %) 
LVEDVI (ml/m2) 114.9±28.4 
LVESVI (ml/m2) 76.7±23.0 
LV EF (%) 32.1±5.5 
Degree of mitral regurgitation 
0 36 (18.5 %) 
I 51 (26.2 %) 
II 63 (32.3 %) 
III 36 (18.4 %) 
IV 9 (4.6 %) 
Hypertensive disease  126 (64.6 %) 
Diabetes mellitus   30 (15.4 %) 
Obesity  39 (20.0 %) 
Peripheral atherosclerosis 33 (16.9 %) 
Table 1. Initial clinical characteristics of the patients enrolled into the study 
Intraoperative control of the remaining LV cavity was performed with the help of special 
devices (sizers) and satisfied a physiological norm for each patient (55-60 ml/m2). 
Reduction of LV cavity had to be combined with giving it elliptical shape, which was 
performed with the use of endovascular patch and retraction of papillary muscles. 
Interventions on mitral valve were performed in 51 patients (26.2 %). MV repair was made 
in 36 cases (18.5 %); MV prosthesis was placed in 12 cases (6.2 %). The spectrum of surgical 
interventions is shown in table 2. 
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Spectrum of surgical interventions Absolute value (n = 195) Relative value (%) 
CABG+SVR 132 67.6 
CABG+SVR+MV repair 39 20.0 
CABG+SVR+MV prosthesis 12 6.2 
SVR+TMLR 6 3.1 
SVR+CABG+TMLR 6 3.1 
Note: CABG – coronary artery bypass grafting; SVR – surgical ventricular reconstruction; MV repair – 
mitral valve repair; MV prosthesis – mitral valve prosthesis; TMLR – transmyocardial laser 
revascularization. 
Table 2. The spectrum of surgical interventions carried out in the patients with ICMP 
enrolled into the study 
Biopsy samples of RA auricle and LV were taken from the border area of endocardial scar 
and from the area of the myocardium without visual changes from all the patients (n=195, 
100%) with ICMP. RA auricle biopsy was performed during the period of RA cannulation. 
LV biopsy samples were taken during surgical ventricular reconstruction from the transient 
zone on the border between scarred tissue and unchanged myocardium. 
All the patients signed an informed consent form for the participation in the study; the 
study was approved by the local ethical committee of Tomsk Institute of Cardiology.  
In order to find noninvasive molecular markers of postoperative LV remodeling blood 
samples were taken from 53 patients with ICMP (27.2%) to identify the content of natriuretic 
peptides and matrix metalloproteinases in blood plasma and serum correspondingly. In 37 
patients antibodies titre to myocardial structures was identified in blood serum. 
In the early postoperative period (1 month) control transthoracic EcoCG was made. In 12 
months after the surgical treatment the patients were hospitalized again for clinical 
examination and control EchoCG. 
In the late follow-up period repeated LV remodeling and HF progressing took place in a 
part of the patients which resulted in assignment of the patients into two groups: with 
positive (regressive remodeling – group I) and negative (progressing postoperative 
remodeling – group II) dynamics. 
To achieve the objectives of identification tissue, cellular and molecular markers of 
postoperative LV remodeling we have used histological, electron-microscopic, 
morphometrical, biochemical and statistical methods of study. 
To compare morphometrical parameters, as a control group  we took autopsy samples of the 
identical sites of LV myocardium and myocardium of RA auricle from 25 cadavers of both 
sexes and of a comparable age died from an acute trauma with no signs of cardio-vascular 
pathology. 
Seventeen healthy male and female volunteers of comparable age comprised a control group 
for the evaluation of the content of natriuretic peptide and matrix metalloproteinases in 
blood plasma and serum, respectively, as well as for identification of the antibodies titre to 
myocardial structures.  
2.2 Histological study methods 
Histological methods include preliminary treatment of the studied material necessary for its 
further microscopic evaluation. Preparation of histological samples was performed as 
follows (Krivolapov, 2006): the samples of myocardium were being fixed in 10% solution of 
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neutral formalin during 24 hours, and then they were washed  in running water and 
dehydrated in the solution for histological treatment (dehydration and clearing) based on 
absolute isopropyl alcohol IsoPrep (BioVitrum, Saint Petersburg, Russia). After dehydration 
the myocardial samples were placed into homogenized paraffin media HISTOMIX® 
(BioVitrum, Saint Petersburg, Russia). Paraffin section of about 5-7mcm thick obtained with 
the use of a sliding microtome MC-2 were stained by hematoxylin and eosine and by 
Mallori method (stains and staining kits by BioOptica, Italy). The stained samples were 
place into synthetic monitoring media BioMount (BioOptica, Italy). 
Histological samples were studied with a routine light and polarization microscopy on 
Axioskop 40 microscope (Carl Zeiss, Germany). Microimages of histological samples were 
taken with the Canon G10 camera (Japan). 
2.3 Methods of electron-microscopic study  
We took LV myocardium and RA auricle myocardium samples from 58 ICMP patients (50 
men, 8 women) for electron-microscopy study. Myocardial samples of not more than 2mm3 
were fixed in 2.5% glutaric aldehyde solution on 0.2M cacodylate buffer with pH=7.2 with 
the temperature of +4 °C and postfixed in 1% OsO4 solution  in cold during 4 hours. The 
bioptates were then dehydrated in ethanol of rising concentration and placed into the 
mixture of epone and araldite. Semifine and ultrafine sections were prepared on ultratome 
LKB III (Sweden). The semifine sections were stained by 1% azure II solution and evaluated 
visually through a light microscope. The ultrafine sections were contrasted by lead citrate 
and uranyl acetate and studied in an electron microscope JEM-100 CX (Japan).  
2.4 Morphological methods of study 
For quantitative characteristic of the changes morphometrical methods were applied such as 
measurement of specific volume (SV) of edema, vessels, parenchyma and myocardial 
stroma by the point counting methods (Avtandilov, 1990; Glagolev & Chepulin, 1968). 
Measurement of parenchyma, stroma, vessels and edema SV was performed in 5-7 random 
microscopic fields of each section with the use of the software for graphic images procession 
(AxioVision by Carl Zeiss, ImageJ, Germany). One mm3 of the tissue was considered as a 
unit volume for the study on the light-optical level (Avtandilov, 1990). Ocular micrometer 
МОВ-1-16х («ЛОМО», Saint Petersburg, Russia) was used to measure diameter of 
cardiomyocytes on longitudinal sections on the level of myocardial cells nuclei. For the 
quantitative characteristics of the interrelation among myocardial parenchyma, stroma of 
the organ and exchange link of microcirculatory bed the following morphometrical 
parameters were evaluated to reveal risk factors of postoperative heart remodeling: 
parenchyma-stromal ratio (PSR), trophic index (TI)  and pericapillar diffusion zone (PcDZ); 
and for the quantitative characteristics of microvasculature and their capacity Kernogan 
index (KI) was calculated. PSR is a ratio between myocardial parenchyma SV and stromal 
SV; TI (the best index reflecting the condition of myocardial trophy) – is the ratio between 
capillary SV and parenchyma SV; PcDZ (the area of tissue supplied with blood by one 
capillar) – the ratio between the capillary diameter and their SV; KI (the index of carrying 
capacity of microcirculatory bed) – is the ratio between arterioles vascular wall and the 
radius of their lumens (Avtandilov, 1990). 
Morphometry of the ultrastructures was performed on digitized negative photoplates with 
initial magnitude 4800–10000. We calculated SV of myofibrils, mitochondrias and granules 
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of atrial cardiomyocytes. One mcm3 of tissue was taken as a unit volume for the study on a 
light-microscopic level (Avtandilov, 1990). Mitochondrial-myofibrillar ratio was evaluated 
as the ratio of mitochondrial SV to the SV of miofibrills. 
Electron-microscopic study of myocardial microcirculatory bed allowed for evaluation of 
the ratio between open (functioning) and closed (not functioning) capillaries. For the open 
capillaries we performed quantitative evaluation of their lumen and active transport 
through endothelium with the help of micropinocytic vesicles. For that, we identified the 
number of pinocytic vesicles associated with a length unit of a luminal contour on an area 
unit of capillary lumen, as well as density of free pinocytic vesicles per a volume unit of 
endothelial cells cytoplasm. 
2.5 Biochemical methods of study of blood plasma and serum of the ICMP patients 
The content of natriuretic peptides (pro-ANP и NT-proBNP), matrix metalloproteinases 
(pro-ММР-1, MMP-3, MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in blood 
plasma and serum of the ICMP patients was identified by immunoenzyme method with 
standard kits by: pro-ANP and NT-proBNP – Biomedica (Austria); ММP-1 and MMP-9 – 
Quantikine® (R&D Systems, USA); MMP-3 and TIMP-1 – Biosource (Belgium). Evaluation of 
circulating antibodies to myocardium in blood serum had been performed in 37 patients 
with ICMP by the method based on the indirect immunofluorescence reaction («IMMCO 
Diagnostics» set, USA): we registered the presence of antifibrillar, antisarcolemmic and 
antinuclear antibodies by localization of fluorochrome on histological preparations by the 
method of fluorescent microscopy using the Axio Scope A1 microscope (Carl Zeiss, 
Germany). The concentration of the antibodies was expressed in titre. 
2.6 Clinical and instrumental methods of study 
Every patient underwent twelve-lead ECG study (Schiller АТ-6 machine, Switzerland) 
before and after the surgery. The degree of cardiomegalia and the condition of pulmonary 
circulation was evaluated by radiographic methods of study. Each patient underwent 
EchoCG examination with color dopplerography on Асuson 128 XP/10 (Japan). To study 
global systolic function of LV the following parameters were evaluated: end-diastolic size of 
LV, end-systolic size of LV, LV stroke volume and their indexes, LV EF, thickness of 
ventricular septum and that of posterior LV wall. Contractility of 16 segments was 
evaluated by a 4-score system and the index of local contractility disturbance was calculated 
to study disturbances of local LV myocardial contractility. To study LV diastolic function we 
evaluated transmitral blood flow by dopplerography. We also assessed the sizes of left 
atrium, degree of mitral regurgitation, estimate pressure in pulmonary artery. All the 
patients underwent EchoCG study before the surgery and in the postoperative period. 
Using the obtained data of echocardiography we calculated an estimate indicator – the index 
of specific thickness of LV wall by the following formula: thickness of ventricular septum + 
thickness of LV posterior wall/end-diastolic LV size. To assess this indicator we used the 
following grading: with remodeling index <0.30 – maladaptive remodeling; with the index 
from 0.30 to 0.45 – adaptive remodeling; >0.45 – asymptomatic remodeling.  
Coronary angiography and left ventriculargraphy were performed on Philips maximus 
C1250, Philips polydiagnost C20 angiographic units. Selective coronary angiography was 
performed by Judkins method (1967) with freezing monitoring images.  
To calculate changes of ESVI expressed as a percentage we used the formula: 
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 ( )ΔESVI = preoperative ESVI /ESVI in a year after the surgery x 100  – 100.   
To study the values of central hemodynamics the patients were subjected to catheterization 
of heart chambers with measurements of LVEDP and pressure in the pulmonary artery.  
2.7 Statistical analysis of the results 
The results were statistically analyzed with the software package SSPS 11.5 for Windows. 
Normality of a distribution law of quantitative values was assessed by Shapiro-Wilk test. 
Parameters which obey the normal distribution law were described with the help of the 
mean value (M) and standard deviation (m); those which do not obey the normal 
distribution law - with the use of median (Me) and interquintile interval (Q25–Q75). 
Qualitative data were described by the frequency of occurrence or its percentage. If the 
distribution law was normal, Student t-test was used for the assessment of reliability of 
quantitative values differences in the compared groups; Mann-Whitney test – in the case of 
not normal distribution law. To evaluate reliability of quantitative data 2χ criterion was 
used (or Fisher exact test in cases when 2χ test was not possible). To find statistical 
dependences of linear character, to identify their strength and direction Pearson correlation 
coefficient (r) (among quantitative values obeying the law of normal distribution) and 
Spearsman correlation coefficient (for quantitative values not obeying the law of normal 
distribution and for qualitative values in the ordinal scale) were calculated. All statistical 
values were considered significant with p<0.05. 
3. Results and discussion 
3.1 Morphological predictors of postoperative LV remodeling in ICMP patients 
During the study of morphofunctional condition of LV myocardium and myocardium of RA 
auricle in the patients with ICMP there was found that the density of vessels distribution 
was significantly decreased in comparison with that in the control group. Irrespectively of 
the blood vessels diameter the signs of hemodynamic disturbances were noticed 
everywhere: perivascular edema, venous plethora, desolation and spasm of arterioles and 
small arteries (fig. 1). Nuclei of endothelial cells in spasm arterioles were visually 
“extruded” into the vessels lumen. Microcirculatory link of vascular bed was plethoric; 
phenomena of erythrocyte stasis in capillaries, pericapillaries and arterioles were observed 
quite often. In separate capillaries we noticed rounding of endothelial cells manifesting as 
extrusion of endothelial cells nuclei into the capillaries lumen which, without any doubt, 
lowered their carrying capacity and the level of myocardial trophy. 
In LV myocardium and in that of RA auricle of the ICMP patients stroma had enlarged 
volume and was edematous; its collagen fibers were curved and sometimes swollen. Mixed 
(lymphocytic-macrophage) infiltrate (> 14 per mm2 of tissue by Marburg classification 
(World Heart Federation Consensus Conferences Definition of Inflammatory 
Cardiomyopathy (Myocarditis), 1997) was found in some patients’ LV myocardial stroma 
and RA auricle which was considered as myocarditis (fig. 2). 
In the ICMP patients LV myocardial cardiomyocytes were, as a rule, hypertrophic and 
located either singly or in small foci surrounded by the areas of scarred tissue which had 
been formed at the sites of previous infarctions. It is worth mentioning a pronounced 
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polymorphism of myocardial cells nuclei: their enlargement, changing shape and tinctoral 
properties. In the most cases the shape of cardiomyocytes was oval with fuzzy contours. 
Quite often the nuclei had the shapes of “eights”, “bow”, “spring”, etc. Chromatin in such 
the nuclei was condensed and located mostly along the nuclei periphery. Oxyphilous 
inclusions looking like apoptotic bodies were noticed either close to some nuclei or inside 
them. Such cardiomyocytes had eosinophilic cytoplasm and irregular contours of the cells. 
 
 
Fig. 1. LV myocardium of ICMP patients: a – perivascular edema; b –venous plethora. 
Stained with hematoxylin and eosin. X 450 (a) and 400 (b) 
 
 
Fig. 2. LV myocardium of ICMP patients: а – mixed (lymphocytic-macrophage) focal 
infiltration; b – diffuse lymphocytic infiltration of myocardial stroma. Stained with 
hematoxylin and eosin. X 500 (a) and 300 (b) 
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Intracellular edema in cardiomyocytes of LV was noticed everywhere and its degree varied 
very much from cell to cell. In a polarized light on histological preparations stained with 
hematoxyline and eosine alongside with unchanged areas of cardiomyocytes’ cytoplasm we 
observed damaged areas of sarcoplasm with predominantly subsegmental contractures, 
contracture lesions of the Ist, IInd and less often IIId degree which differed by the 
enhancement of luminescence of disdiaclasts with different degrees of isotropic discs 
shortening; we also noticed isolated areas of intracellular myocytolysis and primary clump 
disintegration of myofibrillas and cytolysis of cardiomyocytes.  The described changes of 
mosaic nature were also noticed in RA auricle myocardium. 
Study of morphofunctional condition of LV myocardium in patients with ICMP revealed 
very interesting peculiarities: cardiomyocytes organization disturbance in muscular fibers 
and disturbance of fibers orientation relative to each other, disintegration of myocardial cells 
on intercalated disks, elimination of cardiomyocytes along muscular fibers (fig. 3). 
Myocardium in these cases had not fibrous but cellular structure which resulted in its poor 
contractility (Anderson, 2005). Sometimes cardiac myocytes were star-shaped. Besides, on 
the longitudinal sections of LV myocardium of ICMP patients one could observe wave-
shape deformation of cardiomyocytes along myocardial fibers. 
 
 
Fig. 3. LV myocardium of ICMP patients: а- disturbance of muscular fiber orientation, star-
shaped cardiomyocytes; b- wave-shaped deformation of muscular fibers. Stained with 
hematoxylin and eosin. X 370 (a) and 330 (b) 
During electron-microscopic study of myocardial cardiomyocytes of LV and RA auricle our 
attention was drawn to the polymorphism of ultrastructures of myocardial cells. Nuclei 
often having irregular scalloped shape with multiple intussusceptums and outgrowths of 
nuclear membrane were located in the center of the cells, but in some cardiomyocytes they 
were displaced into subsarcolemmic zone. Genetic material was observed mostly as 
euchromatin which took a central position. In some cardiomyocytes’ nuclei, vice versa, 
heterochromatin prevailed and was situated mostly in juxtamembrane zone. Chromatin 
aggregation (compaction) was noticed quite often. Nuclear envelope was continuous 
throughout and had pores. 
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Perinuclear space was dilated; it was not filled with mitochondrias, granular reticulum and 
elements of Golgi organ but consisted mostly of rare matrix containing glycogen of β-shape 
and having round or elongated shape (monogranular glycogen) (fig. 4). Rosettes of  
-glycogen were present in a very insignificant number in intermiofibrillar spaces. 
 
 
Fig. 4. A fragment of a left ventricular cardiomyocyte of an ICMP patient: vacuolization (V) 
of a nucleus (N) with its further desolation; dilatation of perinuclear space filled with  
β- glycogen (G) 
Dispersed nucleoli, segregation of fibrillar and granular components of nucleolonema, ring-
shaped nucleoli were noticed which evidenced suppression of rRNA biosynthesis (fig. 5). 
 
 
Fig. 5. A fragment of a left ventricular cardiomyocyte of an ICMP patient. Dispersion of 
nucleoles (Nu), segregation of granular and fibrillar components. N- a nucleus of a 
cardiomyocyte; MF – myofibrils 
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We also found wide variety of myofibril lesion forms in LV and RA auricle myocardial 
cardiomyocytes in ICMP patients such as: contracture lesions of myofibrils of the Ist, less 
often of the IInd and IIId degrees, isolated areas of primary clump of fibrillar disaggregation 
(fig. 6). The presence of contracture lesions of the IIId degree in a cell was associated with 
formation of sarcolemma festoons, contraction and deformation of a nucleus and 
mitochondrias due to overcontraction of myofibrils and with displacement of mitochondrias 
into the space between myofibrils and formation of compact assemblies. 
 
 
Fig. 6. Primary clump disintegration of LV myocardial cardiomyocite’s myofibrils of an 
ICMP patient: alteration of the areas of mosaic lysis (L) and contractures (C) in isolated 
groups of myofibrillar (MF) sarcomeres; MCh- mitochondrias 
In the most cardiomyocytes small-focal and diffuse lysis of myofibrillar bundles, myofibril 
“melting” were registered. I-disks with thin (actin) filaments in them were lysed to a greater 
extent. Myofibrils were becoming less dense, cavities appeared in some sarcomeres, total 
lysis of myofilaments within a sarcomere was noticed. Sarcomeres in the area of intercalated 
disks and in perinuclear zone were significantly destructed. 
It was very seldom when foci of intracellular regeneration of ultrastructures were found in 
LV and RA auricle myocardial cardiomyocytes. The foci were evaluated by the 
accumulation of free ribosomes on the stumps of survived myofibrils contributing to the 
synthesis and neoformation of contractile proteins. As the newly formed myofilaments 
synthesized on polyribosomes and got matured they gathered into the bundles of 
myofibrils. But in the process of their neoformation their normal orientation is disturbed, 
they elongate excessively and it results in growing distance between Z-bands. 
Apart from disturbance of normal orientation of the newly formed myofibrils we observed 
chaotic orientation of “mature” contractile proteins. Myofibrilar bundles and even 
individual myofilaments were oriented at different angles in relation to each other. Besides, 
wave-shaped deformation of a contractile apparatus of LV and RA auricle myocardial 
cardiomyocytes took place in the patients with ICMP. All these circumstances, with no 
doubt, made their contribution into desynchronization of contractile processes, thus 
preconditioning systolic dysfunction of myocardium (Anderson, 2005). 
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Polymorphism of mitochondrias attracted our attention. We observed large mitochondrias 
reaching a length of 2-3 sarcomeres in the space among myofibrils. On the contrary, more 
often we were observing small round mitochondrias located randomly or in clusters. 
Sometimes we saw mitochondrias with destructive and degenerative changes, with cleared 
matrix, destroyed and reduced cristas, few mitochondrias with electron-dense matrix in 
condition of vacuolization.  
Cisterns and vacuoles of cytoplasmic reticulum and Golgi apparatus in LV and RA auricle 
myocardium cardiomyocytes were deduced and sometimes dilated in the samples of ICMP 
patients. Dilation of the cisterns was found mostly in perinuclear zone and less often in the 
space between fibrils (in the area of Z-bands) and mitochondrias. 
Atrial cardiomyocytes contained electron-dense granules of atrial natriuretic peptide of 
various sizes. 
Thus, electron-microscopic study revealed mixed, alterative and regenerative-plastic 
insufficiency of cardiomyocytes in both LV and RA auricle. 
Electron-microscopic study of peculiarities of microvasculature functional morphology was 
performed for intraoperative samples of LV and RA auricle from 47 ICMP patients (44 men, 
3 women). Hemocapillaries having a sufficient lumen for passage of blood cells or 
containing these cells in their lumen were considered open (functioning). Hemocapillaries 
with a minimal lumen between plasmalemmas of endothelial cells insufficient for blood 
cells circulation were considered closed (non-functioning).  
In endothelial cells of myocardial capillaries a large number of micropinocytic vesicles of 
different diameters (from 30 to 120nm) was found; these vesicles were present in both closed 
and open capillaries. The content of small vesicles was electron-optically low dense. On the 
contrary, large vesicles were electron-optically transparent. The number of micropinocytic 
vesicles in endotheliocytes in different capillaries was variable and their number in closed 
capillaries was very insignificant. 
In cytoplasm of endothelial cells unexpanded canaliculi of granular and granular 
endoplasmic reticulum were observed as well as multiple crests and dints on a luminal 
surface of the cells.  
Electron-microscopic study of microvasculatory link of LV and RA auricle myocardial 
vascular bed one could notice a bulging endotheliocytes into the capillaries lumen, 
reduction of their lumen and their decreased capacity. Rounding of endotheliocytes, 
probably, has adaptive meaning and is directed toward slowing blood flow in capillaries 
and more efficient use of blood mass in transcapillar exchange (Kawamura et al., 1974). 
Matrix of endothelial cells cytoplasm in one and the same capillary is vividly cleared in one 
cells evidencing swelling of cytoplasm and in other cells it becomes electron-optically dense. 
If an endothelial cell matrix was cleared, we could visualize mostly singular small size 
micropinocytic vesicles situated predominantly on free and basal edges of cytoplasm. In 
cytoplasm of dark endotheliocytes larger pinocytic vesicles were present quite often (fig. 7). 
Often one could see mitochondrias in capillary endotheliocytes of LV and RA auricle 
myocardium. Usually no changes in functional morphology of cellular energy apparatus 
were noticed, but sometimes we observed mitochondrias with cleared matrix, dilated 
intracristal spaces and destroyed crysts. Myelin-like structures were found in some 
mitochondrias. 
In clear endotheliocytes were swallow and chromatin was loose. In osmium dark cells nuclei 
remained unchanged. Chromatin aggregation and pyknotic nuclei were noticed eventually. 
In nuclei of singular endotheliocytes we noticed the lost connection between 
heterochromatin and nuclear membrain. Heterochromatin was displaced deeper into the 
nuclei of endothelial cells and was present there as ring-shaped structures. 
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Fig. 7. A capillary from LV myocardium of an ICMP patient: Capillary lumen (CL) is limited 
by an endothelial cell with osmium dark matrix (a dark cell - DC) and by an endothelial cell 
with cleared matrix (a clear cell - CC). PCS – pericapillar space 
Sometimes large lipid inclusions were noticed in cytoplasm of endothelial cells of capillaries 
in both LV and RV auricle myocardium; large vacuoles – only in singular cardiomyocytes. 
Glycogen granules were eventually found in insignificant amount. 
Subendocardial capillary zone as a rule was not changed. Sometimes on longitudinal 
sections one could see isolated local dilations. Basal membrane was uninterrupted 
throughout and in most cases had the same thickness with only rare local thickened parts. 
Noncellular element of a basal layer was thickened locally and loose, occasionally thinned 
and interrupted. 
The space between basal capillary membrane and cardiomyocytes (adventitious layer) was, 
as a rule, dilated and filled mostly with fibrous component of a loose connective tissue (with 
the prevalence of collagen fibers) and less often – with electron-transparent amorphous 
substance of low electron density (with separate fibrous structures like collagen fibers). In 
the latter case pericapillar space was sharply cleared; areas of a substance with low electron-
optical density identical to that of plasma in a capillary lumen were found. The contours of 
these areas were not clear. 
Cytoplasmic crest of pericytes were close to cytoplasm adjusting immediately to it. There 
were no any pronounced changes of functional morphology in pericytes found. 
Pericapillar edema was registered in almost all the patients with ICMP, its degree varied 
significantly. 
Thus, a thorough analysis of functional morphology of microvasculature in ICMP patients 
revealed specific changes of endothelial capillaries situated in foci of chronic ischemia. 
Early postoperative mortality during 30 days after the surgery in the group of ICMP 
patients was 7.7% (n=15). First year postoperative mortality comprised 9.2% (n=18). Mean 
period of the control follow-up comprised 369±147 days. Only 153 (78.5 %) patients took 
part in the further study since 33 patients (16.9%) died in the early and mid-term 
postoperative period and communication with 9 patients (4.6%) was lost. During control 
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examination (in a year after the surgery) clinical and echocardiography evaluation of the 
surgical treatment outcomes was performed. 
In January 2009 all the patients who had underwent reexamination (n=153) were 
interviewed over the telephone. Mean follow-up period was 4.24 years, maximal follow-up 
period – 6 years. We managed to acquire information about all the patients who had had 
control examination. By the time of the interview there had been 108 alive patients of all 
included into the study. Mortality in the group during all the follow-up period comprised 
29.4% (n=45), 27.5% (n=42) died from cardiac diseases. 
Echocardiography was used as an instrumental method of the evaluation of heart cavities 
sizes and for the calculation of their indexed values. Despite obvious benefits of this method 
of study, it has low reproducibility of results, which varies within 20% from obtained values 
(Geidel, 2005; Gelsomino, 2008). 
With an artificially introduced efficacy endpoint (∆ESVI – delta ESVI- postoperatively less 
than 20% from preoperative values) we managed to divide the initially homogeneous group 
of the patients into two subgroups, different by the character of clinical course of HF after 
surgical treatment. To calculate ∆ESVI parameter we used the following formula:  
 ( )ESVI = postoperative ESVI /preoperative ESVI x 100  – 100Δ   
To evaluate changes of LV ESVI 20% interval in comparison with preoperative values was 
used: changes > 20% into positive or negative side were considered sufficient to take these 
changes as true. The patients in which LV ESVI was <80% from preoperative values were 
assigned to group I. In these patients the process of LV remodeling was stopped and 
reversed by surgical intervention i.e. reverse (regressive) remodeling type. The calculated 
value of ∆ESVI was < minus 20%. 
The patients in which ESVI was > 80% from preoperative values were assigned to group II 
of the study. In these patients the course of HF remained unchanged due to the complex 
surgical treatment of ICMP: remodeling process was either resistant to the exposure or went 
on progressing after surgical treatment, i.e. had progressing remodeling type. The calculated 
value of ∆ESVI was > minus 20%. 
The distribution of the patients between the groups basing on the ∆ESVI value was the 
following: the 1st group consisted of 97 patients (63.4%) with the reverse remodeling type 
(i.e. with positive dynamics of the late postoperative period); the 2nd group consisted of 56 
patients (36.6%) with progressing remodeling type (i.e. with negative dynamics of the late 
postoperative period). 
Analysis of the control EchoCG data showed that in the early postoperative period in all the 
patients end-diastolic and end-systolic heart volumes decreased: LV EDVI from (114.9±28.4) 
ml/m2 to (98.0±25.3) ml/m2, LV ESVI from (83.9 ±21.6) ml/m2 to (64.3±21.0) ml/m2; and LV 
EF significantly increased from (32.1±5.5) % to (36.7±8.9) %.The values of echocardiography 
study performed during control follow-up period are shown in Table 3. 
Performed comparison of EchoCG data in the group of the patients with reverse LV 
remodeling showed that LV EF was significantly higher and the values of LVESVI and 
LVEDVI – significantly lower. 
It should be noted that the great majority of the patients continued medical treatment 
recommended at the time of their dismissal from the hospital after the surgery. The groups 
with reverse and progressing types of remodeling were comparable in respect to the 
frequency of taking of different drug groups and their mean dosages. 
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Value Before the surgery (n=153)
In a year after surgical intervention 






FC NYHA 2.6±0.5* 2.3±0.3* 2.1±0.2** 3.0±0.2** 
LV EDVI (ml/m2) 114.9±28.4* 98.0±25.3* 84.4±13.7** 102.6±14.6** 
LV ESVI (ml/m2) 83.9±21.6* 64.3±21.0* 50.4±11.6** 71.9±17.3** 
LV EF (%) 32.1±5.5* 36.7±8.9* 43.0±3.7** 33.0±5.1** 
Note * – significance of the differences between the groups of the patients before surgical intervention 
and in a year after the surgery; ** – significance of the differences between the groups of the patients 
with reverse and progressive LV remodeling (p < 0.05). 
Table 3. The values of HF functional class and the data of EchoCG study in the patients with 
ICMP in the control follow-up period 
Among 153 patients included into the study and examined in a year after surgical treatment 
mean value of ΔESVI was minus 24.0: maximum value – 36.8, minimum – minus 64.7. 
It is obvious that SVR results in higher values of ΔESVI in comparison with isolated CABG 
providing more significant decrease of LVESVI in a year after the surgery. To avoid 
statistical and methodological mistakes in the analysis of correlation relationships, the 
patients with maximum and minimum values of ΔESVI and the patients with 
hypercorrection associated with diastolic LV dysfunction with postoperative EDVI less than 
60ml/m2  were excluded from the further study. One hundred and thirty eight patients out 
from 153 were included into the further analysis: 90 patients with reverse remodeling 
(group I) and 48 patients with progressive remodeling (group II). 
Screening analysis of correlation relationships between clinical data and ∆ESVI with the use 
of Spearman test showed moderate reverse correlation relationship with the age of a patient 
(Table 4). This correlation relationship was also proved during detailed analysis; an absolute 
p value was 0.0001. Thus, taking into account that the smallest (negative) values of ∆ESVI 
are optimal for a favorable clinical course, older patients with ICMP are prone to the 
development of progressive remodeling in postoperative period. 
Initial clinical data characterizing the degree of coronary artery disease and heart failure did 
not demonstrate any correlation with the values of ∆ESVI after surgical treatment. 
 
Parameters Value R value р<0.05 MЕ max min
Age 54.3 43 68 0.600 S 
Number of MI 1 1 4 –0.097 NS 
Hypertonic disease 3 0 3 –0.060 NS 
Angina FC  III I IV –0.244 NS 
NYHA FC 3 2 4 0.127 NS 
Men –0.166 NS 
Women –0.166 NS 
Diabetes mellitus –0.088 NS 
Obesity –0.147 NS 
Note: NS – statistically insignificant difference; S – statistically significant difference. 
Table 4. Correlation relationships of clinical signs with the degree of LVESVI changes after 
surgical treatment of the patients with ICMP. 
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Analysis of preoperative EchoCG data and the values calculated on their basis revealed 
correlation relationship with ∆ESVI shown in Table 5.  
Mixed lymphocytic-macrophage infiltrate in LV myocardium of the IInd group patients was 
found in 42 out of 48 ICMP patients (87.5%) and in only 24 out of 90 patients (26.7 %) with 
reverse remodeling (p<0.01). In LV myocardium, as a rule, fibrosis was moderate (degree II 
according to Marburg classification) in the Ist group of patients; in the IInd group of patients 
with ICM in the most cases it was severe (unfavorable, or the IIId degree fibrosis) and in rare 
cases – moderate. 
In 8 out of 24 patients from group I (33.3%) and in 33 out of 42 patients from group II (78.6) 
infiltration had diffuse nature (p<0.01), in the rest of the cases – focal and even less often – 
confluent. 
Besides, in 18 patients (37.5%) with repeated LV dilatation and in 13 patients (14.4%) with 
favorable late outcomes of surgical treatment the infiltrate of a similar nature was found in 
myocardium of RA auricle (p<0.01). As a rule, fibrosis in RA auricle myocardium was I-II 
degrees lower by Marburg classification than that in LV myocardium. 
 
Parameters Values R value р<0.05 ME max min 
Mitral regurgitation (degree) 2 4 0 –0.149 NS 
Tricuspid regurgitation (degree) 0 3 0 –0.120 NS 
Mean pressure in RV(mm Hg) 40 60 30 –0.025 NS 
LV ESV (ml) 142 266 65 0.294 S 
LV EDV(ml) 245.5 395.0 104.0 0.199 NS 
LV ESVI (ml/m2) 75.5 133.6 45.6 0.843 S 
LV EDVI (ml/m2) 111.1 190.0 71.2 –0.215 NS 
LV EF M-mode (%) 34 40 20 –0.131 NS 
LV EF B-mode (%) 32 38 19 –0.213 NS 
Cardiac index (l/min/m2) 2.2 5.0 1.6 –0.099 NS 
Thickness of ventricular septum (mm) 10.5 15.0 6.0 –0.055 NS 
Index of relative LV wall thickness  0.307 0.222 0.410 –0.026 NS 
Note: NS – statistically insignificant difference; S – statistically significant difference. 
Table 5. Correlation relationships of EchoCG parameters with the degree of LV dilatation in 
the patients with ICMP after combined surgical treatment. 
It should be mentioned that there was no a case of cellular inflammatory infiltrate found in 
myocardial stroma in the autopsy material of the similar sites of LV myocardium and RA 
auricle myocardium taken from 25 cadavers which were the relative control group. 
Statistical analysis of the obtained morphometrical data did not reveal any significant 
differences of the values of specific volume of edema and vessels among the patients with 
progressive and regressive remodeling. The specific volume of parenchyma was 
significantly higher and stroma specific volume – lower in both LV myocardium and in 
myocardium of RA auricle of the Ist group patients. Morphometrical parameters of mean 
value of capillary diameter and diameter of LV and RA auricle myocardial cardiomyocytes 
did not differ significantly among the patients with different late outcomes of surgical 
treatment. Specific volume of capillaries in the aforementioned heart parts was significantly 
higher in the patients with reverse remodeling (group I). All the morphometrical parameters 
mentioned above differed statistically significantly from those of the control study group. 
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mentioned above differed statistically significantly from those of the control study group. 
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Parenchymo-stromal ratio reflecting quantitative relationships between parenchyma and 
stroma of cardiac muscular tissue was significantly lower in LV myocardium and in 
myocardium of RA auricle in 48 ICMP patients with unfavorable late outcomes of surgical 
treatment (Table 6). 
 
Patients Myocardium PSR TI PcDZ (mcm) KI 
Group I 
(n=90) 
RA 2.17±0.31* 0.042±0.016* 245.6±27.9* 1.61±0.37* 
LV 2.18±0.27** 0.027±0.011** 385.5±51.3** 1.55±0.32** 
Group II 
(n=48) 
RA 1.85±0.38* 0.024±0.008* 481.2±61.7* 1.84±0.30* 
LV 1.65±0.31** 0.008±0.003** 1315.7±88.2** 1.85±0.21** 
Control 
group(n=25) 
RA 5.96±0.14 0.086±0.006 81.0±1.7 1.13±0.10 
LV 9.48±0.20 0.087±0.003 66.1±2.6 1.15±0.08 
Note: *, ** – significance of morphometrical values differences between the patient groups with positive 
and negative dynamics of late postoperative follow-up period for RA auricle and LV myocardium 
respectively (p<0.05). 
Table 6. Morphometrical parameters of LV and RA auricle myocardium in ICMP patients 
with different late outcomes of surgical treatment, Van-der-Waerden test (M±m) 
Trophic index of these parts of myocardium which better reflects the condition of cardiac 
muscular tissue and is assessed as a ratio between capillary specific volume and specific 
volume of cardiomyocytes, was statistically lower in patients with progressive remodeling; 
according to the data of intraoperative biopsies of LV myocardium the condition of 
myocardial trophy in these patients was 8-12 times lower in comparison with that of the 
control study group. 
Pericapillar diffusion zone (the value reflecting load on capillary bed) and Kernogan index (the 
value showing carrying capacity of microvasculature – the bigger index is the less is carrying 
capacity of arterioles and the worse are the values of tissue trophy) of LV and RA auricle 
myocardium were statistically higher in the patients of group II. Values of PcDZ in ICMP 
patients with unfavorable late outcomes of surgical treatment assessed as a ratio of capillary 
diameter to their specific volume, 15-20 times exceeded those of the IInd group patients. 
There was no significant difference between the groups concerning cardiomyocytes 
diameter in both LV and RA auricle myocardium found. 
As a result of the complex clinical-morphological study we were granted the patent “The 
prognostic method for postoperative heart remodeling in patients with ischemic 
cardiomyopathy” #2310372 of 20.11.2007 by the Federal Intellectual Property, Patent and 
Trademark Service. The method was based on the evaluation of morphofunctional condition 
of LV myocardial samples on histological preparations stained with hematoxylin-eosin and 
by Mallory with the help of light microscopy. With simultaneous presence of 
pathomorphological picture of myocarditis and values of parenchyma-stromal ratio < 1.7, 
trophic index  < 0.010, pericapillar diffusion zone  > 1000 mcm and Kernogan index > 
1.6 postoperative heart remodeling and progressive chronic heart failure can be predicted. 
The offered prediction method of postoperative heart remodeling based on complex 
evaluation of myocardial morphology in preoperative period or during surgical 
intervention allows to avoid unfavorable late outcomes of surgical treatment. Clinical cases 
are the best proof of reliability of the patented prognostic method: 
Clinical case 1. Patient N., 56 years old 
Diagnosis: CAD. Obliterating atherosclerotic stenosis of coronary arteries. Postinfarction cardiac 
sclerosis. LV aneurism. HF of III functional class by NYHA. 
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CAD history – 5 years. 
Preoperative examination 
EchoCG: LV EDVI – 102.4 ml/m2; LV ESVI – 68.2 ml/m2; LV EF – 34 %. Mild mitral 
regurgitation. 
Surgery: SVR by Menicanti, CABG. Intraoperative biopsy of LV myocardium taken for 
histological study.   
During histological study of intraoperative samples of LV myocardium pathomorphological 
signs of myocarditis were found: presence of diffuse-macrophage inflammatory infiltration 
of myocardial stroma, the 3d degree fibrosis (severe or unfavorable by Marburg 
classification of myocarditis). 





Fig. 8. Intraoperative biopsy sample of LV myocardium. Patient N, 56 year old. Diffuse-
macrophage inflammatory infiltration of myocardial stroma. Severe (unfavorable) fibrosis. 
Stained with hematoxylin and eosin. X 300. 
Morphometrical values of LV myocardium: parenchyma-stromal ratio – 1.04; trophic index 
– 0.0097; pericapillar diffusion zone – 1375.0 mcm; Kernogan index – 1.74; diameter of 
cardiomyocytes – 20.6 mcm. Thus, the morphological study revealed prognostic criteria 
associated with unfavorable late outcomes of surgical treatment. 
Hospitalization in a year after the surgery. 
CHF II FC. LV EDVI – 96.6 ml/m2; LV ESVI – 62.2 ml/m2, LV EF – 36%. Mild mitral 
regurgitation. Pre- and postoperative EchoCG images are shown in Figure 9. 
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Clinical case 1. Patient N., 56 years old 
Diagnosis: CAD. Obliterating atherosclerotic stenosis of coronary arteries. Postinfarction cardiac 
sclerosis. LV aneurism. HF of III functional class by NYHA. 
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CAD history – 5 years. 
Preoperative examination 
EchoCG: LV EDVI – 102.4 ml/m2; LV ESVI – 68.2 ml/m2; LV EF – 34 %. Mild mitral 
regurgitation. 
Surgery: SVR by Menicanti, CABG. Intraoperative biopsy of LV myocardium taken for 
histological study.   
During histological study of intraoperative samples of LV myocardium pathomorphological 
signs of myocarditis were found: presence of diffuse-macrophage inflammatory infiltration 
of myocardial stroma, the 3d degree fibrosis (severe or unfavorable by Marburg 
classification of myocarditis). 





Fig. 8. Intraoperative biopsy sample of LV myocardium. Patient N, 56 year old. Diffuse-
macrophage inflammatory infiltration of myocardial stroma. Severe (unfavorable) fibrosis. 
Stained with hematoxylin and eosin. X 300. 
Morphometrical values of LV myocardium: parenchyma-stromal ratio – 1.04; trophic index 
– 0.0097; pericapillar diffusion zone – 1375.0 mcm; Kernogan index – 1.74; diameter of 
cardiomyocytes – 20.6 mcm. Thus, the morphological study revealed prognostic criteria 
associated with unfavorable late outcomes of surgical treatment. 
Hospitalization in a year after the surgery. 
CHF II FC. LV EDVI – 96.6 ml/m2; LV ESVI – 62.2 ml/m2, LV EF – 36%. Mild mitral 
regurgitation. Pre- and postoperative EchoCG images are shown in Figure 9. 
 




Fig. 9. Pre- and postoperative EchoCG images of the 56 year old patient N. Notice repeated 
postoperative LV remodeling and progression of chronic HF. 
Clinical case 2. Patient B. 53 year old. 
Diagnosis: CAD. Obliterating atherosclerotic stenosis of coronary arteries. Postinfarction 
cardiosclerosis. LV aneurism. HF FC III by NYHA. 
Six year CAD history. 
Preoperative examination 
EchoCG: LV EDVI – 98.7 ml/m2; LV ESVI – 61.3 ml/m2; LV EF – 37 %. Mild mitral 
regurgitation. 
Surgery: SVR by Menicanti, CABG. Intraoperative biopsy of myocardium taken for 
histological study. 
Histological study of intraoperative samples of LV and RA auricle myocardium did not 
reveal any signs of inflammatory infiltration of myocardium. In Figure 10 one can see a 
microimage of the histological sample of LV myocardium from the 53 year old patient B.  
Morphometrical values of LV myocardium: parenchyma-stromal ratio – 2.83; trophic index – 
0.0417; pericapillar diffusion zone – 311.2 mcm; Kernogan index – 1.21; diameter of 
cardiomyocytes – 28.7 mcm. Thus, combination of the prognostic criteria for the progression 
of heart failure was not found, postoperative heart remodeling in the late follow-up period 
is not predicted. 
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Fig. 10. A microimage of the histological sample of LV myocardium from the 53 year old 
patient B. No stromal inflammatory infiltration and fibrosis. Stained with hematoxylin and 
eosin. X 350. 
Hospitalization in a year after the surgery. 
CHF I FC. LV EDVI – 62.5 ml/m2; LV ESVI – 33.8 ml/m2, LV EF – 46%. Mild mitral 
regurgitation. Pre- and postoperative EchoCG images are shown in Figure 11. 
Clinical examples support our conclusions about improper use of a mean value of LV 
myocardial cells diameter as a predictor of postoperative heart remodeling for ICMP 
patients: in a patient with the LV cardiomyocytes diameter > 28mcm signs of progressive 
HF were not found, however with the diameter of cardiac muscular cells <21mcm repeated 
heart remodeling was registered in the late postoperative follow-up period (as it was 
described by Moreira et al for the patients with dilated CMP (2001)). 
Out from 58 ICMP patients whose myocardium was studied by electron-microscopy, 47 
were included into the further analysis (43 men and 4 women): 34 with the reverse 
remodeling (group Ia) and 13 with the progressive remodeling (group IIa). 
Morphometrical analysis of the specific volumes of LV and RA auricle myocardial 
cardiomyocytes ultrastructures confirmed our hypothesis about reduction of myocardial 
cells contractile apparatus as HF progressing as a result of exhaustion of compensatory 
adaptation processes: myofibrillar SV of cardiomyocytes significantly decreases. As 
myofibrillar SV decreases in cardiomyocytes, specific rate of mitochondrias grows, 
mitochondrial-myofibrillar ratio increases. 
SV of natriuretic peptide of RA auricle cardiomyocytes insignificantly grows as chronic HF 
progressing. Nuclear SV does not change significantly. 
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Fig. 11. Pre- and postoperative EchoCG images of the 53 year old patient B. Repeated 
postoperative LV remodeling and progressing chronic HF were not noticed. 
Out from 47 ICMP patients whose myocardium was taken for the investigation of functional 
morphology of microcirculatory link of the LV and RA auricle vascular bed at an ultrasonic 
level, 39 patients were included into the further analysis (37 men and 2 women): 33 with the 
reverse remodeling (group Ib) and 6 with the progressive remodeling (group IIb). 
Morphometrical values of functional morphology of microvasculature of the LV and RA 
auricle myocardium of ICMP patients are presented in Table 7. 
The rate of open capillaries in myocardium of LV and RA auricle myocardium in ICMP 
patients with reverse remodeling type was significantly higher than that in the patients of 
Group II (73.0% vs 56.4% respectively). A similar value for RA auricle myocardium did not 
differ significantly among the patients with different late outcomes of surgical treatment. 
Luminal area of the open capillaries in ICMP patients with the reverse and progressive 
remodeling types as well as the number of pinocytic vesicles connected with a luminal 
contour of endotheliocytes per a unit of capillary luminal area were identical for both LV 
myocardium and myocardium of RA auricle.  
Density of free pinocytic vesicles in capillary endotheliocytes of LV myocardium has 
become another value of functional morphology of microvasculature which differed 
significantly in ICMP patients with different late outcomes of surgical treatment: 0.0796 
mcm3/mcm3 in the group of patients with positive postoperative dynamics versus 
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0.0678 mcm3/mcm3 in the group of ICMP patients with progressing chronic HF in the late 
follow-up period. All in all morphofunctional condition of microvasculature in ICMP 
patients with the reverse type of heart remodeling looks favorable in comparison with ICMP 







Luminal area of 
open capillaries 
(mcm2) 
Density of free 






per 1 mcm2 
Group Ib 
(n=33) 
RA 82.0 10.5±1.9 0.0547±0.0079 5.7±0.6 
LV 73.0* 10.5±1.4 0.0796±0.0113* 6.8±0.7 
Group IIb 
(n=6) 
RA 82.8 10.4±2.1 0.0539±0.0092 5.5±0.8 
LV 56.4* 10.5±1.8 0.0678±0.0127* 6.3±0.9 
Note: * – significance of morphological values differences between the groups of patients with positive 
and negative dynamics in the late follow-up period (p<0.05). 
Table 7. Morphometrical values of functional morphology of the LV and RA auricle 
myocardial microvasulature of ICMP patients with different outcomes of surgical treatment, 
Van-der-Waerden test (М±m) 
To make sure of diagnostic reliability of intraoperative myocardial biopsies we studied LV and 
RA autopsy material of 9 ICMP patients (7 men and 2 women) died at different periods after 
surgical intervention whose intraoperative myocardial samples we had taken during surgical 
intervention. We have not found any false-positive or false-negative results of diagnostics of 
pathomorphological myocarditis signs according to intraoperative biopsy samples (with the 
control on the autopsies material). Morphometric values of autopsy and biopsy samples were 
also comparable. Intraoperative biopsy of myocardium should not be considered as an 
absolute true, but on the whole, without any doubt, it reflects functional morphology of 
cardiac muscular tissue. First of all it depends on the volume of the material obtained for 
morphological studies and on the possibility of a targeted harvesting of a necessary LV area. 
3.2 Molecular markers of postoperative LV remodeling in patients with ICMP  
Samples of peripheral blood from 53 ICMP patients were taken 1-2 days prior to the surgical 
intervention. The control group consisted of 17 healthy volunteers. 
Analysis of the obtained data revealed that in ICMP patients the content of pro-ANP and 
NT-proBNP in blood plasma was significantly higher than that in the group of healthy 
volunteers (p<0.001). The study of the content of matrix metalloproteinase in blood serum 
showed that between the groups of ICMP patients and healthy volunteers there were no 
differences in the content of matrix metalloproteinases of types 1, 3, 9 and tissue inhibitor 
ММР-1 (ТIMP-1).  But only MMP-9 content in blood serum obeyed normal distribution law. 
During evaluation of the detection rate of antimyocardial antibodies of difference specificity 
in the healthy volunteers group in 53% of the cases there were no found autoantibodies to 
the cardiac tissue; in 47% of the cases antibodies to fibrillar structures were detected, but in 
only 6% of them these antibodies were present in a titre exceeding acceptable values. In the 
group of patients with ICMP the distribution of antibodies titres to fibrillar structures was 
the following: in 46 % of the patients the antibodies were detected in titre 20, in 24.3 % – in 
titre 40, in 21.6 % – in titre 80, in 2.7 % the titre reached 160 and in only 5.4 % of the patients 
autoantibodies were not detected. 
In determining antibodies to sarcolemmic structures it was found that in 53% of the cases 
these antibodies in healthy donors were absent. Antibodies to sarcolemmic structures were 
 




Fig. 11. Pre- and postoperative EchoCG images of the 53 year old patient B. Repeated 
postoperative LV remodeling and progressing chronic HF were not noticed. 
Out from 47 ICMP patients whose myocardium was taken for the investigation of functional 
morphology of microcirculatory link of the LV and RA auricle vascular bed at an ultrasonic 
level, 39 patients were included into the further analysis (37 men and 2 women): 33 with the 
reverse remodeling (group Ib) and 6 with the progressive remodeling (group IIb). 
Morphometrical values of functional morphology of microvasculature of the LV and RA 
auricle myocardium of ICMP patients are presented in Table 7. 
The rate of open capillaries in myocardium of LV and RA auricle myocardium in ICMP 
patients with reverse remodeling type was significantly higher than that in the patients of 
Group II (73.0% vs 56.4% respectively). A similar value for RA auricle myocardium did not 
differ significantly among the patients with different late outcomes of surgical treatment. 
Luminal area of the open capillaries in ICMP patients with the reverse and progressive 
remodeling types as well as the number of pinocytic vesicles connected with a luminal 
contour of endotheliocytes per a unit of capillary luminal area were identical for both LV 
myocardium and myocardium of RA auricle.  
Density of free pinocytic vesicles in capillary endotheliocytes of LV myocardium has 
become another value of functional morphology of microvasculature which differed 
significantly in ICMP patients with different late outcomes of surgical treatment: 0.0796 
mcm3/mcm3 in the group of patients with positive postoperative dynamics versus 
Morphological Predictors and Molecular Markers of Progressing  
Postoperative Remodeling of Left Ventricle in Patients with Ischemic Cardiomyopathy 
 
129 
0.0678 mcm3/mcm3 in the group of ICMP patients with progressing chronic HF in the late 
follow-up period. All in all morphofunctional condition of microvasculature in ICMP 
patients with the reverse type of heart remodeling looks favorable in comparison with ICMP 







Luminal area of 
open capillaries 
(mcm2) 
Density of free 






per 1 mcm2 
Group Ib 
(n=33) 
RA 82.0 10.5±1.9 0.0547±0.0079 5.7±0.6 
LV 73.0* 10.5±1.4 0.0796±0.0113* 6.8±0.7 
Group IIb 
(n=6) 
RA 82.8 10.4±2.1 0.0539±0.0092 5.5±0.8 
LV 56.4* 10.5±1.8 0.0678±0.0127* 6.3±0.9 
Note: * – significance of morphological values differences between the groups of patients with positive 
and negative dynamics in the late follow-up period (p<0.05). 
Table 7. Morphometrical values of functional morphology of the LV and RA auricle 
myocardial microvasulature of ICMP patients with different outcomes of surgical treatment, 
Van-der-Waerden test (М±m) 
To make sure of diagnostic reliability of intraoperative myocardial biopsies we studied LV and 
RA autopsy material of 9 ICMP patients (7 men and 2 women) died at different periods after 
surgical intervention whose intraoperative myocardial samples we had taken during surgical 
intervention. We have not found any false-positive or false-negative results of diagnostics of 
pathomorphological myocarditis signs according to intraoperative biopsy samples (with the 
control on the autopsies material). Morphometric values of autopsy and biopsy samples were 
also comparable. Intraoperative biopsy of myocardium should not be considered as an 
absolute true, but on the whole, without any doubt, it reflects functional morphology of 
cardiac muscular tissue. First of all it depends on the volume of the material obtained for 
morphological studies and on the possibility of a targeted harvesting of a necessary LV area. 
3.2 Molecular markers of postoperative LV remodeling in patients with ICMP  
Samples of peripheral blood from 53 ICMP patients were taken 1-2 days prior to the surgical 
intervention. The control group consisted of 17 healthy volunteers. 
Analysis of the obtained data revealed that in ICMP patients the content of pro-ANP and 
NT-proBNP in blood plasma was significantly higher than that in the group of healthy 
volunteers (p<0.001). The study of the content of matrix metalloproteinase in blood serum 
showed that between the groups of ICMP patients and healthy volunteers there were no 
differences in the content of matrix metalloproteinases of types 1, 3, 9 and tissue inhibitor 
ММР-1 (ТIMP-1).  But only MMP-9 content in blood serum obeyed normal distribution law. 
During evaluation of the detection rate of antimyocardial antibodies of difference specificity 
in the healthy volunteers group in 53% of the cases there were no found autoantibodies to 
the cardiac tissue; in 47% of the cases antibodies to fibrillar structures were detected, but in 
only 6% of them these antibodies were present in a titre exceeding acceptable values. In the 
group of patients with ICMP the distribution of antibodies titres to fibrillar structures was 
the following: in 46 % of the patients the antibodies were detected in titre 20, in 24.3 % – in 
titre 40, in 21.6 % – in titre 80, in 2.7 % the titre reached 160 and in only 5.4 % of the patients 
autoantibodies were not detected. 
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not found in 10.8 % of ICMP patients, in 24.3 % – they were detected in titre 20, in 43.3 % – 
in titre 40, in 16.2 % – in titre 80, in 5.4 % – in titre 160. 
Maximal detection rate of antibodies to nuclear structures in titre 80 in the control group 
was 11.8%, in 88.2% of the patients did not have these antibodies. The highest titre in ICMP 
patients where nuclear antibodies were found was equal to 80 (2.7%); in 5.4% of the cases 
antibodies to nuclear structures were detected in titre 40, in 32.4% - in titre 20, in 59.5% 
autoantibodies of this specificity were absent. 
In a year after the surgical treatment all the patients included into the study were examined 
(n=53, 100%). In accordance with the aforementioned algorithm for the evaluation of late 
postoperative period 40 patients were assigned into group I (with positive dynamics of the 
late postoperative period), 13 patients – into group II (with negative dynamics of the late 
postoperative period). The levels of pro-ANP, NT-proBNP and pro-ММР-1, MMP-3, MMP-
9, TIMP-1 in blood plasma and serum In the ICMP patients with different dynamics of the 













t- TEST n=40 n=13 
Nonnormal distribution law U p Q25 Me Q75 Q25 Me Q75 
pro-ANP 




0.729 <0.01 59 0.82 12.30 38.45 58.42 19.48 39.93 90.37 
MMP-3 
(ng/ml) 0.861 0.002 25 0.03* 5.16 5.70 7.05 6.25 7.11 8.49 
TIMP-1 
(ng/ml) 0.838 0.001 46 0.32 426.0 455.8 502.6 447.4 480.8 512.4 
Normal distribution law t р Mean Std. Dev. Mean Std. Dev. 
MMP-9 
(ng/ml) 0.954 0.26* –2.255 0.03* 64.51 24.23 90.64 27.97 
MMP-1 
(ng/ml) 0.948 0.19* –0.651 0.52 6.10 3.72 7.25 4.28 
Note: * – statistically significant data. 
Table 8. The content of natriuretic peptides and matrix meatlloproteinases in blood plasma 
and serum in ICMP patients with different dynamics of the late postoperative treatment 
We managed to follow the late postoperative period of 32 (86.5%) out from 37 patients 
whose blood was tested for antimyocardial antibodies. Postoperative LV remodeling took 
place in only 5 patients which does not allow to reliably associate the activity of 
inflammatory response in myocardium with postoperative heart function.  
Thus, evaluation of the content of MMP-3 and MMP-9 in blood serum at the preoperative 
stage let us “foresee” the outcome of possible surgical treatment since their content is 
significantly higher in the group of patients with postoperative heart remodeling. We made 
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an attempt to calculate sensitivity and specificity of molecular prognostic criteria of 
postoperative heart remodeling basing on the obtained material. 
Test sensitivity (Se) may be identified as a probability of a positive outcome in the patients: 
Se=p(P/D). Calculation is performed as follows: 
 
Se=(the number of positive outcomes in the group of patients P / number of the patients D) 
×  100 %. 
Specificity (Sp) – is the probability of negative results of the test in healthy volunteers: 
Sp=p(N/H). Calculated as follows: 
Sp=(the number of negative results among the healthy N / number of the healthy H) 
 ×  100 %. 
A test with high specificity, as a rule, does not refer healthy people to the category of 
patients. 
For MMP-3 
Cut-off value = 7.7 ng/ml. 
Se = (11/13) × 100 % = 84.6 %. 
Sp = (40/40) × 100 % = 100.0 %. 
For MMP-9 
Cut-off value = 102.4 ng/ml. 
Se = (7/13) × 100 % = 53.8 %. 
Sp = (40/40) × 100 % = 100.0 %. 
 
As for antibodies to myocardial structures, their titre is much higher in ICMP patients. This 
fact proves our hypothesis about the presence of inflammatory infiltrate in myocardial 
stroma as the key factor for unfavorable outcome of surgical treatment. Nowadays it is 
obvious that taking blood of the patients with massive postinfarction cardiac sclerosis at the 
preoperative stage for the evaluation of MMPs content and antibodies titre to myocardial 
structures in order to make prognosis for the late postoperative period is not only 
perspective but reasonable. Identification of the antimyocardial antibodies titre in blood 
serum preoperatively as well as in the dynamics of early and mid-term postoperative period 
will indirectly allow for monitoring of inflammatory process in myocardium and evaluation 
of the efficacy of a complex medical treatment avoiding repeated biopsies of myocardium.  
4. Conclusion 
Our clinical observations demonstrate progress of chronic HF in the late postoperative 
period and inefficiency of SVR in ICMP patients in 35% of the cases. These patients should 
be refused from the standard procedure of surgical restoration of normal left ventricular 
geometry in favor of alternative methods of surgical treatment – isolated bypass grafting for 
the patients with symptomatic CAD, cardiac resynchronization therapy for patients with  
QRS >120 msec and left bundle branch block, primary heart transplantation and implant of 
the devices preventing ventricular dilatation. Attempts to find clinical, instrumental or other 
markers of chronic HF progression have been made many times but the results are very 
modest. The age older than 55 years and high values of LV ESVI in preoperative period have 
been considered as risk factors of such interventions. 
In our opinion the reason of unfavorable outcomes of surgical treatment lies in peculiarities 
of myocardial functional morphology of an each and every patient and depends on 
irreversibility of the far gone pathological changes in cardiac muscular tissue. Assessment of 
an initial morphofunctional condition of myocardium (at the moment of surgical treatment) 
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based on pre- and/or intraoperative LV biopsies taken for the detection of irreversible 
pathological changes in myocardium by a number of qualitative and quantitative 
histomorphometrical values taking into account the condition of tissue trophy to the full 
extent, should contribute into prevention of repeated heart remodeling and progression of 
chronic HF in the late postoperative period. 
Cellular-stromal relationships on the background of chronic ischemia of myocardium 
precondition destructive processes of a heart muscular tissue remodeling which is reflected 
also in peripheral blood of ICMP patients: the content of MMPs and MMP-3 and MMP-9 in 
particular, which becomes molecular prognostic markers of the late postoperative period. 
Basing on the obtained data we offer the following algorithm of surgical treatment of patients 
with ICMP: for the candidates for a complex surgical treatment older than 55 years old with 
preoperative LV ESVI  >80 ml/m2 it would be reasonable to widen indications for 
endomyocadial biopsy at the preoperative stage or  to perform intraoperative biopsy of LV 
myocardium in order to identify prognostic criteria of the postoperative progressive heart 
remodeling and take blood samples for the detection of blood markers of HF progression. If 
the combination of unfavorable prognostic criteria takes place: the presence of diffuse 
inflammatory infiltration of myocardial stroma in combination with pronounced fibrosis, low 
TI (<0.010)  and high values of KI (>1.5) and PcDZ (>1000 mcm) of LV myocardium as well as 
high concentrations of MMP-3 (>7.7 ng/ml) and MMP-9 (>102.4 ng/ml) in blood serum, the 
patient should be refused from a standard procedure of surgical reconstruction of normal left 
ventricular geometry in favor of alternative methods of surgical treatment (in the case of 
taking preoperative biopsy of myocardium) or surgeons should refuse from SVR in favor of a 
surgical procedure with less risk (in case of taking intraoperative biopsy of myocardium). 
5. Study limitations 
The success of reconstructive surgeries in patients with ICMP depends not so much on 
functional morphology of cardiomyocytes and the condition of myocardial trophy as on 
cellular-stromal interactions in cardiac muscular tissue with the background of chronic 
ischemia. In our opinion, identification of myocarditis etiology with the purpose of its 
etiotropic treatment is one of the key factors of prevention of heart failure progression in the 
late postoperative period in patients with ICMP. By far the correlation of the presence of 
myocardial inflammatory infiltration with activation of metalloproteinase system has not 
been fully understood. Probably, quantitative and, what is also important, qualitative 
content of myocardial stroma (collagen types, fibronectin, laminin, etc) determines 
“tolerance” of the tissue to progressive dilatation. 
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1. Introduction 
Since the first cardiac surgical operations in the early ‘50s, the early and long-term outcomes 
have been dramatically improved also because of the refinement of technology regarding 
the extracorporeal circulation (ECC). It is recognized the ECC is associated with a systemic 
inflammatory response (SIRS), which is implicated in myocardial, renal, pulmonary and 
neurologic dysfunction. However, although the effects of ECC are very often subclinical, in 
some situations they can be responsible of worse outcome in the early post-operative period. 
In the early 1990s, many surgeons started to perform coronary revascularization without the 
use of ECC with the aim of strongly reducing the subclinical and clinical effects of the SIRS. 
Over the past fifteen years, the “off-pump” coronary artery bypass grafting (OPCABG) has 
demonstrated to have good results by reducing postoperative morbidity and mortality. On 
the other hand, the OPCABG presents some drawbacks such as the significant learning 
curve of the surgeon, the high rate of incomplete revascularization in dilated and 
hypokinetic heart due to very difficult exposure of obtuse coronary marginal branches and 
the lesser quality of the coronary anastomosis. 
Over the past 10 years, concepts of miniaturized extracorporeal circulation (MECC) were 
developed with the aim of reducing the side effects of the standard ECC, strengthening the 
advantages of ECC and eliminate the limitations of OPCABG. In other words, the MECC 
joins the best of ECC with the best of “off-pump” surgery. 
2. Anatomy of the miniaturized extracorporeal circulation system 
Different types of MECC circuits are on the market and although they can have some 
differences among them in terms of characteristics of blood pump, oxygenator membrane, 
length of tubing, arterial and venous filters, the principle key is substantially equal for each 
system: closed circuit without a venous cardiotomy reservoir. 
The MECC circuit consists of a closed loop, which includes the oxygenator and the pump. 
The circuit has not any open venous reservoir. All components of MECC circuit are pre-
treated with heparin according to different techniques available on the market. The 
heparin pre-treatment of the circuit minimizes the systemic heparinization dose 
requirements (usually half dose of conventional ECC: 150IU/Kg instead of 300IU/Kg) 
(Curtis et al. 2010; Formica et al. 2009, Puheler et al. 2009; Beghi et. 2006) and provides 
biocompatibility for blood cells (Koivisto et al. 2010; Remadi et al. 2007; Remadi et al. 
2004; Fromes et al 2002;) 
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Fig. 1. Miniaturized extracorporeal circuit on the left and conventional extracorporeal 
circulation on the right 
The tubing length is described to be shorter than conventional ECC in different published 
reports. Tubing length of about 100 cm is frequently reported as well as a smaller tubing 
section than conventional ECC tubing (3/8” size instead of 1/2” size) (Formica et al 2009; 
Mazzei et al 2007). These characteristics lead to a circuit prime volume smaller than 
standard ECC, ranging between 200-650 ml for the MECC against 1200-1600 ml for the 
standard ECC (Formica et al 2009, Stalder et al. 2007; Remady et al. 2006). The combination 
of short length tubing, heparin pre-treatment, small size tubing and absence of a venous 
reservoir, leads to a significant reduction of hemodilution with as well as a reduction in 
clotting factor consumption ad triggering of SIRS (Vohra et al 2009; Ohata et al. 2007; 
Wippermann et al. 2005; Fromes et al. 2002). The blood pump included in the circuit is 
usually a centrifugal pump. The centrifugal pump is a very versatile pump, which reduces 
the cells trauma on the erythrocytes, and the platelets with possible lower effects on 
hemolysis. Moreover the centrifugal pump can generate up to 900 mmHg of forward 
pressure and only 400 mmHg of negative pressure with less cavitation and lower 
microemboli formation. The oxygenator of the MECC circuit is one of the most important 
components of the circuit itself. Oxygenators have the oxygenation membrane of either 
microporous polypropylene (El-Essawi et al. 2010; Wippermann et al. 2005) or 
polymethylpentene (Anastasiadis et al. 2011; Puehler et al. 2010; Formica et al. 2009; Remady 
et al 2006; ). In the latter case the membrane is considered as a diffusion membrane Usually 
the oxygenator has an integrated heat exchanger and one of the largest gas exchange surface 
areas, reaching about 2.4 m2. In this way the oxygenator can give a full oxygenation also 
with high blood flow pump up to 7 L/min.  
Many MECC circuits include an arterial filter between the oxygenator and the aortic 
cannula. The filter has a prime ranging between 150-200 ml but its presence is of extreme 
importance because strongly reduce the risk of cerebral and systemic embolization or air, 
thrombus and calcium. Moreover some MECC circuits include a venous bubble trap or 
some similar device with the aim of reducing the big air entrainment in the circuit that could 
be one of the causes of accidental blockage of the MECC circuit. These devices are located 
between the venous cannula and the blood centrifugal pump. 
 




Fig. 2. MECC system.  
Aortic and atrial cannulation are equal to conventional ECC. Usually an aortic vent is 
positioned in ascending aorta and a further vent is inserted in the pulmonary main trunk 
during aortic valve surgery. 
A cell-saver device can be associated with the MECC with the aim to sucked all the 
pericardial and bloodshed. 
The very strong difference between the MECC and the standard ECC circuit is the absence 
of a venous reservoir. In the MECC, the patient is the own venous reservoir and for this 
reason the straight collaboration among the cardiac surgeon, the anaesthesiologist and the 
perfusionist is extremely important to guarantee the best outcome. Use of vasodilator and 
vasoconstrictor drugs, Trendelemburg or anti-Trendelemburg position of the patient, 
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3.1 Activated blood cells 
3.1.1 Neutrophils 
Neutrophils are strongly activated during ECC. When activated, the neutrophils are recruited 
to inflammation site by inflammatory cytokines (IL-1β, TNF-α, IL-8), complement proteins and 
adhesion molecules (Royston 1997). The activated neutrophils can contribute to myocardial 
damage by infiltrating the myocardium and worsening the mechanism of ischemia-
reperfusion damage that initiates after aortic cross clamp removal (Paparella et al 2002). 
Moreover the neutrophils can infiltrate not only the myocardium but also the lungs and the 
brain (Lagan et al. 2008). Usually the neutrophils blood count and the total white blood cell 
count increase during ECC and over the first 48 hours after the operation (Fromes et al 2002) 
3.1.2 Monocytes 
Monocytes are activated during ECC and play a role in thrombin formation, but also they 
can produce a potent arsenal of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-8, MCP-
1 and CD40 ligand), reactive oxygen substances and prostaglandin (Borregaard & Cowland 
1997). Monocytes also release different types of enzymes (elastase, collagenases, 
lipooxygenase), interferons, growth factors, matrix proteins. Moreover, monocytes produce 
nitric oxide (Paparella et al. 2002) 
3.1.3 Endothelial cells 
The vascular endothelium is actively involved during the pathologic processes of the SIRS by 
means of endothelial cells activation. During the SIRS the several endothelium control 
mechanisms of the vascular tone and permeability can modify. A large variety of agonist plays 
an important role in endothelial cells activation. Among them cytokines such as IL-1β, TNF-α, 
thrombin and complement C5 are the most important (Beghetti et al. 1998). In particular, IL-1β, 
TNF-α may induce the expression of P-Selectin and of E-Selectin by the endothelium. The P-
Selectin is a glycoprotein that is stored in platelets and in the body of endothelial cells. P-
Selectin participates in myocardial injury caused by myocardial ischemia-reperfusion 
mechanism (Robertson & Coopersmith 2006; Royston 1997). E-Selectin is minimally expressed 
on activated endothelium and for this reason this glycoprotein and its soluble form are 
considered a very strong marker of endothelial damage and activation (Asimakopoulous & 
Taylor 1998). Moreover E-Selectine is elevated in congestive heart failure (Chong et al. 2003). 
The activated endothelium induces also the expression of intercellular adhesion molecule-1 
(ICAM-1) and vascular cell adhesion molecule-2 (VCAM-2). These two molecules bind 
monocytes and neutrophils to the endothelium (Asimakopoulous & Taylor 1998). 
3.1.4 Platelets 
Platelets are directly involved during the SIRS and several potent platelet agonists activate 
them. Thrombin is probably the most important of platelet agonist. Other platelet agonist 
activators are epinephrine, vasopressin, platelet-activating factor (PAF), serotonin and 
thromboxane A2 (Downing & Edmunds. 1992). Activation of platelets during and after ECC 
leads to platelet aggregation and aggregates with monocytes and neutrophils. 
3.2 Other inflammation mediators 
3.2.1 Cytokines 
Cytokines are small pro-inflammatory peptides produced and released by tissue and blood 
cells. Cytokines influence hemodynamic mechanism and regulation and negatively affect 
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renal function and lung function (Royston 1997). Cytokines are strongly involved in 
myocardial stunning process and in multiorgan failure syndrome (Larmann & Theilmeier 
2004) Important cytokines involved in the SIRS are the interleukin 1β (IL-1β), the interleukin 
6 (IL-6), the tumor necrosis factor α (TNF-α), soluble CD 40 ligand (sCD40L). 
IL-1β is produced mainly by monocytes. This cytokine derives from IL-1 by the action of the 
IL-1β converting enzyme. An increase of IL-1β was found after ECC with a peak 
concentration after 24 hours (Fromes et al 2002). 
IL-6 is produced and released by the monocytes and endothelial cells following a stimulus 
by the IL-1 and TNF-α The IL-6 has the peak concentration few hours after the end of ECC 
and gradual decrease within the following 24 hours (Beghi et al 2006; Whipperman et al 
2005; Fromes et al 2002). The IL-6 concentration increase also after major noncardiac 
operation and the peak concentration occur after 6-24 hours the end of operation. 
TNF-α is a cytokine produced by neutrophils and monocytes. This cytokine stimulates the 
surrounding stromal and parenchymal cells to produce more cytokines and chemokines. A 
significant increase of TNF-α was shown after removal of the cross-clamp and a peak 
concentration is reached after 24 hours the end of ECC. The TNF-α has an inotropic negative 
effect and the myocardium is a major source after ischemia reperfusion injury. 
sCD40L is produced by activated platelets and upregulates the expression of inflammatory 
adhesion receptors including E-selectin, VCAM-1, tissue factor and matrix 
mettalloproteinases (Nannizzi-Alaimo et al 2002). Furthermore, sCD40L was described has a 
major mediator of vascular inflammation (Antoniades et al 2009a). Plasma levels of CD40L 
increase within 1 hour on ECC and increased further to almost 4 fold hours after 2 hours. 
(Nannizzi-Alaimo et al 2002). High preoperative level of CD40L were associated with an 
high risk of postoperative atrial fibrillation in patients underwent off-pump myocardial 
revascularization (Antoniades et al 2009b) 
3.2.2 Chemotactic proteins 
Chemotactic proteins play an important role in inflammatory response to ECC. Monocyte 
chemotactic protein 1 (MCP-1) is implicated in transendothelian monocyte recruitment to 
inflammatory site (Luster 1998). Various stimuli in the heart cause the production and 
releasing of MCP-1, leading to recruitment of monocytes that causes a stress response in the 
heart. There is strong evidence that MCP-1 plays a role in atherosclerosis, myocarditis, 
ischemia/reperfusion injury and transplant rejection. 
3.2.3 Mettalloproteinases 
Metalloproteinases are proteolityc enzymes that have a role in degradation of proteins and 
collagens of extracellular matrix and vascular basement membrane. MMP-8 and MMP-13 
increase at the end of ECC and 30 minutes later (Joffs et al. 2001). MMP-9 increases after the 
removal of aortic cross-clamp and the reaches the peak concentration after 24 hours  
3.2.4 Oxidative stress 
Oxidative stress describes an increased bioactivity of reactive oxidant substances (ROS) that 
can participate to endothelial and myocardial damage. The ROS are produced and released 
by neutrophils, monocytes and macrophages when they are activated. The ROS are a potent 
arsenal of cytotoxic mediators of acute inflammation response (Babior 2000). There are four 
enzymes that generate a various amount of ROS. They are represented by nicotamide 
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adenine dinucleotide phosphate (NADPH), oxidase, superoxide dismutase and nitric oxide 
dismutase. When the aortic cross clamp is removed, myocardial ischemia is followed by 
reperfusion, which generates oxidative stress with production of reactive oxidants (O2-, 
H2O2, NO and HOCl) by the action of the four enzymes. 
4. Clinical application of miniaturized extracorporeal circulation 
Clinical experience with the MECC is rapidly increasing over the last 10 years. Several 
reports describe the application of MECC in isolated CABG operation; however some 
reports describe the use of this strategy during aortic valve replacement operation, mitral 
valve surgery, ascending aorta operation. 
4.1 Miniaturized extracorporeal circulation and isolated CABG operation 
Different studies have reported the use of MECC compared to conventional ECC strategy in 
isolated CABG to demonstrate a clinical superiority of the MECC versus ECC. Actually no 
clinical benefits of MECC were reported in terms of early mortality and in terms of 
neurological or renal impairment. The most important differences between MECC and 
standard ECC that were reported regard the impact of SIRS, the myocardial protection and 
hemodilution. 
Many Authors have conducted randomized studies to compare MECC system with 
conventional ECC in patients undergoing isolated CABG operations. Fromes et al. 
(Fromes 2002) reported a series of 60 patients divided into two groups. They 
demonstrated that in both MECC and standard ECC groups the monocyte count drops 
following the initiation of bypass and then increases again during the next 24 hours. The 
drop in monocyte count was greater in standard ECC group probably as a consequent 
major hemodilution Moreover the MECC group had reduced release of IL-6, TNF-α, 
neutrophil elastase and S100B. No differences were found in IL-1β or β-thromboglobulin 
in both groups. In this study Fromes et al measured the release of cytokines at six interval 
points during and after extracorporeal circulation up to 24 hours postoperatively. Van 
Boven et al. (Van Boven et al. 2004) measured the levels of malondialdehyde (MDA) and 
allantoin/urate ratio in 184 patients divided in MECC and standard ECC. They can 
demonstrate a reduced release of MDA and allantoin/urate ratio in MECC patients. 
Moreover a significant blood transfusion rate was described in the MECC group. They 
found also reduced levels of oxidative stress in the MECC patients following the release of 
the aortic cross clamp. In a cohort of 400 patients, Remady et al. (Remady 2007) 
demonstrated a higher CRP levels in the standard ECC patients, at 24 and 48 hours, a less 
hemodilution and a reduced need for blood product transfusion in MECC patients, a 
higher evidence of focal neurological and renal impairment in standard ECC and a lower 
release of troponine in MECC groups. In another randomized trial, Skrabal et al (Skrabal 
et al. 2007) reported lower myocardial damage with lower levels of creatine-kinase MB 
and troponine T in patients operated on with MECC system. In a prospective randomized 
multicenter study (El-Essawi et al. 2010), comparing MECC system with conventional 
ECC, the Authors found statistical differences in need of total transfusion and blood 
product transfusion. Moreover a lower incidence rate of postoperative atrial fibrillation 
was detected in MECC group. In a big series of 1.053 patients operated on with the MECC 
system, Immer et al (Immer et al. 2007) reported a reduced troponine level release, a 
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reduced postoperative release of IL-6 and also a low incidence of postoperative atrial 
fibrillation and an early extubation time. Similar results were already reported by others 
(Wiesenack 2004). In some prospective randomized trials comparing MECC and OPCAB, 
some Authors did not find dramatic difference between the two techniques. In particular 
Mazzei et al. (Mazzei et al. 2007) comparing 150 MECC patients with 150 OPCAB patients, 
found that the mortality and morbidity had not significant difference and the release of 
IL-6 and S-100 protein were similar in both groups as wel as the length of stay and the use 
of blood product. In a recent prospective randomized study (Formica et al.2009) we 
wanted to study the inflammatory response and the myocardial damage in two groups of 
patients operated either with MECC or with OPCAB technique. We can demonstrate that 
the releases of cardiac TNF-α and IL-6 from coronary sinus were similar in both groups 
during the operative period and that the hemoglobin levels were higher in MECC GROUP 
than in OPCAB after 24 hours. Moreover the production of blood lactate from coronary 
sinus did not reach statistical difference in both groups. Other Authors (Reber et al. 2010) 
have observed in a retrospective study that MECC system can guarantee a more complete 
revascularization compared to OPCAB. In a recent publication (Puelher et al 2011), the 
outcome of 2243 patients underwent CABG operation with MECC were reported. They 
found a 30-mortality of 2.3%, and a very low incidence of blood transfusion, need for 
inotropic support, renal substitute therapy, release of myocardial necrosis enzymes and 
neurological dysfunction. The rate of conversion from the MECC was extremely low 
(0.4%).  
Other Autrhors (Anastasiadis et al 2011a) have reported better neurocognitive outcome in 
MECC system compared to conventional ECC on the day of discharge and at 3 months. 
4.2 Miniaturized extracorporeal circulation and aortic valve replacement 
The first application of MECC for aortic valve replacement (AVR) was reported by Remady 
et al (Remady et al. 2004). They applied the MECC system in 45 patients requiring isolated 
AVR or associated with CABG. The Authors reported a very low 30-day mortality and 
morbidity incidence rate and considered the MECC system a new cardiopulmonary concept 
safe and reliable in aortic valve surgery too. Since than few Authors reported the use of 
MECC for AVR. In a prospective randomized study Remady et al (Remady 2004) reported 
better clinical results with reduced myocardial damage, good preservation of renal function 
and better platelets count in MECC group compared than standard ECC group. In another 
prospective randomized study conducted on a total of 40 patients, Castiglioni et al 
(Castiglioni et al. 2007) reported better clinical data with lower hemodilution, lower 
intraoperative blood transfusion and lower postoperative bleeding in the MECC group 
compared to standard ECC. Furthermore they reported a lower release of troponine in 
MECC patients than standard ECC groups.  
4.3 Miniaturized extracorporeal circulation and other surgical applications 
At the best of our knowledge no other surgical application of MECC are schematically 
reported in the literature. Some reports (Anastasiadis et al 2011b; Palombo et al. 2004) 
described the use of MECC in elective thoracoabdominal aortic surgery. They described 
only 7 cases without any complications. We used the MECC system in few case of CABG 
associated with mitral valve annuloplasty and in 5 cases of kidney cancer and inferior vena 
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(Castiglioni et al. 2007) reported better clinical data with lower hemodilution, lower 
intraoperative blood transfusion and lower postoperative bleeding in the MECC group 
compared to standard ECC. Furthermore they reported a lower release of troponine in 
MECC patients than standard ECC groups.  
4.3 Miniaturized extracorporeal circulation and other surgical applications 
At the best of our knowledge no other surgical application of MECC are schematically 
reported in the literature. Some reports (Anastasiadis et al 2011b; Palombo et al. 2004) 
described the use of MECC in elective thoracoabdominal aortic surgery. They described 
only 7 cases without any complications. We used the MECC system in few case of CABG 
associated with mitral valve annuloplasty and in 5 cases of kidney cancer and inferior vena 
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cava metastathic thrombosis. In this operation, we used the MECC system to cool the 
patients during the isolation of renal tumor mass. The two surgical equips could work 
contemporaneously. Once the patients reaches the body temperature of 20 °C, the MECC 
system was converted in a standard ECC to drained all the blood and arrested the systemic 
circulation. Once the thrombus was from the inferior vena cava and the vessel was sutured, 
we restarted the systemic circulation and the standard ECC was converted in MECC system. 
We preferred to use this strategy to reduce the risk of bleeding from the abdomen, which is 
very high in such tumoral pathologies. 
5. Conclusion 
We did not find in the literature significant differences in terms of clinical results regarding 
post-operative mortality. One of the reasons is because the MECC strategy is widely applied 
in low risk populations and only few Authors describe the use of MECC in high-risk 
patients (Puehler 2011, Koivisto 2010). At the moment, most of the clinical benefits with the 
use of MECC were seen in the SIRS, hemodilution, platelet function protection.  
The good amount of data described in favor of MECC could induce to apply this strategy in 
more cardiac surgical operations. However, the MECC system presents some limitations 
that create some concern about a wider use of this technique. One important limitation is 
high risk of air entrapment along the venous line that could suddenly stop the 
cardiopulmonary bypass. Another limitation is the need of learning curve because, as well 
as in the OPCAB, the MECC technique requires an experienced team (surgeon, 
anesthesiologist and perfusion) before to be applied routinely in all CABG patients and by 
all surgical staff. 
We feel that the MECC technology gives better advantages than standard ECC and we feel 
that MECC could be applied to other surgical procedures. Of course more randomized, 
large, multicenter studies are mandatory to verify the safety of this technology in such 
cardiac complex surgical operation (aortic dissection, congenital disease). 
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1. Introduction 
The first use of hypothermia in cardiac surgery is attributed to Dr. John Lewis who 
performed an atrial septal defect closure on September 2, 1952 at the University of 
Minnesota (Gott, 2005). 
Cardiopulmonary by-pass (CPB) and hypothermic cardio-circulatory arrest (HCCA) has 
been introduced for the first time in clinical practice for aortic arc substitution (Pierangeli et 
al., 1974). More recently the same technique has been proposed to remove atrial thrombi 
originated from renal carcinomas (Marshall et al., 1984), adrenal carcinomas (Shahinian et 
al., 1989), hepatocellular carcinoma (Hamazaki et al., 1995) and other abdominal 
malignancies such as caval leiomyosarcoma, uterine endometrial sarcoma or intravenous 
leiomyomatosis, ovarian or testicular tumors (Hassan et al.,, 2010; Vargas-Barron et al., 1990; 
Ariza et al., 1982; Kanda et al., 1991).   
There is still a debate pro and cons the use of hypothermic arrest with some favours the 
normothermic (Lubahn et al., 2006; Stewart et al., 1991) and some others the hypothermic, 
because of the operative field appears better exposed and almost completely bloodless so 
the blood loss resulted much lower. Furthermore they claim a better visualization of some 
critical areas with an easier removal of the tumoural thrombus, that may invade the hepatic 
veins or the coronaric sinus, may either remain attached to the tricuspid valve or may have 
embolized into the pulmonary artery (Chiappini et al., 2002; Kalkat et al., 2008; Leo et al., 
2010; Topcouglu et al., 2004). In all these occasions HCCA offers the possibility of a better 
tumoural cleaning with the possibility of R0 resection. The incomplete removal of this 
tumoural thrombi in fact is correlated to an early recurrence and a worst postoperative 
survival (Skinner et al., 1989). Furthermore the hepatic, renal and splacnic damage from 
warm ischemia due to the Pringle’s manoeuvre and/or aortic/mesenteric cross-clamping 
(usually necessary when CPB is used without cardio-circulatory arrest) is reduced when the 
HCCA is instead used (Chiappini et al., 2002, Davlouros et al., 2005). This permits its use 
even in the setting of mild hepatic damage (Leo et al., 2010). 
2. Kidney  
Tumour thrombus extension in the inferior vena cava (IVC) occurs in 4 % to 10% of patients 
with renal cell carcinoma (RCC) (Marshall et al., 1988). The cephalic extension of tumour 
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thrombus in RCC was first defined in 1987 by Neves and Zincke (Neves & Zincke, 1987) and 
classified in four levels (level I : thrombus at the level of the renal vein, level II : thrombus 
extending into the infra-hepatic IVC, level III : thrombus extending into the retro-hepatic 
IVC, level IV : intra-atrial thrombus (suprahepatic IVC involvement or right atrium 
thrombus). Libertino classification system (Moinzadeh & Libertino, 2004) distinguishes: 
renal vein only involvement, level I caval involvement (IVC below the diaphragm), level II 
caval involvement (IVC above the diaphragm) and level III involvement (when the 
thrombus reaches the atrium).  
Recently an updated staging system by the American Joint Committee on Cancer (AJCC) 
and the “Union International Contre le Cancer” (UICC) was utilized and the current staging, 
according to the 2009 UICC/AJCC TNM staging classification system, designates renal vein 
involvement as pT3a Level III, when the thrombus involves the intra-hepatic portion of the 
IVC but below the diaphragm is designated as p T3b, while level IV when the thrombus 
extends above the diaphragm, as T3c.  The thrombus may extend as far as the right atrium 
(IV level) in 1% of patients with RCC. Accurate information about the presence and 
complete extent of IVC involvement is essential for surgical planning. Routine CT scanning 
and abdominal ultrasonography are less reliable in delineating the cephalic extent of the 
thrombus. Contrast inferior venacavography is an accurate, but invasive, diagnostic tool and 
a single anterograde study may be insufficient in complete caval obstruction. Occasionally 
has been employed trans oesophageal echocardiography and trans-abdominal colour flow 
Doppler ultrasonography. MRI has become the preferred, non invasive, diagnostic study 
though its frequent inability to differentiate actual invasion of the vena cava wall which is 
generally associate with a poor prognosis. Contrast inferior venography is reserved for 
patients in whom MRI finings are equivocal or for whom MRI is contraindicated. Another 
option in this group of patients is multiplanar CT. 
Renal arteriography is useful in the preoperative study because it may highlighted a distinct 
vascularisation of the thrombus (observed in 35% to 40% of the cases) allowing to perform a 
preoperative embolization of the kidney, causing the shrinkage of the thrombus and its 
more easily intra-operative removal. 
The prognostic significance of venous involvement and tumour thrombus level remains 
highly controversial. According to the literature in the absence of metastasis, when adjusting 
for clinical and pathologic features, radical nephrectomy with total tumour thrombus 
excision in patients with RCC and level I to III vena caval involvement is associated with a 
cancer specific 5 –year survival rate between 47% and 68% (Staheler & Brkovic, 2000; Belis et 
al., 2000). 
Some authors generally accepted that neoplastic extension in the IVC was not a prognostic 
determining factor (Libertino et al., 1987; Skinner et al., 1989; Ciancio et al., 2010). Some 
others, more recently, have shown that tumour thrombus level is an independent predictor 
of survival (Mart´nez-Salamanca et al., 2011). 
RCC with vascular invasion into the IVC, direct invasion of the vein’s wall appears to be 
an important prognostic factor and should be noted during tumour staging. With no peri-
nephric fat or lymph nodal involvement, patients who undergo tumour excision with 
radical nephrectomy and IVC thrombectomy have an overall and cancer specific 5–year 
survival of 30% to 72% with an operative mortality of 2.7% to 13.5 %. When the thrombus 
locally invades the wall of the vena cava, aggressive resection of the vascular wall with 
reconstruction along with the attainment of negative surgical margins provides a survival 
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benefit (Hatcher et al., 1991). Grafting or reconstitution sometimes is required only in 
those patients with not complete occlusion of IVC and collateral blood flow. In 1913, Berg 
first described nephrectomy and vena caval thrombectomy as primary surgical treatment 
of these patients (Berg, 1913). Usually, in level I and II disease the tumour thrombus can 
safely be excised by means of proximal and distal control of the IVC. In level III and IV 
disease the exposure and isolation of IVC requires liver mobilization with or without the 
use of CBP. Several techniques have been used during the years to remove large caval 
thrombi when distal caval control cannot be achieved below the liver such as cross-
clamping of the supraceliac aorta (Cummings et al., 1979), occlusion of the intra 
pericardial vena cava with simultaneous occlusion of the “porta hepatis” and superior 
mesenteric artery (Skinner et al., 1989), use of an intraoperative venous (cava-atrial) shunt 
(Foster et al.,1988), and cardiopulmonary by pass alone  (Novick & Cosgrove, 1980). The 
use of CBP alone is limited to the period during which the liver and the kidneys undergo 
warm ischemia. Skinner and co-workers reported an average warm ischemia of 14 
minutes ranging from 8 to 20 minutes. Post operative complications occurred in 41% to 
60% of the patients and included transient hyperbilirubinemia, renal dysfunction and 
respiratory failure (Skinner et al., 1989). When the thrombus extends above the diaphragm 
the use of CPB with deep HCCA have been used. Marshall et al., 1984 and Krane et al., 
1984 first demonstrated the feasibility of this approach. The most common post operative 
complications related to this procedure are haemorrhage, coagulopathy, increased 
transient and/or permanent neurologic risk. Novick et al., 1990 in their experience 
reported  up to 60 minutes of safe ischemia with direct visual inspection of the entire vena 
caval lumen in a bloodless field reducing risk of sudden massive intra-operative 
haemorrhage or distal pulmonary tumour Thrombo-embolization. Operative mortality 
rate reported was 4.7% (Novick et al., 1990). Heart surgery have been used more 
frequently to treat intra-cardiac extension of infra-diaphragmatic tumours and the safety 
of this procedure has increased. Chiappini and co-workers in their series of 13 patients 
reported no in-hospital deaths while 2 patients experienced postoperative complications 
such as respiratory failure and bleeding (Chiappini et al., 2002). On the other side, Ruel 
and co-workers in 2001 reported their experience in cavo-atrial thrombus excision in 6 
patients affected by RCC without circulatory arrest (Ruel et al., 2001). During the last 10 
years the traditional approach using CBP and HCCA was revisited. Deep hypothermic 
circulatory arrest was therefore not considered imperative and some studies reported that 
its avoidance may decrease morbidity and mortality. Shinghal et al., in 2003 reported in a 
single patient a novel technique by placing an aortic occlusive balloon in the abdominal 
aorta at the level of the diaphragm, limiting flow in the IVC and maintaining both cerebral 
and spinal cord perfusion during cardiopulmonary bypass (Shingai et al., 2003). In 2005 
Ciancio & Soloway described  a technique that can be safely used to approach RCC with a 
tumour thrombus extending into the supra-diaphragmatic IVC and right atrium through 
a trans-abdominal approach without sternotomy and/or  cardiopulmonary bypass 
utilizing a complete liver mobilization and minimizing the vena caval cross–clamp time. 
The trans-abdominal incision exposes the intra-pericardial IVC and right atrium trans-
diaphragmatically. (Ciancio & Soloway, 2005; Ciancio G, Shirodkar S et al.,2009). Step by 
step description of this technique based on orthotopic liver transplantation was reported 
in 2011 by the same author regarding a cohort of 56 patients with retro-hepatic extension 
of the thrombus and 12 patients  with a supra-hepatic/intra atrial localizations. Mean 
operative time was 5h and 32 min. Five patients required CPB (7.3%). Three patients died 
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in the immediate post operative period (4.4%) (Ciancio G, Gonzalez J,et al., 2011). In 2007 
Chowdhury et al., reported their experience in a cohort of 6 patients with RCC and intra 
atrial tumour thrombus using mild hypothermic CPB and intermittent cross- clamping of 
the supra-celiac abdominal aorta (Chowdhury et al., 2007)  
RCC with vascular invasion into the IVC remains a crucial challenge to the urologic 
oncologist. Complete excision of the tumour together with the thrombus and negative 
margins offers the best chance for patients survival. Surgical resection of these complex 
tumours requires multidisciplinary approach.  
2.1 Adrenal 
The use of CPB to remove the tumour thrombus from adrenocortical carcinoma (ACC) was 
first reported in 1976 (Scully et al., 1976) while the first procedure using HCCA was in 1989 
(Shahian et al., 1989) but because of the poor prognosis of this tumour at this stage and the 
technical difficulties that has to be faced such as the invasion of surrounding organs and 
vascular control/reconstruction, radical surgical resection remains controversial. A recent 
review from France (Chiche et al., 2006) collected the outcome of 32 patients reported in 
literature with cavo-atrial invasion in whom a CPB was used in 26 including 6 under HCCA. 
Reported peri-operative mortality was 3/26 (11.5%) and took place in patients operated 
using CPB alone. 
In their own series of ACC with tumour thrombi extending into the vena cava or in the right 
atrium, they reported the outcome of 15 patients treated by a combination of venous control 
ranging from cross clamping to hepatic vascular exclusion or normo/ipothermic cardio-
pulmonary by-pass. The extension grade C (above the liver) was in 7 patients, including 4 
with atrial thrombi and represents the 7% of the overall series. Of these patients 3 had 
HCCA and 1 (33.3%) died p.o. from multi-organ failure but the patient was cirrhotic with a 
portal thrombosis. 
They concluded that CPB should always be used for tumours extending to the cavo-atrial 
junction or into the right atrium and additional HCCA provides a bloodless field that allow 
a precise dissection of the thrombus while reducing the blood loss.  
2.2 Liver 
Macroscopic vascular invasion (either portal or supra-hepatic) is a major complication of 
hepatocellular carcinoma (HCC). Major vascular invasion is the evolution of microscopic 
vascular invasion over the time so the liver tumour is of the large type at diagnosis and 
usually require major liver resection. 
The natural history of HCC complicated with macroscopic vascular invasion of the portal 
vein, shows a median survival time of only 9 to 10 weeks (Okada et al., 1992).  
Treatments with systemic chemotherapy, intra-arterial chemotherapy or radiofrequency 
ablation result in a dismal survival at 1 year ranging from 7% to 18% (Raul et al., 1994; 
Akashi et al., 1991; Poon et al., 2003). Hepatic resection remains the only option for these 
patients and a recent multicentric study showed that, resected patients lived longer, 
compared to those not treated surgically, with a five-year survival rate of 10% (Pawlik et al., 
2005; Lin et al., 2007).  
Liver tumour with extension to the hepatic veins represents instead a controversial issue 
and its extension in the right atrium (RA) via the inferior vena cava is more uncommon, 
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with percentage of incidence reported of 2.9% by imaging techniques, 0.7% at operation, and 
18.2% at autopsy in Japan (Yogita et al., 2000).  
Therapeutics options at this stage are few and debatable because of the high risk for lung 
metastasis (Masaki et al., 1995) but, on the other hand, the risk of developing a “ball valve 
syndrome”(Hahne & Climie, 1962) or a pulmonary embolism is very high (Fujisaki et 
al.,1991). The overall survival time of these patients with cavo-atrial thrombi and who do 
not undergo operative treatment is reported to be very low: from 3 days to 2 months (Lin et 
al., 2007) 
Liver resection and cavo-atrial thrombectomy remains, in this situation, the only effective 
therapeutic option with reported survival time ranging from 5 to 56 months (Miyazawa et 
al., 2005). 
The firsts authors describing the removal of a tumoural thrombus in the RA from HCC on 
cirrhosis using CBP were Goto et al. in 1986 who removed only the thrombus. Fujisaki et al. 
in 1991 first removed the thrombus along with the primary tumour using CPB hepatic 
vascular exclusion while Hamazaki et al. in 1995 added the use of HCCA in a similar 
situation. Indeed, HCCA was first applied in liver surgery, in a young child to remove atrial 
thrombi from hepatoblastoma, which usually occurs on a normal liver parenchyma, in 1981 
(Ein et al., 1981). 
The majority of patients with HCC has a diseased liver because of the presence of hepatitis 
viruses infection and /or previous alcohol abuse. The presence of hepatic vein, vena cava 
and atrial thrombosis contraindicate liver transplantation and, liver resection with 
thrombectomy, is the only real therapeutic option in this setting (Wu et al., 2000). As 
previously stated, acute pulmonary embolism or congestive heart failure may complicate 
liver tumours involving hepatic vein with tumours thrombi in the inferior vena cava/right 
atrium. This latter situation represent an impending life-threatening condition that should 
be surgically treated as soon as possible (Novick et al., 1990). 
Atrial thrombus removal may be achieved under normothermic CPB and total liver vascular 
exclusion. Tolerance of the cirrhotic liver to normothermic ischemia is reported as safe up to 
33 minutes (Huguet et al., 1994) which is quite similar to the safety time reported to avoid 
neurological complications when using HCCA (McCullough et al., 1999).  
Extracorporeal circulation with HCCA has been increasingly used to remove atrial 
thrombi due to retroperitoneal malignancies (Ogata et al., 2006) but its use in cirrhotic 
patients has been limited, for many years, because of the fear of post-operative liver 
failure and poor outcome. However, in more recent time, we have assisted to an increase 
number of reports where HCCA has been used to remove cavo-atrial thrombi due to HCC 
with no mortality and low morbidity, probably, lower than expected thus, we can assume 
that, a short lasting HCCA, has to be considered safe in a well compensated liver cirrhosis 
(Novick et al., 1990; Yogitaet al., 2000; Ohwada et al., 2008; Florman et al., 2009; Leo et al., 
2010). 
Since the vast majority of patients with HCC and atrial tumour thrombi has large type of 
HCC, a major liver resection is usually required and the possibility of postoperative liver 
failure raises accordingly, liver function tests and indocyanin green retention test, should be 
carried out in these patients in order to demonstrate the presence of a good functional 
reserve (Kawasaki et al., 1995). Furthermore we think that adding a sequential arterial and 
portal embolization of a hemi-liver could lessen the possibilities of post-operative liver 
failure when a major resection is planned (Ogata et al., 2006).  
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with percentage of incidence reported of 2.9% by imaging techniques, 0.7% at operation, and 
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Therapeutics options at this stage are few and debatable because of the high risk for lung 
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Fig. 1. A: Ct scan of a cavo-atrial tumour thrombus (yellow arrow). B and C: Extraction of 
the thrombus, after a left hemi-hepatectomy, from the sectioned left and middle hepatic vein 
ostium (white arrow) using a rings clamps to pull and an index finger, inserted from the 
atriotomy site, to push the thrombus downward. D: Cleaned ostium (red arrow), closed 
atriotomy (black arrow) and distal middle hepatic vein stump (green arrow) to be 
reconstructed. Please note the completely bloodless field of the procedure under 
hypothermic cardiocirculatory arrest.  
2.3 Uterus 
The uterus is seldom the site of origin of a cavo-atrial thrombi owing to two distinct 
tumours: the endometrial stromal sarcoma (ESS) and the “benign” intravenous 
leiomyomatosis (IVL). This latter situation differs from the other types of neoplastic thrombi 
because the endovascular material is represented mainly by myofibroblastic cells, growing 
into the vessel, rather than by a neoplastic thrombotic apposition. 
2.3.1 Endometrial stromal sarcoma 
ESS represents only the 0.2% of all uterine malignancies and it has been described to invade 
the great vessels rarely. In a recent review only 9 patients had a tumour thrombus reaching 
the right atrium, ventricle or the pulmonary artery that underwent radical resection by 
means of total abdominal hysterectomy and thrombectomy. Normothermic CPB was 
reported in 7 out the 9 patients with only 1 (14.3%) complication due to renal acute tubular 
necrosis. No perioperative deaths were reported (Renzulli et al., 2008). 
2.3.2 Intravenous leyomiomatosis 
IVL is an uncommon “benign” tumour of middle age parous women arising from either the 
uterine venous wall or uterine leiomyoma (Nam et al., 2002). It is known also as benign 
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metastatic fibro-leiomyoma because pulmonary nodules (proliferating leiomycites) are often 
present. Although this tumour is usually confined to the pelvis, it sometime extends to the 
right cardiac cavities through the iliac vein and the vena cava (Wakiama et al., 2000) by 
means of intra-vascular proliferation and growth of fibro-myocites which results in an 
extension of the fibro-leiomyoma rather than in a thrombus formation conferring a typical 
consistency and resistance to traction to the endo-vascular proliferation (Galajda et al., 2010).  
IVL with cardiac extension is an exceedingly rare disease first reported in 1907 in an autopsy 
series (Durk, 1907). Since then a further 34 cases have been reported involving the right 
heart (Wakiyama et al., 2000). Patients often have a history of hysterectomy or leiomyoma 
resection and various lengths of intravascular proliferation up to 29 cm with a diagnosis 
performed up to 18 yrs after the primary surgery ( Galajda et al., 2010). 
Complete surgical removal of the uterus and IVL is the therapy of choice (Topcouglu et al., 
2004) and it has been carried out for the first time in 1974 using CPB and HCCA 
(Mandelbaum et al., 1974). 
We came across a similar case (Fig. 2) in whom we performed a total abdominal hysterectomy 
and IVL removal through a cavotomy and atriotomy under CPB and HCCA (Fig. 3). Due to 
the typical consistency of IVL and the usual absence of adhesions the complete heart and retro-
hepatic vena cava cleaning was achieved by simple traction from the infra-renal cavotomy site 
(Fig. 3A) while the iliac portion was stacked and required separate iliac vein incision.  
 
 
Fig. 2. Preoperative ct scan of intra-vascular leiomyomatosis arising from uterine leiomyoma 
(white arrow) extending to the right iliac vein (blue arrow), infra and retro-hepatic vena 
cava (green arrow), right atrium (red arrow) and to the rignt ventricle (yellow arrow). 
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Fig. 3. Same Patient of figure 2. Operative view of the removal, through a cavotomy (A) and 
atriotomy (B), of intravascular leiomyomatosis. Operative specimen removed is shown in C: 
1 and 2 are the right atrial extensions, 3 the right ventricular extension, 4 the caval iliac 
extensions and 5 right ovarian vein involvement. 
2.4 Vena cava 
Leiomysarcomas of the inferior vena cava (IVC) are rare malignant tumours originating 
from the smooth muscle cells of the media layer that typically show three growth patterns: 
extra-luminal, intra-luminal and both (Mingoli et al., 1996). They may be classified 
anatomically according to Chiappini et al., 2002, as for renal tumours, into four types: Type I 
infra-hepatic, type II retro-hepatic, type III supra-hepatic IVC and type IV the thrombus 
extends in the right atrium.  
Patient with type IV was treated and reported by Hassan et al., 2010, using normothermic 
CPB and Pringle’s manoeuvre to remove the atrial thrombus reporting mild 
hyperbilirubinemia and normal renal function. They discussed the possible advantages of 
the technique used, compared to HCCA which they thought to be associated with an 
extended CPB time, increased postoperative bleeding and coagulopathy, and increased 
neurological risk. On the other hand HCCA provides a bloodless surgical field with reduced 
risk of spreading/embolization, and fatal haemorrhage. Furthermore the advantages 
include reduced liver and kidney warm ischemia, reduced risk of incomplete excision, 
optimal visualization of the IVC/right atrial lumen minimizing the need for a too extensive 
retro-peritoneal dissection (Chiappini et al., 2002).  
2.5 Others 
Scattered case reports of ovarian haemangioma (Tamburino et al., 1992), testicular tumour 
(Kanda et al., 1991), embrional carcinoma of the testis (Paule et al., 1991), testicular teratoma 
(Moon et al., 1992) and even pancreatic cancer (Ozben et al., 2007) have been reported so far. 
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The problems when dealing with these situations are almost the same of those reported 
above and at the moment it is impossible to draw any conclusion due the scarcity of the 
cases.  
3. Anesthetic management  
In the following sections, an overview of the main technical features for the management of 
anaesthesia, extracorporeal circulation and hypothermic circulatory arrest for cavo-atrial 
thrombectomy are summarized.  
3.1 Monitoring and anesthesia 
Any operative procedure involving large vessels entail the risk of developing hemodynamic 
instability, mainly due to massive bleeding. Moreover, a number of specific conditions have 
to be taken into consideration, including coexisting multisystemic diseases, non-
physiological conditions associated with CPB and deep HCCA. In light of these concerns, 
patients undergoing cavo-atrial thrombectomy require extensive monitoring to provide 
early warning of conditions that may lead to potentially life-threatening states.  
3.1.1 Monitoring 
An intraoperative electrocardiogram, using the five-leads technique, is the standard 
monitoring procedure always recommended during surgery and anesthesia. In this setting, 
it is useful for the diagnosis of both myocardial ischemia (DII – V5 identify 90% of ischemic 
episodes) and dysrhythmias. 
Intravascular pressure measurements represent the standard technique during this type of 
surgery. Arterial pressure is usually measured by placing a catheter in a peripheral 
(radial, ulnar, brachial) or central (femoral) artery. Direct arterial pressure measurement 
allows monitoring during the pre-CPB stage and nonpulsatile ECC. Moreover, during the 
post-CPB/HCCA period, patients are usually hemodynamically unstable, and close 
surveillance of arterial blood pressure, other than with blood-gas analysis, is of primary 
importance. 
A central venous line (internal jugular, subclavian) for pressure monitoring (central venous 
pressure [CVP]) is influenced by circulating blood volume, venous tone and capacitance, 
and right ventricular function; therefore, a number of pieces of information can be obtained 
from the CVP. A central venous catheter (3 lumens, 7-8.5 Fr) can be used for both pressure 
measurement and inotropic-vasoactive drug administration. Central venous lines can also 
be used for pulmonary artery catheter (PAC) positioning if the patient’s comorbidities 
suggest the monitoring of pulmonary artery pressures, the measurement of cardiac output 
and mixed venous oxygen saturation. Central venous cannulation should be performed 
under ultrasound guidance because up to 30% of patients have some abnormalities of the 
jugular vein anatomy (Carid et al., 1988; Bevilacqua et al., 2005). 
Hemodynamic monitoring is completed with transesophageal echocardiography, which has 
gained widespread use in cardiac operating rooms (where this intervention for cavo-atrial 
invasion is usually performed) because it provides a great deal of information about the 
heart’s global performance during systole and diastole, the valve function and cardiac 
volume loads, as well as morphologic details on thrombotic cardiac invasion from the 
inferior vena cava.  
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Temperature monitoring. Assessment of accurate central temperature is of primary 
importance in this setting. The core temperature (vital organ temperature) can be measured 
by means of a PAC thermistor, nasopharyngeal probe (provides accurate measurement of 
brain temperature during CPB and HCCA), bladder probe (it may be inaccurate when renal 
blood flow and urine output are decreased), CPB arterial line (temperature of the heat 
exchanger), CPB venous line (reflects core temperature well during CPB, when no active 
cooling or warming is ongoing), or rectal probe (when the tip of the probe rests in stool, the 
measurement may be imprecise) (FIG. 4 & 5).  
 
 
Fig. 4. Monitoring. (NIRS, near infrared spectroscopy; CVC, central venous catheter). 
 
 
Fig. 5. Near infrared spectroscopy. (DHCA Deep Hypothermic Circulatory Arrest; CPB, 
cardiopulmonary bypass). 
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Renal function. Acute kidney injury (AKI) is one of the well-known complications occurring 
during CPB that has significant implications for both short- and long-term outcomes. The 
incidence of acute renal failure rages from 20 to 30% of patients (Kumar & Suneja, 2004). 
Pre-operative renal function is one of the most important factors related to post-CPB AKI. 
The major risk factors for AKI after CPB include advanced age, preexisting kidney disease, 
diabetes mellitus, chronic obstructive pulmonary disease, CPB duration, emergency surgery, 
female sex, left ventricle ejection fraction <40%, and hemodilution on CPB. Hemolysis 
always occurs during CPB, and serum hemoglobin levels rise; therefore, urine output 
should be maintained to avoid tubular damage. Diuretic therapies (mannitol is used 
routinely in CPB priming) are also useful for eliminating the hemodilution induced with the 
onset of CPB. As a consequence, urinary catheter positioning and urine output are the best 
monitoring systems for renal function evaluation. 
3.1.2 Anesthesia  
These patients usually require a smooth induction because wide modifications in vascular 
tone, myocardial contractility, and reductions in venous returns due to increased intra-
thoracic pressures under mechanical ventilation may worsen the organ and tissue perfusion. 
Midazolam or etomidate, in association with an opioid (remifentanil, fentanyl), are useful 
drugs for anesthesia induction; propofol and/or sevoflurane or desflurane can be used for 
anesthesia maintenance, and a nondepolarizing muscle relaxant should be administered for 
the duration of the intervention (Table 1). 
 
 Drug Induction dose 
Hypnotics Propofol 1-1.5 mg/Kg 
 Thiopental 3-4 mg/Kg 
 Etomidate 0.2-0.3 mg/Kg 
 Midazolam 0.1-0.2 mg/Kg 
Opioids Fentanyl 3-10 mcg/Kg 
 Sufentanyl 0.5-1 mcg/Kg 
 Remifentanil 0.1-0.75 mcg/Kg/min  
Muscle relaxants Cisatracurium 0.07- 0.1 mg/Kg 
 Vecuronium 0.07- 0.1 mg/Kg 
 Rocuronium 0.6 mg/Kg 
Table 1. Hypnotics, opioids, and muscle relaxants (induction doses) 
The choice of drug for anesthesia induction and maintenance depends on the patient’s 
general conditions and, in particular, his/her heart, renal, and liver function. In addition, 
antibiotic prophylaxis should be administered at least 30 minutes before skin incision.   
3.2 Cardiopulmonary bypass, deep hypothermic circulatory arrest and neuroprotection 
3.2.1 Cardiopulmonary bypass 
Cardiopulmonary bypass permits blood to bypass the heart and lungs (Fig. 6). 
Venous blood is drained by gravity into an oxygenator (artificial lung), and a pump injects 
it, after oxygenation and removal of CO2, into a great artery (aorta, subclavian, femoral 
artery). Adequate anticoagulation is necessary during the CPB period, and an activated 
clotting time longer than 420-480 seconds is usually considered safe (the optimal target of 
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Cardiopulmonary bypass permits blood to bypass the heart and lungs (Fig. 6). 
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it, after oxygenation and removal of CO2, into a great artery (aorta, subclavian, femoral 
artery). Adequate anticoagulation is necessary during the CPB period, and an activated 
clotting time longer than 420-480 seconds is usually considered safe (the optimal target of 
  
 




Fig. 6. Cardiopulmonary bypass. 
ACT is still debated). Anticoagulation is obtained with heparin 300-400 U/kg, and 
supplemental doses of 5000 U can be administered if necessary. Use of heparin-coated 
circuits does not eliminate the need for heparin. The pump flow has to be set at values that 
guarantee an adequate oxygen delivery. “Normal” pump flow is considered to be 2.4 
l/min/m2, although recent studies have demonstrated that a redistribution of flow toward 
organs occurs during CPB in both normothermia and hypothermia (Slater et al., 2001). 
Muscle flow is significantly reduced during CPB, and if flow is reduced, splacnic, renal and 
cerebral flow decrease as well, in that order. During CPB, blood pressure depends on pump 
flow, total arterial impedance and haematocrit. During CPB, blood pressure is less 
important in determining global perfusion if pump flow is adequate, but minimal values of 
blood pressure may be significant in providing specific regional flows; therefore, during 
mild to moderate hypothermia (30-34°C), the blood pressure is generally maintained at 
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approximately 70 mm Hg. During CPB and HCCA, the loss of flow auto regulation (<20°C 
and for several hours after HCCA) is still debated, but pressure levels as low as 30-40 mm 
Hg are considered safe values (Croughwell et al., 1992). Despite several techniques for 
cerebral protection have been developed, central nervous system dysfunction associated 
with cardiac surgery is very frequent, with an incidence that depends on the type of 
intervention (up to 65%) (Arrowsmith et al., 2000). Apart from ischemic events, cognitive 
dysfunction has been observed within the first postoperative week in more than 80% of 
patients undergoing coronary artery bypass grafting under CPB, and at five years after 
surgery, some degree of neuropsychological dysfunction can be observed in up to 35% of 
patients (Arrowsmith et al., 2000). A number of risk factors have been identified, and they 
can be divided into patient-related and technology-related factors. The patient-related 
factors are age>70 year old, cerebrovascular disease, aortic atherosclerosis, and diabetes 
mellitus; the technology-related factors are open chamber procedures, CPB duration >90 
minutes, use of bubble rather than membrane oxygenators, and circulatory arrest. Apart 
from open chamber procedures, all the other risk factors have to be taken into consideration 
when cavo-atrial thrombectomy with CPB and HCCA is performed.  
3.2.2 Deep hypothermic circulatory arrest 
After CPB has been started, the temporary interruption of cerebral blood flow is a necessary 
condition to remove the thrombus from the vena cava and, in such cases, from the right 
atrium. Interruption of cerebral blood flow has been associated with a high incidence of 
neurologic injury because the brain is susceptible to ischemic injury within minutes of the 
onset of circulatory arrest as a result of its high metabolic rate and limited reserves 
(Harrington et al., 2003). The physiologic basis for hypothermia as a neuroprotective 
strategy is its ability to reduce the cerebral oxygen metabolic rate and the accumulation of 
toxic metabolites. In adults, a decrease in core temperature leads to a reduction in the 
cerebral metabolic rate that increases in ischemic tolerance from 2-3 minutes 
(normothermia) to 20-34 minutes (17°C) (Reich et al., 1999). However, the optimal level of 
hypothermia is still debated. Studies based on electroencephalographic monitoring have 
shown that a median nasopharyngeal temperature of 18°C allows electrocortical silence 
(Stecker et al., 2001). Today, based on the results of several studies, HCCA at 18°C is 
considered safe for durations of up to 40 minutes (Griepp, 2001). It has been also suggested 
that hypothermia provides neurological protection through mechanisms other than the 
cerebral metabolic rate. In the face of an incomplete understanding of the involved 
mechanisms, hypothermia remains the most efficacious intervention for preventing 
ischemic brain injuries. In addition to systemic hypothermia, topical cooling, obtained by 
packing the head with ice, can be used to prevent passive warming of the brain during 
circulatory arrest, but consensus on this adjunctive strategy is still lacking because re-
warming during circulatory arrest could be negligible (Reich et al., 1999). After the targeted 
core temperature has been reached, the pump is turned off, allowing brain protection 
during surgery performed in a bloodless field. HCCA has several potential adverse 
consequences. Achieving the target temperature prolongs the duration of the CPB period, 
thus amplifying problems related to CPB (loss of pulsatile flow, injury to blood elements, 
risk of embolization, coagulation system derangements, etc.). Re-warming increases the 
cerebral metabolic rate and has the potential to make the brain vulnerable to ischemic injury. 
With the aim of limiting brain injuries, a short period (10 minutes) of hypothermic 
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reperfusion is achieved before re-warming, and maintaining a temperature gradient of less 
than 10°C in the heat exchanger and avoiding complete re-warming are usually performed.  
Currently, there is no class of drug representing the standard of practice, but some drugs 
can be used as adjunctive strategies for cerebral protection. A number of drugs cause EEG 
burst suppression, resulting in a reduction in the cerebral metabolic rate by approximately 
50%, but the most used of these drugs is thiopental at a dose of 5-8 mg/kg. The 
administration of thiopental results in EEG burst suppression for few minutes at 
normothermia. Thiopental and/or steroids are administered before circulatory arrest in 
some centres, without a clear demonstration of beneficial effects.  
3.2.3 pH management during hypothermia 
There is an inverse relationship between gas solubility and blood temperature. When blood 
temperature decreases, an apparent respiratory alkalosis occurs due to a decrease in PaCO2 
and an increase in pH. To compensate for this PaCO2 reduction, CO2 can be added to the 
oxygenator (pH-stat management) or the CPB gas sweep rate can be reduced. The technique 
of pH-stat management was commonly used until the mid-1980s, but there is more recent 
evidence that pH-stat management can increase the incidence of postoperative cognitive 
dysfunction when CPB lasts longer than 90 minutes (Murkin et al., 1995). It has been 
suspected that the increase in CO2 should increase the cerebral blood flow during perfusion 
phases, uncoupling flow and metabolism. The most used α-stat (not temperature-correcting) 
requires that neutrality be maintained at only 37°C, and it permits hypothermic alkaline 
drift. Thus, additional CO2 is not needed. Cellular trans-membrane pH gradients, protein 
functioning, and enzyme activity are more normal when the pH is allowed to drift into the 
alkaline range, in parallel with the temperature-dependent pKa of protein and the neutral 
pH of water. Moreover, a relatively alkaline pH is beneficial before the ischemic insult of 
circulatory arrest. Despite considerable laboratory and animal research into these 
mechanisms, substantial controversy remains over which strategy produces the best clinical 
outcomes (Duebener et al., 2002).   
3.2.4 Coagulation management  
Coagulation system management during and after CPB is based on the administration of 
heparin, followed by neutralization with protamine, and this approach has been unchanged 
for almost 50 years. Heparin binds to antithrombin-III (AT-III), potentiating the action of 
AT-III (more than 1000-fold) to inhibit thrombin and factor Xa most importantly (but also 
factors IXa, XIa, and XIIa). After central venous administration, heparin’s effect peaks within 
1 minute. The onset of CPB increases the circulating blood volume by approximately 1500 
ml, reducing the heparin blood concentration; therefore, 5000 U of heparin are added to the 
CPB prime. Before CPB, heparin is administered at a dose of 300-400 U/kg to obtain ACT 
for 420-480 seconds, and successive supplemental doses are guided by monitoring the ACT. 
Some centres monitor blood heparin concentrations. ACT is prolonged by hypothermia and 
hemodilution. After CPB weaning is successfully achieved and a satisfactory spontaneous 
circulation is restored, heparin anticoagulation must be reversed with protamine 
administration. The most used protamine-heparin ratio is 0.6-1 mg/100 U. Protamine must 
always be administered slowly to prevent adverse hemodynamic effects. After protamine 
administration, ACT should return to a value no more than 10% above the basic value. If 
more prolonged, heparin residual activity is likely, and additional doses of protamine 
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should be administered. During CPB, antifibrinolytic agents (ξ-aminocaproic acid or 
tranexamic acid) have beneficial effects in restoring coagulation equilibrium. 
Antifibrinolytics act as lysine analogues that bind to the lysine-binding sites of plasmin and 
plasminogen. ξ -aminocaproic acid can be administered at a dose of 100-150 mg/kg in bolus 
form, followed by 10-15 mg/kg/h or a 50 mg/kg bolus followed by 20-25 mg/kg/h. 
Tranexamic acid can be administered at a dose of 10-20 mg/kg followed by 1-2 mg/kg/h, 
although some centres prefer a 5 g bolus and repeat bolus to a total of 15 g. Post-bypass 
bleeding is common after CPB/HCCA. Evaluation of haemostasis and correct intervention 
are key factors for preventing indiscriminate use of transfusion medicine. After surgical 
haemostasis has been achieved, the first approach is the confirmation of adequate heparin 
neutralization (heparinase ACT, protamine titration test, thromboelastography-TEG). In 
addition, a test of platelet function should be available (TEG maximal amplitude, Platelet-
Function-Analyzer-100). Finally, the fibrinolysis pathway must be explored (TEG lysis 
index). Packed red blood cells must be available at every moment of the intervention, and 
fresh frozen plasma and platelets should be prepared in case of established coagulation 
abnormalities (very frequent in this population of patients) to replace coagulation factors 
and platelets.  
4. Conclusions 
In conclusion we think that CPB with HCCA should be considered for atrial thrombi 
removal in patient affected by several abdominal malignancies such as renal, adrenal 
carcinomas, primary liver tumours also in presence of a well compensated liver cirrhosis, 
uterine endometrial stromal tumours and intravascular leiomyomatosis, vena cava 
leiomysarcoma and others, because it is simpler and safer compared to CPB alone. It permits 
the careful cleaning of the vena cava, right atrium, ventricle and even of the pulmonary 
artery in a bloodless field which entails in a lower recurrence rate. Mortality and morbidity 
seem to be the same when compared to CPB alone but further studies are necessary due to 
the small number of patients. 
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Restoration of Transposed Great Arteries With 
or Without Subpulmonary Obstruction to Nature 
Ing-Sh Chiu and Chi-Ren Hung  
Department of Surgery, National Taiwan University Hospital and 
 National Taiwan University, College of Medicine, Taipei, 
Taiwan  
Surgical correction on transposition of the great arteries was proposed by many in the past half-century, 
and was claimed as the anatomical correction; but the treatment of choice was ever changing. The 
current technique usually included Lecompte maneuver to bring the pulmonary bifurcation in front of 
the aorta. Although the ventriculoarterial connection was corrected, it is not “normal” yet---------.                           
1. Introduction 
Looking back into the evolution of surgical treatments on transposed great arteries (TGA), is 
full of fascinating and challenging stories. Many pondered the best option to correct this 
tricky, yet not the most complex congenital heart disease. Some operations that had been 
replaced by another were later revived. Senning once had been replaced by Mustard as the 
treatment of choice (Senning, 1959; Mustard, 1964), but was revived because autologous 
tissue was utilized, although it was more difficult (Quaegebeur, 1977). As people learned the 
functional implications of the ventricles, both atrial redirection procedures were replaced by 
the arterial switch operation (ASO) (Jatene et al., 1975; Lecompte et al., 1981; Castaneda et 
al., 1984). ASO was attempted initially, without transferring the larger right coronary artery, 
by Mustard (Mustard et al., 1954). Nikaidoh described aortic translocation, which in essence 
is an ASO including the arterial valve (Nikaidoh, 1984). In the past, few practiced this 
procedure because of its demanding techniques and potentially worse outcome. However, 
aortic translocation has recently gained popularity as an alternative to the Rastelli operation 
and Reparation l’etage ventriculaire (REV) as the treatment for TGA with a left ventricular 
outflow obstruction (Rastelli, 1969; Yeh et al., 2007; Emani et al., 2009). ASO has become the 
procedure of choice for TGA (Prêtre et al., 2001; Losay et al., 2002). However, TGA is 
considered to be a mere reversal of the great arteries anteroposteriorly (Shaher, 1964; Van 
Mierop, 1971); nonexistence of the normal spiral relationship of the great arteries in TGA has 
not been widely appreciated. Thus posterior pulmonary bifurcation is mobilised anteriorly 
to the aorta (the so-called Lecompte maneuver) in an effort simply to reverse transposed 
great arteries (Lecompte et al., 1981). We proposed an arterial Senning operation 13 years 
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maneuver mobilized pulmonary arteries away from its original position. To avoid the 
complications of unnecessary mobilization, an in situ transfer technique and the common 
wall concept to redirect the coronary arteries should also be applied to the pulmonary 
arteries (Chiu et al., 2000b; Chiu et al., 2001). Tissue deficiency of the pulmonary outflow 
tract in cyanotic cardiac defects could be recruited from the larger aorta to compensate for 
the smaller main pulmonary artery (MPA); or vice versa, from the big MPA to a small aorta. 
We called this the Robin Hood approach or, in the current vernacular, a redistributive 
approach (Chiu et al., 2009). In this review, we describe an innovative technique to 
reconstruct the great arteries in spiral fashion, which is the natural relationship of aorta and 
pulmonary artery. The structural and functional studies underlying the basics of natural 
spiral great arteries we published in the last two decades will be presented. We emphasize 
the surgical principles of nature and even distribution, using autologous tissues. Anatomical 
features will be discussed first, then the technique of the above two redistributive 
approaches in TGA and finally their three-dimensional CT follow-up results. 
2. Anatomical features 
Transposition of the great arteries is the consequence of distal fusion between the dorsal 
protrusion of the aortic sac and the outflow cushions during embryogenesis (Figure 1) (Van 
Praagh, 2010). The conal septum and great arteries remain straight and parallel instead of 
being torsaded around each other. As a consequence, the aorta emerges from the right 
ventricle and the MPA from the left ventricle. 
 
Fig. 1. There are only two ways in which conotruncal rotation can be done correctly as in: (1) 
solitus normally related great arteries and (2) inversus normally related great arteries; in 
contrast to many other ways that it can be done wrong. 
2.1 Outlet septum  
The ventricular outflows are in parallel when there is a side-by-side great arteries. When the 
aortic root is directly anterior or even left anterior, the outlet septum is no longer in parallel, 
it is vertical to the rest of the ventricular septum (Chiu et al., 1984). It is often asked that 
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since the outflow tract was not switched and did a spiral ASO offer any help by just 
restoring the spiral arterial trunks without altering outflow tracts below the valves? 
Although the ventricular outflow was not switched in spiral ASO, the facing commissure of 
the old aorta was mobilized along with a topmost outflow below it and fixed it to the 
direction of future MPA (Figure 1, solitus normal). In other words, by our technique the top 
portion of the right ventricular outflow just below the facing commissure is rotated toward 
the direction of future MPA (Chiu et al., 2000b; Chiu et al., 2002b; Chiu et al., 2010). As just 
clarified, when the aorta is left-sided with usual atrial arrangement, there CAN be 
spiraling of the outflow tracts; the outlet septum is vertical to the rest of the ventricular 
septum in the setting with a directly anterior or left anterior old aortic root (Chiu et al., 1984; 
Anderson & Weinberg, 2005), thus a slight rotation like our technique is adequate for spiral 
correction at the ventricular outlet in that group. Wheras in side-by-side gruop, Lecompte 
maneuver is usually not performed by all, the ventricular outflows are in parallel as they 
are. When the aortic root is right anterior to MPA, we fix the facing commissure to the right 
anterior aspect of old MPA (Chiu et al., 2000b). The result is as the inverted normal in Figure 
1. We did not fix the facing commissure of the new MPA to directly anterior aspect of new 
aortic root or leave the new MPA alone without fixation, as in conventional ASO, which 
corrects the ventriculo-arterial discordance without modifying the outflows. Restoring the 
natural curvature of both great vessels is the key to avoiding obstruction at the ventricular outflows, 
instead of just reverse them anteroposteriorly. 
2.2 Coronary artery 
Embryologically, the coronary arteries (CA) develop after septation of the aortopulmonary 
trunk and pierce the aortic sinus at the nearest site after aortopulmonary rotation. We found 
that the pattern of the CA is dependent on aortopulmonary rotation, thus proposed a new 
categorization scheme based on the aortic root rotation (Chiu et al., 1995). In addition to the 
short-axis rotation, which is related to the juxtacommissural origin of the CA (JOCA) (Chiu 
et al., 1997), there is also a long-axis rotation, which is related to high takeoff of the CA 
(Chiu et al., 1996b). On the basis of these findings, we have also proposed appropriate 
diagnostic and surgical techniques to manage unusual CA patterns in TGA (Chiu et al., 
1997; Chiu et al., 1996a). In short, for JOCA near the facing commissure, a superiorly based 
trapdoor (single-button technique) or lateral funnel (two-button technique), and near the 
nonfacing commissure, a medially based trapdoor, are vital for coronary redirection. The 
categorization of CA based on the aortopulmonary rotation can be applied to all congenital 
heart defects and normal hearts (Chiu et al., 2000a; Chiu et al., 2002a; Chiu et al., 2003; Chen 
et al., 2007; Huang et al., 2011; Chiu et al., 2011). 
2.3 Pulmonary artery  
Paillole et al. documented the existence of central pulmonary artery (PA) hypoplasia before 
surgery and its persistence until after ASO (Paillole et al., 1988). Central PA hypoplasia, 
which is frequently seen in TGA, is related to posterior inclination of the proximal MPA in 
this setting (Figure 2, Chen et al., 2007). We have demonstrated that the same pathogenesis 
would lead to smaller PA size after a Senning procedure than ASO with Lecompte 
maneuver. In addition, Lecompte with Pacifico’s modification (direct connection between 
the distal MPA and the aortic sinus defect), which mobilized the proximal MPA toward 
anterior aspect farther than by the patch-repair of the sinus defect, could facilitate better PA 
growth after ASO (Pacifico et al., 1983; Imoto et al., 1995). Spiral ASO would be even better 
to block that pathogenesis than the above to permit PA growth (Chiu et al., 2010).  
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Fig. 2. Our studies on 101 angiograms showed the wider the main to branch PA angle, the 
better PA size. Narrow L/R PA angle resulted in bilateral PA hypoplasia in the upper panel. 
Thus wider angle facilitates bilateral PA growth before ASO. Any maneuver that did not 
correct this inborn error of ventriculoarterial discordance or make even narrower angle like 
Lecompte maneuver will compromise PA growth. 
2.4 Aorta 
The aortic arch is kept wide open by the presence of the MPA bifurcation below it (Chiu et 
al., 2000b; Chiu et al., 2002b). Neo-aortic kinking is the narrowing of the aortic arch window 
and may become slit-like, can also be called aortic neocoarctation (Figure 3, Chiu et al., 2010; 
Muster et al., 1987). One group reported an incidence of 0.54% (Serraf et al., 1995). A 
coarctation is not present and the arch is wide open before conventional ASO with 
Lecompte maneuver. A pressure gradient across it is rare, less seen than is supravalvular PS 
because of systemic-pressure in aorta. 
 
Fig. 3. After conventional arterial switch with Lecompte maneuver, a slit like arch window 
can be seen in the right panel, which was wide open before switch.  
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We have to take down the “Lecompte maneuver” in a patient eight years after conventional 
ASO to restore the spiral arterial trunks (Chen et al., 2010). 
2.5 Bronchus  
The aorta is not the only structure behind the MPA bifurcation after Lecompte maneuver, 
the left main bronchus (airway-pressure with cartilage) is also present. Bronchial 
compression or even atelectasis has been reported after Lecompte maneuver (Robotin et al., 
1996; Toker et al., 2000), although in the majority of cases the bcronchial patency was not so 
severely compromised. 
 
Fig. 4. After conventional ASO with Lecompte maneuver, not only supra-aortic stenosis 
occurs at the site posterior to the anteriorly mobilized pulmonary bifurcation (*), but also the 
left main brobchus, that is cartilage stented, is ccompreesed; its lumen becomes pin hole like 
on brochoscope, both virtual and real. In the right lower panel, the aortic arch window 
becomes slit-like at lesser curvature site. 
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3. Surgical management 
3.1 Spiral ASO   
(Chiu et al., 2000b; Chiu et al., 2002b; Chiu et al., 2010) Figure 5 and 6 showed the techniques 
that restored the heart to solitus normal in Figures 1, posterior MPA could remain 
undivided to avoid difficult posterior hemostasis and tamponade, and bilateral hilar 






Fig. 5. Technical conceptions for spiral repair (B, C, D). (A) In-situ transfer and common 
wall were used to redirect the left ventricular output via the old MPA stump into right 
and left coronary artery (RCA and LCA) as reported (Murthy and Cherian, 1996). 
Semiflaps were fashioned on the facing sinuses of both great arteies, creating a common 
arterial trunk that was then septated. Red or blue color in B, C and D indicated the final 
result after ASO. (B) A big MPA flap was tailored from the MPA. A pericardial patch can 
be used to augment this flap if the MPA is not large enough. The distal MPA (blue clay) 
could be reattached to the old MPA stump (red clay), at the neoaortic anastomosis site 
(blue/red junction marked with @) or proximal to it on the posterior wall of old MPA 
stump (marked with an asterisk), or remain undivided (in that case blue/red junction 
indicated site of neoaortic anastomosis); thus, the troublesome posterior neoaortic    
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Fig. 5. (continued) anastomosis site bleeder can be drained into PAs. Nonfacing sinus was 
cut open for exposure during coronary transfer. (C) The transparent ascending aorta, with 
a left aortic lip (procured by oblique amputation of aorta, Chiu et al., 2000b), was rotated 
counterclockwise to sit on the neoaortic stump. The posterior cut-edge of MPA could be 
attached to the posterior neoaorta at this stage as leftward as possible.(D) The RPA orifice 
must be visible behind the aorta to ensure patency of RPA, not just probed with a Hegar 
dilator. A big enough MPA flap could be reattached to the neoaorta without pericardial 
patch. (Ao = Aorta, L or R = Left or Right portion of nonfacing sinus wall after cut back, 
LCA = Left Coronary Artery, LPA =Left Pulmonary Artery, RCA = Right Coronary Artery, 
RPA = Right Pulmonary Artery) 
No-fault transfer of the coronary artery is the cornerstone of a successful ASO. Various 
techniques (Aubert et al., 1978; Yacoub and Randly Smith, 1978; Kurosawa et al., 1986; 
Quaegebeur et al., 1986; Brawn and Mee, 1988; Idriss et al., 1988; Bove et al., 1989; Takeuchi 
and Katogi, 1990; Mee, 1994; de Leval et al., 1994; Murthy & Cherian, 1996; Chiu et al., 1996a 
& 1997) have been proposed to achieve this goal: de Leval et al. (1994) pointed out that the 
key point is to take the aorta away from the coronary arteries and the MPA is brought to 
them, rather than moving the coronaries from the aorta and transferring the coronary 
scallops to the MPA or neoaorta. To implement this concept, in situ transfer technique, 
proposed by Aubert et al. (1978) and Takeuchi and Katogi (1990), was developed by Murthy 
and Cherian (1996). This principle is the key (Figure 5) we adopted to redirect the neoaortic 
outflow tract to the coronary arteries as in situ as possible by a common wall concept. In this 
way the coronary redirection can be achieved more securely than the conventional 
“coronary transfer”. 
In situ transfer and the common wall concept not only for the coronary arteries, but also 
for both great arteries are our guiding principle. We have designed two pedicled grafts, 
aortic lip and MPA flap, to achieve our goal. The purpose of these two flaps is described 
below. The aortic lip (Figures 2, 3A and 3B) is initially called left lip (Chiu et al., 2002b). In 
our first spiral arterial switch, we used a free flap taken from MPA to cover the left-sided 
portion of the neoaortic stump (Chiu et al., 2000b), to solve the size discrepancy when 
connecting small aorta to a very large, original MPA stump; the other effect is to act as the 
floor of the neopulmonic pathway. Since the nonfacing aortic sinus was cut back (Figure 
5B and 5C) for exposure during coronary transfer, later we used an aortic pedicled graft 
including the nonfacing aortic sinus wall (Figure 6A and 6B) to achieve the above 2 
purposes of the aortic lip. In addition, using the aortic lip taken from anterior sinus wall 
to cover the left-sided portion (Figure 6B and 6C, light blue arrow), we can achieve the 
effect of counterclockwise rotation of the ascending aorta. This, in turn, would give way 
to the RPA so that it can sling around the ascending aorta (Figure 6C, Hegar dilator in 
RPA). The fourth effect of the aortic lip might lessen the chance of coronary kinking by 
avoiding take-up the larger stump on neoaortic anastomosis, as noted by Quaegebeur et 
al. (1986).  
The purposes of the MPA flap include: (1) accommodating the ascending aorta, (2) 
achieving a more leftward shift of RPA, and (3) attaching to the ascending aorta without 
pericardium. Thus, the spiral relationship of the great arteries is resumed by using the 
autologous pedicled flaps tailored from both arterial trunks, respectively. 
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Fig. 6. Operative techniques for spiral ASO with neo-MPA in left anterior portion. Semilunar 
valves are all omitted for clear illustration in all insets. (A) The aorta is located left anterior to 
the MPA before ASO. The aortic lip will be taken from the anterior aortic sinus wall along the 
light blue line on the aorta, an excision that also facilitates exposure on coronary transfer. MPA 
flap will be incised along the pink dotted line on the anterior MPA, yellow line on the 
posterior MPA (black arrow) to accommodate the ascending aorta. 
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Fig. 6. (continued) Left posterior wall of MPA is not divided. Annulus near facing commissure 
in old aorta is xed to left anterior wall of MPA (depicted by Y stitches in inset) before incising 
MPA. Two J-shaped incisions are made to fashion semiflaps on facing sinuses of both great 
arteries. (B) A big MPA flap can be tailored from the anterior wall of huge MPA, even to its 
posterior aspect (black arrow, see also inset). Coronary transfer was done, using the technique 
in Figure 5A. A big aortic lip, redundantly covering the distal aortic orifice in picture, was 
taken along with the distal aorta during aortic amputation. Pink dotted line along the cut edge 
of the aortic lip was concordant with the light blue dotted line along the nonfacing sinus wall, 
and almost the whole nonfacing sinus wall was excised; the light blue arrow indicated 
corresponding point of the aortic lip originally attached to the aortic sinus. Note the remaining 
sinus wall on the left (L) and right (R) portion of the remaining nonfacing sinus, and the light 
blue arrow indicated the same location through the whole Figure 6. One commissure of 
neoaortic valve is marked with black arrowhead. Neoaorta will sit on the pink dashed line. 
Aortic lip will cover the left-sided portion of neoaortic stump. (C) The distal aorta was sutured 
already above the neoaortic valve and coronary to LV outflow. Light blue arrow from anterior 
to left indicated counterclockwise rotation. Note the Hegar dilator in the RPA. After neoaortic 
connection and de-crossclamp, the rest of MPA cut-edge near RPA, which was shifted 
leftward, was attached to the posterior wall of the neoaorta (inset). Caudal edge of MPA flap 
can be attached at or proximal to cut edge of the old MPA stump and the aortic sinus 1 along 
the green dotted line (the tissue nearby is more clearly shown in B) and cut edge of the 
nonfacing sinus wall, which was stay-sutured and indicated here by light blue dots. (D) 
Attachment to form the oor of pulmonary pathway was finished. The adventitia of the aorta 
inside the pulmonary pathway (white asterisk) must be peeled off (Chiu et al., 2001; Chiu et 
al., 2010), because it will be the inner wall of future PA. Cephalic edge of anterior MPA flap can 
be attached to the outer wall of neoaorta directly (D inset) to roof the pulmonary pathway; 
ASO can be completed without any pericardial or prosthetic patch, and thus the procedure 
was named “arterial Senning”. (L or R = Left or right portion of nonfacing sinus wall after 
excising the aortic lip, LV = Left Ventricle, RA = Right Atrium, RV = Right Ventricle, other 
Abbreviations see Figure 5) 
It would be interesting to see the current status of this patient 7 years after such spiral ASO 
(Figure 7). 
 
Fig. 7. Three-D CT reconstruction of the patient in Figure 6 seven years after ASO (A, B & C) 
showed the natural spiral relationship of the great arteries with harmonic growth of their 
branches. (desc = descending, LA = Left Atrium, R or L SVC = Right or Left Superior Vena 
Cava, other Abbreviations see Figure 5 & 6. Reproduced with permission from Chiu et al., 
2010) 
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Between March 1998 and June 2011, spiral ASO was performed in 57 patients (38.3%), 
conventional nonspiral ASO with Lecompte maneuver in 92 patients (61.7%) at our hospital. 
The median age and weight at operation were 9 days and 3.3 kg. Cross-clamp time was 
significantly lower (p < 0.011) in the spiral than the nonspiral group (128 ± 36 vs 144 ± 37 
minutes), because of the common wall technique in spiral ASO, wheras additional time for 
patch repair on defects in the sinuses of the new MPA was needed in conventional 2-vessel 
technique. The average follow-up was 6.9 ± 4.2 years (up to 13.5 years). Kaplan Meier 
survival was 94.1 ± 3.3% at 10 years and the reoperation-free rate 88.3 ± 4.5% for spiral 
repair. Both ratios were satisfactory and similar to those for the nonspiral group (89.6 ± 3.3% 
and 89.3 ± 4.1%, respectively). Signicant aortic regurgitatin in the nonspiral group (Chen et 
al., 2010) was not observed in the spiral group. The supravalvular PS and aortic 
neocoarctation that occurred in the nonspiral group (7.6% and 2.2 %, respectively) did not 
occur in the spiral group (0 %) (Chiu et al., 2010); these 2 complications are related to 
Lecompte maneuver and the unnatural relationship of the great arteries. Tiny 
aortopulmonary fenestration with a small left to right shunt occurred in 15 cases of spiral 
group (26.3%), but they closed spontaneously after a median follow up of 6 months by echo. 
TGA is not merely a reversal of the great arteries; nonexistence of the spiral function in TGA 
should be appreciated. Recognition of the spiral function and further modification might 
justify its future application. 
3.2 Modified rastelli operation  
In complete TGA with left ventricular outflow obstruction, a segment of the aorta is cut in 
transverse fashion and donated to the pulmonary circulation to establish the 
ventriculoarterial continuity (Figure 8). 
 
Fig. 8. Operative techniques for TGA with irreparable left ventricular outflow obstruction.  
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Fig. 8. (continued) The ascending aorta was amputated, and a curved segment (18 mm x 6 
mm) was harvested (A) and then reconnected (B). The ventricular septal defect was rerouted 
to the systemic outflow with a patch. The MPA was divided and the proximal stump was 
closed. The aortic free graft was sutured to the distal MPA with the greater curvature on the 
left (B). The lengthened MPA was then connected directly to the cephalic margin of 
ventriculotomy. Finally, a piece of fresh pericardium was harvested and sutured to cover 
the right ventricular outflow tract (C). (TAP = TransAnnular Patch, other Abbreviations see 
Figures 5-7. Reproduced with permission from Chiu et al., 2009) 
End to end anastomosis of the ascending aorta after excision of a segment shortened the 
distance between the right ventriculotomy and the PA, so that the aortic free graft could 
achieve its bridging effect comparable to the conventional conduit of double length without 
aortic shortening. This advantage of aortic shortening is also observed in patients 
undergoing Nikaidoh operation (Morell & Wearden, 2006). We agree with Metras and 
coworkers (Metras et al., 1997) that Lecompte maneuver to mobilize the pulmonary 
bifurcation anterior to the aorta is unnecessary. This is because if the pulmonary bifurcation 
is left in situ as it is originally by nature, the chance for developing supravalvular PS may 
decrease (Chiu et al., 2000b; Chiu et al., 2002b). Our direction for placement of a free graft of 
this curved aortic segment is opposite to that proposed by Metras (Metras et al., 1997). 
Follow-up CT showed satisfactory result (Figure 9). 
 
Fig. 9. Three-D CT reconstruction six years after Modified Rastelli operation; no stenosis was 
observed at the site of free graft. The natural spiral arterial trunks with harmonic growth of 
their branches were evident. Abbreviations see Figure 7. 
A major complication of the Rastelli operation was related to the conduit itself; crossing the 
midline, conduit dysfunction or valve degeneration might lead to conduit failure early or 
late after surgery. Our technique of recruiting autologous arterial tissue will avoid these 
complications and help free the patients from reoperation. 
4. Comment  
The natural spiral relationship of the great arteries and their branches can grow on follow-up 
(Figure 7 and 9). We have demonstrated that the common wall between the great arteries 
could grow and become thinner on follow-up (Chiu et al., 2009). Spiral reconstruction in TGA 
is seldom performed, because the functional implications of spiral relationship of the great 
arteries remain unknown; thus, the Lecompte maneuver was used either in conventional ASO 
or Nikaidoh and Lecompte (REV) operation (Emani et al., 2009; Morell & Wearden, 2006; 
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Lecompte et al., 1982). Review of surgical treatment for TGA reveals that once the functional 
implications of two normal ventricles were well known, nobody selected the right ventricle as 
the systemic pumping chamber. The rationale of spiral reconstruction (Figure 10) at the great 
arterial and ventricular level includes (1) widening of arch window to avoid aortic 
neocoarctation (Figure 3), (2) widening of main to branch PA angle to facilitate PA growth 
(Figure 2, Chen et al., 2007), and (3) avoiding PA compression  by the aorta posteriorly.  
 
Fig. 10. Spiral relationship of the great arteries in normal heart (C) was not restored by 
conventional ASO with Lecompte maneuver (B) on TGA (A). With spiral ASO (D), 
pulmonary bifurcation is free from posterior compression by high-pressure aorta. Note that 
acute angulation of arch that is present after Lecompte maneuver (B) is absent in other three 
illustrations. Acute angulation from the main pulmonary artery to its branches is also 
present in A and B, but not in C and D, in which main to branch pulmonary artery angle is 
wider and smoother. Reprinted with permission from Elsevier (Eu J Cardiothorac Surg 
2010;37:1239-45). 
To facilitate PA growth, mobilise the posterior inclination of the proximal MPA and restore 
its ‘normal’ position (Figure 10C) to direct a natural and smooth blood flow into the PA in 
the neonatal period is the surgical principle. Thus widening this acute angle to both PA in 
spiral fashion (Figure 10D) is more helpful than the Lecompte maneuver with a huge patch 
(Figure 10B) for promoting PA growth (Norwood et al., 1988; Paillole et al., 1988; Lupinetti 
et al., 1992). The systemic high-pressure ascending aorta may compress the neo-MPA from 
its posterior end towards its anterior end. Insufficient dissection of the distal PAs was 
suggested to explain this flattened (oval-shaped) MPA in 1988 (Wernovsky et al., 1988), but 
a later study showed that the cross section of the MPA is still flattened 6 to 22 months after 
conventional ASO with hilar dissection and the Lecompte maneuver (Massin et al., 1998). 
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After the Lecompte maneuver, not only flattened anterior MPA (low-pressure), branch PA 
stenosis, and supravalvular PS at pulmonary bifurcation can occur as a consequence of 
posterior compression of MPA by the ascending aorta (Williams et al., 1997; Gutberlet et al., 
2000); but also the aorta itself (systemic-pressure) may be compromised. Therfore, aortic 
neocaorctation was reported (Muster et al., 1987; Serraf et al., 1995).  
Most interestingly, we used computational fluid dynamics on mathematic modeling to 
compare flow phenomena of the spiral and nonspiral models (Figure 11). The functional 
superiority of the spiral over the nonspiral model is demonstrated because the blood flow 








Fig. 11. The regions of minimal wall shear stress in purple color in the left panel are the site 
where supravalvular PS is prone to occur. On the contrary, there is no purple color in spiral 
model. Wall shear stress is more uniform and the blood flow is more in streamline. 
Spiral reconstruction would be beneficial to reduce supravalvular PS (Figure 10), supra-
aortic stenosis (Figure 4), and aortic neocoarctation (Figure 3 & 10). This is to say, the great 
arteries are normally in a spiral fashion, thus the MPA bifurcation avoids being compressed 
by the aorta, and the arch window is kept wide open by the adjacent pulmonary bifurcation. 
Potential limitations of our proposal merit consideration. First, the number of cases studied is 
small. Second, this is aretrospective study, and longer-term follow-up is mandatory to 
ascertain the benefit or possible drawbacks of spiral ASO over non-spiral ASO. Subvalvular PS 
still occurred, but mainly related to infundibular hypertrophy, and not supravalvular as in the 
non-spiral group. Subvalvular PS was probably related to an unusual coronary artery 
traversing the infundibulum (Chiu et al., 2010), which may be associated with a thick subaortic 
muscle bundle that can produce subpulmonary narrowing after ASO (Kurosawa, 1991). 
It might be questioned whether our technique will reproduce the old dire complicarions that 
was avoided by Lecompte maneuver such as compression on the transferred coronary 
arteries (Chiu et al., 2010, discussant). Acually secure coronary redirection like our method 
is more important than a mere absence of a near-by low-pressure vessel like pulmonary 
artery. The so-called complications are not seen in our series. Any method that redirect 
coronary safely can be done in combination with spiral arterial trunk reconstruction. 
Our previous publications (Chiu et al., 2000b; Chiu et al., 2002b; Tang et al., 2001) were cited 
by Dr. Corno at the 86th annual meeting of American Association for Thoracic Surgery, in a 
symposium about the potential implications of the helical heart to congenital heart disease 
(Corno, 2006a; Corno, 2006b). In 2001, following we presented our spiral arteial switch at 
National Cardiovascular Center in Osaka, Japan, Dr. Hideki Uemura named our procedure 
as “arterial Senning”. He is affiliated now with Royal Brompton Hospital in London, UK. 
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We are grateful to his thoughtful nomenclature for our procedure. We dare not call the 
spiral arterial switch this name by ourselves before his proposal. 
5. Conclusions 
The concept of in situ transfer and common wall technique should be applied to redirect not 
only the coronary arteries but also the PAs and the aorta in TGA. Thus, tamponade, 
coronary events, supravalvular PS, and aortic neocoarctation can be prevented and natural 
spiral flow can be restored. Study of TGA and its natural or secondary natural history 
provides a means to understand the functional implications of the normal cardiac anatomy. 
As said by Einstein: ”All our science, measured against reality, is primitive and child-like 
and yet is the most precious thing we have.” How to restore TGA as much as possible to 
resemble its natural and unique likeness, awaits further modification and continued effort to 
conceive more surgical options in the coming half-century. Those stick to the surgical 
principle of nature and even distribution using autologous tissues, although more difficult 
and technically demanding, will be revived again and again, as shown by examples such as 
Senning versus Mustard, arterial switch versus atrial redirection, Nikaidoh versus Rastelli, 
arterial Senning versus arterial Mustard----etc. 
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We are grateful to his thoughtful nomenclature for our procedure. We dare not call the 
spiral arterial switch this name by ourselves before his proposal. 
5. Conclusions 
The concept of in situ transfer and common wall technique should be applied to redirect not 
only the coronary arteries but also the PAs and the aorta in TGA. Thus, tamponade, 
coronary events, supravalvular PS, and aortic neocoarctation can be prevented and natural 
spiral flow can be restored. Study of TGA and its natural or secondary natural history 
provides a means to understand the functional implications of the normal cardiac anatomy. 
As said by Einstein: ”All our science, measured against reality, is primitive and child-like 
and yet is the most precious thing we have.” How to restore TGA as much as possible to 
resemble its natural and unique likeness, awaits further modification and continued effort to 
conceive more surgical options in the coming half-century. Those stick to the surgical 
principle of nature and even distribution using autologous tissues, although more difficult 
and technically demanding, will be revived again and again, as shown by examples such as 
Senning versus Mustard, arterial switch versus atrial redirection, Nikaidoh versus Rastelli, 
arterial Senning versus arterial Mustard----etc. 
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1. Introduction 
Congenital heart defects (CHD) affect approximately 1% of live births. Some of them are 
associated with a significant morbidity and mortality and congenital heart diseases remain 
the first cause of death among infants in North America and Europe (Bruneau, 2008).  
The major causes in CHD are thought to be chromosomal aberrations or mutations in genes 
regulating cardiac development during embryogenesis (Pierpont et al., 2007). However, 
from the epidemiological data, it seems that the environment can have a small “teratogenic” 
effect (Jenkins et al., 2007). For example, some substances (e.g. prenatal exposure to 
angiotensin converting-enzyme inhibitors, alcohol abuse and Rubella virus) can alter the 
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the underlying disease mechanisms. 
During heart development complex interactions, among cells originating from different cell 
lineages, occur.  In normal human heart development, a four-chambered heart ensure 
normal cardiac physiology with a right heart serving to the low-pressure pulmonary system 
and a left heart to the high pressure body circulation (Srivastava, 2004). A malformed 
cardiac growth results in abnormal hemodynamic characteristics because of volume or 
pressure overload leading to an adaptation process of the heart.  
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science era. The available genomic data will markedly improve our ability to diagnose and 
treat a great number of diseases including heart disease. Examining an individual’s genomic 
profile or “molecular fingerprint” in a disease context now might help us to understand 
disease mechanisms and could found a new health care tailored to individual patient that take 
into account the predicted disease course and response to therapies of that patient. There’s 
now a real opportunity to replace invasive diagnostic tests with genomic tests that can be 
carried out with no or little risk or stress to the patients (Bell, 2004; Collins et al., 2003).  
The objective of this chapter is to provide an overview of gene expression profiling 
technology and the state of genomic research in congenital heart diseases, specifically with 
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blood results in the blue appearance of affected infants. Defects contributing to this 
condition include transposition of the great arteries (TGA), tetralogy of Fallot (TOF), 
tricuspid atresia, pulmonary atresia, Ebstein's anomaly of the tricuspid valve, double outlet 
right ventricle (DORV), persistent truncus arteriosus (PTA) and total anomalous pulmonary 
venous connection. The second main type of congenital heart disease, left-sided obstructive 
lesions, includes hypoplastic left heart syndrome (HLHS), mitral stenosis, aortic stenosis, 
aortic coarctation and interrupted aortic arch (IAA). The third type of congenital heart 
disease, septation defects, can affect septation of the atria (atrial septation defects, ASDs), 
septation of the ventricles (ventricular septal defects, VSDs) or formation of structures in the 
central part of the heart (atrioventricular septal defects, AVSDs). Other types of congenital 
defect that do not fit into the above three main categories are bicuspid aortic valve (BAV) 
and patent ductus arteriosus (PDA). 
 
 
Fig. 1. Congenital heart defects. Diagram of heart illustrating the structures that are affected 
by congenital heart diseases. AC, aortic coarctation; AS, aortic stenosis; ASD, atrial septal 
defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; DORV, double 
outlet right ventricle; Ebstein's, Ebstein's anomaly of the tricuspid valve; HLHS, hypoplastic 
left heart syndrome; HRHS, hypoplastic right heart; IAA, interrupted aortic arch; MA, 
mitral atresia; MS, mitral stenosis; PDA, patent ductus arteriosus; PS, pulmonary artery 
stenosis; PTA, persistent truncus arteriosus; TA, tricuspid atresia; TAPVR, total anomalous 
pulmonary venous return; TGA, transposition of the great arteries; TOF, tetralogy of Fallot; 
VSD, ventricular septal defect. 
Depending on the severity of the congenital heart disease, mortality and morbidity varies 
but can be serious. The number of surgeries needed to correct many of the anatomical 
defects can weaken the affected children and considerably compromise their quality of life.  
Congenital heart surgery has made tremendous gains over the past 10 years; however, 
recovery and outcome statistics continue to point out the need for improvements in this 
increasingly younger patient population. Paediatric patients undergoing cardiac surgery 
continue to need mechanical assist devices, as well as prolonged inotropic support or an 
open chest despite a technically perfect repair. Moreover, perioperative myocardial damage 
with low cardiac output remains the most common cause of morbidity and death after 
repair of congenital lesions (Hammon, 1995). It is therefore essential to improve our 
understanding of the genetic mechanisms and pathways associated with the different 
congenital heart conditions and their response to the surgical stress of ischaemia and 
reperfusion injury and cardiopulmonary bypass.  
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3. Gene expression profiling 
In the pre-human genome sequencing era, the possibility to identify a relevant set of 
causative genes for multigenic diseases such as cardiomyopathies was limited. Classical 
genetic approaches were developed to find single loci or genes with the power to cause 
Mendelian disorders. In this case, disorders can result from a single base change in the 
deoxyribonucleic acid (DNA) that leads to significant alteration in protein abundance or 
function. However in disorders resulting from multiple gene variants that collectively 
contribute to an individual’s multigenic defect, new genomics approaches are needed. With 
the arrival of such genomics technologies, genes microarrays approach has emerged as a 
real opportunity allowing the performance of gene expression analysis of disease-relevant 
tissues. If DNA defines the inherent genetic make up of a person, it is the transcription of the 
DNA into RNA (that could be translated into protein) that integrates the dynamic 
interaction of an individual with the environment. Consequently, microarrays provide us 
with an opportunity to measure mRNA abundance that correlate with a particular disease 
state, clinical outcome, or therapeutic response, giving us an unprecedented opportunity to 
investigate the genomic contribution to cardiovascular diseases (Cook and Rosenzweig, 
2002; Goldsmith and Dhanasekaran, 2004; Napoli et al., 2003). 
3.1 Microarray technology 
Expression profiling is the study of the expression level changes of large numbers of genes 
simultaneously. The concept of microarray technology is simple: specific DNA sequences, 
called “probes,” are selected to “target” genes of interest. Microarrays refer to solid 
substrates of glass, plastic, or silicon containing hundreds or thousands of microscopic spots 
of DNA (Figure 2). Each of the DNA spots, apposed to the solid material, contains hundreds 
to thousands of identical probes. Each probe has a sequence of nucleotide bases that is 
complementary and unique to a single gene. Because of the technology’s advances, it is 
common to use microarrays carrying the entire complement of the human genome in 
today’s microarray experiments. 
 
 
Fig. 2. Schematic of a microarray experiment. cDNA, complementary deoxyribonucleic acid; 
cRNA, complementary ribonucleic acid. 
In a typical microarray experiment, RNA is extracted from a tissue or sample of interest. The 
small part of the RNA population that represents the transcribed genes, mRNA, is 
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amplified, and fluorescent tags are attached to each molecule. The labelled mRNA is then 
incubated with the microarray allowing the tagged mRNA molecules to hybridize to the 
probes containing the specific complementary sequence of genes. Complementary mRNAs 
bind to probes on the array during hybridization. The microarray is then washed and placed 
in a scanner where a laser is directed onto each spot, causing the tags to fluoresce. The 
resulting fluorescence intensity is proportional to the number of tagged RNAs that have 
hybridized to the probes in each spot. The measured intensity represents the expression 
level or activity of that gene. Consequently, an expression profile can be generated for a 
particular tissue at different stages of health or disease. 
The identified gene signatures are useful because they represent an initial step in 
identifying disease-associated genes, or “candidate genes”. Furthermore, they represent a 
disease biomarker. The genes that comprise the genomic signature are associated with 
disease susceptibility or a particular treatment outcome. These candidate genes might 
substantially improve our understanding of disease biology and subsequently lead to 
identification of potential targets for new treatment strategies (King et al., 2005). The other 
great potential for transcriptomic information is to use the gene signatures as a disease 
biomarker. Gene expression data could offer a remarkable detailed patient phenotype that 
could be used to correctly classify patient populations as to their disease risk or response 
to therapies. In both cases, genomic data represent a means to distinguish between 
patients who are otherwise alike by classical clinical variables (Cook and Rosenzweig, 
2002; Goldsmith and Dhanasekaran, 2004; Napoli et al., 2003). This is still a work in 
progress in cardiovascular medical research. But we can look to the cancer research field 
to see where the future lies. 
3.2 Standardization 
Experimental conditions can affect microarray technology in a way that leads to considerable 
variability and low reproducibility of the results. To make it possible to compare data obtained 
from different laboratories, efforts have been directed towards the definition of standards in 
gene expression studies (Stoeckert et al., 2002). These standards cover all experimental steps in 
microarray investigations and extend from sample selection and experimental design to the 
functional classification of altered genes. Complex statistical algorithms are increasingly used 
for data modeling and expression change identification. Additionally, comparative approaches 
have been proposed to evaluate the performance of various algorithms on gene expression 
data (Bolstad et al., 2003; Cope et al., 2004; Irizarry et al., 2006).  
3.3 Experimental design 
Microarray experiments should always be replicated. There are two types of replications: 
biological replication, where multiple homogeneous samples are used on multiple arrays, 
and technical replication, where RNA from the same sample is used on multiple arrays. If 
biological replication allows the estimation of both measurements and biological variability, 
technical replication allows only the estimation of measurement variability. Ideally, 
experimental design should include both types. Although there is no agreement about the 
optimum number of biological replicates, a minimum of 5 for each group is generally 
considered as a minimum. 
RNA pooling is another crucial issue. Pooling RNA from biological replicates can reduce 
variability among arrays. Pooling can be necessary for samples of limited quantity. However 
the analysis of one single pool can be misleading because it prevents the estimation of 
biological variability and the presence of outlier samples which could change the results. An 
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alternative approach is the multiple pooling, in which for example 25 samples can be divided 
into 5 pools of 5 samples, and each pool may be used on distinct microarray platforms. Many 
studies have used pooling. In contrast not many have used multiple pooling. 
3.4 Data normalization 
Because of variability of microarray data, each array must be brought into the same scale as 
others in order to compare 2 or more arrays. This normalization, performed by removing 
systematic variation between the arrays and rendering different experiments comparable, 
remains an issue that is not yet fully resolved. Although, many of the early microarray 
studies in the literature ignored this issue, a statistically rigorous approach is needed.  
Early software allowed for array-to-array comparisons by using a scaling factor to normalize 
gene expression patterns across arrays. However, in general, these algorithms assume that 
intensity differences between arrays are linearly related (Schadt et al., 2000). Such linear 
relationship often does not hold true. An example of this approach is the global method that 
consists in re-scaling each chip data set by its total intensity.   
A more advanced normalization approaches have been developed. The invariant set method 
is based on the assumption that there is a subset of unchanged genes between any two 
samples compared by microarray analysis so that their fluorescence values can be used to 
normalize the entire expression data set (Li and Wong, 2001). The LOcally WEighted 
Scatterplot Smoothing (LOWESS) is a widely used technique based on non-linear regression 
(Yang et al., 2002). The quantile normalization uses non-parametric procedure to normalize 
each chip (Bolstad et al., 2003). However, one of the best statistically robust normalization 
methods is the “Robust Multiarray Average” technique (RMA) (Irizarry et al., 2003). This 
method corrects microarray data for local background; it normalizes data on normal 
distribution and uses a linear model to estimate expression values on a log scale. It has been 
demonstrated that RMA performs better than other normalization technologies for 
Affymetrix data (Irizarry et al., 2003). 
3.5 Identification of differentially expressed genes 
The fold-change (FC) was the first used method to identify significantly deregulated genes. 
Although this simple technique can be efficient and effective for focusing on expanding sets 
of differentially expressed sequences, such an analysis does not take advantage of the full 
potential of genome-scale experiments to enhance our comprehension of cellular biology 
that would be provided by an inclusive analysis of the entire repertoire of transcripts in a 
cell as it goes through a biological process. Additionally, FC is now considered an 
inadequate statistical test since it does not incorporate variance and offers no associated 
levels of confidence. To compare groups of data, the parametric t-test and the analysis of 
variance (ANOVA) are more robust and commonly used. However, due to the small sample 
size in a microarray experiment, parametric methods are not recommended and should be 
substituted with a non-parametric moderated test.  
Statistical analysis of microarray data faces an important challenge because testing the 
expression level of tens of thousands of transcripts (multiple testing) may produce hundreds 
of false positive. Therefore, multiple test corrections should be applied. Since the Bonferroni 
approach is too conservative in the case of large number of tests, a good alternative is the 
use of false discovery rate (FDR) (Benjamini and Hochberg, 1995). FDR, defined as the 
expected number of false positive in a list of genes, is at the present widely used for gene 
expression data analysis. 
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3.6 Data organization and presentation 
In order to detect and extract patterns within microarray data, statistical algorithms can be 
applied. The basic assumption of many expression profiling’ investigations is that knowing 
where and when a gene is expressed provides information about the function of the gene. 
Therefore, organizing genes on the basis of similarities in their expression profiles is a 
crucial starting point in the analysis (Bassett et al., 1999). However, similarity of gene 
expression profile does not guaranty similarity of function or mechanistic pathway, and it 
may occur entirely by chance. Nonetheless, clustering genes on the basis of their expression 
patterns is well accepted (Eisen et al., 1998). Typically, cluster analysis is applied when more 
than 3 experiments’ data sets are available. It is generally performed in a two-way method 
(cluster analysis on genes and samples). Nowadays, cluster analysis is one of the most 
popular statistical techniques applied to large-scale microarray data. 
Another method called discriminant analysis, that is different from the descriptive cluster 
analysis, belongs to the group of predictive algorithms. At the start of the analysis, the 
samples are divided into two or more classes. Then based on a training set, where the 
scientist knows a priori the source class of each sample, the algorithms predict the class of 
new samples using its expression profile. 
The different cluster techniques can usefully organize tables of gene expression values. 
However the resulting organized but still large collection of numbers remains hard to 
assimilate. Therefore, powerful data visualization methods and tools have been developed. 
These approaches present clustering results in simple graphical displays such as dendrograms 
(Figure 3). Dendrograms represent relationships among genes by a tree whose branch lengths 
reflect the degree of mathematically defined similarity in expression between the genes (Alon 
et al., 1999). It is possible to make visual assimilation more intuitive by combining clustering 
methods with representation of each data point with a color that quantitatively and 
qualitatively reflects the original experimental observations (Eisen et al., 1998). 
 
 
Fig. 3. Hierarchical clustering of two groups of three samples. Hierarchical groups are 
displayed on the heat map and dendrogram at the left side of the heat map. 
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3.7 Network and pathway analysis 
More recently, new analysis methods have been developed to help interpreting microarray 
data within biological and physiopathological contexts. These approaches are gene 
interaction network analysis and pathway analysis. In gene interaction network analysis 
(Figure 4), automated text mining software is usually used to scan the scientific literature to 
identify gene-gene interactions. A human expert can improve the quality of these gene 
relationships. When a list of differentially expressed genes is presented to the program, a 
search system returns relevant interaction networks. In pathway analysis, the pathways, 
made-up of gene-gene interactions, are accepted by the scientific community and entered 
into the system by human experts. Because of the higher confidence, needed before a set of 
interacting genes is called a pathway, these databases are smaller but more accurate. It is 
however possible to identify new pathways based on gene network interactions if the 
interactions can be validated and accepted by the peer review community. Many 
bioinformatics programs are now available enabling in-depth analysis of any interrelated 
biological data, finding common regulators and associating pathway components with like-
behaving biological entities and processes. 
 
 
Fig. 4. Example of interaction network analysis (Ghorbel et al., 2010). The association 
between the network entities were based on available PubMed citations.  
3.8 Data archiving 
Successful interpretation of expression profiling investigations is likely to be dependent on 
the integration of experimental data with external information resources. Since the amount 
of data from multiple studies involving multiple cell types and tissues from multiple 
research groups is fast growing, data archiving is becoming an important issue. It is ideal if 
all gene expression data would be deposited in the public domain and are freely accessible. 
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Such endeavour would require a user-friendly and powerful database system and 
standardization of correction and normalization procedures to allow comparison of data 
sets from various projects (Granjeaud et al., 1999). Public data repositories have been 
developed at the European Bioinformatics Institute (ArrayExpress) and the National Center 
for Biotechnology Information (Gene Expression Omnibus), institutions that pursue these 
internationally recognized standards. Several scientific journals now request submission of 
microarray data into databases as a prerequisite for manuscript publication.  
4. Exploring transcriptomic alterations in congenital heart diseases 
The refinement of the human genome sequence and its associated annotation will soon have 
a great impact on the diagnosis and treatment of cardiovascular diseases when this 
information is coupled to the application of new technologies such as DNA microarrays. 
The latter provides a genomic approach to explore the genetic markers and molecular 
mechanisms leading to congenital heart disease and heart failure. 
The first genome-wide gene expression study of congenitally malformed hearts in humans 
attempted to identify genes associated with dysdevelopment as well as genes involved in 
adaptation processes of the heart (Kaynak et al., 2003). The authors of this study, examined 
and compared genes dysregulated in defined congenitally malformed hearts with the 
molecular response to pressure overload leading to hypertrophy and the chamber-specific 
cardiac molecular portrait (Kaynak et al., 2003). By comparing the gene expression in atria 
and ventricle, this study found diverse previously unknown chamber-specific genes for 
muscle contraction, extracellular components, cell growth and differentiation, and energy 
metabolism (Kaynak et al., 2003). This is in addition to well-known chamber-specific genes, 
like atrial and ventricular myosin light chains. The comparison of Tetralogy of Fallot (TOF) 
and Right ventricular Hypertrophy (RVH), showed a distinct molecular portraits of TOF 
and RVH with genes of various functional classes (Kaynak et al., 2003) even though the right 
ventricular hypertrophy is part of TOF. Beside genes involved in cell cycle, a characteristic 
feature of the TOF signature is the upregulation of ribosomal proteins (Kaynak et al., 2003). 
Whereas a hypertrophy-specific gene expression pattern of genes mainly involved in stress 
response, cell proliferation, and metabolism was observed in RVH (Kaynak et al., 2003). In 
addition, to obtain a molecular portrait that is not influenced by biomechanical adaptation 
processes, RA samples of patients with ventricular septal defect (VSD), intact tricuspid 
valve, and normal RA pressure were studied (Kaynak et al., 2003). A VSD-specific molecular 
signature dominated by downregulated genes with respect to the other RA samples was 
shown (Kaynak et al., 2003). A thorough literature study of downregulated genes in VSD 
revealed that a major part is involved in cell proliferation and differentiation during 
embryogenesis as well as apoptosis (Kaynak et al., 2003). This investigation indicated 
distinct gene expression profiles associated with tetralogy of Fallot, ventricular septal defect, 
and right ventricular hypertrophy (Kaynak et al., 2003). Furthermore, the study design 
allowed the suggestion that alterations associated with primary genetic abnormalities can be 
distinguished from those associated with the adaptive response of the heart to the 
malformation (right ventricular pressure overload hypertrophy) (Kaynak et al., 2003).  
The evidence for the developmentally regulated capacity of the immature heart to generate 
an adaptive response to reduced oxygen availability, although compelling, is derived 
largely from acute experimental interventions in animal models. Further, the reductionist 
approach of these studies, which typically address a single target, fails to capture the global 
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complexity of the response. Nevertheless, the general observation that the human neonatal 
heart copes well with dramatic degrees of hypoxia and hypertrophy is in accordance with 
these experimental findings. To determine the molecular basis of this putatively adaptive 
response, Konstantinov et al. conducted microarray-based differential gene expression 
profiling on tissue samples acquired in patients of varying ages undergoing repair of right 
ventricular (RV) obstructive heart lesions, including TOF and focusing on potential age-
related differences (Konstantinov et al., 2004). Their findings seem to confirm the existence 
of a protective reprogramming response that is most evident in the neonatal myocardium 
and is subject to the hemodynamic and metabolic stress imposed by structural congenital 
heart disease (Konstantinov et al., 2004). Indeed this study showed that neonatal 
myocardium has a unique pattern of gene expression dominated by genes with 
cardioprotective, antihypertrophic and antiproliferative properties reflecting a stress-
induced protective program (Konstantinov et al., 2004). 
Another investigation examined the differential gene expression profile during RVH in the 
developing heart with TOF congenital defect (Sharma et al., 2006). Using high-density DNA 
microarray, the authors showed that more than 200 myocardial genes are up- or 
downregulated in patients with TOF (Sharma et al., 2006). Among other genes, the 
expression of ECM proteins, such as collagens and fibronectin, was predominantly elevated, 
whereas MMP and TIMP expression either remained unchanged or decreased in TOF 
patients (Sharma et al., 2006). These results indicate for the myocardial fibrosis that may 
account for diminished function in patients with TOF (Sharma et al., 2006). They also 
provide further evidence that myocardial architecture in patients with TOF depict a complex 
and differential gene expression pattern with drastically increased expression level of ECM 
proteins (collagen Iα and III and fibronectin) mRNA and the VEGF/VEGF-R system 
(Sharma et al., 2006). The authors concluded that this up-regulation of genes involved in 
ECM homeostasis is associated with RVH and diminished cardiac function in TOF patients. 
Furthermore, the VEGF/VEGF-receptor (R) system could play an important role in 
enhanced myocardial angiogenesis that could be stunted due to limited vascular 
remodelling (Sharma et al., 2006). 
In contrast to the previous investigation examining gene expression changes in cyanotic 
TOF in comparison to normal hearts (Sharma et al., 2006), we recently determined the global 
gene expression profiles associated with chronic hypoxia by comparing gene expression of 
cyanotic and acyanotic patients with TOF (Ghorbel et al., 2010). Our data showed that, 
overall, the transcriptional profile in the cyanotic group was characterized by increased 
expression level of genes with literature-validated apoptosis and 
growth/morphogenesis/remodeling properties. It also showed decreased expression levels 
of genes with cardiac function, cell survival, and cytoprotective properties (Ghorbel et al., 
2010). The molecular signatures identified suggest a reprogramming response in the 
cyanotic myocardium activated by the chronic hypoxia imposed by the structural congenital 
heart disease (Ghorbel et al., 2010). The difference between the adaptive and injury-related 
responses would dictate the overall fate of heart cells. 
In addition to investigating the gene expression profiling of the myocardium in response to 
congenital heart defect, other studies focused on gene expression alterations in response to 
surgery. One of these studies examined the gene expression profiles during intra-operative 
myocardial ischemia-reperfusion in corrective cardiac surgery of ventricular septal defect 
(Arab et al., 2007). It described the sequential changes in gene expression in the human 
ventricle during surgically imposed ischemia-reperfusion. The annotation of several genes 
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exhibiting differential expression suggested that the elicited transcriptional response in this 
context is compensatory and adaptive. In silico functional clustering of several genes 
comprising this response revealed dominant up-regulation of transcripts encoding elements 
of pro-hypertrophic cellular growth factor pathways, involving multiple levels of 
regulation, including receptors, cognate signaling kinases, and programmatically linked 
transcription factors. The majority of genes up-regulated in response to cardioplegic arrest 
have literature-confirmed cytoprotective properties, including several that have been 
previously validated as endogenous mediators of ischemic preconditioning. This study 
provided evidence that myocardial ischemic stress associated with repair of VSD induces a 
net protective transcriptional response (Arab et al., 2007). It showed that reversible 
myocardial ischemia-reperfusion during cardiac surgery is associated with an immediate 
genomic response that predicts a net cardioprotective phenotype (Arab et al., 2007). 
The molecular signatures identified with microarray technology can be interpreted as either 
mechanistically relevant to the congenital heart disease pathogenesis or as markers of 
disease progression. We believe that this approach can also be used to identify endogenous 
patterns of gene profiles that are activated in response to the primary disease-causing 
pathway and have the effect of generating a counteracting and highly adaptive pattern of 
gene activation, which serves to suppress aberrant disease-related molecular pathways.  
5. Conclusion 
Overall the information collected by gene expression profiling will help our understanding 
of disease mechanisms and provide insights useful for improving contemporary clinical 
treatment and prognosis of patients with congenital heart defects. 
Congenital heart disease genomic research is still in its early stages with regard to the 
translation of studies’ findings into clinical settings. However, inspection of other medical 
areas shows the potential of genomic medicine and where congenital heart medicine will be, 
possibly within the next few years. Microarrays are already being used in other fields to 
help clinicians better risk-stratify patients in addition to predict therapeutic responses and 
direct clinical and surgical decision making. Although considerable challenges remain, 
congenital heart disease genomic medicine promises to improve patient care and lower 
health care costs. 
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1. Introduction 
In 1988 Sudoh and colleagues described a novel natriuretic peptide in porcine brain -- brain 
natriuretic peptide(Sudoh et al. 1988). In fact, the peptide is most abundant in the heart and 
thus it is now commonly termed B-type natriuretic peptide (BNP). Myocyte pressure and/or 
stretch results in the release of BNP, and BNP levels are easily quantified by several 
commercially available assays. Data from numerous studies have now firmly established a 
role for BNP as a biomarker for diagnosis, prognostication, and management of adults with 
cardiac disease, including those undergoing cardiac surgery(Silver et al. 2004; Mitchell and 
Webb 2011; Rodseth, Padayachee, and Biccard 2008; Fellahi et al. 2011). Unfortunately, far 
fewer data are available on the role of BNP in the management of neonates, infants, and 
children who require cardiac surgery. This chapter will provide a brief review of these data 
in order to understand the potential utility of BNP determinations in this population. 
2. Natriuretic hormone system 
Beginning with the observation by de Bold and colleagues that rats infused with atrial tissue 
extracts developed natriuresis and diuresis, much has been learned over the past three decades 
about the role of the natriuretic hormone system in the homeostatic control of fluid balance 
and vascular tone(de Bold et al. 1981). The natriuretic hormone system comprises several 
related peptides that activate specific receptors, particularly in the kidneys, myocardium, and 
vasculature, which use cyclic guanosine 3’,5’-monophosphate (cGMP) as a second 
messenger(Levin, Gardner, and Samson 1998). These peptides include atrial natriuretic 
peptide (ANP), BNP, C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide 
(DNP), kaliuretic peptide, and urodilantin. The primary stimulus for their release is an 
increase in intravascular or cardiac volume, that causes increased atrial stretch, ventricular 
wall stress, vascular shear stress, intravascular volume, and/or intravascular sodium 
concentration(Levin, Gardner, and Samson 1998). The precise roles of individual natriuretic 
peptides depend upon their distribution and abundance within the cardiovascular system, as 
well as the specific stimulus for their release(Levin, Gardner, and Samson 1998).  
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3. B-Type natriuretic peptide (BNP)  
BNP is predominantly produced in the cardiac ventricles. However under pathologic 
conditions, such as fluid overload, the cardiac atrium can also become a significant source of 
BNP(Sudoh et al. 1988; McGrath, de Bold, and de Bold 2005). Biosynthesis of BNP begins 
with a 134 amino acid precursor, preproBNP. Stimuli, such as myocyte stretch, trigger the 
cleavage of preproBNP forming proBNP, which is subsequently cleaved by a serine protease 
to the active C-terminal 32 amino acid hormone, BNP, and the inactive N-terminal proBNP 
(NT-proBNP). BNP binds to 3 known cell membrane receptors, termed natriuretic peptide 
receptors (NPR-A, NPR-B, and NPR-C). NPR-A and NPR-B are transmembrane receptors 
that activate particulate guanylate cyclase, which catalyzes the conversion of guanosine 
triphosphate to cGMP. The third receptor, NPR-C, is involved in clearance via endocytosis. 
Circulating BNP is also inactivated by cleavage by neutral endopeptidases found in vascular 
cells and renal tubules (Figure 1) (Yandle 1994; Silver et al. 2004). Animal studies suggest 
that approximately half of natriuretic peptide clearance is via the NPR-C receptor and half 
via endopeptidase degradation, but the relative contributions in the human are unclear. 
 
  
Fig. 1. A schematic of B-type natriuretic peptide (BNP) signaling. BNP binds to 3 natriuretic 
peptide receptors (NPR), types A, B, and C, on various target cells located in the 
vasculature, kidney, heart, adrenal glands, and brain. NPR-A and NPR-B are high-affinity 
receptors with an extracellular binding domain, a single membrane-spanning region, and an 
intracellular guanylylcyclase domain. Guanylylcyclase catalyzes the conversion of 
guanosine-5'-triphosphate (GTP) to guanosine-3',5'-cyclic monophosphate (cGMP). BNP is 
degraded by two mechanisms. Neutral endopeptidases degrade circulating BNP, and 
binding to NPR-C results in receptor internalization and degradation by endocytosis. NPR-
C is then recycled to the cell membrance (not shown).  
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The mechanisms that mediate BNP release and metabolism in health and disease are 
incompletely understood. In addition, the effect of development on these mechanisms is 
unknown, but clearly may have great relevance in a pediatric population. Active BNP is 
stored in the atria in specific storage organelles(McGrath, de Bold, and de Bold 2005). Basal 
BNP levels result from continuous secretion from the atria. With acute myocardial 
distention, BNP release increases from this storage pool, in a manner independent of BNP 
synthesis. However, under acute, sub-acute and chronic conditions of increased cardiac 
volume or pressure loading, increases in circulating BNP are maintained due to ventricular 
re-expression of the fetal gene program (Zhang, Carreras, and de Bold 2003; Hama et al. 
1995). In addition to volume and pressure loading, acute myocardial ischemia, α agonist 
stimulation, endothelin-1, and inflammatory mediators, such as tumor necrosis factor-α and 
interleukin-1β, result in rapid ventricular expression of BNP(Hama et al. 1995). The primary 
actions of BNP are vascular smooth muscle relaxation and anti-mitogenesis, mediated by 
cGMP, diuresis, caused by a shift of intravascular volume into the interstitium, and 
natriuresis, caused by antagonism of renin and aldosterone release(McGrath, de Bold, and 
de Bold 2005; Sudoh et al. 1988; Yandle 1994).  
Of all the natriuretic peptides, BNP has emerged as the most useful biomarker for cardiac 
disease. Its major advantage over the other natriuretic peptides is the fact that it is produced 
predominantly in the ventricles, as opposed to the atrium (ANP) or the vascular 
endothelium (CNP)(Silver et al. 2004; Costello, Goodman, and Green 2006). Both active BNP 
and the inactive byproduct of its production, NT-proBNP, are used as biomarkers. BNP 
levels may be better suited to follow dynamic alterations in myocardial performance given 
the shorter circulating half-life of BNP compared to NT-proBNP (20 minutes vs. 60-120 
minutes)(Costello, Goodman, and Green 2006). In addition, the kidneys excrete NT-proBNP, 
and thus renal function, independent of myocardial function, has a greater influence on NT-
proBNP levels than BNP levels.  
Limited data suggest that BNP levels are high at birth but fall during the first week of life, 
reaching levels below adult values by 2 weeks of age. Interestingly, although levels in boys 
tend to decrease with age, girls have an elevation during the second decade of life that is 
associated with puberty (Koch and Singer 2003; Yoshibayashi et al. 1995; Ationu and Carter 
1993).  
4. BNP in pediatric heart disease 
In comparison to the adult experience, there are far fewer data regarding BNP in pediatric 
cardiac disease(Das 2010). Knirsch and colleagues measured BNP levels before and during 
treatment in 522 pediatric patients (age of 6.4±5.2 years, range of 14 days to 18 years) with 
congenital heart disease, cardiomyopathies, or pulmonary arterial hypertension(Knirsch et 
al. 2011). They found that BNP levels were elevated in each type of heart disease, and that 
levels fell in all groups with therapy.  
As opposed to adults with congestive heart failure, BNP levels in infants and children with 
congenital heart disease are quite varied, and are dependent in part upon the age of the 
patient and the specific physiology associated with the cardiac defect. For example, Law and 
colleagues performed a study that included 42 neonates and 58 older children between the 
age of 7 days and 19 years presenting in an acute care setting with symptoms potentially 
attributable to heart disease. BNP levels were higher in both age groups in those patients 
with heart disease compared to those without heart disease, but the cut-off values differed. 
A BNP level of 170 pg/ml was 94% sensitive and 73% specific for heart disease in neonates, 
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whereas a lower level of 41 pg/ml was 87% sensitive and 70% specific for heart disease in 
the older patients(Law et al. 2009).  Koch and colleagues found in a study of 288 pediatric 
patients (mean age of 6 years) with congenital cardiac defects that normal BNP levels did 
not exclude cardiac pathology such as the presence of structural defects or ventricular 
hypertrophy, but rather were associated with the extent of ventricular impairment(Koch, 
Zink, and Singer 2006). Conversely, Cantinotti and colleagues studied 152 neonates with 
congenital heart disease and 154 healthy neonatal controls, and found the BNP levels were 
higher in neonates with congenital heart disease than controls with a diagnostic accuracy 
defined by the area under the curve (on receiver operating characteristic analysis) of 0.935 
for neonates with congenital heart disease between 4 and 30 days of age(Cantinotti et al. 
2010). Thus, it appears that age modifies the diagnostic utility of BNP for cardiac disease in 
pediatric patients. In fact, in a separate study Koch and colleagues demonstrated age-
dependent differences in the metabolic clearance of BNP and NT-proBNP(Koch, Rauh, et al. 
2006).  
A number of studies indicate that cardiopulmonary hemodynamics also modify the 
diagnostic utility of BNP in pediatric patients with congenital heart disease. For example, in 
a study of infants and children with ventricular septal defects, Suda and colleagues found 
that BNP levels correlated with the pulmonary-to-systemic blood flow (Qp:Qs) ratio and the 
mean pulmonary arterial pressure(Suda, Matsumura, and Matsumoto 2003). Koch and 
colleagues demonstrated similar correlations, in their study of 288 patients with various 
cardiac defects(Koch, Zink, and Singer 2006). They found that in patients with left-to-right 
shunts, BNP levels were increased and correlated with shunt volume, systolic right 
ventricular pressure, mean pulmonary artery pressure, and pulmonary vascular 
resistance(Koch, Zink, and Singer 2006). Likewise, Kunii and colleagues compared BNP 
levels between normal children (n=253), and children with ventricular septal defects (n=91), 
patent ductus arteriosus (n=29), and atrial septal defects (n=34). Like the studies of Suda and 
Koch, they found that BNP levels correlated with the Qp:Qs ratio, and also the left 
ventricular end-diastolic volume, and the right ventricular to left ventricular pressure 
ratio(Kunii et al. 2003). Mainwaring and colleagues also found a positive correlation 
between preoperative BNP levels and the Qp:Qs ratio in a study of 18 patients (2 months – 
15.6 years of age) with ventricular septal defects(Mainwaring et al. 2007). Ozhan and 
colleagues found the same relationship between BNP and the Qp:Qs ratio in their study of 
35 children (mean age 70±129 weeks) with ventricular or atrial septal defects. Receiver 
operating characteristic analysis found that a plasma BNP cutoff of ≥20 pg/ml was 69% 
sensitive and 79% specific for a Qp:Qs of greater than 1.5(Ozhan et al. 2007).  
A number of studies of premature neonates found that BNP levels correlated with the 
degree of shunting across a patent ductus arteriosus and predicted hemodynamic 
significance as determined by echocardiography-based criteria(Choi et al. 2005; Flynn et al. 
2005; Puddy et al. 2002; Sanjeev et al. 2005; Holmstrom and Omland 2002; da Graca et al. 
2006). However, the precise cut-off value for BNP that was predictive varied widely. For 
example, Choi and colleagues reported that a BNP level of > 1110 pg/ml was 100% sensitive 
and 95% specific for the presence of a hemodynamically significant patent ductus arteriosus, 
while Sanjeev and colleagues reported a 92% sensitivity with a cut-off level of 70 
pg/ml(Choi et al. 2005; Sanjeev et al. 2005).  
Holmgren and colleagues studied 38 patients with single ventricular physiology. They 
found that BNP levels were higher in patients after first stage palliation (31.6 pg/ml) 
compared to patients after second and third stage palliation (6.7 and 9 pg/ml, respectively). 
In fact, BNP levels in patients after second and third stage palliation did not differ from 
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normal control patients, but interestingly, BNP levels were higher in those patients with 
single ventricles of right ventricular morphology compared to left ventricular 
morphology(Holmgren et al. 2008). In contrast, Koch and colleagues studied 48 patients 
with d-transposition of the great arteries, after arterial switch procedure, or congenitally 
corrected transposition of the great arteries. They found no difference in BNP levels between 
patients with systemic ventricles of right ventricular morphology compared to left 
ventricular morphology(Koch, Zink, and Singer 2008). They did, however, find correlations 
between BNP and the severity of tricuspid regurgitation and decreasing exercise capacity. 
Likewise, Inuzuka and colleagues measured BNP levels in 51 patients (mean age 1.1 years) 
with single ventricular defects undergoing cardiac catheterization before second stage 
palliation. Mean BNP levels were 90.4 pg/ml. BNP levels above 100 pg/ml were associated 
with increased Qp:Qs, end-diastolic volume, AV valve regurgitation, and lower ventricular 
mass to end-diastolic volume ratio, all consistent with an inadequate adaptation to volume 
overload(Inuzuka et al. 2011). In addition, multivariate regression analysis demonstrated 
that the BNP concentration was independently predictive of death or the need for cardiac 
transplantation (with a hazard ratioof 3.05, CI: 1.06-8.83)(Inuzuka et al. 2011).  
Thus, it is clear that BNP determinations can provide physiologically relevant information 
about individual patients, but that finding cut-off values that can be generalized for clinical 
use across the spectrum of congenital heart disease may not be possible. Indeed, in adult 
patients the primary utility of BNP determinations is in establishing the diagnosis of 
congestive heart failure in acute care settings(Maisel et al. 2002). In a pediatric population, 
the questions are more diverse. They might include, when to repair a left-to-right shunt, 
when to proceed with staged palliation of single ventricle defects, or when to refer for 
cardiac transplantation. However, even studies focused on pediatric heart failure have 
revealed a wide range of BNP values, again likely related at least in part to age and 
cardiopulmonary hemodynamics. For example, in a study of infants and children with 
biventricular hearts and chronic left ventricular dysfunction, Price and colleagues found that 
a BNP level of ≥300 pg/ml was predictive of death, hospitalization, or listing for cardiac 
transplant(Price et al. 2006). Shah and colleagues also found that increasing BNP was 
associated with heart failure in their study of 29 patients with single ventricular physiology, 
but with a ten-fold lower cut-off of 30 pg/ml (Shah, et al., 2009).  
5. BNP as a biomarker following cardiac surgery 
5.1 Early post-operative period 
As a cardiac hormone with a relatively short circulating half life that is dynamically released 
in response to deranged myocardial performance, BNP appears perfectly suited for the 
perioperative management of pediatric patients undergoing cardiac surgery for repair or 
palliation of congenital cardiac defects.  
A number of investigators have studied perioperative BNP levels in neonates, infants, and 
children undergoing cardiac surgery. Ationu and colleagues measured perioperative BNP 
levels in 9 children undergoing repair of congenital heart defects(Ationu et al. 1993). In that 
study, BNP levels decreased at 12 hours following surgery(Ationu et al. 1993). Most studies, 
however, have found increases in BNP and NT-proBNP levels after surgery. Costello and 
colleagues measured natriuretic peptide levels, including BNP, in 5 infants undergoing 
surgical repair of left-to-right shunts(Costello et al. 2004). As opposed to ANP and DNP, 
BNP concentrations increased after cardiopulmonary bypass. Sun and colleagues measured 
BNP levels before and after surgery in 27 infants and children undergoing biventricular 
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whereas a lower level of 41 pg/ml was 87% sensitive and 70% specific for heart disease in 
the older patients(Law et al. 2009).  Koch and colleagues found in a study of 288 pediatric 
patients (mean age of 6 years) with congenital cardiac defects that normal BNP levels did 
not exclude cardiac pathology such as the presence of structural defects or ventricular 
hypertrophy, but rather were associated with the extent of ventricular impairment(Koch, 
Zink, and Singer 2006). Conversely, Cantinotti and colleagues studied 152 neonates with 
congenital heart disease and 154 healthy neonatal controls, and found the BNP levels were 
higher in neonates with congenital heart disease than controls with a diagnostic accuracy 
defined by the area under the curve (on receiver operating characteristic analysis) of 0.935 
for neonates with congenital heart disease between 4 and 30 days of age(Cantinotti et al. 
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2006).  
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that BNP levels correlated with the pulmonary-to-systemic blood flow (Qp:Qs) ratio and the 
mean pulmonary arterial pressure(Suda, Matsumura, and Matsumoto 2003). Koch and 
colleagues demonstrated similar correlations, in their study of 288 patients with various 
cardiac defects(Koch, Zink, and Singer 2006). They found that in patients with left-to-right 
shunts, BNP levels were increased and correlated with shunt volume, systolic right 
ventricular pressure, mean pulmonary artery pressure, and pulmonary vascular 
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A number of studies of premature neonates found that BNP levels correlated with the 
degree of shunting across a patent ductus arteriosus and predicted hemodynamic 
significance as determined by echocardiography-based criteria(Choi et al. 2005; Flynn et al. 
2005; Puddy et al. 2002; Sanjeev et al. 2005; Holmstrom and Omland 2002; da Graca et al. 
2006). However, the precise cut-off value for BNP that was predictive varied widely. For 
example, Choi and colleagues reported that a BNP level of > 1110 pg/ml was 100% sensitive 
and 95% specific for the presence of a hemodynamically significant patent ductus arteriosus, 
while Sanjeev and colleagues reported a 92% sensitivity with a cut-off level of 70 
pg/ml(Choi et al. 2005; Sanjeev et al. 2005).  
Holmgren and colleagues studied 38 patients with single ventricular physiology. They 
found that BNP levels were higher in patients after first stage palliation (31.6 pg/ml) 
compared to patients after second and third stage palliation (6.7 and 9 pg/ml, respectively). 
In fact, BNP levels in patients after second and third stage palliation did not differ from 
B-Type Natriuretic Peptide (BNP) in Neonates, 
Infants, and Children Undergoing Cardiac Surgery  
 
203 
normal control patients, but interestingly, BNP levels were higher in those patients with 
single ventricles of right ventricular morphology compared to left ventricular 
morphology(Holmgren et al. 2008). In contrast, Koch and colleagues studied 48 patients 
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cardiopulmonary hemodynamics. For example, in a study of infants and children with 
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a BNP level of ≥300 pg/ml was predictive of death, hospitalization, or listing for cardiac 
transplant(Price et al. 2006). Shah and colleagues also found that increasing BNP was 
associated with heart failure in their study of 29 patients with single ventricular physiology, 
but with a ten-fold lower cut-off of 30 pg/ml (Shah, et al., 2009).  
5. BNP as a biomarker following cardiac surgery 
5.1 Early post-operative period 
As a cardiac hormone with a relatively short circulating half life that is dynamically released 
in response to deranged myocardial performance, BNP appears perfectly suited for the 
perioperative management of pediatric patients undergoing cardiac surgery for repair or 
palliation of congenital cardiac defects.  
A number of investigators have studied perioperative BNP levels in neonates, infants, and 
children undergoing cardiac surgery. Ationu and colleagues measured perioperative BNP 
levels in 9 children undergoing repair of congenital heart defects(Ationu et al. 1993). In that 
study, BNP levels decreased at 12 hours following surgery(Ationu et al. 1993). Most studies, 
however, have found increases in BNP and NT-proBNP levels after surgery. Costello and 
colleagues measured natriuretic peptide levels, including BNP, in 5 infants undergoing 
surgical repair of left-to-right shunts(Costello et al. 2004). As opposed to ANP and DNP, 
BNP concentrations increased after cardiopulmonary bypass. Sun and colleagues measured 
BNP levels before and after surgery in 27 infants and children undergoing biventricular 
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repair and 27 patients undergoing palliation of univentricular congenital heart defects(Sun 
et al. 2005). Plasma BNP levels increased after bypass in patients with biventricular defects, 
but not in patients with univentricular defects(Sun et al. 2005). Costello and colleagues 
examined BNP levels before and following cardiac surgery in 25 infants and children with 
congenital heart disease undergoing complete or palliative repair with the use of 
cardiopulmonary bypass(Costello et al. 2004). BNP levels increased postoperatively, and 
remained elevated over the first postoperative day. The increase in BNP from baseline to 12 
hours was associated with the cardiopulmonary bypass time.Koch and colleagues measured 
BNP levels in 65 pediatric patients (age 4 days – 17 years, mean age of 3.6), undergoing 
surgical repair of congenital cardiac defects preoperatively, and for one week after 
surgery(Koch, Kitzsteiner, et al. 2006). BNP levels increased after surgery (from a median of 
31 pg/ml to 453 pg/ml) and remained elevated over the first week, with a bimodal pattern 
(initial peak at 1.3 days and a second peak at 5.1 days after surgery). Postoperative BNP 
levels correlated with cardiopulmonary bypass time and serum lactate concentrations on the 
first postoperative day.  
Shih and colleagues conducted the first study demonstrating that BNP predicted outcome 
after cardiac surgery in children(Shih et al. 2006). BNP levels were determined before and 
after surgery in 51 patients. They found that BNP levels increased after surgery, peaking at 
12 hours, and that BNP levels 12 hours following surgery were predictive of a requirement 
for mechanical ventilation beyond 48 hours and the presence of low cardiac output 
syndrome within the first 48 hours, postoperatively. Further, the study found that 12-hour 
BNP levels of 540 pg/ml had a sensitivity of 88.9% and a specificity of 82.5% for predicting 
the need for mechanical ventilation beyond 48 hours, and that a 12-hour BNP of 815 pg/ml 
had a sensitivity of 87.5% and a specificity of 90.2% for predicting the development of low 
cardiac output syndrome.  
Similarly, Perez-Piaya and colleagues measured NT-proBNP levels in 68 patients (0-15 years 
of age) undergoing cardiac surgery(Perez-Piaya et al. 2011). They found that NT-proBNP 
levels increased postoperatively, peaking at 24 hours. Moreover, peak NT-proBNP levels 
correlated with risk adjustment congenital heart surgery-1 scores, length of 
cardiopulmonary bypass, inotropic score, duration of mechanical ventilation, and intensive 
care unit length of stay. In addition, preoperative NT-proBNP levels were independent 
predictors of intensive care unit length of stay. Gessler and colleagues also measured NT-
proBNP levels before and after cardiac surgery in 40 children(Gessler et al. 2006). In their 
study, higher preoperative levels were noted in patients with a complicated postoperative 
course.  
It is well known that neonates undergoing cardiac surgery and patients with single 
ventricular physiology represent high-risk groups. Hsu and colleagues examined BNP levels 
before and after surgery in 31 consecutive neonates undergoing repair or palliation of their 
cardiac defects(Hsu et al. 2007). BNP levels at all time points were markedly elevated, 
compared to published normal values. But interestingly, as opposed to the majority of 
studies of older patients, they found that 24-hour postoperative BNP levels were lower than 
preoperative BNP levels in most patients (75%). However, in those patients whose BNP 
levels increased after surgery outcomes were worse. In fact, an increase in post-operative 
BNP was associated with an increased incidence of low cardiac output syndrome (100% vs. 
36 %), and fewer ventilator-free days (17 ± 13 days vs. 25 ± 3 days), and predicted the 6-
month composite endpoint of death, an unplanned operation, or cardiac transplant (57% vs. 
0%). Furthermore, an increase in BNP after surgery had a sensitivity of 100% and a 
specificity of 87% for predicting a poor postoperative outcome. Notably, neither arterial-
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venous oxygen saturation differences (AVdO2) nor lactate levels (or their corresponding 
changes) were associated with postoperative outcomes in this study(Hsu et al. 2007).  
In another neonatal study, Cannesson and colleagues measured perioperative BNP levels in 
30 neonates undergoing the arterial switch operation (ASO) for d-transposition of the great 
arteries(Cannesson et al. 2007). Contrary to the findings of Hsu, BNP levels increased over 
the first 48 hours postoperatively. However, like the study by Hsu these investigators found 
that postoperative BNP levels predicted adverse clinical outcomes, including prolonged 
mechanical ventilation, prolonged stay in the intensive care unit, low cardiac output 
syndrome, and the need for inotropic support. These investigators found that a BNP level of 
>160 pg/ml, 6 hours postoperatively, predicted a complicated postoperative course with a 
sensitivity of 93% and a specificity of 67%. Similarly, Niedner and colleagues studied 102 
neonates and non-neonatal controls undergoing surgical repair for various congenital 
cardiac defects(Niedner et al. 2010). They found that BNP levels increased after surgery, 
peaking at 12 hours. Levels at 24 hours were significantly higher in neonates than in non-
neonates (median of 1506 vs 286 pg/ml). In addition, postoperative BNP levels correlated 
with the inotropic requirement, duration of mechanical ventilation, and intensive care unit 
and hospital length of stay. When comparing the various cardiac defects, these investigators 
found great variability between lesions and noted the significant impact of age, with 
postoperative elevations occurring earlier and to a much greater magnitude in neonates 
compared to older children. One might speculate that the differences between the neonatal 
studies of Hsu, Cannesson, and Niedner relate in part to differences between single and bi-
ventricular physiology, and the impact of surgery on ventricular volume and pressure 
loading. Furthermore, these studies demonstrate that the potential clinical utility for BNP 
determinations as a part of management after cardiac surgery may depend upon analyzing 
patterns of change, as opposed to single time points. Moreover, relevant patterns of change 
may differ between cardiac defects and age groups. 
In fact, Berry and colleagues studied 20 neonates, infants, and children undergoing various 
stages of palliation for cardiac defects with single ventricle physiology(Berry et al. 2007). They 
found that BNP levels were highest in neonates undergoing a Norwood procedure compared 
with patients undergoing bidirectional cavopulmonary anastomosis or a Fontan procedure. 
They also found that postoperative BNP levels were predictive of hospital length of stay and 
postoperative inotropic support.Likewise, Hsu and colleagues measured perioperative BNP 
levels in 36 infants and children undergoing bidirectional cavopulmonary anastomosis (n=25) 
or total cavopulmonary connection (n=11)(Hsu et al. 2008). Plasma BNP levels were measured 
before and at various time points after surgery. They found that BNP levels increased after 
surgery, peaking at 12 hours in most patients. In the bidirectional cavopulmonary anastomosis 
group, patients with a 12-hour BNP level of ≥500 pg/mL had a longer duration of mechanical 
ventilation, intensive care unit stay, and hospital stay. A 12-hour BNP level of ≥500 pg/mL 
had a sensitivity of 80% and a specificity of 80% for predicting an unplanned surgical or 
transcatheter cardiac intervention, including transplantation. In the total cavopulmonary 
connection group, preoperative BNP levels were highest in patients with total cavopulmonary 
connection failure compared with patients with a good outcome, whereas postoperative BNP 
levels were not predictive of outcome.Importantly, preoperative cardiac catheterization data 
did not correlate with these outcomes in either group.  
5.2 BNP in patients requiring mechanical support after cardiac surgery 
Chikovani and colleagues studied the potential utility of BNP levels in the assessment of 
native myocardial performance in ten neonates and infants being supported with 
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repair and 27 patients undergoing palliation of univentricular congenital heart defects(Sun 
et al. 2005). Plasma BNP levels increased after bypass in patients with biventricular defects, 
but not in patients with univentricular defects(Sun et al. 2005). Costello and colleagues 
examined BNP levels before and following cardiac surgery in 25 infants and children with 
congenital heart disease undergoing complete or palliative repair with the use of 
cardiopulmonary bypass(Costello et al. 2004). BNP levels increased postoperatively, and 
remained elevated over the first postoperative day. The increase in BNP from baseline to 12 
hours was associated with the cardiopulmonary bypass time.Koch and colleagues measured 
BNP levels in 65 pediatric patients (age 4 days – 17 years, mean age of 3.6), undergoing 
surgical repair of congenital cardiac defects preoperatively, and for one week after 
surgery(Koch, Kitzsteiner, et al. 2006). BNP levels increased after surgery (from a median of 
31 pg/ml to 453 pg/ml) and remained elevated over the first week, with a bimodal pattern 
(initial peak at 1.3 days and a second peak at 5.1 days after surgery). Postoperative BNP 
levels correlated with cardiopulmonary bypass time and serum lactate concentrations on the 
first postoperative day.  
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after cardiac surgery in children(Shih et al. 2006). BNP levels were determined before and 
after surgery in 51 patients. They found that BNP levels increased after surgery, peaking at 
12 hours, and that BNP levels 12 hours following surgery were predictive of a requirement 
for mechanical ventilation beyond 48 hours and the presence of low cardiac output 
syndrome within the first 48 hours, postoperatively. Further, the study found that 12-hour 
BNP levels of 540 pg/ml had a sensitivity of 88.9% and a specificity of 82.5% for predicting 
the need for mechanical ventilation beyond 48 hours, and that a 12-hour BNP of 815 pg/ml 
had a sensitivity of 87.5% and a specificity of 90.2% for predicting the development of low 
cardiac output syndrome.  
Similarly, Perez-Piaya and colleagues measured NT-proBNP levels in 68 patients (0-15 years 
of age) undergoing cardiac surgery(Perez-Piaya et al. 2011). They found that NT-proBNP 
levels increased postoperatively, peaking at 24 hours. Moreover, peak NT-proBNP levels 
correlated with risk adjustment congenital heart surgery-1 scores, length of 
cardiopulmonary bypass, inotropic score, duration of mechanical ventilation, and intensive 
care unit length of stay. In addition, preoperative NT-proBNP levels were independent 
predictors of intensive care unit length of stay. Gessler and colleagues also measured NT-
proBNP levels before and after cardiac surgery in 40 children(Gessler et al. 2006). In their 
study, higher preoperative levels were noted in patients with a complicated postoperative 
course.  
It is well known that neonates undergoing cardiac surgery and patients with single 
ventricular physiology represent high-risk groups. Hsu and colleagues examined BNP levels 
before and after surgery in 31 consecutive neonates undergoing repair or palliation of their 
cardiac defects(Hsu et al. 2007). BNP levels at all time points were markedly elevated, 
compared to published normal values. But interestingly, as opposed to the majority of 
studies of older patients, they found that 24-hour postoperative BNP levels were lower than 
preoperative BNP levels in most patients (75%). However, in those patients whose BNP 
levels increased after surgery outcomes were worse. In fact, an increase in post-operative 
BNP was associated with an increased incidence of low cardiac output syndrome (100% vs. 
36 %), and fewer ventilator-free days (17 ± 13 days vs. 25 ± 3 days), and predicted the 6-
month composite endpoint of death, an unplanned operation, or cardiac transplant (57% vs. 
0%). Furthermore, an increase in BNP after surgery had a sensitivity of 100% and a 
specificity of 87% for predicting a poor postoperative outcome. Notably, neither arterial-
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venous oxygen saturation differences (AVdO2) nor lactate levels (or their corresponding 
changes) were associated with postoperative outcomes in this study(Hsu et al. 2007).  
In another neonatal study, Cannesson and colleagues measured perioperative BNP levels in 
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arteries(Cannesson et al. 2007). Contrary to the findings of Hsu, BNP levels increased over 
the first 48 hours postoperatively. However, like the study by Hsu these investigators found 
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syndrome, and the need for inotropic support. These investigators found that a BNP level of 
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neonates and non-neonatal controls undergoing surgical repair for various congenital 
cardiac defects(Niedner et al. 2010). They found that BNP levels increased after surgery, 
peaking at 12 hours. Levels at 24 hours were significantly higher in neonates than in non-
neonates (median of 1506 vs 286 pg/ml). In addition, postoperative BNP levels correlated 
with the inotropic requirement, duration of mechanical ventilation, and intensive care unit 
and hospital length of stay. When comparing the various cardiac defects, these investigators 
found great variability between lesions and noted the significant impact of age, with 
postoperative elevations occurring earlier and to a much greater magnitude in neonates 
compared to older children. One might speculate that the differences between the neonatal 
studies of Hsu, Cannesson, and Niedner relate in part to differences between single and bi-
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loading. Furthermore, these studies demonstrate that the potential clinical utility for BNP 
determinations as a part of management after cardiac surgery may depend upon analyzing 
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or total cavopulmonary connection (n=11)(Hsu et al. 2008). Plasma BNP levels were measured 
before and at various time points after surgery. They found that BNP levels increased after 
surgery, peaking at 12 hours in most patients. In the bidirectional cavopulmonary anastomosis 
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connection group, preoperative BNP levels were highest in patients with total cavopulmonary 
connection failure compared with patients with a good outcome, whereas postoperative BNP 
levels were not predictive of outcome.Importantly, preoperative cardiac catheterization data 
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extracorporeal life support (ECLS) after cardiac surgery(Chikovani et al. 2007). In particular, 
alterations in BNP during weaning trials off of ECLS were determined and compared to 
other biochemical markers, including lactate and the AVDO2.This study did not find 
associations between long-term outcome and alterations in lactate and the AVDO2 during 
trials off ECLS. However, an increase in BNP during the final trial off ECLS had a sensitivity 
of 80% and a specificity of 100% for predicting the need for an unplanned operation or death 
within 3 months.  A notable finding of this study was that BNP levels decreased during 
trials off of ECLS support (which were accomplished through the use of a bridge placed in 
the ECLS circuit, allowing mechanical support to be diverted away from the patient before 
the ECLS cannulae were removed) in patients who were successfully separated from ECLS 
after a trial. Since trials off ECLS were associated with increased cardiac filling (increased 
central venous pressures) in all patients, this study suggests that BNP levels may be 
regulated by additional mechanisms (other than just myocyte stretch). Furthermore, during 
trials off of ECLS, inotropic support, lactate levels and the AVDO2 increased in all patients 
(both those who successfully separated from ECLS and those who did not), suggesting that 
BNP levels may capture myocardial performance in a unique manner.  
In a similar earlier study, Huang and colleagues studied fifteen pediatric patients requiring 
ECLS for cardiogenic shock(Huang et al. 2006). Eleven of the fifteen patients developed 
shock after cardiac surgery. These investigators did not find an association between BNP 
levels during the course of ECLS and survival after ECLS. However, they did find that BNP 
levels on the first and fourth day following separation from ECLS were significantly higher 
in nonsurvivors than survivors(Huang et al. 2006). 
5.3 Long-term outcomes 
Koch and colleagues measured BNP levels in 130 children and adolescents (mean age of 16.1 
years) with a history of surgically repaired tetralogy of Fallot, at a mean time of 13±6.5 years 
after repair. They also performed exercise testing and echocardiograms. BNP levels were 
increased above normal gender and age specific values in 60% of the patients, but were less 
than 200 pg/ml in all patients(Koch et al. 2010). BNP levels were higher in patients awaiting 
pulmonary valve replacement, and in those in NYHA class II compared to class I. 
Furthermore, BNP levels correlated with right ventricular dilatation and the severity of 
tricuspid and pulmonary valve regurgitation, and were inversely correlated with exercise 
time. In addition, BNP levels increased over time in patients awaiting pulmonary valve 
replacement and decreased after surgery. The authors suggested that BNP levels might aid 
in the long-term management of these patients, particularly in the timing of pulmonary 
valve replacement.  
Pietrzak and Werner conducted a similar study, in which they measured NT-proBNP levels 
in 20 adolescents (10 to 17 years of age) during a follow-up period of 7 to 16 years after 
repair of tetralogy of Fallot(Pietrzak and Werner 2009). They found that NT-proBNP levels 
were higher in those patients than in age matched healthy controls. NT-proBNP levels were 
higher in patients who had undergone repair with a transannular patch compared to those 
who underwent repair without a transannular patch. Furthermore, NT-proBNP levels were 
increased in patients with: QRS prolongation during exercise testing, severe pulmonary 
regurgitation, and severe triscuspid regurgitation. Likewise, Dodge-Khatami and colleagues 
measured plasma NT-proBNP levels and obtained cardiac magnetic resonance imaging in 
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23 patients with repaired tetralogy of Fallot, severe pulmonary insufficiency, and increased 
right ventricular end-diastolic volume that were undergoing pulmonary valve 
replacement(Dodge-Khatami et al. 2006). Log-NT-proBNP levels were inversely correlated 
with right ventricular ejection fraction before and 6 months after surgery. NT-proBNP 
levels, right ventricular end-diastolic volume, and pulmonary insufficiency all decreased by 
6 months after surgery.  
These three studies differed from a study by Apitz and colleagues. These investigators 
measured BNP levels and recorded pressure-volume loops using conductance catheters in 
16 adolescents (median age of 14.2 years) with a known history of right ventricular dilation 
(NYHA class I, and Ross class 0) secondary to pulmonary regurgitation after repair of 
tetralogy of Fallot(Apitz et al. 2009). Latent right ventricular dysfunction was defined as 
impaired contractility (calculated by the slope of the end-systolic pressure-volume relation) 
in response to a dobutamine infusion. Latent right ventricular dysfunction was identified in 
5 patients, but no clear relationship with BNP levels could be observed. The difference 
between this study and those of Koch, Pietrzak, and Dodge-Khatami may relate to the 
severity of disease, suggesting that BNP may not be useful in detecting subclinical 
deterioration in this patient population. 
In a small pilot study, Paul and colleagues measured BNP levels before and after surgical 
repair of ventricular septal defects in 14 patients who were less than 2 years of age(Paul et 
al. 2009). Mean BNP levels decreased by 94 pg/ml after repair. Longitudinal analysis found 
that there was a weak inverse correlation between the postoperative change in BNP and 
postoperative weight gain (weight z-score change per month). 
Recently, Atz and colleagues described their findings in a study of 510 children (6-18 years 
of age), who were enrolled in the Pediatric Heart Network Fontan cross-sectional study(Atz 
et al. 2011). The patients had all undergone 3rd stage palliation of single ventricle cardiac 
defects with a Fontan procedure (median time from Fontan of 8.2 years). The distribution of 
BNP levels in these patients were highly skewed, but were generally within the normal 
range (median 13 pg/ml). However, logBNP levels were independently associated with a 
history of pre-Fontan systolic dysfunction, and post-Fontan complications, including 
thrombosis. LogBNP levels were higher in patients with atrial-to-pulmonary connections 
compared to extracardiac conduits. Furthermore, increased logBNP levels were associated 
with a lower level of physical functioning, chronotropic index during exercise, diastolic 
dysfunction, and greater ventricular mass measured by cardiac magnetic resonance 
imaging.  
In a similar study, Koch and colleagues measured plasma BNP levels in 67 patients after a 
modified Fontan procedure(Koch et al. 2008). Although there was a wide range, BNP levels 
were normal in 81% of the patients, with a median value of 13 pg/ml. Levels were not 
different between patients with right or left ventricular morphology. BNP levels were higher 
in patients in NYHA class II compared to those in class I, and were positively correlated 
with the severity of AV valve regurgitation. Likewise, Man and colleagues measured plasma 
BNP levels and assessed ventricular function (by tissue Doppler assessments, acoustic 
quantification, and myocardial performance index) in 35 asymptomatic patients who had 
previously undergone a Fontan procedure(Man and Cheung 2007). Comparisons were made 
to 34 healthy controls. Although BNP levels were low in the Fontan group (median 21 
pg/ml), they were higher than the control group. Moreover, BNP levels were inversely 
correlated with ventricular function, particularly diastolic function.  
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extracorporeal life support (ECLS) after cardiac surgery(Chikovani et al. 2007). In particular, 
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in the long-term management of these patients, particularly in the timing of pulmonary 
valve replacement.  
Pietrzak and Werner conducted a similar study, in which they measured NT-proBNP levels 
in 20 adolescents (10 to 17 years of age) during a follow-up period of 7 to 16 years after 
repair of tetralogy of Fallot(Pietrzak and Werner 2009). They found that NT-proBNP levels 
were higher in those patients than in age matched healthy controls. NT-proBNP levels were 
higher in patients who had undergone repair with a transannular patch compared to those 
who underwent repair without a transannular patch. Furthermore, NT-proBNP levels were 
increased in patients with: QRS prolongation during exercise testing, severe pulmonary 
regurgitation, and severe triscuspid regurgitation. Likewise, Dodge-Khatami and colleagues 
measured plasma NT-proBNP levels and obtained cardiac magnetic resonance imaging in 
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to 34 healthy controls. Although BNP levels were low in the Fontan group (median 21 
pg/ml), they were higher than the control group. Moreover, BNP levels were inversely 
correlated with ventricular function, particularly diastolic function.  
 




The essential relationship between BNP production by the cardiac ventricle and increased 
myocyte stretch is the foundation for the potential use of BNP as a biomarker in any 
condition in which abnormal ventricular loading conditions are primarily involved in the 
pathophysiology. To date, plasma BNP determinations have not attained the same clinical 
prominence in pediatric patients as in adults. The growing utilization of BNP 
determinations in the care of adult patients likely stems from the ability to make clinical 
decisions, indeed to titrate therapy, in response to BNP levels(Troughton et al. 2000). Thus, a 
widespread use of BNP in pediatric patients is restrained by the scarcity of data that 
supports BNP guided therapies. It is likely that this discrepancy between the adult and 
pediatric experience relates, in part, to the number of investigations. However, compared to 
adult CHF, pediatric cardiac diseases resulting in ventricular dysfunction and CHF are far 
more heterogeneous. In fact, coronary artery disease is the leading cause of CHF in adults, 
whereas pediatric CHF may result from a wide spectrum of congenital cardiac defects and 
various cardiomyopathies. Moreover, clinically relevant cutoff values for plasma BNP levels 
within these various disease processes are not well established or are completely unknown. 
Nonetheless, the ability to readily quantify plasma BNP levels is attractive as few markers 
are so directly related to the pathobiology of the cardiac ventricle. This is particularly true in 
the management of critically ill pediatric patients, where we often employ surrogate 
markers of disease severity, such as serum lactate levels, that reflect global processes as 
opposed to organ specific functioning. 
Based on the studies outlined above, it is clear that BNP determinations can offer valuable 
clinical information to aid in the management of neonates, infants, and children undergoing 
surgical repair of cardiac defects. It is also clear, however, that the information is unlikely to 
come from single cut-off values that can be generalized across populations. Rather, a clinical 
utility for BNP determinations will likely come from an advanced understanding of 
expected perioperative patterns of change in BNP levels – patterns that will differ between 
age groups and specific cardiac defects. Furthermore, future studies must begin to evaluate 
the utility of guiding therapy in response to plasma BNP values. Fortunately, the ease of 
measuring BNP levels should facilitate these studies. For now the available data 
demonstrate that BNP has emerged as a novel biomarker with great potential.  
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1. Introduction 
Surgical therapy for aortic arch disease involves partial or complete replacement of the 
aortic arch with reimplantation of the great vessels while the cerebral blood flow is 
temporarily altered. Patients undergoing this mandatory period of circulatory arrest during 
arch replacement are at an increased risk for adverse neurologic outcomes, and strategies for 
cerebral protection must be implemented to achieve successful results. The optimal strategy 
for management of the circulation during aortic arch surgery remains controversial. Arch 
reconstruction has historically been associated with significant morbidity and mortality due 
to global ischemic end-organ damage occurring during the circulatory arrest period.  As 
surgical techniques have evolved, survival has improved; however, neurologic dysfunction 
due to cerebral ischemia remains a significant concern.  
Profound hypothermia was the initial method of cerebral protection utilized during the 
period of circulatory arrest. The first successful series of arch reconstructions using deep 
hypothermic circulatory arrest (DHCA) with body temperatures of 18°C was reported in 
1975 (1). Further efforts to improve cerebral protection during arch reconstruction have led 
to the development of antegrade cerebral perfusion (ACP) and retrograde cerebral perfusion 
(RCP). Both techniques provide continuous blood flow to the brain and are used in 
conjunction with hypothermic circulatory arrest (HCA). The optimal method of cerebral 
perfusion (antegrade vs. retrograde) is a controversial topic and has yet to be determined. In 
the this chapter, the indications for aortic arch surgery will be delineated, and the various 
methods of cerebral protection strategies and their results will be reviewed. 
2. Pathology/indications for aortic arch surgery 
The most common indication for arch replacement is the presence of aneurysmal disease. 
The most common type of arch aneurysm is a degenerative aneurysm. The media of the 
aortic wall in degenerative aneurysms develops cellular necrosis which results in a loss of 
smooth muscle cells that are replaced by cystic spaces filled with mucoid material. Dr. 
Cooley coined the phrase cystic medial necrosis to describe this characteristic histologic 
pattern found in degenerative aneurysms (2). These aneurysms also have a significant 
reduction in elastin content due to a poorly understood increase in elastin fragmentation.  
The second most common cause of arch aneurysms is atherosclerosis. The development of 
invasive atheromas is thought to destroy the elastin fibers and smooth muscle cells of the 
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aortic media resulting in aneurysm formation.(3). Inherited genetic connective tissue 
disorders such as Marfan syndrome, Ehlers-Danlos and Loeys-Dietz syndrome are less 
common causes of arch aneurysms. Familial arch aneurysms are a subtype of heritable 
aneurysms which do not express a recognizable phenotype of a known connective tissue 
disorder, and do not have a specific gene or product which has been identified (3). Bicuspid 
aortic valve (BAV) disease is a congenital anomaly occurring in 0.9-2% of the population 
which is associated with an intrinsic aortopathy that leads to the development of proximal 
arch aneurysms. BAV aneurysms are thought to be due to an abnormal extracellular matrix 
of the aortic wall. Infection is a rare cause of (mycotic) arch aneurysms and requires 
replacement with aortic homograft. 
The presence or absence of symptoms is the most important factor in the management of 
patients with arch aneurysms. Most patients with arch aneurysms are asymptomatic, and 
the aneurysm is discovered incidentally on radiographic imaging obtained for another 
purpose. Patients with symptomatic arch aneurysms typically experience chest or back pain. 
However, symptoms can also include compression or stretching of surrounding anatomic 
structures. Tracheal compression can cause stridor, esophageal compression may result in 
dysphagia, superior vena cava compression can cause plethora, and aneurysmal stretching 
of the recurrent laryngeal nerve produces hoarseness. The sudden onset of pain is 
considered an ominous warning sign of imminent rupture or dissection, and urgent surgery 
is indicated for all patients with symptomatic arch aneurysms (4).  Operative therapy for 
asymptomatic arch aneurysms is performed for prophylactic replacement of the aorta in 
order to prevent rupture or dissection, and thereby improve patient survival. Total aortic 
arch replacement for an isolated arch aneurysm should be performed at sizes ≥ 5.5cm. Rapid 
expansion of the aneurysm at a rate ≥0.5cm/year is another indication for surgery. 
Concomitant proximal (hemi-) arch replacement is recommended at the time of ascending 
aortic replacement if the proximal arch is enlarged (4).  
The other common indication for surgical intervention on the aortic arch is acute Type A 
aortic dissection. Surgical treatment of acute Type A aortic dissection requires resection of 
the primary tear, restoration of aortic valve competency, aortic replacement, and obliteration 
of the false lumen at the proximal and distal anastomoses. The distal extent of aortic 
replacement depends upon whether the arch is involved in the dissection. Arch involvement 
requires hemi-arch or total arch replacement under circulatory arrest using an open distal 
anastomosis. Total arch replacement in the setting of acute Type A aortic dissection is 
recommended when the arch is aneurysmal or there is extensive destruction or leakage (4). 
Nevertheless, it should be emphasized that total arch replacement significantly increases the 
risk of stroke and death during repair of an acute Type A dissection and should only be 
performed by experienced surgeons. 
3. Cerebral protection strategies 
3.1 Deep hypothermic circulatory arrest 
In 1952, John Lewis used systemic hypothermia at 28°C and inflow occlusion to perform the 
first successful atrial septal defect repair in a 5 year old girl (5). Systemic hypothermia was 
gradually phased out with the introduction of the cardiopulmonary bypass machine, but 
was rediscovered and used by separate investigators in isolated reports of aortic arch 
replacement in the 1960’s (6,7). Dr. Griepp reported the first successful series of total arch 
replacements in adults in 1975, using deep hypothermic circulatory arrest) at 18°C for 
cerebral protection (1). 
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The technique of DHCA for aortic arch replacement involves placing the patient on 
cardiopulmonary bypass and initiating systemic hypothermia to a core temperature of 18°C. 
Once this core temperature has been achieved, cardiopulmonary bypass is interrupted and 
the systemic circulation is arrested.  The aortic arch is resected and reconstructed, deairing 
maneuvers are performed, and cardiopulmonary bypass is resumed. The exact mechanism 
of cerebral protection afforded by deep hypothermia is not completely understood, but its 
main beneficial effect is the suppression of cerebral metabolism. This is important because it 
enables an extension of the period of cerebral ischemic tolerance required for arch 
replacement.  
Systemic hypothermia at 20°C has been shown to reduce the cerebral metabolic rate by 76% 
(8) (Table 1). It has also been postulated that there is an uncoupling of cerebral blood flow 
and cerebral metabolism at approximately 22C, likely due to a loss of autoregulation in the 
cerebral vasculature. The ratio of cerebral blood flow to cerebral metabolism increases from 
20:1 at normothermia, to 75:1 with deep hypothermia (9). Once the period of DHCA has 
been completed and cerebral reperfusion has been initiated, severe cerebral vasoconstriction 
occurs. There is also an accumulated cerebral oxygen debt from the ischemic period which 
must be “paid back”, and therefore, normal levels of cerebral metabolism are maintained by 
increased oxygen extraction (10, 11, 12). During the period following DHCA, the brain is at 
high risk for both ongoing ischemic injury due to low cerebral blood flow, and reperfusion 
injury.  There has also been experimental data to suggest that following DHCA, there is an 
increase in intracranial pressure due to cerebral edema which negatively impacts 
neurophysiologic recovery (13). 
 
 
Table 1. From McCullough JN, Zhang N, Reich DL et al. Cerebral metabolic suppresion 
during hypothermic circulatory arrest in humans. Ann Thorac Surg 1999; 67:1895-1921. 
Cerebral injury following procedures requiring circulatory arrest is manifested clinically as 
post-operative transient or permanent neurologic injury. Permanent neurologic dysfunction 
(PND) appears as a focal neurologic deficit or stroke, which is thought to be the result of 
embolic phenomena. The incidence of PND following arch reconstruction has been shown to 
be directly related to the site of arterial cannulation (14). Transient neurologic deficit (TND) 
is defined as postoperative confusion, delirium, obtundation, or transient focal deficits 
(resolution within 24 hours) with negative brain computed tomography or magnetic 
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aortic media resulting in aneurysm formation.(3). Inherited genetic connective tissue 
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aortic dissection. Surgical treatment of acute Type A aortic dissection requires resection of 
the primary tear, restoration of aortic valve competency, aortic replacement, and obliteration 
of the false lumen at the proximal and distal anastomoses. The distal extent of aortic 
replacement depends upon whether the arch is involved in the dissection. Arch involvement 
requires hemi-arch or total arch replacement under circulatory arrest using an open distal 
anastomosis. Total arch replacement in the setting of acute Type A aortic dissection is 
recommended when the arch is aneurysmal or there is extensive destruction or leakage (4). 
Nevertheless, it should be emphasized that total arch replacement significantly increases the 
risk of stroke and death during repair of an acute Type A dissection and should only be 
performed by experienced surgeons. 
3. Cerebral protection strategies 
3.1 Deep hypothermic circulatory arrest 
In 1952, John Lewis used systemic hypothermia at 28°C and inflow occlusion to perform the 
first successful atrial septal defect repair in a 5 year old girl (5). Systemic hypothermia was 
gradually phased out with the introduction of the cardiopulmonary bypass machine, but 
was rediscovered and used by separate investigators in isolated reports of aortic arch 
replacement in the 1960’s (6,7). Dr. Griepp reported the first successful series of total arch 
replacements in adults in 1975, using deep hypothermic circulatory arrest) at 18°C for 
cerebral protection (1). 
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resonance imaging scans. TND is a reversible, diffuse, subtle injury which is an indicator of 
global cerebral injury due to inadequate cerebral protection. TND following arch 
reconstruction using DHCA alone has been shown to occur in approximately 25% of all 
cases, and a linear relationship has been demonstrated between the incidence of TND and 
the duration of DHCA (15, 16, 17).   
In order to limit adverse neurologic outcomes, many investigations have focused upon 
determining a “safe” duration of DHCA. Based upon direct measurements of cerebral 
metabolism in adults, the safe period of DHCA has been estimated to be 30 minutes at 15°C, 
and 40 minutes at 10°C. Cellular anoxia occurs when these time periods are exceeded. (8). In a 
series of 656 patients undergoing arch surgery with DHCA alone, Svensson and colleagues 
reported a 10% mortality rate, and a 7% incidence of transient or permanent stroke. In a 
multivariate analysis, these authors demonstrated an increased risk of stroke following a 
period of DHCA > 40 minutes, and an increased mortality rate following a DHCA period >65 
minutes (18). Griepp’s group reported a 22% incidence of TND in 443 patients undergoing 
hemi-arch replacement with DHCA alone. In a multivariate analysis, these authors showed a 
DHCA time >30 minutes was an independent risk factor for TND (19). Using 
neuropsychologic tests, these investigators also demonstrated in a separate study that a DHCA 
duration > 25 minutes is a risk factor long-term deficits in neurocognitive function (20). 
DHCA was the first successful cerebral protection strategy used in aortic arch surgery. Over 
the past three decades, aortic surgeons have improved their techniques for arch replacement 
and novel strategies for circulation management and cerebral protection have evolved. 
However, for short circulatory arrest times ≤ 30 minutes, there are still many surgeons who 
achieve excellent outcomes with DHCA alone as their sole method of cerebral protection 
during arch reconstruction.  For more complex, extended arch reconstructions that require 
circulatory arrest times > 30 minutes, there is a consensus that DHCA alone is an inadequate 
cerebral protection strategy. In the current era, most experts in the field of aortic surgery use 
either antegrade or retrograde cerebral perfusion as an adjunctive method of cerebral 
protection in addtion to deep or moderate hypothermic circulatory arrest. (21).  
3.2 Retrograde Cerebral Perfusion 
Retrograde cerebral perfusion (RCP) was first described by Mills and Ochner as a method of 
treating a massive air embolus during cardiopulmonary bypass (22). RCP is employed by 
cannulating and snaring the superior vena cava, and infusing blood up the superior vena 
cava to perfuse the brain in a retrograde direction during the period of circulatory arrest. 
Flow rates are adjusted to achieve an SVC pressure of 20-25mm Hg. It is well recognized 
that RCP is a highly effective method of flushing embolic material from the cerebral 
circulation, and it maintains cerebral hypothermia by continuously bathing the brain in cold 
blood. There is a theoretical benefit that RCP can provide sufficient cerebral blood flow to 
support cerebral metabolism and remove toxic metabolites and waste products (9).  
Although there was initial enthusiasm for RCP’s ability to support cerebral metabolism, this 
hypothesis has subsequently been disproved. Multiple animal studies in different species 
have demonstrated minimal or no cerebral blood flow with the use of RCP (23, 24, 25). 
Although cerebral perfusion can be improved with higher retrograde perfusion pressures 
and occlusion of the inferior vena cava, there is a concomitant increase in cerebral edema 
with histologic evidence of cerebral injury (26). 
Many groups adopted the use of RCP in conjunction with DHCA in the 1990’s as their 
routine strategy for circulatory management during arch reconstruction with excellent 
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outcomes. Bavaria and colleagues demonstrated a significant improvement over previous 
reported series of Type A aortic dissection repairs using DHCA and RCP. In their series of 
104 patients, these investigators reported a 9% mortality rate and 5% stroke rate with a mean 
duration of DHCA+RCP of 42 minutes in 104 consecutive patients undergoing emergent 
repair of Type A aortic dissection (27). In a series of 479 patients undergoing arch surgery 
with DHCA for aneurysmal disease or dissection, Coselli compared the results using DHCA 
alone vs. DHCA+RCP. The subgroup who received DHCA+RCP had significantly reduced 
mortality (DHCA+RCP 3.4% vs. DHCA 14.8%, p<0.001) and stroke rates (DHCA+RCP 2.4% 
vs. DCHA 6.5%, p<0.05) (28).  
Estrera and colleagues also reported excellent results with the use of DHCA+RCP in both 
elective and emergent arch repairs. These investigators reported a mortality rate of 10.4% 
and a 2.8% stroke rate in a series of 1107 patients in which 907 (82%) patients received 
DHCA+RCP. However, the incidence of TND was 15.5% with relatively short mean RCP 
times of 26 minutes (29). Although this is lower than the 25% incidence of TND associated 
with arch reconstruction using DHCA alone (17), it is still a significant incidence of 
inadequate cerebral protection. Other groups have also reported a significant incidence of 
TND with the use of DHCA+RCP (30, 31, 32). The high incidence of TND and the recent 
popularity of antegrade cerebral perfusion has led to decreased utilization of RCP by most 
aortic surgeons (21). Nevertheless, RCP remains an important adjunctive cerebral protection 
strategy to DHCA is still used by many high volume aortic centers with excellent outcomes 
(33, 34). It is a highly effective anti-embolic technique which is especially useful for arch 
reconstruction in patients with carrying a heavy atherosclerotic burden. 
3.3 Antegrade Cerebral Perfusion 
Debakey and Cooley were the first to successfully describe the use of antegrade cerebral 
perfusion (ACP) in the surgical repair of an arch aneurysm (35). In their initial report, 
cannulas were placed into the right femoral artery and both carotid arteries, and a separate 
pump from the main cardiopulmonary bypass machine was used to perfuse normothermic 
blood into the carotid arteries. Despite its initial success, this method was considered 
complex and cumbersome, and was subsequently abandoned in favor of DHCA + RCP. The 
use of ACP began to reappear in reports of arch reconstructions in the late 1980’s. Bachet 
reported a 2.1% PND rate and a 4.3% TND rate with the use of ACP with “cold 
cerebroplegia” via bilateral carotid cannulation in a series of 54 patients (36). A year later, 
Kazui published excellent neurologic outcomes in a series of arch reconstructions by 
introducing catheters into the innominate and left common carotid arteries and providing 
ACP at a rate of 10mL/Kg/min during the period of DHCA. This perfusion rate was 
considered 50% of physiologic levels based upon experimental data, and has subsequently 
become the standard perfusion rate of ACP by most groups using this technique (37). 
During the 1990’s most centers performing a significant volume of aortic arch surgery began 
using either ACP or RCP as an adjunctive form of cerebral protection in addition to DHCA.  
It should be recognized that the utilization of ACP changes the paradigm of circulatory 
arrest. Circulatory arrest, as originally described, refers to the total arrest of the circulation 
and the absence of perfusion to all organs (except the heart via cardioplegia). The addition 
of ACP changes this concept from total body circulatory arrest to lower body circulatory 
arrest, as the brain, arms and the spinal cord (via collateral circulation) are being perfused. 
Therefore the legs and the abdominal visceral are the only truly ischemic organs during the 
circulatory arrest period with the use of ACP. 
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resonance imaging scans. TND is a reversible, diffuse, subtle injury which is an indicator of 
global cerebral injury due to inadequate cerebral protection. TND following arch 
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metabolism in adults, the safe period of DHCA has been estimated to be 30 minutes at 15°C, 
and 40 minutes at 10°C. Cellular anoxia occurs when these time periods are exceeded. (8). In a 
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outcomes. Bavaria and colleagues demonstrated a significant improvement over previous 
reported series of Type A aortic dissection repairs using DHCA and RCP. In their series of 
104 patients, these investigators reported a 9% mortality rate and 5% stroke rate with a mean 
duration of DHCA+RCP of 42 minutes in 104 consecutive patients undergoing emergent 
repair of Type A aortic dissection (27). In a series of 479 patients undergoing arch surgery 
with DHCA for aneurysmal disease or dissection, Coselli compared the results using DHCA 
alone vs. DHCA+RCP. The subgroup who received DHCA+RCP had significantly reduced 
mortality (DHCA+RCP 3.4% vs. DHCA 14.8%, p<0.001) and stroke rates (DHCA+RCP 2.4% 
vs. DCHA 6.5%, p<0.05) (28).  
Estrera and colleagues also reported excellent results with the use of DHCA+RCP in both 
elective and emergent arch repairs. These investigators reported a mortality rate of 10.4% 
and a 2.8% stroke rate in a series of 1107 patients in which 907 (82%) patients received 
DHCA+RCP. However, the incidence of TND was 15.5% with relatively short mean RCP 
times of 26 minutes (29). Although this is lower than the 25% incidence of TND associated 
with arch reconstruction using DHCA alone (17), it is still a significant incidence of 
inadequate cerebral protection. Other groups have also reported a significant incidence of 
TND with the use of DHCA+RCP (30, 31, 32). The high incidence of TND and the recent 
popularity of antegrade cerebral perfusion has led to decreased utilization of RCP by most 
aortic surgeons (21). Nevertheless, RCP remains an important adjunctive cerebral protection 
strategy to DHCA is still used by many high volume aortic centers with excellent outcomes 
(33, 34). It is a highly effective anti-embolic technique which is especially useful for arch 
reconstruction in patients with carrying a heavy atherosclerotic burden. 
3.3 Antegrade Cerebral Perfusion 
Debakey and Cooley were the first to successfully describe the use of antegrade cerebral 
perfusion (ACP) in the surgical repair of an arch aneurysm (35). In their initial report, 
cannulas were placed into the right femoral artery and both carotid arteries, and a separate 
pump from the main cardiopulmonary bypass machine was used to perfuse normothermic 
blood into the carotid arteries. Despite its initial success, this method was considered 
complex and cumbersome, and was subsequently abandoned in favor of DHCA + RCP. The 
use of ACP began to reappear in reports of arch reconstructions in the late 1980’s. Bachet 
reported a 2.1% PND rate and a 4.3% TND rate with the use of ACP with “cold 
cerebroplegia” via bilateral carotid cannulation in a series of 54 patients (36). A year later, 
Kazui published excellent neurologic outcomes in a series of arch reconstructions by 
introducing catheters into the innominate and left common carotid arteries and providing 
ACP at a rate of 10mL/Kg/min during the period of DHCA. This perfusion rate was 
considered 50% of physiologic levels based upon experimental data, and has subsequently 
become the standard perfusion rate of ACP by most groups using this technique (37). 
During the 1990’s most centers performing a significant volume of aortic arch surgery began 
using either ACP or RCP as an adjunctive form of cerebral protection in addition to DHCA.  
It should be recognized that the utilization of ACP changes the paradigm of circulatory 
arrest. Circulatory arrest, as originally described, refers to the total arrest of the circulation 
and the absence of perfusion to all organs (except the heart via cardioplegia). The addition 
of ACP changes this concept from total body circulatory arrest to lower body circulatory 
arrest, as the brain, arms and the spinal cord (via collateral circulation) are being perfused. 
Therefore the legs and the abdominal visceral are the only truly ischemic organs during the 
circulatory arrest period with the use of ACP. 
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Different methods and nomenclature are used in the literature to describe ACP techniques. 
It is most commonly referred to as selective antegrade cerebral perfusion (SACP), because 
many surgeons introduce individual cathethers or cannulae into the orifices of the 
innominate and left common carotid arteries, thus selecting out the individual great vessels 
for cerebral perfusion. This is also referred to as bilateral selective antegrade cerebral 
perfusion (bSACP). Another modality is unilateral SACP (uSACP), which can refer to two 
different sites of cannulation. One method is to directly cannulate or sew a graft on to the 
base of the innominate artery to provide antegrade cerebral perfusion up the right common 
carotid artery. A different technique is to directly cannulate or sew a graft on to the right 
axillary artery. At the time of circulatory arrest, a clamp is placed across the base of the 
innominate artery, and blood is forced up the right common carotid. Both methods are 
considered uSACP. 
The hypothesis of ACP is that antegrade cerebral blood flow is more physiologic than no 
blood flow (HCA) or retrograde blood flow (RCP), and should therefore provide superior 
cerebral protection. Data from experimental animal models of DHCA comparing ACP and 
RCP have confirmed this hypothesis. Hagl and colleagues showed in an acute porcine 
model that a strategy of DHCA+ACP compared to DHCA alone is associated with 
improved neurophysiologic recovery, lower intracranial pressure, less cerebral edema, and 
reduced tissue acidosis following the circulatory arrest period (38). In a porcine model of 
circulatory arrest and reperfusion, Filgueiras and colleagues showed that near normal 
cerebral metabolism was maintained with DHCA+ACP, based upon pH measurements and 
levels of cerebral metabolites. The pigs who underwent DHCA+RCP or DHCA alone 
demonstrated a significant drop in cerebral pH during the protocol (39). In a separate study 
using the same model, these same investigators demonstrated preserved cell structure upon 
histopathologic analysis with HCA+ACP compared to HCA+RCP (40) 
The Mount Sinai group under Dr. Griepp has performed extensive laboratory work on the 
topic of ACP. These investigators determined that hypothermic SACP at 10-15C provides 
better cerebral protection than SACP at 20-25C based upon post-op behavioral scores in a 
chronic porcine circulatory arrest model (41).  They also showed that a short period of HCA 
prior to SACP initiation does not impact the level of cerebral protection compared to 
continuous SACP. This is important clinically because many surgeons will use a short 
period of HCA alone prior to initiating SACP to keep the field clean while they are 
performing arch resection in order to reduce the risk of atheroembolization (42).  Ye and 
colleagues compared unilateral and bilateral SACP to determine whether there was any 
difference in cerebral perfusion and cerebral protection between the two techniques. Using 
magnetic resonance perfusion imaging, these investigators compared cerebral blood volume 
and regional cerebral perfusion patterns in pigs undergoing circulatory arrest with uSACP 
via the right axillary artery to a separate group undergoing bSACP via bilateral carotid 
artery cannulation. Both methods provided uniform blood distribution to both cerebral 
hemispheres and preserved normal morphology of the cerebral neurons (43). 
Clinical studies have also supported DHCA+ACP as a superior method of cerebral 
protection compared to DHCA+RCP or DHCA alone. Using transcranial Doppler 
measurements during DHCA, Tanoue and colleagues demonstrated superior middle 
cerebral artery blood flow in patients undergoing DHCA+ACP compared to those 
undergoing DHCA+RCP (44).  Neri and colleagues demonstrated that the cerebrovascular 
autoregulation function was preserved in the immediate postoperative period in patients 
undergoing DHCA+ACP.  However, the autoregulatory function was significantly impaired 
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in patients undergoing DHCA alone or DHCA+RCP. Based upon the higher incidence of 
TND in the DHCA and DHCA+RCP groups, this post-operative impairment in cerebral 
autoregulation was considered to be an expression of CNS injury (45).  
Hagl reviewed the neurologic outcomes from the Mount Sinai experience of 717 patients 
undergoing arch replacement with the three different methods of cerebral protection. The 
incidence of stroke (PND) and TND was 5.7% and 30%. Due to significant differences in the 
circulatory arrest times, they were unable to determine whether the method of cerebral 
protection impacted the stroke rate. However, by using a multivariate analysis, the use of 
DHCA+ACP significantly reduced the incidence of TND compared to DHCA+RCP or 
DHCA alone (31). In a randomized controlled trials comparing ACP vs RCP for total arch 
replacements performed under DHCA, Okita and colleagues showed no difference in stroke 
between patients undergoing ACP vs RCP, however ACP significantly reduced the 
incidence of TND (ACP 13.3% vs. RCP 33.3%, p=0.05) (46). These results were also 
replicated in series of 48 patients undergoing arch reconstruction during type A aortic 
dissection repair. In this series, Apostolakis and colleagues reported no difference in 
mortality or PND between patients undergoing DHCA+ACP vs DHCA+RCP. However, the 
incidence of TND was significantly higher in the DHCA+RCP group (DHCA+RCP 43.5% vs. 
DHCA+ACP 16%, p=0.04) (47).  
In the current era, ACP has become the preferred method of cerebral protection employed 
by most aortic surgeons at the time of arch reconstruction (21). The lessons learned from the 
majority of studies comparing the various methods of cerebral protection are: 1)an adjunct 
form of cerebral protection (ACP or RCP) is superior to DHCA alone and 2)the method of 
cerebral perfusion (ACP or RCP) has no impact upon the incidence of PND, however ACP 
significantly reduces the incidence of TND.  
3.4 Moderate hypothermia 
Since Griepp’s initial report of the successful use of DHCA for cerebral protection during 
arch replacement, profound systemic hypothermia at a core temperature of 18°C has been 
the standard point of hypothermia at which most surgeons will initiate circulatory arrest. As 
discussed above, deep hypothermia affords excellent cerebral protection by suppressing 
cerebral metabolism. Studies in the field of transplantaiton have also demonstrated that 
hypothermia acts in a similar fashion in the preservation of organs (e.g. lungs, liver, heart, 
kidneys)(48). However, profound systemic hypothermia has been shown to have adverse 
effects in multiple organ systems including endothelial dysfunction, neuronal apoptosis, 
coagulopathy and renal failure (49, 50, 51, 52). The time required to cool and rewarm the 
body to 18°C leads to prolonged cardiopulmonary bypass which is detrimental to multiple 
organ system. Furthermore, deep hypothermia has been shown to be a strong risk factor for 
bleeding requiring re-exploration following arch reconstruction (16). Furthermore, despite 
the cerebral metabolic suppressive effects of profound hypothermia, a linear relationship 
has been demonstrated between the incidence of TND and the duration of DHCA alone (53). 
In an attempt to avoid the morbidity associated with DHCA, reduce cardiopulmonary 
bypass times and improve neurologic outcomes there has been a strong initiative from 
many different high volume aortic centers to begin performing arch replacements under 
moderate hypothermia circulatory arrest with ACP. This technique still provides maximum 
cerebral protection because the brain is being perfused with antegrade “cold cerebroplegia” 
at temperatures ≤ 18°C for ACP. It is the abdominal viscera which are the organs placed at 
risk with the technique of MCHA+ACP. However there has yet to be a report of increased 
risk of mesenteric ischemia, liver or renal failure with the use of MHCA. 
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Different methods and nomenclature are used in the literature to describe ACP techniques. 
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innominate artery, and blood is forced up the right common carotid. Both methods are 
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improved neurophysiologic recovery, lower intracranial pressure, less cerebral edema, and 
reduced tissue acidosis following the circulatory arrest period (38). In a porcine model of 
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undergoing DHCA+RCP (44).  Neri and colleagues demonstrated that the cerebrovascular 
autoregulation function was preserved in the immediate postoperative period in patients 
undergoing DHCA+ACP.  However, the autoregulatory function was significantly impaired 
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in patients undergoing DHCA alone or DHCA+RCP. Based upon the higher incidence of 
TND in the DHCA and DHCA+RCP groups, this post-operative impairment in cerebral 
autoregulation was considered to be an expression of CNS injury (45).  
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undergoing arch replacement with the three different methods of cerebral protection. The 
incidence of stroke (PND) and TND was 5.7% and 30%. Due to significant differences in the 
circulatory arrest times, they were unable to determine whether the method of cerebral 
protection impacted the stroke rate. However, by using a multivariate analysis, the use of 
DHCA+ACP significantly reduced the incidence of TND compared to DHCA+RCP or 
DHCA alone (31). In a randomized controlled trials comparing ACP vs RCP for total arch 
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DHCA+ACP 16%, p=0.04) (47).  
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significantly reduces the incidence of TND.  
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arch replacement, profound systemic hypothermia at a core temperature of 18°C has been 
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effects in multiple organ systems including endothelial dysfunction, neuronal apoptosis, 
coagulopathy and renal failure (49, 50, 51, 52). The time required to cool and rewarm the 
body to 18°C leads to prolonged cardiopulmonary bypass which is detrimental to multiple 
organ system. Furthermore, deep hypothermia has been shown to be a strong risk factor for 
bleeding requiring re-exploration following arch reconstruction (16). Furthermore, despite 
the cerebral metabolic suppressive effects of profound hypothermia, a linear relationship 
has been demonstrated between the incidence of TND and the duration of DHCA alone (53). 
In an attempt to avoid the morbidity associated with DHCA, reduce cardiopulmonary 
bypass times and improve neurologic outcomes there has been a strong initiative from 
many different high volume aortic centers to begin performing arch replacements under 
moderate hypothermia circulatory arrest with ACP. This technique still provides maximum 
cerebral protection because the brain is being perfused with antegrade “cold cerebroplegia” 
at temperatures ≤ 18°C for ACP. It is the abdominal viscera which are the organs placed at 
risk with the technique of MCHA+ACP. However there has yet to be a report of increased 
risk of mesenteric ischemia, liver or renal failure with the use of MHCA. 
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Bachet’s initial description of arch reconstructions using “cold cerebroplegia” at 6-12C in 
1991 was also remarkable for the fact that he performed all of his arch reconstructions under 
moderate hypothermic circulatory arrest at core temperatures between 25-28°C (36). Using 
this technique he reported excellent neurologic outcomes with an incidence of PND and 
TND of 2.1% and 4.3% respectively. Minatoya and colleagues evaluated outcomes of 229 
patients who received arch reconstruction with HCA+bSACP at three different 
temperatures: 20C (n=81), 25C (n=81), and 28C (n=67). 81% of all patients received total 
arch replacement. There were no significant differences between the three groups with 
regards to the incidence of mortality, PND or TND (54). The use of MHCA+ACP for arch 
reconstruction has also been reported by several groups in the setting of acute Type A aortic 
dissection with results equivalent to those achieved with DHCA (55, 56, 57). 
At Emory, MHCA+uSACP is our preferred method of cerebral protection. All circulatory 
arrest cases are performed by cannulating an 8mm Dacron graft sewn to the right axillary 
artery. This is based upon a strong belief that axillary artery cannulation reduces the 
incidence of PND. This is supported by the important analysis by Svensson and colleagues 
who reviewed their stroke rates in 1336 circulatory arrest cases with different sites for 
arterial cannulation (ascending aorta, femoral, axillary, and innominate). They determined 
that cannulating a graft sewn to the right axillary artery resulted in the lowest incidence of 
PND (14). Although the mechanism of the protective effect of axillary cannulation is 
unknown, we have two hypotheses. The first is that axillary artery cannulation provides 
retrograde blood flow down the innominate artery, which may prevent atheroembolic 
disease from the ascending aorta. The second hypothesis relates to the differences in 
technique between uSACP and bSACP. In bSACP, there is a risk of cannulation-induced 
embolic injury from the introduction of cerebral perfusion catheters into the innominate and 
left common carotid arteries, especially in patients with atheromatous aortic arch disease. 
With uSACP, the innominate artery is occluded at the time of circulatory arrest and 
antegrade blood at 16°C is perfused at 10ml/kg/min through the right common carotid 
artery, right vertebral artery as well as through the left carotid system via intracranial and 
extracranial collaterals (58). This avoids manipulation of the ostia of the great vessels which 
are often covered with large, friable atherosclerotic plaques.  
In our initial report using this technique, we reviewed 412 arch reconstruction cases (elective 
and emergent) performed under MHCA with uSACP at core temperature of 25.7°C at the 
initiation of circulatory arrest. Operative mortality was 7.0%, and the incidence of PND and 
TND were 3.6% and 5.1% respectively with no cases of paraplegia. There were four (1%) 
deaths due to mesenteric inschemia, and three of these four patients presented with an acute 
Type A aortic dissection with preoperative visceral malperfusion. There was a 4.6% 
incidence of renal failure requiring dialysis. In a multivariate analysis, moderate 
hypothermia was not found to be an independent risk factor for mortality, PND, TND or 
renal failure requiring dialysis (55). Since that initial report, our experience has grown and 
we have continued to perform arch reconstructions at more moderate levels of hypothermia. 
In our recent study, we compared the outcomes of 257 patients undergoing arch 
reconstruction at 24.3°C to 265 patients undergoing arch reconstruction using at 28.5 °C. 
Both groups had adjunctive uSACP. There was no difference in mortality, TND or renal 
failure requiring dialysis between the two groups. The Stroke rate, cardiopulmonary bypass, 
cross clamp, post op ventilator times and ICU and hospital lengths of stay were all reduced 
in the 28.5C group (Table 2) (59). We feel that these results add to the growing body of 
literature which supports the strategy of moderate hypothermic circulatory arrest + uSACP 
as a highly effective cerebral protection strategy for aortic arch replacement (36, 54, 55, 56).  
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Temperature (°C) 28.5 ±1.1 24.3 ± 1.3 <0.01 
Mortality 5.8% 7.8% 0.37 
Stroke 1.5% 4.7% 0.04 
TND  3.9% 5.1% 0.49 
Dialysis  3.9% 3.9% 0.61 
CPB (min) 183 ± 57 209 ± 67 <0.01 
Cross Clamp (min) 145 ± 55 162 ± 65 <0.01 
HCA (min) 29 ± 14 34 ± 18 <0.01 
Ventilator time (hours) 44 ± 101 69 ± 128 0.02 
ICU Stay (hours) 102 ± 144 127 ± 149 0.06 
Hospital stay (Days) 9.5 ± 7.8 10.8 ± 7.2 0.06 
TND=Temporary Neurologic Dysfunction, HCA=Hypothermic Circulatory Arrest,*P<0.05 
Table 2. Comparative Analysis of Perioperative Data and Outcomes between Patients 
undergoing Aortic Arch Reconstruction at Mild vs. Moderate levels of Hypothermia. 
From Leshnower BG, Thourani VH, Myung RJ, et al. Aortic Arch Reconstruction at 28°C: A 
Comparative Analysis of Outcomes using Mild vs Moderate Hypothermia. Ann Thorac Surg 
Submitted. 
4. Conclusion 
Overall outcomes of patients undergoing aortic arch surgery have significantly improved 
over the past 3 decades. Advancements in surgical technique, prosthetic grafts and most 
importantly cerebral protection strategies have all contributed to better results. Despite the 
evidence presented in the preceding paragraphs, the optimal method of cerebral protection 
for arch reconstruction remains a controversial topic. All of these data are observational or 
retrospective studies. Due to surgeon bias and the limited number of arch cases performed, 
it is unlikely that there will ever be a prospective, randomized, controlled trial to determine 
the “gold standard” method of cerebral protection.  
As we have demonstrated, there are many different methods of cerebral protection which 
range from simple to complex. The arterial cannulation site, level of hypothermia, and the 
use of adjunctive cerebral perfusion are factors which have been shown to impact 
neurologic outcomes following arch reconstruction. It is highly likely that most 
cardiothoracic surgeons do 1-2 arch reconstructions/year (usually in the setting of Type A 
dissection) and are most comfortable using DHCA at 18C with femoral cannulation as their 
sole method of cerebral protection (Personal communications). The cerebral protection 
conferred by deep hypothermia is undisputed, and for short circulatory arrest times (<30 
minutes) the addition of RCP or ACP may not significantly impact neurologic outcomes. 
However it is generally agreed upon that for prolonged circulatory arrest times (>45) 
minutes, adjunctive ACP or RCP should be utilized. When using MHCA, ACP must be 
employed as it is the only adjunctive method reported with more moderate levels of 
hypothermia. Animal studies have demonstrated equivalent bilateral perfusion with the use 
of uSACP or bSACP, and clinical data has reported excellent neurologic outcomes with 
either method (43, 54, 55, 57).  Surgeons should be familiar with the technical aspects of all 
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of these different methods of cerebral protection. The arch pathology of each individual 
patient is different and may dictate the optimal method of cerebral protection on an 
individual case basis.  
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Type A acute aortic dissection is one of the most serious cardiovascular conditions and is 
associated with significant morbidity and mortality. A half century ago, Hirst et al 
published a milestone article describing the linearized mortality rate of one percent per hour 
after the onset of an ascending aortic dissection [1]. Hence, the importance of accurate, quick 
and reliable diagnosis, as the timing of procedure is vital for optimal management of this 
highly lethal condition. Despite improvements in the diagnostic modalities, surgical 
techniques and perioperative care, the overall mortality remains high, between 10% and 
30% [2]. 
Due to its major role in systemic perfusion, the aorta and its main branches after dissection 
are often challenging when trying to prevent surgical morbidity and mortality. The 
complexity of aortic dissection presents not only a pure cardiovascular surgical task, but 
also consideration must be given to protection of the myocardium, cerebrum, peripheral 
tissues and organs. An early fatal result of aortic dissection is due to ischaemic injury to the 
brain or heart, although longer peripheral ischaemia can cause multiorgan failure resulting 
in extended hospital stay, increased morbidity and mortality. Alexis Carrel highlighted the 
risks of surgery in 1910 with the following short summary on aortic interventions: “The 
main danger of the aortic operation does not come from the heart or from the aorta itself, 
but from the central nervous system.” Even a century later, we are still trying to optimize 
cerebral protection, despite having significantly wider range of diagnostic and therapeutic 
modalities. 
Advances in our understanding of varying pathologies of aortic dissections have improved 
as have the technological developments in the modes of detection. These advances together 
with improved therapeutic options have raised expectations for better outcomes. 
                                                 
Maik Foltan1, Peter Ugocsai2, Andrea Thrum1, Alois Philipp1, Steven A. Livesey3, Geoffrey M. Tsang3 
and Sunil K. Ohri3  
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2. Acute aortic syndrome 
The term “acute aortic syndrome” (AAS) became widely accepted in the last decade. It 
involves not only aortic dissections, but intramural haematomas and penetrating 
atherosclerotic ulcers in the same anatomical location. This constellation of presentations 
have similar emergency status, diagnostic and therapeutic requirements. As a definition, 
AAS is an acute pathophysiological process involving the tunica media of aortic wall, which 
results in rupture or any further life-threatening complications. 
2.1 Epidemiology 
Population-based epidemiological studies suggest an incidence of AAS of about thirty cases 
per one million people per year. Eighty percent is represented by acute aortic dissections, 
15% by intramural haematomas and 5% as penetrating ulcers. Seventy percent of the 
affected population is male with an average of 60 years [3]. A Swedish epidemiological 
study found the same incidence in an observational period between 1987 and 2002 among 
4425 cases. In this study, the incidence of AAS has increased by 50% in men and 30% in 
women over study period. This may be related to enhanced diagnostics, although a further 
component could also be the increasing age of the population. Overall, 20% of affected 
patients died before reaching a medical facility, 30% during the hospital stay and further 
20% over the following 10 years [4]. Both circadian and seasonal variations have been 
observed in the occurrence of AAS, with the peak frequency found between 0800hr and 
0900hr, with an increased likelihood during the winter period. The most likely explanation 
is a link to the circadian variation in blood pressure [5, 6]. 
2.2 Pathophysiology 
The mechanisms leading to AAS arise from many sources, although preexisting medial 
degeneration is proven to be an important risk factor for acute aortic dissection. Cystic 
medial necrosis is a hallmark of the histology, especially in aortic aneurysm patients. 
Microscopic features include decreased amount of vascular smooth-muscle cells, mucoid 
deposits and elastin deficiency [7]. However, over 80% of acute dissections occur in absence 
of a pre-existing aneurysm. The International Registry of Acute Aortic Dissection (IRAD) 
has collected an impressive amount of data for the demography of patients who present 




• Previous cardiovascular surgery, especially previous aortic aneurysm or dissection 
repair 
• Connective tissue disorders (Marfan`s syndrome, Ehlers-Danlos` syndrome, Erdheim-
Gsell`s syndrome) 
• Infective involvement of the aortic tissue (Lues, Takayashu aortitis) 
• Congenital causes (PDA ampulla, Sinus of Valsava aneurysm, bicuspid aortic valve) 
• External factors (Trauma, cocaine abuse) 
Improvements in the resolution of aortic imaging has led to the identification of pathological 
submodalities, i.e. intramural haematoma or penetrating atherosclerotic ulcer. Histological 
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findings of these lesions generally demonstrate significant intimal atherosclerosis, which is 
not a constant finding in aortic dissection biopsies. Studies suggest that aortic dissection is 
an end process with a wide pathological spectrum, many of which facilitate weakening 
and/or increased stress of the aortic wall. The chain of pathological events might begin with 
a small superficial intimal rupture; atherosclerotic ulcers may provide a good millieu for 
development of such a tear. Alternatively, disruption of vasa vasorum might result in an 
intramural haematoma, which later ruptures into the aortic lumen or leads to dissection. 
However, it is likely that many aortic dissections develop without having a pre-stage of 
intramural haematoma or penetrating ulcer [8]. 
2.3 Presentation and diagnosis 
Although the typical symptom is described as sharp, tearing, ripping chest pain, the 
presentation is diverse and about 10% do not complain of pain; sometimes the aortic 
pathology is an accidental clinical finding. In some patients shoulder or back pain occurs 
or just a husky voice, with or without shortness of breath and/or haemophthysis. 
Hypotension or shock is seen in 25% of patients, whereas hypertension can also be a 
presenting symptom, although more often found in type B dissections. Further findings, 
such as migrating pain, neurological deficits, acute abdomen, cardiac failure, myocardial 
ischaemia, aortic valve regurgitation are less common. Connective tissue diseases are 
characterized by additional specific symptoms, i.e. skeletal, pharyngeal or lens 
abnormalities and extreme laxity [3]. 
Early acute diagnosis can be vital, as an emergency surgery may be indicated. Blood 
pressure control is essential, and a goal of systolic ≤110 mmHg is recommended. The 
administration of β-blockers, sodium-nitroprusside, calcium-channel-blockers with 
analgesia is helpful, if indicated. In some advanced dissections resustitative measurements 












 + +++ +++ +++ 
Intramural 
haematoma - ++ ++ +++ 
Penetrating ulcer 
 - + +++ +++ 
Dissection entry 
 + +++ ++ ++ 
Aortic 
regurgitation +++ +++ - +++ 
Pericardial effusion
 +++ +++ ++ ++ 
Periaortic bleeding 
 - + +++ +++ 
Table 1. Efficacy of different imaging modalities in AAS. 
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• Previous cardiovascular surgery, especially previous aortic aneurysm or dissection 
repair 
• Connective tissue disorders (Marfan`s syndrome, Ehlers-Danlos` syndrome, Erdheim-
Gsell`s syndrome) 
• Infective involvement of the aortic tissue (Lues, Takayashu aortitis) 
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• External factors (Trauma, cocaine abuse) 
Improvements in the resolution of aortic imaging has led to the identification of pathological 
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findings of these lesions generally demonstrate significant intimal atherosclerosis, which is 
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 + +++ +++ +++ 
Intramural 
haematoma - ++ ++ +++ 
Penetrating ulcer 
 - + +++ +++ 
Dissection entry 
 + +++ ++ ++ 
Aortic 
regurgitation +++ +++ - +++ 
Pericardial effusion
 +++ +++ ++ ++ 
Periaortic bleeding 
 - + +++ +++ 
Table 1. Efficacy of different imaging modalities in AAS. 
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In patients with suspected acute aortic dissection various investigations are performed on 
admission including blood tests, electrocardiography, chest radiography, 
echocardiography, computed tomography and magnetic resonance imaging. Some 
investigations, such as ECG, chest radiography and routine blood tests do not carry 
sufficient sensitivity and specificity to exclude or confirm the diagnosis of an acute aortic 
dissection. Biomarker assays are increasingly utilized in the diagnosis of AAS, i.e. elastin 
fragments, smooth-muscle myosin heavy-chain protein, D-dimers, but are not widely 
available and provide only supporting evidence. The definite diagnosis can only be 
established using an imaging modality [9]. Table 1. summarizes efficacy of different 
imaging modalities in AAS. Table 2. shows the diagnostic features of the imaging 
modalities currently available in a hospital setting. 
 
 








Availability +++ ++ +++ + 
Speed +++ +++ ++ + 
Portability +++ +++ - - 
Tolerance +++ + ++ ++ 
Monitoring +++ ++ ++ ++ 
Table 2. Diagnostic features of imaging modalities in AAS. 
2.4 Management of AAS 
Currently, there are no randomized trials available to guide the management of AAS. The 
European Society of Cardiology has developed guidelines for diagnosis and management of 
aortic dissection based on a task force of international societies [10], although in most of 
decision making clinical pathways are usually based on case series or registries, systematic 
reviews, local experience, consensus based guidelines. Following initial stabilization of the 
patient, after diagnostic measurements and imaging, a treatment should be tailored to the 
pathological entity: 
• Type A dissection  
Over 50% mortality in the first 48 hours without surgical intervention, only 1-10% survives 
the first 5 weeks on conservative treatment. The perioperative mortality is 10-30%. 
Contraindications are quite limited as type A dissection is a highly lethal condition without 
surgical treatment, although age >80 years, ongoing coma with definitive extensive cerebral 
lesions (but not localized ischaemia or paraplegia!) or extensive abdominal necrosis may be 
contraindications for surgery. A subacute type A dissection, is a rare finding that requires an 
elective/semi-urgent operation as the patient has already successfully survived the high 
mortality period may now benefit from a well planned elective procedure [10]. 
• Intramural haematoma 
Classical therapeutic indication as for type A dissection, although in an uncomplicated and 
non-progressing situation, without ongoing pain and periaortic bleeding, patients can undergo 
surgery on an urgent basis (within 24 hours) rather than as an emergency. Over the age of 80 
years, accompanied by significant comorbidities, conservative therapy in an intensive care 
 
Recent Advances in the Management of Acute Aortic Syndrome 
 
233 
facility with the support of repeat imaging should be considered. If sudden progression 
occurs, a surgical intervention may be life saving. In this patient group 40% of intramural 
haematomas resolve after 4 years of follow up without mortality according to a small patient 
cohort study [11]. Another study demonstrated 34% regression of the disease, while 36% 
progressed into a dissection (12% acute type A dissection, 24% localized dissection) and 30% 
resulted in aneurysm formation over long term. They have also demonstrated, that a rupture 
or dissection is a very rare phenomenon with an aortic diameter of <60 mm at any location 
with an intramural haematoma [9]. These observations guide the clinical management of 
intramural haematomas, despite the lack of large multicentric studies, each patient requires a 
tailored individual management plan. As penetrating atherosclerotic ulcers are usually 
incidental operative or postmortem findings and are seldom discovered at imaging, there are 
no widely discussed clinical therapeutic strategies available. 
• Typ B dissection 
As this diagnosis generally requires conservative medical treatment in an intensive care 
setting, we only briefly discuss the indications for surgery. Medical treatment is associated 
with a mortality of 20%, compared to surgery, which has much higher mortality of 30%; 
medical therapy is therefore considered first. Classical operative indications are progressive 
organ malperfusion, ongoing pain with uncontrollable hypertension. In the last decade stent 
grafting of the affected region has become an alternative option as it can treat these 
problems at a low risk profile in most of the cases and without need for further 
cardiovascular surgery [12]. 
3. Surgical considerations and recent techniques for repair of type A 
dissections 
3.1 Perfusion approaches in type A dissections 
Cannulation of an extended type A dissection often represents a challenge for surgeons 
when either the subclavian or lower limb arteries are involved in the process. There are 
some alternative cannulation sites published in current literature i.e. brachiocephalic trunk, 
right common carotid artery, transapical cannulation, although we prefer an innovative 
method through non dissected aortic wall on lesser curvature at level of Botallo`s ligament 
using a Seldinger technique. 
Our first experience was a 50 year-old man with sudden onset of ripping chest pain, 
admitted unconscious accompanied by anisochoria. Computed tomography scan revealed 
an extensive type A aortic dissection. The dissection began exactly over the aortic valve; 
maximal diameter of ascending aorta measured 60 x 55 mm. On the lesser curvature of arch, 
particularly at Botallo`s ligament, preservation of the true lumen with an intact wall was 
observed, although the dissection involved all supraaortic vessels. Visceral arteries 
originated from the true lumen except the left renal artery. Dissection in both iliac arteries 
was also present. Rapid deterioration of the patient with cardiovascular instability led us to 
cannulate at Botallo`s ligament applying a minimal invasive cannulation method with a 
Seldinger technique [Figure 1, 2]. At Botallo`s ligament the aorta is firmly bound to 
pulmonary trunk with a mass of connective tissue, which usually protects it from a 
complete dissection in this area. Position of cannula has to be guided by either 
transoesophageal or epiaortic ultrasonography. With this rapid and safe cannulation 
method extracorporeal circulation can be easily established, thus reducing the risk of 
perioperative shock and increased mortality [13]. 
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Fig. 1. Seldinger cannulation of a type A aortic dissection (first dialation step) 
 
Fig. 2. Arterial cannula in situ at Botallo´s ligament 
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Cardiopulmonary bypass via axillary/subclavian artery has become an alternative 
perfusion site in the past decade, predominantly in acute aortic dissections but also for 
patients with severe aortic atherosclerosis [14-20]. Despite several advantages of 
axillary/subclavian artery cannulation such as dominantly antegrade perfusion of the aorta, 
this technique is not without its complications. Establishment of axillary/subclavian artery 
inflow may not be ideal for providing rapid antegrade perfusion in cases with 
hemodynamic instability, as dissection and cannulation can take too long. In small patients, 
a limitation of CPB pump flow due to a narrow axillary artery may be a concern [21, 22]. 
Applying the standard technique, however, only the right hemisphere is continuously 
perfused, which can result in malperfusion of the contralateral hemisphere, as Merkkola et 
al demonstrated, up to 17% of the patients having incomplete circle of Willis [23]. Even with 
a complete circle of Willis, concern has been raised, if this type of perfusion alone can 
sufficiently supply the left hemisphere. 
Transapical cannulation is another technique for establishing reliable antegrade arterial 
access, as described by Wada et al [24]. In large cohort of 138 patients, cannula was placed 
through a 1 cm apical incision into true lumen via aortic valve under transoesophageal 
echocardiography guidance. Impact of causing an acute aortic insufficiency in this context is 
not discussed in detail. This technique carries disadvantage of resulting in prolonged 
cardiopulmonary bypass times, since no additional manipulations can be performed during 
cooling phase, i.e. inspection and preparation of aortic root. 
Right carotid artery cannulation, performed by Urbanski in 100 patients, including 27 with 
type A dissections, provides another possible alternative, but also carries the risk of left 
hemisphere malperfusion and potential complications when the vessel is de-cannulated [25]. 
Experience with innominate artery cannulation by Di Eusanio et al includes 55 patients with 
only two in acute aortic dissections [26], so it is difficult to evaluate the efficacy of this 
method due to the small experience.  
Fusco at al presented their results in femoral artery cannulation in 2004 [27]. With a 
conversion rate of 2.5% to ascending aortic cannulation, they conclude that femoral 
cannulation is appropriate and yields excellent clinical results. They are not aware of having 
encountered retrograde embolism from the descending aorta, probably since atherosclerosis 
is less common in dissection patients.  
3.2 Cerebral protection in dissection surgery 
Avoiding neurological damage is one of the main aims of dissection surgery, as Carrel 
emphasised a century ago. Deep hypothermia with circulatory arrest (HCA) is the most 
common technique for cerebral protection in aortic surgery with a well defined safe period 
for circulatory arrest, of 45-50 minutes at a core temperature of 20°C. Systemic hypothermia 
to extend the period of safe cerebral ischaemia has been the mainstay of neuroprotection for 
many decades [28, 29]. Safety of this approach relies on adequate systemic cooling and if this 
is incomplete, it risks the patient for neurological injury. Introduction of selective antegrade 
carotid perfusion (ACP) has prolonged this safe period. A combination of cold selective 
antegrade cerebral perfusion and deep/moderate hypothermic circulatory arrest allows 
adequate protection for the body and is not associated with higher risk of cerebral 
microemboli [30, 31]. The efficacy of selective antegrade cerebral perfusion as an adjunctive 
to hypothermic arrest has been proven by numerous publications [32, 33]. 
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Unilateral brain perfusion, i.e. right subclavian/axillary artery, right carotid artery, 
brachiocephalic trunk is safe under monitoring with near infrared spectroscopy (NIRS), as 
nearly 1/5 of the population has an incomplete circle of Willis. Therefore a significant 
number of patients require bilateral ACP, on the other hand, in the rest population it is still 
debatable, if in left haemisphere the same temperature can be achieved as the contralateral 
hemisphere, with unilateral perfusion, after blood has perfused the right side. Further 
concern is raised with unilateral perfusion, that by aiming for bilateral equal brain 
saturations, the right haemisphere is may be slightly overperfused, leading to right 
hemishperal oedema. Near infrared spectroscopy does not provide this type of information, 
so unilateral perfusion enhances but cannot guarantee cerebral protection. These latter 
considerations require further research, although applying bilateral ACP may resolve these 
issues. 
In our practice, during HCA, selective antegrade cerebral perfusion is applied through both 
carotid arteries (DLP Retrograde Coronary Sinus Perfusion Cannula with manual Inflating 
Cuff®, Medtronic Inc., Minneapolis, USA) at a flow rate adapted to keep a constant cerebral 
O2 saturation each side with a perfusion pressure of 35-40 mmHg [Figure 3]. Cerebral 
monitoring is performed using NIRS, with the aim of maintaining brain tissue oxygen 
saturation measures at 65-70% continuously during perfusion, which should correspond to 
the induction values. 
 
Fig. 3. Selective antegrade carotid perfusion 
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Retrograde cerebral perfusion via superior vena cava may also be undertaken, although in 
arch surgery carotids are available for ACP. If the carotids are severely destroyed by 
dissection, retrograde cerebral perfusion may be considered as an option, so long carotids 
are replaced by tube grafts. However, retrograde cerebral perfusion is associated with a 
significantly higher incidence of temporary neurological complications, later extubation, 
longer ICU-stay, hospitalization, than ACP [34]. 
In a study of 4670 patients who underwent extensive aortic surgery between 1985 and 2002 
at the Heart Centre Leipzig, Germany, superiority of ACP over retrograde cerebral 
perfusion or stand-alone deep hypothermia was confirmed. ACP was associated with 5-14% 
mortality and 4-10% permanent neurological deficit, retrograde cerebral perfusion showed 
12-22%; 10-20%, stand- alone deep hypothermia 15-30%; 8-24%, respectively. 
Rigorous patient temperature monitoring is crucial to a balanced cerebral protection during 
CPB. As a standard body temperature measurement, rectal monitoring has been widely 
used for decades in many departments. In the past decade tympanic and urinary bladder 
temperature monitoring has been studied and suggested as an alternative to gold standard. 
Tympanic measurements provide a very good estimation of the brain temperature with 
minimal delay in the changes due to its close proximity to the central nervous system [35, 
36]. Tympanic measurements are well established even in everyday body temperature 
measurement with portable thermometers in general health care. However, to obtain 
reliable values from the tympanic membrane, debris free status of the ear channel has to be 
proven by otoscopy prior to placement of probe, followed by a good heat insulation of ears 
by i.e. using swabs to prevent accidental heat loss due to theatre ventilation system. 
Urinary probes are available built into urinary catheters, so their placement is very 
convenient, although measurement reliability depends slightly on urine flow [37]. Rectal 
measurements are less reliable, since faecal matter prevents sudden heat exchange [38]. 
Nasopharyngeal/oesophageal temperature monitoring in HCA as standard measurement 
site, has limitations as it may significantly over- and underestimate brain temperatures 
during the cooling and rewarming phases [39-41]. Akata et al have furthermore 
demonstrated, that pulmonary artery temperatures closely reflect changes in brain 
temperatures, but nasopharyngeal/oesophageal measurements could not be considered as a 
reliable index of brain temperature during the rapid induction of moderate/deep 
hypothermia [42]. 
4. Follow-up 
As aortic dissections often develop on a background of preexisting aortic aneurysms, this 
mandates regular follow-up in these patients to facilitate elective intervention when 
required. These elective operations carry less risks as the patient can be thoroughly 
prepared using the ideal imaging modalities and optimizing the patient’s medical condition 
for major surgery. At the Department of Cardiothoracic Surgery, University Hospital 
Regensburg, Germany there is a regular aortic day-clinic available on weekly basis for pre- 
and postoperative follow-ups, that has been running for over a decade, which allows this 
endangered patient population to be monitored on a 6-monthly basis. Regular postoperative 
monitoring is essential to provide good long term results with the early discovery of endo-
leaks, progression of aortopathy, control of hypertension, etc. As the AAS population is 
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young, average age of involved is sixty years [3], regular follow up contributes to the 
restoration of health in this still relatively active age group. 
Patients with AAS have a long-term outcome which is less favorable when associated with a 
past medical history of previous cardiac surgery or generalized atherosclerosis [43]. Surgical 
repair has been recommended when maximal ascending aortic diameter reaches 50 mm (45 
mm at Marfan´s syndrome) or 60 mm when involving the descending aorta, although 
decision making has to be individualized to patient and other comorbidities [10]. Blood 
pressure control is essential for these patients, with the aim of maintaining the blood 
pressure no more than 130/80 mmHg [44]. If there is a well know hereditary component 
present, the patient´s complete family should be offered the opportunity to be genetically 
tested and councilled. 
Some recent publications have already highlighted the role of angiotensin II in progression 
of aortic aneurysms, although the relative contribution of its type 1 (AT1) and type 2 (AT2) 
receptors remain unknown. Habashi et al demonstrated that loss of AT2 expression 
accelerates the aberrant growth and rupture of aorta in a mouse model of Marfan`s 
syndrome. Losartan, a selective AT1 blocker reduces aneurysm progression in mice; a full 
protection required intact AT2 signaling. The angiotensin-converting enzyme inhibitor 
enalapril, which limits signaling through both receptors, is less effective. Both drugs 
attenuated transforming growth factor-ß (TGF ß) signaling in the aorta, but losartan 
uniquely inhibited TGF ß-mediated activation of extracellular signal regulated kinase, by 
allowing continued signaling through AT2, which shows the protective nature of AT2 
signaling and the choice of therapy in aortic aneurysms [45]. 
International multicentric studies are currently evaluating the possible pharmacological 
prevention and postoperative medical supportive therapy options in Marfan´s syndrome 
provided by AT1 blockers, especially losartan in a combination with a ß-blocker, such as 
nebivolol. The key molecule in aortic aneurysms, TGF ß, normally attached to extracellular 
matrix, is free and activated. Under experimental circumstances, TGF ß blockade prevents 
aortic wall damage and dilatation. AT1 blockers exert an anti-TGF ß effect; trials are now 
ongoing for evaluating the effect of losartan compared with atenolol or nebivolol. The third 
generation ß-blocker nebivolol retains the ß-adrenergic blocker effects on heart rate and 
further exerts antistiffness effects, typically increased in aortic aneurysms [46, 47]. 
After evaluation these ongoing human studies we have more insight to the pharmacological 
support of AAS and aortic aneurysms, which completes the surgical management 
possibilities of this severe disease group. 
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1. Introduction 
Cardiothoracic surgeons are faced with the challenge of protecting the brain during the 
sensitive time of interruption of normal cerebral blood flow.  The brain is an exceptionally 
complex organ with a functional anatomy that is difficult both to understand and assess.  
Experimental and clinical studies have shown that the mechanism of neural injury is 
multifactorial. As such, discussions regarding the best surgical strategies for 
neuroprotection during circulatory arrest are formidable, at best. Although we are armed 
with excellent experimental and clinical studies that demonstrate the deleterious effects of 
prolonged exposure to cardiopulmonary bypass (CPB) on brain function and structure, the 
various neuroprotective strategies, particularly that of deep hypothermic circulatory arrest 
(DHCA) remain an issue of debate. This is related in part to the gap between the basic 
science understanding of brain injury caused by these events and the clinical application of 
various neuroprotective strategies and their subsequent clinical outcomes. The goal here is 
to address the current understanding of the mechanisms underlying brain injury after HCA 
and relevant strategies of neural protection, supported by primary experimental data from 
our laboratory. 
2. Hypothermic ciruclatory arrest 
The use of therapeutic hypothermia dates back to the ancient Egyptians, Greeks, and 
Romans. In modern times, the use of therapeutic hypothermia progressed from observation 
case reports to animal studies to clinical use in children and then adults. Initially there were 
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undergoing surgical repair of the tetralogy of Fallot. (Apostolakis & Shuhaiber, 2007) 
The use of deep hypothermic cardiopulmonary arrest (DHCA, 14-18°C) was first applied as 
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surgeries such as the repair of thoracoabdominal aortic lesions, clipping of giant and 
complex cerebral aneurysms, and resection of renal carcinoma with tumor thrombus 
extending into the inferior vena cava or atrium.    
Deep hypothermic circulatory arrest (DHCA or HCA) provides 2 clinical benefits. The 
circulatory arrest component provides a bloodless surgical field without the need for the use 
of intrusive clamps and cannulae. The deep hypothermic component significantly decreases 
brain metabolism and oxygen requirements and thus permits a longer period of interrupted 
blood perfusion to the brain. The cerebral metabolic rate is related exponentially to brain 
(core body) temperature, with the cerebral metabolic rate decreasing by about 50% for each 
6°C drop in brain temperature. Since the first experimental studies, the use of DHCA has 
become the standard technique for the surgical repair of certain congenital and acquired 
cardiovascular lesions. The outcome after these operations improved considerably over the 
past two decades and surgery requiring HCA can usually be performed with an acceptable 
risk for the patient. However, it is likely that these improvements are more a consequence of 
an increasing expertise with this type of surgery, rather than the influence of one particular 
organ protection method employed. Despite this fact, there is still room for improvement, 
since prolonged periods of HCA are still associated with significant morbidity and 
mortality. As the brain is the organ most sensitive to ischemic damage, it is considered to be 
the limiting factor for the duration of HCA. Nevertheless, despite its protective effects, HCA 
can be detrimental for other organ systems. 
The basic established techniques and perfusion strategies during aortic arch replacement 
number three: hypothermic circulatory arrest (HCA), antegrade cerebral perfusion (ACP), 
and retrograde cerebral perfusion (RCP). During the past decade and after several 
experimental studies, RCP lost its previous place in the armamentarium of brain protection, 
giving it up to ACP as a major method of brain perfusion during HCA. HCA should be 
applied at a temperature of ≈20°C with long-lasting cooling and rewarming and should not 
exceed by itself the time of 20–25 min. RCP does not seem to prolong safe brain-ischemia 
time beyond 30 min, but it appears to enhance cerebral hypothermia by its massive 
concentration inside the brain vein sinuses. HCA combined with ACP, however, could 
prolong safe brain-ischemia time up to 80 min. Cold ACP at 10°–13°C should be initially 
applied through the right subclavian or axillary artery and continued bihemispherically 
through the left common carotid artery at first and later the anastomosed graft, with a mean 
perfusion pressure of 40–70 mm Hg. The safety of temporary perfusion is being confirmed 
by the meticulous monitoring of brain perfusion through internal jugular bulb O2 saturation, 
electroencephalogram, and transcranial comparative Doppler velocity of the middle cerebral 
arteries (Kouchoukos et al, 2003). 
3. Methods of end-organ protection during DHCA  
3.1 Hypothermia 
Hypothermia acts by reducing the metabolic rate of the brain and improving the balance 
between energy supply and demand. Hypothermia reduces cerebral blood flow (CBF) in a 
linear manner, but the decrease in cerebral metabolic rate of oxygen (CMRO2) is not exactly 
linear. On average, the reduction in CMRO2 is about 7%/1°C. Between 37°C and 22°C, 
CMRO2 is reduced by about 5%/1°C, and then the reduction accelerates when CMRO2  
reaches 20% at 20°C and 17% at 18°C, at which point about 60% of patients achieve electrical 
silence on electroencephalography (EEG).  
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3.2 Drug interventions 
To increase the tolerance to ischemia, the use of potentially neuroprotective drugs is an 
appealing concept, especially since the circulatory arrest interval is well defined and allows 
a preischemic treatment. Therefore, it is evident that the use of these pharmaceuticals is 
more promising in HCA patients than for the postischemic treatment of patients after 
embolic strokes. Studies in a chronic porcine model showed that nontoxic drugs are 
available that have neuroprotective effects, making them potential candidates for clinical 
use. Additionally, combining drug treatment with selective perfusion techniques, to support 
adequate delivery of the agent into the target organ, seems to be a promising concept. 
Among the various neuroprotective pharmacologic agents are barbiturates, which are 
believed be protective in focal ischemia by reducing CMRO2, CBF, free fatty acids, free 
radical and cerebral edema. Steroids decrease proinflammatory responses, while beta-
blockers decrease the inflammatory response. Mannitol reduces cerebral edema, scavenges 
free radicals and protects the kidneys by lowering renal vascular resistance. Furosemide 
blocks renal reabsorption of sodium, and insulin controls hyperglycemia, which in turn 
prevents intracellular acidosis.  Lidocaine is a selective blocker of Na+ channels in neuronal 
membranes and thus, reduces CMRO2. Dexmedetomidine inhibits ischemia-induce 
norepinephrine release and is protective for both focal and global ischemia. Acadesine 
appears to mitigate the effects of reperfusion injury. 
3.3 Intraoperative neuromonitoring 
Neurophysiological monitoring during thoracic aortic surgery using HCA became 
increasingly popular in the last decade. Besides its value during an ongoing operation, the 
collection of data in combination with outcome analysis might help to improve or change 
surgical strategies. Continuous recording of electroencephalograms (EEGs) as well as SSEPs 
is now routine in most neurosurgical units. The use of neuromonitoring in cardiothoracic 
surgery is in part hampered by the fact that hypothermia has an impact on the sensitivity of 
neurophysiological measures, so they cannot be used during deep hypothermia. On the 
other hand, some surgeons have found this an asset, and use disappearance of the EEG to 
determine the optimal level of hypothermia before they stop the extracorporeal circulation. 
Therefore, the value of the EEG as an isolated method for ascertaining whether cerebral 
protection is adequate is questionable. Furthermore, nonsynaptic metabolic activity may 
persist even when the EEG is isoelectric. On the other hand, the EEG may provide valuable 
information for those groups which are using relative high blood temperatures during SCP. 
Furthermore, EEG seems to be a good tool for detecting electrophysiological recovery in the 
early postoperative period. Monitoring of SSEPs is generally easier than EEG since electric 
noise does not play such a substantial role. It is generally less influenced by anesthetic 
drugs, and it remains detectable as long as cortical activity can be encountered. From clinical 
experience, SSEPs seem especially valuable during surgery on the descending or 
thoracoabdominal aorta (which is not subject of the present synopsis) but muscle evoked 
potentials (MEPs) may be even more sensitive for detection of spinal cord injury. 
3.4 Acid-base management during hypothermia  
Hypothermia alters the results of analysis of arterial blood gases by increasing the solubility 
of CO2 and O2 in plasma. The increase in CO2 solubility decreases the concentration of the 
insoluble portion and, thus, the partial pressure. However, the total content of CO2 in the 
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blood remains the same. During hypothermia, if a blood sample is taken and warmed to 
37°C in the blood gas analyzer, the CO2 initially dissolved will now contribute to the partial 
pressure of CO2 (PCO2) and the PCO2 will be within the normal normothermic range. If, on 
the other hand, the value is estimated at the patient’s actual temperature, the PCO2 will be 
reduced despite similar arterial CO2 content. In addition to its effect on gas solubility, 
hypothermia decreases the metabolic rate and CO2 production. Maintaining the PCO2 within 
the normal range in rewarmed  37°C blood is called “alpha-stat.” If the PCO2 is corrected to 
the patient’s actual temperature and that value is kept within the normal range, the 
management is called “pH-stat.” 
4. Duration of DHCA 
A number of biochemical and cellular structural changes take place as the duration of 
circulatory arrest lengthens. After 15 minutes of ischemia at 18°C, the recovery of oxygen 
consumption is impaired, and after 20 minutes, cerebral lactate is detected in the effluent 
blood. The safe duration of circulatory arrest at 15°C was predicted to be about 29 minutes 
and at 10°C about 40 minutes. If ischemic tolerance is considered 5 minutes at 
normothermia, the calculated safe period of circulatory arrest at 18°C would be 15 minutes. 
Clinical studies have shown a persistent loss of cognitive function (lasting more than 6 
weeks) and deterioration in postoperative cognitive scoring/testing in patients who 
underwent aortic arch surgery by using DHCA for more than 25 minutes at 10°C. 
5. Complications of DHCA 
Disadvantages of DHCA include increased cardiopulmonary bypass (CPB) time, edema 
formation, coagulopathy, and alteration in many organ functions including the kidney, the 
brain, vascular smooth muscles, intestinal mucosa, alveolar epithelium, the liver, and the 
pancreas. Based on reports from 8 major cardiac surgery centers in the United States, 
Europe, and Japan, the risk of permanent neurologic injury after aortic arch surgery using 
DHCA ranged from 3% to 12%, renal dysfunction from 5% to 14%, pulmonary insufficiency 
from 5% to 39%, and left ventricular failure or low-cardiac-output syndrome from 7% to 
34%. Alternatives to the use of DHCA during aortic arch replacement are the use of 
normothermic CPB or mild-to-moderate degrees of hypothermia. These alternatives 
obviously require  the use of a perfusion system for the brain, separate from the rest of the 
body, which might increase the risk of cerebral emobilization.   
5.1 Neurologic injury  
Neurologic injury is the most troublesome adverse effect of DHCA and CPB, presenting 
either as transient neurologic deficit (5.9%-28.1%) or irreversible neurologic injury (1.8%- 
13.6%). Early postoperative mortality markedly is increased (18.2%) in patients with 
neurologic injury, and long-term cognitive disability is common among survivors.  
Neurologic deficit after DHCA encompasses a wide scale of disorders ranging from deep 
coma to subtle, hardly perceptible alterations in cognitive functions or behavior. In the 
immediate postoperative period, the return of sophisticated neurologic functions is often 
obscured by the administration of sedative and analgesic agents. Neurologic injury presents 
at that time mostly as a focal or diffuse deficit. A focal deficit is due to interruption of blood 
in a terminal vascular territory, usually following embolism of material or gas bubbles. The 
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clinical expression is typically motor-sensory deficit, aphasia, or cortical blindness (Kunihara 
et al, 2005; Lipton, 1999). Computed tomography and magnetic resonance imaging are 
usually able to detect a sharply demarcated area of necrosis in the brain. 
A focal deficit is usually an embolic phenomenon, whereas a prolonged poor perfusion of 
the brain may produce necrosis in watershed zones. Age, atherosclerosis, and manipulation 
of the aorta are risk factors for both. Global cerebral ischemia leads to diffuse neurologic 
deficit, which may be benign and reversible or more debilitating (seizures, Parkinsonism, 
and coma). Risk factors include increased duration of circulatory arrest and CPB, diabetes 
mellitus, and hypertension. Transient neurologic dysfunction appears to be a marker of 
long-term cerebral injury. Deficits of memory and fine-motor function may persist after 
hospital discharge. Reductions in CMRO2 and the duration of DHCA reduce the risk of 
neurologic injury. The length of time on CPB might be a better predictor of postoperative 
death and stroke than the duration of DHCA time (Hagl et al, 2003). 
Aortic procedures requiring hypothermic circulatory arrest have been specifically correlated 
with increased risk of both stroke and mortality in all patients. This may be accentuated in 
the elderly, who may have less tolerance for neurological insult.  Many physicians think 
patients >75 years old are too frail and lack the reserve to survive a major cardiothoracic 
surgery. In particular, there remains some hesitancy in performing procedures with a higher 
risk of stroke in patients with a higher susceptibility for adverse neurological sequelae. This 
perceived combination of risk and susceptibility may be a barrier to care for elderly patients 
requiring hypothermic circulatory arrest to address their aortic pathology. According to 
Coselli et al. (2008), in a study accessing the safety and efficacy of HCA, there are various 
major complications associated with HCA. These included death (interoperative, during 
hospital stay, and within 30 days), stroke, paraplegia, paraparesis, uncontrolled bleeding 
which required reoperation, renal failure, cardiac complications, and vocal cord paralysis. 
6. Strategies for brain protection during DHCA 
6.1 Hypothermia – reduction of metabolism 
Hypothermia is the most efficient measure to prevent or reduce ischemic damage to the 
central nervous system when blood circulation is reduced. The central nervous system has a 
high metabolic rate and limited energy stores, which make it extremely vulnerable to 
ischemia (Elrich et al, 2002).  Hypothermia acts by reducing the metabolic rate of the brain 
and improving the balance between energy supply and demand, and thus lengthens the 
period of tolerated ischemia. Hypothermia reduces cerebral blood flow (CBF) in a linear 
manner, but the decrease in cerebral metabolic rate of oxygen (CMRO2) is not exactly linear. 
On average, the reduction in CMRO2 is about 7%/1°C. Between 37°C and 22°C, CMRO2 is 
reduced by about 5%/1°C, and then the reduction accelerates when CMRO2  reaches 20% at 
20°C and 17% at 18°C, at which point about 60% of patients achieve electrical silence on 
electroencephalography (EEG) (McCullough et al, 1999). 
6.2 Techniques and perfusion strategies 
Although reduction of cerebral metabolism and swift surgery are the two fundamental 
measures that can prevent or reduce brain damage during circulatory arrest, there are 
adjunctive protective measures that can be considered. The basic established techniques and 
perfusion strategies during aortic arch replacement number three: hypothermic circulatory 
arrest (HCA), antegrade cerebral perfusion (ACP), and retrograde cerebral perfusion (RCP). 
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7. Experimental investigation of cerebral injury following DHCA 
A clearer understanding of the consequences of HCA will be pivotal in clinical decision-
making, including when to initiate circulatory arrest and the appropriate interval. Delayed 
cell death is of special interest because of the potential for intervention. Although apoptosis 
is believed to play a part in the cerebral injury, its role has generally been identified through 
histologic techniques. These snapshots do not permit a clear delineation of the time-line of 
apoptosis. Because its role is not clear, therapies have yet to be designed for the specific 
purpose of inhibiting apoptosis.  
The balance between cell survival and death is under tight genetic control (Almeida et al., 
2000). A multiplicity of extracellular signals and intracellular mediators are involved in 
maintaining this balance. When the cell is exposed to physical, biochemical or biological 
injury, or deprived of necessary substances, it activates a series of stress-response genes.  
Although with minimal insults, the cell may recover, with greater insults, single cell death 
results.  The current understanding of the neurons response to insult has been supported by 
evidence from a series of studies using a porcine model system to investigate the effects 
hypothermic circulatory arrest and ischemic insult on the integrity of neuronal populations. 
7.1 Clinically relevant animal models 
Evaluating various strategies and treatments in animal studies in order to determine clinical 
feasibility remains a challenge. Animal models have contributed immensely to our 
understanding of cerebral consequences of HCA, with several animal models having been 
used. To date, the preclinical investigation of cerebral injury mechanisms related to deep 
hypothermic circulatory arrest has been limited to large-animal models (porcine, canine and 
ovine). These models are expensive, personnel demanding, cumbersome and are usually 
performed without validated neuropsychologic assessment. Rodent models have been 
attempted to overcome some of these disadvantages, although treatment effects cannot 
always be confirmed in the rat model. Ultimately, however, each experimental model 
system from cell cultures to rats, to large animals and ultimately to clinical trials, have their 
advantages and disadvantages, and ultimately their place in these investigations.  
Most animal models require an extended period of arrest to produce a reproducible level of 
neuronal injury that would facilitate elucidating the mechanisms of injury and efficacy of 
neuroprotective interventions. Many large animal models require DHCA for at least 90-120 
minutes to demonstrate neurologic deficits. Although such prolonged DHCA interval might 
not be considered clinically realistic, they may be more appropriate for demonstrating the 
molecular pathways behind acute neuronal injury and hence, modes of intervention (Conti 
et al, 1998). 
Study of a neuroprotective strategy includes appropriate selection of an animal model and 
functional indices. The model is selected with respect to their relevance and feasibility of 
assessing the parameters of interest. Investigations of promising neuroprotectvie methods 
require validation (validation study), use in experimental settings to optimize cerebral 
protection during CPB and DHCA (performance study) and test during routine cardiac 
surgery (clinical study). 
Hypothermia is essential for cerebral protection during HCA. Hypothermia reduces 
cerebral metabolic activity, oxygen demand, and prevents the release of neurotransmitters 
and delays the onset of fatal biochemical cascade (Elrich et al., 2002; McCullough et al., 
1999). Although reduced, brain metabolism is not suppressed adequately and remains 
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relatively high at 18°C in traditional HCA protocols (McCullough et al., 1999).   In light of 
evidence suggesting that the apoptotic pathway may be reversible in their earlier stages 
(McCullough et al., 1999), studies from our team were undertaken to assess whether 
cooling to 10°C can reduce neurological injury during 75 minutes of HCA in an acute 
porcine model compared to less profoundly cooled (18°C) animals, as assessed by DNA 
fragmentation, anti-apoptotic protein Bcl-2 expression, and ultrastructural changes in the 
sensory cortex. Sixteen male juvenile pigs from a commercial farm, 2-3 months of age and 
weighing 25-35 Kg were used for this study. The animals were divided into three groups: 
Group A (n=6) underwent hypothermic circulatory arrest at 18oC for 75 min, Group B 
(n=6) underwent hypothermic circulatory arrest at 10oC for 75 min and Group C (n=4) 
served as normal controls. 
Preparation and surgery were performed as previously described (Ananiadou et al 2005). 
Briefly, catheters were inserted in an ear vein and the left femoral artery for monitoring 
purposes and withdrawal of blood samples. Anesthesia was induced with intramuscularly 
ketamine hydrochloride (15 mg/kg), atropine (0.05 mg/kg), and dormicum (0.1 mg/kg) and 
was maintained with intravenous fentanyl (50-200 μg/kg), dormicum and 1% to 2% 
isoflurane. Paralysis was achieved with a bolus intravenous rocuronium (0.6 mg/kg) and 
was maintained with 20% of the total dose every 30 min.  
Animals were ventilated mechanically with 100% oxygen, after endotracheal intubation. 
Ventilator rate and tidal volume were adjusted to maintain the arterial carbon dioxide 
tension at 40 mmHg. Hematocrit values during cardiopulmonary bypass (CPB) were 
maintained between 13%-23%.  A temperature probe was placed in the rectum, while brain 
temperature was determined with bilateral tympanic membrane probes. Urine output was 
collected through a bladder catheter (Foley 8-10 F). Arterial pressure, end-expired carbon 
dioxide, electrocardiogram, and blood gases (ABL Radiometer Medical A/S DK-2700, 
Copenhagen, Denmark) were monitored. 
As previously described, the chest was opened via a right thoracotomy in the fourth 
intercostal space (Ananiadou et al., 2005). After administration of intravenous heparin (300 
IU/kg), cannulas were advanced to the ascending aorta (16 F arterial cannula) and to the 
right atrium (single 26 F cannula). Non-pulsatile CPB, was initiated at a flow rate of 100 
ml/kg per min and then adjusted to maintain a minimum arterial pressure of 50 mmHg. To 
avoid distension of the left ventricle during CPB, a 10 F vent catheter was inserted via the 
superior pulmonary vein. The lungs were allowed to collapse after CPB was initiated. The 
CPB circuit was primed with a bloodless solution consisting of 1000cc lactated Ringer’s, 50 
ml mannitol, and 5000 IU heparin. Sodium bicarbonate was added to adjust the pH to 7.4, as 
necessary.  
CPB was continued for an average 58 or 106 minutes, to reach a deep brain temperature of 
18oC or 10oC, respectively. Myocardial protection was afforded by applying iced saline (4oC) 
topically during the 75-minute interval of hypothermic circulatory arrest. When the 
tympanic membrane temperature reached 18oC or 10oC, bypass was discontinued, the blood 
was drained into the oxygenator reservoir, and circulatory arrest was maintained for 75 
minutes. Ice bags were positioned around the head to maintain the brain temperature 
during HCA. At the end of the arrest, bypass was initiated again with gradual rewarming to 
a rectal temperature of approximately 35oC to 36oC. A temperature gradient exceeding 10oC 
between the perfusate and the core temperature was avoided. A temperature of 36oC was 
reached after an average of 83 or 104 minutes of reperfusion for animals treated with 18 oC 
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7. Experimental investigation of cerebral injury following DHCA 
A clearer understanding of the consequences of HCA will be pivotal in clinical decision-
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evidence from a series of studies using a porcine model system to investigate the effects 
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understanding of cerebral consequences of HCA, with several animal models having been 
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attempted to overcome some of these disadvantages, although treatment effects cannot 
always be confirmed in the rat model. Ultimately, however, each experimental model 
system from cell cultures to rats, to large animals and ultimately to clinical trials, have their 
advantages and disadvantages, and ultimately their place in these investigations.  
Most animal models require an extended period of arrest to produce a reproducible level of 
neuronal injury that would facilitate elucidating the mechanisms of injury and efficacy of 
neuroprotective interventions. Many large animal models require DHCA for at least 90-120 
minutes to demonstrate neurologic deficits. Although such prolonged DHCA interval might 
not be considered clinically realistic, they may be more appropriate for demonstrating the 
molecular pathways behind acute neuronal injury and hence, modes of intervention (Conti 
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Study of a neuroprotective strategy includes appropriate selection of an animal model and 
functional indices. The model is selected with respect to their relevance and feasibility of 
assessing the parameters of interest. Investigations of promising neuroprotectvie methods 
require validation (validation study), use in experimental settings to optimize cerebral 
protection during CPB and DHCA (performance study) and test during routine cardiac 
surgery (clinical study). 
Hypothermia is essential for cerebral protection during HCA. Hypothermia reduces 
cerebral metabolic activity, oxygen demand, and prevents the release of neurotransmitters 
and delays the onset of fatal biochemical cascade (Elrich et al., 2002; McCullough et al., 
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relatively high at 18°C in traditional HCA protocols (McCullough et al., 1999).   In light of 
evidence suggesting that the apoptotic pathway may be reversible in their earlier stages 
(McCullough et al., 1999), studies from our team were undertaken to assess whether 
cooling to 10°C can reduce neurological injury during 75 minutes of HCA in an acute 
porcine model compared to less profoundly cooled (18°C) animals, as assessed by DNA 
fragmentation, anti-apoptotic protein Bcl-2 expression, and ultrastructural changes in the 
sensory cortex. Sixteen male juvenile pigs from a commercial farm, 2-3 months of age and 
weighing 25-35 Kg were used for this study. The animals were divided into three groups: 
Group A (n=6) underwent hypothermic circulatory arrest at 18oC for 75 min, Group B 
(n=6) underwent hypothermic circulatory arrest at 10oC for 75 min and Group C (n=4) 
served as normal controls. 
Preparation and surgery were performed as previously described (Ananiadou et al 2005). 
Briefly, catheters were inserted in an ear vein and the left femoral artery for monitoring 
purposes and withdrawal of blood samples. Anesthesia was induced with intramuscularly 
ketamine hydrochloride (15 mg/kg), atropine (0.05 mg/kg), and dormicum (0.1 mg/kg) and 
was maintained with intravenous fentanyl (50-200 μg/kg), dormicum and 1% to 2% 
isoflurane. Paralysis was achieved with a bolus intravenous rocuronium (0.6 mg/kg) and 
was maintained with 20% of the total dose every 30 min.  
Animals were ventilated mechanically with 100% oxygen, after endotracheal intubation. 
Ventilator rate and tidal volume were adjusted to maintain the arterial carbon dioxide 
tension at 40 mmHg. Hematocrit values during cardiopulmonary bypass (CPB) were 
maintained between 13%-23%.  A temperature probe was placed in the rectum, while brain 
temperature was determined with bilateral tympanic membrane probes. Urine output was 
collected through a bladder catheter (Foley 8-10 F). Arterial pressure, end-expired carbon 
dioxide, electrocardiogram, and blood gases (ABL Radiometer Medical A/S DK-2700, 
Copenhagen, Denmark) were monitored. 
As previously described, the chest was opened via a right thoracotomy in the fourth 
intercostal space (Ananiadou et al., 2005). After administration of intravenous heparin (300 
IU/kg), cannulas were advanced to the ascending aorta (16 F arterial cannula) and to the 
right atrium (single 26 F cannula). Non-pulsatile CPB, was initiated at a flow rate of 100 
ml/kg per min and then adjusted to maintain a minimum arterial pressure of 50 mmHg. To 
avoid distension of the left ventricle during CPB, a 10 F vent catheter was inserted via the 
superior pulmonary vein. The lungs were allowed to collapse after CPB was initiated. The 
CPB circuit was primed with a bloodless solution consisting of 1000cc lactated Ringer’s, 50 
ml mannitol, and 5000 IU heparin. Sodium bicarbonate was added to adjust the pH to 7.4, as 
necessary.  
CPB was continued for an average 58 or 106 minutes, to reach a deep brain temperature of 
18oC or 10oC, respectively. Myocardial protection was afforded by applying iced saline (4oC) 
topically during the 75-minute interval of hypothermic circulatory arrest. When the 
tympanic membrane temperature reached 18oC or 10oC, bypass was discontinued, the blood 
was drained into the oxygenator reservoir, and circulatory arrest was maintained for 75 
minutes. Ice bags were positioned around the head to maintain the brain temperature 
during HCA. At the end of the arrest, bypass was initiated again with gradual rewarming to 
a rectal temperature of approximately 35oC to 36oC. A temperature gradient exceeding 10oC 
between the perfusate and the core temperature was avoided. A temperature of 36oC was 
reached after an average of 83 or 104 minutes of reperfusion for animals treated with 18 oC 
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or 10 oC HCA, respectively. Systemic pressure was maintained above 60 mmHg during 
reperfusion. Measurements of hemodynamics (heart rate, mean arterial pressure), arterial 
blood gases, hematocrit, glucose lactate, as well as temperatures were recorded at five time 
points during the experiment. These were: 1) Baseline at 37oC and prior to CPB; 2) At the 
initiation of CPB; 3) During CPB, while cooling to a brain temperature of 18oC or 10oC just 
before HCA; 4) During rewarming; and 5) At the end of CPB. 
The mean duration (+SD) of CPB cooling and CPB warming for animals with 18oC HCA was 
57.50+17.25 and 82.50+10.37 minutes, and for 10oC was 105.8±21.8 and 104.2±19.8 minutes, 
respectively.  Perioperative physiological variables are shown in Table 1. Although there 
were some minor variations, no apparent clinically relevant hemodynamic differences were 
observed between treatment groups. Lactate levels were significantly higher following HCA 
at 10oC compared to 18oC. PO2 levels were significantly lower in 18oC HCA animals 
compared to 10oC during cooling, and hematocrit levels dropped to a similar degree in all 
experimental animals during the procedure. 
 
Variable Baseline Init CPB Cooling Warming End CPB  
 
Brain Temperature (oC) 
18 oC 36.5+0.4 34.1+1.8 18.0+0.0 25.8+3.2 36.5+0.8 
10 oC 36.5+0.4 33.2+1.6 10.0+0.0 28.2+3.1 36.9+0.2 
 
MAP (mmHg) 
18 oC 114.0+14.9 57.2+16.3 55.2+8.1 67.8+15.7 68.3+25.7 
10 oC 118.7+13.0 59.7+10.1 54.0+3.4 69.4+16.5 85.0+8.9 
 
Arterial pH  
18 oC 7.40+0.12 7.26+0.19 7.26+0.12 7.20+0.07 7.35+0.14 
10 oC 7.34+0.13 7.32+0.11 7.28+0.11 7.32+0.08 7.38+0.13 
 
pO2 (mmHg) 
18 oC 409.9+67.8 751.4+202.8 787.1+319.06* 429.0+126.9 424.6+112.1 
10 oC 378.4+118.3 689.5+45.5 1066.0+122.8 562.8+123.4 459.4+45.4 
 
pCO2 (mmHg) 
18 oC 51.32+19.0 73.7+37.8 67.2+31.3 69.3+14.4 38.7+18.7 
10 oC 58.1+23.3 60.0+17.7 58.2+12.4 44.0+12.9 31.7+9.0 
 
Hematocrit (%) 
18 oC 26.4+3.8** 16.4+3.4 15.51+3.3 16.6+3.9 15.5+3.1 
10 oC 26.0+3.8** 18.5+3.0 18.6+3.7 19.2+3.5 19.2+3.0 
 
Lactate (mmol/L) 
18 oC 2.7+1.8 4.5+2.1 5.6+2.5 6.3+1.7* 11.0+4.3 
10 oC 3.1+1.03 4.4+1.6 8.3+3.0 11.6+2.8 11.9+3.5 
  
Table 1. Typical Physiologic Variables During HCA Paradigm in a Porcine Model 
All values are expressed as mean + SD. *P<0.05 between animals treated with HCA at 18oC 
vs 10oC (unpaired, 2-tailed, t-test). **P<0.05 between sample times (ANOVA followed by 
Fisher PLSD).   
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8. Neuronal injury and nerve cell death: basic sciences 
Neuronal death is normal during development of the nervous system, but it is abnormal 
in brain and spinal cord disease and injury. The available evidence indicates that the 
survival of neurons and their death are highly regulated and finely orchestrated dynamic 
events that depend on a number of internal and external factors. Two types of cell death 
are recognized: cell necrosis resulting from injury and causes inflammation and apoptosis, 
observed normally in development and now identified as programmed cell death. 
Apoptosis and necrosis are types of cell death. They are generally considered to be 
distinct forms of cell death, but there is mounting evidence supporting an apoptosis-
necrosis cell death continuum (Portera-Calliau, et al, 1997). In this continuum, neuronal 
death can result from varying contributions of coexisting apoptotic and necrotic 
mechanisms, resulting in some of the distinctions between apoptosis and necrosis 
becoming blurred. Today it is believed that apoptosis may contribute to the neuronal 
degeneration in neurological injuries such as cerebral ischemia and trauma (Kerr et al 
1972; MacManus and Linnik, 1997; Martin, 2001). 
Necrosis can result from acute oxidative stress characterized by passive cell swelling, rapid 
energy losss, and generalized disruption of internal homeostasis with lysis of the nucleus, 
intra-nuclear organelles and plasma membranes leading to the release of intracellular 
components that induce a local inflammatory response that in turn, result in edema and 
injury to neighboring cells. Morphologically, cell death is characterized by swelling of 
organelles and rupture. Necrotic cell death is characterized by inflammation and wide-
spread damage. 
Apoptosis is a process of cell suicide, the mechanisms of which are encoded in the 
chromosomes of all nucleated cells.  Although the capacity to carry out apoptosis appears to 
be inherent in all cells, the susceptibility to apoptosis varies markedly and is influenced by 
external and cell-autonomous events. Apoptosis is regulated by complex molecular 
signaling systems resulting in an orderly, energy-dependent enzymatic breakdown into 
characteristic molecular fragments, DNA, lipids and other macromolecules.  Apoptosis can 
be induced by cell surface receptor engagement, growth factor withdrawal and DNA 
damage. In contrast to those observed in cell necrosis, the morphological changes that occur 
during developmental cell death include cell shrinkage, membrane blebbing, chromatin 
condensation and DNA fragmentation. Earlier studies showed that one of the biochemical 
hallmarks of apoptosis is DNA cleavage at internucleosomal linker regions, resulting in 
ladder formation of DNA of 180-200 bp or multiples thereof. However, this ladder-type 
DNA fragmentation is also found in some cells dying of necrosis, indicating that DNA 
fragmentation cannot be the sole criterion, but simultaneous morphological assessment 
must also be done for identifying apoptosis. 
8.1 Mechanisms of apoptotic cell death 
Several families of proteins and specific biochemical signal-transduction pathways regulate 
cell death. Cell death signaling can involve plasma membrane death receptors, 
mitochondrial death proteins, proteases, kinases and transcription factors. Predominant 
factors in cell death and cell survival include fas receptor, Bcl-2 and Bax (and their 
homologues), cytochrome c, caspases, p53 and extra cellular signal-regulated protein 
kinases. Some forms of cell death require gene activation, RNA synthesis and protein 
synthesis, whereas other forms are transcriptionally-translationally independent and are 
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or 10 oC HCA, respectively. Systemic pressure was maintained above 60 mmHg during 
reperfusion. Measurements of hemodynamics (heart rate, mean arterial pressure), arterial 
blood gases, hematocrit, glucose lactate, as well as temperatures were recorded at five time 
points during the experiment. These were: 1) Baseline at 37oC and prior to CPB; 2) At the 
initiation of CPB; 3) During CPB, while cooling to a brain temperature of 18oC or 10oC just 
before HCA; 4) During rewarming; and 5) At the end of CPB. 
The mean duration (+SD) of CPB cooling and CPB warming for animals with 18oC HCA was 
57.50+17.25 and 82.50+10.37 minutes, and for 10oC was 105.8±21.8 and 104.2±19.8 minutes, 
respectively.  Perioperative physiological variables are shown in Table 1. Although there 
were some minor variations, no apparent clinically relevant hemodynamic differences were 
observed between treatment groups. Lactate levels were significantly higher following HCA 
at 10oC compared to 18oC. PO2 levels were significantly lower in 18oC HCA animals 
compared to 10oC during cooling, and hematocrit levels dropped to a similar degree in all 
experimental animals during the procedure. 
 
Variable Baseline Init CPB Cooling Warming End CPB  
 
Brain Temperature (oC) 
18 oC 36.5+0.4 34.1+1.8 18.0+0.0 25.8+3.2 36.5+0.8 
10 oC 36.5+0.4 33.2+1.6 10.0+0.0 28.2+3.1 36.9+0.2 
 
MAP (mmHg) 
18 oC 114.0+14.9 57.2+16.3 55.2+8.1 67.8+15.7 68.3+25.7 
10 oC 118.7+13.0 59.7+10.1 54.0+3.4 69.4+16.5 85.0+8.9 
 
Arterial pH  
18 oC 7.40+0.12 7.26+0.19 7.26+0.12 7.20+0.07 7.35+0.14 
10 oC 7.34+0.13 7.32+0.11 7.28+0.11 7.32+0.08 7.38+0.13 
 
pO2 (mmHg) 
18 oC 409.9+67.8 751.4+202.8 787.1+319.06* 429.0+126.9 424.6+112.1 
10 oC 378.4+118.3 689.5+45.5 1066.0+122.8 562.8+123.4 459.4+45.4 
 
pCO2 (mmHg) 
18 oC 51.32+19.0 73.7+37.8 67.2+31.3 69.3+14.4 38.7+18.7 
10 oC 58.1+23.3 60.0+17.7 58.2+12.4 44.0+12.9 31.7+9.0 
 
Hematocrit (%) 
18 oC 26.4+3.8** 16.4+3.4 15.51+3.3 16.6+3.9 15.5+3.1 
10 oC 26.0+3.8** 18.5+3.0 18.6+3.7 19.2+3.5 19.2+3.0 
 
Lactate (mmol/L) 
18 oC 2.7+1.8 4.5+2.1 5.6+2.5 6.3+1.7* 11.0+4.3 
10 oC 3.1+1.03 4.4+1.6 8.3+3.0 11.6+2.8 11.9+3.5 
  
Table 1. Typical Physiologic Variables During HCA Paradigm in a Porcine Model 
All values are expressed as mean + SD. *P<0.05 between animals treated with HCA at 18oC 
vs 10oC (unpaired, 2-tailed, t-test). **P<0.05 between sample times (ANOVA followed by 
Fisher PLSD).   
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Neuronal death is normal during development of the nervous system, but it is abnormal 
in brain and spinal cord disease and injury. The available evidence indicates that the 
survival of neurons and their death are highly regulated and finely orchestrated dynamic 
events that depend on a number of internal and external factors. Two types of cell death 
are recognized: cell necrosis resulting from injury and causes inflammation and apoptosis, 
observed normally in development and now identified as programmed cell death. 
Apoptosis and necrosis are types of cell death. They are generally considered to be 
distinct forms of cell death, but there is mounting evidence supporting an apoptosis-
necrosis cell death continuum (Portera-Calliau, et al, 1997). In this continuum, neuronal 
death can result from varying contributions of coexisting apoptotic and necrotic 
mechanisms, resulting in some of the distinctions between apoptosis and necrosis 
becoming blurred. Today it is believed that apoptosis may contribute to the neuronal 
degeneration in neurological injuries such as cerebral ischemia and trauma (Kerr et al 
1972; MacManus and Linnik, 1997; Martin, 2001). 
Necrosis can result from acute oxidative stress characterized by passive cell swelling, rapid 
energy losss, and generalized disruption of internal homeostasis with lysis of the nucleus, 
intra-nuclear organelles and plasma membranes leading to the release of intracellular 
components that induce a local inflammatory response that in turn, result in edema and 
injury to neighboring cells. Morphologically, cell death is characterized by swelling of 
organelles and rupture. Necrotic cell death is characterized by inflammation and wide-
spread damage. 
Apoptosis is a process of cell suicide, the mechanisms of which are encoded in the 
chromosomes of all nucleated cells.  Although the capacity to carry out apoptosis appears to 
be inherent in all cells, the susceptibility to apoptosis varies markedly and is influenced by 
external and cell-autonomous events. Apoptosis is regulated by complex molecular 
signaling systems resulting in an orderly, energy-dependent enzymatic breakdown into 
characteristic molecular fragments, DNA, lipids and other macromolecules.  Apoptosis can 
be induced by cell surface receptor engagement, growth factor withdrawal and DNA 
damage. In contrast to those observed in cell necrosis, the morphological changes that occur 
during developmental cell death include cell shrinkage, membrane blebbing, chromatin 
condensation and DNA fragmentation. Earlier studies showed that one of the biochemical 
hallmarks of apoptosis is DNA cleavage at internucleosomal linker regions, resulting in 
ladder formation of DNA of 180-200 bp or multiples thereof. However, this ladder-type 
DNA fragmentation is also found in some cells dying of necrosis, indicating that DNA 
fragmentation cannot be the sole criterion, but simultaneous morphological assessment 
must also be done for identifying apoptosis. 
8.1 Mechanisms of apoptotic cell death 
Several families of proteins and specific biochemical signal-transduction pathways regulate 
cell death. Cell death signaling can involve plasma membrane death receptors, 
mitochondrial death proteins, proteases, kinases and transcription factors. Predominant 
factors in cell death and cell survival include fas receptor, Bcl-2 and Bax (and their 
homologues), cytochrome c, caspases, p53 and extra cellular signal-regulated protein 
kinases. Some forms of cell death require gene activation, RNA synthesis and protein 
synthesis, whereas other forms are transcriptionally-translationally independent and are 
 
Front Lines of Thoracic Surgery 
 
252 
driven by posttranslational mechanisms such as protein phosphorylation and protein 
translocation. 
The precise signaling cascade starting from the detection of the signal at the cell surface to 
the events that occur in the nucleus in apoptosis is not well established, with several grey 
zones in most suggested pathways.  However, many events that occur at the cell surface and 
intracellularly during apoptosis in the nervous system have been reported. Following an 
appropriate stimulus, the first stage or “decision phase” of apoptosis is the genetic control 
point of cell death. This is followed by the second state or “execution phase”, which is 
responsible for the morphological changes of apoptosis. The decision phase or genetic 
control appears to be mediated by two genes Bcl-2 and p53, while the execution phase 
appears to result from the activation of caspases. It has become apparent that the Bcl-2 
family of proteins constitutes a critical intracellular checkpoint within a distal common 
pathway of programmed cell death (Almeida et al, 2000).  
8.2 Selective vulnerability of neural populations to neural insult after HCA 
After assessing acute neuronal injury in various regions of the brain after HCA in a porcine 
animal model, we found that neurons in the sensory and motor neocortex, as well as those 
in the hippocampus, were vulnerable to cell injury acutely after 75 min of HCA at 18oC, as 
determined by a positive TUNEL reaction for DNA fragmentation (Ananiadou et al, 2005).   
TUNEL positive cells are identified by a red-stained, condensed nucleus with apoptotic 
bodies, along with a diminutive or absent cytoplasm. (Figure 1) Although nerve cell 
populations in the cerebellum, thalamus and ventral medulla were also found vulnerable to 
cell injury, the percentage of TUNEL positive cells in these areas was significantly less than 




Fig. 1. Typical Presentation of TUNEL Positive Cells.   
Photomicrograph showing apoptosis in the brain following HCA in an acute porcine model.  
Cluster of TUNEL (+) apoptotic neurons (nucleus is red stained) are interspersed among 
normal neurons in the anteroventral medulla. (magnification x400) 
 




Brain Region 18 oC 10 oC Control 
Motor Cortex 3.28+0.32* 1.79+0.38+ 0.50+0.22 
Sensory Cortex 3.88+0.13** 1.60+0.31+++ 0.14+0.14 
Hippocampus 2.67+0.36* 1.39+0.24++ 0.17+0.17 
Cerebellum 2.13+0.48 1.82+0.23++ 0.71+0.18 
Medulla 2.00+0.41 2.08+0.23+++ 0.57+0.20 
Thalamus 2.33+0.67 1.54+0.31+++ 0.00+0.00 
  
Table 2. TUNEL Scores in Brain Regions of Animals Treated with HCA   
All values are expressed as mean + SE. *p<0.006 and **p<0.0001 compared to values from 
animals treated with 10oC HCA.  +p<0.05; ++p<0.005; +++p<0.002 compared to normal 
control levels. 
Age and temperature appear to influence neuronal injury, by making certain nerve cell 
populations more vulnerable to injury. In particular, the hippocampus, cerebellum, 
striatum, thalamus, amygdala and neocortex have been reported vulnerable in adult 
normothermic ischemia. In contrast, newborns were more vulnerable to injury in the 
neocortex and striatum. In the present model of hypothermic ischemia in juvenile pigs, the 
neocortex and hippocampus demonstrated the greatest vulnerability to insult during HCA. 
The apparent higher level of TUNEL positive cells in the primary sensory cortex (post-
central gyrus) is not clear. 
Although these previous studies clearly support that some of the cell death observed in 
HCA is via an apoptotic pathway, the experimental conditions used may underestimate the 
contribution of apoptosis to the cerebral sequelae after HCA (Kurth et al, 1999; Hagl et al, 
2001). In this regard, some authors have expressed concern regarding the temporal pattern 
of brain damage and apoptosis after HCA. Thus, although recently improved methods of 
perfusion-fixation and more sophisticated analysis, have clearly shown the HCA initiates a 
series of events that ultimately leads to cell death via a typical apoptotic pattern, the time 
course of these events remains unclear. Most of these previous studies use the classic 90-min 
HCA, 20 oC model, which results in more severe cerebral injury than that usually observed 
clinically, where HCA is carried out for shorter intervals. The results from earlier studies 
also demonstrated that serious cell injury exists as early as 6 h after HCA, and that this 
process continues for at least 72h. 
The importance of understanding the time course of events is underscored by an earlier 
study of long-term survivors of the 90-min, 20 oC protocol. Although treatment with CsA 
was reported to improve behavioral recovery after 7 days, at the 7 days time point after 
HCA there was no difference between CsA treated animals and controls for apoptosis 
measures. The authors concluded that they had missed the peak of apoptosis, and that an 
effective reduction in nerve cell injury would be found most likely with CsA treatment had 
they examined brain tissues at an earlier time point. 
We found no morphological evidence of apoptosis or necrosis, but significantly greater levels 
of TUNEL positive cells in the brain regions assessed, compared to normal control animals. 
We hypothesize, that these findings indicate an early point of activation of the apoptotic 
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driven by posttranslational mechanisms such as protein phosphorylation and protein 
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pathway. This is consistent with the rapid cell death observed in normal cell suicide programs 
that can kill a cell within 2 to 3 h. At an earlier time point, such as that in this study, we would 
not anticipate completion of the apoptotic mechanism, resulting in cell death with its classic 
morphological characteristics, but rather the initiation of the cellular response cascade.   
Certain cell populations appeart to be more vulnerable to injury.  In particular, the 
hippocampus, cerebelleum, striatum, thalamus, amygdala and neocortex are more 
vulnerable in adult normothermic ischemia. In contrast, newborns are more vulnerable to 
injury in the neocortex and striatum. Our studies show that hypothermia does not provide 
equal protection to all regions of the brain.  In the juvenile pig model, the neocortex and 
hippocampus demonstrated the greatest vulnerability to insult during HCA. The apparent 
higher level of TUNEL positive cells in the primary sensory cortex (post-central gyrus) is not 
clear, and demands further investigation.  (Figure 2) 
 
 
Fig. 2. Positive TUNEL Reaction in Vulnerable Neural Regions 
Regional pattern of neuronal death after deep hypothermic circulatory arrest in juvenile 
pigs. Each point represents the mean score from six experimental animals for each brain 
region.  The brackets indicate the S.D. Among the HCA treated animals, significantly higher 
concentrations of TUNEL (+) cells were observed in the sensory cortex, motor cortex and 
hippocampus, compared to the cerebellum, thalamus and medulla (P< 0.05 by ANOVA 
followed by Fisher PSLD). Although not statistically significantly greater than the motor 
neocortex and hippocampus, the postcentral gyrus had greater TUNEL scores compared to 
the medulla and thalamus (P<0.01). [*P<0.05 vs sensory and motor cortex, and 
hippocampus; ** P<0.001 vs sensory cortex} 
8.3 Profound hpothermia rduces aoptotic nurologic ijury ater HCA 
The use of HCA in aortic repair and congenital heart surgery is based on the idea of 
reducing the metabolic rate and thus, allowing a more prolonged interval without perfusion 
that can be safely tolerated by the brain. The brain, in general, is very sensitive to hypoxia-
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ischemia because it has a high metabolic rate and small reserve of high-energy 
carbohydrates and phosphates. Several studies have indicated that cerebral metabolism is 
reduced effectively at profound levels of hypothermia, suggesting that protection of the 
brain should be greater when HCA is performed at even lower temperatures, such as that 
used in our studies (Strauch et al, 2005).  
We have found that profound hypothermia at 10°C during HCA resulted in a significant 
reduction in neurological injury in selectively vulnerable brain regions. TUNEL (+) staining 
was significantly less at 10°C in the motor and sensory cortex and the hippocampus 
compared to 18°C HCA, indicating that there was increased cerebral protection (Ananiadou 
et al, 2008). These findings are compatible with previous reports that profound hypothermia 
results in a superior neurological outcome compared to conventional HCA methods. 
Although this study does not elucidate the mechanisms, it does affirm that profound 
hypothermia exerts a neuroprotective effect. 
8.4 The decision phase for apoptotic nerve cell death: evidence for Bcl-2 
Apoptosis is controlled genetically, and two genes, Bcl-2 and p53 are now believed to be 
important.  It is now established that proteins encoded by the Bcl-2 gene family are major 
regulatory components of the apoptotic pathway (Kroemer, 1997). Within the apoptotic 
cascade, several proteins that facilitate neuronal survival compete with molecules that 
contribute to cell death. Ultimately, the final balance between cell survival–promoting 
proteins versus cell death–promoting proteins determines the fate of the cell.  The Bcl-2 
family of proteins plays an important role in this cell survival-cell death decision. 
This hypothesis is supported by our findings in Bcl-2 expression. The Bcl-2 family of 
proteins is important for the regulation of apoptosis during the “decision phase.” An 
increase of Bcl-2 has been suggested as an internal protective mechanism against apoptotic 
cell death, where Bcl-2 is persistently expressed in neurons that survive in ischemia. In the 
present study, brain regions that were selectively vulnerable to neurologic injury, 
particularly the neocortex and hippocampus, showed higher levels of Bcl-2 expression after 
HCA at 18°C compared with other brain regions (thalamus, cerebellum, and medulla). 
Moreover, profound hypothermia at 10°C resulted in a significant decrease in TUNEL 
staining in these brain regions. Although a concomitant increase in Bcl-2 expression was 
observed in the neocortex, it remains unclear whether profound hypothermia deters from 
neuronal injury by activation of anti-apoptotic protein Bcl-2 expression (Ananiadou et al, 
2007). (Table 3) 
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8.5 Morphological and ultrastructural evidence of neural protectin during profound 
cooling 
Necrosis can be characterized by passive cell swelling, rapid energy losss, and generalized 
disruption of internal homeostasis with lysis of the nucleus, intranuclear organelles and 
plasma membranes leading to the release of intracellualar components that induce a local 
inflammatory response that in turn, result in edema and injury to neighboring cells. 
Morphologically, cell death is characterized by swelling of organelles and rupture. Necrotic 
cell death is characterised by inflammation and wide-spread damage. In contrast to those 
observed in cell necrosis, the morphological changes that occur during apoptotic cell death 
include cell shrinkage, membrane blebbing, chromatin condensation and DNA 
fragmentaion (Kerr et al., 1972). In continuation of the above studies, we assessed the 
morphological evidence that profound cooling of the cortex to 10°C can reduce neurological 
injury during hypothermic circulatory arrest (HCA) in our porcine model. Electron 
microscopy assessed ultrastructural changes indicative of activation of programmed cell 
death.  
Parafin embedded samples described above were dewaxed in xylene. After rehydration 
using graded ethanol, slices were washed in cold 0.1 M sodium cacodylate buffer and fixed 
in 2.5% glutaraldeyde in 0.1 M cacodylate buffer overnight. Samples were washed in cold 
cacodylate buffer and then post-fixed with 1% osmium tetroxide in the same buffer for 1 hr 
at room temperature. After osmium tetroxide treatment, the samples were washed with 0.1 
M sodium cacodylate buffer. The selected area was identified with a dissecting microscope, 
and 2x2x2 mm sections were cut out from the coronal slices and dehydrated in a graded 
series of ethanol, before being embedded in epoxy resin. Blocks were trimmed, and semithin 
0.5-μm sections were cut with an ultramicrotome and stained with toluidine blue for light 
microscopy analysis. Ultrathin (75-90 mm) sections were cut and placed on 200-mesh copper 
grids for double-staining with uranyl acetate and lead citrate. Samples were examined with 
a JEOL JEM 100 CX-II electron microscope. 
Samples were examined in a blind fashion by one observer using a JEOL 100CX electron 
microscope who was instructed to find 10 representative neurons (per experimental brain 
specimen) as identified by a typical nucleus and surrounding perikaryon. Two blinded 
investigators using an objective grading system analyzed electron micrographs of these 
neurons. Each investigator was asked to examine each neuron for evidence of nuclear 
changes (chromatin dispersion or clumping), for the presence of cytoplasmic changes, for 
the overall shape of the neuron (shrunken, swollen) and the appearance of rough 
endoplasmic reticulum (RER) compared with matched controls. Similarly, each investigator 
was instructed to examine the perinuclear neuronal mitochondria for abnormalities in 
mitochondrial distribution or shape, matrix density, crystal structure, and appearance of 
any abnormal structures compared with matched controls; each finding was indicated as 
mild, moderate, or severe depending on its frequency.  
Electron microscopic observations in our study provided no appreciable morphological 
evidence to confirm apoptosis or necrosis of the sensory cortical neurons in this acute 
paradigm of HCA. In general, neurons showed normal nuclear and cytoplasmic 
morphology in all three treatment groups, with only minor ultrastructural changes observed 
ater HCA at 18°C. There was no evidence of cells swelling.  The neurons of the sensory 
cortex in control animals had large round or oval nuclei with an evenly distributed 
chromatin. No discontinuities were found in cytoplasmic membrane and nucleolemma. 
Well-developed rough endoplasmic reticulum (RER) that was arranged in parallel stacks 
was observed in the cytoplasm. Polyribosomes formed characteristic rosettes, and 
mitochondria appeared normal in all control animals. Blood capillaries were surrounded by 
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thin astrocytic end feet and showed endothelial cells with euchromatic nuclei, tight 
junctions between the adjacent plasma membranes. 
Compared to normal controls, treatment with HCA at 18°C (group A) resulted in minor 
ultrastructural alterations in the sensory cortex. (Table 4) Most neurons exhibited a pale round 
or oval nuclei. Nucleoli were intact, although sometimes they were localized in eccentric 
positions. Plasma and nuclear membranes remained intact, as did the mitochondria, which 
maintained their normal appearance, with recognizable cristae. While most neurons had 
slightly dilated RER and Golgi apparatus, some cells displayed more significant edema and 
morphological modifications of their organelles and dilated mitochondria. (Figure 3). In some 
cases, polysomes were disassociated, displaying desegregated ribosomes. In addition, some 
neurons, also exhibited some chromatin clumps.  Although some mitochondria were slightly 
dilated, they showed an otherwise normal morphology.  
 
    
Fig. 3. Ultrastructural Changes in the Sensory Cortex 
Sensory cortex from HCA at 18oC. (Left) Electron micrograph following HCA at 18oC with 
detail of neuron, showing nucleus(x18400). (Right) The same neuron showed dilated rough 
endoplasmic reticulum (x25200). 
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Deep hypothermia at 10°C resulted in negligent ultrastructural changes in the sensory 
cortex. Most neurons exhibited pale round or oval nuclei and intact nucleoli. In a few cases, 
the nucleoli were localized in eccentric positions. Plasma and nuclear membranes remained 
intact, and the structure of the cytoplasmic organelles was similar to that observed in control 
animals.  
The first stage or the decision phase of apoptosis is initiated after an appropriate stimulus. 
This is referred to as the genetic control point of cell death and appears to be regulated by 
the Bcl-2 family of genes. The “execution phase” which follows is responsible for the 
morphologic changes of apoptosis (Kam and Ferch, 2000). The absence of clear morphologic 
evidence of apoptosis potentially suggests that these observations may represent an early 
point of activation of the apoptotic pathway (decision phase), which is supported by the Bcl-
2 expression findings.  As important regulators of the “decision phase,” an increase of Bcl-2 
may represent an internal protective mechanism against apoptotic cell death. Bcl-2 is 
persistently expressed in neurons that survive in ischemia. The sensory cortex is selectively 
vulnerable to neurologic injury and showed high levels of Bcl-2 expression after HCA at 
18°C compared (Ananiadou et al., 2008). Moreover, profound hypothermia at 10°C resulted 
in a significant decrease in TUNEL(+) staining in this brain region. The concomitant increase 
in Bcl-2 expression that was observed in the sensory neocortex, suggests that profound 
hypothermia (at 10°C) may deter from neuronal injury by activation of anti-apoptotic 
protein Bcl-2 expression (Almeida et al., 2000).  Although subtle, electron microscopy 
showed that at 18°C cells exhibited dilation of the rough endoplasmic reticulum and 
mitochondria, ribosome detachment and Golgi derived vacuolation, while at 10°C cells 
exhibited only dilation of the rough endoplasmic reticulum and ribosome detachment, 
indicating Phase II and Phase I of the apoptotic process, respectively. 
The observation that TUNEL labeled cells may eventually, but not necessarily, progress into 
morphologically distinct apoptotic cells also confirms the idea that different morphologic 
characteristics may reflect different stages of the same death process.  This is supported by 
our electron microscopy findings.  At 18°C HCA, the neurons of the sensory cortex 
displayed dilation of the rough endoplasmic reticulum and detachment of ribosomes, along 
with Golgi derived vacuolation.  According to Portera-Cailliau and colleagues (Portera-
Calliau, et al., 1997), these findings suggest that the sensory cortex was in Phase II of the 
apoptotic process. At 10°C hypothermia, the ultrastructural findings indicate that the 
sensory cortex was in Phase I, showing only dilation of the rough endoplasmic reticulum 
and detachment of ribosomes.  Although both groups appear to be in earlier stages of 
apoptosis, the findings clearly indicate that HCA at 18°C is associated with more 
morphological characteristics of apoptosis, compared to 10°C. 
Although subtle, electron microscopy showed that at 18°C cells exhibited dilation of the 
rough endoplasmic reticulum and mitochondria, ribosome detachment and Golgi derived 
vacuolation, while at 10°C cells exhibited only slight changes.  Our findings of significantly 
reduced TUNEL(+) staining, a concomitant increase in Bcl-2 expression and slightly 
decreased ultrastructural evidence of activation of programmed cell death support that deep 
hypothermia at 10°C further protects the sensory neocortex.  
9. Conclusions 
Cardiac surgeons are faced with the challenge of protecting the brain during the sensitive 
time of interruption of normal cerebral blood flow.  The brain is an exceptionally complex 
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organ with a functional anatomy that is difficult both to understand and assess.  
Experimental and clinical studies have shown that the mechanism of neural injury is 
multifactorial. As such, discussions regarding the best surgical strategies for 
neuroprotection during circulatory arrest are formidable, at best. Although we are armed 
with excellent experimental and clinical studies that demonstrate the deleterious effects of 
prolonged exposure to cardiopulmonary bypass (CPB) on brain function and structure, the 
various neuroprotective strategies, particularly that of deep hypothermic circulatory arrest 
(DHCA) remain an issue of debate. This is related in part to the gap between the basic 
science understanding of brain injury caused by these events and the clinical application of 
various neuroprotective strategies and their subsequent clinical outcomes.  
Our goal has been to assess a possible mechanism of the neuronal injury (eg apoptosis) 
following DHCA. As this appears to involve a subtle and complex cascade of events, we 
decided to apply a paradigm that on the one hand may not be totally clinically relevant, but 
on the other hand would allow a robust response for assessment. Further study is clearly 
warranted to unravel relevant mechanisms and sensitive markers, which in turn, would 
allow us to appreciate the potential clinical relevance of these experimental findings. 
Evaluating various strategies and treatments in animal studies in order to determine clinical 
feasibility remains a challenge. Animal models have contributed immensely to our 
understanding of cerebral consequences of HCA, with several animal models having been 
used. To date, the preclinical investigation of cerebral injury mechanisms related to deep 
hypothermic circulatory arrest has been limited to large-animal models (porcine, canine and 
ovine). These models are expensive, personnel demanding, cumbersome and are usually 
performed without validated neuropsychologic assessment. Rodent models have been 
attempted to overcome some of these disadvantages, although treatment effects cannot 
always be confirmed in the rat model. Ultimately, however, each experimental model 
system from cell cultures to rats, to large animals and ultimately to clinical trials, have their 
advantages and disadvantages, and ultimately their place in these investigations.  
There is now convincing evidence that there is a general relationship between CNS damage 
and increasing duration of DHCA.  Although one of the goals of experimental studies is to 
assess the upper safe limit of DHCA, in order to do so we must more clearly understand the 
mechanism of cerebral injury. In most animal models, an extended period of arrest is 
necessary to produce a consistent and reproducible level of neuronal injury that would 
facilitate elucidating the mechanisms of injury, as well as the efficacy of potential 
neuroprotective interventions. Many large animal models require DHCA for at least 90-120 
minutes in order to demonstrate neurologic deficits. Although such prolonged DHCA 
interval might not be considered clinically realistic, they may be more appropriate for 
demonstrating the molecular pathways behind acute neuronal injury and hence, modes of 
intervention. 
Profound hypothermia of the brain results in a reduction of cerebral blood flow and steady 
state cerebral oxygen consumption (considered a true index of brain metabolic activity). 
Research in laboratory animals and clinical observations have now documented that 
considerable residual cerebral metabolism remains with cooling to levels of 15-18oC, 
particularly when cooling interval are short. Both experimental and clinical paradigms are 
faced with unresolved issues, including cooling gradients, nonuniformity of brain cooling, 
rewarming, pH management, among others. 
Various strategies have been addressed in an effort to reduce neurological complications, 
including profound hypothermia, antegrade cerebral perfusion, retrograde cerebral 
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perfusion, etc, each with their advantages and disadvantages. Cold reperfusion has shown 
promising results in animal studies and needs further clinical evaluation, while 
pharmacological interventions may offer a very promising pathway for preventing cerebral 
injury. 
Experimental study of a neuroprotective strategy includes appropriate selection of an 
animal model, as well as functional indices.  Of the available animal models, selection is 
made with respect to their relevance and feasibility of assessing the parameters of interest.  
The later are identified in the context of the available data.    Investigations of promising 
neuroprotectvie methods require validation in an experimental model (validation study), 
use of the method in experimental settings to optimize cerebral protection during CPB and 
DHCA (performance study) and test its utility during routine cardiac surgery (clinical 
study).  Despite the plethora of experimental and clinical studies, we still require a clearer 
understanding of the pathophysiologic consequences of HCA.  This information will be 
pivotal in clinical decision-making, including when to initiate circulatory arrest and the 
appropriate interval.  
Delayed cell death via apoptotic pathways is of special interest because of the potential for 
intervention. Although apoptosis is believed to play a part in the cerebral injury, its role has 
generally been identified through histologic techniques in animal models.  These snapshots 
do not permit a clear delineation of the time-line of apoptosis in the course of HCA.  Because 
it clinical role is not clear, therapies have yet to be designed for the specific purpose of 
inhibiting apoptosis.  Both the cascade of events and identification of pharmacologic agents 
that can act on molecular mediators require active investigation. 
Rewarming represents a critical time period, during which any additional harm to cerebral 
cells might induce permanent injury or even precipitate their death. How rapidly a stable 
energetic and biochemical homeostasis can be obtained in order to prevent the occurrence of 
secondary injuries remains unclear. 
Optimal perfusion characteristics required to reduce neurologic morbidity remain important 
issues for experimental study.  While there is ample evidence supporting the effectiveness of 
antegrade perfusion, its optimal delivery and perfusion characteristics remain unclear. 
Overall, there are still many gaps in our knowledge about how to best study cerebral 
outcome following DHCA.  The wealth of available evidence suggests that investigations 
require coordinated efforts by multiple research groups, pursuing systematic, multilevel 
research – spanning from cell cultures, to various animal model systems ranging from 
rodents to large animals and ultimately to clinical trials.  
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1. Introduction 
1.1 Background  
1.1.1 The beginning 
Vascular surgery was quite obviously conditioned by the development and evolution of the 
techniques for vascular anastomosis, started around the beginning of the past century. 
Apart in fact from few episodic and lucky clinical cases of lateral laceration repair as well as 
many experimental endeavours of vascular suture, accurately described and illustrated in a 
detailed historical italian review (Zannini G 1967), before that point in time vascular surgery 
clinical practice was substantially confined to vascular ligature. 
 
 
Fig. 1. Payr and Carrel pioneering techniques. 
Payr first reported device for vascular anastomosis substantially derived from elaboration of 
the common method for rubber tubing connection (left square) while Carrel triangulation 
was apparently derived from refinements of gastrointestinal suture (right square). 
In 1900 Erwin Payr reported to the German Surgical Society results on animal experiments 
of the apparently first device for vascular anastomosis, which is essentially based on 
external legature of vascular stumps over a rigid and absorbable magnesium ring (Payr E, 
1900), thus trying to adapting to surgery a method already universally used for coupling 
floppy/elastic tubing. In spite of its elegance (intima-to-intima facing, absorbable 
magnesium ring) one of its implicit mechanical limits was already outlined in the original 
report: elastic retraction of the vascular wall when clamped significantly reduces its 
diameter, thus making quite difficult to put in place a rigid ring of appropriate diameter. 
In those very years Alexis Carrel, as well as many others in fact (Zannini G 1967), was 
focusing his attention on suture techniques, already currently adopted in the 
gastrointestinal tract, and was able to realize blood-tight, low thrombogenic vascular 
anastomoses by careful refinements of the needles, threads and techniques for their use 
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(Carrel A, 1902, 1907), thus establishing the standard technique of vascular surgery. 
Although technically demanding, its versatility allowed to deal with virtually all clinical 
occurrences, from large aortic to microsurgical anastomosis, so that the many and 
significant improvements in needles (i.e. curved, atraumatic), threads (i.e. polypropylene) 
and surgical technique (i.e. parachute, etc) developed throughout more than a century 
could not break the ideal line linking the Nobel prize acknowledged (1912) Carrel original 
work with today clinical practice. 
Interestingly enough for more than a century vascular anastomosis technique research 
moved forward, very slowly to say the truth, with occasional brief clinical applications 
essentially along these two basic principles only, with the possible exception of gluing based 
methods. 
1.2 Vascular staplers 
It was in fact substantially a technological evolution of the Carrel coupling principle (full 
thickness wall stump stitching) that gave origin, around the middle of the past century, to 
stapling devices with the aim of automating the anastomoses. 
 
 
Fig. 2. Models of URSS vascular staplers (1960-70). 
Similar bulky and cumbersome devices were also realized at that time in Canada, USA and 
Japan. 
However, while stapling devices have long since allowed standardization and simplification 
of digestive tract circular anastomosis, despite extensive research (see exhaustive reviews: 
Tesauro 1967; Tesauro & Persico 1979), including our own (Nazari S et al, 1990), the stapling 
principle has so far failed to be of significant use for vascular anastomosis, which remains 
substantially the only basic surgical task still to be automated. 
The 60-70ies stapling devices (fig 2) have all quite cumbersome and heavy configuration in 
particular in relation to the delicate structure of the quite small diameter vessel to which 
they were intended to be used in those years. 
 




Fig. 3. Vascular stapler for reducing warm ischemia in organ transplantation. 
With our model each stapler end can be mounted on donor and recipient by independent 
surgical teams without care for reciprocal orientation, being the maximal possible vascular 
axis torsion ≤30°. Activating guide-wire is connected just immediately before firing (Nazari 
et al 1990). Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
 
 
Fig. 4. Vascular stapler for reducing warm ischemia in experimental lung transplantation. 
In a canine model of left single lung transplantation one stapler end was applied on donor 
pulmonary artery at back table (a) and the other by the recipient surgical team; then the two 
ends are quickly connected together (b), the firing wire connected and activated (c). After 
having sectioned the two sutures linking the vascular stumps to the device ends, the two 
stapler parts were divided and removed (d) and anastomosis checked (e) still preventing 
graft perfusion until atrial connection was established (Nazari et al 1990).  
Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
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With this in mind first of all we tried to simplify the procedure by severing the stapling 
device (fig 3) from the activating handle, which in our device consisted in a flexible, camera-
type, firing guide-wire that could be connected to the stapler after its coupling with vascular 
stumps just before firing (fig. 4,c), at the more convenient of the two opposite sides 
connectors (fig. 3). Moreover the two stapler parts were designed in such a way that each 
one could be mounted on the vascular stump by independent surgical teams without taking 
care for their reciprocal orientation; the connectors of the two parts of the stapler in fact 
allowed to limit the maximal possible vascular axis torsion to 30°. 
One of the crucial points mechanically implicit in any vascular stapler model, is related to 
the requirement of temporary fixation of the vascular stumps to the device ends in 
preparation for the anastomosis. The vascular stump link to each device end in fact must be, 
on one side, strong enough to be maintained during device manipulation for ends coupling 
but, on the other side, should be weak enough to be easily released after stapler firing, to 
allow the device ends to be divided and removed. 
Being our stapler ideated for use in organ transplantation to reduce the warm ischemic 
phase, we could solve this problem by temporarily suturing vascular stumps to the stapler 
end by single thread on predisposed little rings (fig 3, d); this can be done independently by 
the donor surgical team at back table to one stapler end (fig 4, a) and by the recipient team to 
the other stapler end, without interfering with time critical surgical phases. When the donor 
organ is at the recipient operative table (fig 4, b) the two stapler ends can be easily and 
quickly connected and the stapler fired (fig. 4,c). Only when the circulation is resumed the 
sutures temporarily connecting the vascular stumps to the stapler ends can be sectioned and 
the device removed (fig 4, d) without impacting on the organ warm ischemia time.  
 
 
Fig. 5. Kolesov VI vacuum assisted vascular stapler.  
To temporarily connect coronary artery stumps to the stapler ends, vacuum is applied to the 
predisposed device whose surface then sucks and holds the vascular wall (red arrows). 
An elegant technical solution to this problem was provided by V. Kolesov (Kolesov VI et al 
1970, 1991), credited for the first LIMA-coronary artery by pass (Konstantinov IE, 2004) and 
the first (and at this point in time the only one) surgeon to have clinically used coronary 
stapling device. He devised to realize this vascular stump-stapler end temporary link by 
applying vacuum to each device end whose surface was appropriately predisposed (Fig. 5, 
red arrows) thus sucking and holding the vascular stump in position. This seems a simple 
and effective method that can ideally fit with the surgical need and possibly solve this part 
of the vascular stapler problems. 
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In synthesis however, even though research restlessly continue to produce new prototypes, 
the apparently unavoidable critical point is that the intrinsic manual surgical skill required 
to put in position and operate any stapler on the delicate vascular structure didn’t yet 
(can’t?) result in a easier, simpler, quicker and more efficient task than standard hand 
suture, even when its use is for very large diameter vessel only (Takata et al 2011). 
1.3 Intraluminal ringed prosthesis 
In the 1970–1980s, a simplified Payr concept was revived with the introduction of 
intraluminal ringed prostheses, whose use in aortic substitution was quite extensively 
reported (Lemole et al, 1982; Berger et al, 1983; Crawford ES & JL, 1984). 
 
 
Fig. 6. Intraluminal ringed prosthesis.  
Aortic anastomotic device commercially available (FDA) in 70-90ies. 
The reasons for their clinical failure have been numerous. Facts mechanically implicit in the 
method (fig 7) are related both to the elastic retraction of the vessel when is clamped, 
already outlined in the Payr report (Payr, 1900), and to the floppy consistency of the 
vascular wall that requires a further significant gap to be left between the clamped internal 
aortic wall and the external ring diameter to allow the ring to be easily slipped into the 
vascular stump without friction. Accordingly a ringed prosthesis with a diameter 
significantly smaller than appropriate must be used to keep the cross-clamping time shorter 
than that attainable with manual suturing (Nazari, 1996a). Thus when the aorta is re-
perfused, the resulting discrepancy between perfused vascular stump and intraluminal ring 
diameter generates conditions greatly favouring coupling instability (fig. 7, C); moreover 
possible generation of systolic movements of the aortic wall at ligature hinge may 
potentially cause mechanical friction/erosion and thus eventually rupture. (fig 7, D). 
Many other inappropriate constructive features of those devices were probably responsible 
for their eventual failure. Thus the rigid ring was too short to be easily identified from 
outside the aorta, making very difficult the appropriate positioning of the external ligature; 
moreover the groove shape and dimension were inappropriate to maintain coupling 
stability. 
This latter point offers the occasion for some important consideration. Vascular anastomosis 
must guarantee two essential mechanical facts: haemostatic sealing and stability of the 
coupling. This may seem a self-evident, unnecessary distinction since both are obviously 
provided at once by the standard hand suture; not so however with the “Payr” coupling 
principle, which is at basis of 70-80ies intraluminal prosthesis as well as of our expandable 
device. 
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Fig. 7. Facts related to intraluminal ringed prosthesis (Payr type coupling).  
When the vessel is clamped there is a significant reduction of the stump diameter due to its 
elastic retraction (a); moreover because of the floppy consistency of the vascular wall a 
significant gap (b) must be left between outer ring and inner stump diameter for a rapid 
positioning. When blood flow is resumed the resulting significant diameter mismatch (c) 
generates conditions for coupling instability and device dislocation. It may also be 
hypothesized that systolic movements on ligature hinge (d) may generate mechanical 
erosion and possibly rupture. 
 
 
Fig. 8. Haemostasis and stability in Payr coupling type.  
While hemostasis can be achieved by applying an external pressure ≥ blood pressure, even 
much higher pressure may not prevent the stump from slipping over the inner sleeve and 
split apart (larger square). Grooves on the inner sleeve outer surface can prevent dislocation 
only if appropriately dimensioned and shaped (right upper square). Intraluminal prosthesis 
groove appears inappropriate in deepness, length and shape to keep coupling stability (right 
lower square). 
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While in fact to achieve haemostatic seal is sufficient to apply on the vascular stump 
external surface a pressure equal or just exceeding the blood pressure, that pressure or even 
a much higher pressure may not be enough to prevent the vascular stump from slipping off 
from the inner sleeve (fig. 8, large square). Then means to increase friction (i.e. groove or 
hooks, etc) between the opposing surfaces or to permanently link them together (i.e. full 
thickness stitches) must be put in place to prevent vascular stump from sliding off. 
Although this was soon appreciated (and solved!) by gardeners since many years (fig. 8, 
upper right square), the failure of the 70-80ies intraluminal prosthesis may have been caused 
also by underestimation (fig. 8, lower right square) of this not irrelevant detail. 
1.4 Endovascular surgery 
In the last decade of the past century, preceded by pioneering work of C. Gianturco 
(Charnsangavej et al, 1985; Wright et al, 1985; Yoshioka et al, 1988) and popularized by J.C 
Parodi clinical reports (Parodi 1991, 1994), endovascular techniques burst into clinical 
vascular surgery, allowing prosthesis positioning into the aneurysm and excluding it from 
blood stream without open surgery. This provided a less invasive and lower complications 
rate therapeutic tool that allowed cure for patients previously not amenable to open surgery 
for age, general conditions or associated risk factors. First successfully popularized in 
infrarenal aortic aneurysm, techniques and materials continuing improvements allowed 
endovascular prosthetic substitution of virtually all segments of aorta, including arch, even 
though sometime with hybrid procedures (Canaud et al, 2010;Antoniou et al, 2010; Tsagakis 
et al, 2010, Di Eusanio, 2011). 
It is not the aim of this chapter to describe, even summarily, the historical evolution of these 
techniques, but rather to try to outline the proved facts of these new therapeutic tools at this 
point in time. 
While obviously technological evolution will further extend indications and improvements 
in clinical results, superiority of endovascular method vs open surgery at this point in time 
was conclusively proved in infrarenal aortic aneurysms and in uncomplicated, non genetic, 
isolated descending aorta aneurysms (Gopaldas et al, 2010). An interesting result of several 
recent studies (The UK EVAR Trial Investigators, 2010; De Bruin, 2010; Schermerhorn, 2008) 
showed that, despite a two-thirds decrease in 30-day operative mortality rate after 
endovascular abdominal aortic aneurism repair (EVAR) compared with open repair, the all-
cause mortality curves converge during the first 2-3 years thereafter, with no significant 
difference in all-cause mortality beyond this time. A recent study (Brown et al, 2011) seems 
to indicate that more cardiovascular deaths in the EVAR patients group contribute to the 
convergence in all-cause mortality during the first 2 years. 
Quite wide clinical experience however already showed that endovascular procedures 
cannot protect from spinal chord ischemia and consequent paraplegia in extended 
descending aorta prosthetic substitution. It has been hypothesized that this could be due, at 
least in some case, to the fact that while endoprosthesis immediately prevents intercostal 
branches to be physiologically perfused, cannot prevent, at least for a certain time in the 
initial phase, backwards blood flow into the space between endoprosthesis and aortic wall, 
thus generating conditions for a blood flow “steal” from perfusion of the spinal chord 
(Kawaharada et al, 2010). 
Last but not least overall recent USA Nationwide Inpatient Sample data 2006-2007 review 
(Gopaldas et al, 2010) showed that only 23% (2,563/11,669) of ideal candidate to 
endovascular treatment (uncomplicated, elective descending aortic aneurysms) underwent 
endovascular procedure (TEVAR), while the remaining 77% (9,106/11,669) still underwent 
open surgical repair. 
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These facts prompted us to consider new strategies against aortic aneurysm based on new 
tools we developed for its treatment and prevention. 
2. New expandable devices for easier, safer and more efficient open surgery 
for large thoracic or thoracoabdominal aneurysms 
Even though endovascular techniques will continuously gain wider indications for 
prosthetic substitution of the aorta, more complex cases will always remain in which open 
surgery is the only or the best option. Moreover while acute aortic syndrome is obviously 
spread throughout the territory only highly specialized centers can offer endovascular 
techniques as an emergency measure; current data show that vast majority (77%) of 
uncomplicated, non genetic elective descending aorta aneurisms still underwent standard 
open surgery in US (Gopaldas et al, 2010). On the other hand open thoracic aorta prosthetic 
substitution still carries significant risk of serious complications that cannot be prevented 
even in very highly specialized centers, in particular to CNS and spinal cord. 
Although the pathogenesis of these complications is multifactorial, there is general 
agreement that the length of clamping/circulatory arrest time is an extremely important 
factor. Since nearly all the clamping/arrest time is spent for vascular anastomosis 
construction, a device able to quicken and simplify the vascular anastomosis can be 
expected to have a significant impact on the incidence of these complications. 
Suture line haemostasis is another important source of intra- and postoperative 
complications with standard open technique. In fact due to the altered aortic wall 
mechanical features, impaired by the underlying aortic pathology (arteriosclerosis, medial 
cystic degeneration, Marfan disease etc.), the suture line haemostasis may be difficult to 
achieve in spite of appropriate surgical technique or may require additional surgical 
maneuvers (buttressing, gluing etc.) that imply prolongation of the ischemia time. 
Moreover in cases of dissection, it may be difficult to achieve firm layers approximation and 
to prevent re-dissection and false lumen persistent perfusion, in particular at suture lines. 
 
 
Fig. 9. Expandable device working principle. 
Loops of nitinol wire wrapped by Dacron fabric form a rigid sleeve whose diameter can be 
modified by varying the diameter of the nitinol loops, while the regular cylindrical shape is 
maintained. 
For these reasons several years ago we started research (Nazari et al, 1994) to develop a new 
expandable device aimed: 1-to simplify the surgical technique; 2-to significantly reduce the 
ischemic time and thus the ischemic complications rate; 3-to enhance suture line 
anastomosis; 4-to achieve firm and reliable dissected layers approximation, thus preventing 
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re-dissection and/or false lumen persistent perfusion at suture lines, particularly in acute 
dissection repairs. 
The device consists of loops of nitinol wires, wrapped within a Dacron fabric and connected 
to a prosthesis end (Type I). The nitinol wire loops can be expanded and tightened by 
activating a removable guide in such a way that device end varies its diameter, while 
maintaining a regular cylindrical shape. This allows the easy and quick insertion of the 
retracted device into the vascular stump and then its expansion to perfectly fit with the 




Fig. 10. Expandable device vs intraluminal ringed prosthesis. 
The expandable configuration of the ring allows to solve all the insertion, positioning and 
diameter mismatch problems of the 70ies intraluminal prosthesis. 
Its quite evident that the expandable configuration of the ring allows to solve all the 
insertion, positioning and stability problems of the 70ies intraluminal prosthesis (fig. 10). 
That makes performing an anastomosis a very simple task, which can be carried out in 
seconds vs the 10-15 min per anastomosis at best required with standard hand suture. 
The aortic wall being not perforated by the suture, the coupling is immediately blood-thigh 
(“air-tight” in fact!) and independent by the integrity of the physiological coagulation 
mechanisms. 
The device underwent many modifications and refinements, finally resulting in three main 
models (Type I, II and III) applying the same working mechanism, but with different shape 
to fit with all aorta segments as well as special conditions of use. 
Extensive “ex vivo” and “in vivo” animal experiments (Nazari et al 1994, 1996a, 1996d, 1997, 
2006, 2009; Rossella et al 2008) were carried out and few clinical cases were also successfully 
treated with this device (Nazari et al.1999; Aluffi et al, 2002, Buniva et al 2002). 
2.1 Device description and operational details  
2.1.1 Device type I and II 
Device type I and II differ because of the orientation of the activating guide in respect to the 
main axis of the device wireframe expandable sleeve (fig 11, upper right and lower left 
squares); that allows the devices to be ideally used for the first and second anastomosis 
respectively. Thus the type I device, activated by guide-wire coaxial to the lumen, is sutured 
at one end of the tube graft of appropriate size before clamping, can be quickly and easily 
positioned either in the proximal or distal end of the aortic tract to be replaced (fig. 11, top 
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maneuvers (buttressing, gluing etc.) that imply prolongation of the ischemia time. 
Moreover in cases of dissection, it may be difficult to achieve firm layers approximation and 
to prevent re-dissection and false lumen persistent perfusion, in particular at suture lines. 
 
 
Fig. 9. Expandable device working principle. 
Loops of nitinol wire wrapped by Dacron fabric form a rigid sleeve whose diameter can be 
modified by varying the diameter of the nitinol loops, while the regular cylindrical shape is 
maintained. 
For these reasons several years ago we started research (Nazari et al, 1994) to develop a new 
expandable device aimed: 1-to simplify the surgical technique; 2-to significantly reduce the 
ischemic time and thus the ischemic complications rate; 3-to enhance suture line 
anastomosis; 4-to achieve firm and reliable dissected layers approximation, thus preventing 
 
New Approaches for Treatment and Prevention of Aortic Aneurysms 
 
271 
re-dissection and/or false lumen persistent perfusion at suture lines, particularly in acute 
dissection repairs. 
The device consists of loops of nitinol wires, wrapped within a Dacron fabric and connected 
to a prosthesis end (Type I). The nitinol wire loops can be expanded and tightened by 
activating a removable guide in such a way that device end varies its diameter, while 
maintaining a regular cylindrical shape. This allows the easy and quick insertion of the 
retracted device into the vascular stump and then its expansion to perfectly fit with the 




Fig. 10. Expandable device vs intraluminal ringed prosthesis. 
The expandable configuration of the ring allows to solve all the insertion, positioning and 
diameter mismatch problems of the 70ies intraluminal prosthesis. 
Its quite evident that the expandable configuration of the ring allows to solve all the 
insertion, positioning and stability problems of the 70ies intraluminal prosthesis (fig. 10). 
That makes performing an anastomosis a very simple task, which can be carried out in 
seconds vs the 10-15 min per anastomosis at best required with standard hand suture. 
The aortic wall being not perforated by the suture, the coupling is immediately blood-thigh 
(“air-tight” in fact!) and independent by the integrity of the physiological coagulation 
mechanisms. 
The device underwent many modifications and refinements, finally resulting in three main 
models (Type I, II and III) applying the same working mechanism, but with different shape 
to fit with all aorta segments as well as special conditions of use. 
Extensive “ex vivo” and “in vivo” animal experiments (Nazari et al 1994, 1996a, 1996d, 1997, 
2006, 2009; Rossella et al 2008) were carried out and few clinical cases were also successfully 
treated with this device (Nazari et al.1999; Aluffi et al, 2002, Buniva et al 2002). 
2.1 Device description and operational details  
2.1.1 Device type I and II 
Device type I and II differ because of the orientation of the activating guide in respect to the 
main axis of the device wireframe expandable sleeve (fig 11, upper right and lower left 
squares); that allows the devices to be ideally used for the first and second anastomosis 
respectively. Thus the type I device, activated by guide-wire coaxial to the lumen, is sutured 
at one end of the tube graft of appropriate size before clamping, can be quickly and easily 
positioned either in the proximal or distal end of the aortic tract to be replaced (fig. 11, top 
 
Front Lines of Thoracic Surgery 
 
272 
strip). Any further manipulation of the tube graft is then easily possible, including accessory 
side anastomosis with aortic branches, without any hindrance. The tube graft can then be 
sectioned at its exact required length and fixed with a single stitch at the rear anastomosis 
side (fig 11, middle strip); type II device, activated by guide-wire orthogonal to the vascular 
axis allowing stump connection at both sides, is then inserted, expanded and fixed by 
external ligature (fig 11, lower strip) ending the ischemia phase. 
When the perfusion is resumed, permanent fixation is carried out by tying ligature and 
applying few full thickness polypropilen 4-0 equidistant stitches, to further stabilize the 
device thus virtually preventing any possible late dislocation. Activating guide can then be 
removed by predisposed tools. 
 
 
Fig. 11. Device Type I and II.  
Device type I, previously sutured to the appropriate diameter tube graft end, is used for the 
first anastomosis; then after having carried out any other collateral branch anastomosis 
possibly required, the tube graft is cut at its final measure, fixed with a single stitch at rear 
anastomosis side (arrow) and device Type II is applied for the anastomosis. Circulation can 
be immediately resumed after tourniquets tightening. Thus final ligature, full thickness 
stabilizing stitches (3 at each anastomosis) and activating guide removal can be carried out 
without prolonging the ischemic phase. 
Use of the external ligature (umbilical tape or polipropilene) allows to minimize ischemic 
time, since the blood flow can be resumed after the simple tourniquet tension, the final 
stabilization being carried out afterward. With a very little prolongation of ischemia time 
however a polypropilene suture can be passed in a purse-string fashion also in the vascular 
intimal surface, totally or partially, with the same functional results (fig. 12). Even in this 
case it is important to pass the suture full thickness through the device at least in 3 roughly 
equidistant points in order to prevent any possible late dislocation. 
 




Fig. 12. Purse-string device fixation.  
With type I and II devices, the vascular stump encirclement can be avoided and substituted 
by endovascular (full or partial) purse-string polipropilene suture prepared at the site of 
expandable device positioning. The required full thickness security stitches can be passed 
after the circulation has been re-estableshed (from Nazari, 2010). 
The solution of positioning and stability problems of the 70ies intraluminal prosthesis (fig. 
10) allows for the first time the clinical appreciation of the most important feature of the 
“Payr principle” of anastomosis (vascular stumps compression against/between rigid 
structures i.e. an inner rigid ring and external ligature/outer rigid ring) which is to achieve 
an immediate hermetic seal (“air-tight” in fact) ensuring reliable haemostasis at the 
anastomosis line, not dependent from coagulation. Interestingly enough were just the 
positioning problems of Payr model as well as of its more recent modification 
(Intraluminal ringed prosthesis), that prevented in fact the clinical implementation of this 
coupling method, which is the most intuitive (and in fact was the first to be attempted in 
vascular surgery) and whose application failed only in the surgical field, while was in use 
(and still is) in all other technological fields where connectors between elastic/floppy 
tubing are required. 
Of course clinical experience over more than a century has shown that the standard suturing 
technique does not need to provide an “air-tight” anastomosis to ensure perfect hemostasis 
in virtually all clinical circumstances. In particular cases however (acute dissection, cystic 
medial necrosis, etc.), structural impairments of the aortic wall may necessitate additional 
maneuvers including graft strips buttressing, gluing and a variety of accessory techniques, 
whose efficacy at achieving hemostasis are not always fully predictable and that obviously 
further significantly prolong the period of ischemia in this most critical area. A coupling 
method that provides haemostasis by compression of the stumps’ vascular wall between 
two rigid structures (i.e. inner and outer expandable rigid sleeves) without perforation may 
be then particularly useful in these cases, not only because of its ease and quickness, but also 
because it offers the best mechanical chance of immediate blood-tightness. The expected 
advantages with regards to approximation of dissecting layers and false lumen permanent 
sealing rely on the same concept.  
An other important difference with 70-80ies intraluminal ringed devices is that the 
expandable sleeve is much more thin and porous, being formed substantially by a double 
layer of standard vascular dacron fabric, and can, therefore, be wholly and quickly 
colonized by fibroblasts and integrated with the aortic wall. 
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Fig. 13. Expandable device operational details. 
Left square. When a clamp is applied the linearization of the stump requires to keep its length 
significantly longer than usual in order to leave the space necessary for full expansion of the 
expandable end. It is also important to avoid full longitudinal vascular opening as carried 
out with current technique and thus keeping intact the entire circumference of the vascular 
stump for a tract long enough to host the whole device expandable end. 
Right square. The expandable end also can be positioned against aneurysmal wall, provided 
that its distal end would reach the healthy vascular wall. Thrombosis of the tract between 
the ligature and the prosthesis end will soon move the effective anastomosis line (upper 
right square*) where it would be with standard suture (mod from Nazari et al, 1997). 
The nitinol wire-frame in fact forms a very thin and wide mesh net that accounts for a very 
small proportion of the device’s volume and that offers no significant barrier to fibroblastic 
invasion of the dacron fabric and thus to stable biological integration of the device.  
Few technical details must be considered with the expandable devices. 
First of all care must be taken when entering the aneurysm not to extend the incision up to 
both the distal and proximal ends as usually carried out with standard suture; it is in fact 
very important to keep intact the entire circumference of the vascular stump for a tract long 
enough to host the device expandable end. 
Due to the linearization of the vessel diameter induced by the clamp, the length of the 
vascular stump distal to it must be significantly longer than imagined before clamping; in 
practice it is advisable to isolate the vessel for a length exceeding its diameter (Fig. 13, left 
square ). 
It may be argued that the use of the device may require a distinct healthy vascular neck, as 
with endovascular techniques. This is not necessary; the device in fact can be expanded even 
within the aneurysmal wall and fixed there by the external ligature, provided that its end 
reaches the healthy vascular wall limit, where ideally the standard suture would be placed 
(Fig 13, right square). The thrombosis developing in the tract between the ligature and the 
prosthesis end will soon exclude the brief tract of aneurysmal wall from the bloodstream, 
thus moving the effective anastomosis line (fig 13,* at upper right square) where it would be 
with standard suture. 
Thus devices type I and II can be ideally used anywhere in descending and abdominal aorta 
and allow to carry out any required additional surgical maneuver on the tube graft, i.e. 
collateral branch anastomosis, as well as its appropriate tailoring at the required length 
measured directly on the operative field as in standard technique without obstacle or 
hampering condition. Its great simplicity of use allows the devices to be used also in condition 
of suboptimal operative field exposure. Thus for example both proximal and distal 
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anastomosis in extended descending thoracic aorta substitution be easily and safely carried out 
though a single space thoracotomy; moreover aortic prosthetic substitution via mini-access 
thoracotomy or laparotomy video-assisted setting may be also predictably considered. 
2.1.2 Device type III 
In this version of the device the external ligature is substituted by an expandable sleeve, 
which is based essentially on the same working principle as the inner sleeve, but activated 
contrariwise. Thus, the vascular stump is compressed between two sleeves (Fig. 14, upper 
left little squares), with variable and controllable diameters, allowing full control of the 
pressure (amount and surface of its application) applied to the vascular stump. 
Operative technique for device type III is illustrated in fig 14 in ascending aorta “ex vivo” 
model and it is really very simple. First of all both sleeves diameter is set at the predicted 
value of the aortic tract where the device will be applied. Then the inner sleeve diameter 
only is reduced as much as possible by acting on its guide-wire; this causes also the 
backwards eversion and partial rotation of the outer sleeve thus greatly enhancing inner 
sleeve visibility and then its easy positioning into the vascular stump. The inner sleeve is 
then re-expanded against the vascular stump inner surface; at this point the outer sleeve is 
gently retracted acting on its own activating guide to compress the vascular stump. 
The primary aim of this new version of the device is to make possible and convenient to 
apply this coupling principle also to acute ascending aorta and arch dissection, in order to 
simplify the technique, to reduce the ischemic time, to improve hemostasis of the 
anastomosis line and to achieve reliable, stable sealing of the dissection layers in this very 
complex surgical setting. The device in fact allows to actually automate substantially the 
same aortic wall sandwiching between two graft strips procedure usually carried out in the 
dissection cases and realizing at once the prosthesis anastomosis, being the tube graft (not 
shown in the figure) obviously previously sutured to the inner sleeve proximal end. 
Interestingly enough the particular configuration of the device allows full and easy 
compliance with aortic anatomy, perfectly adapting also to the elliptic, asymmetric 
“oblique”stump resulting from inclusion of the arch concavity in the anastomosis line (Fig. 
15, B). Full and persistent air-tight sealing of the device-aortic wall coupling was verified at 
endovascular pressures of up to 150 mmHg in “ex vivo” swine aortic models, including 
those involving an elliptic, ‘oblique’ anastomosis (Fig. 15, b) (Nazari, 2010). As expected, 
standard vascular sutures were not air-tight even at pressures below 10 mmHg (Fig. 15, c). 
Type III device use is then ideally indicated in dissection cases for distal anastomosis sited at 
distal ascending aorta, including as much as required of the concavity of the arch during a 
very brief circulatory arrest phase; proximal anastomosis will be then carried out either by 
hand suture or with the expandable device version most appropriated for the particular 
anatomical condition, in normal CEC in no rush and after having performed any additional 
procedure possibly required, for example on the valve.  
Anastomosis at the distal arch/proximal descending aorta in case of full arch substitution 
is also an ideal indication for type III device use in case of dissection or whenever, for 
particular aortic wall fragility, graft strips sandwiching buttressing may be advisable. 
Supra-aortic trunks in these cases can be ideally re-vascularized by devices type I 
previously appropriately connected to the main tube graft so that they can be plugged in 
and there fixed by purse-string partially or entirely passed from inside the vascular lumen 
(fig. 11). 
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anastomosis in extended descending thoracic aorta substitution be easily and safely carried out 
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contrariwise. Thus, the vascular stump is compressed between two sleeves (Fig. 14, upper 
left little squares), with variable and controllable diameters, allowing full control of the 
pressure (amount and surface of its application) applied to the vascular stump. 
Operative technique for device type III is illustrated in fig 14 in ascending aorta “ex vivo” 
model and it is really very simple. First of all both sleeves diameter is set at the predicted 
value of the aortic tract where the device will be applied. Then the inner sleeve diameter 
only is reduced as much as possible by acting on its guide-wire; this causes also the 
backwards eversion and partial rotation of the outer sleeve thus greatly enhancing inner 
sleeve visibility and then its easy positioning into the vascular stump. The inner sleeve is 
then re-expanded against the vascular stump inner surface; at this point the outer sleeve is 
gently retracted acting on its own activating guide to compress the vascular stump. 
The primary aim of this new version of the device is to make possible and convenient to 
apply this coupling principle also to acute ascending aorta and arch dissection, in order to 
simplify the technique, to reduce the ischemic time, to improve hemostasis of the 
anastomosis line and to achieve reliable, stable sealing of the dissection layers in this very 
complex surgical setting. The device in fact allows to actually automate substantially the 
same aortic wall sandwiching between two graft strips procedure usually carried out in the 
dissection cases and realizing at once the prosthesis anastomosis, being the tube graft (not 
shown in the figure) obviously previously sutured to the inner sleeve proximal end. 
Interestingly enough the particular configuration of the device allows full and easy 
compliance with aortic anatomy, perfectly adapting also to the elliptic, asymmetric 
“oblique”stump resulting from inclusion of the arch concavity in the anastomosis line (Fig. 
15, B). Full and persistent air-tight sealing of the device-aortic wall coupling was verified at 
endovascular pressures of up to 150 mmHg in “ex vivo” swine aortic models, including 
those involving an elliptic, ‘oblique’ anastomosis (Fig. 15, b) (Nazari, 2010). As expected, 
standard vascular sutures were not air-tight even at pressures below 10 mmHg (Fig. 15, c). 
Type III device use is then ideally indicated in dissection cases for distal anastomosis sited at 
distal ascending aorta, including as much as required of the concavity of the arch during a 
very brief circulatory arrest phase; proximal anastomosis will be then carried out either by 
hand suture or with the expandable device version most appropriated for the particular 
anatomical condition, in normal CEC in no rush and after having performed any additional 
procedure possibly required, for example on the valve.  
Anastomosis at the distal arch/proximal descending aorta in case of full arch substitution 
is also an ideal indication for type III device use in case of dissection or whenever, for 
particular aortic wall fragility, graft strips sandwiching buttressing may be advisable. 
Supra-aortic trunks in these cases can be ideally re-vascularized by devices type I 
previously appropriately connected to the main tube graft so that they can be plugged in 
and there fixed by purse-string partially or entirely passed from inside the vascular lumen 
(fig. 11). 
 




Fig. 14. Device type III. 
The type III device incorporates an external sleeve that substitutes the external ligature, thus 
allowing standardization of the pressure applied to the vascular stump wall. The wire-frame 
of the device is quite soft and compliant, and can be easily compressed and widely 
deformed while maintaining perfect reciprocal alignment of the internal and external 
sleeves (top left squares). Lower squares: First of all both sleeves are set at predicted final 
aperture. Acting only on the activating guide of the inner sleeve results in outer sleeve 
backwards rotation and eversion, bringing the retracted inner sleeve in full visibility, so that 
can be easily inserted into the vascular stump. Then inner ring is expanded as much as the 
vascular wall can be distended by acting contrariwise on the same guide. At this point, the 
outer sleeve is only slightly retracted towards the aortic wall using its own guide. (Nazari, 
2010) Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
 
 
Fig. 15. Device type III seal test.  
The outer surface of the inner sleeve was wrapped by a latex cuff (top squares) in order to 
overcome the problem of the porosity of the dacron graft and the requirement for the 
connection of the tube graft to the proximal end of the inner sleeve as in its final clinical use. 
A) The air-tightness of the connection was verified at endovascular pressures of up to 150 
mmHg in a regular cylindrical anastomosis of ascending aorta (white bars). (B) The same 
was verified when the anastomosis is irregularly oriented, such as when involves the arch 
concavity. (C) As easily predictable, a standard suture (4–0 prolene) of an approximately 3 
cm incision of the aortic wall cannot be proved airtight even at minor endovascular 
pressure. (Nazari, 2010). Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
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Thus in all cases where sandwiching buttressing is planned the use of the device type III 
requires exactly the same aortic stump external wall preparation required for hand suture 
double graft strips application. When anatomical conditions do not require sandwiching 
buttressing, device type I or type II may be also used even without external vascular stump 
encircling, being possible to fix the expanded device end by purse-string passed entirely or 
partially from inside the aortic lumen (fig. 11). 
The great simplification and the very significant quickening of this complex surgical part 
together with the higher accuracy and “mechanical” reliability of this coupling method in 
comparison with manual suture could potentially have impact that may exceed that strictly 
related to the anastomosis. For example being possible to carry out even the entire arch re-
vascularization in few minutes of circulatory arrest, the level of hypothermia may be very 
significantly reduced and even the type of cerebral protection may be tailored to these very 
restricted time lapses, just to say the firsts coming in mind. 
2.1.3 Other expandable device models 
We also realized a variety of modified versions of the device to better fit with the anatomical 
configurations occurring in particular clinical circumstances.  
2.1.3.1 Type I – SOLD (Single Outer Layer for small Diameters) 
In small vessel diameters obviously device dimensions can interfere more significantly with 
physiological lumen amplitude in their range of use. More in particular the unpredictable 
way of folding of the inner fabric layer when the device is incompletely opened may 
significantly reduce the lumen available for the blood flow. Accordingly for diameters ≤ 12 
and ≥6 mm we decided to use devices wrapped by fabric only at external layer (fig. 16). Two 
sizes were prepared respectively for diameter from 6 to 9 (SS) and from 10 to 12 mm (S). 
This may fit for renal artery, celiac axis and supraortic trunks. The device is previously 
prepared at the end of collateral branch of the main tube graft tailored at the expected 
appropriated length or directly on the main tube graft. The particular fabric disposition 
implies a mandatory blood flow direction, which however allows the use as main tube graft 
lateral branches for the major aortic branches.  
 
 
Fig. 16. Device type I – SOLD.  
For small diameters vessels (≥6mm ≤12mm) device type I was prepared with single outer 
fabric graft in order to prevent the possible significant interference with vascular lumen of 
unpredictable way of folding of the inner layer when the device cannot be fully expanded. 
These devices allow one way flow direction only.  
Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
2.1.3.2 Type II – BIO (Bending and Independent Opening) 
This type II device modified version is intended for use in ascending aorta substitution in 
absence of dissection. The two ends of the device can vary their reciprocal axis up to 90° to 
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partially from inside the aortic lumen (fig. 11). 
The great simplification and the very significant quickening of this complex surgical part 
together with the higher accuracy and “mechanical” reliability of this coupling method in 
comparison with manual suture could potentially have impact that may exceed that strictly 
related to the anastomosis. For example being possible to carry out even the entire arch re-
vascularization in few minutes of circulatory arrest, the level of hypothermia may be very 
significantly reduced and even the type of cerebral protection may be tailored to these very 
restricted time lapses, just to say the firsts coming in mind. 
2.1.3 Other expandable device models 
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configurations occurring in particular clinical circumstances.  
2.1.3.1 Type I – SOLD (Single Outer Layer for small Diameters) 
In small vessel diameters obviously device dimensions can interfere more significantly with 
physiological lumen amplitude in their range of use. More in particular the unpredictable 
way of folding of the inner fabric layer when the device is incompletely opened may 
significantly reduce the lumen available for the blood flow. Accordingly for diameters ≤ 12 
and ≥6 mm we decided to use devices wrapped by fabric only at external layer (fig. 16). Two 
sizes were prepared respectively for diameter from 6 to 9 (SS) and from 10 to 12 mm (S). 
This may fit for renal artery, celiac axis and supraortic trunks. The device is previously 
prepared at the end of collateral branch of the main tube graft tailored at the expected 
appropriated length or directly on the main tube graft. The particular fabric disposition 
implies a mandatory blood flow direction, which however allows the use as main tube graft 
lateral branches for the major aortic branches.  
 
 
Fig. 16. Device type I – SOLD.  
For small diameters vessels (≥6mm ≤12mm) device type I was prepared with single outer 
fabric graft in order to prevent the possible significant interference with vascular lumen of 
unpredictable way of folding of the inner layer when the device cannot be fully expanded. 
These devices allow one way flow direction only.  
Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
2.1.3.2 Type II – BIO (Bending and Independent Opening) 
This type II device modified version is intended for use in ascending aorta substitution in 
absence of dissection. The two ends of the device can vary their reciprocal axis up to 90° to 
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better fit with the curvature of the ascending aorta; their aperture can be independently 
controlled in order to comply with possible differences in diameter of the proximal and 
distal stumps. In this way the ascending aorta substitution can be carried out very quickly 
by one single device.  
 
 
Fig. 17. Device Type II – BIO.  
This type II device version allows the bending up to a 90° degree angle of the axis of their 
ends, whose aperture can be independently controlled. This allows to fit curved anatomy of 
ascending aorta and possible variations in diameter of the vascular stumps. 
Video at: http://www.fondazionecarrel.org/tsb2/tsb2.html 
In case of dissection however type III device previously connected with graft tube should be 
better used for distal anastomosis. Proximal anastomosis can be carried out with standard 
suture, time being not here a critical factor, or by a second type III device if dissection 
involves also the proximal anastomosis line. 
This device version can also be used in isthmus rupture repair, having care of entering the 
aorta through or close to the laceration in order to preserve integrity of the vascular wall at 
site of device ends deployment.  
2.1.3.3 Recent refinements 
The extensive past experience provided full mechanical reliability of devices in all their 
versions and proved their easy applicability to aortic stump in all conditions. While the 
expandable device allows a much easier, quicker and more efficient (“airtight” seal) graft-
aortic stump coupling than standard suture (Nazari 2010), it implies however the 
permanence of endovascular tubular wireframe and external ligature that could, at least 
theoretically, mechanically conflict with aortic wall, particularly at device ends, and with 
confining tissues/organs.  
Aorto-digestive fistula is an infrequent but well documented occurrence after aortic open 
(Geraci et al 2008; Luo et al, 2010) as well as after endovascular (Ruby & Cogbill, 2007; Marone 
et al, 2007; Chiesa et al, 2010) repair. While graft or/and suture line contamination/infection 
may occasionally be suspected as the primary etiological factor, pure mechanical erosion from 
systolic movements of graft and even from the suture line only (Tanaka et al, 2009) may 
probably represent the first triggering factor in a portion of cases difficult to quantify.   
The pure mechanical effect of these movements on the confining tissue/organ is predictably 
higher the harder/less compliant is the prosthetic material as well as the more conflicting is 
its orientation in relation to the confining tissue/organ.  
We then recently focused on optimal consistency of the expandable wireframe and on means 
to provide external fixation with the final aim of achieving mechanical forces of coupling as 
much as possible similar to those taking place in standard hand suture anastomosis.  
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For this purpose, on one side, the wireframe consistency was decreased by variably reducing 
the gauge of nitinol wires and their respective position within wireframe and, on the other 
side, the external ligature was carried out with the thinnest possible prolene (5-0) encircling 
suture, transfixing full thickness the device and aortic wall at three equidistant points. The 
limit of the former was the ability to sustain the external ligature without wireframe 
deformation/collapse at pressure providing “airtight” seal; the limit of the later was the ability 
to provide stability of the aortic stump-expandable device coupling at stretch test. 
The present versions of the devices with minimal consistence and great compliance 
minimize the risk of mechanical conflict and erosion with the confining tissue/organs; 
moreover wireframe consistency was settled in such a way that is minimal at the device end 
where the possible conflict with aortic wall could be higher. 
Concerning the external ligature and its many possible ways of application, it may be useful 
to recall that vascular anastomosis must guarantee haemostatic sealing and stability of the 
coupling which, contrariwise to standard suture, rely on different mechanisms with this 
type of coupling (Fig. 8).  
Thus even though external devices surface is provided with short needles perpendicularly 
positioned around its circumference at 4-6 equidistant points, reduction of the wireframe 
consistency may probably decrease their reliability in keeping coupling stability. 
To optimize coupling stability in this lighter expandable wireframe we successfully tested 5-
0 prolene encircling suture, transfixing full thickness the device and aortic wall at three 
equidistant points (fig. 18). In this way in fact the minimal expandable wireframe 
consistence to sustain the external ligature can be further significantly reduced and stability 
increased, by splitting the external ligature circumference in three separate and equivalent 
segments. In this embodiment the expandable ring will be then really only a bit more 
consistent of a common graft tube. 
 
 
Fig. 18. Carrel’s triangulation - back to the future. 
To provide reliable coupling stability, instead of simple external ligature, 5-0 prolene 
encircling suture, transfixing full thickness the device and aortic wall at three equidistant 
points, was passed and tied as shown, in a sort of revival of the Carrel triangulation 
historical technique. Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
This coupling stability was proved by a stretch test consisting in a sequence of manoeuvres  
carried out on the anastomosis that includes: 1) complete compression of the anastomosis in 
orthogonal directions and then 2) vigorous manual stretching of the anastomosis in the 
coaxial plane separately at four points of its circumference. The sequence was repeated three 
times and the anastomosis checked for any significant vascular stump backwards 
dislocation on the expandable wireframe throughout the entire circumference.  
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Fig. 19. Stretch test. 
Stability coupling was validate by stretching test consisting in vigorous manual stretching of 
the anastomosis in the coaxial plane separately at four points of its circumference; the 
anastomosis was than checked for any significant vascular stump backwards dislocation on 
the expandable wireframe throughout the entire circumference.  
Video at: http://www.fondazionecarrel.org/tsb2/tsb2.html 
Device type III stability was also increased by further buttressing the inner and outer 
Dacron wrapping by 4-0 prolene suture transfixing the circumference in 3-6 points (fig. 20), 
a manoeuvre that however can be predictably carried out after perfusion is resumed.  
While it’s certainly easier and also a bit quicker to use expandable device wireframe strong 
enough to block the aortic stump between simple external ligature and outer surface of the 
device fixing needles, I think that it’s much more technically appropriate and probably safer to 
realize a vascular/graft coupling where the forces applied are as much as possible similar to 
those involved in standard vascular suture, even though this can mean a minimal increase of 
ischemic time, required for placing the 3 full thickness stitches around the positioned device. 
 
 
Fig. 20. Type III security fixation. 
A simpler in and out 4-0 prolene buttressing in 4-6 points of the inner and outer device 
wireframe will greatly increase coupling stability. 
Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
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In synthesis this method ideally allows to change any vascular-graft anastomosis ≥ 6 mm in 
diameter from the current facing ends Carrel suture into a simpler, quicker and more 
efficient (“airtight” seal) telescoping anastomosis, sealed and fixed by single thread external 
ligature passed full thickness at three points (or more when appropriate), in a sort of ideal 
re-elaboration of the historical Carrel triangulation technique.  
The hypothesizable potential impact (table 1) may exceed that expected on complication rate 
of open prosthetic substitution of all aortic tracts and in particular in those higher risk 
conditions as acute dissection. In fact the technical simplification with increased reliability of 
anastomosis haemostasis and dissection layer approximation with false lumen permanent 
seal has the logical direct consequence, for example, of enabling also lesser expert 
cardiovascular surgeons to deal with these clinical cases very often requiring immediate 
surgical attention, thus increasing surgical team efficiency and hospital unit productivity. 
 
 
Table 1. Potential impact of expandable device aortic anastomosis compared with current 
hand suture technique 
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3. New endovascular “net” prosthesis for aortic wall strengthening without 
blocking aortic branches perfusion to early stop aneurysm progression or to 
prevent its formation in high risk patients  
3.1 Background 
While endovascular procedures already proved lower mortality and complications rate than 
open surgery and as good long term results in infrarenal and upper descending aorta, in all 
other aortic tracts endovascular techniques are much more complex and long term results 
less predictable mainly due to the presence of significant collateral branches, that require 
additional maneuvers to avoid their obstruction by the endoprosthesis (i.e. hybrid 
procedure with open surgery for supraortic trunks de-branching).  
Moreover endovascular procedures failed to protect from spinal chord ischemia and 
consequent paraplegia in extended descending aorta prosthetic substitution; it has been 
hypothesized that this could be due, at least in some case, to the fact that while 
endoprosthesis prevents intercostal branches to be physiologically perfused, cannot prevent, 
at least for a certain time in the initial phase, backwards blood flow into the space between 
endoprosthesis and aortic wall, thus generating conditions for a blood flow “steal” from 
perfusion of the spinal chord (Kawaharada et al, 2010).  
On the other hand current data  (Gopaldas et al, 2010) show that only less than 1/4 of ideal 
candidates to endovascular treatment (uncomplicated, non genetic, isolated, elective 
descending aortic aneurysms) underwent endovascular procedure, while the remaining 3/4 
still underwent open surgical repair in US. 
3.2 The rational 
The relative slowness of aneurysm formation and progression to rupture indicates that the 
decrease in the strength of the arterial wall under the aneurysm formation threshold may be 
very gradual and limited. Consequently one can imagine that measures to increase, even 
moderately, the mechanical strength of the arterial wall, for example by means of a dacron 
fabric network, should be successful in preventing aneurysm formations and thus its 
complications (dissection and rupture), without requiring complete prosthetic substitution. 
Moreover the conclusive understanding that a destruction of the elastin fibrils network is at 
the basis of aneurysm formation [Gott et al, 1996], might acknowledge the re-establishment 
of a uniform and regular network strengthening of the vascular wall with a net prosthesis as 
a logic, direct correction of the primary defect. On the other hand this mechanical approach  
since long time is already in use in many other technology fields for prevention of 
deformation of elastic/floppy tubes or structures subject to inner high pressure, as for 
example gardening tubes, tires, rubber boat etc. 
In previous animal experiments we showed that the endovascular positioning of polypropilen 
“net” prosthesis, if kept in contact with the inner vascular surface, is spontaneously covered by 
new intima and included in the aortic wall in few weeks (fig 21 and fig 22), still keeping 
perfusion of some intercostals vessels, even though the net meshes used in those experiments 
were certainly too tight to assure their long term patency. 
The experimental hypothesis is based on the fact that the net prosthesis positioned and 
maintained in stable contact with the aortic walls (A) is spontaneously, gradually covered 
by the neo-intima (B), invaded by fibroblasts and thus stably associated to the aortic wall. If 
the net mesh is appropriately dimensioned, it may be expected that the blood flow through 
the collateral branches is not affected (arrows) (from Nazari et al, 1996c) 
 




Fig. 21. The Rational. The experimental hypothesis is based on the fact that the net prosthesis 
positioned and maintained in stable contact with the aortic walls (A) is spontaneously, 
gradually covered by the neo-intima (B), invaded by fibroblasts and thus stably associated to 
the aortic wall. If the net mesh is appropriately dimensioned, it may be expected that the blood 
flow through the collateral branches is not affected (arrows) (from Nazari et al, 1996c)  
 
 
Fig. 22. Swine experimental model. 
Left square. After 6 weeks the net prosthesis, a braided polipropilene fitted with a co-axial 
thin stainless steel coil surgically positioned in swine upper descending aorta, was found to 
be covered by the new intima and well attached to the aortic wall. In the lower right side of 
the prosthesis segment the net is no longer visible and presumably, with little more time, 
this smooth, normal intimal surface would extend to completely cover the whole net 
prosthesis (metallic coil was removed). Right square. Histology shows  the net prosthesis 
completely included into the intima layer and lying in contact with the media. The square 
area shows the magnified polypropylene mesh net pattern. (mod from Nazari et al 1996 c) 
Video http://www.fondazionecarrel.org/tsb2/tsb2.html 
The fabric framework linked to the aortic wall would then condition its significant, regular 
and uniform mechanical strengthening that fractionates and absorbs the centrifuge systolic 
stress of the bloodstream. The significant mechanical strengthening achieved in this way 
was measurable by comparison of compliance (∆V/∆P) of the treated aortic tract with that 
of the immediately confining segment (fig 23)  
 
Front Lines of Thoracic Surgery 
 
282 
3. New endovascular “net” prosthesis for aortic wall strengthening without 
blocking aortic branches perfusion to early stop aneurysm progression or to 
prevent its formation in high risk patients  
3.1 Background 
While endovascular procedures already proved lower mortality and complications rate than 
open surgery and as good long term results in infrarenal and upper descending aorta, in all 
other aortic tracts endovascular techniques are much more complex and long term results 
less predictable mainly due to the presence of significant collateral branches, that require 
additional maneuvers to avoid their obstruction by the endoprosthesis (i.e. hybrid 
procedure with open surgery for supraortic trunks de-branching).  
Moreover endovascular procedures failed to protect from spinal chord ischemia and 
consequent paraplegia in extended descending aorta prosthetic substitution; it has been 
hypothesized that this could be due, at least in some case, to the fact that while 
endoprosthesis prevents intercostal branches to be physiologically perfused, cannot prevent, 
at least for a certain time in the initial phase, backwards blood flow into the space between 
endoprosthesis and aortic wall, thus generating conditions for a blood flow “steal” from 
perfusion of the spinal chord (Kawaharada et al, 2010).  
On the other hand current data  (Gopaldas et al, 2010) show that only less than 1/4 of ideal 
candidates to endovascular treatment (uncomplicated, non genetic, isolated, elective 
descending aortic aneurysms) underwent endovascular procedure, while the remaining 3/4 
still underwent open surgical repair in US. 
3.2 The rational 
The relative slowness of aneurysm formation and progression to rupture indicates that the 
decrease in the strength of the arterial wall under the aneurysm formation threshold may be 
very gradual and limited. Consequently one can imagine that measures to increase, even 
moderately, the mechanical strength of the arterial wall, for example by means of a dacron 
fabric network, should be successful in preventing aneurysm formations and thus its 
complications (dissection and rupture), without requiring complete prosthetic substitution. 
Moreover the conclusive understanding that a destruction of the elastin fibrils network is at 
the basis of aneurysm formation [Gott et al, 1996], might acknowledge the re-establishment 
of a uniform and regular network strengthening of the vascular wall with a net prosthesis as 
a logic, direct correction of the primary defect. On the other hand this mechanical approach  
since long time is already in use in many other technology fields for prevention of 
deformation of elastic/floppy tubes or structures subject to inner high pressure, as for 
example gardening tubes, tires, rubber boat etc. 
In previous animal experiments we showed that the endovascular positioning of polypropilen 
“net” prosthesis, if kept in contact with the inner vascular surface, is spontaneously covered by 
new intima and included in the aortic wall in few weeks (fig 21 and fig 22), still keeping 
perfusion of some intercostals vessels, even though the net meshes used in those experiments 
were certainly too tight to assure their long term patency. 
The experimental hypothesis is based on the fact that the net prosthesis positioned and 
maintained in stable contact with the aortic walls (A) is spontaneously, gradually covered 
by the neo-intima (B), invaded by fibroblasts and thus stably associated to the aortic wall. If 
the net mesh is appropriately dimensioned, it may be expected that the blood flow through 
the collateral branches is not affected (arrows) (from Nazari et al, 1996c) 
 




Fig. 21. The Rational. The experimental hypothesis is based on the fact that the net prosthesis 
positioned and maintained in stable contact with the aortic walls (A) is spontaneously, 
gradually covered by the neo-intima (B), invaded by fibroblasts and thus stably associated to 
the aortic wall. If the net mesh is appropriately dimensioned, it may be expected that the blood 
flow through the collateral branches is not affected (arrows) (from Nazari et al, 1996c)  
 
 
Fig. 22. Swine experimental model. 
Left square. After 6 weeks the net prosthesis, a braided polipropilene fitted with a co-axial 
thin stainless steel coil surgically positioned in swine upper descending aorta, was found to 
be covered by the new intima and well attached to the aortic wall. In the lower right side of 
the prosthesis segment the net is no longer visible and presumably, with little more time, 
this smooth, normal intimal surface would extend to completely cover the whole net 
prosthesis (metallic coil was removed). Right square. Histology shows  the net prosthesis 
completely included into the intima layer and lying in contact with the media. The square 
area shows the magnified polypropylene mesh net pattern. (mod from Nazari et al 1996 c) 
Video http://www.fondazionecarrel.org/tsb2/tsb2.html 
The fabric framework linked to the aortic wall would then condition its significant, regular 
and uniform mechanical strengthening that fractionates and absorbs the centrifuge systolic 
stress of the bloodstream. The significant mechanical strengthening achieved in this way 
was measurable by comparison of compliance (∆V/∆P) of the treated aortic tract with that 
of the immediately confining segment (fig 23)  
 




Fig. 23. Aortic wall compliance (ΔV/ΔP). 
To quantify aortic wall strengthening induced by the net prosthesis its compliance (ΔV/ΔP). 
was compared with that of the confining segments that was found significantly higher. 
(from Nazari et al 1996b) Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
 
 
Fig. 24. Aortic wall strengthening factors. 
The structural properties of the aortic wall associated to the intraluminal net prosthesis  
rely  on  three factors: 1) the structural properties of the net prosthesis, 2) the structural 
properties of the aortic wall, 3) the strength of the bonds between the aortic wall and the 
net prosthesis, based substantially on fibroblastic invasion of the net fabric and its 
permanent integration with aortic wall. The latter is the crucial point and can be viewed 
as the true “functional unit” of this model. In fact if this link is sufficiently strong and 
stable in the time it can be hypothesized to be able to stabilize aortic wall and prevent 
dilatation even independently from the “net” prosthesis own diameter, which could not 
be further distended after that their fabric threads have been integrated into the aortic 
wall. (mod. from Nazari et al 1996b) 
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The structural properties of the aortic wall associated to the intraluminal net prosthesis  rely 
on three factors (fig 24): 1) the structural properties of the net prosthesis, 2) the structural 
properties of the aortic wall, 3) the strength of the bonds between the aortic wall and the net 
prosthesis, based substantially on fibroblastic invasion of the net fabric and its permanent 
integration with aortic wall. Given the structural adequacy of the net prosthesis 
(polypropylene net prosthesis squared mesh 5x5 mm with a thread diameter of 0.5 mm 
sustaining a pressure of 300 mmHg (0.04 Nmm2) is charged at 50% of its failure tension 
(Nazari at al, 1996b, 1996c) and the mechanical effect of fractioning the aortic wall in the 
small area of the net meshes (fig 24, lower part), the important point of this model is the 
strength of the links biologically established between the threads of the mesh and the aortic 
wall tissues (point 3 in fig. 24) during the 4-6 weeks integration process. 
It may be hypothesized that its strength relies mainly in the degree of integration of the net 
thread with the intimal layer mainly due to fibroblastic invasion and is then predictably 
stronger with porous material (PTFE) or multifilament braided polyester (Dacron).  
 
 
Fig. 25. Variation of the circumferential stress through the aortic wall thickness. 
For a thick cylinder (thickness > 8% of the radius (R)) such as the aorta, the stress is not 
uniform throughout the wall; it is maximal on the inner wall, it decreases through the 
thickness of the wall and is minimal on the outer wall. This explains the pathogenic 
mechanism of dissection, where only stress to the inner part of the wall is strong enough to 
cause tear; moreover it adds arguments to the rationale of intraluminal positioning of the 
net prosthesis in order to achieve the structural strengthening just where this is most 
needed, i.e. where the circumferential stress is maximal. This allows for the required 
strengthening with optimization of the amount of prosthetic material (thinner threads) (Mod 
from Robicsek and Thubrikar 1994) 
The latter is the crucial point of this model. In fact if this link is sufficiently strong and stable 
in the time, it can be hypothesized to be able to stabilize aortic wall and prevent dilatation 
even independently from the “net” prosthesis own diameter, which could not be further 
distended after that their meshes have been firmly integrated into the aortic wall (Redaelli & 
Fiore, 2011). The practical consequence is that the precise equivalence between diameter of 
the net prosthesis and aortic diameter is not necessary; the prosthesis in fact can be 
 




Fig. 23. Aortic wall compliance (ΔV/ΔP). 
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(from Nazari et al 1996b) Video at http://www.fondazionecarrel.org/tsb2/tsb2.html 
 
 
Fig. 24. Aortic wall strengthening factors. 
The structural properties of the aortic wall associated to the intraluminal net prosthesis  
rely  on  three factors: 1) the structural properties of the net prosthesis, 2) the structural 
properties of the aortic wall, 3) the strength of the bonds between the aortic wall and the 
net prosthesis, based substantially on fibroblastic invasion of the net fabric and its 
permanent integration with aortic wall. The latter is the crucial point and can be viewed 
as the true “functional unit” of this model. In fact if this link is sufficiently strong and 
stable in the time it can be hypothesized to be able to stabilize aortic wall and prevent 
dilatation even independently from the “net” prosthesis own diameter, which could not 
be further distended after that their fabric threads have been integrated into the aortic 
wall. (mod. from Nazari et al 1996b) 
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thread with the intimal layer mainly due to fibroblastic invasion and is then predictably 
stronger with porous material (PTFE) or multifilament braided polyester (Dacron).  
 
 
Fig. 25. Variation of the circumferential stress through the aortic wall thickness. 
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from Robicsek and Thubrikar 1994) 
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in the time, it can be hypothesized to be able to stabilize aortic wall and prevent dilatation 
even independently from the “net” prosthesis own diameter, which could not be further 
distended after that their meshes have been firmly integrated into the aortic wall (Redaelli & 
Fiore, 2011). The practical consequence is that the precise equivalence between diameter of 
the net prosthesis and aortic diameter is not necessary; the prosthesis in fact can be 
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significantly redundant in respect to the effective aortic diameter, thus allowing for its easier 
adaptability to geometrical irregularity of aneurysm wall without consequences on its 
efficiency in keeping stable aortic diameter. The final “functional unit” of this model for 
aortic wall strengthening is then the single mesh of the net integrated into the aortic wall, 
whose efficiency relies then on the bonds between net threads and aortic tissue. 
Interestingly enough in this model the endovascular net prosthesis provides aortic wall 
mechanical support just where the mechanical stress is higher (Robicsek & Thubrikar, 1994) 
(fig. 25), and thus just where it’s most needed both to prevent further dilatation, 
theoretically preventable also by external aortic wall wrapping (Pepper et al 2010), and to 
avoid partial (dissection) or total rupture, with optimization of the amount of prosthetic 
material. The reduced volume of the net prosthesis in comparison with current 
endoprosthesis (≤1/6th approximately) further greatly enhances its introduction through 
peripheral vessel often tortuous and restricted by atherosclerosis. 
3.3 Methodology 
The previous experimental work as well as structural mechanical theoretical considerations 
allow to predict applicability and reliability of the method in the clinical setting of 
preventing aneurysm formation or arresting its progression at an early stage. 
The organizative plan for achieving this final goal however includes several further distinct 
steps. 
3.3.1 Ideal “net” prosthesis prototypes setup 
This part of the project includes  
 the selection of the best fabric material (PTFE, multifilament polypropylene, etc) with 
the best chances of the strongest links with aortic wall 
 identification of its appropriated dimensioning and mechanical features, including 
elasticity, to provide the best support to the stream pressure stress up to its extreme 
pathological limit (300 mm hg) 
 identification of the most appropriate net prosthesis embodiment able to maintain it in 
permanent contact with intimal surface, which is essential to its quick and spontaneous 
incorporation into the aortic wall. This may include a thin nitinol wireframe associated 
to the main net prosthesis; a prototype for descending aorta currently in study is 
illustrated at fig. 26. However fluid-dynamic shapes of the net threads will be also 
evaluated in mechanical models with the aim to verify if it is possible to achieve 
conduit inner wall contact by means of pure fluid stream 
 Ascending aorta and Arch require variably curved net prosthesis (fig 26, right); for 
these tracts however bespoke prosthesis on the individual TC scan, maybe with wider 
meshes for the supraortic trunks area, is an option to be considered for clinical use; 
bespoke prosthesis however have being already realized in a external ascending aorta 
wrapping protocol (Pepper et al, 2010)). 
 Endovascular delivery system is also to be realized 
The nitinol wireframe adds to the net further structural strengthening then greatly 
exceeding that required; an accurate structural mechanics computation would theoretically 
allow the achievement of the necessary aortic wall structural strengthening to permanently 
fix aortic diameter with really a very thin and wide meshes net prosthesis. 
 




Fig. 26. “Net” prosthesis prototypes. 
Possible prototypes versions were realized by 5x5mm meshes of braided fabric embodied 
with very thin nitinol wider helicoidal wireframe (left:blu lines, red arrows, 12-15 mm). 
Ascending aorta and arch would require curved prosthesis (right), maybe bespoke to the 
patient aortic anatomy on CT scans. 
A more straight, ready, maybe oversimplified method, but still mechanically efficient, could 
consist in the simple substitution of the Dacron tube with a fabric net prosthesis in any of 
the current endovascular devices. 
3.3.2 Experimental protocol 
The prototypes resulting from the above project phase will undergo “in vivo” animal 
experiments. Ideally these experiments should include long term (≥12 months) evaluation in 
an appropriate animal (sheep) models. These may consist in prototypes positioning in the 
thoraco-abdominal aorta (model 1) and in the aortic arch (model 2) surgically or, possibly, as 
endovascular procedure if the endovascular delivery system is realized and suitable with 
the animal model peripheral vascular diameter. Half surviving animals could be sacrificed 
at 12 months and examined to verify:  
 regular integration of the net prosthesis into the intimal layer, looking for site and 
extension of possible areas on lacking integration with aortic wall 
 preserved perfusion of all collateral branches for the extent of the net prosthesis 
 the real structural strengthening achieved by measuring the aortic wall compliance 
(∆V/∆P) compared to that of the confining aortic segment (Fig. 5) 
 absence of complications such as migration, ulceration, perforation etc 
The remaining animals could be followed indefinitely and examined in case late 
complication or death. 
3.3.3 Preparation of clinical trial 
Ideally during the experimental phase will be identified and monitored Marfan patients 
with still normal or initial dilatation of any tract of the aorta in order to select those to be 
offered/accepting the prophylactic endovascular aortic strengthening. Obviously associated 
risk factors, in particular familiar history of aneurism and rupture, as well as other inclusion 
and exclusion criteria indicated by the Marfan Associations and clinical Institution Marfan 
Centers, will form the basis for planning the possible future clinical trial. 
Marfan diseases is a condition where pure prophylaxis of aortic aneurism would be in most 
cases “per se” appropriate, due to its very high incidence and rather early in the patient life; 
on the other hand prophylactic surgical aortic substitution is an already considered option 
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significantly redundant in respect to the effective aortic diameter, thus allowing for its easier 
adaptability to geometrical irregularity of aneurysm wall without consequences on its 
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in occasional patients. Prophylaxis is then particularly suitable for these patients with this 
new method when its long term safety, efficacy, simplicity and predictably low cost are 
proved; the re-establishment of an artificial elastic network in fact will represent a logic, 
direct correction of the primary defect, i.e. fragmentation and destruction of vascular wall 
physiological elastin fibrils network (Gott et al 1996). 
This will otherwise open interesting new perspectives in the “very early treatment” of any 
type of aortic aneurisms as soon as they appear, well in advance the current endovascular or 
surgical treatments are indicated, when the still limited aortic geometry distortion both 
simplifies net prosthesis positioning and integration into the aortic wall and increase its 
efficiency. 
The final goal is then the mininvasive, low cost, full prevention of the costly and still risky 
endovascular or surgical treatments of overt aortic aneurysm of any nature, ideally in all 
aortic tracts.  
 
 
Fig. 27. Prophylactic or very early strengthening of Aortic Arch and Descending Aorta. 
Sketches illustrate an hypothetical application of the method in high risk aortic area as a 
pure prophylactic measure for example in Marfan patient. In extended descending aorta this 
method is the only one that may theoretically provide full prevention of spinal chord 
complications, not yet fully achieved neither by surgery nor by endovascular techniques. 
(From Nazari et al 1996b) 
Last but not least this method could be the only one theoretically able to totally annul 
complications related to spinal chord ischemia due to critical intercostal collaterals, still a 
major problem not yet solved by any surgical nor endovascular technique. 
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Lung Transplantation 
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The foundation for lung transplantation was laid in the early 1900 by Guthrie and Carrel. 
In recognition of his work in vascular anastomosis, Dr. Carrel received the first Nobel 
Prize in Medicine. Following this early work, in 1946 Demikov in Russia performed a 
canine lung transplant as a unit. The dog subsequently died of bronchial dehiscence. The 
first human lung transplant was performed by Hardy at the University of Mississippi in 
1963. Patient survived a few days and succumbed to complications. Derom in Belgium 
was credited with the first successful human lung transplantation when he reported 10 
month survival of a patient who had undergone lung transplant for end-stage pulmonary 
fibrosis in 1971. By 1978, 38 lung transplants had been performed worldwide but Derom’s 
patient was the only one that had approached a beneficial outcome. Consistently noted 
poor outcome in the 60s and 70s led to a moratorium on clinical lung transplantation  
in the late 70s. Rejection and infection were the common causes of death in this early 
group and bronchial anastomotic healing was the barrier for transplant survival beyond 2 
weeks (1).  
Cyclosporine based immune suppression in kidney and liver transplantation in the early 
1980s resulted in dramatic improvements in organ function and patient survival. With this 
experience Shumway and Reitz successfully transplanted heart-lung blocks using a 
cyclosporine based immune suppression on primates. Airway complications were rare in 
heart-lung transplantation due to the non coronary collaterals, where as this was a major 
drawback of isolated lung transplantation. The success of the Stanford group led to the 
reinstitution of clinical heart-lung transplantation in the 80s (2).  
Meanwhile in Toronto, significant experimental work were done by Pearson and Cooper 
to solve the bronchial healing problem in animal models. The technique of omental wrap 
around the bronchial anastomosis was developed by Cooper et al. In 1986 the Toronto 
Lung Transplant Group reported successful single lung transplantation for pulmonary 
fibrosis in two patients (3). Technique of en-bloc double lung transplant failed due to the 
tracheal anastomotic complication related to ischemia. Finally bilateral sequential 
transplantation was developed as a method of transplanting both lungs without the heart. 
Currently around 147 centers perform over 2000 isolated lung transplants a year. The 
bronchial anastomotic technique has evolved since and bronchial wrapping is no longer 
considered necessary.  
 16 
Lung Transplantation 
Wickii T. Vigneswaran 




The foundation for lung transplantation was laid in the early 1900 by Guthrie and Carrel. 
In recognition of his work in vascular anastomosis, Dr. Carrel received the first Nobel 
Prize in Medicine. Following this early work, in 1946 Demikov in Russia performed a 
canine lung transplant as a unit. The dog subsequently died of bronchial dehiscence. The 
first human lung transplant was performed by Hardy at the University of Mississippi in 
1963. Patient survived a few days and succumbed to complications. Derom in Belgium 
was credited with the first successful human lung transplantation when he reported 10 
month survival of a patient who had undergone lung transplant for end-stage pulmonary 
fibrosis in 1971. By 1978, 38 lung transplants had been performed worldwide but Derom’s 
patient was the only one that had approached a beneficial outcome. Consistently noted 
poor outcome in the 60s and 70s led to a moratorium on clinical lung transplantation  
in the late 70s. Rejection and infection were the common causes of death in this early 
group and bronchial anastomotic healing was the barrier for transplant survival beyond 2 
weeks (1).  
Cyclosporine based immune suppression in kidney and liver transplantation in the early 
1980s resulted in dramatic improvements in organ function and patient survival. With this 
experience Shumway and Reitz successfully transplanted heart-lung blocks using a 
cyclosporine based immune suppression on primates. Airway complications were rare in 
heart-lung transplantation due to the non coronary collaterals, where as this was a major 
drawback of isolated lung transplantation. The success of the Stanford group led to the 
reinstitution of clinical heart-lung transplantation in the 80s (2).  
Meanwhile in Toronto, significant experimental work were done by Pearson and Cooper 
to solve the bronchial healing problem in animal models. The technique of omental wrap 
around the bronchial anastomosis was developed by Cooper et al. In 1986 the Toronto 
Lung Transplant Group reported successful single lung transplantation for pulmonary 
fibrosis in two patients (3). Technique of en-bloc double lung transplant failed due to the 
tracheal anastomotic complication related to ischemia. Finally bilateral sequential 
transplantation was developed as a method of transplanting both lungs without the heart. 
Currently around 147 centers perform over 2000 isolated lung transplants a year. The 
bronchial anastomotic technique has evolved since and bronchial wrapping is no longer 
considered necessary.  
 
Front Lines of Thoracic Surgery 
 
296 
2. Patient selection for lung transplantation 
2.1 Indications 
Lung transplant is indicated for patients with chronic, end-stage lung disease for whom no 
effective medical therapy is available (4,5). The primary goal of lung transplantation is to 
provide a survival benefit. Such benefit can be conferred to patients with advanced 
pulmonary fibrosis, cystic fibrosis and primary pulmonary hypertension. Reports for 
emphysema are conflicting and for Eisenmenger’s syndrome transplant did not find a 
survival benefit. However, as lung transplantation is a palliative treatment, improvements 
in quality of life in addition to survival benefit should be used to assess effectiveness of this 
therapy. 
2.2 Contraindications 
2.2.1 Major contraindications 
A history of malignancy during the past two years, except for skin cancers. In general 5 year 
disease free survival is expected (4). 
Untreatable advanced disease of another organ system, except the heart, where a heart-lung 
transplantation could be considered. 
Untreatable extra-pulmonary infections, including chronic, active viral hepatitis and HIV 
infection. 
Significant chest deformity. 
Unreliable social support, medical non-compliance or major psychiatric or psychological 
disorder. 
Active substance abuse or use within the past 6 months. 
2.2.2 Relative contraindications 
Older age; older patients have less optimal survival following lung transplantation. 
Critical or unstable conditions, such as Extra Corporeal Membrane Oxygenation or 
mechanical ventilation. 
Severely limited functional class with poor rehabilitation potential. 
Colonization with highly virulent or antibiotic resistant organism. 
Obesity or malnutrition (BMI>30 or BMI<17). 
Mechanical Ventilation except in carefully selected patients 
Severe or untreated gastroesophageal reflux disease. 
2.3 Timing of referral 
In general referral for transplantation evaluation is recommended when the patient’s median 
survival (50%) is about 2 years or less or New York Heart Association class 3 or 4. Due to the 
natural history of underlying disease, the referral time will depend on the underlying disease. 
The waiting period for transplant depends on underlying disease, waiting time, blood group, 
height of patient and presence of pre-formed antibodies in the recipient.  
3. Lung transplantation procedure 
3.1 Donor selection and operation 
The donor is evaluated for ABO compatibility, size, medical and social history, function, 





improvements in clinical results and shortage of donor organs the generally accepted donor 
criteria are continually being challenged and expanded. Donor lung selection also depends 
on subjective assessment at the time of exploration in the operating room and judgment of 
the donor surgical team (6).  
The donor pneumonectomy is approached via a midline sternotomy. The lung is inspected to 
evaluate its suitability for transplantation by the donor surgical team. Heparin is administered 
and a pulmonary plegia cannula is inserted into the main pulmonary artery ensuring both 
main pulmonary arteries are perfused by the cannula. A clamp is placed on the left atrial 
appendage and the tip of the appendage is excised for free drainage of the pulmonary effluent 
during the pulmonary plegic infusion. Prostaglandins and pulmonary vasodilators are 
administered into the main pulmonary artery followed by cold pulmonary plegia that also 
contains vasodilator medications. The lung is inflated to moderate amount and the trachea is 
stapled with lung inflated. The lung block is dissected away from the mediastinal structure 
with the heart or separately after the heart is excised by the ‘cardiac’ team. Left atrium is 
divided midway between the confluence of the pulmonary veins and the atrial groove 
ensuring that an adequate “atrial cuff” will be available with the lungs for implantation. The 
ligamentum arteriosum is divided toward the descending aorta avoiding injury to the left 
main pulmonary artery and the entire lung block is dissected away from the descending aorta 
and esophagus. The lungs are separated from each other at the back table by dividing the left 
main bronchus with the staples, pulmonary artery at the bifurcation, and left atrium between 
the right and left pulmonary veins. Retrograde cold flush of the preservation solution is 
performed through the pulmonary veins before packaging the organs in sterile fashion for 
transportation to the recipient operating room (8,9).  
Satisfactory early and midterm outcomes had been reported with using lung donation after 
cardiac death expanding potential lung donors (10). Recent exciting developments on 
normothermic ex-vivo perfusion allowing repair of injured lung and the ability to evaluate 
function of the lung prior to transplantation has potential benefit of increasing the donor 
pool even further (11). 
 
Age < 60 
ABO Compatibility 
Clear Chest Radiograph 
PaO2 > 300 on FIO2 = 1.0 and PEEP of 5 cm H2O 
Tobacco history < 20 pack years 
Absence of significant chest trauma 
No evidence of sepsis or blood borne infections (Hepatitis B, C or HIV) 
Prior cardiopulmonary surgery 
Presence of lung pathology on CT scan 
Purulent secretion on bronchoscopy or evidence of aspiration
Table 1. Established Criteria for Donor Selection 
3.2 Recipient operation 
3.2.1 Single lung transplant 
Once a donor is verified and deemed suitable for transplant, the recipient is brought into the 
operating room for transplantation (12). Generally the contra-lateral lung is used to support 
the recipient during the transplantation procedure. Some patient will require 
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cardiopulmonary bypass to perform the lung transplantation safely. General anesthesia is 
provided via a double lumen endo-tracheal tube, a left sided tube is preferred thus avoiding 
the potential complication of obstructing the right upper lobe orifice. Following placement 
of arterial and venous access lines as well as a Trans-esophageal Echo (TEE) probe, the 
patient is placed in a lateral decubitus position, with groin exposed on the same side to 
allow canulation of femoral vessels, if needed. A variety of incisions may be used to enter 
the thorax including a posterolateral incision, anterior submammary incision, or a lateral 
incision that either spares or partially divides the muscle.  
Hilar dissection is performed exposing the pulmonary vessels while preserving the phrenic 
nerve. Vagus neurovascular bundles are carefully preserved particularly on the left side 
where the recurrent laryngeal nerve emerges and encircles the ligamentum arteriosus. The 
recurrent laryngeal nerve may be injured during the dissection of the left main pulmonary 
artery and a heightened awareness of this will help to avoid injury. Dissection around main 
bronchus is kept to minimum to preserve its blood supply. The pericardium is opened 
around the pulmonary veins to release the left atrium for placement of vascular clamp. 
When the donor lung is in the room the recipient is given heparin intravenously and the 
pulmonary veins and artery are divided as distal as possible. We use a linear cutting 
vascular stapler. The main bronchus is divided at the lobar branch level initially and then 
divided with a sharp knife about 2-3 cartilage rings from the carina.  
At the back table, final dissections are made to the donor lung. This includes removal of 
excess mediastinal tissue, mobilization of the main pulmonary artery and the left atrial and 
venous structures from pericardial attachments. We perform a repeat cold retrograde 
flushing of the pulmonary vascular bed with the preservation solution prior to implantation 
to evacuate any residual debris from the pulmonary vascular bed and improve preservation 
(9).  The main bronchus of the donor is opened and microbiological specimens are collected. 
The bronchus is then divided with a knife leaving two rings of cartilage from the origin of 
the upper lobe bronchus. The donor lung is then brought to the operative field. We perform 
the bronchial anastomosis as to “frame” the lung in position first. The membranous portion 
of the bronchus is anastamosed using a running 4-0 absorbable monofilament suture while 
the cartilaginous portion is secured with interrupted figure-of-eight suture of the same type. 
Single-running suture techniques have also been described in the literature and appear to be 
equally effective. Next, attention is turned to the venous anastomosis. A vascular clamp is 
placed along a portion of the left atrium and the recipient left pulmonary vein orifices are 
connected by dividing the bridge of atrial tissue in-between to create a single oval “atrial 
cuff”. The donor atrial cuff is then anastamosed to the recipient atrial cuff in an end-to-end 
fashion using a single, double-armed running 4-0 polypropylene suture. Finally the 
pulmonary artery is prepared for the final anastomosis. Excess length of pulmonary artery is 
removed after appropriately sizing the vessel. This is particularly important on the right 
side, as there is a long length available on the donor. The donor pulmonary artery is 
anastomosed to the recipient in an end-to-end fashion with a single, double-armed running 
5-0 polypropylene suture. Occasionally, a size mismatch exists where the recipient 
pulmonary artery is larger than the donor pulmonary artery. In this case, the larger inferior 
pulmonary trunk arising from the main pulmonary artery is anastomosed end-to-end with 
the donor main pulmonary artery. In this situation the upper branch is divided flush with 
the main artery to prevent any clots forming in the ‘blind-end’. Attention is paid to keep the 
donor lung cold during the entire period using ice slush and cold sponges, until reperfusion. 
Bolus of solumedrol is given intravenously (we give 500 mg) prior to reperfusion of the 





and debris are vented through the pulmonary artery anastomosis first. Then pulmonary 
plegia solution is allowed to vent from the left atrial cuff anastomosis by releasing the 
arterial clamp to allow a slow flush. While the left atrium is observed by TEE for air bubbles 
the left atrial clamp is removed and the anastomosis is secured. The reperfusion is 
controlled by slow release of the arterial clamp and any hypotension is treated promptly by 
alpha-agonists. The lung is inflated while monitoring the left atrium on TEE. A leak test may 
be performed at this time by carefully ventilating the new lung with the bronchus 
submerged in warm normal saline and inspecting for air bubbles. After placement of chest 
tube, with satisfactory hemostasis, hemodynamics and oxygenation the chest is closed in 
layers with absorbable sutures. With the patient in the supine position the double-lumen 
endotracheal tube is changed to a single lumen tube and a fiber-optic bronchoscopy is 
performed to inspect the bronchial anastomosis and remove any clots or secretions present 
in the bronchial tree.  
3.2.2 Bilateral sequential lung transplant  
A bilateral anterolateral thoracotomy is a preferable incision for bilateral sequential lung 
transplant as it preserves the structural integrity of the sternum and prevents significant 
incision-related morbidity (13). In a patient with small chest cavity or when there is 
potential need for cardiopulmonary bypass, a clamp-shell incision is made dividing the 
sternum across for the transplantation. The dissection of the lung and the donor lung 
preparation is performed as described above. The lung with the lesser physiologic 
contribution is transplanted first as the other lung support single-lung ventilation.  
The single lung transplants are performed sequentially while the patient is supported by the 
contra-lateral lung. If the operation is being performed without cardiopulmonary bypass 
(CPB), it is important to stabilize the patient after the first lung implantation before 
proceeding with the next. Following implantation of the second lung and patient stable, 
chest tubes are placed and sternum approximate using metal plates or sternal wires. Then 
the wound is closed in layers with absorbable sutures.  
4. Post-operative management 
Patient undergoing lung transplantation requires a team of caregivers who are committed, 
familiar with the protocols and able to ensure ongoing communication between members of 
the team. The team members include, transplant coordinators, transplant pulmonologist, 
transplant surgeon, anesthesiologist, pain management team, critical care specialist, ICU 
nurses, Infectious disease specialist, pharmacologist, physical and occupational therapist, 
nutritionist and social worker. Clinical pathways are developed addressing complete patient 
care with incorporation of immunosuppressive and infection prophylaxis protocols (14). 
Despite clinical pathways, regular team meeting discussing daily care of patient facilitate 
efficient and timely interventions and improve post-operative care.  
5. Respiratory management 
Despite advances in the donor management and preservation of lung, primary graft 
dysfunction is not uncommon following lung transplantation (15). In the majority however 
the degree of dysfunction is minor to moderate and reversible, therefore does not progress 
to graft failure. The incidence of primary graft dysfunction has been reported between 11-57 
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% (16). When there is primary graft failure, extra corporeal membrane oxygenation (ECMO) 
may be required. Early institution of ECMO had been shown to be more successful than late 
(17-19). When the graft dysfunction is mild to moderate, management strategies are 
employed as used in patients with significant lung injury.  
The ventilatory management would be influenced, if the patient received a single or bilateral 
lung transplant. In patients with bilateral lung transplant it would be aimed at minimizing 
barotraumas by using low inflation volumes and moderate levels of positive end expiratory 
pressure (PEEP, less than 10 cm water). In patients with single lung transplant the patho-
physiology of the remaining native lung will influence ventilatory strategy. Significant air 
trapping and auto PEEP is not uncommon in patients with emphysema. Low ventilatory 
volumes, adequate expiratory time and avoidance of excessive PEEP will help to prevent air 
trapping and significant hemodynamic instability in these patients. Positioning patients with 
the allograft side up and bronchodilator therapy are useful strategies in patients with single 
lung transplant. Very rarely isolated lung ventilation with double lumen tube is necessary to 
effectively ventilate when there is significant graft dysfunction.  
Inhaled Nitric Oxide (NO) through the ventilator has been shown to reduce reperfusion 
injury in experimental models and clinical transplantation, when used as prophylaxis. It’s 
usefulness in established graft dysfunction is controversial. Selective use of inhaled NO in 
peri-operative period in patients with pre-existing pulmonary hypertension is not an 
uncommon practice. The aim of the inhaled NO use is to reduce pulmonary artery pressures 
during the operation and immediately afterwards thereby assisting the right ventricular 
function. 
As a rule aggressive weaning off the ventilator is practiced following lung transplantation to 
prevent nosocomial infection and promote early rehabilitation. Sedation should be carefully 
monitored and sparingly used. It is advisable to use short acting agents while patient is 
intubated. Majority of the patients are extubated within the first 24 hours after 
transplantation. After extubation we advocate use of epidural analgesia and avoidance of 
narcotics and benzodiazepines. Aggressive bronchial hygiene is mandatory to prevent 
collapse and development of pneumonia. While patients are intubated using soft suction 
catheters to clear secretion should be performed routinely. Once the patient is extubated 
incentive spirometry, chest physiotherapy and ambulation are necessary to promote 
clearance of bronchial secretions. In patients who are debilitated and have retention of 
secretion we have employed ‘mini-tracheostomy’ to facilitate removal of the secretion with a 
soft tip 10 french catheter. Alternatively patients will require repeat bronchoscopic suction 
of secretions. When a patient fails trial extubation, early tracheostomy facilitates rapid 
weaning of ventilation, assist in effective management of secretions and promote early 
physical rehabilitation. 
6. Hemodynamic management  
Patients selected for lung transplant undergo a detailed cardiac evaluation. Isolated single 
vessel coronary artery disease alone is not a contra-indication for lung transplantation. 
These patients would be candidates for pre-transplantation, percutaneous revascularization 
or would be candidates for simultaneous surgical re-vascularization (19,20). Correctable 
cardiac lesions such as ASD or simple VSD they are repaired during lung transplantation. 
Patients with primary or secondary pulmonary hypertension will have varying degrees of 





operative use of inhaled NO or other pulmonary vasodilator pharmacotherapy is not 
uncommon and certainly useful to reduce post-operative pulmonary hypertension and the 
fluctuations in pressures and reduce the hemodynamic instability.  
The most common hemodynamic disturbance following lung transplantation is hypotension 
and supra-ventricular tachyarrhythmia. The principle of keeping these patients in a relative 
hypovolemic status, make them susceptible to hypotension, if there is any degree of 
vasodilation. It is important to maintain adequate intravascular volume to maintain 
adequate cardiac output as well as urine output. The fluid therapy is aimed at maintaining 
low or low normal cardiac filling pressures. It is however not necessary to monitor 
pulmonary artery wedge pressures in all patients and monitoring of right atrial filling 
pressures are most often adequate. The fact that the lymphatic drainage is interrupted from 
the lung allograft following transplantation, any capillary leak in to the lung parenchyma 
will be cleared less efficiently. It had been shown that fluid restriction in patients with lung 
injury promotes early recovery (21). This may be an important factor to consider during the 
post operative period, due to the fact that majority of the lung grafts suffer some degree of 
reperfusion injury. Systemic vasodilation whether it is produced by medications or 
sympathetic blockade due to epidural or release of cytokines, best treated with 
vasoconstriction using intravenous short acting alpha-blockers than by volume. 
Neosynephrine is the drug of choice in the treatment of systemic vasodilation in these 
patients. Vasopressin is an effective systemic vasoconstricor but also appears to cause 
profound bronchial vasoconstriction and may cause bronchial ischemia in these patients and 
may affect bronchial anastomotic healing, therefore its use is avoided. 
The incidence of supraventricular arrhythmias are not uncommon following lung 
transplantation (22). The commonest arrhythmias are supraventricular tachycardia and 
atrial fibrillation. Many programs take preventive measures for atrial fibrillation in the post-
operative period which can reduce the incidence of this complication but unlikely to prevent 
it completely. The effects and complication due to atrial fibrillation are systemic 
hypotension and systemic embolization, perhaps made worse by fresh suture line on the left 
atrium. Although amiodarone is generally avoided due to its effects on the lung, we have 
used amidarone in patients who are resistant or unsuitable for treatment with calcium 
channel blockers or beta blockers. Anticoagulation will be necessary as in other patients 
with atrial fibrillation and the biopsy schedules needed to be considered and preferentially 
treated with short acting agents in the post operative period. It will be prudent to check 
clotting studies prior to transbronchial biopsy or endobronchial intervention as 
uncontrollable bronchial hemorrhage is invariably fatal.  
7. Diagnosis and management of early surgical complication 
The major surgical complications are bleeding, anastomotic complications and mal-rotation 
of the graft (24). The latter two are rare with current understanding and experience. 
Bleeding is less common and is due to refinement in surgical techniques, judicious use of 
pharmacological agents and blood products. The patients at high risk are the ones with 
extensive pleural adhesions, large and extensive mediastinal collateral vessels and patients 
with connective tissue disorders with secondary pulmonary hypertension. Patients with 
right heart failure and congested liver or patients on chronic anticoagulation or anti-platelet 
therapy are particularly susceptible and correction of coagulation defect is mandatory in 
these patients. If a patient persists with significant blood loss (>100 cc/hr), for 4-6 hours, the 
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patient needs to return to the operating room unless there is evidence of significant 
coagulation abnormalities. 
The dreaded complication of complete bronchial anastomotic dehiscence is rarely seen now 
but stenosis at the anastomotic site is not that uncommon, being reported between 5-25% of 
the anastomoses. This complication is usually delayed for several weeks following 
transplantation (25). In the presence of anatamotic site infection or significant donor 
bronchial ischemia minor bronchial dehiscence may present as early as 1-2 weeks.  
Vascular anastomotic complications are infrequently reported, and their real incidence may 
be higher than that reported in the literature. The venous complication if severe enough can 
present few hours following transplantation as acute graft dysfunction. This presents as 
rapidly progressing pulmonary edema, with diffuse, dense infiltrate of the affected lung or 
lobe. This is a potentially lethal condition and diagnosis require high index of suspicion. 
TEE is helpful to confirm diagnosis. Surgical correction is required if this is due to 
anatomotic narrowing due to surgical technique. Thrombus formation at the anastomotic 
site can also cause venous obstruction and this is insidious in origin and progressive. 
Thrombolytic agents had been successfully used in these circumstances. Arterial 
anastomotic stenosis presents as hypoxemia, usually associated with exercise. This should 
be suspected if there is no other reason for hypoxemia. Pulmonary angiogram is diagnostic 
and catheter based intervention including stent placement has been successfully employed. 
Mal-rotation of Lobar or lung on its axis is a rare complication and if not corrected 
immediately will result in necrosis of the lobe or lung. Complete opacification of the lobe or 
lung is noted in chest radiograph. Bronchoscopic examination is confirmatory of the 
bronchial torsion. 
8. Pain management 
Patients undergoing thoracic surgery require effective pain relief to allow deep breathing, 
coughing and facilitate early ambulation. In lung transplant patients this becomes crucial as 
they are chronically debilitated and have difficulty clearing secretions. While providing 
effective pain relief it is necessary to prevent sedation to promote early ambulation and 
therefore avoidance of narcotics is preferred. Thoracic epidural analgesia is effective in 
providing pain relief without causing sedation. We advocate placement of the thoracic 
epidural pre-operatively or place it soon after patient is extubated. NSAID are avoided 
because of the potential interactions with other nephrotoxic agents particularly the 
calcineurin inhibitors. Transitioning to oral pain medication is monitored carefully prior to 
discharge from the hospital.  
9. Immunosuppression 
Immunosuppression after lung transplantation includes three major categories of 
immunosuppressive agents; calcineurin inhibitors (tacrolimus, cyclosporine A), 
antimetabolites (azathioprine, mycophenolate mofetil) and corticosteroids. In addition, 
approximately 45% of lung transplant patients receive induction therapy after lung 
transplantation. The calcineurin inhibitors are administered within hours after 
transplantation and may be given either intravenously or sublingually. In general, 





be given sublingually at a dose of 0.03 mg/kg twice daily. Target tacrolimus trough levels 
range between 10-20 ng/ml in the first six months after transplantation, followed by levels 
around 10ng/ml thereafter. Cyclosporine is administered at a rate of 3 mg/kg over 24 hours 
with target trough levels between 350-450 ng/ ml in the first month, between 300-350 ng/ml 
during the first year and between 200-300 ng/ml thereafter. Both of these medications are 
available in oral formulation and should be given orally after extubation. Although current 
data have not shown a superiority of one of the calcineurin inhibitors, there has been an 
increasing use of tacrolimus in the lung transplant population due to reports of improved 
pulmonary function and possibly a reduction in the incidence of bronchiolitis obliterans 
syndrome (26,27). 
Antimetabolites (either azathioprine or mycophenolate mofetil) are the second 
immunosuppressive medication that are used in the treatment of lung transplant recipients.  
The first dose may be initially administered prior to implantation of the lung allograft. 
Azathioprine is dosed at 2mg/kg daily and can be administered either intravenously or 
orally. Mycophenolate mofetil is dosed orally at 2-3 gram in daily divided doses. In general, 
antimetabolites may be associated with myelosuppression and gastrointestinal distress and 
doses may be adjusted based on these side effects. Two randomized multicenter studies that 
have not shown any difference in acute rejection, or survival between these two agents 
(28,29). 
Corticosteroids have been the mainstay of immunosuppression since the advent of 
successful lung transplantation in the 1980s. First dose of methylprednisolone (between 500 
to 1000 mg intravenously) is usually given prior to reperfusion of the graft in the operating 
room. Subsequent doses of corticosteroids range between 0.5-1 mg/kg during the first few 
weeks after transplantation. In general, corticosteroids are tapered to the equivalent of 5-10 
mg of prednisone daily by three to six months after transplantation. 
The role of induction therapy in lung transplantation has yet to be defined. There are several 
different types of induction therapy that are currently being used in lung transplantation 
including the interleukin- 2 receptor antagonists (daclizumab, basiliximab), the polyclonal 
agents(ATGAM, thymoglobulin) and the monoclonal antibody (OKT3). Several reports have 
suggested that induction therapies may reduce the incidence of acute rejection during the 
first six months after lung transplantation. However, longer term outcomes including 
prevention of chronic rejection or improving survival have not been associated with the use 
of induction therapy after lung transplantation (30-32). 
10. Infection prophylaxis 
Infections remain a major source of morbidity and mortality after lung transplantation.  
Prophylaxis against bacterial, viral and fungal organisms usually starts immediately 
postoperatively in the recipients. Initial antibiotic prophylaxis should be directed towards 
adequate anaerobic coverage and tailored towards any positive donor or recipient culture 
detected prior to transplantation. These antibiotics are usually continued between three to 
fourteen days post transplant depending upon the individual transplant center’s protocol.  
Lung transplant recipients with septic lung disease (cystic fibrosis, bronchiectasis) who may 
be colonized with resistant organisms often receive two synergistic antibiotics based on 
prior sensitivities during this time period. 
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(28,29). 
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adequate anaerobic coverage and tailored towards any positive donor or recipient culture 
detected prior to transplantation. These antibiotics are usually continued between three to 
fourteen days post transplant depending upon the individual transplant center’s protocol.  
Lung transplant recipients with septic lung disease (cystic fibrosis, bronchiectasis) who may 
be colonized with resistant organisms often receive two synergistic antibiotics based on 
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Viral prophylaxis is most commonly targeted against cytomegalovirus (CMV). Aggressive 
prophylactic therapy is directed towards this organism because of its high virulence and 
association with mortality in the lung transplant population. Lung transplant recipients 
with either donor or recipient serology that is positive for CMV usually receive 
prophylactic therapy with valganciclovir anywhere between three months to lifelong 
therapy. CMV negative lung transplant recipients who received a CMV positive donor 
lung may also receive CMV immunoglobulin in addition to their current valganciclovir 
therapy. Unfortunately, while valganciclovir prophylaxis decreases the incidence of CMV 
infection during the time of administration, prophylaxis does not completely prevent the 
development of CMV infection especially after prophylaxis therapy is discontinued. The 
optimal duration and type of therapy are still a matter of debate. Acyclovir and its 
derivatives are given to CMV negative lung transplant recipients who receive CMV 
negative donors in order to prevent the development of Herpes infections. 
Fungal prophylaxis varies among the different transplant centers depending upon  
prior colonization, mechanical airway complications and environmental factors. In 
general some centers provide general fungal prophylaxis while others consider 
preemptive therapy depending upon surveillance bronchoscopy findings. Lung 
transplant recipients are at increased risk for developing Aspergillus spp. colonization of 
the airways leading to anastomotic infections and ulcerative tracheobronchitis. 
Itraconazole (or other azole substitutes) and inhaled amphotericin are the most common 
fungal prophylactic agents that are currently used. The azoles will increase the levels of 
the calcineurin inhibitors (cyclosporine and tacrolimus) so that the doses of these 
immunosuppressive medications should be decreased by at least 1/3 of their original 
dose. Calcineurin levels should be checked approximately one week after starting an 
azole. Of note, voriconazole and sirolimus should not be used together due to the 
significant rise in sirolimus levels. 
11. Transplant outcomes 
Significant improvements have been achieved in the past two decades with organ 
preservation, surgical techniques, critical care and immunosuppression. At present over 
80% of patients receiving a lung transplant for end-stage lung disease are alive at 1 year and 
half of them are at 5 years (33). There are differences in the survival for different etiology for 
the underlying end-stage lung disease (Figure 1). Primary graft dysfunction is an important 
cause of post-operative mortality (33). The major cause of early and late mortality is 
infectious complications and bronchiolitis obliterans, a condition of progressive airflow 
obstruction associated with chronic airway fibrosis a pathologic finding known as 
bronchiolitis obliterans (BO). Majority of the late mortality is directly or indirectly due to the 
development of bronchiolitis obliterans syndrome or OB (Table 2) (34,35). Although the 
pathological mechanism that lead to BO is not well understood there have been many 
associations reported. A significant predictor of OB is prior acute rejection. Other conditions 
are primary graft dysfunction, gastroesophageal reflux or infections (36). Currently there are 
few well established therapies available for prevention or treatment of OB. Ongoing 
research continues to advance our understanding of the pathogenesis which may lead to 






Fig. 1. Kaplan-Meier survival by diagnosis for adult lung transplants performed between 
January 1990 and June 2008. AT Def, α1-antitrypsin deficiency emphysema; CF, cystic 
fibrosis; COPD, chronic obstructive pulmonary disease; IPAH, idiopathic pulmonary arterial 
hypertension; IPF, idiopathic pulmonary fibrosis. 
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Bronchiolitis 6 (0.3) 159 (4.7) 781 (25.4) 508 (29.2) 507 (25.2) 95 (19.7) 
Acute rejection 74 (3.8) 61 (1.8) 48 (1.6) 10 (0.6) 15 (0.7) 1 (0.2) 
Lymphoma 1 (0.1) 86 (2.5) 63 (2.1) 28 (1.6) 46 (2.3) 23 (4.8) 
Other malignancy 4 (0.2) 100 (3.0) 202 (6.6) 151 (8.7) 219 (10.9) 47 (9.7) 
Infection       
CMV 0 96 (2.8) 29 (0.9) 5 (0.3) 4 (0.2) 0 
Non-CMV 396 (20.1) 1,205 (35.6) 710 (23.1) 329 (18.9) 363 (18.0) 81 (16.8) 
Graft failure 557 (28.3) 589 (17.4) 591 (19.2) 327 (18.8) 379 (18.8) 87 (18.0) 
Cardiovascular 213 (10.8) 144 (4.3) 118 (3.8) 82 (4.7) 99 (4.9) 36 (7.5) 
Technical 162 (8.2) 76 (2.2) 18 (0.6) 8 (0.5) 12 (0.6) 6 (1.2) 
Other 553 (28.1) 871 (25.7) 513 (16.7) 289 (16.6) 370 (18.4) 107 (22.2) 
Table 2. Causes of Death Following Lung Transplantation in Adult Recipients. 
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12. Conclusion 
Lung transplant remains an effective treatment for selected patients with end-stage lung 
disease. The major rate limiting step for lung transplantation at present is the available 
donor organs. Chronic allograft dysfunction remains a major source of morbidity and 
mortality after lung transplantation. Investigations into improving donor lung availability, 
preventive and therapeutic approaches for OB and alternative for transplantation for end-
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stage lung disease are subjects currently under intense investigation aimed at improving 
short and long term result of therapy for end-stage lung disease. 
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1. Introduction 
Surgical correction of esophageal atresia with tracheo-esophageal fistula (EA-TEF) has been 
performed since 1943 (Cameron Haight) via postero-lateral thoracotomy using an extra-
pleural approach in most cases. This procedure can be considered as the standard treatment 
of EA. The pitfalls of the operation, the incidence of complications and the outcomes, both 
short term and long term, have been analysed and reported by many pediatric surgeons 
around the world. 
Since 1999, minimal access surgery (MAS) has been practised for the correction of EA 1. The 
risk of complications and short term outcomes have been reported as equal to the open 
approach. MAS has been advocated because of a possibly reduced risk of impairment of 
shoulder function, and a possible reduction in occurrence of postoperative scoliosis. Next to 
that, it has been postulated the MAS repair might lead to a better cosmesis. 
Several advantages and disadvantages of both procedures have been described. The open 
approach is well standardized and is resorted to in difficult cases. Disadvantages of the 
open approach are the presence of a scar, possible chest wall deformities and rib fusion. The 
occurrence of scoliosis and possible shoulder function impairment has been related to the 
open approach as well. 
The thoracoscopic approach has the advantage of magnification of view. Next to that the 
chance on a postoperative scoliosis and impaired shoulder function may be reduced due to 
the small incisions which also might lead to better cosmesis. Technically, the thoracoscopic 
approach is more demanding than the open approach which has consequences for training 
and education. 
So far, it seems that there is no difference between open and MAS approach in the frequency 
of anastomotic leakages, strictures, recurrent fistulas, tracheomalacie or GERD. 
In 2005, Holcomb et al presented their results of MAS (thoracoscopic) EA-TEF repair in 104 
patients in multiple centres. This landmark paper has been extensively discussed by leaders 
 
Front Lines of Thoracic Surgery 
 
308 
[25] Vigneswaran, WT, Sakiyalak P, Bhorade SM, Bakhos M. Airway complications after 
isolated lung transplantation, Transplantation Reviews (Eds) Peter J Morris and 
Nicholas L. Tilney. Elsiver Science (USA). 16(2) pp 87-94, 2002. 
[22] Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid management 
strategies in acute lung injury. N Engl J Med 15:2564-75, 2006. 
[19] Zenati M, Pham SM, Keenan RJ, Griffith BP. Extracorporeal membrane oxygenation for 
lung transplant recipients with primary severe donor lung dysfunction. Transplant 
Int 1996;9:227-30. 
[27] Zuckermann, AH, Reichenspurner T, Birsan H, et al. Cyclosporine A versus tacrolimus 
in combination with mycophenolate mofetil and steroids as primary 
immunosuppression after lung transplantation: one-year results of a 2-center 
prospective randomized trial. J Thorac Cardiovasc Surg 125: 891-900, 2003. 
 
17 
Systematic Review of the Literature: 
Comparison of Open and Minimal Access 
Surgery (Thoracoscopic Repair) of Esophageal 
Atresia with Tracheo-Esophageal 
 Fistula (EA-TEF) 
M. W. N. Oomen 
Pediatric Surgical Centre of Amsterdam, 
 VU Medical Centre & Emma’s children hospital of the AMC, 
The Netherlands 
1. Introduction 
Surgical correction of esophageal atresia with tracheo-esophageal fistula (EA-TEF) has been 
performed since 1943 (Cameron Haight) via postero-lateral thoracotomy using an extra-
pleural approach in most cases. This procedure can be considered as the standard treatment 
of EA. The pitfalls of the operation, the incidence of complications and the outcomes, both 
short term and long term, have been analysed and reported by many pediatric surgeons 
around the world. 
Since 1999, minimal access surgery (MAS) has been practised for the correction of EA 1. The 
risk of complications and short term outcomes have been reported as equal to the open 
approach. MAS has been advocated because of a possibly reduced risk of impairment of 
shoulder function, and a possible reduction in occurrence of postoperative scoliosis. Next to 
that, it has been postulated the MAS repair might lead to a better cosmesis. 
Several advantages and disadvantages of both procedures have been described. The open 
approach is well standardized and is resorted to in difficult cases. Disadvantages of the 
open approach are the presence of a scar, possible chest wall deformities and rib fusion. The 
occurrence of scoliosis and possible shoulder function impairment has been related to the 
open approach as well. 
The thoracoscopic approach has the advantage of magnification of view. Next to that the 
chance on a postoperative scoliosis and impaired shoulder function may be reduced due to 
the small incisions which also might lead to better cosmesis. Technically, the thoracoscopic 
approach is more demanding than the open approach which has consequences for training 
and education. 
So far, it seems that there is no difference between open and MAS approach in the frequency 
of anastomotic leakages, strictures, recurrent fistulas, tracheomalacie or GERD. 
In 2005, Holcomb et al presented their results of MAS (thoracoscopic) EA-TEF repair in 104 
patients in multiple centres. This landmark paper has been extensively discussed by leaders 
 
Front Lines of Thoracic Surgery 
 
310 
in the field and highlights the need for a randomized clinical trial. Since that discussion, 
several more articles have been published on MAS repair of EA-TEF, but no prospective 
comparative studies, let alone RCT’s. The Clinical Trials Register (www.clinicaltrials.gov) 






Search strategy:  
EmBase and PubMed (Medline) search using keywords (MESH terms): <Minimal access 
surgery> OR <thoracoscopic surgery> OR <thoracoscopy> AND <esophageal atresia> 
Only full text papers in English were included. If more than one paper had been published 
by the same author or group of authors 2, only the most recent paper was included in order 
to avoid duplications.  
Two authors reviewed all papers and selected those that contained sufficient data on 
patients characteristics and outcome parameters to enable comparison with reports on open 
repair of EA-TEF of patients operated after 1995. 
Parameters recorded are represented in table 1.  
Three categories can be discerned 
1. patients’ characteristics 
2. intra-operative and post-operative data, including complications 
3. follow-up data 
3. Results 
The initial search resulted in 55 articles. After critical review by two independent reviewers 
twenty-one articles were included, based on the criteria stated above.  
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There were no RCT’s or prospective studies. All papers were based on retrospective 
analysis, mostly single center cohort or case studies. The largest population was reported in 
a multicenter review by experts in minimally invasive pediatric surgery combining the 
experience in 104 patients.  
Together the 22 articles contained 332 patients who had (type C) EA-TEF repair via the 
thoracoscopic approach, 11 patients with isolated (type A) 3,4,5,6 and one case report of type 
D (proximal and distal fistula) 7.  
At a closer look there are different study-designs in those 22 articles in which only four 
papers 4,8,9,10 did a retrospective analysis with historic 4 or contemporary 8,9,10 open 
approaches as controls. (Table 1) Seven papers reported the results of thoracoscopic EA-
TEF repair containing at least 20 patients per report for a total of 312 patients 4,11,5,12,13,2,10. 
(Table 2)  
Several papers, particularly in the early period, concentrated on technical and feasibility 
aspects dealing with the initial diagnosis of esophageal atresie. Other studies highlighted 
special characteristics of the patients, like cardiac malformations 14. Also on 
anesthesiological subjects, including the effects of CO2 inflation 15,16 and pain after 




To compare the results of the minimal invasive operations with open operations, data were 
distilled from the literature (Table 3). This represents the results from textbooks and 
standard papers on open repair of EA-TEF. Also these results on open approach are based 
on retrospective studies and did not comprise RCT’s or prospective studies.  
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4. Patiens’ characteristics  
The gestational age and the birth weight of MAS patients were not  different from open repairs 
in the comparative studies (2.7-2.8 kg MAS vs 2.0-2.4 open Table 1). In the minimal invasive 
group the thoracoscopic approach was succesfully performed even in premature babies with 
weights below 1500 g 18,5,2 but these are not different from data in the literature for open 
repair (19 , mean 2557 with range 1100-4460 g). 
Concerning the associated malformations and risk classification only Holcomb 11 et al present 
data on Waterston classification(A 62, B 30 and C12) respectively. The reported associated 
malformations were seen in up to 87.5% 9 of the thoracoscopically repaired babies, but in the 
comparative studies no difference is seen between MAS (39-87%) and open (47-72%) 
concerning these associated malformations 
5. Perioperative data  
Mean duration of operation was recorded in 12 articles and ranged between 95 and 260 
minutes. In the comparative studies the paper of Szavay 10 reveals a significantly longer 
operation time (open 106  min versus MAS 141). But Al Tokhais 4 and Lugo 9 did not find a 
significant difference in operation time between them with 179 and 123 min open and 149 
and 156 min.for MAS. 
The conversion rate was reported in 15 papers, in which no conversion was done in 9 papers 
and in the remaining 6 papers the rates varied between 5 and 16%. 
The duration of postoperative ventilation was mentioned in 10 papers. One reported no 
difference between open and MAS patients 4, others reported mean duration of 4 days post-
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operative ventilation 11,3,20,9,13 (range 1-4.6). Of interest is the paper of Krosnar 16 where, 
although in a small number, a comparison between open and MAS approach is done 
concerning extubation time (extt) and discharge to PICU(DPICU) .  
These results were for an open approach with an extt of 54 hrs and DPICU discharge of 3.4 
days and for the MAS approch extt 37.6 hrs and DPICU of 2.75 days. This numbers suggest 
a better postoperative recovery of the MAS approach.  
Length of hospital stay was reported in 7 articles, some giving mean, others median values so 
a good comparison of these numbers is not justified. The mean length of stay in Hollcombs’ 
paper compares favorably with open repairs as reported by Manning 21 18.1 days for MAS 
and 24 for the open method. This historic group however might not be representative for 
present l.o.s so the evidence is not clear. Also Lugo 9 found a difference in l.o.s as it is 21 
days in MAS (n=8) and 66 days in the open approach (n=25) but in here hard evidence 
seems to be scarce as the numbers are small. Mortality related to the procedure was recorded 
in 14 articles and 11 reported no mortality; in the other three it varied between 1 and 16%. 
But these were small numbers also 18. In the series reported by Holcomb the mortality rate 
was 0.9 %. Yanchar 22, reported 1.1 % mortality after open repair in 90 patients. For this 
parameter no difference could be demonstrated. 
6. Complications  
The main short term complications are leakage of the anastomosis, anastomotic strictures 
and recurrent TEF. (Table 1, 2, 3) 
Anastomotic leakage was reported in 18 papers. Important is that the definition may differ 
between the papers depending on whether routine esophagograms were performed or not. 
Most leaks were described as minor and healed spontaneously. The incidence varies 
between 0 and 30% with a median 15%. There is no difference with the reported leak rates in 
the open thoracotomies in the papers 8,9,23,24,22 and in the literature.(Table 3) 
A clear definition of anastomotic stricture is an important factor. Most authors define 
stricture by the need for (repeated) dilatations however others state that narrowing of 
more than 50% of the lumen or every narrowing detected on an esophagram with a 
symptomatic patient can be seen as an anastomic stricture 25,26. Sixteen papers reported an 
incidence between 9 and 45%, with a median of 22%. This incidence is comparable to the 
rates reported after open repair (6-52%) by Holland 24 and in the literature (Table 3). 
The incidence of the serious complication of a recurrent tracheo-oesophageal fistula was noted 
in 8 articles. The incidence varied between 0 (in 5 papers) and 4%. In the open repair series 
and in the literature, similar incidences have been reported (Table 3). 
7. Other complications  
Allthough gastro-oesophageal reflux is often seen after repair of esophageal atresia with TEF, 
the need for anti-reflux surgery was mentioned in 4 articles. The incidence of anti-reflux 
surgery  varied from 22 to 50% (1,3,4,19). Procedures performed, if reported, were Thal or 
Nissen-fundoplication. Antireflux surgery numbers after open approach was performed in 
18 to 32.2% of cases 19,27,28,21,22.  
The need for aortopexy in case of a severe tracheomalacia is mentioned in only one paper 11 
were it was performed in 6.8% of the cases. This is compatible  with the rate of 4.7% and 16% 
after open repair 21,27. 
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There were no reports on any cosmetic benefit in any of the papers on MAS. And although 
there is more awareness of the effect of thoracotomy on shoulder-function and scoliosis this 
was not reported in any of these papers.  
The duration of follow-up after discharge from the hospital was reported in 7 papers with 
means varying between 6 and 30 months. No further long-term complications as dysphagia, 
late pulmonary disease both restrictive and obstructive and late sequelae from GER are 
reported.  
8. Discussion 
In summary a total of 22 papers reporting on 332 EA-TEF repairs performed via MAS 
revealed no prospective studies and only four comparative studies with historic and 
contemporary open repairs as controls.  
The focus of this chapter is on the type C, or esophageal atresia with fistula (TEF) as this is 
the most common form in esophageal atresia. Even with these numbers data are sometimes 
scarce and difficult to compare.  
Allthough it is not the aim of this chapter a special mention has to be made of the role of 
MAS in correction of type A (long gap) EA. In some of the reviewed papers, these patients 
have been included because a esophago-esophagostomy was performed 3,5,6. And there are 
a number of other reports on the role of MAS in esophageal replacement. For example 
Stanwell 29 describes 7 patients in whom gastric transposition was performed and were 
laparoscopically assisted. In this study five of these had a long gap EA. Esteves 30 reported 
on laparoscopically assisted colon interposition in 5 children with long gap EA. 
Nevertheless because of the small numbers in these studies, the different nature and the 
conflicting views on the various procedures (primary anastomosis vs replacement by stomach, 
colon or jejunum), these papers have not been included in this review.  
9. Clinical outcomes 
When analyzing the results on patients characteristics it does not appear that there is a 
difference in the selection of patients in favour of any of the procedures. The gestational 
age, birth weight and associated malformations were similar to data recorded in open 
repair. 
There is a wide variety between reports when focusing on post-operative results and 
complications. Consistent differences are lacking when compared with results reported for 
open thoracotomies as is seen in Table 1 and 2. The biggest problem however is the 
definition of a complication in these cases like anastomotic leakage and anastomotic 
stricture. For example esophagrams are not made routinely everywhere. Therefore, a 
difference in the incidence of esophageal strictures is likely to be present due to the 
difference in classification and not due to an incidence of occurrence of anastomotic 
strictures.  
Also the follow-up data on MAS repair of EA-TEF is scarce, but again, they do not indicate 
that the incidence of gastro-oesophageal reflux (GER) and GER requiring anti-reflux surgery is 
different from that in patients who had open repairs of the esophageal atresia with TEF. 
Kawahara 8et al studied the influence of MAS on esophageal motor function and gastro-
esophageal reflux in 7 patients in comparison to 10 patients who had an open repair. 
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Manometry and 24-hours pH monitoring did not demonstrate any differences between 
MAS and open repair. 
There is only one paper 11 mentioning the consequences of tracheomalacia requiring 
aortopexy. There seem to be no differences between MAS and studies after open repair. 
10. Studies on systemic effects of MAS 
In several papers the systemic effects of thoracoscopy in neonates are emphasized. In the 
findings of Bishay 15 (6 Congenital Diafragmatic Hernias and 2 EA-TEF) on decreased 
cerebral oxygen saturation measured by Near Infra Red Spectrometry (NIRS) might cause 
concern. These changes and also the decreased arterial pH values had not recovered after 24 
hours. However the real value of NIRS is still not clear and is extensively discussed in a 
study by Pennekamp 31. So far, the long term effect on brain development remains unknown 
but will have to be followed very carefully.  
In the study by Kalfa et al 32 a cohort of 49 neonates who underwent MAS was investigated, 
among them five with esophageal atresia. They also found decreased values of saturation 
due to thoracic insufflation of CO2. Some other data are reported, such as thermic loss, 
which is proportional to duration of operation, and a decreased systolic arterial pressure, 
responding to vascular expansion. But these data are not comparative to open surgery. 
Krosnar 16 also noted a decrease of oxygen saturation, and their patients required 100% 
inspired oxygen in order to maintain the saturation above 85%. They also experienced 
difficulties in end-tidal CO2 monitoring.  But on the other hand Szavay 10 in his retrospective 
comparative analysis in 68 patients of which 25 were operated via MAS showed no differences 
in postoperative pCO2 max levels as in postoperative PH and base excess. 
What do these findings mean? 
To begin with, all papers are retrospective studies with inconsistent reporting of results. 
Obviously, the multi-center study by Holcomb 11 et al should be seen as the standard at this 
moment with only few institutions reporting on datasets of more than 20 MAS procedures 
5,13,2,10,12,4 of which one comparative multicenter study 4. Even if these papers are compiled 
no consistent pattern arises to show superiority or inferiority of MAS versus open repair in 
terms of early post-operative results. 
Secondly, almost all reports come from pioneers in this field who have endeavoured with 
great zeal to advance the skills in pediatric MAS. On one hand, this implies that these 
studies represent early experiences and learning curves. On the other hand, these results 
were obtained by the experts and therefore may be difficult to attain by less experienced 
surgeons. There is still a world to win in MAS as spreading of MAS is possible in centres 
without pioneers. After passing their learning curves their results would become better and 
the patients could benefit from it. Already from adult literature we know that there are 
benefits of minimal invasive surgery when compared with open surgery by means of better 
cosmesis, body-image, lenght of stay and reduced postoperative complications 33 34 35.   
One of the reasons to advocate MAS for EA-TEF repair is the cosmesis and elimination of 
shoulder function disturbances and scoliosis, that in the past has been reported after open 
thoracotomies. But until now hard evidence is not available for either for the contention that 
MAS gives better cosmetic and functional results, or for the better results of muscle-sparing 
thoracotomies in children. It is interesting that also breast-development, chronic pain (in 
50%) and even paraplegia is reported after thoracotomy 36,37,38.  
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inspired oxygen in order to maintain the saturation above 85%. They also experienced 
difficulties in end-tidal CO2 monitoring.  But on the other hand Szavay 10 in his retrospective 
comparative analysis in 68 patients of which 25 were operated via MAS showed no differences 
in postoperative pCO2 max levels as in postoperative PH and base excess. 
What do these findings mean? 
To begin with, all papers are retrospective studies with inconsistent reporting of results. 
Obviously, the multi-center study by Holcomb 11 et al should be seen as the standard at this 
moment with only few institutions reporting on datasets of more than 20 MAS procedures 
5,13,2,10,12,4 of which one comparative multicenter study 4. Even if these papers are compiled 
no consistent pattern arises to show superiority or inferiority of MAS versus open repair in 
terms of early post-operative results. 
Secondly, almost all reports come from pioneers in this field who have endeavoured with 
great zeal to advance the skills in pediatric MAS. On one hand, this implies that these 
studies represent early experiences and learning curves. On the other hand, these results 
were obtained by the experts and therefore may be difficult to attain by less experienced 
surgeons. There is still a world to win in MAS as spreading of MAS is possible in centres 
without pioneers. After passing their learning curves their results would become better and 
the patients could benefit from it. Already from adult literature we know that there are 
benefits of minimal invasive surgery when compared with open surgery by means of better 
cosmesis, body-image, lenght of stay and reduced postoperative complications 33 34 35.   
One of the reasons to advocate MAS for EA-TEF repair is the cosmesis and elimination of 
shoulder function disturbances and scoliosis, that in the past has been reported after open 
thoracotomies. But until now hard evidence is not available for either for the contention that 
MAS gives better cosmetic and functional results, or for the better results of muscle-sparing 
thoracotomies in children. It is interesting that also breast-development, chronic pain (in 
50%) and even paraplegia is reported after thoracotomy 36,37,38.  
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Another argument for MAS could be the reduced need for opioid administration 
postoperatively.The effects of MAS on post-operative pain as measured by opioid 
requirements were studied by Ceelie 17 et al in 10 CDH and 14 EA patients. No differences 
were found compared to matched controls (20 CDH and 28 EA) concerning cumulative 
opioid doses at different time points postoperatively. 
An improved esophageal function after thoracoscopic repair, represented by more effective 
motility and less gastro-esophageal reflux have not been demonstrated in the patients series 
of Kawahara 8. 
Could MAS have negative influences in comparison to open repair? 
The insufflation of the pleural cavity appears to have greater impact on arterial oxygen 
saturation particularly in cerebro than open repair, as demonstrated by Bishay 15 using 
NIRS. But as mentioned earlier no comparative study has been done and the validation in 
open surgery for EA with TEF has not been done. 
In summary, making up the balance between MAS and open repair, there appear to be no 
differences in short term results, both in terms of complications and postoperative pain or 
ICU-stay. Little is known about the long term outcomes, but again, no differences have been 
recorded. So far there is no data available on the cosmetic or shoulder/spine/chestwall 
outcomes after MAS. However Holcomb is mentioning that ample literature is now 
available about long term sequelae from thoracotomies such as, besides scoliosis, mammary 
maldevelopment and chronic postoperative pain, even after muscle-sparing thoracotomy 39. 
Some concern has been raised about the harmful effects of MAS in newborns on cerebral 
perfusion and subsequent development. 
This emphasises the need for a prospective, randomised trial as has already been stated by 
Holcomb 11 in 2005. 
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1. Introduction 
Mechanical ventilation has become a standard technique to support the life of the critically 
ill patient in the intensive care unit (ICU) (Tobin, 2001). In general, mechanical ventilation is 
applied when the patient’s spontaneous ventilation is inadequate to maintain life. Especially 
patients who have developed acute respiratory failure require mechanical ventilation 
(Slutsky, 1993). Patients diagnosed with acute lung injury (ALI) suffer from severe 
pulmonary dysfunction which may persist for a long period of time. The extent and severity 
of ALI differs among patients, with the acute respiratory distress syndrome (ARDS) being 
the most severe manifestation of this lung disease (Schwarz, 2001). ALI and ARDS are 
characterized by the acute onset of diffuse neutrophilic alveolar infiltrates, protein-rich 
edema due to enhanced alveolar-capillary permeability and hypoxemic respiratory failure 
(ratio of arterial oxygen partial pressure to fractional inspired oxygen concentration, 
PaO2/FiO2 < 300 for ALI or < 200 for ARDS) (Ashbaugh et al, 1967; Petty & Ashbaugh, 
1971). These pulmonary disorders may result from local injuries like pneumonia, gastric 
aspiration, near-drowning and lung contusion, but also from systemic events like severe 
sepsis, shock and blood transfusions (Hudson et al, 1995; Ware & Matthay, 2000). 
Although mechanical ventilation is a life-saving procedure, it has the potential to cause 
damage in healthy lung tissue or aggravate damage in diseased lung tissue (Dreyfuss & 
Saumon, 1998; Slutsky, 1999). The pulmonary complications secondary to mechanical 
ventilation are frequently referred to as ventilator-associated lung injury (VALI) in the 
clinical setting and ventilator-induced lung injury (VILI) in the experimental setting. As this 
chapter will primarily focus on experimental findings, the term VILI will be used.  
2. Pathogenesis of ventilator-induced lung injury 
VILI is characterized by enhanced alveolar-capillary permeability, accumulation of protein-
rich lung edema, disturbed alveolar fibrin turnover, production of inflammatory mediators, 
and - ultimately - impaired gas exchange. Interestingly, these patterns of injury are very 
similar to those seen in ALI and ARDS (Tsuno et al, 1991).  
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Over the years, various experimental models have been used to gather further insights into 
the mechanism(s) that may underlie the pathogenesis of VILI. These in vitro and in vivo 
studies support the clinical observations that mechanical ventilation evokes stretch trauma 
due to cyclic opening and collapse and/or overdistention of alveoli (Dreyfuss et al, 1985; 
Webb & Tierney, 1974). Ventilator-induced cyclic opening and closing of alveoli results in 
depletion of surfactant and renders the lung more prone to collapse (Dreyfuss et al, 1988; 
Mead et al, 1970). Extensive research demonstrated that surfactant depletion initiates loss of 
alveolar-capillary barrier function (Lachmann et al, 1987; Seeger et al, 1993; Verbrugge et al, 
1997). In turn, serum proteins will leak from the circulation into pulmonary tissue. Protein 
accumulation in the lung will lead to surfactant inactivation, causing even more protein 
leakage and edema formation and eliciting a vicious circle of progressive lung injury 
(Ikegami et al, 1984; Lachmann et al, 1994). Besides surfactant dysfunction, other 
mechanisms have been proposed to be crucially involved in the development of VILI as 
well. It is reasonable to assume that these underlying mechanisms are interconnected. 
2.1 Inflammatory response 
Leukocyte-endothelial interactions have been described to be important in the pathogenesis of 
severe inflammatory diseases related to VILI, like ALI/ARDS (Abraham, 2003; Moraes et al, 
2003). In inflammation, pulmonary endothelial cells undergo a phenotypic shift (Orfanos et al, 
2004). Activated endothelial cells secrete chemotactic cytokines (chemokines) which are 
essential for the recruitment of leukocytes to the site of inflammation (Luscinskas & Gimbrone, 
Jr., 1996). The main pulmonary chemoattractant is interleukin (IL)-8 or its rodent equivalents 
macrophage inflammatory protein (MIP)-2 and keratinocyte-derived chemokine (KC) 
(Donnelly et al, 1993). Besides release of chemokines and other inflammatory mediators, 
activated endothelial cells express various adhesion molecules on their cell surface thereby 
directing the multi-step cascade of leukocyte transmigration from blood vessels into affected 
tissue (Luscinskas & Gimbrone, Jr., 1996). The initial step of transmigration involves members 
from the selectin family (P- and E-selectin) which tether circulating leukocytes to vascular 
endothelium and facilitate rolling of leukocytes along the blood vessel wall (Carlos & Harlan, 
1994). Subsequent leukocyte adhesion and extravasation are mediated by the immunoglobulin 
(Ig) superfamily comprising vascular cell adhesion molecule (VCAM)-1, intercellular adhesion 
molecule (ICAM)-1 and platelet-endothelial cell adhesion molecule (PECAM)-1. In ALI and 
ARDS patients, Gando et al. observed that soluble P-selectin, E-selectin, ICAM-1 and VCAM-1 
levels were elevated within 24 hours after diagnosis (Gando et al, 2004). In addition, these 
authors showed a marked increase in these soluble adhesion molecules when subdividing 
patients into survivors and non-survivors. Together, these findings imply that adhesion 
molecules may have a prognostic value for development and clinical outcome of inflammatory 
lung diseases (Gando et al, 2004). 
Activated leukocytes release oxygen-based free radicals and proteolytic enzymes to restore 
physiological conditions of inflamed tissue. However, activated leukocytes may obstruct 
micro-capillaries in the lung due to an increased cellular size leading to ischemia and 
augmented oxygen-based free radical production. Accumulation of these inflammatory cells 
in the alveoli may therefore cause severe disruption of pulmonary epithelial-endothelial 
barriers leading to impaired gas exchange (Abraham, 2003; Lee & Downey, 2001). 
Kawano et al. were the first to describe that granulocyte depletion prior to injurious 
mechanical ventilation ameliorates pulmonary dysfunction in a rodent model of surfactant 
deficiency, stressing the importance of inflammatory mediators in the pathogenesis of VILI 
(Kawano et al, 1987). Later, Tremblay et al. revealed that alveolar stretch imposed by ex vivo 
mechanical ventilation caused IL-1β, tumor necrosis factor (TNF)-α, IL-6, MIP-2, interferon 
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(IFN)-γ and IL-10 expression and introduced the term “biotrauma” to describe the ventilator-
induced secretion of inflammatory mediators (Tremblay et al, 1997; Tremblay & Slutsky, 1998). 
In line with this concept, it has been shown that alveolar macrophages secrete cytokines and 
chemokines upon in vitro applied mechanical stretch (Pugin et al, 1998). Although alveolar 
macrophages are considered to be the most important source of pulmonary cytokines and 
chemokines, other cell types like fibroblasts, leukocytes, epithelial and endothelial cells are also 
capable of producing inflammatory mediators (Kelley, 1990). In this respect, in vitro studies 
clearly showed that alveolar epithelial and capillary endothelial cells indeed release cytokines 
and chemokines upon mechanical stretch (Iwaki et al, 2009; Vlahakis et al, 1999). Ranieri et al. 
were the first to provide clinical evidence for the biotrauma-hypothesis (Ranieri et al, 1999). In 
a randomized controlled trial, these authors observed elevated concentrations of IL-1β, TNF-α, 
IL-6 and IL-1 receptor antagonist in the bronchoalveolar lavage fluid (BALf) of ALI/ARDS 
patients when excessive tidal volumes were used for 36 hours (Ranieri et al, 1999).  
Based on experimental and clinical observations, it has been hypothesized that the 
ventilator-induced inflammatory response in the lung may lead to pulmonary injury 
(Haitsma et al, 2003; Wilson et al, 2003; Wilson et al, 2005). Most experimental models of 
VILI, however, applied excessively high tidal volumes and/or inspiratory pressures 
compared to those applied in the clinical setting (Copland et al, 2004; Haitsma et al, 2003; 
Wilson et al, 2003). In an attempt to better reflect the human situation, we used clinically 
more relevant ventilator settings in our animal studies (Hegeman et al, 2010). In this way, 
we were able to prevent shock, metabolic acidosis and substantial damage to lung 
architecture commonly associated with high tidal volumes and/or inspiratory pressures 
(Wolthuis et al, 2009b). However, even in our relatively mild model of VILI, mechanical 
ventilation with either low (LVT) or high tidal volumes (HVT) caused increased cytokine, 
chemokine and adhesion molecule expression compared to non-ventilated control (NVC) 
animals, which was accompanied by marked granulocyte infiltration (Hegeman et al, 
2011b). BALf neutrophil numbers and inflammatory mediator levels were even higher when 
comparing lungs of HVT-ventilated mice to lungs of LVT-ventilated mice (Hegeman et al, 
2011b). Since lower PaO2/FiO2 ratios were only observed after HVT-ventilation, it seems 
plausible that ventilator-induced lung inflammation ultimately impairs gas exchange. In this 
respect, investigators suggested that enhanced pro-inflammation due to mechanical 
ventilation makes the patient more susceptible to a “second hit” (Bregeon et al, 2002). 
Mechanical ventilation itself may be the “second hit” when ventilating critically ill patients 
suffering from pulmonary injuries like ALI/ARDS or systemic events like sepsis (Headley et 
al, 1997; Meduri et al, 1995; Slutsky & Tremblay, 1998).  
2.1.1 Local versus systemic inflammation 
An important clinical observation is that most ventilated critically ill patients do not 
succumb to acute respiratory failure but rather to progressive multiple organ failure (MOF) 
(Ferring & Vincent, 1997; Montgomery et al, 1985; Valta et al, 1999). A definition of MOF has 
been provided by John Marshall, who defined it as “the development of potentially 
reversible physiologic derangement involving two or more organ systems not involved in 
the disorder that resulted in ICU admission, and arising in the wake of a potentially life-
threatening physiologic insult” (Marshall, 2001). In a clinical study, comprising 3147 
patients from 198 ICUs in 24 European countries, Vincent et al. observed significant organ 
dysfunction in 71% of the ICU patients most of them being septic patients (Vincent et al, 
2006). Moreover, they found a positive correlation between the number of organ systems 
failing and ICU mortality stressing the importance of MOF in the clinical outcome of 
critically ill patients (Vincent et al, 2006).  
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physiological conditions of inflamed tissue. However, activated leukocytes may obstruct 
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in the alveoli may therefore cause severe disruption of pulmonary epithelial-endothelial 
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(IFN)-γ and IL-10 expression and introduced the term “biotrauma” to describe the ventilator-
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macrophages are considered to be the most important source of pulmonary cytokines and 
chemokines, other cell types like fibroblasts, leukocytes, epithelial and endothelial cells are also 
capable of producing inflammatory mediators (Kelley, 1990). In this respect, in vitro studies 
clearly showed that alveolar epithelial and capillary endothelial cells indeed release cytokines 
and chemokines upon mechanical stretch (Iwaki et al, 2009; Vlahakis et al, 1999). Ranieri et al. 
were the first to provide clinical evidence for the biotrauma-hypothesis (Ranieri et al, 1999). In 
a randomized controlled trial, these authors observed elevated concentrations of IL-1β, TNF-α, 
IL-6 and IL-1 receptor antagonist in the bronchoalveolar lavage fluid (BALf) of ALI/ARDS 
patients when excessive tidal volumes were used for 36 hours (Ranieri et al, 1999).  
Based on experimental and clinical observations, it has been hypothesized that the 
ventilator-induced inflammatory response in the lung may lead to pulmonary injury 
(Haitsma et al, 2003; Wilson et al, 2003; Wilson et al, 2005). Most experimental models of 
VILI, however, applied excessively high tidal volumes and/or inspiratory pressures 
compared to those applied in the clinical setting (Copland et al, 2004; Haitsma et al, 2003; 
Wilson et al, 2003). In an attempt to better reflect the human situation, we used clinically 
more relevant ventilator settings in our animal studies (Hegeman et al, 2010). In this way, 
we were able to prevent shock, metabolic acidosis and substantial damage to lung 
architecture commonly associated with high tidal volumes and/or inspiratory pressures 
(Wolthuis et al, 2009b). However, even in our relatively mild model of VILI, mechanical 
ventilation with either low (LVT) or high tidal volumes (HVT) caused increased cytokine, 
chemokine and adhesion molecule expression compared to non-ventilated control (NVC) 
animals, which was accompanied by marked granulocyte infiltration (Hegeman et al, 
2011b). BALf neutrophil numbers and inflammatory mediator levels were even higher when 
comparing lungs of HVT-ventilated mice to lungs of LVT-ventilated mice (Hegeman et al, 
2011b). Since lower PaO2/FiO2 ratios were only observed after HVT-ventilation, it seems 
plausible that ventilator-induced lung inflammation ultimately impairs gas exchange. In this 
respect, investigators suggested that enhanced pro-inflammation due to mechanical 
ventilation makes the patient more susceptible to a “second hit” (Bregeon et al, 2002). 
Mechanical ventilation itself may be the “second hit” when ventilating critically ill patients 
suffering from pulmonary injuries like ALI/ARDS or systemic events like sepsis (Headley et 
al, 1997; Meduri et al, 1995; Slutsky & Tremblay, 1998).  
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An important clinical observation is that most ventilated critically ill patients do not 
succumb to acute respiratory failure but rather to progressive multiple organ failure (MOF) 
(Ferring & Vincent, 1997; Montgomery et al, 1985; Valta et al, 1999). A definition of MOF has 
been provided by John Marshall, who defined it as “the development of potentially 
reversible physiologic derangement involving two or more organ systems not involved in 
the disorder that resulted in ICU admission, and arising in the wake of a potentially life-
threatening physiologic insult” (Marshall, 2001). In a clinical study, comprising 3147 
patients from 198 ICUs in 24 European countries, Vincent et al. observed significant organ 
dysfunction in 71% of the ICU patients most of them being septic patients (Vincent et al, 
2006). Moreover, they found a positive correlation between the number of organ systems 
failing and ICU mortality stressing the importance of MOF in the clinical outcome of 
critically ill patients (Vincent et al, 2006).  
 




Fig. 1. Mechanical ventilation induces endothelial activation and inflammation in 
pulmonary, hepatic and renal tissue. 
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Reprinted with permission of Critical Care (Hegeman et al, 2009). To investigate whether 
alveolar stretch may cause endothelial activation and inflammation in the lung and distal 
organs, healthy mice were mechanically ventilated for 1, 2 or 4 hours with high pressures 
(i.e. high level of alveolar stretch). Non-ventilated mice served as a reference group. 
Spontaneous breathing animals were placed in an oxygen saturated box for 4 hours (FiO2 of 
1.0, hyperoxia) to evaluate whether the high FiO2 associated with our ventilation strategy 
may contribute to changes in the immune response. A, E, I: In total lung, liver and kidney 
homogenates, respectively, mRNA expression of the adhesion molecule E-selectin was 
determined by real-time RT-PCR. B-C, F-G, J-K: In addition, mRNA expression of the pro-
inflammatory cytokine interleukin (IL)-1β and the chemokine keratinocyte-derived 
chemokine (KC) was determined. Levels were normalized for expression of internal 
controls, i.e. the average value of β-actin and glyceraldehyde 3-phosphate dehydrogenase 
(GAPdH). D, H, L: In total lung, liver and kidney homogenates, respectively, 
myeloperoxidase (MPO) activity was determined as a measure of granulocyte infiltration. 
Levels were normalized for total protein concentration. Data are depicted relative to NVC 
and expressed as mean ± SEM for n = 4-8 animals. * p<0.05, ** p<0.01, *** p<0.001 
(parameters were analyzed by one-way ANOVA with least significant difference (LSD) 
post-hoc test). NVC = non-ventilated controls; 1h, 2h, 4h = ventilated for either 1, 2 or 4 
hours; O2 = hyperoxia for 4 hours; MV = mechanical ventilation.  
There is convincing evidence that leukocyte-endothelial interactions are not only important 
in the pathogenesis of pulmonary disorders (Abraham, 2003; Moraes et al, 2003) but also in 
systemic events like sepsis and MOF (Whalen et al, 2000). It has been proposed that an 
elevation of adhesion molecule expression might contribute to tissue injury and ultimately 
to MOF by facilitating leukocyte activation and migration (Bone, 1991; Parrillo, 1993). In this 
regard, we examined whether alveolar stretch due to mechanical ventilation results in 
endothelial activation and inflammation in healthy mice, not only in the lung but also in 
organs distal to the lung (Hegeman et al, 2009). We observed that 4 hours of mechanical 
ventilation with high pressures, i.e. high level of alveolar stretch, induced de novo synthesis 
of various adhesion molecules in pulmonary but also in hepatic and renal tissue (figures 1a, 
e, i). In addition, increased cytokine and chemokine mRNA levels were found in the lung 
and distal organs after mechanical ventilation (figures 1b-c, f-g, j-k) accompanied by 
enhanced granulocyte infiltration (figures 1d, h, l). Our data imply that ventilator-induced 
endothelial activation in the lung, liver and kidney facilitates migration and adhesiveness of 
activated immune cells to inflamed tissue, which in turn may lead to tissue injury in these 
organs (Hegeman et al, 2009).  
Since we observed increased endothelial activation and inflammation after mechanical 
ventilation in the lung and distal organs, it seems plausible that mechanical ventilation plays 
a significant role in the development of both VILI and MOF (Hegeman et al, 2009). 
Supporting this hypothesis, earlier experimental research provided evidence that 
mechanical ventilation evokes detrimental effects in distal organs (Imai et al, 2003; Nin et al, 
2006). Imai et al. demonstrated that mechanical ventilation with high tidal volumes induces 
epithelial cell apoptosis in the kidney and small intestine (Imai et al, 2003). Moreover, these 
authors showed that mechanical ventilation leads to elevated levels of serum markers such 
as creatinine indicative for renal failure (Imai et al, 2003). Ventilator-induced cardiovascular 
and hepatic injury has been described as well (Nin et al, 2006). It should be noted that these 
previous studies used animals with pre-existing lung injury whereas our study used healthy 
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Reprinted with permission of Critical Care (Hegeman et al, 2009). To investigate whether 
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(i.e. high level of alveolar stretch). Non-ventilated mice served as a reference group. 
Spontaneous breathing animals were placed in an oxygen saturated box for 4 hours (FiO2 of 
1.0, hyperoxia) to evaluate whether the high FiO2 associated with our ventilation strategy 
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homogenates, respectively, mRNA expression of the adhesion molecule E-selectin was 
determined by real-time RT-PCR. B-C, F-G, J-K: In addition, mRNA expression of the pro-
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chemokine (KC) was determined. Levels were normalized for expression of internal 
controls, i.e. the average value of β-actin and glyceraldehyde 3-phosphate dehydrogenase 
(GAPdH). D, H, L: In total lung, liver and kidney homogenates, respectively, 
myeloperoxidase (MPO) activity was determined as a measure of granulocyte infiltration. 
Levels were normalized for total protein concentration. Data are depicted relative to NVC 
and expressed as mean ± SEM for n = 4-8 animals. * p<0.05, ** p<0.01, *** p<0.001 
(parameters were analyzed by one-way ANOVA with least significant difference (LSD) 
post-hoc test). NVC = non-ventilated controls; 1h, 2h, 4h = ventilated for either 1, 2 or 4 
hours; O2 = hyperoxia for 4 hours; MV = mechanical ventilation.  
There is convincing evidence that leukocyte-endothelial interactions are not only important 
in the pathogenesis of pulmonary disorders (Abraham, 2003; Moraes et al, 2003) but also in 
systemic events like sepsis and MOF (Whalen et al, 2000). It has been proposed that an 
elevation of adhesion molecule expression might contribute to tissue injury and ultimately 
to MOF by facilitating leukocyte activation and migration (Bone, 1991; Parrillo, 1993). In this 
regard, we examined whether alveolar stretch due to mechanical ventilation results in 
endothelial activation and inflammation in healthy mice, not only in the lung but also in 
organs distal to the lung (Hegeman et al, 2009). We observed that 4 hours of mechanical 
ventilation with high pressures, i.e. high level of alveolar stretch, induced de novo synthesis 
of various adhesion molecules in pulmonary but also in hepatic and renal tissue (figures 1a, 
e, i). In addition, increased cytokine and chemokine mRNA levels were found in the lung 
and distal organs after mechanical ventilation (figures 1b-c, f-g, j-k) accompanied by 
enhanced granulocyte infiltration (figures 1d, h, l). Our data imply that ventilator-induced 
endothelial activation in the lung, liver and kidney facilitates migration and adhesiveness of 
activated immune cells to inflamed tissue, which in turn may lead to tissue injury in these 
organs (Hegeman et al, 2009).  
Since we observed increased endothelial activation and inflammation after mechanical 
ventilation in the lung and distal organs, it seems plausible that mechanical ventilation plays 
a significant role in the development of both VILI and MOF (Hegeman et al, 2009). 
Supporting this hypothesis, earlier experimental research provided evidence that 
mechanical ventilation evokes detrimental effects in distal organs (Imai et al, 2003; Nin et al, 
2006). Imai et al. demonstrated that mechanical ventilation with high tidal volumes induces 
epithelial cell apoptosis in the kidney and small intestine (Imai et al, 2003). Moreover, these 
authors showed that mechanical ventilation leads to elevated levels of serum markers such 
as creatinine indicative for renal failure (Imai et al, 2003). Ventilator-induced cardiovascular 
and hepatic injury has been described as well (Nin et al, 2006). It should be noted that these 
previous studies used animals with pre-existing lung injury whereas our study used healthy 
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animals, suggesting that already existing inflammation is not a prerequisite for unveiling 
the negative effects of mechanical ventilation on distal organs. In line with this notion, a 
recent clinical trial showed that mechanical ventilation contributes to the development of 
acute kidney injury (AKI) in critically ill patients without ALI at onset of mechanical 
ventilation (Cortjens et al, 2011). Nonetheless, infectious events are known to aggravate 
ventilator-induced effects (Imai et al, 2003; O'Mahony et al, 2006) and possibly underlie the 
high incidence of MOF in critically ill patients ventilated with high tidal volumes and/or  
inspiratory pressures (Schultz, 2008). 
It remains to be determined which underlying mechanisms initiate the onset of endothelial 
activation and inflammation in distal organs during mechanical ventilation. Haitsma et al. 
and Tutor et al. demonstrated that ventilator-induced permeability of alveolar-capillary 
barriers provokes inflammatory mediator release into the blood circulation (Haitsma et al, 
2000; Tutor et al, 1994). Although there is quite some evidence that inflammatory mediators 
will be released from inflamed pulmonary tissue into the systemic environment, a causal 
relationship between ventilator-induced spill-over and the pathogenesis of MOF has not 
been confirmed yet.  
Our experimental data indicate that ventilator-induced changes in de novo expression of 
adhesion molecules, cytokines and chemokines occur simultaneously in the lung, liver and 
kidney (Hegeman et al, 2009). Moreover, granulocyte recruitment to the liver and kidney 
was already observed after 1 hour of mechanical ventilation (Hegeman et al, 2009). In view 
of this spatiotemporal pattern of inflammatory mediator expression, we suggest that release 
or spill-over of cytokines and chemokines from the lung into the blood circulation is 
probably not the only cause of the enhanced pro-inflammatory environment in distal organs 
during mechanical ventilation. It cannot be excluded, however, that inflammatory mediators 
released into the circulation may contribute to de novo synthesis of adhesion molecules, 
cytokines and chemokines in distal organs, since cytokines like IL-1β and TNF-α are known 
to induce the production of a host of inflammatory mediators (Goodman et al, 2003). Since 
cytokines have in general only a very short half-life in plasma (± 20 minutes), it is more 
logical that locally produced mediators dictate the level of distal organ involvement. Local 
induction of cytokines by e.g. oxygen-based free radicals may be another important pro-
inflammatory source in distal organs.  
Previously, it has been suggested that the physical stress of mechanical ventilation may 
trigger the sympathetic nervous system leading to an increase in catecholamine secretion 
(Plotz et al, 2004). Locally released catecholamines have been described to activate 
transcription factors like nuclear factor (NF)-κB in macrophages and promote production of 
IL-1β, TNF-α and IL-8 (Elenkov et al, 2000; Flierl et al, 2009; Spengler et al, 1990). These 
findings imply that stimulation of sympathetic nerve terminals in e.g. the liver and kidney 
may evoke a pro-inflammatory response in these peripheral organs (Elenkov et al, 2000; 
Straub et al, 2000). Subsequently, the presence of IL-1β, TNF-α and IL-8 may result in an 
acute phase response in the liver possibly via α–adrenergic activation (Elenkov et al, 2000; 
Flierl et al, 2009; Spengler et al, 1990). Based on these notions, we would like to propose that 
ventilator-induced activation of sympathetic nerve terminals in distal organs may contribute 
to the pro-inflammatory state of these organs. In turn, this pro-inflammatory state in distal 
organs may prime for the development of MOF in the critically ill patient (Imai et al, 2003; 
O'Mahony et al, 2006; Schultz, 2008). If so, modulation of adrenergic receptor function might 
be advantageous for the outcome of patients with MOF. Supporting this hypothesis, Miksa 
et al. showed in experimental models of sepsis that an α2A-adrenocepter antagonist reduced 
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plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and 
creatinine, indicative for attenuated liver and kidney injury (Miksa et al, 2009). Moreover, 
these authors showed that inhibition of α2A-adrenocepter activation significantly improved 
survival in septic animals from 45 to 75% (Miksa et al, 2009).  
Another pathway of neuroimmune regulation is considered to be involved in the 
pathogenesis of VILI and MOF as well. In various inflammatory diseases, the efferent vagus 
nerve mediates anti-inflammatory action by downregulating pro-inflammatory immune 
responses (Kumar & Sharma, 2010). Recently, dos Santos et al. showed that disruption of the 
vagus nerve aggravates pulmonary wet-to-dry ratio, neutrophil infiltration, IL-6 production 
and apoptotic cell death, whereas stimulation of the vagus nerve was attenuating these 
parameters of VILI (dos Santos et al, 2011). These recent findings imply that the 
immunoregulatory function of the vagus nerve is of importance in VILI (dos Santos et al, 
2011). Also in systemic diseases like sepsis, vagus-mediated neuroimmune signaling has 
been suggested to be important (Kumar & Sharma, 2010). In this respect, Pavlov et al. 
revealed that pharmacological activation of the vagus nerve improved survival of septic 
mice by inhibiting pro-inflammation (Pavlov et al, 2007). Taken together, stimulating the 
cholinergic anti-inflammatory pathway by pharmacological agents may represent potential 
therapeutic intervention strategies in patients diagnosed with VILI and/or MOF. 
Besides an enhanced systemic pro-inflammatory milieu, it has been hypothesized that 
suppression of the peripheral immune system may also be crucially involved in the 
pathogenesis of MOF (Pinsky et al, 1993; Syrbe et al, 1994). Initially, suppression of the 
peripheral immune function may provide a compensatory mechanism to restore homeostasis 
under physiological circumstances (Bone, 1996). Yet, the compensatory reaction may become 
maladaptive when existing for prolonged periods of time consequently leading to excessive 
suppression of peripheral lymphocytes and augmented susceptibility to infections. In this 
respect, Angele and Faist reported that many ventilated, critically ill patients suffer from 
unexplained immune suppression and thus have an associated increased risk for infections 
and MOF (Angele & Faist, 2002). Therefore, locally enhanced production of cytokines by e.g. 
endothelial cells, hepatic or renal cells in the distal organs - in combination with a hampering 
immune function - may be detrimental for the patient to survive.  
Previously, we demonstrated that mechanical ventilation suppresses lymphocyte function 
outside the lung (Plotz et al, 2002; Vreugdenhil et al, 2004). In children without lung 
pathology, the functional capacity of peripheral blood leukocytes to produce TNF-α, IL-6 and 
IFN-γ in vitro was significantly reduced after 2 hours of mechanical ventilation (Plotz et al, 
2002). This was accompanied by a reduction in natural killer (NK) cell activity (Plotz et al, 
2002). Also in healthy rats, we observed that 4 hours of mechanical ventilation with high 
pressures suppressed peripheral immune functioning, i.e. reduced NK cell activity, mitogen-
induced splenocyte proliferation and cytokine production (Vreugdenhil et al, 2004). 
Supporting these earlier findings, 5 hours of HVT-ventilation resulted in diminished mitogen-
induced splenocyte proliferation compared to NVC in our murine model of VILI (figure 2).  
Taken together, our data indicate that mechanical ventilation does not only induce a pro-
inflammatory environment in organs distal to the lung, but also impairs the functioning of 
peripheral lymphocytes. Whether organ failure results from ongoing pro-inflammation of 
the environment (Pinsky et al, 1993) and/or persistent suppression of the immune function 
(Syrbe et al, 1994), these dysregulated immune responses may contribute to the 
development of MOF and subsequently cause increased morbidity and mortality in the 
critically ill patient (Rittirsch et al, 2008). 
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animals, suggesting that already existing inflammation is not a prerequisite for unveiling 
the negative effects of mechanical ventilation on distal organs. In line with this notion, a 
recent clinical trial showed that mechanical ventilation contributes to the development of 
acute kidney injury (AKI) in critically ill patients without ALI at onset of mechanical 
ventilation (Cortjens et al, 2011). Nonetheless, infectious events are known to aggravate 
ventilator-induced effects (Imai et al, 2003; O'Mahony et al, 2006) and possibly underlie the 
high incidence of MOF in critically ill patients ventilated with high tidal volumes and/or  
inspiratory pressures (Schultz, 2008). 
It remains to be determined which underlying mechanisms initiate the onset of endothelial 
activation and inflammation in distal organs during mechanical ventilation. Haitsma et al. 
and Tutor et al. demonstrated that ventilator-induced permeability of alveolar-capillary 
barriers provokes inflammatory mediator release into the blood circulation (Haitsma et al, 
2000; Tutor et al, 1994). Although there is quite some evidence that inflammatory mediators 
will be released from inflamed pulmonary tissue into the systemic environment, a causal 
relationship between ventilator-induced spill-over and the pathogenesis of MOF has not 
been confirmed yet.  
Our experimental data indicate that ventilator-induced changes in de novo expression of 
adhesion molecules, cytokines and chemokines occur simultaneously in the lung, liver and 
kidney (Hegeman et al, 2009). Moreover, granulocyte recruitment to the liver and kidney 
was already observed after 1 hour of mechanical ventilation (Hegeman et al, 2009). In view 
of this spatiotemporal pattern of inflammatory mediator expression, we suggest that release 
or spill-over of cytokines and chemokines from the lung into the blood circulation is 
probably not the only cause of the enhanced pro-inflammatory environment in distal organs 
during mechanical ventilation. It cannot be excluded, however, that inflammatory mediators 
released into the circulation may contribute to de novo synthesis of adhesion molecules, 
cytokines and chemokines in distal organs, since cytokines like IL-1β and TNF-α are known 
to induce the production of a host of inflammatory mediators (Goodman et al, 2003). Since 
cytokines have in general only a very short half-life in plasma (± 20 minutes), it is more 
logical that locally produced mediators dictate the level of distal organ involvement. Local 
induction of cytokines by e.g. oxygen-based free radicals may be another important pro-
inflammatory source in distal organs.  
Previously, it has been suggested that the physical stress of mechanical ventilation may 
trigger the sympathetic nervous system leading to an increase in catecholamine secretion 
(Plotz et al, 2004). Locally released catecholamines have been described to activate 
transcription factors like nuclear factor (NF)-κB in macrophages and promote production of 
IL-1β, TNF-α and IL-8 (Elenkov et al, 2000; Flierl et al, 2009; Spengler et al, 1990). These 
findings imply that stimulation of sympathetic nerve terminals in e.g. the liver and kidney 
may evoke a pro-inflammatory response in these peripheral organs (Elenkov et al, 2000; 
Straub et al, 2000). Subsequently, the presence of IL-1β, TNF-α and IL-8 may result in an 
acute phase response in the liver possibly via α–adrenergic activation (Elenkov et al, 2000; 
Flierl et al, 2009; Spengler et al, 1990). Based on these notions, we would like to propose that 
ventilator-induced activation of sympathetic nerve terminals in distal organs may contribute 
to the pro-inflammatory state of these organs. In turn, this pro-inflammatory state in distal 
organs may prime for the development of MOF in the critically ill patient (Imai et al, 2003; 
O'Mahony et al, 2006; Schultz, 2008). If so, modulation of adrenergic receptor function might 
be advantageous for the outcome of patients with MOF. Supporting this hypothesis, Miksa 
et al. showed in experimental models of sepsis that an α2A-adrenocepter antagonist reduced 
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plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and 
creatinine, indicative for attenuated liver and kidney injury (Miksa et al, 2009). Moreover, 
these authors showed that inhibition of α2A-adrenocepter activation significantly improved 
survival in septic animals from 45 to 75% (Miksa et al, 2009).  
Another pathway of neuroimmune regulation is considered to be involved in the 
pathogenesis of VILI and MOF as well. In various inflammatory diseases, the efferent vagus 
nerve mediates anti-inflammatory action by downregulating pro-inflammatory immune 
responses (Kumar & Sharma, 2010). Recently, dos Santos et al. showed that disruption of the 
vagus nerve aggravates pulmonary wet-to-dry ratio, neutrophil infiltration, IL-6 production 
and apoptotic cell death, whereas stimulation of the vagus nerve was attenuating these 
parameters of VILI (dos Santos et al, 2011). These recent findings imply that the 
immunoregulatory function of the vagus nerve is of importance in VILI (dos Santos et al, 
2011). Also in systemic diseases like sepsis, vagus-mediated neuroimmune signaling has 
been suggested to be important (Kumar & Sharma, 2010). In this respect, Pavlov et al. 
revealed that pharmacological activation of the vagus nerve improved survival of septic 
mice by inhibiting pro-inflammation (Pavlov et al, 2007). Taken together, stimulating the 
cholinergic anti-inflammatory pathway by pharmacological agents may represent potential 
therapeutic intervention strategies in patients diagnosed with VILI and/or MOF. 
Besides an enhanced systemic pro-inflammatory milieu, it has been hypothesized that 
suppression of the peripheral immune system may also be crucially involved in the 
pathogenesis of MOF (Pinsky et al, 1993; Syrbe et al, 1994). Initially, suppression of the 
peripheral immune function may provide a compensatory mechanism to restore homeostasis 
under physiological circumstances (Bone, 1996). Yet, the compensatory reaction may become 
maladaptive when existing for prolonged periods of time consequently leading to excessive 
suppression of peripheral lymphocytes and augmented susceptibility to infections. In this 
respect, Angele and Faist reported that many ventilated, critically ill patients suffer from 
unexplained immune suppression and thus have an associated increased risk for infections 
and MOF (Angele & Faist, 2002). Therefore, locally enhanced production of cytokines by e.g. 
endothelial cells, hepatic or renal cells in the distal organs - in combination with a hampering 
immune function - may be detrimental for the patient to survive.  
Previously, we demonstrated that mechanical ventilation suppresses lymphocyte function 
outside the lung (Plotz et al, 2002; Vreugdenhil et al, 2004). In children without lung 
pathology, the functional capacity of peripheral blood leukocytes to produce TNF-α, IL-6 and 
IFN-γ in vitro was significantly reduced after 2 hours of mechanical ventilation (Plotz et al, 
2002). This was accompanied by a reduction in natural killer (NK) cell activity (Plotz et al, 
2002). Also in healthy rats, we observed that 4 hours of mechanical ventilation with high 
pressures suppressed peripheral immune functioning, i.e. reduced NK cell activity, mitogen-
induced splenocyte proliferation and cytokine production (Vreugdenhil et al, 2004). 
Supporting these earlier findings, 5 hours of HVT-ventilation resulted in diminished mitogen-
induced splenocyte proliferation compared to NVC in our murine model of VILI (figure 2).  
Taken together, our data indicate that mechanical ventilation does not only induce a pro-
inflammatory environment in organs distal to the lung, but also impairs the functioning of 
peripheral lymphocytes. Whether organ failure results from ongoing pro-inflammation of 
the environment (Pinsky et al, 1993) and/or persistent suppression of the immune function 
(Syrbe et al, 1994), these dysregulated immune responses may contribute to the 
development of MOF and subsequently cause increased morbidity and mortality in the 
critically ill patient (Rittirsch et al, 2008). 
 




Fig. 2. Mechanical ventilation with high tidal volumes induces suppression of splenocyte 
proliferation.  
To investigate whether mechanical ventilation suppressed functioning of peripheral 
lymphocytes, healthy mice were mechanically ventilated for 5 hours with either low or high 
tidal volumes. Non-ventilated mice served as a reference group. In vitro mitogen-induced 
splenocyte proliferation was assessed as a measure of peripheral lymphocyte functioning. 
Splenocytes were stimulated in vitro with αCD3 (1μg/ml), a T cell specific antibody. After 48 
hours 3H-thymidine was added and 16 hours later incorporation of 3H-thymidine was 
determined. Data are depicted relative to LVT and expressed as mean ± SEM for n = 10-16 
animals. * p<0.05 (parameter was analyzed by one-way ANOVA with least significant 
difference (LSD) post-hoc test). NVC = non-ventilated controls; LVT, HVT = ventilated with 
either low or high tidal volumes. 
2.2 Alveolar-capillary permeability 
The primary site of pulmonary gas exchange is the < 0.2 µm thin part of the alveolar-
capillary membrane, consisting of alveolar epithelial and capillary endothelial cells (Burns et 
al, 2003; Weibel, 1984). Back in the 1980s, investigators observed that mechanical ventilation 
and the subsequent stretch of pulmonary tissue induces damage to epithelial-endothelial 
barriers thereby impairing gas exchange (Dreyfuss et al, 1985; Egan, 1982; Parker et al, 1984). 
In addition, Dreyfuss et al. demonstrated that enhanced microvascular permeability was 
responsible for the formation of pulmonary edema during mechanical ventilation with high 
tidal volumes (Dreyfuss et al, 1985). Besides apoptotic and/or necrotic cell death, loss of 
alveolar epithelial and capillary endothelial cell integrity is thought to play a crucial role in 
the ventilator-induced disruption of alveolar-capillary barriers (Pugin, 2003).  
2.2.1 Cell death 
Apoptosis is distinguished by cell shrinkage and nuclear fragmentation, while cell 
organelles and plasma membrane maintain their integrity for a prolonged period (Chang & 
Yang, 2000; Rossi & Gaidano, 2003). Apoptotic cell death is primarily regulated by cysteine 
aspartyl-specific proteases (caspases) and consists of two distinct routes: the intrinsic 
(mitochondria-mediated) and extrinsic (death receptor-mediated) pathway (Lavrik et al, 
2005a). In response to oxidative stress, DNA damage and other types of severe intracellular 
stress, mitochondria undergo marked changes in membrane integrity and activate the 
intrinsic apoptotic pathway (Denecker et al, 2001; Festjens et al, 2004). Enhanced 
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mitochondrial membrane permeability leads to release of pro-apoptotic proteins, like 
cytochrome c, from the mitochondria into the cytosol. Cytochrome c associates with 
apoptototic protease-activating factor (APAF)-1 and procaspase-9 to generate an 
apoptosome complex (Acehan et al, 2002; Jiang & Wang, 2000). In the apoptosome, 
procaspase-9 is cleaved to its mature form and activates the executioner caspase-3. 
Consequently, caspase-dependent DNAses are activated thereby causing chromatin 
condensation and DNA degradation (Chang & Yang, 2000). The extrinsic apoptotic pathway 
is initiated by triggering cell surface death receptors like the TNF receptor (TNFR)-1 and Fas 
(Lavrik et al, 2005b). Triggering of death receptors evokes formation of a death-inducing 
signaling complex (DISC) (Danial & Korsmeyer, 2004). The DISC brings procaspase-8 
molecules in close proximity to each other resulting in their autoproteolytic activation 
(Chang et al, 2003). After autocleavage of procaspase-8, active caspase-8 is released into the 
cytosol and cleaves important executioner caspases (Chang et al, 2003). Caspase-8 is also 
involved in an indirect pathway linking the extrinsic and intrinsic routes of apoptotic cell 
death (Korsmeyer et al, 2000; Zamzami & Kroemer, 2003). In this pathway, activation of 
caspase-8 leads to the cleavage of Bid to truncated Bid (tBid) which induces permeability of 
the mitochondrial membrane. An important mediator of both the intrinsic and extrinsic 
apoptotic pathway is p53, a tumor suppressor molecule (Haupt et al, 2003). P53 is a 
transcription factor for several Bcl-2 family genes, including Bid and Bax, thereby promoting 
cytochrome c release from mitochondria and initiating the intrinsic apoptotic pathway 
(Haupt et al, 2003). In addition, p53 induces APAF-1 expression which is required for 
formation of the apoptosome complex (Kannan et al, 2001). P53 may also initiate the 
extrinsic apoptotic pathway through induction of Fas and activation of caspase-8 (Ding et al, 
2000).  
Necrosis is characterized by irreversible plasma membrane damage, cytoplasmic swelling, 
organelle breakdown and, ultimately, cell rupture with leakage of cellular contents into 
the extracellular space (Fiers et al, 1999; Kroemer et al, 2005). Consequently, this type of 
cell death is associated with a marked inflammatory response. It has been proposed that 
necrosis might provide a backup suicide mechanism when caspase-dependent pathways 
of apoptosis cannot be properly activated (Fiers et al, 1999; Leist & Jäättelä, 2001) although 
this hypothesis may be too simplistic. Depletion of adenosine triphosphate (ATP) for 
instance may favor a switch from apoptosis to necrosis, in part because ATP is necessary 
for optimal activation of caspases (Leist et al, 1997). For many years, necrosis has been 
considered to be an uncontrolled process. However, recent evidence suggests that the 
course of necrotic cell death might be as tightly regulated as apoptotic cell death (Festjens 
et al, 2006; Golstein & Kroemer, 2007). It has to be kept in mind though, that necrotic and 
apoptotic traits might co-exist (Kroemer et al, 2009) and that the same cell death inducers 
may promote either necrosis or apoptosis depending on the specific environmental setting 
(Galluzzi et al, 2009). In this regard, previous research showed that triggering of TNFR-1 
by TNF does not only lead to activation of the extrinsic pathway of apoptosis but also to 
programmed necrosis involving receptor-interacting protein (RIP) kinases (Galluzzi et al, 
2009; Hitomi et al, 2008). Data from Cho et al., He et al. and Zhang et al. implicate RIP3 as 
a pivotal switch between TNF-induced apoptosis and necrosis (Cho et al, 2009; He et al, 
2009; Zhang et al, 2009a). Based on this notion, the protein complex containing RIP1/RIP3 
has been proposed to function as a “necrosome” (Declercq et al, 2009). In this setting, RIP3 
promotes mitochondrial dysfunction, subsequent production of reactive oxygen species 
(ROS) and eventually necrotic cell death. Besides the production of ROS, necrotic cell 
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mitochondrial membrane permeability leads to release of pro-apoptotic proteins, like 
cytochrome c, from the mitochondria into the cytosol. Cytochrome c associates with 
apoptototic protease-activating factor (APAF)-1 and procaspase-9 to generate an 
apoptosome complex (Acehan et al, 2002; Jiang & Wang, 2000). In the apoptosome, 
procaspase-9 is cleaved to its mature form and activates the executioner caspase-3. 
Consequently, caspase-dependent DNAses are activated thereby causing chromatin 
condensation and DNA degradation (Chang & Yang, 2000). The extrinsic apoptotic pathway 
is initiated by triggering cell surface death receptors like the TNF receptor (TNFR)-1 and Fas 
(Lavrik et al, 2005b). Triggering of death receptors evokes formation of a death-inducing 
signaling complex (DISC) (Danial & Korsmeyer, 2004). The DISC brings procaspase-8 
molecules in close proximity to each other resulting in their autoproteolytic activation 
(Chang et al, 2003). After autocleavage of procaspase-8, active caspase-8 is released into the 
cytosol and cleaves important executioner caspases (Chang et al, 2003). Caspase-8 is also 
involved in an indirect pathway linking the extrinsic and intrinsic routes of apoptotic cell 
death (Korsmeyer et al, 2000; Zamzami & Kroemer, 2003). In this pathway, activation of 
caspase-8 leads to the cleavage of Bid to truncated Bid (tBid) which induces permeability of 
the mitochondrial membrane. An important mediator of both the intrinsic and extrinsic 
apoptotic pathway is p53, a tumor suppressor molecule (Haupt et al, 2003). P53 is a 
transcription factor for several Bcl-2 family genes, including Bid and Bax, thereby promoting 
cytochrome c release from mitochondria and initiating the intrinsic apoptotic pathway 
(Haupt et al, 2003). In addition, p53 induces APAF-1 expression which is required for 
formation of the apoptosome complex (Kannan et al, 2001). P53 may also initiate the 
extrinsic apoptotic pathway through induction of Fas and activation of caspase-8 (Ding et al, 
2000).  
Necrosis is characterized by irreversible plasma membrane damage, cytoplasmic swelling, 
organelle breakdown and, ultimately, cell rupture with leakage of cellular contents into 
the extracellular space (Fiers et al, 1999; Kroemer et al, 2005). Consequently, this type of 
cell death is associated with a marked inflammatory response. It has been proposed that 
necrosis might provide a backup suicide mechanism when caspase-dependent pathways 
of apoptosis cannot be properly activated (Fiers et al, 1999; Leist & Jäättelä, 2001) although 
this hypothesis may be too simplistic. Depletion of adenosine triphosphate (ATP) for 
instance may favor a switch from apoptosis to necrosis, in part because ATP is necessary 
for optimal activation of caspases (Leist et al, 1997). For many years, necrosis has been 
considered to be an uncontrolled process. However, recent evidence suggests that the 
course of necrotic cell death might be as tightly regulated as apoptotic cell death (Festjens 
et al, 2006; Golstein & Kroemer, 2007). It has to be kept in mind though, that necrotic and 
apoptotic traits might co-exist (Kroemer et al, 2009) and that the same cell death inducers 
may promote either necrosis or apoptosis depending on the specific environmental setting 
(Galluzzi et al, 2009). In this regard, previous research showed that triggering of TNFR-1 
by TNF does not only lead to activation of the extrinsic pathway of apoptosis but also to 
programmed necrosis involving receptor-interacting protein (RIP) kinases (Galluzzi et al, 
2009; Hitomi et al, 2008). Data from Cho et al., He et al. and Zhang et al. implicate RIP3 as 
a pivotal switch between TNF-induced apoptosis and necrosis (Cho et al, 2009; He et al, 
2009; Zhang et al, 2009a). Based on this notion, the protein complex containing RIP1/RIP3 
has been proposed to function as a “necrosome” (Declercq et al, 2009). In this setting, RIP3 
promotes mitochondrial dysfunction, subsequent production of reactive oxygen species 
(ROS) and eventually necrotic cell death. Besides the production of ROS, necrotic cell 
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death is associated with sustained elevation of cytosolic calcium levels (Harwood et al, 
2005). Calcium overload leads to activation of calcium-dependent cysteine proteases, 
calpains. Active calpains promote release of lysosomal catabolic aspartyl proteases, 
cathepsins, which cleave essential cytoskeletal components like spectrin (also known as 
fodrin), microtubule subunits and microtubule-associated proteins thereby resulting in 
enhanced destabilization of the cell and ultimately in necrotic cell death (Artal-Sanz & 
Tavernarakis, 2005; Zhang et al, 2009b).  
Apart from necrosis, autophagy has been recognized as a distinct form of non-apoptotic cell 
death. Authophagy is the main cellular pathway for degradation of damaged cytoplasmic 
organelles or denatured proteins (Levine & Klionsky, 2004). In response to stress (e.g. 
hyperoxia, oxidative stress, pro-inflammation), autophagic vacuoles sequester damaged 
organelles or proteins. Subsequently, autophagic vacuoles fuse with lysosomes where the 
internalized contents will be degraded by lysosomal enzymes like cathepsins (Ryter & Choi, 
2010). While basal activation of autophagy ascertains the physiological turnover of 
cytoplasmic organelles and proteins, dysregulation or excessive activation of autophagy 
may induce non-apoptotic cell death (Galluzzi et al, 2008; Maiuri et al, 2007). A potential 
cross-talk has been proposed between the mechanisms that regulate autophagy and those 
regulating apoptosis or necrosis (Galluzzi et al, 2008).  
Cell death has been considered to play a crucial role in the disruption of alveolar-capillary 
barriers (Pugin, 2003). Previously, in vitro studies demonstrated that mechanical stretch 
may activate apoptotic cell death (dos Santos et al, 2004; Edwards et al, 1999; 
Hammerschmidt et al, 2004). Moreover, several investigators reported enhanced 
apoptosis after 2 to 5 hours of mechanical ventilation with high tidal volumes (Chiang et 
al, 2011; Le et al, 2008; Li et al, 2007). Although the precise role of necrotic cell death has 
not been elucidated in VILI yet, it has been demonstrated in vitro that mechanical stretch 
as such induces necrosis (Hammerschmidt et al, 2004; Tschumperlin et al, 2000). 
Therefore, we investigated whether apoptotic and/or necrotic cell death pathways were 
activated in lungs of healthy mice exposed to either 5 hours of LVT or HVT-ventilation. 
Protein expression of cleaved caspase-8, -9 and -3 was determined in total lung 
homogenates as measures of caspase-dependent cell death. Protein expression of cleaved 
α-fodrin (145/150kDa fragments yielded by calcium-activated calpains) was determined 
as a measure of caspase-independent cell death. Our data demonstrate unequivocally that 
basal cleavage of caspase-8 was not enhanced by LVT or HVT-ventilation (figure 3a). 
Furthermore, cleaved caspase-9 and -3 were below detection level in all experimental 
groups implying that caspase-dependent pathways of apoptosis were not activated. 
Cleaved α-fodrin levels, however, were significantly increased in lungs of ventilated mice 
in comparison to NVC, which was independent of ventilation strategy (figure 3b). On the 
basis of these findings, it is tempting to speculate that 5 hours of mechanical ventilation 
induces cell death primarily via caspase-independent necrotic pathways. In contrast to 
our present data, Wolthuis et al. observed in a comparable model of VILI that the number 
of caspase 3-positive cells on lung sections was higher in HVT-ventilated mice than in 
control animals although this increase did not reach statistical significance (p=0.055) 
(Wolthuis et al, 2009a). Taken together, we propose that apoptosis is not the major 
executive mechanism of cell death in our experimental model of VILI. Nonetheless, we 
cannot exclude that caspase-dependent pathways of cell death are modestly activated 
which - together with necrotic activities induced in the target cell - will determine the 
level of cell death.  
 




Fig. 3. Mechanical ventilation activates caspase-independent pathways of cell death. 
To investigate whether mechanical ventilation activated caspase-dependent and/or caspase-
independent pathways of cell death, healthy mice were mechanically ventilated for 5 hours 
with either low or high tidal volumes. Non-ventilated mice served as a reference group. A: 
In total lung homogenates, protein expression of cleaved caspase-8 was determined by 
Western blotting as a measure for activation of caspase-dependent cell death pathways. 
Cleaved caspase-9 and -3 were below detection level in all experimental groups. B: In 
addition, protein expression of cleaved α-fodrin (145/150kDa fragments yielded by calcium-
activated calpains) was determined as a measure for activation of caspase-independent cell 
death pathways. Levels were normalized for total protein levels (Coomassie staining). Inset: 
representative Western blot depicting immunodetectable cleaved capase-8 and α-fodrin, 
respectively. Data are depicted relative to NVC and expressed as mean ± SEM for n = 5-8 
animals. * p<0.05, *** p<0.001 (parameters were analyzed by one-way ANOVA with least 
significant difference (LSD) post-hoc test). NVC = non-ventilated controls; LVT,  
HVT =  ventilated with either low or high tidal volumes. 
2.2.2 Loss of vascular integrity 
Under normal conditions, quiescent vascular endothelium establishes a tight barrier which 
controls the movement of plasma and/or leukocytes from the circulation into the 
underlying tissue (Cines et al, 1998). To achieve this barrier function, tight cell-cell contacts 
are formed by junctional transmembrane proteins such as vascular endothelial (VE)-
cadherin (Dejana, 2004). Vascular leakage is an important feature of inflammatory disorders 
and is predominately caused by hyperpermeability of the endothelial barrier (Lentsch & 
Ward, 2000; Michel & Curry, 1999). 
One of the crucial systems regulating vascular cell integrity is the angiopoietin (Ang)-Tie2 
system (Fiedler & Augustin, 2006). Ang-1 and Ang-2 are, respectively, an agonist and 
antagonist of the tyrosine kinase receptor Tie2 (Fiedler et al, 2003). Constitutive Ang-1 
expression and Tie2 phosphorylation in adult vasculature implies that Ang-1−mediated Tie2 
signaling is required to maintain endothelial cell integrity and quiescence (Fiedler & 
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death is associated with sustained elevation of cytosolic calcium levels (Harwood et al, 
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controls the movement of plasma and/or leukocytes from the circulation into the 
underlying tissue (Cines et al, 1998). To achieve this barrier function, tight cell-cell contacts 
are formed by junctional transmembrane proteins such as vascular endothelial (VE)-
cadherin (Dejana, 2004). Vascular leakage is an important feature of inflammatory disorders 
and is predominately caused by hyperpermeability of the endothelial barrier (Lentsch & 
Ward, 2000; Michel & Curry, 1999). 
One of the crucial systems regulating vascular cell integrity is the angiopoietin (Ang)-Tie2 
system (Fiedler & Augustin, 2006). Ang-1 and Ang-2 are, respectively, an agonist and 
antagonist of the tyrosine kinase receptor Tie2 (Fiedler et al, 2003). Constitutive Ang-1 
expression and Tie2 phosphorylation in adult vasculature implies that Ang-1−mediated Tie2 
signaling is required to maintain endothelial cell integrity and quiescence (Fiedler & 
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Augustin, 2006). Binding of Ang-1 leads to autophosphorylation of Tie2, subsequently 
activating several intracellular signaling pathways and maintaining endothelial cell integrity 
(Fiedler & Augustin, 2006). One of the signal transduction routes initiated upon Tie2 
activation is the phosphatidylinositol 3 kinase (PI3K)–Akt pathway, which in general 
promotes cell survival (DeBusk et al, 2004; Kim et al, 2000; Papapetropoulos et al, 2000). In 
this regard, it has been shown that Ang-1−mediated Tie2 signaling may prevent endothelial 
cell apoptosis by activating Akt and upregulating survivin, an apoptosis inhibitor 
(Papapetropoulos et al, 2000). Daly et al. proposed a molecular mechanism through which 
Ang-1−mediated Akt activation may promote vascular stability (Daly et al, 2004). These 
authors demonstrated that Akt activation inactivates the forkhead transcription factor FKHR 
(FOXO1) which regulates genes associated with endothelial cell apoptosis (survivin) and 
vascular destabilization (Ang-2) (Daly et al, 2004). These findings imply that Ang-
1−mediated Tie2 signaling prevents Ang-2 expression and subsequent loss of vascular 
integrity. Another signal transduction route that may be influenced upon Tie2 
phosphorylation is the NF-κB pathway. Hughes et al. showed that Tie2 interacts with A20-
binding inhibitor of NF-κB (ABIN)-2, a NF-κB regulatory protein (Hughes et al, 2003). As a 
consequence of ABIN-2 recruitment, Ang-1-mediated Tie2 signaling inhibits activation of 
the NF-κB pathway and results in an anti-inflammatory and quiescent status of the 
endothelial barrier (Hughes et al, 2003). Finally, Gavard et al. described that Ang-
1−mediated Tie2 signaling protects against vascular endothelial growth factor (VEGF)-
stimulated endothelial permeability by inhibiting VEGF-triggered endocytosis of VE-
cadherin, a junctional transmembrane protein establishing tight cell-cell contacts (Gavard et 
al, 2008). Until now, an increase in Ang-2 levels has been recognized to be the modulating 
factor of the Ang-Tie2 system. In situations of endothelial activation, Ang-2 proteins are 
released from endothelial specific storage granules (Weibel-Palade bodies) and compete 
with Ang-1 for binding to the Tie2 receptor (Fiedler & Augustin, 2006). Accordingly, Ang-2 
may exert antagonistic functions on Ang-1−mediated Tie2 signaling and alter vascular 
integrity, destabilize the endothelial barrier and prime the endothelium to attain 
responsiveness to pro-inflammatory mediators (Fiedler & Augustin, 2006). In line with this, 
van der Heijden et al. demonstrated that circulating Ang-2 and increased Ang-2/Ang-1 
ratios are related to pulmonary permeability edema and severity of ALI/ARDS in ventilated 
patients with or without sepsis (van der Heijden et al, 2008). Furthermore, Gallagher et al. 
showed that high circulating Ang-2 levels in ALI/ARDS patients are associated with a poor 
outcome (Gallagher et al, 2008). Since 67% of these ALI/ARDS patients were mechanically 
ventilated, the authors proposed that ventilatory support alone does not cause enhanced 
Ang-2 levels (Gallagher et al, 2008). However, there is also conflicting evidence that Ang-2 
may induce Tie2 activation in stressed endothelial cells (Daly et al, 2006). 
Both clinical and experimental studies recognized the importance of the Ang-Tie2 system in 
the pathogenesis of lung diseases related to VILI, like ALI and ARDS (van der Heijden et al, 
2009). Karmpaliotis et al. demonstrated that vascular permeability and pulmonary edema 
were accompanied by reduced Ang-1 and enhanced VEGF levels in lungs of 
lipopolysaccharide (LPS)-challenged mice (Karmpaliotis et al, 2002). The same authors 
proposed that changes in the balance between Ang-1 (anti-leakage) and VEGF (pro-leakage) 
might contribute to the pathophysiology of ALI (Karmpaliotis et al, 2002).  
It may well be that a disturbed balance between Ang-1 and VEGF plays an indispensable 
role in VILI as well. Therefore, we examined whether 5 hours of either LVT or HVT-
ventilation would influence the Ang-Tie2 system and VEGF expression in lungs of healthy 
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mice (Hegeman et al, 2010). Particularly in lungs of HVT-ventilated mice, marked changes in 
the Ang-Tie2 system were observed. We demonstrated that Ang-1, Ang-2 and Tie2 mRNA 
expression was significantly reduced in HVT-ventilated mice in comparison with NVC 
(figures 4a-c). At this time point, Ang-1 and Ang-2 protein expression also tended to 
decrease (figures 4d-f). Moreover, we observed that HVT-ventilation caused increased 
expression of VEGF (figure 4g) which is in agreement with a prior report (Nin et al, 2008). 
Our findings strongly suggest that changes in the Ang-Tie2 system, together with elevated 
VEGF expression, are involved in the development of VILI  (Hegeman et al, 2010).  
 
 
Fig. 4. Mechanical ventilation affects the angiopoietin (Ang)-Tie2 system and vascular 
endothelial growth factor (VEGF) expression. 
Reprinted with permission of PLoS One (Hegeman et al, 2010). To investigate whether 
mechanical ventilation influences the Ang-Tie2 system, healthy mice were mechanically 
ventilated for 5 hours with high tidal volumes. Non-ventilated mice served as a reference 
group. A-C: In total lung homogenates, mRNA expression of Ang-1, Ang-2 and Tie2 was 
determined by real-time RT-PCR. Levels were normalized for expression of internal 
controls, i.e. the average value of β-actin and glyceraldehyde 3-phospate dehydrogenase 
(GAPdH). D-E: In total lung homogenates, protein expression of Ang-1 and Ang-2 was 
determined by Western blotting. Membranes were reprobed with antibody recognizing total 
Akt (Akt1/PKBα) to control for equal loading. No group differences in total Akt were 
found. Inset: representative Western blot depicting immunodetectable Ang-1 and Ang-2, 
respectively. F-G: In total lung homogenates, protein expression of Tie2 and VEGF was 
determined by ELISA. Levels were normalized for total protein concentrations. Data are 
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Augustin, 2006). Binding of Ang-1 leads to autophosphorylation of Tie2, subsequently 
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Ang-1−mediated Akt activation may promote vascular stability (Daly et al, 2004). These 
authors demonstrated that Akt activation inactivates the forkhead transcription factor FKHR 
(FOXO1) which regulates genes associated with endothelial cell apoptosis (survivin) and 
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integrity. Another signal transduction route that may be influenced upon Tie2 
phosphorylation is the NF-κB pathway. Hughes et al. showed that Tie2 interacts with A20-
binding inhibitor of NF-κB (ABIN)-2, a NF-κB regulatory protein (Hughes et al, 2003). As a 
consequence of ABIN-2 recruitment, Ang-1-mediated Tie2 signaling inhibits activation of 
the NF-κB pathway and results in an anti-inflammatory and quiescent status of the 
endothelial barrier (Hughes et al, 2003). Finally, Gavard et al. described that Ang-
1−mediated Tie2 signaling protects against vascular endothelial growth factor (VEGF)-
stimulated endothelial permeability by inhibiting VEGF-triggered endocytosis of VE-
cadherin, a junctional transmembrane protein establishing tight cell-cell contacts (Gavard et 
al, 2008). Until now, an increase in Ang-2 levels has been recognized to be the modulating 
factor of the Ang-Tie2 system. In situations of endothelial activation, Ang-2 proteins are 
released from endothelial specific storage granules (Weibel-Palade bodies) and compete 
with Ang-1 for binding to the Tie2 receptor (Fiedler & Augustin, 2006). Accordingly, Ang-2 
may exert antagonistic functions on Ang-1−mediated Tie2 signaling and alter vascular 
integrity, destabilize the endothelial barrier and prime the endothelium to attain 
responsiveness to pro-inflammatory mediators (Fiedler & Augustin, 2006). In line with this, 
van der Heijden et al. demonstrated that circulating Ang-2 and increased Ang-2/Ang-1 
ratios are related to pulmonary permeability edema and severity of ALI/ARDS in ventilated 
patients with or without sepsis (van der Heijden et al, 2008). Furthermore, Gallagher et al. 
showed that high circulating Ang-2 levels in ALI/ARDS patients are associated with a poor 
outcome (Gallagher et al, 2008). Since 67% of these ALI/ARDS patients were mechanically 
ventilated, the authors proposed that ventilatory support alone does not cause enhanced 
Ang-2 levels (Gallagher et al, 2008). However, there is also conflicting evidence that Ang-2 
may induce Tie2 activation in stressed endothelial cells (Daly et al, 2006). 
Both clinical and experimental studies recognized the importance of the Ang-Tie2 system in 
the pathogenesis of lung diseases related to VILI, like ALI and ARDS (van der Heijden et al, 
2009). Karmpaliotis et al. demonstrated that vascular permeability and pulmonary edema 
were accompanied by reduced Ang-1 and enhanced VEGF levels in lungs of 
lipopolysaccharide (LPS)-challenged mice (Karmpaliotis et al, 2002). The same authors 
proposed that changes in the balance between Ang-1 (anti-leakage) and VEGF (pro-leakage) 
might contribute to the pathophysiology of ALI (Karmpaliotis et al, 2002).  
It may well be that a disturbed balance between Ang-1 and VEGF plays an indispensable 
role in VILI as well. Therefore, we examined whether 5 hours of either LVT or HVT-
ventilation would influence the Ang-Tie2 system and VEGF expression in lungs of healthy 
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mice (Hegeman et al, 2010). Particularly in lungs of HVT-ventilated mice, marked changes in 
the Ang-Tie2 system were observed. We demonstrated that Ang-1, Ang-2 and Tie2 mRNA 
expression was significantly reduced in HVT-ventilated mice in comparison with NVC 
(figures 4a-c). At this time point, Ang-1 and Ang-2 protein expression also tended to 
decrease (figures 4d-f). Moreover, we observed that HVT-ventilation caused increased 
expression of VEGF (figure 4g) which is in agreement with a prior report (Nin et al, 2008). 
Our findings strongly suggest that changes in the Ang-Tie2 system, together with elevated 
VEGF expression, are involved in the development of VILI  (Hegeman et al, 2010).  
 
 
Fig. 4. Mechanical ventilation affects the angiopoietin (Ang)-Tie2 system and vascular 
endothelial growth factor (VEGF) expression. 
Reprinted with permission of PLoS One (Hegeman et al, 2010). To investigate whether 
mechanical ventilation influences the Ang-Tie2 system, healthy mice were mechanically 
ventilated for 5 hours with high tidal volumes. Non-ventilated mice served as a reference 
group. A-C: In total lung homogenates, mRNA expression of Ang-1, Ang-2 and Tie2 was 
determined by real-time RT-PCR. Levels were normalized for expression of internal 
controls, i.e. the average value of β-actin and glyceraldehyde 3-phospate dehydrogenase 
(GAPdH). D-E: In total lung homogenates, protein expression of Ang-1 and Ang-2 was 
determined by Western blotting. Membranes were reprobed with antibody recognizing total 
Akt (Akt1/PKBα) to control for equal loading. No group differences in total Akt were 
found. Inset: representative Western blot depicting immunodetectable Ang-1 and Ang-2, 
respectively. F-G: In total lung homogenates, protein expression of Tie2 and VEGF was 
determined by ELISA. Levels were normalized for total protein concentrations. Data are 
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depicted relative to NVC and expressed as mean ± SEM for n = 6-12 animals. *** p<0.001 
(parameters were analyzed by independent T-test). NVC = non-ventilated controls; HVT = 
ventilated with high tidal volumes. 
In addition to the Ang-Tie2 system, Rho guanosine triphosphatases (GTPases) are 
recognized to be crucially involved in the mechanosensitive regulation of vascular 
permeability (Birukov, 2009; Spindler et al, 2010). Rho GTPases act as molecular switches 
that regulate a wide variety of signal transduction pathways involved in cell behavior 
(Schmidt & Hall, 2002; Wojciak-Stothard & Ridley, 2002). Rho GTPases cycle between an 
active guanosine triphosphate (GTP)-bound and an inactive guanosine diphosphate (GDP)-
bound conformational state. Switching between the active and inactive form is tightly 
regulated. Guanine nucleotide exchange factors (GEFs), for example, promote the exchange 
from GDP to GTP leading to activation of Rho GTPases (Wojciak-Stothard & Ridley, 2002).  
Rac1 and Cdc42 are the main Rho GTPases needed for maintaining endothelial barrier 
function, whereas RhoA primarily has a destabilizing effect on endothelial barrier properties 
(Spindler et al, 2010). RhoA activation has been described to induce formation of stress 
fibers comprising actin and myosin (Ridley & Hall, 1992; Wojciak-Stothard et al, 1998). 
Consequently, actin-myosin contractility is suggested as the major mechanism of RhoA-
mediated impairment of endothelial barrier properties (Spindler et al, 2010). RhoA signals 
through a downstream effector kinase, so-called Rho-kinase or Rho-associated coiled-col 
forming kinase (ROCK) (Liao et al, 2007). Activation of ROCK by RhoA inhibits myosin 
phosphatase acitivty subsequently leading to myosin light chain phosphorylation and stress 
fiber formation  (Amano et al, 1997; Kimura et al, 1996).  
3. Therapeutic interventions in critically ill patients with ventilator-induced 
lung injury 
The recognition that conventional mechanical ventilation itself provokes detrimental effects 
in ventilated patients has led to the introduction of “lung-protective” ventilation strategies 
(Gillette & Hess, 2001). So far, mechanical ventilation with reduced tidal volumes is the only 
therapeutic approach effectively attenuating pulmonary injury and subsequent morbidity 
and mortality in critically ill ALI/ARDS patients (Amato et al, 1998; the ARDS network, 
2000; Villar et al, 2006). In this regard, the ARDS Network revealed a 22% relative risk 
reduction in mortality rate when ventilating ALI/ARDS patients with “lung-protective” 
strategies, i.e. mechanical ventilation with tidal volumes of 6 ml/kg instead of with  
12 ml/kg (the ARDS network, 2000). Notably, Determann et al. showed mechanical 
ventilation with lower tidal volumes also to attenuate development of lung injury in 
patients without ALI at the onset of mechanical ventilation (Determann et al, 2010). Recent 
research however, provided striking evidence that even “lung-protective” ventilator settings 
may result in the development of important aspects of VILI (Cobelens et al, 2009; Vaneker et 
al, 2007; Wolthuis et al, 2009b). We confirmed these prior reports in a murine model of VILI. 
We observed that not only conventional ventilation strategies with high tidal volumes but 
also clinically relevant ventilation strategies with low tidal volumes causes inflammation 
and vascular leakage in the lung (Hegeman et al, 2010; Hegeman et al, 2011b). Interestingly, 
a recent clinical trial revealed that mechanical ventilation with tidal volumes of 6ml/kg did 
not protect against the development or worsening of AKI in critically ill patients without 
ALI at onset of mechanical ventilation (Cortjens et al, 2011).  
Apart from preserving alveolar integrity by reducing tidal volumes, additional therapeutic 
intervention strategies that prevent the detrimental effects of mechanical stretch are therefore 
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urgently needed. Based on the mechanisms that may underlie the pathogenesis of VILI (as 
mentioned above), therapies manipulating the course of inflammation and/or alveolar-
capillary permeability might be advantageous for the clinical outcome of ventilated patients. 
3.1 Inhibition of ventilator-induced lung inflammation: does it preclude lung injury? 
It has been recognized that granulocytes and inflammatory mediators are important in the 
pathogenesis of VILI (Haitsma et al, 2003; Wilson et al, 2003; Wilson et al, 2005). 
Consequently, anti-inflammatory agents like glucocorticoids are suggested to attenuate or 
prevent the detrimental effects induced by mechanical ventilation (Brower et al, 2001; Luce, 
2002). Glucocorticoids are a class of steroid hormones that exert their anti-inflammatory and 
immunosuppressive effects by binding to intracellular glucocorticoid receptors (GRs). After 
binding, the GR complex migrates from the cytosol to the nucleus where it regulates a wide 
range of gene activity, including inhibition of NF-κB and activator protein (AP)-1 driven 
expression of inflammatory genes (Barnes, 2006). Furthermore, glucocorticoids are known to 
suppress granulocyte recruitment and activation, preserve endothelial cell integrity and 
control vascular permeability (Ohta et al, 2001; Thompson, 2003). Although the efficacy of 
synthetic glucocorticoids to treat ALI/ARDS in critically ill patients is still under debate 
(Agarwal et al, 2007; Fernandes et al, 2005; Meduri et al, 2008), previous experimental 
research demonstrated that glucocorticoid treatment has the potential to attenuate 
ventilator-induced lung inflammation (Held et al, 2001; Ohta et al, 2001).  
Unfortunately, the anti-inflammatory effects of synthetic glucocorticoids cannot be separated 
from their metabolic effects. In particular when given at higher doses and for longer periods, 
systemic administration of glucocorticoids is associated with severe side effects like elevated 
blood glucose levels, deposition of body fat, suppressed systemic immunity and increased 
susceptibility to infections (Schacke et al, 2002). One way to reduce the unwanted side effects 
of glucocorticoid treatment is to selectively deliver these therapeutic agents into the diseased 
tissue (Asgeirsdottir et al, 2007). In this respect, liposomal formulations are valuable drug 
delivery systems as they can act as a depot from which the encapsulated drug will be slowly 
released to enable prolonged, local drug exposure at low concentrations (Storm & Crommelin, 
1998). Moreover, liposomes preferably extravasate into tissues with increased capillary 
permeability (Storm & Crommelin, 1998) facilitating delivery at sites of inflammation and/or 
mechanical stretch. Previously, Ásgeirsdóttir et al. clearly showed that delivery of liposome-
encapsulated dexamethasone inhibits pro-inflammatory gene expression without affecting 
blood glucose levels (Asgeirsdottir et al, 2007), one of the first clinically relevant side effects of 
free dexamethasone treatment (Feldman-Billard et al, 2006; Weinstein et al, 1995). Because 
local delivery of glucocorticoids by liposomal formulations could be of therapeutic importance 
in the context of VILI as well, we studied whether liposomes containing dexamethasone (Dex-
liposomes) inhibited ventilator-induced lung inflammation (Hegeman et al, 2011a). We 
observed that administration of Dex-liposomes at initiation of ventilation diminished crucial 
inflammatory parameters of VILI such as IL-1β, IL-6 and KC mRNA expression, especially in 
LVT-ventilated mice (Hegeman et al, 2011a). Yet, this formulation was not as effective as free 
dexamethasone in preventing granulocyte infiltration into pulmonary tissue (Hegeman et al, 
2011a). As granulocytes are considered to be important in the development of VILI (Kawano et 
al, 1987), we hypothesized that phagocytosis of liposomes by activated granulocytes may be 
advantageous and should therefore be enhanced (Hegeman et al, 2011a). We proposed that 
IgG-modified Dex-liposomes (IgG-Dex-liposomes) may be more efficient in attenuating 
ventilator-induced lung inflammation than Dex-liposomes due to interaction with Fcγ-
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depicted relative to NVC and expressed as mean ± SEM for n = 6-12 animals. *** p<0.001 
(parameters were analyzed by independent T-test). NVC = non-ventilated controls; HVT = 
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inflammatory parameters of VILI such as IL-1β, IL-6 and KC mRNA expression, especially in 
LVT-ventilated mice (Hegeman et al, 2011a). Yet, this formulation was not as effective as free 
dexamethasone in preventing granulocyte infiltration into pulmonary tissue (Hegeman et al, 
2011a). As granulocytes are considered to be important in the development of VILI (Kawano et 
al, 1987), we hypothesized that phagocytosis of liposomes by activated granulocytes may be 
advantageous and should therefore be enhanced (Hegeman et al, 2011a). We proposed that 
IgG-modified Dex-liposomes (IgG-Dex-liposomes) may be more efficient in attenuating 
ventilator-induced lung inflammation than Dex-liposomes due to interaction with Fcγ-
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receptors (FcγRs) on activated granulocytes and macrophages (McKenzie & Schreiber, 1998). 
Indeed, IgG-Dex-liposomes were pharmacologically more effective than Dex-liposomes 
particularly in preventing granulocyte infiltration induced by either LVT or HVT-ventilation 
(Hegeman et al, 2011a). Additionally, IgG-Dex-liposomes inhibited most parameters of 
ventilator-induced lung inflammation as efficient as free dexamethasone. Our experimental 
data imply that conjugation of IgG to Dex-liposomes significantly improves their efficacy in 
attenuating ventilator-induced lung inflammation (Hegeman et al, 2011a). Importantly, the use 
of liposomes may favor local release of dexamethasone thereby preventing unwanted systemic 
side effects (Asgeirsdottir et al, 2007). 
At present, it is thought that ventilator-induced lung inflammation may precede lung 
injury. Therefore, we hypothesized that reducing the inflammatory response by 
therapeutic intervention strategies would prevent vascular leakage and impaired gas 
exchange associated with mechanical ventilation. We observed, however, that the potent 
anti-inflammatory agent dexamethasone did not prevent occurrence of the more crude 
parameters of VILI like the elevation in BALf protein level, the increase in pulmonary 
wet-to-dry ratio and the reduction in PaO2/FiO2 ratio (Hegeman et al, 2011b). Our 
findings oppose previous studies describing protective effects of glucocorticoid therapy 
on lung injury (Nin et al, 2006; Ohta et al, 2001). In a rat model of VILI, dexamethasone 
was shown to restore pulmonary function after 75 minutes of mechanical ventilation as 
indicated by improved PaO2/FiO2 ratios (Nin et al, 2006). Moreover, Ohta et al. 
demonstrated that administration of methylprednisolone caused a marked leftward 
shifting of the pressure-volume (P-V) curve of rats ventilated for 40 minutes (Ohta et al, 
2001). However, the deterioration of the P-V curve was still evident regardless of the  
significant reduction in granulocyte infiltration (Ohta et al, 2001). Ohta et al. explained 
these findings by the effects of mechanical stretch on lung tissue like stress failure of 
pulmonary capillaries, which may contribute to lung injury to a great extent (Ohta et al, 
2001; West et al, 1991). Since mice were exposed to 5 hours of mechanical ventilation in 
our experimental model of VILI, it is tempting to speculate that the progressive lung 
injury induced by prolonged mechanical stretch may not be influenced by the anti-
inflammatory action of dexamethasone (anymore).  
Similar to dexamethasone, administration of the vessel protective factor Ang-1 only 
inhibits inflammatory aspects of VILI (Hegeman et al, 2010). In a murine model of VILI, 
we observed that intravenous Ang-1 treatment at initiation of ventilation inhibited 
granulocyte infiltration and inflammatory mediator release, and completely abolished the 
increase in VEGF protein in lungs of HVT-ventilated mice (Hegeman et al, 2010). 
Although Ang-1 was preventing development of these important aspects of VILI, it did 
not influence the end points of VILI such as vascular leakage and impaired gas exchange 
(Hegeman et al, 2010). Our data are in apparent contrast with previously reported 
protective effects of Ang-1 on vascular leakage in endotoxin-challenged animals (Huang 
et al, 2008; McCarter et al, 2007; Mei et al, 2007; Witzenbichler et al, 2005). Using a similar 
dosing and administration procedure of Ang-1, David et al. showed that Ang-1 therapy 
also stabilized endothelial barrier function in an murine model of polymicrobiological 
abdominal sepsis as evidenced by attenuation of protein leakage from lung capillaries into 
the alveolar compartment (David et al, 2011). These findings underline that the pathways 
involved in sepsis- and ventilator-induced lung injury are different. An explanation for 
this discrepancy might be that the enhanced inflammation is not the primary inducer of 
vascular leakage and impaired gas exchange during HVT-ventilation as is the case in the 
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induction of lung injury by sepsis. Indeed, it has been shown that ventilator-induced 
mechanical stretch itself may destabilize alveolar-capillary barrier function thereby 
resulting in increased vascular permeability and pulmonary edema (Dreyfuss et al, 1985; 
Egan, 1982; Parker et al, 1984). Ang-1 treatment will probably affect the capillary-
endothelial but not the alveolar-epithelial barrier since the Tie2 receptor is mainly 
expressed on endothelial cells (Lemieux et al, 2005). Thus, the possibility remains that 
Ang-1 treatment is not capable of restoring lung injury induced by HVT-ventilation as it 
only modulates endothelial inflammation (Hegeman et al, 2010). The fact that Ang-1 
prevents pulmonary vascular leakage in animals exposed to LPS, which induces a 
generalized inflammation primarily in the endothelial cells of the lung (Weppler & 
Issekutz, 2008), supports this hypothesis. In this respect, it is of interest that the TNF-α 
inhibitor Etanercept diminished inflammation and coagulation in the lungs of ventilated 
mice without affecting alveolar-capillary permeability and pulmonary edema (Wolthuis et 
al, 2009a), which is in line with our findings.  
Taken together, we would like to suggest that prevention of lung inflammation does not 
preclude a loss of pulmonary function in our experimental model of VILI, in contrast to 
what has been shown in models of endotoxin- or sepsis-induced ALI. Probably the 
mechanism of injury caused by mechanical ventilation is different from the injury caused by 
endotoxin-challenge. In this regard, our in vivo studies revealed that endotoxin-challenge 
provokes lung injury via both caspase-dependent apoptosis and caspase-independent 
necrosis (unpublished data by Kooijman et al.). Lung injury induced by either LVT or HVT-
ventilation, however, is for the greater part caspase-independent and probably executed by 
pathways involving destabilization of the cytoskeleton via proteolytic activity of calpains 
(figure 3). Thus, the primary functional deficit induced by mechanical ventilation may be 
more geared at early cellular death due to alveolar (over)stretch which will most likely not 
be counteracted by anti-inflammatory intervention strategies. 
3.2 Focus of future therapeutic interventions  
We have clearly shown that anti-inflammatory intervention strategies do not prevent 
aspects of VILI driven by mechanosensitive alterations in barrier properties but will only 
regulate the pulmonary inflammation (Hegeman et al, 2010; Hegeman et al, 2011b). It may 
well be that it is difficult to diminish the effect of mechanical stretch on lung injury solely by 
anti-inflammatory therapy. So, we now propose that anti-inflammatory agents should not 
be applied to combat the mechanosensitive aspects of VILI. However, anti-inflammatory 
intervention strategies may well be considered when inflammation is the primary inducer of 
lung injury like in non-ventilated patients diagnosed with ALI or ARDS.  
3.2.1 Inhibitors of RhoA and/or ROCK 
Our findings imply that future therapeutic interventions in the ventilated, critically ill patient 
should aim at attacking the ventilator-induced impairment of alveolar-capillary barrier 
function. As Rho GTPases have been described to be important in the mechanosensitive 
regulation of endothelial barrier function (Birukov, 2009), inactivation of RhoA and/or ROCK  
may have a protective effect on endothelial barrier function in the context of VILI. In this 
respect, we investigated the effects of the selective ROCK inhibitor Y-27632 in a rat model of 
LPS-induced ALI (unpublished data by Kooijman et al.). ROCK inhibition significantly 
diminished endothelial permeability in LPS-challenged lungs, which was associated with 
decreased pulmonary inflammation and suppressed activation of caspase-dependent and 
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receptors (FcγRs) on activated granulocytes and macrophages (McKenzie & Schreiber, 1998). 
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particularly in preventing granulocyte infiltration induced by either LVT or HVT-ventilation 
(Hegeman et al, 2011a). Additionally, IgG-Dex-liposomes inhibited most parameters of 
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inhibits inflammatory aspects of VILI (Hegeman et al, 2010). In a murine model of VILI, 
we observed that intravenous Ang-1 treatment at initiation of ventilation inhibited 
granulocyte infiltration and inflammatory mediator release, and completely abolished the 
increase in VEGF protein in lungs of HVT-ventilated mice (Hegeman et al, 2010). 
Although Ang-1 was preventing development of these important aspects of VILI, it did 
not influence the end points of VILI such as vascular leakage and impaired gas exchange 
(Hegeman et al, 2010). Our data are in apparent contrast with previously reported 
protective effects of Ang-1 on vascular leakage in endotoxin-challenged animals (Huang 
et al, 2008; McCarter et al, 2007; Mei et al, 2007; Witzenbichler et al, 2005). Using a similar 
dosing and administration procedure of Ang-1, David et al. showed that Ang-1 therapy 
also stabilized endothelial barrier function in an murine model of polymicrobiological 
abdominal sepsis as evidenced by attenuation of protein leakage from lung capillaries into 
the alveolar compartment (David et al, 2011). These findings underline that the pathways 
involved in sepsis- and ventilator-induced lung injury are different. An explanation for 
this discrepancy might be that the enhanced inflammation is not the primary inducer of 
vascular leakage and impaired gas exchange during HVT-ventilation as is the case in the 
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induction of lung injury by sepsis. Indeed, it has been shown that ventilator-induced 
mechanical stretch itself may destabilize alveolar-capillary barrier function thereby 
resulting in increased vascular permeability and pulmonary edema (Dreyfuss et al, 1985; 
Egan, 1982; Parker et al, 1984). Ang-1 treatment will probably affect the capillary-
endothelial but not the alveolar-epithelial barrier since the Tie2 receptor is mainly 
expressed on endothelial cells (Lemieux et al, 2005). Thus, the possibility remains that 
Ang-1 treatment is not capable of restoring lung injury induced by HVT-ventilation as it 
only modulates endothelial inflammation (Hegeman et al, 2010). The fact that Ang-1 
prevents pulmonary vascular leakage in animals exposed to LPS, which induces a 
generalized inflammation primarily in the endothelial cells of the lung (Weppler & 
Issekutz, 2008), supports this hypothesis. In this respect, it is of interest that the TNF-α 
inhibitor Etanercept diminished inflammation and coagulation in the lungs of ventilated 
mice without affecting alveolar-capillary permeability and pulmonary edema (Wolthuis et 
al, 2009a), which is in line with our findings.  
Taken together, we would like to suggest that prevention of lung inflammation does not 
preclude a loss of pulmonary function in our experimental model of VILI, in contrast to 
what has been shown in models of endotoxin- or sepsis-induced ALI. Probably the 
mechanism of injury caused by mechanical ventilation is different from the injury caused by 
endotoxin-challenge. In this regard, our in vivo studies revealed that endotoxin-challenge 
provokes lung injury via both caspase-dependent apoptosis and caspase-independent 
necrosis (unpublished data by Kooijman et al.). Lung injury induced by either LVT or HVT-
ventilation, however, is for the greater part caspase-independent and probably executed by 
pathways involving destabilization of the cytoskeleton via proteolytic activity of calpains 
(figure 3). Thus, the primary functional deficit induced by mechanical ventilation may be 
more geared at early cellular death due to alveolar (over)stretch which will most likely not 
be counteracted by anti-inflammatory intervention strategies. 
3.2 Focus of future therapeutic interventions  
We have clearly shown that anti-inflammatory intervention strategies do not prevent 
aspects of VILI driven by mechanosensitive alterations in barrier properties but will only 
regulate the pulmonary inflammation (Hegeman et al, 2010; Hegeman et al, 2011b). It may 
well be that it is difficult to diminish the effect of mechanical stretch on lung injury solely by 
anti-inflammatory therapy. So, we now propose that anti-inflammatory agents should not 
be applied to combat the mechanosensitive aspects of VILI. However, anti-inflammatory 
intervention strategies may well be considered when inflammation is the primary inducer of 
lung injury like in non-ventilated patients diagnosed with ALI or ARDS.  
3.2.1 Inhibitors of RhoA and/or ROCK 
Our findings imply that future therapeutic interventions in the ventilated, critically ill patient 
should aim at attacking the ventilator-induced impairment of alveolar-capillary barrier 
function. As Rho GTPases have been described to be important in the mechanosensitive 
regulation of endothelial barrier function (Birukov, 2009), inactivation of RhoA and/or ROCK  
may have a protective effect on endothelial barrier function in the context of VILI. In this 
respect, we investigated the effects of the selective ROCK inhibitor Y-27632 in a rat model of 
LPS-induced ALI (unpublished data by Kooijman et al.). ROCK inhibition significantly 
diminished endothelial permeability in LPS-challenged lungs, which was associated with 
decreased pulmonary inflammation and suppressed activation of caspase-dependent and 
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caspase-independent cell death pathways. Our results are supported by previous studies in 
experimental models of ALI. Tasaka et al. showed that treatment with the ROCK inhibitor Y-
27632 attenuated pulmonary edema formation and neutrophil infiltration induced by LPS 
(Tasaka et al, 2005). Also in an experimental model of oleic acid-induced ALI, ROCK inhibition 
resulted in diminished lung injury as demonstrated by improved lung histology and reduced 
myeloperoxidase (MPO) activity (Koksel et al, 2005). Together these data imply that ROCK 
inhibition might be a beneficial therapeutic strategy in preventing lung injury, at least in the 
absence of mechanosensitive aspects of mechanical ventilation.  
GEF inhibitors may be superior to direct pharmacological inhibitors of RhoA or ROCK 
(Birukova et al, 2010). Pharmacological targeting of GEF enables inhibition of excessive Rho 
signaling resulting from pathological conditions, while basal RhoA activity will remain 
unchanged. GEF factor H1 (GEF-H1) has been characterized as a RhoA-specific GEF (Ren et 
al, 1998). Consequently, (excessive) activation of GEF-H1 is associated with endothelial 
permeability. Evidence for the importance of GEF-H1 in endothelial barrier dysfunction has 
been provided by Birkova et al. (Birukova et al, 2006; Birukova et al, 2010). These authors 
showed that small interfering (si)RNA-based knockdown of GEF-H1 abolished Rho 
signaling, stress fiber formation and permeability in an in vitro model of cell stretch 
(Birukova et al, 2010). Depletion of GEF-H1 also showed to attenuate vascular leakage in a 
murine model of VILI (Birukova et al, 2010). In view of these findings, GEF-H1 might be an 
attractive target to prevent the detrimental effects induced by the pathological 
mechanosensitive aspects associated with mechanical ventilation. 
3.2.2 Inhibitors of cell death 
Pulmonary cell death is thought to be involved in the ventilator-induced disruption of 
alveolar-capillary barriers and thus in the impairment of alveolar-capillary barrier function 
(Pugin, 2003). In lungs of LVT and HVT-ventilated mice, we observed elevated protein levels 
of cleaved α-fodrin, but not of cleaved caspases, signifying that 5 hours of mechanical 
ventilation primarily activates the caspase-independent cell death pathway (figure 2). In 
view of this notion, it would be of interest to evaluate the effects of calpain inhibitors in our 
experimental model of VILI. Protective effects of calpain inhibitors have already been shown 
in experiment models of inflammation (Cuzzocrea et al, 2000; Cuzzocrea et al, 2002; Rose et 
al, 2006).  Cuzzocrea et al. described that treatment with calpain inhibitors diminishes 
granulocyte infiltration, lipid peroxidation and the degree of lung injury caused by 
intrapleural injection of carrageenan, a polysaccharide extracted from seaweed (Cuzzocrea 
et al, 2000). In addition, the same research group demonstrated that calpain inhibitors may 
decrease the degree of lung inflammation and injury induced by zymosan, which leads to 
the formation of reactive oxygen species (Cuzzocrea et al, 2002). More importantly, these 
authors demonstrated that inhibition of calpain activity did not only attenuate inflammation 
and injury in the lung but also in organs like the liver and intestine (Cuzzocrea et al, 2002). 
As we observed that mechanical ventilation with high pressures induces marked 
inflammation in both the lung and distal organs (Hegeman et al, 2009), treatment with 
calpain inhibitors may be beneficial in ventilated patients suffering from respiratory failure 
and/or MOF.  
For many years, necrosis has been considered to be an uncontrolled process. However, 
recent evidence suggests that the course of necrotic cell death might be as tightly regulated 
as apoptotic cell death (Festjens et al, 2006; Golstein & Kroemer, 2007). It has to be kept in 
mind though, that necrotic and apoptotic traits may co-exist (Kroemer et al, 2009) and the 
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same cell death inducers may promote either necrosis or apoptosis depending on the 
specific environmental setting (Galluzzi et al, 2009). Triggering of TNFR-1 by TNF-α does 
not only lead to activation of the extrinsic pathway of apoptosis but also to programmed 
necrosis involving RIP-kinases (Galluzzi et al, 2009; Hitomi et al, 2008). Necrostatin has been 
described as a small molecule inhibitor of programmed cell necrosis which prevents RIP1 
kinase activation (Degterev et al, 2005). Importantly, previous research already showed that 
inhibition of programmed cell necrosis by necrostatin protects against the development of 
brain injury (Degterev et al, 2005; Northington et al, 2011; You et al, 2008). Northington et al. 
described that necrostatin exerts its protective effects by inhibition of the RIP1-RIP3 
interaction, decreased oxidative injury and suppression of the pro-inflammatory response 
(Northington et al, 2011). The effect of necrostatin has not yet been evaluated in models of 
lung injury which are clearly associated with increased cell death, oxidative injury and pro-
inflammation. Since mechanical ventilation in our experimental model of VILI primarily 
activated the caspase-independent route of cell death, treatment with necrostatin might be a 
preventive strategy for the devastating mechanosensitive effects of mechanical ventilation.  
3.2.3 Mesenchymal stem cells 
Adult stem cells have retained the ability to differentiate into a variety of cell lineages 
(McCulloch & Till, 2005). One of the most well characterized adult stem cells are the 
mesenchymal stem cells (MSCs) (Pittenger et al, 1999). MSCs can be isolated from various 
tissues such as bone marrow, placenta and adipose tissue. MSCs have been described to 
home to injured tissue beds, interact with injured cells and secrete multiple paracrine factors 
that regulate endothelial and epithelial permeability, decrease inflammation, enhance tissue 
repair and inhibit bacterial growth (Lee et al, 2011). In addition, MSC therapy may support 
endogenous stem cells residing in pulmonary tissue (Lee et al, 2011). In view of these 
notions, cell–based therapy with MSCs has been proposed as a potential intervention 
strategy for severe lung diseases.  
Previously, MSCs have been shown to restore function of damaged tissue in experimental 
models of lung disease. To our knowledge, the effecs of MSCs were primarily studied in 
rodent models of ALI. In this regard, intravenous MSC administration reduced lung 
inflammation and prolonged survival in a murine model of bleomycin-induced lung injury 
and fibrosis (Ortiz et al, 2003; Rojas et al, 2005). Similar effects of MSC treatment have been 
described in murine models of endotoxin–induced lung injury (Mei et al, 2007; Xu et al, 
2007; Xu et al, 2008). Xu et al. observed that intravenous MSC administration prevents 
endotoxin-induced lung injury, edema formation and inflammation in mice (Xu et al, 2007). 
Moreover, genetic engineering of MSCs showed to improve the protective effects of MSCs 
even more (Mei et al, 2007; Xu et al, 2008). Mei et al. evaluated the integrity of the alveolar-
capillary membrane barrier by measuring total protein, albumin and IgM concentration in 
BALf in a murine model of LPS-induced ALI (Mei et al, 2007). They showed that treatment 
with MSCs alone already partially reduced these indicators of lung injury in LPS-exposed 
mice. MSCs overexpressing the vessel protective factor Ang-1, however, restored total 
protein, albumin and IgM to levels not different from naive control animals (Mei et al, 2007). 
It should be noted though, that mechanical ventilation provokes a different spectrum of 
pulmonary injury compared to LPS-challenge as demonstrated by the difference in efficacy 
of Ang-1 treatment in our model of VILI (Hegeman et al, 2010). Nonetheless, it is tempting 
to speculate that autologous stem cell transplantation could become a beneficial approach to 
protect ventilated patients against detrimental effects induced by mechanical ventilation. 
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caspase-independent cell death pathways. Our results are supported by previous studies in 
experimental models of ALI. Tasaka et al. showed that treatment with the ROCK inhibitor Y-
27632 attenuated pulmonary edema formation and neutrophil infiltration induced by LPS 
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resulted in diminished lung injury as demonstrated by improved lung histology and reduced 
myeloperoxidase (MPO) activity (Koksel et al, 2005). Together these data imply that ROCK 
inhibition might be a beneficial therapeutic strategy in preventing lung injury, at least in the 
absence of mechanosensitive aspects of mechanical ventilation.  
GEF inhibitors may be superior to direct pharmacological inhibitors of RhoA or ROCK 
(Birukova et al, 2010). Pharmacological targeting of GEF enables inhibition of excessive Rho 
signaling resulting from pathological conditions, while basal RhoA activity will remain 
unchanged. GEF factor H1 (GEF-H1) has been characterized as a RhoA-specific GEF (Ren et 
al, 1998). Consequently, (excessive) activation of GEF-H1 is associated with endothelial 
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showed that small interfering (si)RNA-based knockdown of GEF-H1 abolished Rho 
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murine model of VILI (Birukova et al, 2010). In view of these findings, GEF-H1 might be an 
attractive target to prevent the detrimental effects induced by the pathological 
mechanosensitive aspects associated with mechanical ventilation. 
3.2.2 Inhibitors of cell death 
Pulmonary cell death is thought to be involved in the ventilator-induced disruption of 
alveolar-capillary barriers and thus in the impairment of alveolar-capillary barrier function 
(Pugin, 2003). In lungs of LVT and HVT-ventilated mice, we observed elevated protein levels 
of cleaved α-fodrin, but not of cleaved caspases, signifying that 5 hours of mechanical 
ventilation primarily activates the caspase-independent cell death pathway (figure 2). In 
view of this notion, it would be of interest to evaluate the effects of calpain inhibitors in our 
experimental model of VILI. Protective effects of calpain inhibitors have already been shown 
in experiment models of inflammation (Cuzzocrea et al, 2000; Cuzzocrea et al, 2002; Rose et 
al, 2006).  Cuzzocrea et al. described that treatment with calpain inhibitors diminishes 
granulocyte infiltration, lipid peroxidation and the degree of lung injury caused by 
intrapleural injection of carrageenan, a polysaccharide extracted from seaweed (Cuzzocrea 
et al, 2000). In addition, the same research group demonstrated that calpain inhibitors may 
decrease the degree of lung inflammation and injury induced by zymosan, which leads to 
the formation of reactive oxygen species (Cuzzocrea et al, 2002). More importantly, these 
authors demonstrated that inhibition of calpain activity did not only attenuate inflammation 
and injury in the lung but also in organs like the liver and intestine (Cuzzocrea et al, 2002). 
As we observed that mechanical ventilation with high pressures induces marked 
inflammation in both the lung and distal organs (Hegeman et al, 2009), treatment with 
calpain inhibitors may be beneficial in ventilated patients suffering from respiratory failure 
and/or MOF.  
For many years, necrosis has been considered to be an uncontrolled process. However, 
recent evidence suggests that the course of necrotic cell death might be as tightly regulated 
as apoptotic cell death (Festjens et al, 2006; Golstein & Kroemer, 2007). It has to be kept in 
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same cell death inducers may promote either necrosis or apoptosis depending on the 
specific environmental setting (Galluzzi et al, 2009). Triggering of TNFR-1 by TNF-α does 
not only lead to activation of the extrinsic pathway of apoptosis but also to programmed 
necrosis involving RIP-kinases (Galluzzi et al, 2009; Hitomi et al, 2008). Necrostatin has been 
described as a small molecule inhibitor of programmed cell necrosis which prevents RIP1 
kinase activation (Degterev et al, 2005). Importantly, previous research already showed that 
inhibition of programmed cell necrosis by necrostatin protects against the development of 
brain injury (Degterev et al, 2005; Northington et al, 2011; You et al, 2008). Northington et al. 
described that necrostatin exerts its protective effects by inhibition of the RIP1-RIP3 
interaction, decreased oxidative injury and suppression of the pro-inflammatory response 
(Northington et al, 2011). The effect of necrostatin has not yet been evaluated in models of 
lung injury which are clearly associated with increased cell death, oxidative injury and pro-
inflammation. Since mechanical ventilation in our experimental model of VILI primarily 
activated the caspase-independent route of cell death, treatment with necrostatin might be a 
preventive strategy for the devastating mechanosensitive effects of mechanical ventilation.  
3.2.3 Mesenchymal stem cells 
Adult stem cells have retained the ability to differentiate into a variety of cell lineages 
(McCulloch & Till, 2005). One of the most well characterized adult stem cells are the 
mesenchymal stem cells (MSCs) (Pittenger et al, 1999). MSCs can be isolated from various 
tissues such as bone marrow, placenta and adipose tissue. MSCs have been described to 
home to injured tissue beds, interact with injured cells and secrete multiple paracrine factors 
that regulate endothelial and epithelial permeability, decrease inflammation, enhance tissue 
repair and inhibit bacterial growth (Lee et al, 2011). In addition, MSC therapy may support 
endogenous stem cells residing in pulmonary tissue (Lee et al, 2011). In view of these 
notions, cell–based therapy with MSCs has been proposed as a potential intervention 
strategy for severe lung diseases.  
Previously, MSCs have been shown to restore function of damaged tissue in experimental 
models of lung disease. To our knowledge, the effecs of MSCs were primarily studied in 
rodent models of ALI. In this regard, intravenous MSC administration reduced lung 
inflammation and prolonged survival in a murine model of bleomycin-induced lung injury 
and fibrosis (Ortiz et al, 2003; Rojas et al, 2005). Similar effects of MSC treatment have been 
described in murine models of endotoxin–induced lung injury (Mei et al, 2007; Xu et al, 
2007; Xu et al, 2008). Xu et al. observed that intravenous MSC administration prevents 
endotoxin-induced lung injury, edema formation and inflammation in mice (Xu et al, 2007). 
Moreover, genetic engineering of MSCs showed to improve the protective effects of MSCs 
even more (Mei et al, 2007; Xu et al, 2008). Mei et al. evaluated the integrity of the alveolar-
capillary membrane barrier by measuring total protein, albumin and IgM concentration in 
BALf in a murine model of LPS-induced ALI (Mei et al, 2007). They showed that treatment 
with MSCs alone already partially reduced these indicators of lung injury in LPS-exposed 
mice. MSCs overexpressing the vessel protective factor Ang-1, however, restored total 
protein, albumin and IgM to levels not different from naive control animals (Mei et al, 2007). 
It should be noted though, that mechanical ventilation provokes a different spectrum of 
pulmonary injury compared to LPS-challenge as demonstrated by the difference in efficacy 
of Ang-1 treatment in our model of VILI (Hegeman et al, 2010). Nonetheless, it is tempting 
to speculate that autologous stem cell transplantation could become a beneficial approach to 
protect ventilated patients against detrimental effects induced by mechanical ventilation. 
 




Although mechanical ventilation is a life-saving procedure in the ICU, it has the potential to 
aggravate or even induce detrimental effects (Dreyfuss & Saumon, 1998; Slutsky, 1999). Our 
previous studies aimed at evaluating the mechanisms that may underlie the pathogenesis of 
VILI and MOF (figure 5). To summarize, we demonstrated that both LVT and HVT-
ventilation increased pulmonary cytokine, chemokine and adhesion molecule expression 
accompanied by significant granulocyte infiltration (Hegeman et al, 2011b). We observed 
that 5 hours of either LVT or HVT-ventilation primarily induced caspase-independent 
pathways of cell death (figure 3). In addition, our findings strongly suggest that changes in 
the Ang-Tie2 system, together with elevated VEGF expression, are involved in the 
development of VILI  (figure 4) (Hegeman et al, 2010). An intriguing clinical observation is 
that most critically ill ALI/ARDS patients do not succumb to acute lung failure but rather to 
progressive non-pulmonary organ dysfunction, so-called MOF (Ferring & Vincent, 1997; 
Montgomery et al, 1985; Valta et al, 1999). In this respect, we showed that mechanical 
ventilation with high pressures increased the pro-inflammatory state of the lung but also of 
the liver and kidney (figure 1) (Hegeman et al, 2009). Moreover, we observed that HVT-
ventilation impairs functioning of peripheral lymphocytes (figure 2). Together, these data 
indicate that ventilator-induced alveolar (over)stretch may play a significant role in the 
pathogenesis of both VILI and MOF.  
Based on the hypothesis that a ventilator-induced inflammatory response may precede lung 
injury, we evaluated the effects of different anti-inflammatory intervention strategies on 
various aspects considered to be important in the development of VILI. One of the most 
potent drugs to downregulate inflammatory responses are glucocorticoids (Brower et al, 
2001; Luce, 2002). Despite the successful inhibitory effect on lung inflammation, we 
observed that glucocorticoid therapy did not prevent the elevation in BALf total protein 
levels, the increase in pulmonary wet-to-dry ratio and reduction of PaO2/FiO2 ratio during 
mechanical ventilation (Hegeman et al, 2011b). Similarly, the vessel protective factor Ang-1 
did not protect ventilated mice against these more crude aspects of VILI even though 
granulocyte infiltration, inflammatory mediator and VEGF expression were markedly 
diminished (Hegeman et al, 2010). Thus, prevention of inflammation does not preclude loss 
of pulmonary function implying that lung inflammation and injury are two independent 
components of VILI.  
In view of these most recent findings, we propose that anti-inflammatory therapy may not 
prevent the aspects of VILI driven by mechanosensitive alterations in barrier properties, like 
vascular leakage and impaired gas exchange, but will only regulate pulmonary 
inflammation. Therefore, future therapeutic intervention strategies in the ventilated, 
critically ill patient should aim at attacking the ventilator-induced impairment of alveolar-
capillary barrier function. As Rho GTPases have been described to be important in the 
mechanosensitive regulation of endothelial barrier function (Birukov, 2009), ROCK or GEF-
H1 inhibitors might be an attractive target to prevent the detrimental effects induced by the 
alveolar (over)stretch associated with mechanical ventilation. In addition, the attenuation of 
caspase-independent cell death – via calpain inhibitors or RIP-kinase inhibitors such as 
necrostatin – might also be a preventive strategy in maintaining alveolar-capillary barrier 
function. Moreover, restoring function of damaged tissue by autologous stem cell 
transplantation could become a beneficial approach to treat the critically ill patient as well. 
Nonetheless, preventing prolonged exposure to mechanical stretch by reducing tidal 
volumes remains of utmost importance. 
 








Fig. 5. Possible mechanisms that may underlie the pathogenesis of ventilator-induced lung 
injury (VILI) and multiple-organ failure (MOF).  
Part of illustration adapted with permission of H.A.E. Vreugdenhil (Thesis “Mechanical 
ventilation and immune function” by H.A.E. Vreugdenhil, 2003). Although life-saving, 
mechanical ventilation may cause harm by itself. Our previous studies investigated the 
mechanisms that may underlie the pathogenesis of VILI and MOF in healthy mice. We 
showed that mechanical ventilation provokes endothelial activation (including changes in 
the angiopoietin (Ang)-Tie2 system), inflammation and cell death (primarily via activation 
of the caspase-independent route) in pulmonary tissue. Besides these local effects of 
mechanical ventilation, we also demonstrated enhanced endothelial activation and 
inflammation in hepatic and renal tissue (enhanced pro-inflammatory milieu of distal 
organs). In addition, we observed reduced mitogen-induced splenocyte proliferation after 
mechanical ventilation with high tidal volumes (suppressed peripheral lymphocyte 
functioning). Alv = alveolar epithelial cell; Mϕ = macrophage. 
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Although mechanical ventilation is a life-saving procedure in the ICU, it has the potential to 
aggravate or even induce detrimental effects (Dreyfuss & Saumon, 1998; Slutsky, 1999). Our 
previous studies aimed at evaluating the mechanisms that may underlie the pathogenesis of 
VILI and MOF (figure 5). To summarize, we demonstrated that both LVT and HVT-
ventilation increased pulmonary cytokine, chemokine and adhesion molecule expression 
accompanied by significant granulocyte infiltration (Hegeman et al, 2011b). We observed 
that 5 hours of either LVT or HVT-ventilation primarily induced caspase-independent 
pathways of cell death (figure 3). In addition, our findings strongly suggest that changes in 
the Ang-Tie2 system, together with elevated VEGF expression, are involved in the 
development of VILI  (figure 4) (Hegeman et al, 2010). An intriguing clinical observation is 
that most critically ill ALI/ARDS patients do not succumb to acute lung failure but rather to 
progressive non-pulmonary organ dysfunction, so-called MOF (Ferring & Vincent, 1997; 
Montgomery et al, 1985; Valta et al, 1999). In this respect, we showed that mechanical 
ventilation with high pressures increased the pro-inflammatory state of the lung but also of 
the liver and kidney (figure 1) (Hegeman et al, 2009). Moreover, we observed that HVT-
ventilation impairs functioning of peripheral lymphocytes (figure 2). Together, these data 
indicate that ventilator-induced alveolar (over)stretch may play a significant role in the 
pathogenesis of both VILI and MOF.  
Based on the hypothesis that a ventilator-induced inflammatory response may precede lung 
injury, we evaluated the effects of different anti-inflammatory intervention strategies on 
various aspects considered to be important in the development of VILI. One of the most 
potent drugs to downregulate inflammatory responses are glucocorticoids (Brower et al, 
2001; Luce, 2002). Despite the successful inhibitory effect on lung inflammation, we 
observed that glucocorticoid therapy did not prevent the elevation in BALf total protein 
levels, the increase in pulmonary wet-to-dry ratio and reduction of PaO2/FiO2 ratio during 
mechanical ventilation (Hegeman et al, 2011b). Similarly, the vessel protective factor Ang-1 
did not protect ventilated mice against these more crude aspects of VILI even though 
granulocyte infiltration, inflammatory mediator and VEGF expression were markedly 
diminished (Hegeman et al, 2010). Thus, prevention of inflammation does not preclude loss 
of pulmonary function implying that lung inflammation and injury are two independent 
components of VILI.  
In view of these most recent findings, we propose that anti-inflammatory therapy may not 
prevent the aspects of VILI driven by mechanosensitive alterations in barrier properties, like 
vascular leakage and impaired gas exchange, but will only regulate pulmonary 
inflammation. Therefore, future therapeutic intervention strategies in the ventilated, 
critically ill patient should aim at attacking the ventilator-induced impairment of alveolar-
capillary barrier function. As Rho GTPases have been described to be important in the 
mechanosensitive regulation of endothelial barrier function (Birukov, 2009), ROCK or GEF-
H1 inhibitors might be an attractive target to prevent the detrimental effects induced by the 
alveolar (over)stretch associated with mechanical ventilation. In addition, the attenuation of 
caspase-independent cell death – via calpain inhibitors or RIP-kinase inhibitors such as 
necrostatin – might also be a preventive strategy in maintaining alveolar-capillary barrier 
function. Moreover, restoring function of damaged tissue by autologous stem cell 
transplantation could become a beneficial approach to treat the critically ill patient as well. 
Nonetheless, preventing prolonged exposure to mechanical stretch by reducing tidal 
volumes remains of utmost importance. 
 








Fig. 5. Possible mechanisms that may underlie the pathogenesis of ventilator-induced lung 
injury (VILI) and multiple-organ failure (MOF).  
Part of illustration adapted with permission of H.A.E. Vreugdenhil (Thesis “Mechanical 
ventilation and immune function” by H.A.E. Vreugdenhil, 2003). Although life-saving, 
mechanical ventilation may cause harm by itself. Our previous studies investigated the 
mechanisms that may underlie the pathogenesis of VILI and MOF in healthy mice. We 
showed that mechanical ventilation provokes endothelial activation (including changes in 
the angiopoietin (Ang)-Tie2 system), inflammation and cell death (primarily via activation 
of the caspase-independent route) in pulmonary tissue. Besides these local effects of 
mechanical ventilation, we also demonstrated enhanced endothelial activation and 
inflammation in hepatic and renal tissue (enhanced pro-inflammatory milieu of distal 
organs). In addition, we observed reduced mitogen-induced splenocyte proliferation after 
mechanical ventilation with high tidal volumes (suppressed peripheral lymphocyte 
functioning). Alv = alveolar epithelial cell; Mϕ = macrophage. 
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1. Introduction 
1.1 Mechanical ventilation 
Mechanical ventilation is often employed to replace spontaneous breathing of patients 
under general anesthesia. Even after operation, the patient still needs ventilation support 
until the respiratory muscles regain full function. A ventilator delivers a certain amount of 
air flow through a facial mask or tracheal tube to the patient whose respiratory system fails 
to function properly due to the effects of anesthetics or diseases. Based on the difference in 
breath initiation, mechanical ventilation can be divided into two categories: controlled 
ventilation and assisted ventilation. In this chapter, we focus on controlled mechanical 
ventilation, under which the patient is not able to trigger a valid breath and the ventilator 
overtakes all the workload of respiratory muscles. Respiratory parameters such as 
respiratory rate (RR), inspiratory–to-expiratory time ratio (I:E), tidal volume (Vt) (or minute 
volume) are controlled by the ventilator. 
Traditionally, controlled mechanical ventilation can either be volume controlled (VCV) or 
pressure controlled (PCV). Ideal respiratory signals obtained in a healthy human during 
VCV and PCV are shown in Fig. 1. In the VCV mode, a patient receives constant flow from 
the ventilator until a preset Vt is reached. A severe drawback of VCV is missing control of 
the peak airway pressure. Airway pressure (Paw) depends on respiratory system compliance 
and resistance. In patients with certain lung diseases, such as acute lung injury (ALI), the 
same setting of Vt as in patients with healthy lungs may lead to a higher peak Paw with the 
potential to further injure the lung. Therefore, VCV is often applied with a pressure 
limitation. Once the peak Paw rises above this limit, the ventilator will stop delivering gas 
even if the preset Vt is not yet reached. In the PCV mode, a maximum airway pressure (Pmax) 
is defined. Inspiration ends when Pmax is reached i.e. the flow driven by the pressure 
difference decreases to zero. PCV may be superior to VCV in patients requiring one-lung 
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anesthesia (Tuğrul et al., 1997). However, the Vt is not controlled by the ventilator in the 
PCV mode, but determined by the preset maximum pressure and respiratory system 
mechanics. There is no guarantee that sufficient gas will be delivered into the lung. Hence, 
Vt and minute volume that the patient receives must be monitored. In reality, the respiratory 
signals measured by the ventilator do not look exactly like the ideal tracings shown in Fig. 1. 
Signals are subjected to various error sources, such as environmental noise, sense 
dysfunction, and calibration failure and they also depend on individual physiological or 
pathophysiological properties of the patient’s respiratory system. 
Respiratory signal analysis is helpful for the clinician and beneficial to the patient. Lung 
diseases influence tidal ventilation, which is reflected in the Paw, air flow and respiratory 
volume signals. Based on a shape analysis of respiratory signals, clinical diagnosis can be 
supported. For example, the flow-volume curve of a patient with cystic fibrosis during 
forced respiration, measured by body plethysmography, is plotted in Fig. 2. Low expiratory 
flow rates compared to the normal values at 75%, 50% and 25% of volume capacity indicate 
airway obstruction in this patient.    
 
     
Fig. 1. Ideal respiratory signals (airway pressure, air flow and respiratory volume) of a 
healthy human under volume controlled (left) and pressure controlled (right) ventilation 
mode. 
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To better understand the respiratory system, many mathematical models were proposed 
(Gillis and Lutchen, 1999, Lutchen and Costa, 1990). The simplest one is based on the first 
order equation of motion:  
 0( ) ( ) / '( )aw rs rsP t V t C V t R P= + × +  (1) 
where Paw, V and V’ denote airway pressure, volume and airway flow, Crs and Rrs represent 
respiratory system compliance and resistance, respectively; P0 is the pre-existing pressure in 
the lung. With the measured respiratory signals, lung mechanics (Crs and Rrs) can be 
calculated. These measures provide a better insight into the lung status and thereby help the 
physicians to establish diagnosis and make adequate therapeutical decisions. 
 
 
Fig. 2. Flow-volume curve of a patient with cystic fibrosis during forced respiration. The 
inspiration phase is depicted on the left side and expiration on the right side of the vertical 
axis. Rectangle points indicate maximal expiratory flow, expiratory flow at 75%, 50%, 25% of 
vital capacity and the end of expiration, from top to bottom respectively. The dashed-line 
shows the normal reference of expiratory flow rate with respect to this patient’s age, height 
and weight. 
At different locations i.e. the airway opening, the trachea or at the alveoli, pressure 
measurements are of interest. If the patient is intubated, tracheal pressure (Ptrach) is 
sometimes more desired than Paw since the endotracheal tube contributes significantly to 
total airflow resistance, and thus affects the Rrs calculation (Guttmann et al., 1993). Alveolar 
pressure (Palv) is a decisive factor of alveolar recruitment/derecruitment. Palv is usually 
calculated by subtracting total resistive pressure from Paw or Ptrach. Typical examples of 
different pressure-volume curves based on Paw, Ptrach and Palv are plotted in Fig. 3. Note that 
at the start of inspiration and expiration, the signals are disturbed due to the non-ideal 
mechanics of the ventilator. 
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Fig. 3. Three pressure-volume curves obtained in a lung healthy patient undergoing 
orthopedic surgery. Paw (blue line): airway pressure; Ptrach (red circle): tracheal pressure; Palv 
(black dashed line): alveolar pressure. 
1.2 Lung protective ventilation strategy  
When patients are generally anesthetized, the alveoli in the dependent lung regions may 
collapse while non-dependent regions remain open. With the help of sufficient external 
pressure delivered by a ventilator during inspiration, some of the collapsed lung regions 
may be opened up (i.e. they are recruited) but already open regions may be overinflated. 
Neither atelectasis nor hyperinflation of lung regions is beneficial in most clinical cases, 
however, one or the other or a mixture of both processes is inevitable to a certain degree. 
During expiration, while gas is exhaled, the alveolar pressure drops, which may lead to 
alveolar collapse (i.e. derecruitment) of the dependent lung regions. Different types of 
ventilator-induced lung injury (VILI) are therefore observed during mechanical ventilation 
(Dreyfuss and Saumon, 1998, Uhlig and Frerichs, 2008), such as shear stress trauma caused 
by cyclic recruitment/derecruitment, barotrauma and pulmonary edema caused by high 
ventilation pressure. As one of many perioperative complications, acute respiratory distress 
syndrome (ARDS) was found developed in 3.1% of patients after thoracic surgery and 
carrying a high mortality rate of over 30% (Grichnik and D’Amico, 2004, Phua et at., 2009). 
Various lung protective ventilation strategies have therefore been proposed, including high 
positive end-expiratory pressure (PEEP) combined with low Vt (Brower et al., 2004, Brochard 
et al., 1998, The Acute Respiratory Distress Syndrome Network, 2000), permissive 
hypercapnia (Hickling et al., 1990), and recruitment maneuvers (Lachmann, 1992), to reduce 
the adverse consequences of mechanical ventilation. In this chapter, we focus on 
optimization of PEEP. 
PEEP was introduced to maintain the once recruited atelectatic areas open and thereby 
reduce the risk of hypoxemia, cyclic recruitment/derecruitment and biotrauma (Gattinoni et 
al., 2001, Slutsky and Tremblay, 1998). Figure 4 illustrates the effect of PEEP on keeping the 
lung open. In healthy subjects, although the pulmonary alveoli increase their size at the end 
of inspiration and decrease at the end of expiration, the shape of alveoli doesn’t change 
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thanks to the pulmonary surfactant. However, in patients with lung injury or with other 
types of lung disease as well as during thoracic surgery, some alveoli collapse at the end of 
expiration when the pressure drops below a critical value, and reopen in the next inspiration 
when the pressure rises above a certain opening pressure. To avoid cyclic 
recruitment/derecruitment (open/collapse) and to “keep the lung open”, an adequate PEEP 
is applied (Fig. 4B). At the end of expiration, Paw doesn’t drop to 0 cmH2O (relative to 
atmospheric pressure). Instead, the pressure is held by the ventilator at a preselected 
positive level. The recruited lung regions remain aerated, which leads to a better 
oxygenation.  
2. PEEP optimization 
2.1 History 
In 1960’s, Ashbaugh et al. proposed the use of PEEP to improve oxygenation in a clinical 
syndrome characterized by atelectasis and hypoxemia (Ashbaugh et al., 1967). The use of 
PEEP has become widespread ever since that study. Suter and his colleagues later published 
the concept of “optimal” PEEP (Suter et al., 1975). Because at that time, cardiac output and 
blood gas measurements were not always available, they suggested that maximizing tidal 
compliance could be used to identify a PEEP level, at which oxygen delivery was optimized. 
In the past three decades, a multitude of physicians and scientists dedicated themselves to 
identify the best PEEP levels for patients under surgeries (Beiderlinden et al., 2003, Berendes 
et al., 1996, Bensenor et al., 2007), as well as patients with variable diseases, such as ALI or 
ARDS (Badet et al., 2009, Huh et al., 2009), morbid obesity (Bohm et al., 2009, Erlandsson et 
al., 2006), chronic obstructive pulmonary disease (COPD) (Glerant et al., 2005, Mancebo et al., 
2000), brain-injury (Shapiro and Marshall, 1978, Huynh et al., 2002), including infants 
(Greenough et al., 1992, Dimitriou et al., 1999). Although different terminologies and end-
points for optimizing PEEP were used (Villar, 2005), most of the approaches tried to obtain 
the best oxygenation while minimizing VILI as outcome. A lower mortality rate and a better 
quality of life would be the most desirable goals of therapies. While PEEP has 
experimentally been shown to reduce VILI, there is no consent in the literature if a suitable 
PEEP is able to reduce mortality (Miller et al., 1992, DiRusso et al., 1995, Brower et al., 2004), 
due to the fact that the effect of PEEP is hard to be assessed independently. 
It remains under debate how to titrate an adequate PEEP level in individual patients, 
despite the widely used application of PEEP in clinical practice (Rouby et al., 2002). Increase 
of PEEP may prevent alveolar derecruitment in dependent areas but may lead to 
hyperinflation in the non-dependent areas, which may trigger pulmonary inflammation 
(Terragni et al., 2007). Besides, high PEEP levels may reduce cardiac output (Baigorri et al., 
1994) and impair the hemodynamic stability (Herff et al., 2008). Therefore, as also stated by 
Rouby and Brochard in an editorial (Rouby and Brochard, 2007), one goal of setting PEEP is 
to find a suitable level, high enough to keep the lung open while minimizing adverse side 
effects. 
Generally speaking, the current available methods of PEEP titration can be mainly divided 
into three categories: They are based on 1) arterial blood gases such as partial pressure of 
oxygen in arterial blood (PaO2) and oxygen saturation (SpO2); 2) lung mechanics such as 
dynamic compliance and static pressure-volume (P/V) curve; 3) imaging techniques such as 
computed tomography (CT) and electrical impedance tomography (EIT). In the following, 
representative methods within these three categories are introduced and their assets and 
drawbacks discussed. 
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Fig. 4. The effect of positive end-expiratory pressure (PEEP) on keeping the alveoli open. A: 
Under controlled mechanical ventilation without PEEP, alveoli of a healthy subject stay 
open throughout the whole breathing cycle, while the alveoli of a patient with lung disease 
collapse at the end of expiration. B: When PEEP is applied, the recruited alveoli will no 
longer collapse at the end of expiration in a patient with lung disease. 
2.2 Optimizing PEEP with blood gas analysis 
One of the main goals of PEEP selection is to optimize oxygenation. Therefore, it is 
reasonable to guide the PEEP settings by analyzing blood gases (Girgis et al., 2006, Borges et 
al., 2006, Luecke et al., 2005). It was suggested that “best” PaO2 (maximum value) indicates 
the “optimal” PEEP in many studies (Borges et al., 2006, Suarez-Sipmann et al., 2007). Toth et 
al. suggested setting PEEP at the level where PaO2 starts to drop rapidly during a 
decremental PEEP trial (Toth et al., 2007). A typical course of PaO2 values obtained during a 
decremental PEEP trial in an experimental model of ALI is shown in Fig. 5. PEEP decreased 
from 30 cmH2O to 5 cmH2O in steps of 5 cmH2O. Decrease of PaO2 implies worse aeration 
and oxygenation. Optimal PEEP is defined at the pressure level before PaO2 decreases 
significantly. 
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Fig. 5. Change of PaO2 during a decremental PEEP trial in a porcine model of acute lung 
injury. Vertical dashed line indicates the optimal PEEP level with respect to PaO2.  
Luecke et al. argued that improving only PaO2 was not good enough, the elevation of PaCO2 
should not be ignored (Luecke et al., 2005). Girgis et al. have shown in twenty ALI/ARDS 
patients that the PaO2/FiO2 ratio was improved by tuning FiO2 after a recruitment 
maneuver and monitoring the SpO2 changes during decremental PEEP titration (Girgis et al., 
2006). SpO2 values were measured by pulse oximetry, which is a noninvasive method, 
however, less precise than direct measurement of arterial oxygen saturation. Rouby 
concluded in a review that the highest PaO2 and SaO2 at the lowest FiO2 indicated the right 
PEEP level (Rouby et al., 2002). Caramez et al. have compared ten different parameters for 
setting PEEP following a recruitment maneuver, including blood gas analysis and lung 
mechanics (Caramez et al., 2009). The results of PEEP selection using Crs, PaO2 with or 
without PaCO2 were statistically indistinguishable (Caramez et al., 2009). Statistically 
significant differences may have not been revealed due to the small number of studied 
subjects (n = 14) and high variation. Although these studies indicate that PaO2 is a possible 
criterion for setting PEEP, precise blood gas analysis is invasive and discontinuous and, 
thus, not suitable for continuous bedside monitoring. 
2.3 Optimizing PEEP with lung mechanics 
The P/V curve has been introduced to individualize Vt and PEEP settings in patients with 
ARDS by Matamis et al. in 1984 (Matamis et al., 1984). In this concept, a lower inflection 
point (LIP) and an upper inflection point (UIP) are identified on the inflation limb of the 
P/V curve (Fig. 6B). The LIP was considered to be the pressure level at which massive 
alveolar recruitment occurs (Jonson and Svantesson, 1999); UIP was considered to be the 
pressure level indicating alveolar overdistension (Roupie et al., 1995). In consequence, a 
ventilation strategy was developed to keep the lung open (by setting PEEP above LIP) and 
to minimize overdistension (by restricting Vt such that peak pressure is smaller than UIP) 
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Optimizing Perioperative Ventilation Support with  




Fig. 5. Change of PaO2 during a decremental PEEP trial in a porcine model of acute lung 
injury. Vertical dashed line indicates the optimal PEEP level with respect to PaO2.  
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(Dambrosio et al., 1997, Hermle et al., 2002). Takeuchi et al. proposed that setting PEEP at LIP 
+ 2 cmH2O might be more appropriate (Takeuchi et al., 2002). However, studies indicate that 
LIP is only the beginning of recruitment and the UIP is not a reliable marker of 
overdistension (Crotti et al., 2001, Hickling, 2002, Downie et al., 2004). New findings suggest 
that it may be better to set PEEP according to UIP on the deflation limb of the P/V curve 
(Albaiceta et al., 2004). In order to obtain quasi-static P/V curves, the normal ventilation 
process has to be interrupted by performing a specific respiratory maneuver such as low-
flow inflation (Servillo et al., 1997), super-syringe inflation (Matamis et al., 1984) or SCASS, 
i.e. static compliance by automated single steps (Sydow et al., 1991), (Fig. 6A). As pointed 
out by LaFollette et al., the key to bedside application is acquiring a dynamic curve, which is 
easier and more applicable, instead of a static one (LaFollette et al., 2007). 
Respiratory system compliance Crs or elastance Ers (Crs=1/Ers) can be measured quasi-
statically by airway occlusion (D'Angelo et al., 1991) or dynamically by applying linear least-
squares regression on the first order equation of motion (Eq. 1) (Iotti et al., 1995). 
Considering the limitation of static Crs (Stenqvist et al., 2008) and the significant difference 
between static and dynamic Crs (Stahl et al., 2006), it is the dynamic lung mechanics that 
should be monitored. Many studies have shown that “optimal” PEEP may be obtained by 
identifying maximal dynamic Crs, or minimal Ers (Fig. 7) (Suter et al., 1975, Carvalho et al., 
2008, Stahl et al., 2006). Hickling demonstrated with a mathematical model of an ARDS lung 
that maximizing Crs during a decremental PEEP trial may be more suitable to indicate the 
“optimal” PEEP (Hickling, 2001). Several studies support this result (Suarez-Sipmann et al., 
2007, Hanson et al., 2009).  
 
 
Fig. 6. A: Airway pressure (Paw) of an ARDS patient during the SCASS maneuver to 
determine static compliance by automated single steps (Sydow et al., 1991) and B: the 
corresponding P/V curves with lower inflection point (LIP) and upper inflection point (UIP) 
marked on both inflation and deflation limbs.  
Methods other than P/V curve and maximum dynamic compliance are rarely used in 
clinical practice. Mols et al. suggested that the intra-tidal compliance-volume curve, 
calculated by the SLICE method (Guttmann et al., 1994), was able to indicate the ongoing 
recruitment and overdistension of alveoli in the lung (Mols et al., 1999). The shapes of the 
  
Optimizing Perioperative Ventilation Support with  




Fig. 7. Mean dynamic respiratory system compliances (Crs) of a sedated patient under 
mechanical ventilation at different PEEP levels. Dashed line indicates the “optimal” PEEP 
level, at which Crs is maximum.  
compliance-volume curves are classified into three categories: 1) a decrease in slope 
indicates overdistension; 2) an increase in slope indicates recruitment; 3) a quasi-horizontal 
compliance-volume curve indicates a suitable PEEP setting (Mols et al., 1999). However, the 
method has not yet been evaluated for clinical relevance. Ranieri et al. used the pressure-
time curve as an index to predict pulmonary stress (Ranieri et al., 2000). This method 
requires phases with constant air flow which limits its applicability. Nevertheless, these 
methods have brought the importance of pulmonary mechanical stress into focus. Talmor et 
al. estimated the transpulmonary pressure with help of esophageal balloon catheters and set 
PEEP to such a level that transpulmonary pressure stayed between 0 and 10 cmH2O during 
end-expiratory occlusion, and less than 25 cmH2O during end-inspiratory occlusion (Talmor 
et al., 2008). They observed improvement of PaO2/FiO2 ratio and Crs compared to the group 
guided according to the ARDS network standard-of-care recommendations. This finding is 
interesting, but the placement of esophageal balloon catheters needs additional effort in 
clinical care. Therefore, this method will only become accepted if advantages over other 
methods using Crs and blood gas analysis are outweighing the extra burden of complex 
handling. 
2.4 Optimizing PEEP with imaging techniques 
CT has a very good spatial resolution and is able to show the distribution of the tissue 
density in the chest, thereby providing primarily morphological data. Hence, CT is the gold 
standard for assessment of tidal volume distribution in injured lungs and many validation 
studies were done by comparing various methods with the CT results (Gattinoni et al., 2006, 
Carvalho et al., 2008, Suarez-Sipmann et al., 2007, Meier et al., 2008). Figure 8 shows two 
chest CT images of a patient under mechanical ventilation at two different PEEP levels. 
Higher aeration and reversal of lung collapse in the dependent lung regions were detected 
at a PEEP level of 15 cmH2O (Fig. 8, right) compared to that of 5 cmH2O (Fig. 8, left). 
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Fig. 8. CT images of a patient under mechanical ventilation at two different PEEP levels. 
Left: PEEP=5 cmH2O; Right: PEEP=15 cmH2O. Pneumonic infiltrates in the left lung and 
intrapleural fluid accumulation are discernible. Lung aeration is increased, e.g. in the 
anterior region of the right lung (white circle) and dependent lung regions are recruited 
(black circles) at the higher PEEP level. 
Unfortunately, application of CT imaging for bedside monitoring is limited due to complex 
handling (e.g. large equipment) and radiation exposure of patients. Hertzog et al. have 
reported a case study using mobile CT scanners to optimize PEEP in a 6-month-old 
premature infant (Hertzog et al., 2001). However, even with the development of low-dose 
CT, radiation exposure makes it practically impossible to use CT to guide PEEP titration at 
the bedside. 
In contrast to CT, the relatively new imaging technique, electrical impedance tomography 
(EIT) is noninvasive and radiation-free. EIT utilizes the phenomenon that changes in 
regional air content modify electrical impedance of lung tissue (Nopp et al., 1993). Small 
alternating electrical currents are applied at the chest wall surface during examination and 
the resultant potential differences are measured. The distribution of electrical impedance 
within the chest can be determined from these data. Although EIT has a relatively low 
resolution, it has the potential to monitor regional lung aeration and to visualize regional 
ventilation distribution dynamically at the bedside (Zhao et al., 2010). Thus, EIT may 
provide additional information to individualize protective ventilation strategies by titrating 
PEEP.  
Several applications of EIT for selecting PEEP were recently proposed. Erlandsson and 
colleagues used EIT to set PEEP in morbidly obese patients by maintaining a stable end-
expiratory lung volume, and suggested that the corresponding PEEP level was optimal 
(Erlandsson et al., 2006). Although the PaO2/FiO2 ratio and Crs increased in these patients, 
this “optimal” PEEP need not be the best oxygenation point. Besides, the identification of 
stable, horizontal end-expiratory EIT values may be difficult. Luepschen and colleagues 
modified the centre of gravity index from Frerichs et al. (Frerichs et al., 1998) to evaluate 
functional lung opening and overdistension of the lung tissue in an animal model of lavage-
induced acute lung injury (Luepschen et al., 2007). Dargaville et al. have applied EIT during 
an incremental and decremental PEEP trial to identify the PEEP level at which the most 
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homogeneous distribution of regional Crs and ventilation was observed in healthy, injured 
and surfactant-treated lungs (Dargaville et al., 2010). Zhao and colleagues applied the global 
inhomogeneity (GI) index (Zhao et al., 2009) to facilitate the PEEP titration in mechanically 
ventilated patients undergoing orthopedic surgery (Zhao et al., 2010) (Fig. 9). Lowhagen et al 
proposed the assessment of intratidal ventilation distribution using EIT to identify optimal 
PEEP level in patients with ALI/ARDS (Lowhagen et al., 2010). These results are promising 
but they still need to be confirmed in further larger studies on lung injured patients. Other 
EIT-based methods assessing regional lung filling characteristics (Grant et al., 2009, Hinz et 
al., 2007) have also shown potential to guide PEEP setting. As stated by Dueck in a review 
article, EIT is helpful in achieving the balance between alveolar recruitment and 
hyperinflation for patients with severe lung injury (Dueck, 2006). Although the use of EIT is 
limited to scientific research and clinical experiments, EIT has the potential to gain 
acceptance from more physicians and become a useful tool in clinical routine in the future. 
 
 
Fig. 9. PEEP titration guided by ventilation homogeneity based on electrical impedance 
tomography (EIT) (Zhao et al., 2010). Top: EIT images at different PEEP levels (from left to 
right: PEEP = 0, 15, 28 cmH2O). The color bars at the right side of each image indicate the 
magnitude of change in relative impedance during ventilation. Lung regions with the 
highest ventilation are coded in red. Bottom: global inhomogeneity (GI) index (Zhao et al., 
2009) versus PEEP. The minimum value of GI index implies the PEEP level at which 
ventilation distribution is most homogeneous. 
2.5 Combination of PEEP setting indices 
Individualized PEEP titration is important, especially in patients with severe lung injury 
(Kallet and Branson, 2007). Methods discussed in this chapter focused on different aspects: 
Crs and P/V curves represent the global mechanical properties of the respiratory system; 
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blood gas analysis provides a direct view on the oxygenation status; CT and EIT evaluate 
the local ventilation distribution. Obviously, it is rational to combine these different 
variables to guide PEEP titration. We suggest selecting PEEP according to a weighted 
combination of Crs, GI index (EIT analysis) and SpO2 (or PaO2) to include all available 
information on the patient’s lung status. The disease state of the patient and strategic 
treatment goals may lead to different weighted combinations. A practical way to define 
these weighting factors is still warrant and should be achieved in the future with further 
studies. 
Besides, ventilator settings, such as tidal volume (Suter et al., 1978) and inspired oxygen 
concentration (FiO2) (Rouby et al., 2002) may strongly influence the “optimal” level of PEEP. 
The National Institutes of Health's ARDS Network has developed a recommendation in 
form of a PEEP/FiO2 titration table to adjust these variables (Brower et al., 2004). As 
mentioned before, lung protective ventilation strategies are more than just PEEP 
optimization. The patients will also benefit from adequate tidal volumes and body 
positioning which may additionally limit hyperinflation and reduce the amount of non-
aerated lung tissue. 
3. Summary 
Perioperative ventilation support is indispensable for patients under thoracic surgery. 
Inadequate settings of ventilation support may cause a number of problems, including 
hypoxemia, shear stress trauma, barotraumas and pulmonary edema. A suitable PEEP level 
maintains dependent lung regions open and thereby improves oxygenation and reduces the 
risk of inflammation. The selection of optimal PEEP is still under debate. We propose to 
combine indices of lung mechanics, blood gas analysis and imaging techniques to titrate 
PEEP. Besides, application of PEEP should be complemented with other strategies (e.g. low 
tidal volume, appropriate body positioning, recruitment maneuver), to achieve the best 
outcome of the patient.  
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mentioned before, lung protective ventilation strategies are more than just PEEP 
optimization. The patients will also benefit from adequate tidal volumes and body 
positioning which may additionally limit hyperinflation and reduce the amount of non-
aerated lung tissue. 
3. Summary 
Perioperative ventilation support is indispensable for patients under thoracic surgery. 
Inadequate settings of ventilation support may cause a number of problems, including 
hypoxemia, shear stress trauma, barotraumas and pulmonary edema. A suitable PEEP level 
maintains dependent lung regions open and thereby improves oxygenation and reduces the 
risk of inflammation. The selection of optimal PEEP is still under debate. We propose to 
combine indices of lung mechanics, blood gas analysis and imaging techniques to titrate 
PEEP. Besides, application of PEEP should be complemented with other strategies (e.g. low 
tidal volume, appropriate body positioning, recruitment maneuver), to achieve the best 
outcome of the patient.  
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1. Introduction  
Pulmonary resection is the first therapeutic option of various lung pathologies, among 
which localized non-microcytic bronchogenic carcinoma is the most prevalent. Due to the 
fact that many patients who develop non-microcytic bronchogenic carcinoma present 
significant comorbidity, lung resection is associated with an increased risk (between 2 and 
5%) of perioperative death (Little et al., 2005). Therefore, it is important to assess the 
patient's operability, which is defined as the ability to survive the lung resection without 
leaving any disabling sequelae.  
As most of these patients are or have been smokers, many of them have varying degree of 
obstructive lung disease. It is known that the pulmonary obstruction increases the risk of 
lung resection (Miller et al., 1981), which is why the decision to perform resection 
depends largely on the functional integrity of the lung not affected by tumor. As the 
excision supposes a loss of lung function, many years of research have led to a reasonably 
solid scientific evidence that the postoperative risk depends on post-surgery lung 
function, which can be estimated preoperatively by knowing the amount of tissue to be 
resected basing on  anatomical size or quantifying it by perfusion scintigraphy  (Wernly et 
al., 1980). 
On the other hand, it is also known that the functional capacity measured by exercise tests is 
associated with postoperative mortality (Puente & Ruiz., 2003). This has led to the 
development of integrated strategies in which basal functional tests are followed by 
postoperative function estimate and, in borderline patients, by stress testing (Marshall & 
Olsen 1993).  
2. Perioperative pulmonary physiology 
The major cardiopulmonary complications that alter normal lung function occur as a result 
of surgery (thoracotomy and resection of lung parenchyma) and anaesthesia (table 1). The 
thoracic surgery causes restrictive changes in the lung function characterized by moderate to 
severe reductions (50%) in vital capacity and up to 70% decrease of functional residual 
capacity (FRC). As a result of the  FRC decrease, the volume of airway closure is shifted, so 
 
Front Lines of Thoracic Surgery 
 
370 
Toth, I., Leiner, T., Mikor, A., Szakmany, T., Bogar, L. & Molnar, Z. (2007). Hemodynamic 
and respiratory changes during lung recruitment and descending optimal positive 
end-expiratory pressure titration in patients with acute respiratory distress 
syndrome. Crit Care Med, 35, pp. 787-93. 
Tuğrul, M., Camci, E., Karadeniz, H., Sentürk, M., Pembeci, K. & Akpir, K. (1997). 
Comparison of volume controlled with pressure controlled ventilation during one-
lung anaesthesia. Br J Anaesth, 79, pp. 306-10. 
Uhlig, S. & Frerichs, I. (2008). [Lung protective ventilation - pathophysiology and 
diagnostics]. Anasthesiol Intensivmed Notfallmed Schmerzther, 43, pp. 438-45; quiz pp. 
446. 
Villar, J. (2005). The use of positive end-expiratory pressure in the management of the acute 
respiratory distress syndrome. Minerva Anestesiol, 71, pp. 265-72. 
Zhao, Z., Moller, K., Steinmann, D., Frerichs, I. & Guttmann, J. (2009). Evaluation of an 
electrical impedance tomography-based global inhomogeneity index for 
pulmonary ventilation distribution. Intensive Care Med, 35, pp. 1900-6. 
Zhao, Z., Steinmann, D., Frerichs, I., Guttmann, J. & Moller, K. (2010). PEEP titration guided 
by ventilation homogeneity: a feasibility study using electrical impedance 
tomography. Crit Care, 14, R8. 
20 
Perioperative Pulmonary  
Functional Assessment  
Felipe Villar Álvarez1,  
Germán Peces-Barba Romero1 and Miguel Ángel Palomero Rodríguez2 
1Department of Pneumology, IIS Fundación Jiménez Díaz, CIBERES, 
2Department of Anesthesiology, Hospital La Paz, Madrid, 
 Spain 
1. Introduction  
Pulmonary resection is the first therapeutic option of various lung pathologies, among 
which localized non-microcytic bronchogenic carcinoma is the most prevalent. Due to the 
fact that many patients who develop non-microcytic bronchogenic carcinoma present 
significant comorbidity, lung resection is associated with an increased risk (between 2 and 
5%) of perioperative death (Little et al., 2005). Therefore, it is important to assess the 
patient's operability, which is defined as the ability to survive the lung resection without 
leaving any disabling sequelae.  
As most of these patients are or have been smokers, many of them have varying degree of 
obstructive lung disease. It is known that the pulmonary obstruction increases the risk of 
lung resection (Miller et al., 1981), which is why the decision to perform resection 
depends largely on the functional integrity of the lung not affected by tumor. As the 
excision supposes a loss of lung function, many years of research have led to a reasonably 
solid scientific evidence that the postoperative risk depends on post-surgery lung 
function, which can be estimated preoperatively by knowing the amount of tissue to be 
resected basing on  anatomical size or quantifying it by perfusion scintigraphy  (Wernly et 
al., 1980). 
On the other hand, it is also known that the functional capacity measured by exercise tests is 
associated with postoperative mortality (Puente & Ruiz., 2003). This has led to the 
development of integrated strategies in which basal functional tests are followed by 
postoperative function estimate and, in borderline patients, by stress testing (Marshall & 
Olsen 1993).  
2. Perioperative pulmonary physiology 
The major cardiopulmonary complications that alter normal lung function occur as a result 
of surgery (thoracotomy and resection of lung parenchyma) and anaesthesia (table 1). The 
thoracic surgery causes restrictive changes in the lung function characterized by moderate to 
severe reductions (50%) in vital capacity and up to 70% decrease of functional residual 
capacity (FRC). As a result of the  FRC decrease, the volume of airway closure is shifted, so 
 
Front Lines of Thoracic Surgery 
 
372 
in the areas of pulmonary decline the end point of exhalation  is below the closure volume, 
which causes an early closure of the airway and, therefore, of the areas of atelectasis. The 
factors that reduce FRC include supine position, pain, general anaesthesia and obesity. 
These functional changes occur without apparent obstruction of the airway, so that the ratio 
of forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) does not 
decrease. 
The action of the anaesthetic and the muscle relaxant used in the surgical procedure, 
involves a decrease in lung volumes. In addition, the effects of these drugs on the 
diaphragm and the bulbar center responsible for regenerating respiratory impulses are the 
main reasons that justify changes in lung volumes. 
The cause of the diaphragm muscle dysfunction is not clear yet. Direct damage to the 
muscles during the surgical intervention has been proposed as one of possible mechanisms, 
but transdiaphragmatic pressure measurements during maximal phrenic nerve stimulation 
suggest that the depression of the central nervous system efferent traffic on the diaphragm 
occurs as a result of inhibitory reflexes associated with pain and other stimuli to 
sympathetic or vagal receptors.  
Hypoxemia and arterial hypercapnia  that appear, especially in the postoperative period, are 
mainly due  to the effects of anaesthesia used during the surgery and cause a decrease in the 
interrelation  ventilation/perfusion (V/Q), and besides lead to deterioration of hypoxic 
pulmonary vasoconstriction, alveolar hypoventilation or low cardiac output.  The gas 
exchange disorder is intensified with combination of hypoventilation, increase in dead space 
ventilation, rapid shallow breathing and a decrease in mixed venous oxygen saturation due 
to low cardiac output, anemia and arterial desaturation and increased peripheral oxygen 
consumption with pain, fever or stress (Beckles et al., 2003). 
 
Lung function changes with anesthesia and surgery 
Impairment of gas exchange 
Reduction in lung volumes 
Dysfunction of the diaphragm 
Depression of ventilatory control 
Inhibition of cough and mucociliary system 
Table 1. Mechanism of lung function changes with anesthesia and surgery (Swenson, 1999). 
Ventilatory depression is also typical of the postoperative period and is marked by the 
residual effects of anaesthesia that inhibit normal response to hypoxia and hypercapnia. 
Analgesics and other sedatives may enhance these effects, and impede the implementation 
of pulmonary rehabilitation. They can rarely lead to episodes of sleep apnea. 
The lung defends itself from attacks of infectious and environmental agents with cough and 
mucociliary clearance. The former is suppressed both with excessive and poor pain 
treatment. The latter can be altered by an ineffective cough, limited by restrictive changes 
and weakened respiratory muscles and also by atelectasis and dysfunction and ciliary 
damage caused by anaesthetic gases (Swenson, 1999). 
Finally, it should be noted that many of these functional alterations may come as a result of 
postoperative complications such as atelectasis, infections, respiratory failure or 
exacerbations of chronic obstructive lung disease (table 2). 
 






Infection (Pneumonia or bronchitis) 
Bronchospam 
Respiratory failure 
Prolonged mechanical ventilation 
Exacerbation of chronic lung disease 
Pulmonary embolism 
Obstructive sleep apnea
Specific thoracic surgical complications
Pleural effusion 
Phrenic nerve injury 
Bronchopleural fistula and empyema 
Sternal wound infection 
Gastroesophafeal anastomotic leak
Table 2. Postoperative pulmonary complications in patients with thoracic surgery (Swenson, 
1999). 
3. Lung function tests 
In the preoperative thoracic surgery the functional assessment schemes have varied over the 
past 50 years. Most respirotary function tests which were utilized in order to minimize 
morbidity and postoperative mortality (table 3) are no longer used today, being replaced by 
simpler techniques that provide similar or better information. Today the process of lung 
function assessment is spread out over several phases comprising a series of breathing tests 
that the patients scheduled for thoracic surgery will be given according to their baseline 
pulmonary function and the amount of lung tissue for resection. These steps complement 
each other, so that the degree of severity of impairment of lung function is the fact that 
determines whether or not to go a step higher. 
   
Pulmonary function test Parameter
Spirometry 
Lung  volumes 













% Perfusion en each lung 




Table 3. Pulmonary function test used in the preoperative assessment. FVC: Forced vital 
capacity. FEV1: Forced expiratory volume in 1 second. ppo: postoperative. TLC: Total lung 
capacity. RV: Residual volumen. DLCO: Diffusion capacity of the lung for carbon monoxide. 
PaO2: Oxygen partial pressure of artery. PaCO2: Carbon dioxide partial pressure of artery. 
PAP: Pulmonary artery pressure. PVR: Pulmonary vascular resistance. VO2: Oxygen uptake. 
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Spirometry is a simple, inexpensive test of high reproducibility, easy to perform. From the 
standpoint of the preoperative evaluation the most important variables are the FEV1 and 
FVC. In the early 1950s spirometry was already considered as the most valid technique to 
assess morbidity and postoperative mortality in the thoracic surgery. 
The first authors who used the predictive power of FEV1 in such surgery observed that the 
complications derived from the resection of bronchial carcinoma were associated with 
absolute values of FEV1 lower than 2 liters (Boushy et al., 1971). Subsequently, the 
measurements of spirometry were combined with those of lung volumes and there was 
observed an increase in complications with a FEV1 less than 1.20 liters, reserve volume (RV) 
greater than 3.30 liters and total lung capacity (TLC) greater than 7.90 liters (Lockwood, 
1973). On the other hand, there was an attempt to link the value of FEV1 with the type of 
lung resection and it was noticed that the requirement for pneumonectomy was a FEV1 
more than 2 liters, for lobectomy more than 1 liter and for segmentectomy or wedge 
resection more than 0.6 liter (Miller et al., 1981). 
Considering FEV1 in absolute values can lead to errors in the estimation of lung function, 
especially in patients of advanced age or low height. In this sense, there have been some 
studies whose data contemplate a reduction in complications when the FEV1 is greater than 
60% (Richter et al., 1997) or 89 ± 19% (Wang et al., 2000) of predicted values (table 4). 
Therefore, it is preferable to place greater emphasis on FEV1 percentage value in relation to 
its theoretical value than to the absolute one. In addition, the highest possible FEV1 will be 
chosen using the available therapeutic arsenal (smoking cessation, pulmonary rehabilitation 
or drug treatment with bronchodilators or corticosteroids). Finally, we could say that for 
thoracic surgery the advisable value of FEV1 is greater than or equal to 80%. 
 
 
Table 4. Preoperative lung function variables in relation to complications. FEV1: Forced 
expiratory volume in 1 second. FVC: Forced vital capacity. RV: Residual volume. TLC: Total 
lung capacity. DLCO: Diffusion capacity of the lung for carbon monoxide. VA: Alveolar 
volume. ns: not significant (Wang et al., 2000). 
In the algorithms used for the functional assessment of candidates for lung resection, the 
value of postoperative FEV1 (ppo-FEV1) plays an important role in the alternative to 
perform further tests or exclude patients from surgery without performing these tests 
(Wyser et al., 1999) (figure 1). In this sense, a value of ppo-FEV1 less than 40% of predicted 
increases the risk of perioperative complications and mortality by 16-50% (Pierce et al., 
1994), being higher (60%) when ppo-FEV1 is less than 30% (Nakahara et al., 1985). 
Even today there is a disagreement about whether ppo-FEV1 is a good predictor of 
perioperative complications or not. It has been seen that ppo-FEV1 is not a good predictor of 
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complications in patients with preoperative FEV1 greater than 70%. In addition, among 
these patients, who also have ppo-FEV1 less than 40%, the mortality is 4.8%. These findings 
explain the so-called "lung volume reduction effect", which shows a reduction of functional 
loss in patients with airflow limitations, such as, for example, in patients with chronic 
obstructive lung disease (COPD) (Sekine et al., 2003). 
A ppo-FEV1 value of 40% is currently being used to distinguish between normal and high 
risk of complications in thoracic surgery. However, due to improvements in surgical 
techniques and perioperative management, the value of ppo-FEV1 could fall to 30%. 
Although the ppo-FEV1 is fairly accurate in predicting the final residual value of FEV1 
within 3-6 months after thoracic surgery, the real value of FEV1 is overestimated in the first 
postoperative days, when most of the complications occur. In this regard, it has been shown 
that the first postoperative day and after a lobecctomia the real value of FEV1 was 30% 
lower than expected. Therefore, it would be a better predictor of complications than the 
ppo-FEV1 was (Varela et al., 2007). 
The current recommendations of the ERS / ESTS Task Force are that the ppo-FEV1 should 
not only be used to select patients with pulmonary cancer for lung resection, especially in 
patients with moderate or severe COPD. It is known that in patients with COPD it is likely 
to overestimate the loss of lung function in the early postoperative stages and ppo-FEV1 
does not seem to be a reliable predictor of complications. Finally, a value of ppo-FEV1 less 
than 30% predicted would be a high risk parameter when included in an algorithm for 
assessing pulmonary reserve before thoracic surgery (Brunelli et al., 2009). 
3.2 Diffusing capacity of the lung for carbon monoxide 
The DLCO represents the amount of carbon monoxide trapped by the lungs after inspiration 
of a small amount of this gas. This test provides us with information about the alveolo-
capillary membrane, which is responsible for alveolar oxygen exchange. Thus, the DLCO is 
used to evaluate the surgical risk in patients scheduled for thoracic surgery. 
Although DLCO is a technique which allows to estimate the risk of postoperative 
complications, it is not as well studied as FEV1. Several studies have shown that a 
preoperative DLCO less than 60% predicted was associated with increased mortality and 
postoperative complications were increased when the DLCO was less than 80% of predicted 
value (Ferguson et al., 1998). It has also been observed that patients with decreased DLCO 
(65.3 ± 5.0%) had more respiratory complications than those with normal DLCO (90.1 ± 
5.9%) (Wang et al., 1999). In addition, decreased DLCO is related to an increase in the 
frequency of hospital readmissions and poor quality of life for the long term. 
Therefore, the DLCO is an additional test to spirometry in which if a patient's preoperative 
functional evaluation has a FEV1 and DLCO greater than or equal to 80%, no additional 
testings are required. But if a patient has a DLCO lower than 80% despite a FEV1 greater 
than or equal to 80%, additional tests should be performed to make sure that it is a good 
candidate for thoracic surgery. This indicates that the DLCO is an important test to predict 
postoperative complications both in patients without COPD as well as in patients suffering 
from this pathology (Ferguson et al., 2008). 
On the other hand, a value of postoperative DLCO (ppo-DLCO) of 40% is currently being 
used to distinguish between normal and high risk of complications in patients undergoing 
lung resection (Wyser et al., 1999) (figure 1). However, taking into account advances in 
perioperative care and surgical techniques, the allowed limit of ppo-DLCO should be 
lowered to 30%. 
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value (Ferguson et al., 1998). It has also been observed that patients with decreased DLCO 
(65.3 ± 5.0%) had more respiratory complications than those with normal DLCO (90.1 ± 
5.9%) (Wang et al., 1999). In addition, decreased DLCO is related to an increase in the 
frequency of hospital readmissions and poor quality of life for the long term. 
Therefore, the DLCO is an additional test to spirometry in which if a patient's preoperative 
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Fig. 1. Proposed algorithm for the assessment of the cardio-respiratory reserves of lung 
resection candidates. Tl 5 thallium; Tc 5 technetium. ECG: electrocardiogram. FEV1: Forced 
expiratory volume in 1 second. DLCO: Diffusion capacity of the lung for carbon monoxide. 
ppo: postoperative. VO2: Oxygen uptake. (Wyser et al., 1999). 
The current recommendations of the ERS / ESTS Task Force indicate that the DLCO should 
be a routine measurement of functional evaluation of candidates for lung resection, 
especially if the spirometry is altered. The threshold value of ppo-DLCO of 30% is high risk 
when included in an algorithm for the assessment of pulmonary reserve before thoracic 
surgery (Brunelli et al., 2009). 
3.3 Measurement of gas exchange 
Arterial gasometry, is a test that is requested routinely in patients about to undergo thoracic 
surgery. Unlike spirometry, arterial blood gases values provide some more direct 
information about the problem with the gas exchange that is often present in this type of 
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surgery. However, they do not provide as useful measurement as FEV1 or DLCO in the 
perioperative functional assessment. 
In relation to arterial oxygen pressure (PaO2), few studies describe the exact role of this 
parameter in the assessment of perioperative risk. In some of them it has been shown that 
PaO2 below 50 mmHg is associated with postoperative complications (Mittman & 
Bruderman., 1977). Furthermore, sometimes hypoxemia in patients with bronchial 
carcinoma may be due to a shunt secondary to pulmonary atelectasis that is improved after 
the lung resection. 
With regard to the blood pressure of CO2 (PaCO2), it has been postulated that hypercapnia 
(PaCO2 greater than 45 mmHg) involves an increase in postoperative complications (Meyer-
Erkelenz et al., 1980). However, one study has demonstrated that patients with severe airflow 
obstruction (FEV1 40 ± 6%) and PaCO2 of 44 ± 4 mmHg, did not have any complications after 
lobectomy (Morice et al., 1992) (table 5). In this sense, other authors have also come to the 
conclusion that hypercapnia is not a risk factor for the presence of postoperative pulmonary 
complications (Miller et al., 1981). Therefore, although there is no consensus about the 
usefulness of the arterial gasometry in the perioperative functional assessment, it seems clear 
that hypercapnia should not exclude patients who are candidates for lung resection. 
 
 
Table 5. Relationship among spirometry, arterial blood gases and exercise testing in patients 
undergoing lung resection. FVC: Forced vital capacity. FEV1: Forced expiratory volume in 
1 s. DCO: Diffusion capacity of the lung for carbon monoxide. TLC: Total lung capacity. 
PO2: Oxygen partial pressure of artery. PCO2: Carbon dioxide partial pressure of artery. 
VO2: Oxygen uptake. RV: Right ventricule. (Morice et al., 1992). 
3.4 Quantitative ventilation/perfusion scintigraphy 
The quantitative perfusion scintigraphy is based on the radiation emitted by an isotope that 
is taken up by the lungs after being injected intravenously. The percentage of radioactivity is 
associated with lung function, the right lung being the largest (55% of the total radiation). 
The left lung is responsible for the remaining 45% (figure 2). 
The calculation of ppo-FEV1 in patients scheduled for pneumonectomy, from preoperative 
FEV1 and lung perfusion scintigraphy, is performed as follows (Kristersson et al., 1972): 
 ppo FEV1  preoperative FEV1 x % of perfusion of the undisturbed lung− =   
Therefore, if such a patient is a candidate for left pneumonectomy and has a 3-liter 
preoperative FEV1 and the scintigraphy shows 30% perfusion in the left lung and 70% in the 
right, the value of FEV1 postpneumonectomy is: 
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 ppo FEV1 3 litersx 0,7  2,1 liters− = =    
It has been shown  that there is a good relationship between the ppo-FEV1 and real 
postoperative FEV1, while the ppo-FEV1 can be 10% lower than the measured FEV1  3 
months after the surgery. 
Wernley et al. applied the method of lung perfusion scintigraphy to calculate the FEV1 after 
lobectomy with the following formula (Wernly et al., 1980): 
Estimate of the FEV1 loss  preoperative FEV1 x % affected lung perfusion  x (number of
               segments in the lobe to be resected /  number of segments in the lung)
=
  
Perfusion scintigraphy has also been used to calculate ppo-DLCO, using the same formulas 
for estimating the ppo-FEV1. Therefore, the ppo-DLCO is calculated using the following 
formula: 
 ppo DLCO  preoperative DLCO x % de perfusion of the unresected lung− =   
  
 
Fig. 2. Anterior and posterior images from perfusion scintigram. Three equally sized regions of 
interest over lungs are shown. Counts in each zone are measured. Geometric means of anterior 
and posterior images are then used to calculate relative perfusion and ventilation for each zone 
for each lung. By this method, percentages are obtained for upper, middle, and lower zones of 
right and left lungs for both perfusion and ventilation. (Win et al., 2006). 
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It is difficult to establish a definitive cut-off of ppo-FEV1 or ppo-DLCO above which 
resection of lung parenchyma will be safe. Some authors have estimated 0.8 liters as the 
limit below which it is unreasonable to perform the resection of the pulmonary parenchyma 
(Olsen et al., 1974). As an absolute value it can lead to errors, which is why it is better to use 
the percentage with respect to the theoretical value. 
Several studies have shown that in candidates for lung resection, when ppo-FEV1 is greater 
than 40%, postoperative mortality is reduced (Markos et al., 1989), but other authors did not 
observe its increase when ppo-FEV1 is less than 40% (Morice et al., 1992). In relation to the 
ppo-DLCO it has also been noticed that  the risk of postoperative complications is greater 
when the ppo-DLCO is less than 40% (Markos et al., 1989), and even one study estimates 
that this parameter is the best assessment of mortality and postoperative complications 
(Ferguson et al., 2008). 
In practice, the scintigraphy has not been widely used in the functional assessment of 
patients about to undergo a lobectomy because of the difficulty in interpreting the 
individual contribution of each of the lobes to the whole of ventilation and perfusion. This 
could explain why several researchers consider that the simple calculation of the lung 
segments can predict the ppo-FEV1 as accurately as the ventilation perfusion scintigraphy 
does (Win et al., 2004). The ventilation scintigraphy has been widely used to predict 
postoperative lung function in patients with lung cancer who are scheduled for 
pneumonectomy (Colice et al., 2007). 
The correlation between current and predicted ppo-FEV1 using the ventilation/perfusion 
scintigraphy has been variable with r between 0.67 and 0.9 (Win et al., 2006a). Both the 
ventilation and perfusion scintigraphies offer a good prediction of postoperative lung 
function individually, but it seems that there is no additional benefit in the performance of 
both (Win et al., 2006). However, the interpretation of the results should take into account 
that these techniques may underestimate the actual postoperative value (Zeiher et al., 1995). 
3.5 Exercise test 
During the exercise the patient is subjected to physical stress so that the whole system that 
regulates the uptake, transport and use of oxygen can be studied through the exercise test. 
When the latter is started, the lung increases the ventilation, oxygen uptake (VO2), CO2 
production and blood flow similar to that which occurs during the postoperative period 
following the lung resection. 
Among all the variables mentioned above, the most important is the peak oxygen uptake 
(VO2 peak), which gives us an idea of the global response to the effort and is defined as the 
maximum amount of oxygen a subject can capture, transport and use during the exercise. In 
addition, during the preoperative evaluation process the VO2 peak is the parameter that 
estimates the probability of complications best of all. Despite this, the exercise test should be 
performed only in selected cases (decrease in FEV1 and/or in DLCO below 80%) (Wayser et 
al., 1999). 
3.5.1 Low-technology exercise; stair climbing, shuttle walk, and 6-min walk tests 
Six-minute walk, stair climbing and shuttle walk tests have proved to be useful for 
preoperative risk stratification. In this sense, the 6-min walk test has a high reliability in the 
estimation of VO2 peak in healthy subjects and patients with COPD or those who are about 
to undergo lung transplantation and, therefore, in assessing the postoperative risk after 
thoracic surgery (Brunelli et al, 2009). 
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to undergo lung transplantation and, therefore, in assessing the postoperative risk after 
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The shuttle walk test appears more reproducible and highly correlated with VO2 peak, 
estimating that 25 routes in this test are equivalent to a VO2 peak of 10 mL/kg/min (Singh 
et al, 1994). This cutoff point has been included in the algorithm proposed by the British 
Thoracic Society (BTS, 2001). However, no statistically significant differences have been 
found in the shuttle walk test among patients with and without complications after lung 
resection (Win et al., 2006b). This test tends to overestimate the exercise capacity in its range 
of lower values compared to VO2 peak, concluding that it should not be used alone to 
exclude patients from surgery (BTS, 2001). It has also been observed that patients who walk 
more than 400 meters in the shuttle walk test have a VO2 peak higher than 15 mL/kg/min 
(BTS, 2001). 
The effectiveness of stair climbing test to predict serious cardiopulmonary complications 
following the lung resection surgery has already been demonstrated (Olsen et al., 1991). 
Against this background, the patients who climb less than 12 meters have a 2-fold higher 
rate of complications and mortality 23 times higher when compared with those who climb 
more than 22 meters, with a mortality rate of less than 1% (Brunelli et al., 2008). It has also 
been noticed that in patients with ppo-FEV1 or ppo-DLCO less than 40%, who climed more 
than 22 meters, the mortality rate is nonexistent (Brunelli et al., 2008).  
Oximetry during the exercise has been proposed as a useful test in the preoperative 
assessment of candidates for lung resection (Colice et al., 2007). The role of oxygen 
desaturation during the exercise in postoperative risk stratification has not been defined in 
relation to early complications after the resection. In addition, it has been seen that oxygen 
desaturation during the exercise is a good predictor of postoperative respiratory failure, 
need for admission to an Intensive Care Unit (ICU), prolonged hospital stays and home 
treatment with oxygen (Ninan et al., 1997). On the other hand, oxygen saturation below 90% 
during the exercise test with incremental protocol is not a good predictor of postoperative 
cardiopulmonary morbidity (Varela et al., 2001). 
3.5.2 High-technology exercise; cardiopulmonary exercise testing  
There are 2 types of exercise protocol that have been used to evaluate the surgical risk: 
incremental or submaximal. They are usually carried out on a bicycle or a treadmill. The 
incremental protocol is the most used and consists in increasing the work to be performed 
by each patient to the limit of his tolerance. The exercise ends when the symptoms do not 
allow the patient to continue performing the exercise or when the registered variables do 
not permit to continue the test (ATS, 2003) (table 6). 
 
 
Table 6. Indications for exercise terminations. ECG: electrocardiogram. SpO2: arterial 
oxygen saturation. (ATS, 2003).   
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The reliability of the exercise test with incremental protocol has been confirmed by 
numerous studies. In 1982 it was already proved that the complication rate decreased in 
patients with VO2 peak more than 1 liter (Eugene et al., 1982). In 1984 it was observed that 
the rate of postoperative complications was 100% when the VO2 peak was less than 15 
mL/kg/min, but if this parameter was greater than 20 mL/kg/min, the risk of 
complications was 10% (Smith et al., 1984). 
In 1992 it was found that among the patients with preoperative FEV1 less than or equal to 40%, 
ppo-FEV1 less than or equal to 33% or PaCO2 more than or equal to 45 mmHg, those who did 
not undergo a exercise test and had a VO2 peak above 15 ml/kg/min were considered 
suitable for lung resection with less postoperative complications (Morice et al., 1992). 
In 1995 with a larger group of patients, it was already found that the VO2 peak, expressed as 
a percentage of predicted, estimated better postoperative complications, and that the 
patients with a VO2 peak more than 75% had 10% probability of complications. In contrast, 
in patients with VO2 peak less than 43% this probability increased to 90%, using as the 
cutoff point the VO2 peak of 60% (Bolliger et al. 1995a). At the same time, it was observed 
that patients with complications had a VO2 peak lower than 62.8% and if postoperative VO2 
peak (ppo-VO2 peak) was less than 10 mL/kg/min, the risk of complications was very high 
(Bolliger et al., 1995b). 
Recently it has been noticed that patients with complications have a VO2 peak of 15 
mL/kg/min, while those without complications, have a VO2 peak of 19.2 mL/kg/min 
(Wang et al., 1999). Therefore, we can say that patients with a VO2 peak less than 10 
mL/kg/min are not candidates for lung resection surgery. On the contrary, they are 
candidates if the VO2 peak is more than 15 mL/kg/min. Furthermore, in connection with 
the completion of pneumonectomy, VO2 peak values above 20 mL/kg/min or 75% of 
predicted value indicate a low risk of postoperative complications, while values below 10 
mL/kg/ min or 40% of predicted indicate a high risk (Bolliger et al., 1995b). 
Trying to get a better tolerance for exercise testing, especially in patients with dyspnoea who 
were not able to reach their VO2 peak, the submaximal protocol was proposed. In it the 
patient performs a pre-defined level of work (ATS, 2003). 
After studying the exercise test with submaximal protocol in candidates for lung resection 
surgery, it has been observed that the VO2 reached allowed to predict the risk of 
postoperative complications (Miyoshi et al., 1989). However, this type of protocol usually 
requires invasive techniques which are not tolerated so well, therefore, this type of protocol 
is usually replaced by the incremental one. 
The current recommendations of the ERS / ESTS Task Force is that the cardiopulmonary 
exercise test is sure, reproducible and should be performed in a controlled environment. In 
addition, the VO2 peak measured during the test with incremental protocol should be 
considered as the most important parameter to assess, as a measure of exercise capacity and 
as a good predictor of postoperative complications after thoracic surgery. Finally, to perform 
pneumonectomy the value of 75% of predicted or more than 20 mL/kg/min should be 
considered as cutoff point. The risk of postoperative complications is high if the VO2 peak is 
less than 35% of predicted or less than 10 mL/kg/min for any resection. Instead, there is 
insufficient evidence to recommend cutoff points for lobectomy (Brunelli et al., 2009). 
3.6 Other tests 
Thoracic computed tomography (CT) has efficacy comparable to that of perfusion 
scintigraphy in the calculation of ppo-FEV1 (Wu et al., 2002). In one study that compared 
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The shuttle walk test appears more reproducible and highly correlated with VO2 peak, 
estimating that 25 routes in this test are equivalent to a VO2 peak of 10 mL/kg/min (Singh 
et al, 1994). This cutoff point has been included in the algorithm proposed by the British 
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Table 6. Indications for exercise terminations. ECG: electrocardiogram. SpO2: arterial 
oxygen saturation. (ATS, 2003).   
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The reliability of the exercise test with incremental protocol has been confirmed by 
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the usefulness of thoracic CT (figure 3), single photon emission computed tomography 
(SPECT) and magnetic resonance imaging (MRI) in  patients with bronchogenic carcinoma 
who are candidates for lung resection, MRI proved to be more accurate than the other two 
techniques in the measurement of ppo-FEV1 (Ohno et al., 2007). 
 
 
Fig. 3. Quantitative CT scan shows functional lung (red), pulmonary emphysema (black), and 
lung cancer (white). (Ohno et al., 2007). 
The anatomical method is the calculation of postoperative lung function with the help of a 
formula that uses the preoperative FEV1 or FVC and the number of segments planned for 
resection (Zeiher et al., 1995). In case of lobectomy this formula estimates accurately the 
FEV1 postoperative and FCV which is not true in the case of pneumonectomy. That is why 
the latter is considered as inaccurate anatomical method. 
The studies of pulmonary hemodynamics have also been used in the reseach of respiratory 
function in lung resection candidates. Perioperative risk is estimated by measuring the 
pulmonary arterial pressure and PaO2 during temporary occlusion of the pulmonary artery. 
This technique simulates the "physiological pneumonectomy" and is performed both at rest 
and during the exercise. It has been observed that growth in pressure in the pulmonary 
artery during the occlusion period increases the postoperative risk and complications (Gass 
& Olsen 1986). In addition, it has been observed that if the pulmonary arterial pressure is 
higher than 35 mmHg and PaO2 less than 45 mmHg, the patient is inoperable (Olsen et al., 
1975). Another hemodynamic parameter used in the postoperative pulmonary assessment is 
the measurement of pulmonary vascular resistence (Schuurmans et al., 2002). 
The main drawbacks of the use of pulmonary hemodynamics are the complexity of these 
techniques and the fact that they are invasive. Currently and in practice pulmonary 
hemodynamics is rarely used in respirotary assessing of candidates for thoracic surgery 
because the noninvasive tests have proved to have equal or superior efficacy. 
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4. Algorithms in the preoperative functional assessment 
The use of algorithms in the evaluation of lung function in patients scheduled for thoracic 
surgery has as the main objective the step standardization of a series of diagnostic tests. 
These procedures avoid unnecessary costs, save time and allow you to gain experience in a 
more regulated way. This rationalization process contributes to improved patients care and 
decreased postoperative morbidity and mortality (Juliá Serdá et al., 2010). 
Although several algorithms have been proposed to assess respiratory function in patients 
undergoing thoracic surgery, there are few validations of them. In addition, they depend on 
the patients population being served and the technical possibilities of each hospital or center 
where they are performed (Juliá Serdá et al., 2010). 
One of the most widely accepted algorithms was proposed by Bolliger et al. and performed 
in 80 patients scheduled for resection of lung parenchyma (Bolliger et al. 1995a). This 
algorithm was validated later by Wyser et al. in 137 patients (figure 1), demonstrating a low 
postoperative complication rate (11%) and mortality (1.5%) (Wyser et al., 1999). 
 
 
Fig. 4. Algorithm for assessment of cardiopulmonary reserve before lung resection in lung 
cancer patients. FEV1: Forced expiratory volume in 1 s. DLCO: Diffusion capacity of the 
lung for carbon monoxide. ppo: postoperative. VO2: Oxygen uptake. (Brunelli et al., 2009) 
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Taking into account these issues the ERS / ESTS Task Force has recently published its 
algorithm based fundamentally on the performance of exercise tests when preoperative 
FEV1 or DLCO is less than 80%. If in the exercise test VO2 peak is less than 35% or 10 
mL/kg/min, it should not be recommendable to perform pneumonectomy or lobectomy, 
but if it is higher than 75% or 20 mL/kg/min, any resection (including pneumonectomy) 
would be indicated. If the VO2 peak is between these cutoff values, it would be advisable to 
calculate ppo-FEV1 and ppo-DLCO. If these are greater than 30%, lung resection would be 
indicated according to the calculated extension, and if, at least, one of these parameters is 
less than 30% it would be necessary to calculate the ppo-VO2 peak. After its calculation and 
if it is greater than 35% or 10 mL/kg/min, resection would be indicated depending on the 
calculated extension, and if its value is less than this cutoff, neither pneumonectomy nor 
lobectomy would be recommended. Finally, if it is impossible to perform cardiopulmonary 
exercise test and calculate the VO2 peak, it is recommendable to carry out the stair climbing 
test, but if the reached altitude is less than 22 meters, its calculation would be advisable 
(Brunelli et al., 2009 ) (figure 4). 
One limitation in this type of algorithms, focusing on the completion of cardiopulmonary 
exercise testing, is that some candidates for lung resection are unable to execute any kind of 
exercise test due to the burden of concomitant comorbidities. These patients have 
demonstrated increased mortality after lung resection (Brunelli et al., 2005) and, after careful 
selection based on cardiopulmonary parameters they should be considered as high-risk 
patients and candidates to be perioperatively monitored. 
5. Patient care managment 
The use of bronchodilators, corticosteroids or a combination of both, as well as pulmonary 
rehabilitation and smoking cessation can help reduce postoperative complications occurring 
after thoracic surgery, especially in patients with comorbidities who present declining 
values of FEV1 or DLCO. 
5.1 Smoking cessation 
Smokers have significantly higher risk of postoperative complications, so an intervention for 
smoking cessation during the preoperative period may be effective to reduce the incidences 
of complications. Moreover, the time of surgery may be a unique opportunity for smoking 
cessation attempts to succeed (Moller & Villebro, 2005). 
There is evidence that interventions for smoking cessation, which include nicotine 
replacement therapy (NRT), increase for a short term the rate of smoking cessation and 
decrease postoperative morbidity. In this process it remains unclear which treatment 
intensity is optimal. Derived from indirect comparisons, the interventions that begin from 4 
to 8 weeks before surgery, based on weekly counselling and the NRT are the most effective 
to quit smoking and to prevent long-term postoperative complications (Moller & Villebro, 
2005). 
5.2 Pulmonary rehabilitation 
Pulmonary rehabilitation, that includes exercise and education, is effective in candidates for 
lung volume reduction and in the pre-and postoperative period of lung transplantation 
(Nici et al., 2006). However, this effectiveness is not clearly demonstrated in surgical 
patients with lung cancer. 
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Before the surgery, the preoperative VO2 is inversely proportional to the probability of the 
presence of complications after lung resection (Wu et al., 2002), which, in turn, is associated 
with postoperative loss of lung function (Nagamatsu et al., 2007). In addition, pulmonary 
rehabilitation improves VO2 before the surgery in patients with COPD with low VO2 (less 
than 15 mL/kg/min), which reduces late complications without affecting the operability or 
the prognosis (Bobbio et al., 2008). 
Preoperative training programs lead to a reduction of hospital stay and of complications in 
patients with COPD and lung cancer (Sekine et al., 2005). However, improved accessibility 
to intervention has been observed only in patients with “quasi normal” lung function (Lovin 
et al., 2006). Pulmonary rehabilitation in inpatients has shown benefits in exercise capacity 
and lung volumes (Cesario et al., 2007). 
Therefore, in the light of the data presented, it seems logical that pulmonary rehabilitation 
may decrease the complication rate in candidates for lung resection, which is why future 
researches on the content and duration of rehabilitation programs are priorities. 
5.3 Pharmacologic therapy 
The diagnosis of COPD is often established during the preoperative functional assessment 
in patients scheduled for lung resection after the diagnosis of lung cancer. These patients, 
with a high percentage of respiratory complications, may be excluded from surgery if we 
fail to achieve, with proper treatment, a sufficient pulmonary function value. 
The main guidelines for the management of COPD patients who are to undergo lung 
resection indicate that it is necessary that the patient quit smoking, do exercises in 
pulmonary rehabilitation and optimize proper treatment to improve lung function and 
reduce postoperative complications (Brunelli et al., 2009). However, the treatments indicated 
for patients with COPD and lung cancer do not differ from those which are recommended 
to patients who have only COPD, in which a short-term therapeutic effect is not expected. 
In the scientific literature we have found only few studies that evaluate the short and long 
term effect of initiation of therapy in patients with COPD and lung cancer. Several of them 
value the effect of tiotropium on lung function, establishing its improvement up to 226ml in 
FEV1 (Kobayashi et al., 2009), but without any effect on post sugery complications (Ueda et 
al. 2010). In a recent study, the treatment with formoterol and budesonide added to 
tiotropium improved the FEV1 in 310ml and decreased the number of postoperative 
pulmonary complications (Bölükbas et al., 2011). One of the keys to these results is the 
improvement in lung function that occurs when adding corticosteroids to long-acting 
bronchodilators. Another key is the improvement in FEV1 due to these drugs, since its 
value, both pre-and postoperative, is associated with mortality and morbidity after the 
surgery. Therefore, an elevation of FEV1 can increase the number of candidates for surgical 
resection, thus optimizing the treatment of cancer and improve the prognosis of these 
patients. 
6. Conclusion  
A lot of scientific literature dedicated to pre-operative evaluation before surgical treatment 
of lung diseases has been published. The search for the ideal preoperative test to predict 
major perioperative risk of patients began with the use of spirometry in 1955. Since then, 
scientific evidence allowing the stratification of perioperative risk based in different 
preoperative pulmonary function tests, estimations of postoperative lung function, 
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Taking into account these issues the ERS / ESTS Task Force has recently published its 
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Before the surgery, the preoperative VO2 is inversely proportional to the probability of the 
presence of complications after lung resection (Wu et al., 2002), which, in turn, is associated 
with postoperative loss of lung function (Nagamatsu et al., 2007). In addition, pulmonary 
rehabilitation improves VO2 before the surgery in patients with COPD with low VO2 (less 
than 15 mL/kg/min), which reduces late complications without affecting the operability or 
the prognosis (Bobbio et al., 2008). 
Preoperative training programs lead to a reduction of hospital stay and of complications in 
patients with COPD and lung cancer (Sekine et al., 2005). However, improved accessibility 
to intervention has been observed only in patients with “quasi normal” lung function (Lovin 
et al., 2006). Pulmonary rehabilitation in inpatients has shown benefits in exercise capacity 
and lung volumes (Cesario et al., 2007). 
Therefore, in the light of the data presented, it seems logical that pulmonary rehabilitation 
may decrease the complication rate in candidates for lung resection, which is why future 
researches on the content and duration of rehabilitation programs are priorities. 
5.3 Pharmacologic therapy 
The diagnosis of COPD is often established during the preoperative functional assessment 
in patients scheduled for lung resection after the diagnosis of lung cancer. These patients, 
with a high percentage of respiratory complications, may be excluded from surgery if we 
fail to achieve, with proper treatment, a sufficient pulmonary function value. 
The main guidelines for the management of COPD patients who are to undergo lung 
resection indicate that it is necessary that the patient quit smoking, do exercises in 
pulmonary rehabilitation and optimize proper treatment to improve lung function and 
reduce postoperative complications (Brunelli et al., 2009). However, the treatments indicated 
for patients with COPD and lung cancer do not differ from those which are recommended 
to patients who have only COPD, in which a short-term therapeutic effect is not expected. 
In the scientific literature we have found only few studies that evaluate the short and long 
term effect of initiation of therapy in patients with COPD and lung cancer. Several of them 
value the effect of tiotropium on lung function, establishing its improvement up to 226ml in 
FEV1 (Kobayashi et al., 2009), but without any effect on post sugery complications (Ueda et 
al. 2010). In a recent study, the treatment with formoterol and budesonide added to 
tiotropium improved the FEV1 in 310ml and decreased the number of postoperative 
pulmonary complications (Bölükbas et al., 2011). One of the keys to these results is the 
improvement in lung function that occurs when adding corticosteroids to long-acting 
bronchodilators. Another key is the improvement in FEV1 due to these drugs, since its 
value, both pre-and postoperative, is associated with mortality and morbidity after the 
surgery. Therefore, an elevation of FEV1 can increase the number of candidates for surgical 
resection, thus optimizing the treatment of cancer and improve the prognosis of these 
patients. 
6. Conclusion  
A lot of scientific literature dedicated to pre-operative evaluation before surgical treatment 
of lung diseases has been published. The search for the ideal preoperative test to predict 
major perioperative risk of patients began with the use of spirometry in 1955. Since then, 
scientific evidence allowing the stratification of perioperative risk based in different 
preoperative pulmonary function tests, estimations of postoperative lung function, 
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pulmonary circulation hemodynamics, arterial blood gases or exercise testing has been 
given. Therefore, the functional assessment has undergone major changes; apart from 
preoperative measurement of pulmonary function (FEV1, DLCO or VO2 peak) is getting 
more and more importance. 
In the last few years, a number of decision-making algorithms interpreting the abundant 
literature on the issue have been described. These algorithms are mainly based on that 
postoperative FEV1 should not to be used alone to select patients for lung resection. DLCO 
should be routinely measured during pre-operative evaluation of lung resection candidates 
(regardless of whether the spirometric evaluation is abnormal or not). A postoperative FEV1 
and DLCO values of 30% predicted is suggested to be a high risk threshold for this 
parameter when included in an algorithm for assessment of pulmonary reserve before 
surgery, exercise tests should be indicated for all the patients undergoing surgery with FEV1 
or a DLCO < 80% of normal values and either ventilation scintigraphy or perfusion 
scintigraphy offer good prediction of post-operative lung function.  
Finally, the main recommendation to the patients on which lung resection will be performed 
is to give up smoking for sufficient spell (at least 2–4 weeks) before the surgery, since it may 
decrease post-operative complications. Moreover, early pre- and post-operative 
rehabilitation should also be recommended, since it may produce functional benefits in 
patients with resected lung. 
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pulmonary circulation hemodynamics, arterial blood gases or exercise testing has been 
given. Therefore, the functional assessment has undergone major changes; apart from 
preoperative measurement of pulmonary function (FEV1, DLCO or VO2 peak) is getting 
more and more importance. 
In the last few years, a number of decision-making algorithms interpreting the abundant 
literature on the issue have been described. These algorithms are mainly based on that 
postoperative FEV1 should not to be used alone to select patients for lung resection. DLCO 
should be routinely measured during pre-operative evaluation of lung resection candidates 
(regardless of whether the spirometric evaluation is abnormal or not). A postoperative FEV1 
and DLCO values of 30% predicted is suggested to be a high risk threshold for this 
parameter when included in an algorithm for assessment of pulmonary reserve before 
surgery, exercise tests should be indicated for all the patients undergoing surgery with FEV1 
or a DLCO < 80% of normal values and either ventilation scintigraphy or perfusion 
scintigraphy offer good prediction of post-operative lung function.  
Finally, the main recommendation to the patients on which lung resection will be performed 
is to give up smoking for sufficient spell (at least 2–4 weeks) before the surgery, since it may 
decrease post-operative complications. Moreover, early pre- and post-operative 
rehabilitation should also be recommended, since it may produce functional benefits in 
patients with resected lung. 
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1. Introduction 
Post-thoracotomy pain is one of the most severe and long lasting complications after surgery 
(1-4) which acutely contributes to limit normal respiratory activity impairing the sputum 
clearance and reducing ventilatory function (5). Along with limb amputation, thoracotomy 
is the surgical procedure with the highest risk of severe and long lasting acute postoperative 
pain (6).  
Moreover, a chronic post thoracotomy pain syndrome (PTPS) may delay the long term 
rehabilitation, worsening the quality of life because of the associated neuropathic pain even 
without recurrences of the primary disease (7). Lung cancer still remains the first cause of 
death for cancer (8) and prompt pulmonary surgery may be the only effective therapeutic 
strategy. Consequently, an increasing rate of thoracic surgery will be progressively 
associated with a higher PTPS incidence in the future. 
The syndrome was firstly described in 1944 during the II world war when American 
surgeons reported persistent intercostal pain in soldiers submitted to thoracotomy (9). Until 
the end of the nineties, pain treatment was mainly based on intravenous opioids and the 
incidence of PTPS was about 61% one year after surgery (10).   
2. Definition and incidence 
The International Association for the Study of Pain (IASP) definition of Post Thoracotomy 
Pain Syndrome is the following: ‘Pain that recurs or persists along a thoracotomy scar at 
least 2 months following surgical procedure’ (7). 
PTPS incidence between 11 and 80% has been reported in the literature (11-13). This 
variability is probably related to the setting of retrospective studies, the lack of an 
homogeneous definition of the severity and duration of the syndrome, the difference in 
anesthetic and analgesic protocols, the use of different pain evaluation scales and the time of 
postoperative follow-up. Moreover, the high variability in PTPS incidence may also be 
explained by the different attitude of patients towards discomfort (14). 
3. Pain characteristics after thoracic surgery 
PTPS is mostly described with the typical characteristics of neuropathic pain, often related 
to the surgical scar, since 82—90% of pain patients recognize the pain trigger directly to the 
surgical site (1, 10). Pain is primarily described as aching, tender, with numbness and to a 
lesser degree burning (1, 15); however, PTPS is sometimes described as tingling and pruritus 
sensation within the thoracic injured area. Finally, thoracic sensory deficits are referred by 
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PTPS is mostly described with the typical characteristics of neuropathic pain, often related 
to the surgical scar, since 82—90% of pain patients recognize the pain trigger directly to the 
surgical site (1, 10). Pain is primarily described as aching, tender, with numbness and to a 
lesser degree burning (1, 15); however, PTPS is sometimes described as tingling and pruritus 
sensation within the thoracic injured area. Finally, thoracic sensory deficits are referred by 
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patients in terms of sensory loss and hypoesthesia to cold (16, 17). These neuropathic 
phenomena are principally located within mammary and sub mammary areas and 
ipsilateral scapular and interscapular regions.  
Comparing to acute postoperative pain, PTPS does not specifically influence the respiratory 
function but may be able to limit daily activities. In other words, differences between acute 
and chronic pain are more related to the inability to restore the physiological functions of 
the organism to homeostatic pre-thoracotomy levels (18). Even if the pain intensity is 
moderate, normal daily activities might be hampered up to 50 % of cases and sleep 
disorders could be present in the 25% of patients (10); finally, severe pain could be present 
in 8% and can persist in more than 40% of cases (15). Unfortunately the social consequences 
and subsequent analgesic use have only been recorded in a minority of studies with 
different design (4, 13, 15, 19, 20) so that the actual impact of chronic pain on daily life 
remains undefined. 
4. Pathogenetic features 
The mechanisms that lead to PTPS are multiple and the pathogenesis is still unclear. The 
pathway of the painful experience related to thoracotomy is complex. Inputs from skin, 
muscles, ribs, and parietal pleura are conducted through intercostal nerves to the dorsal 
horn. Moreover, the vagus nerve and the autonomic system are involved in the conduction 
of noxious stimuli from visceral pleura and lung parenchyma; finally, the phrenic nerve is 
related to noxious stimuli from mediastinum, diaphragm and pericardial pleura (21, 22).  
Although the pathogenesis of chronic neuropathic post thoracotomy pain syndrome is 
complex, the direct damage of intercostal nerves and the consequent effect on pain 
transmission seems to play a primary role (23). Many important peripheral and central 
nociceptive adaptions have been described after peripheral nerve injury (23). 
Peripherally, ephaptic conduction or “cross-excitation” generated by neurons linked to 
injured nerves may trigger a distorted pathway of nociceptive stimuli which may be 
clinically relevant for the ongoing neuropathic pain (23, 24). Moreover, in these neurons the 
expression of sodium and calcium channels may be altered (23, 25, 26). A collateral 
sprouting of fibers from sensory axons into denervated areas has been also described in an 
animal model, but the degree of sprouting was not proportional to the degree of 
hyperalgesia after nerve section so that the role of this phenomenon seems to be limited (23, 
27). Another important role may be played by direct coupling of the sympathic nerve 
system and the sensory nervous system in the dorsal root gangliation (28). The trigger signal 
of this sprouting is still unclear but the release of neurotrophic factors and cytokines 
following wallerian degeneration is likely to be decisive (29). 
Central mechanisms are also implicated in the development of this syndrome (23). The 
nerve injury is coupled to a considerable degree of spinal cord reorganization. Large-
diameter, low threshold A-beta fibres from mechanoceptors may wrongly sprout into 
lamina II, which is normally the termination of high-threshold A-delta and C fibres, leading 
to an erroneous interpretation of nociceptive stimuli (30). Peripheral nerve injury, similarly 
to chronic inflammation, is coupled to a persistent state of hyperexcitability of the dorsal 
horn neurons, a process called “central sensitization” (31, 32). The excitatory amino acid 
glutamate is known to be the major excitatory neurotransmitter related to noxious 
stimulation. Many postsynaptic receptors are linked to glutamate release but a strong 
evidence suggests that N-methyl-D-aspartate (NMDA) receptor subtype is the main 
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involved in both inflammation and central sensitization (33). The gamma – amminobutirric 
acid (GABA) pathway represents the major inhibition system in the CNS. The suppression 
of this pathway with pharmacological inhibitors is associated with a dose-dependent 
allodynia (34). GABA receptors level is reduced after peripheral nerve axotomy, maybe 
because of primary degeneration of afferent neuron terminals on which the receptor is 
localized. The consequent reduction in GABA activity may play an important role in central 
sensitization (35). A separate pathway of nociceptive modulation in CNS is the purinergic 
system, including specifically adenosine. Neuropathic patients show a reduction in 
adenosine concentration in both circulating blood and CSF, suggesting a concurrent effect of 
adenosine in the modulation of chronic pain (36). 
Finally, the reduced ability of opiates in relieving neuropathic pain is widely accepted but 
the exact extent of this phenomenon is controversial. The dose response function of opiates 
seems to be unfavorably shifted to the right (23). This clinical evidence may be explained by 
loss of peripheral opiate effect, loss of spinal opiate receptors and increased activity in 
physiological opioid antagonism system (23). 
5. Factors influencing the prevalence of PTPS 
5.1 Predisposing factors for the development of chronic pain are: 
• Female gender (13, 37). 
• Age under 60 years (37, 38) 
• Genetic factors: genetic control of pain involves several genes such as catechol-
Omethyltransferase (COMT), voltage-gated sodium channels, and GTP cyclohydrolase 
and tetrahydrobiopterin-related genes which are characterized by high level of 
variability in the population  (39, 40).  
• Psychological factors:  anxiety, depression, malignant disease and social status, may 
play a determinant role in influencing perception and consequences of chronic pain (13, 
41, 42). However the relationship between preoperative psychological factors and PTPS 
should be investigated with targeted study. 
• Preoperative pain and analgesic consumption: the relationship between preoperative 
pain and analgesic consumption and the development of chronic pain is well 
established for some kinds of surgery (43, 44). Moreover, assessing the preoperative 
pain threshold of each patient may be useful to identify risking patients at risk of 
postoperative pain which may lead to chronification (electrical, heat, cold and pressure 
tests) (45-49). Unfortunately, the role of pre-surgical pain in PTPS recurrence is still 
controversial (13, 45, 50, 51). 
5.2 Perioperative factors are the: 
• Type and extent of surgery (intercostal nerve damage, resection of the chest wall, 
pleurectomy and pneumectomy) 
• Intensity and duration of pain during the first postoperative day. 
5.2.1 The type and extent of surgery 
Many surgical approaches for thoracic cavity are described: median sternotomy, bilateral 
transverse thoracosternotomy, posterolateral thoractomy, muscle sparing thoracotomy and 
video-assisted thoracoscopy (VATS) (52). 
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Intercostal nerves are primarily involved in the rib cage pain transmission. The incision of 
the skin, soft tissue and muscles triggers an inflammatory response. The retraction of the 
intercostal space, and sometimes the resection of the ribs themselves, increases the damage 
to the costovertebral and costotrasversal ligaments with the subsequent involvement of the 
parietal pleura (53). 
The intercostal nerve can be compressed by retractors or damaged during rib resection and 
closure of chest wall or can be trapped by sutures and healing processes. Nociception from 
mediastinic and diaphragmatic pleura is transmitted by different nervous pathways 
(phrenic and vagus nerves). This type of pain is deep and poorly localized. Moreover, this 
painful sensation triggered by diaphragmatic injury is also referred to the homolateral 
shoulder pain. Pleural drainage also produces deep pain due to both skin incision and 
pleural irritation. 
In addition to surgical injury, the breathing cycle constantly involves the damaged 
structures, enhancing the trigger of thoracic pain. 
The diagnosis of nerve injury is often associated with allodynia and/ or hyperalgesia plus 
numbness distributed in the area served by affected nerves. 
The type of incision is strictly associated to post-thoracotomy pain and damage of 
intercostal nerves (54). The posterolateral thoracotomy, sparing serratus anterior and 
trapezius muscles, seems to minimize damaging in intercostal nerves  compared to 
the standard posterolateral thoracotomy. Consequently, this technique is associated with a 
reduction of pain and improvement mobility of the ipsilateral shoulder in the first 
seven postoperative days. 
However, several studies have questioned these results in terms of both acute and 
chronic pain after one year. An anterior axillary approach has been proposed to reduce 
the painful symptoms, but the benefit was not still confirmed by the literature. The technique 
used for closure of the chest wall may play a role in the intercostal nerve damage. 
Nevertheless, all the different surgical approaches described above, may lead either to acute 
and chronic pain. This finding may be firstly explained by frequent anatomical variants in 
the intercostal nerves course so that their integrity is not ensured by any surgical choice. 
Moreover, the surgical retractor, used in all the techniques, may probably play an important 
role in the damage of the intercostal nerves. 
The video-assisted thoracic surgery (VATS) seems to reduce the incidence of PTPS, probably 
because of multiple small incisions that produce a smaller nerve injury than open 
thoracotomy. However VATS does not preserve intercostal nerve from damage because the 
scope may crush nervous fibers against adjacent rib. Moreover the use of retractors to take 
away the lung section may also damage intercostals nerve (63-27). In conclusion VATS 
technique does not prevent the PTPS development but seems to reduce the PTPS incidence 
compared to muscle sparing incision (28) 
5.2.2 The intensity and duration of pain during the first postoperative day 
Several prospective studies show that the most important predictor for the development of 
PTPS is the persistent post surgical pain which is strictly related to the severity of acute 
postoperative pain. Acute postoperative pain, in fact, is related to the amount of intercostal 
nerves damaged (55, 56). However, some studies found no clear relationship between PTPS 
and intensity of acute postoperative pain (1, 4, 10). The literature is not exhaustive because 
no study evaluates overall preoperative, intraoperative and postoperative factors which can 
influence the incidence of PTPS.  Undoubtely, the strict pain control is mandatory in this 
kind of surgery. 
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5.3 Postoperative factors 
5.3.1 Social consequences 
The social impact of PTPS as capability to influence daily activites and consequently quality 
of life were investigated by several studies (4, 10, 13, 15, 20). Commonly the effects of PTPS 
are registered in the following activities: standing, sitting, getting up, sleep. Even if the pain 
intensity is moderate, normal daily activities could be hampered up to 50 % of cases and 
sleep disorders could be present in the 25% of patients (10); finally severe pain could be 
present in 8% and it's not relieved in more than 40% of cases (50). However, because of lack 
of right evaluation of this kind of disabilities, the exact impact of PTPS on social field must 
be better investigated. 
5.3.2 Disease relapse – chemo and radio therapy 
Keller et all (57) suggest that relapse of disease can uncontrovertibly rise PTPS incidence. 
However, even if this data is obvious and well comprehensible, much more data are needed 
to support this evidence. Moreover, since no data are available about the effects of chemo 
and radio-therapy on PTPS incidence, several studies must be encouraged to understand 
their role on PTPS incidence.   
6. Prevention and treatment strategies of PTPS 
6.1 Intra and postoperative analgesia 
Postoperative analgesia is commonly based on the use of regional anesthesia and systemic 
drug infusion. Different regional anesthesia techniques have been used: mostly thoracic 
epidural anesthesia (TEA) (58, 59), thoracic paravertebral block (PVB) (60), and, secondarily, 
pleural infusion or intercostal nerves block.  The role of intrapleural infusion, intercostal 
nerve block and local infiltration in reducing PTPS is still unclear because studies evaluating 
this analgesic technique are confounding and lacking of exhaustive data (45). 
TEA and PVB with opioids and local anesthetics mixture are the most used regional 
techniques. Nowadays, TEA is still considered the gold standard technique even if PVB has 
recently emerged as valid alternative to TEA (61). 
However the role of TEA in reducing PTPS remains controversial and questionable. In any 
case, multimodal analgesia using different modalities as regional and systemic analgesic 
techniques is highly recommended (61).  
On the contrary, there is no consensus on the drug to use for adjunct intravenous analgesia. 
Ketamine has been confirmed as a useful agent (62, 63) while COX-2 inhibitors, celecoxib i.e, 
were recently proposed as a valid alternative (64). Besides, only few studies reported about 
the efficacy of the S(+) - isomer of Ketamine (65) that has been demonstrated to have twice 
the anaesthetic and analgesic potency of the racemic ketamine preparation and is judged to 
induce less psychic emergence reactions, a reduced number of hallucinations (66) and to be 
followed by a more rapid recovery of vigilance (67, 68) preserving the hypoxic pulmonary 
vasoconstriction, enhancing oxygenation and decreasing shunt fractions in monopulmonary 
ventilation (52).  
Only few trials have demonstrated the effect of iv ketamine as an adjunct to TEA. Suzuki et 
al (69) demonstrated the efficacy of 0,05 mg Kg-1 h-1 racemic ketamine combined with TEA 
with ropivacaine and morphine on acute pain control until 3 months postoperatively but not 
at 6 months follow-up. Dualé et al (63) confirmed that racemic ketamine (1mg kg-1h-1 during 
surgery and 1 mg kg-1h-1 in the first 24 hours) was effective in the immediate postoperative 
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Intercostal nerves are primarily involved in the rib cage pain transmission. The incision of 
the skin, soft tissue and muscles triggers an inflammatory response. The retraction of the 
intercostal space, and sometimes the resection of the ribs themselves, increases the damage 
to the costovertebral and costotrasversal ligaments with the subsequent involvement of the 
parietal pleura (53). 
The intercostal nerve can be compressed by retractors or damaged during rib resection and 
closure of chest wall or can be trapped by sutures and healing processes. Nociception from 
mediastinic and diaphragmatic pleura is transmitted by different nervous pathways 
(phrenic and vagus nerves). This type of pain is deep and poorly localized. Moreover, this 
painful sensation triggered by diaphragmatic injury is also referred to the homolateral 
shoulder pain. Pleural drainage also produces deep pain due to both skin incision and 
pleural irritation. 
In addition to surgical injury, the breathing cycle constantly involves the damaged 
structures, enhancing the trigger of thoracic pain. 
The diagnosis of nerve injury is often associated with allodynia and/ or hyperalgesia plus 
numbness distributed in the area served by affected nerves. 
The type of incision is strictly associated to post-thoracotomy pain and damage of 
intercostal nerves (54). The posterolateral thoracotomy, sparing serratus anterior and 
trapezius muscles, seems to minimize damaging in intercostal nerves  compared to 
the standard posterolateral thoracotomy. Consequently, this technique is associated with a 
reduction of pain and improvement mobility of the ipsilateral shoulder in the first 
seven postoperative days. 
However, several studies have questioned these results in terms of both acute and 
chronic pain after one year. An anterior axillary approach has been proposed to reduce 
the painful symptoms, but the benefit was not still confirmed by the literature. The technique 
used for closure of the chest wall may play a role in the intercostal nerve damage. 
Nevertheless, all the different surgical approaches described above, may lead either to acute 
and chronic pain. This finding may be firstly explained by frequent anatomical variants in 
the intercostal nerves course so that their integrity is not ensured by any surgical choice. 
Moreover, the surgical retractor, used in all the techniques, may probably play an important 
role in the damage of the intercostal nerves. 
The video-assisted thoracic surgery (VATS) seems to reduce the incidence of PTPS, probably 
because of multiple small incisions that produce a smaller nerve injury than open 
thoracotomy. However VATS does not preserve intercostal nerve from damage because the 
scope may crush nervous fibers against adjacent rib. Moreover the use of retractors to take 
away the lung section may also damage intercostals nerve (63-27). In conclusion VATS 
technique does not prevent the PTPS development but seems to reduce the PTPS incidence 
compared to muscle sparing incision (28) 
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nerves damaged (55, 56). However, some studies found no clear relationship between PTPS 
and intensity of acute postoperative pain (1, 4, 10). The literature is not exhaustive because 
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pain but failed to prevent a reduction of chronic PTPS at 6 weeks and 4 months after 
surgery.  
S-(+)-isomer of Ketamine has been demonstrated to be more effective than the racemic 
mixture with a lower incidence of side effects. Argiriadou et al (65) recently proposed the 
use of the S(+)-isomer of Ketamine in conjunction with thoracic paravertebral ropivacaine 
providing better early postoperative pain relief than ropivacaine alone or in adjunction with 
perecoxib. 
In the last years a great interest has been elicited by the use of the preemptive analgesia and 
the administration of Ketamine during and after surgery to prevent and lessen the processes 
involved in the development of neuropathic pain (70) even if some contrasting results have 
been published on the use of Ketamine for postoperative pain control (71). 
Patients treated with TEA in pre-empty modality with opioids and local anesthetics showed 
a lower incidence of chronic PTPS if compared to patients who received only intravenous 
opioids (72). Moreover, the exclusive intravenous administration of opioids may induce 
hyperalgesia and tolerance to opioids themselves, both processes NMDA receptors 
activation mediated (73). 
NMDA receptors antagonists may prevent the acute tolerance to opioids and, among them, 
ketamine at a blood concentration of 30-120 ng ml-1 is able to strengthen the nociceptives 
effects of opioids without altering sedation indexes (74). 
The preoperative administration of 0.1 mg/Kg epidural ketamine reduced the area affected 
by hyperalgesia and allodynia around the surgical wound in the first 30 days after incision; 
the same dosage given intramuscolarly did not produce the same effects (75). The 
limitations to these observations are that the neuropathic lesion and pain could appear after 
a period longer than expected (76). 
The administration of NMDA receptors inhibition is hampered by the need of a prolonged 
administration which could be more efficient via an oral route administration (77). 
7. Conclusions 
Many progresses have been done in the identification and the pathophysiological 
understanding of PTPS even if we are far from a well defined understanding of this 
syndrome. From the clinical point of view the priority resides on the continuous 
collaboration among anesthetists, surgeons, pharmacists and nurses to guarantee to any 
patient the best approach and the most correct pharmacological therapy.    
Multimodal analgesia using different modalities as regional and systemic analgesic 
techniques is highly recommended (61). 
In our opinion, pain unit in the management of patients undergoing thoracotomy is likely to 
warrant intensive and aggressive pain control with multimodal strategy in order to assure 
high level of comfort in the perioperative period and consequently reduce the incidence of 
PTPS.  
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